Citrus Sinensis ID: 037258
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | 2.2.26 [Sep-21-2011] | |||||||
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.978 | 0.782 | 0.511 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.975 | 0.783 | 0.516 | 0.0 | |
| O64483 | 876 | Senescence-induced recept | no | no | 0.974 | 0.783 | 0.515 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.941 | 0.778 | 0.504 | 0.0 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.981 | 0.780 | 0.456 | 1e-176 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.977 | 0.773 | 0.477 | 1e-174 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.973 | 0.785 | 0.477 | 1e-174 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.982 | 0.769 | 0.463 | 1e-172 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.964 | 0.779 | 0.450 | 1e-169 | |
| Q9SI06 | 892 | Putative leucine-rich rep | no | no | 0.977 | 0.771 | 0.460 | 1e-164 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/717 (51%), Positives = 483/717 (67%), Gaps = 28/717 (3%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
+RLLK++TYET +SL L +R+D G + VRYKDD++DR+W+P +P + + SL
Sbjct: 180 IRLLKSNTYETP--YDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASL 237
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID+ N F+PA VM+TA + E++S++ +I WEP DP +Y+VYMHF EV L +N+
Sbjct: 238 TIDSNNNEGFQPARFVMNTATSPEDLSQD-IIFSWEPKDPTWKYFVYMHFAEVVELPSNE 296
Query: 121 TREFNITQNGK-FYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEI 179
TREF + N K + P YLYT T PVSG ++E+ + T RSTL PI+NA+E
Sbjct: 297 TREFKVLLNEKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIET 356
Query: 180 YMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRII 239
Y V Q TD+ DV+A+ IKS YGVK++W GDPC P Y W +NCSY DN RII
Sbjct: 357 YRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRII 416
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
S+NLSSSGLTGEI F+NLT + LDLSNNSL+G P+FL L +L LNL+ NKL+G+
Sbjct: 417 SVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGA 476
Query: 300 LPADLVERSNNGSLTLSVDGNTSTTCSSESC-----KKKKHKFVVPVVVSVAAFSTVLFA 354
+P L+ERSN + L +DGN C S SC K KK+ +++P+V SV ++ A
Sbjct: 477 IPVKLLERSNKKLILLRIDGNPDL-CVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLA 535
Query: 355 LAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEV 414
+A+F ++R++R G R R + YSE+ K+TNNFERVLG+GGFG+V
Sbjct: 536 IALFLLYKKRHRRGGSG-----GVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKV 590
Query: 415 YHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469
YHG L+D+Q VAVK+LS S F+ +V+LL+RVHH+NLTALIGYC EG M LIY
Sbjct: 591 YHGVLNDDQ-VAVKILSESSAQGYKEFRA-EVELLLRVHHKNLTALIGYCHEGKKMALIY 648
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529
E+MA+GTL YL G+K ++L+W ERLQI++D+AQGLEYLH GCKPPIV RDVK +NIL+N
Sbjct: 649 EFMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILIN 708
Query: 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLE 589
EKLQAKIADFGLSR +++ ++Q +TAVAGT GYLDPEY++ L+EKSD+YSFGVVLLE
Sbjct: 709 EKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLE 768
Query: 590 IITGRRPVI--SRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALA 647
+++G +PVI SR + HI+ V+ ML+ GDIR IVDP L FD SAWK E+A+A
Sbjct: 769 VVSG-QPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMA 827
Query: 648 CASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
CAS +S RPTM+ V+ ELKE +S DP N D+ P AR
Sbjct: 828 CASSSSKNRPTMSHVVAELKESVSRARAGGGSGASSVTDP---AMTNFDSGMFPQAR 881
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/716 (51%), Positives = 479/716 (66%), Gaps = 29/716 (4%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LRLLKN+ YET S +SL L RR+D G+ + RYKDDI+DR WMP +P + L+TSL
Sbjct: 179 LRLLKNNIYETAS--DSLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSL 236
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID + N F P VMSTAV N S ++V+WEP DP ++Y+Y+HF EVE L +N+
Sbjct: 237 MIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNE 296
Query: 121 TREFNITQNGKFYIGPIV--PTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAME 178
TREF++ N + V P+YLYT T PVSG +E+++ +ST PI+NA+E
Sbjct: 297 TREFSVFLNKEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIE 356
Query: 179 IYMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRI 238
Y L TD++DV+A+ IK+ Y VK+NW GDPC P Y W G+NCSY NNP RI
Sbjct: 357 TYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRI 416
Query: 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
IS+NLS SGLTG+I P F LT ++ LDLSNN L+GT P+FL+ LP L LNL+ NKLTG
Sbjct: 417 ISVNLSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTG 476
Query: 299 SLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKK---HKFVVPVVVSVAAFSTVLFAL 355
LP L+ERS +GSL+L V GN C S+SC+ KK ++++P V SV +L AL
Sbjct: 477 ILPEKLLERSKDGSLSLRVGGNPDL-CVSDSCRNKKTERKEYIIPSVASVTGLFFLLLAL 535
Query: 356 AIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVY 415
F ++R + V + K R + YSEI +ITNNFERVLG+GGFG+VY
Sbjct: 536 ISFWQFKKRQQSV----------KTGPLDTK-RYYKYSEIVEITNNFERVLGQGGFGKVY 584
Query: 416 HGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470
+G L +QVA+KMLS S F+ +V+LL+RVHH+NL ALIGYC EG+ M LIYE
Sbjct: 585 YGVLR-GEQVAIKMLSKSSAQGYKEFRA-EVELLLRVHHKNLIALIGYCHEGDQMALIYE 642
Query: 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
Y+ +GTL YL GK +L+W ERLQI++D+AQGLEYLH GCKPPIVHRDVK +NIL+NE
Sbjct: 643 YIGNGTLGDYLSGKNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINE 702
Query: 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590
KLQAKIADFGLSR F++E Q+ST VAGT GYLDPE+Y + +EKSDVYSFGVVLLE+
Sbjct: 703 KLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEV 762
Query: 591 ITGRRPVISRAE-DDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACA 649
ITG +PVISR+ ++ HIS V+ ML++GDI++IVDP L F+ AWK E+ALACA
Sbjct: 763 ITG-QPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACA 821
Query: 650 SHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRM-VTLNLDTESSPSAR 704
S ++ R TM+ V+ ELKE L + + +P M V++ +D P R
Sbjct: 822 SESTKTRLTMSQVVAELKESLCRARTSGDSGDISFSEPTEMNVSMTVDPGVLPQPR 877
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/716 (51%), Positives = 477/716 (66%), Gaps = 30/716 (4%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPG-WKKLSTS 59
+RLL N+TYET ++L LLRR D+ RYKDDIYDR+W P+ +K L+TS
Sbjct: 179 IRLLLNTTYETP--YDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTS 236
Query: 60 LPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLAN 119
L +D N ++PA VMSTA T+ N S +L + + P DP +++YVYMHF E+EVL +N
Sbjct: 237 LTVDQFLNNGYQPASTVMSTAETARNESL-YLTLSFRPPDPNAKFYVYMHFAEIEVLKSN 295
Query: 120 QTREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEY-IINATERSTLQPILNAME 178
QTREF+I N YL T T ++ PVSG I + ++ L PI+NA+E
Sbjct: 296 QTREFSIWLNEDVISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALE 355
Query: 179 IYMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDN--NPS 236
+Y V Q+ T DV+A+R IK+TY VK+NWQGDPCVP +Y W+G++C DN NP
Sbjct: 356 VYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNP- 414
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
R++SLN+S S L G+I P F+NLT+I LDLS N+L+G P FL+ LP+L LN++ NKL
Sbjct: 415 RVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKL 474
Query: 297 TGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC---KKKKHKFVVPVVVSVAAFSTVLF 353
TG +P L ERS NGSL+L G C S+SC KKK + +V V +L
Sbjct: 475 TGIVPQRLHERSKNGSLSLRF-GRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLT 533
Query: 354 ALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGE 413
ALA+F RR K+ Q+ + RN R F YSE+ ITNNFERV+GKGGFG+
Sbjct: 534 ALALF----RRFKKKQQRGTLG--ERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGK 587
Query: 414 VYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468
VYHG ++ +QVAVK+LS F+ +V LLMRVHH NLT+L+GYC E N+M LI
Sbjct: 588 VYHGVIN-GEQVAVKVLSEESAQGYKEFRA-EVDLLMRVHHTNLTSLVGYCNEINHMVLI 645
Query: 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528
YEYMA+ L YL GK+ +L+W ERL+I++D+AQGLEYLH GCKPPIVHRDVK +NILL
Sbjct: 646 YEYMANENLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILL 705
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLL 588
NEKLQAK+ADFGLSR FS+E S QIST VAG+ GYLDPEYY +NEKSDVYS GVVLL
Sbjct: 706 NEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLL 765
Query: 589 EIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALAC 648
E+ITG +P I+ ++ + HIS V S+LA GDIR IVD L+ +D SAWK E+ALAC
Sbjct: 766 EVITG-QPAIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALAC 824
Query: 649 ASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
HTS++RPTM+ V+MELK+ + + E ++ D +M+T+NLDTE P AR
Sbjct: 825 TEHTSAQRPTMSQVVMELKQIVYGIVTDQENYD----DSTKMLTVNLDTEMVPRAR 876
|
Involved in innate immune response of plants. Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/682 (50%), Positives = 462/682 (67%), Gaps = 19/682 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR L N S +L+ RR+D S+ VRY DD+YDR+W+P+N+ ++++TSL
Sbjct: 175 LRFLGNDNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYCREINTSL 234
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVE--VLLA 118
P+ ++N N++ + VMSTA+T N + + E +DP +Y+VYMHF EVE L
Sbjct: 235 PVTSDN-NSYSLSSLVMSTAMTPINTTRPITMTL-ENSDPNVRYFVYMHFAEVEDLSLKP 292
Query: 119 NQTREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAME 178
NQTREF+I+ NG P YL T T + P S ++I + + T +STL PI+NA+E
Sbjct: 293 NQTREFDISINGVTVAAGFSPKYLQTNTFFLN-PESQSKIAFSLVRTPKSTLPPIVNALE 351
Query: 179 IYMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRI 238
IY+ + SQ LT+++D +A+ ++K++Y VK+NW GDPC+P +Y W+GLNCSY+ P RI
Sbjct: 352 IYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRI 411
Query: 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
SLNLSSSGLTG IS F+NLT I+ LDLSNN L+G PEFLSKL LR LNL+ N LTG
Sbjct: 412 TSLNLSSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTG 471
Query: 299 SLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKK-HKFVVPVVVSVAAFSTVLFALAI 357
S+P++L+ERSN GS +L + G C+ SC+K K V+P+V S AA +L +
Sbjct: 472 SVPSELLERSNTGSFSLRL-GENPGLCTEISCRKSNSKKLVIPLVASFAALFILLLLSGV 530
Query: 358 FCGLR-RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYH 416
F +R RRNK V + ++++ F ++++ K+TNNF +VLGKGGFG VYH
Sbjct: 531 FWRIRNRRNKSVNSAPQTSPMAKSEN----KLLFTFADVIKMTNNFGQVLGKGGFGTVYH 586
Query: 417 GSLDDNQQVAVKMLS--SSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472
G DN QVAVK+LS S+ F+ +V++L+RVHH NLTALIGY EG+ MGLIYE+M
Sbjct: 587 G-FYDNLQVAVKLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFM 645
Query: 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
A+G + +L GK +H L+W +RLQIA+D+AQGLEYLH GCKPPIVHRDVK+SNILLNEK
Sbjct: 646 ANGNMADHLAGKYQHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKN 705
Query: 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
+AK+ADFGLSR F ES +ST VAGTPGYLDP + N LNEKSD+YSFGVVLLE+IT
Sbjct: 706 RAKLADFGLSRSFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMIT 765
Query: 593 GRRPVISRAEDDTTHISQWVNSML-AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASH 651
G+ VI ++ H+S WV S+L + D+ N++D + +FD NS WK VELAL+ S
Sbjct: 766 GKT-VIKESQTKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQ 824
Query: 652 TSSERPTMTDVLMELKECLSLE 673
S+RP M ++ L ECL E
Sbjct: 825 NVSDRPNMPHIVRGLNECLQRE 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1592), Expect = e-176, Method: Compositional matrix adjust.
Identities = 333/730 (45%), Positives = 468/730 (64%), Gaps = 39/730 (5%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKS--VRYKDDIYDRLWMPKNYPGWKKLST 58
LR +K + Y TQS SL L R G I+N S +R+ DD+YDR W P W +++T
Sbjct: 169 LRPMKKNMYVTQS--GSLKYLFR---GYISNSSTRIRFPDDVYDRKWYPLFDDSWTQVTT 223
Query: 59 SLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLA 118
+L ++ + +VM+ A T ++ L + W P +Q+Y Y+H E++ L A
Sbjct: 224 NLKVNTSI--TYELPQSVMAKAATPIKANDT-LNITWTVEPPTTQFYSYVHIAEIQALRA 280
Query: 119 NQTREFNITQNGKFYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILNA 176
N+TREFN+T NG++ GP P L T + + P G R + T +STL P+LNA
Sbjct: 281 NETREFNVTLNGEYTFGPFSPIPLKTASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNA 340
Query: 177 MEIYMVKNSSQLLTDEDDVNALRNIKSTYGVKR-NWQGDPCVPKNYWWDGLNCSYED-NN 234
+E + V + Q+ T+E+DV ++N++ TYG+ R +WQGDPCVPK WDGLNC D +
Sbjct: 341 IEAFTVIDFPQMETNENDVAGIKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDIST 400
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
P I SL+LSSSGLTG I+ NLT ++ LDLS+N+L+G PEFL+ + SL +NL N
Sbjct: 401 PPIITSLDLSSSGLTGIITQAIKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGN 460
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC------KKKKHKFVVPVVVSVAAF 348
L+GS+P L+++ + L+V+GN C++ SC KK +VPVV S+A+
Sbjct: 461 NLSGSVPPSLLQKK---GMKLNVEGNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIASI 517
Query: 349 STVLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKS---------RQFAYSEIQKIT 399
+ ++ AL +F LR++ + + +D P+S R+F+YS++ +T
Sbjct: 518 AVLIGALVLFLILRKKRSPKVEGPPPSYMQASDGRLPRSSEPAIVTKNRRFSYSQVVIMT 577
Query: 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ----VKLLMRVHHRNLTAL 455
NNF+R+LGKGGFG VYHG ++ +QVAVK+LS S Q V+LL+RVHH+NL L
Sbjct: 578 NNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGL 637
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH-MLNWVERLQIAVDSAQGLEYLHYGCKP 514
+GYC EG+N+ LIYEYMA+G L +++ G + +LNW RL+I ++SAQGLEYLH GCKP
Sbjct: 638 VGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKP 697
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
P+VHRDVK++NILLNE +AK+ADFGLSR F IE +ST VAGTPGYLDPEY+ NWL
Sbjct: 698 PMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGYLDPEYHRTNWL 757
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634
EKSDVYSFG++LLEIIT R VI ++ + HI +WV ML +GDI++I+DPSL ++D
Sbjct: 758 TEKSDVYSFGILLLEIITNRH-VIDQSREK-PHIGEWVGVMLTKGDIQSIMDPSLNEDYD 815
Query: 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLN 694
+ S WKAVELA++C +H+S+ RPTM+ V++EL ECL+ E R V+L
Sbjct: 816 SGSVWKAVELAMSCLNHSSARRPTMSQVVIELNECLASENARGGASRDMESKSSIEVSLT 875
Query: 695 LDTESSPSAR 704
TE SP+AR
Sbjct: 876 FGTEVSPNAR 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 349/731 (47%), Positives = 472/731 (64%), Gaps = 43/731 (5%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLW--MPKNYPGWKKLST 58
+R L N +Y TQS SL L R F S ++ +RY +DI+DR+W + W +ST
Sbjct: 176 VRPLNNESYLTQS--GSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVW--IST 231
Query: 59 SLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLA 118
LPID N ++ +VM TA +N SE +L+ +W + +Q YVYMHF EV+ L A
Sbjct: 232 DLPIDTSN--SYDMPQSVMKTAAVPKNASEPWLL-WWTLDENTAQSYVYMHFAEVQNLTA 288
Query: 119 NQTREFNITQNGKF-YIGPIVPTYLYTTTALSSVPVSGAR--IEYIINATERSTLQPILN 175
N+TREFNIT NG + + P L +T + VS + + T STL P+LN
Sbjct: 289 NETREFNITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLN 348
Query: 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTYGV--KRNWQGDPCVPKNYWWDGLNCSYEDN 233
A+EIY V + QL T++D+V+A+ NIK TYG+ K +WQGDPC P+ Y W+GLNCSY D+
Sbjct: 349 ALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDS 408
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
SRIISLNL+ S LTG I+ + LT + LDLSNN LSG P F +++ SL+ +NL
Sbjct: 409 EGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSG 468
Query: 294 N---KLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFST 350
N LT ++P L +R N+ SLTL + N + T ES K +V + SVA
Sbjct: 469 NPNLNLT-AIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVP----MVAIAASVAGVFA 523
Query: 351 VLFALAIFCGLRRRNKRVGQK-----------VEMEFENRNDSFAPKSRQFAYSEIQKIT 399
+L LAIF ++R+N + + V+ E + N S + R+ Y E+ K+T
Sbjct: 524 LLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMT 583
Query: 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTA 454
NNFERVLGKGGFG VYHG+LD +VAVKMLS S F+ +V+LL+RVHHR+L
Sbjct: 584 NNFERVLGKGGFGTVYHGNLD-GAEVAVKMLSHSSAQGYKEFKA-EVELLLRVHHRHLVG 641
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCK 513
L+GYC +G+N+ LIYEYMA+G L + + GK+ ++L W R+QIAV++AQGLEYLH GC+
Sbjct: 642 LVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCR 701
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
PP+VHRDVK++NILLNE+ AK+ADFGLSR F I+ +ST VAGTPGYLDPEYY NW
Sbjct: 702 PPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNW 761
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633
L+EKSDVYSFGVVLLEI+T +PVI + + HI+ WV ML +GDI++IVDP L G++
Sbjct: 762 LSEKSDVYSFGVVLLEIVT-NQPVIDKTR-ERPHINDWVGFMLTKGDIKSIVDPKLMGDY 819
Query: 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTL 693
D N AWK VELALAC + +S+ RPTM V+MEL +C++LE R +G E+ + +L
Sbjct: 820 DTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGSEEMYSMGSVDYSL 879
Query: 694 NLDTESSPSAR 704
+ ++ +P AR
Sbjct: 880 SSTSDFAPGAR 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 611 bits (1576), Expect = e-174, Method: Compositional matrix adjust.
Identities = 342/716 (47%), Positives = 461/716 (64%), Gaps = 31/716 (4%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR L N+TY TQS SL R F S T +RY +DI+DR+W+ + G K +ST L
Sbjct: 176 LRPLNNNTYLTQS--GSLIGFARV-FFSATPTFIRYDEDIHDRVWVRQFGNGLKSISTDL 232
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
+D NP + AV TA N S+ LI W + SQ YVYMHF E++ L N
Sbjct: 233 LVDTSNP--YDVPQAVAKTACVPSNASQP-LIFDWTLDNITSQSYVYMHFAEIQTLKDND 289
Query: 121 TREFNITQNGKFYI-GPIVPTYLYTTTALSSVPVSGARIEYIINATE--RSTLQPILNAM 177
REFNIT NG + + P +T S P+S + ++ T+ STL P++N +
Sbjct: 290 IREFNITYNGGQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGL 349
Query: 178 EIYMVKNSSQLLTDEDDVNALRNIKSTYGV--KRNWQGDPCVPKNYWWDGLNCSYEDNNP 235
EIY V + +L TD+D+V+A+ NIK+TY + K +WQGDPC PK+Y W+GLNCSY +++
Sbjct: 350 EIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQ 409
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN- 294
RIISLNL+ + LTG I+P + LT + LDLS N LSG PEF + + L+ +NL N
Sbjct: 410 PRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNL 469
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFA 354
L ++P + +R ++ SL L + + T + + K K ++P+V SVA +L
Sbjct: 470 GLNSTIPDSIQQRLDSKSLILILSKTVTKTVTLKG--KSKKVPMIPIVASVAGVFALLVI 527
Query: 355 LAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEV 414
LAIF +RR+N + N S K R+ Y E+ K+TNNFERVLGKGGFG V
Sbjct: 528 LAIFFVVRRKNGESNKGT-------NPSIITKERRITYPEVLKMTNNFERVLGKGGFGTV 580
Query: 415 YHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469
YHG+L+D Q VAVKMLS S F+ +V+LL+RVHHRNL L+GYC +G+N+ LIY
Sbjct: 581 YHGNLEDTQ-VAVKMLSHSSAQGYKEFKA-EVELLLRVHHRNLVGLVGYCDDGDNLALIY 638
Query: 470 EYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528
EYMA+G L + + GK+ ++L W R+QIAV++AQGLEYLH GC PP+VHRDVK++NILL
Sbjct: 639 EYMANGDLKENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILL 698
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLL 588
NE+ AK+ADFGLSR F ++ +ST VAGTPGYLDPEYY NWL+EKSDVYSFGVVLL
Sbjct: 699 NERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLL 758
Query: 589 EIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALAC 648
EI+T +PV + + THI++WV SML +GDI++I+DP L G++D N AWK VELALAC
Sbjct: 759 EIVT-NQPVTDKTR-ERTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALAC 816
Query: 649 ASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
+ +S+ RPTM V+ EL EC++LE R +G E+ H + + +E SP AR
Sbjct: 817 VNPSSNRRPTMAHVVTELNECVALENARRQGREEMHTSGYVDFSRSSASEFSPGAR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1560), Expect = e-172, Method: Compositional matrix adjust.
Identities = 339/732 (46%), Positives = 468/732 (63%), Gaps = 40/732 (5%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPK-NYPGWKKLSTS 59
LR LKN+TY TQS SL RY F S + +++RY DD+ DR W P + W +L+T+
Sbjct: 180 LRPLKNNTYNTQS--GSLKYFFRYYF-SGSGQNIRYPDDVNDRKWYPFFDAKEWTELTTN 236
Query: 60 LPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLAN 119
L I++ N + P VM++A T + + + P+ +Q+YVYMHF E++ L +
Sbjct: 237 LNINSSN--GYAPPEVVMASASTPISTFGTWNFSWLLPSS-TTQFYVYMHFAEIQTLRSL 293
Query: 120 QTREFNITQNGKFYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILNAM 177
TREF +T NGK P L T T S P + T +STL P++NA+
Sbjct: 294 DTREFKVTLNGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNAL 353
Query: 178 EIYMVKNSSQLLTDEDDVNALRNIKSTYGV-KRNWQGDPCVPKNYWWDGLNCSYEDNN-P 235
E++ V + Q+ T+ DDV A+++I+STYG+ K +WQGDPCVPK + W+GLNC+ DN+ P
Sbjct: 354 EVFTVIDFPQMETNPDDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTP 413
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ SLNLSSS LTG I+ NLT ++ LDLSNN+L+G PEFL+ + SL +NL N
Sbjct: 414 PIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNN 473
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC-------KKKKHKFVVPVVVSVAAF 348
GS+P L+++ L L ++GN + C C KK V+P+V SVA
Sbjct: 474 FNGSIPQILLQKK---GLKLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVAFV 530
Query: 349 STVLFALAIFCGLRRRNKRVGQKVE----------MEFENRNDSFAPKSRQFAYSEIQKI 398
+ ALA F +++ Q + + + K+R+F YSE+ +
Sbjct: 531 VVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEVRTIRSSESAIMTKNRRFTYSEVVTM 590
Query: 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLT 453
TNNFERVLGKGGFG VYHG++++ +QVAVKMLS S F+ +V+LL+RVHH+NL
Sbjct: 591 TNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKA-EVELLLRVHHKNLV 649
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGC 512
L+GYC EG N+ LIYEYMA+G L +++ GK+ +LNW RL+I V+SAQGLEYLH GC
Sbjct: 650 GLVGYCDEGENLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGC 709
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
KPP+VHRDVK++NILLNE L AK+ADFGLSR F IE +ST VAGTPGYLDPEYY N
Sbjct: 710 KPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTN 769
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
WLNEKSDVYSFG+VLLEIIT + VI+++ + HI++WV ML +GDI+NI+DP L G+
Sbjct: 770 WLNEKSDVYSFGIVLLEIITNQL-VINQSREK-PHIAEWVGLMLTKGDIQNIMDPKLYGD 827
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVT 692
+D+ S W+AVELA++C + +S+ RPTM+ V++EL ECLS E R + + + V+
Sbjct: 828 YDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYENARGGTSQNMNSESSIEVS 887
Query: 693 LNLDTESSPSAR 704
+N D ++P AR
Sbjct: 888 MNFDIGATPDAR 899
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 328/728 (45%), Positives = 454/728 (62%), Gaps = 49/728 (6%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLW---MPKNYPGWKKLS 57
LR L + Y +S SL L R + ++ + Y DD++DR+W +P Y W+ L+
Sbjct: 169 LRPLADDIYTNES--GSLNYLFRVYYSNLKGY-IEYPDDVHDRIWKQILP--YQDWQILT 223
Query: 58 TSLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLL 117
T+L I+ N + VM TAVT S + W P SQ+Y+++HF E++ L
Sbjct: 224 TNLQINVSN--DYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQ 281
Query: 118 ANQTREFNITQNGKFYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILN 175
AN+TREFN+ NG P +L T S+ P G + + T RSTL P++N
Sbjct: 282 ANETREFNVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLIN 341
Query: 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTYGV-KRNWQGDPCVPKNYWWDGLNCS-YEDN 233
AME Y V + Q+ T+ D+V A++NI+STYG+ K WQGDPCVPK + WDGLNC+ +D+
Sbjct: 342 AMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSKTTWQGDPCVPKKFLWDGLNCNNSDDS 401
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
P I SLNLSSSGLTG I NL ++ LDLSNN+LSG PEFL+ + SL +NL
Sbjct: 402 TPPIITSLNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSGGVPEFLADMKSLLVINLSG 461
Query: 294 NKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHK-------FVVPVVVSVA 346
N L+G +P L+E+ L L+++GN C+ ESC K + +P+V S+
Sbjct: 462 NNLSGVVPQKLIEKK---MLKLNIEGNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASIG 518
Query: 347 AFSTVLFALAIFCGLRRRNKRVGQK-----VEMEFENRNDSFAPKSRQFAYSEIQKITNN 401
+ AL IFC +R+ N + + + + + K+++F Y+E+ +TNN
Sbjct: 519 SVVAFTVALMIFCVVRKNNPSNDEAPTSCMLPADSRSSEPTIVTKNKKFTYAEVLTMTNN 578
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ----VKLLMRVHHRNLTALIG 457
F+++LGKGGFG VY+GS++ +QVAVKMLS S Q V+LL+RVHH+NL L+G
Sbjct: 579 FQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVG 638
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
YC EG+ + LIYEYMA+G LD+++ GK+ +LNW RL+IA+++AQGLEYLH GCKP +
Sbjct: 639 YCEEGDKLALIYEYMANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLM 698
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNE 576
VHRDVK++NILLNE K+ADFGLSR F IE +ST VAGT GYLDPEYY NWL E
Sbjct: 699 VHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTE 758
Query: 577 KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636
KSDVYSFGVVLL +IT +PVI + + HI++WV ML +GDI++I DP+L G++++
Sbjct: 759 KSDVYSFGVVLLVMIT-NQPVIDQNREK-RHIAEWVGGMLTKGDIKSITDPNLLGDYNSG 816
Query: 637 SAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLD 696
S WKAVELA++C + +S RPTM+ V+ ELKECL+ E R V++
Sbjct: 817 SVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASE-------------SSREVSMTFG 863
Query: 697 TESSPSAR 704
TE +P AR
Sbjct: 864 TEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 580 bits (1494), Expect = e-164, Method: Compositional matrix adjust.
Identities = 335/728 (46%), Positives = 465/728 (63%), Gaps = 40/728 (5%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPK-NYPGWKKLSTS 59
LR L N TY TQS +L R Y S + + +RY +D+ DR W P + W +L+T+
Sbjct: 181 LRPLINDTYNTQS-GSLKYLFRNY--FSTSRRIIRYPNDVNDRHWYPFFDEDAWTELTTN 237
Query: 60 LPIDAENPNAFRPAPAVMSTAVT--SENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLL 117
L +++ N + P VM++A T S+N NF W +++Y YMHF +++ L
Sbjct: 238 LNVNSSN--GYDPPKFVMASASTPISKNAPFNFT---WSLIPSTAKFYSYMHFADIQTLQ 292
Query: 118 ANQTREFNITQNGKFYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILN 175
AN+TREF++ NG + P T T P G + + T +STL P+ +
Sbjct: 293 ANETREFDMMLNGNLALERYRPKTFATGTIYFIKPQICEGGQCIIELLKTSKSTLPPLCS 352
Query: 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTYGV-KRNWQGDPCVPKNYWWDGLNC--SYED 232
A+E++ V + +L T++DDV A++NI++TYGV K +WQGDPCVPK + WDGLNC SY
Sbjct: 353 ALEVFTVIDFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKRFMWDGLNCNNSYIS 412
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
P+ I LNLSSS LTG I+ NLT ++ LDLSNN+L+G PEFL+ L SL +NL
Sbjct: 413 TPPT-ITFLNLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPEFLAGLKSLLVINLS 471
Query: 293 RNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC-------KKKKHKFVVPVVVSV 345
N L+GS+P L+++ L L+++GN C SC KK VV VVVS+
Sbjct: 472 GNNLSGSVPQTLLQKK---GLKLNLEGNIYLNCPDGSCVSKDGNGGAKKKNVVVLVVVSI 528
Query: 346 AAFSTVLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERV 405
A + ALA+F R+R K +V + + + K+R+F YSE+ K+TNNFE++
Sbjct: 529 ALVVVLGSALALFLVFRKR-KTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMTNNFEKI 587
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCI 460
LGKGGFG VYHG+++D +QVAVKMLS S F+ +V+LL+RVHH+NL L+GYC
Sbjct: 588 LGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKA-EVELLLRVHHKNLVGLVGYCD 646
Query: 461 EGNNMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519
EG N+ LIYEYMA G L +++ G + +L+W RL+I +SAQGLEYLH GCKPP+VHR
Sbjct: 647 EGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHR 706
Query: 520 DVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSD 579
DVK++NILL+E QAK+ADFGLSR F +E ++ T VAGTPGYLDPEYY NWLNEKSD
Sbjct: 707 DVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSD 766
Query: 580 VYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAW 639
VYSFG+VLLEIIT + VI+++ + HI++WV ML +GDI++I+DP G++D S W
Sbjct: 767 VYSFGIVLLEIITNQH-VINQSREK-PHIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVW 824
Query: 640 KAVELALACASHTSSERPTMTDVLMELKECLSLEIVR---NEGHEKGHRDPRRMVTLNLD 696
+AVELA++C + +S+ RPTM+ V++EL ECL+ E R ++ E V+ N
Sbjct: 825 RAVELAMSCVNPSSTGRPTMSQVVIELNECLASENSRRGMSQNMESKGSIQYTEVSTNFG 884
Query: 697 TESSPSAR 704
TE +P AR
Sbjct: 885 TEYTPEAR 892
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | ||||||
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.991 | 0.789 | 0.554 | 0.0 | |
| 1321686 | 876 | light repressible receptor protein kinas | 0.984 | 0.791 | 0.554 | 0.0 | |
| 15233796 | 876 | Leucine-rich repeat transmembrane protei | 0.984 | 0.791 | 0.553 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.987 | 0.786 | 0.550 | 0.0 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.988 | 0.780 | 0.521 | 0.0 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.977 | 0.751 | 0.539 | 0.0 | |
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.988 | 0.785 | 0.526 | 0.0 | |
| 356522218 | 890 | PREDICTED: putative leucine-rich repeat | 0.982 | 0.777 | 0.513 | 0.0 | |
| 449463629 | 877 | PREDICTED: putative leucine-rich repeat | 0.982 | 0.789 | 0.516 | 0.0 | |
| 449516792 | 877 | PREDICTED: putative leucine-rich repeat | 0.982 | 0.789 | 0.514 | 0.0 |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/712 (55%), Positives = 495/712 (69%), Gaps = 14/712 (1%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR LKN+TYE +S +L R DFGS+TNK+VRY DD+YDR+W P +Y W LST
Sbjct: 179 LRPLKNTTYEIRSEG-ALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPE 237
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
IDA+ N F+P VMSTA N SE+ + F + D + Q+Y YMHF E+ L ANQ
Sbjct: 238 TIDAQFHNDFQPPSIVMSTANVPTNASED-MQFFIDNEDTSLQFYFYMHFAEIVKLEANQ 296
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
+R+FNI+ NG + GP++P YLYT++ + +P++ + + STL P+LNA+EIY
Sbjct: 297 SRQFNISLNGTIFFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIY 356
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
+ SQ TD+DDV+A+ IKSTYG+ RNWQGD C P+ Y W GLNCSY DN+P +I S
Sbjct: 357 FFVDLSQSQTDQDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITS 416
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGLTGEI ANL ++EFLDLSNNSLSG P+FLS++PSL+ LNL NKLTG +
Sbjct: 417 LNLSSSGLTGEIVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRI 476
Query: 301 PADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALAIFCG 360
P DL ER+ GSL LSV GN C S SCKKK+ + V V + S + A A+
Sbjct: 477 PVDLFERTQKGSLLLSVSGNPEL-CPSVSCKKKEKS--IAVPVVASVASVFILAAAVAVI 533
Query: 361 LRRRNKR-VGQKVEMEFENR-NDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGS 418
LR R R V + E + + N+ K++QF YSE+ KITNNFE+VLGKGGFG VY+G+
Sbjct: 534 LRYRILRSVSETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGT 593
Query: 419 LDDNQQVAVKMLSSSCCFQ----LLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474
L D QVAVK+LS S L +VKLLMRVHHRNLT L+G CIEG NMGLIYEYMA+
Sbjct: 594 LADGTQVAVKILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMAN 653
Query: 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA 534
G L+ YL G + L+W RL+IA+++ QGLEYLH GCK PIVHRDVK++NILLN+K QA
Sbjct: 654 GNLEDYLSGSNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQA 713
Query: 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR 594
KI+DFGLSRIF + +ST VAGTPGYLDPEYYV NWL +KSDVYSFGVVLLEIIT
Sbjct: 714 KISDFGLSRIFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITC- 772
Query: 595 RPVISRAED-DTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTS 653
RPVI++ + + +HISQWV+SM+ GD+ +I DP L G ++ NS WK VELA+ C S TS
Sbjct: 773 RPVIAQNRNHENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTS 832
Query: 654 SERPTMTDVLMELKECLSLEIVRN-EGHEKGHRDPRRMVTLNLDTESSPSAR 704
+ RPTM V++EL ECL E+ R EG +VT+N+DTESSP AR
Sbjct: 833 ARRPTMNQVVIELNECLKTEMARTREGQSTQSYYSIELVTVNVDTESSPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1321686|emb|CAA66376.1| light repressible receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/712 (55%), Positives = 486/712 (68%), Gaps = 19/712 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
+R LKN TY+T E+L L RR+DFG+ TN +RYKDD YDR+WMP P K L+TSL
Sbjct: 176 IRFLKNDTYDTP--YEALMLGRRWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSL 233
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID N N FRPA VM +A+ N S N L W P DP S++Y+YMHF EV L N+
Sbjct: 234 TIDETNHNGFRPASIVMRSAIAPGNES-NPLKFNWAPDDPRSKFYIYMHFAEVRELQRNE 292
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
TREF+I N P YL+T T + PV E ++ T STL PI+NA+EIY
Sbjct: 293 TREFDIYINDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIY 352
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPS-RII 239
+ QL TD+ DV+A+ IK Y VK+NWQGDPCVP + W+GL C + DNN S R I
Sbjct: 353 QINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPRSI 412
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+LNLSSSGLTG+I P FANLT+I LDLSNNSL+G P+FL+ LP+L LNL+ NKLTGS
Sbjct: 413 ALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGS 472
Query: 300 LPADLVERSNNGSLTLSVDGNTSTTCSSESCK---KKKHKFVVPVVVSVAAFSTVLFALA 356
+PA L+E+S +GSL+L GN C S SC+ KKK ++VPVV S+A VL ALA
Sbjct: 473 IPAKLLEKSKDGSLSLRFGGNPDL-CQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALA 531
Query: 357 IFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYH 416
+ ++R++R G R F YSE+ ITNNFERVLGKGGFG+VYH
Sbjct: 532 LIWHFKKRSRR-GTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYH 590
Query: 417 GSLDDNQQVAVKMLS--SSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472
G L+ +Q VAVK+LS S+ ++ +V+LLMRVHH NLT+LIGYC E N+M LIYEYM
Sbjct: 591 GFLNGDQ-VAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYM 649
Query: 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
A+G L YL GK +L+W ERLQI++D+AQGLEYLHYGCKPPIVHRDVK +NILLNE L
Sbjct: 650 ANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENL 709
Query: 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
QAKIADFGLSR F +E S Q+ST VAGT GYLDPEYY +NEKSDVYSFGVVLLE+IT
Sbjct: 710 QAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVIT 769
Query: 593 GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHT 652
G +P I + ++ H+S V SMLA GDI+ IVD L F+ SAWK ELALACAS +
Sbjct: 770 G-KPAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASES 828
Query: 653 SSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
S +RPTM+ V+MELK+ + + + H+DP RMVT+NLDTE P AR
Sbjct: 829 SEQRPTMSQVVMELKQSIFGRV----NNRSDHKDPVRMVTMNLDTEMVPRAR 876
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233796|ref|NP_194728.1| Leucine-rich repeat transmembrane protein kinase protein [Arabidopsis thaliana] gi|4938475|emb|CAB43834.1| serine/threonine-specific receptor protein kinase LRRPK [Arabidopsis thaliana] gi|7269899|emb|CAB80992.1| serine/threonine-specific receptor protein kinase LRRPK [Arabidopsis thaliana] gi|332660305|gb|AEE85705.1| Leucine-rich repeat transmembrane protein kinase protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/712 (55%), Positives = 486/712 (68%), Gaps = 19/712 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
+R LKN TY+T E+L L RR+DFG+ TN +RYKDD YDR+WMP P K L+TSL
Sbjct: 176 IRFLKNDTYDTP--YEALMLGRRWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSL 233
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID N N FRPA VM +A+ N S N L W P DP S++Y+YMHF EV L N+
Sbjct: 234 TIDETNHNGFRPASIVMRSAIAPGNES-NPLKFNWAPDDPRSKFYIYMHFAEVRELQRNE 292
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
TREF+I N P YL+T T + PV E ++ T STL PI+NA+EIY
Sbjct: 293 TREFDIYINDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIY 352
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPS-RII 239
+ QL TD+ DV+A+ IK Y VK+NWQGDPCVP + W+GL C + DNN S + I
Sbjct: 353 QINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSI 412
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+LNLSSSGLTG+I P FANLT+I LDLSNNSL+G P+FL+ LP+L LNL+ NKLTGS
Sbjct: 413 ALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGS 472
Query: 300 LPADLVERSNNGSLTLSVDGNTSTTCSSESCK---KKKHKFVVPVVVSVAAFSTVLFALA 356
+PA L+E+S +GSL+L GN C S SC+ KKK ++VPVV S+A VL ALA
Sbjct: 473 IPAKLLEKSKDGSLSLRFGGNPDL-CQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALA 531
Query: 357 IFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYH 416
+ ++R++R G R F YSE+ ITNNFERVLGKGGFG+VYH
Sbjct: 532 LIWHFKKRSRR-GTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYH 590
Query: 417 GSLDDNQQVAVKMLS--SSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472
G L+ +Q VAVK+LS S+ ++ +V+LLMRVHH NLT+LIGYC E N+M LIYEYM
Sbjct: 591 GFLNGDQ-VAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYM 649
Query: 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
A+G L YL GK +L+W ERLQI++D+AQGLEYLHYGCKPPIVHRDVK +NILLNE L
Sbjct: 650 ANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENL 709
Query: 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
QAKIADFGLSR F +E S Q+ST VAGT GYLDPEYY +NEKSDVYSFGVVLLE+IT
Sbjct: 710 QAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVIT 769
Query: 593 GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHT 652
G +P I + ++ H+S V SMLA GDI+ IVD L F+ SAWK ELALACAS +
Sbjct: 770 G-KPAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASES 828
Query: 653 SSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
S +RPTM+ V+MELK+ + + + H+DP RMVT+NLDTE P AR
Sbjct: 829 SEQRPTMSQVVMELKQSIFGRV----NNRSDHKDPVRMVTMNLDTEMVPRAR 876
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/716 (55%), Positives = 499/716 (69%), Gaps = 21/716 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR LKN+TY QS A L R D GS+TNK+VRY DD++DR+W P ++ W LST
Sbjct: 178 LRPLKNTTYVAQSGA--LVKSTRLDLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLSTPD 235
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
+DA+N F+P VM TA N SEN + + + D S +YVYMHF E+ L ANQ
Sbjct: 236 TVDAQNHIDFQPPSVVMRTANMPTNASEN-MEFYIDIDDTTSLFYVYMHFAEIVELQANQ 294
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
+R FNI+ NG + GP++P +L + T S P+ G + + E STL P+LNA+EIY
Sbjct: 295 SRLFNISLNGTIWYGPVIPNHLSSGTVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIY 354
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
V + SQ TD+DDV+A+ IKSTYG+ +NWQGDPC P+ Y W GLNCSY D++P + S
Sbjct: 355 FVVDLSQSETDQDDVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKS 414
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGL GEI ANL ++E LDLSNNSLSG+ P+FLS++ SL+ LNL NKLTG++
Sbjct: 415 LNLSSSGLRGEIVSEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTI 474
Query: 301 PADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALAIFCG 360
PADL ERS GSL LSV GN C S SC KKK VVPVV SV AF + A A+
Sbjct: 475 PADLFERSQQGSLLLSVSGNPE-LCPSVSCTKKKKSVVVPVVASVVAF--FILAAALVVI 531
Query: 361 LRR---RNKRVGQKVEMEFENRNDSFA-PKSRQFAYSEIQKITNNFERVLGKGGFGEVYH 416
LR R++ + ++ +E ++ K RQF+YSEI KITNNF+++LGKGGFG VYH
Sbjct: 532 LRYFFVRSQAKTNEAKISYETNDEPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYH 591
Query: 417 GSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471
G+L+D QVAVK+LS S FQ +VKLL+RVHHRNLT L+GYC EG N+GLIYEY
Sbjct: 592 GTLNDGTQVAVKVLSLSSAQGYKEFQ-AEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEY 650
Query: 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531
MA+G L+ YL + L+W RL+IA ++AQGLEYLH GCKP IVHRDVK++NILLN+K
Sbjct: 651 MANGNLEDYLSDSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDK 710
Query: 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEII 591
QAK+ADFGLSRIF ++ S IST VAGTPGYLDPEYYV NWL +KSDV+SFGVVLLEII
Sbjct: 711 FQAKLADFGLSRIFPVDGSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEII 770
Query: 592 TGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASH 651
TG RP I++ + THISQWV+SML +GDI IVDP L G+F+ NS WKA ELA+ C S
Sbjct: 771 TG-RPAIAQTR-ERTHISQWVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSA 828
Query: 652 TSSERPTMTDVLMELKECLSLEIVRN-EGHEKGHRDPR--RMVTLNLDTESSPSAR 704
+S+ RPTM ++EL +CL++E+ R EG + ++T+N+ TE+SP AR
Sbjct: 829 SSARRPTMNQAVVELNDCLNIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/723 (52%), Positives = 495/723 (68%), Gaps = 27/723 (3%)
Query: 2 RLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSLP 61
R LKN TY T+S + L L R D GS+ N+ VRY +D+YDR W P ++ +ST+L
Sbjct: 177 RPLKNGTYVTESGSLGLALFTREDVGSLNNRIVRYPNDVYDRRWFPYHFKRGTDISTTLT 236
Query: 62 IDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQT 121
+D ++ N F+P VM +AV S N S + F+ D + Y YMHF E+ L ANQ+
Sbjct: 237 VDLDDHNDFQPPSIVMRSAVISINTSSP--LEFYINNDTTYKLYAYMHFAEIVKLEANQS 294
Query: 122 REFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIYM 181
R+FNI+ NGK + GP+ PTYLYTTT S+ ++ E+ ++ E S L P+LNA+E+Y
Sbjct: 295 RQFNISLNGKIWYGPVTPTYLYTTTVYSTSAITDGMYEFSLSKVEGSALPPLLNAIELYY 354
Query: 182 VKNSSQLLTDEDDVNALRNIKSTYGVKR-NWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
V + Q T++ DV + NIKSTY + R NWQGDPC P+++ W+GL+C Y + IIS
Sbjct: 355 VVDLLQPETNQRDVIGIMNIKSTYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIIS 414
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGL GEI+P ANL ++E LDLSNN+L+ P+FLS+L SL+ LNL N+L G++
Sbjct: 415 LNLSSSGLHGEIAPDIANLKSLEILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTI 474
Query: 301 PADLVERSNNGSLTLSVDGN----TSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALA 356
P DL++R+++G LTLSVDGN S +C+ + KKK F+VPVV SVAA ++ L
Sbjct: 475 PDDLLKRADSG-LTLSVDGNPELCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLT 533
Query: 357 IFCGLRRRNKR--------VGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGK 408
L+RR ++ + + E E + ++ RQF YS++ KITNNF VLG+
Sbjct: 534 TIWYLKRRKQKGTYLHKYILAGRTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGR 593
Query: 409 GGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGN 463
GGFG VYHG LDD +VAVKMLS S F +V+LL+RVHH+NLT L+GYC EGN
Sbjct: 594 GGFGTVYHGYLDD-VEVAVKMLSPSSVQGYKEFHA-EVRLLLRVHHKNLTTLVGYCDEGN 651
Query: 464 NMGLIYEYMASGTLDQYLKG-KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522
NMGLIYEYMA+G L +L G +L+W RLQIA+++AQGL+YLH GCKPPIVHRDVK
Sbjct: 652 NMGLIYEYMANGNLKHHLSGCDHPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVK 711
Query: 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYS 582
++NILLN++ QAK+ADFGLSR F +E +ST VAGTPGYLDP+YYV NWL EKSDVYS
Sbjct: 712 TTNILLNDRFQAKLADFGLSRTFPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYS 771
Query: 583 FGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAV 642
+GVVLLEIIT RPVI+R D TH+SQWV +ML +GDI+NIVDP L+G+FDNNS WK
Sbjct: 772 YGVVLLEIITS-RPVIARTRDK-THVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVT 829
Query: 643 ELALACASHTSSERPTMTDVLMELKECLSLEIVR-NEGHEKGHRDPRRMVTLNLDTESSP 701
ELA+AC S TS ERP+M+ V+MEL +CL+ E+ R EG +++L+L T SP
Sbjct: 830 ELAMACLSTTSGERPSMSQVVMELNDCLTTEMARAREGRSTQSSSSVEVISLHLHTGVSP 889
Query: 702 SAR 704
AR
Sbjct: 890 LAR 892
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/708 (53%), Positives = 497/708 (70%), Gaps = 20/708 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR ++ S Y T SL SL R D GS TN+++RY DD+YDR+W P ++ W ++STS
Sbjct: 205 LRPIRISAYST-SLG-SLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTSE 262
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
IDA N +RP VM TA N +E + V + D ++ VYMHF E+ L AN+
Sbjct: 263 TIDALAQNDYRPPSIVMRTAGIPANDNEP-MTVSIDFEDTTFRFLVYMHFAEILKLEANE 321
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
+R+FNI+ NG+ + GP+ P YLYTTT S +SG + E+ I TE STL P+LNA+EIY
Sbjct: 322 SRQFNISLNGEHWFGPLRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEIY 381
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
+ + SQ ++++DV+A+ NIKS+YG+KRNWQGDPC P+ Y W+GLNCSY N RIIS
Sbjct: 382 YILDLSQPQSNQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIIS 441
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGLTGEI ++LT++E LDLSNN L+G+ P+FLS+LPSL L L N+L+GS+
Sbjct: 442 LNLSSSGLTGEIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSV 501
Query: 301 PADLVERSNNGSLTLSVDGNTSTTCSSESCK-KKKHKFVVPVVVSVAAFSTVLFALAIFC 359
P LVE+S L LSV GN + C SCK +KK+ VVPVV S+A ++ ALA
Sbjct: 502 PPSLVEKSEQNLLVLSVGGN-ANLCLKSSCKNEKKNNVVVPVVASIAGVLIIISALAAIL 560
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL 419
R+R K+ Q+ + + N K RQF YSEI ITNNFERVLGKGGFG VYHG L
Sbjct: 561 YTRKRRKQ--QEEDTKTSNIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYL 618
Query: 420 DDNQQVAVKMLS--SSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475
DD QVAVK+LS S+ ++ +VKLL+RVHHRNLT+L+G+C EG MGLIYEYMA+G
Sbjct: 619 DDT-QVAVKILSPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANG 677
Query: 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535
L+ L G+ H+L W RL IAV++A+GLEYLH GCKPPIVHRD+K++NILLN++ QA+
Sbjct: 678 DLEHLLSGRNRHVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQAR 737
Query: 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRR 595
+ADFGLS+ F +E +ST VAGTPGYLDPEY + NWL EKSDVYSFGVVLL+IITG R
Sbjct: 738 LADFGLSKSFPVEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITG-R 796
Query: 596 PVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSE 655
PVI+ ++ + HIS WV+S++A GDI+ ++DP L G+FD NS WKAVE+A+AC S TS+
Sbjct: 797 PVIAVIDERSIHISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTSAG 856
Query: 656 RPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSA 703
RPTM V+ EL E L+ E R E+GH+ + +V + TES+P A
Sbjct: 857 RPTMNQVVRELIESLAEETAR---AEEGHKT-KSIVMM---TESTPLA 897
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/718 (52%), Positives = 489/718 (68%), Gaps = 22/718 (3%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR LKN TY ++S SL L R D SITN++VRY DD+YDR W P ++ W +ST+
Sbjct: 177 LRPLKNGTYVSES--GSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDISTTE 234
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID N+++ VM +A T N S + DP ++Y Y HF E+ L ANQ
Sbjct: 235 TIDLGKSNSYQLPSTVMRSAGTPRNSSSPMEVTI-AAEDPTLKFYAYFHFAEIVKLDANQ 293
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
+REFNIT NG + GPI YLY+TT S +SG ++ I STL P+LNA+E+Y
Sbjct: 294 SREFNITLNGDIWYGPITLHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLNAVEVY 353
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
+ QL T ++DV A+ IKSTY + RNWQGDPC P++Y W+GL C+Y ++ IIS
Sbjct: 354 YIVELLQLETKQEDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVIIS 413
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L+LSSSGLTG++ P FANL ++E LDLSNNSL+G P+FLS+L SL+ L+L NKLTG +
Sbjct: 414 LDLSSSGLTGDVPPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTGII 473
Query: 301 PADLVERSNNGSLTLSVDGNTSTTCSSESCK------KKKHKFVVPVVVSVAAFSTVLFA 354
P DL +RS +G L LS GN C+S SC KK + FVVPVV S+AA ++ A
Sbjct: 474 PDDLFKRSQSGLLLLSFGGNPE-LCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVAA 532
Query: 355 LAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEV 414
L I C RRR ++V + E + + + ++R+F YSE+ K+T NFE VLG+GGFG V
Sbjct: 533 LTIICCCRRRKQQVARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFGTV 592
Query: 415 YHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469
Y+G L D +VAVK+LS+S F+ +VKLL+RVHH+NLT L+GYC EG NM LIY
Sbjct: 593 YYGYLGD-IEVAVKVLSTSSVQGYKEFE-AEVKLLLRVHHKNLTTLVGYCDEGGNMILIY 650
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529
EYMA+G L Q+L G+ +L+W RL+IA+++AQGLEYLH GCKPPIVHRDVK++NILL+
Sbjct: 651 EYMANGNLRQHLSGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLD 710
Query: 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLE 589
+K QAK+ADFGLSR+F E +ST VAGTPGYLDPEYYV NWL EKSDVYSFGVVLLE
Sbjct: 711 DKFQAKLADFGLSRMFPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLE 770
Query: 590 IITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACA 649
IIT R VIS+ + TH+SQWV ML GDI+NIVD L G+FD N+AWKA ELA+AC
Sbjct: 771 IITSRS-VISQTSEK-THVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACV 828
Query: 650 SHTSSERPTMTDVLMELKECLSLEIVRN-EGHEKGHRDPR-RMVTLN-LDTESSPSAR 704
S TS+ERP+M+ V+MEL ECL E+ R EG+ + ++++N L T SP +R
Sbjct: 829 SATSTERPSMSQVVMELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522218|ref|XP_003529744.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/728 (51%), Positives = 483/728 (66%), Gaps = 36/728 (4%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR L N+ Y T S AESL +RYD GSITN RY D+YDR+W+P W +LS++L
Sbjct: 175 LRTLNNAFYVTAS-AESLAYYQRYDLGSITNLGYRYNYDVYDRIWVPHGLNQWTQLSSTL 233
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
+ N ++ VMSTA T N S F +W P + ++Y+YMHF EVE+L N+
Sbjct: 234 HLLDIFQNDYKLPEVVMSTAATPINASAPFQF-YWGPDNVDDKFYIYMHFSEVEILAENE 292
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGA-RIEYIINATERSTLQPILNAMEI 179
TR FNI NGK + GP+ P YL T T + ++GA R + + T STL PI+NAMEI
Sbjct: 293 TRTFNIFMNGKLFYGPLTPGYLTTNTIYAKSALTGATRYLFSLAKTGTSTLPPIINAMEI 352
Query: 180 YMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRII 239
Y V + Q T++DDV+A+ NIK+ YGV RNWQGDPC P Y W+GLNCSY DN P RI
Sbjct: 353 YKVIDFPQSETEQDDVDAITNIKNAYGVDRNWQGDPCGPVAYIWEGLNCSY-DNTP-RIT 410
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SLNLSSSGLTG+IS + + LT +++LDLSNNSLSG+ P+FL++L SL+ LNL N LTG
Sbjct: 411 SLNLSSSGLTGQISSFISELTMLQYLDLSNNSLSGSLPDFLTQLQSLKVLNLVNNNLTGP 470
Query: 300 LPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHK--------------FVVPVVVSV 345
+P LVERS GSL+LS+ G C S+ C ++ + V+P SV
Sbjct: 471 VPGGLVERSKEGSLSLSL-GQNPNLCESDPCIQQSNNKQPDAANQNKNKNNIVIPAATSV 529
Query: 346 AAFST--VLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE 403
A ++ AI CGL++R K G+ FA K RQ++++E+ KIT++F
Sbjct: 530 AGILVLVIIVVTAIICGLKKR-KPQGKATNTP---SGSQFASKQRQYSFNELVKITDDFT 585
Query: 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ----LLQVKLLMRVHHRNLTALIGYC 459
R+LG+G FG+VYHG +DD Q VAVKMLS S L +VKLLMRVHHRNLT+L+GYC
Sbjct: 586 RILGRGAFGKVYHGIIDDTQ-VAVKMLSPSAVRGYEQFLAEVKLLMRVHHRNLTSLVGYC 644
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
E NNMGLIYEYMA+G LD+ L GK + L W +RLQIA+D+AQGLEYLH GCKPPI+
Sbjct: 645 NEENNMGLIYEYMANGNLDEILSGKSSRAKFLTWEDRLQIALDAAQGLEYLHNGCKPPII 704
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRDVK +NILLNE QAK+ADFGLS+ F + +ST VAGTPGYLDPEY + + L EK
Sbjct: 705 HRDVKCANILLNENFQAKLADFGLSKSFPTDGGSYMSTVVAGTPGYLDPEYSISSRLTEK 764
Query: 578 SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637
SDVYSFGVVLLE++TG +P I++ + THISQWV ML GDI+NI D LQ +FD +S
Sbjct: 765 SDVYSFGVVLLEMVTG-KPAIAKTPEK-THISQWVKFMLPNGDIKNIADSRLQEDFDTSS 822
Query: 638 AWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRN-EGHEKGHRDPRRMVTLNLD 696
W+ VE+ +A S + +RP+M++++ ELKECL+ E+ R G + + D +VTLN
Sbjct: 823 VWRVVEIGMASVSISPVKRPSMSNIVNELKECLTTELARKYSGRDTENNDSIELVTLNFT 882
Query: 697 TESSPSAR 704
TE P AR
Sbjct: 883 TELGPPAR 890
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463629|ref|XP_004149534.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/712 (51%), Positives = 497/712 (69%), Gaps = 20/712 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LRLLKN++Y T + L L RR D GS N++VRY DDI DR+W+P N+ +K ++TS
Sbjct: 178 LRLLKNASYVTD--FDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSS 235
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
+D+ N++ VMSTA+T+ N S+ L W P DP+++Y++++HF ++E L ANQ
Sbjct: 236 TVDSGGSNSYNLPGIVMSTAITTYNASDP-LEFHWVPEDPSARYHIFLHFADLEKLQANQ 294
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
REFNI QNG ++ GP P YL +TT S+ P+SG I + + T S L PILNA+EIY
Sbjct: 295 LREFNIYQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEIY 354
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
+V ++ Q TDE D+ AL NIKS YGV++NWQGDPC PK++ WDGL CSY+D P+RI +
Sbjct: 355 LVLDTLQSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITT 414
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGL GEI+ Y + LT +++LDLSNN+LSG P+ LSKL SL+ L+L+ N L GS+
Sbjct: 415 LNLSSSGLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSI 474
Query: 301 PADLVERSNNGSLTLSVD-GNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALAIFC 359
P++LVERS NGSL++ V G + C+S SC KKK +V+ +V V++F +L A ++
Sbjct: 475 PSELVERSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAATSVLI 534
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL 419
L R+ R + R + K +Q +YSEI++ITNNFER +G+GGF +V+ G+L
Sbjct: 535 ILWRKRARKQPVI------RLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNL 588
Query: 420 DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475
DD+ QVAVK+L SS F+ +VKLL+R+HHRNLT+L+GYC + N+ LIYEY+ +G
Sbjct: 589 DDS-QVAVKVLKSSVQGYKEFE-AEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNG 646
Query: 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535
L ++L G K +L+W ER+Q+AV+SAQGLEYLH+GC+PPIVHRDVKS+NILLNE+ QAK
Sbjct: 647 NLKEHLSGSKGSVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAK 706
Query: 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRR 595
IADFGLS+ F ES ++T VAGT GYLDPEYY WL EKSDVYSFGV++LEI+T R
Sbjct: 707 IADFGLSKSFPTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTS-R 765
Query: 596 PV--ISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTS 653
PV I RA HISQWV ++ GDIR+IVD ++ NFD +SAWKAVE+A+ C S S
Sbjct: 766 PVLMIDRASSQKYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNS 825
Query: 654 SERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNL-DTESSPSAR 704
+RP M +V+ EL ECL+LE R + V+ N ++E +P AR
Sbjct: 826 IDRPNMKEVVSELSECLALEKARKRKNADTDMRKSNPVSRNFRESEVTPFAR 877
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516792|ref|XP_004165430.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/712 (51%), Positives = 496/712 (69%), Gaps = 20/712 (2%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LRLLKN++Y T + L L RR D GS N++VRY DDI DR+W+P N+ +K ++TS
Sbjct: 178 LRLLKNASYVTD--FDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSS 235
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
+D+ N++ VMSTA+T+ N S+ L W P DP+++Y++++HF ++E L ANQ
Sbjct: 236 TVDSGGSNSYNLPGIVMSTAITTYNASDP-LEFHWVPEDPSARYHIFLHFADLEKLQANQ 294
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
REFNI QNG ++ GP P YL +TT S+ P+SG I + + T S L PILNA+E+Y
Sbjct: 295 LREFNIYQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEVY 354
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
+V ++ Q TDE D+ AL NIKS YGV++NWQGDPC PK++ WDGL CSY+D P+RI +
Sbjct: 355 LVLDTLQSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITT 414
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LNLSSSGL GEI+ Y + LT +++LDLSNN+LSG P+ LSKL SL+ L+L+ N L GS+
Sbjct: 415 LNLSSSGLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSI 474
Query: 301 PADLVERSNNGSLTLSVD-GNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALAIFC 359
P++L+ERS NGSL++ V G + C+S SC KKK +V+ +V V++F +L A ++
Sbjct: 475 PSELMERSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAATSVLI 534
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL 419
L R+ R + R + K +Q +YSEI++ITNNFER +G+GGF +V+ G+L
Sbjct: 535 ILWRKRARKQPVI------RLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNL 588
Query: 420 DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475
DD QVAVK+L SS F+ +VKLL+R+HHRNLT+L+GYC + N+ LIYEY+ +G
Sbjct: 589 DDG-QVAVKVLKSSVQGYKEFE-AEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNG 646
Query: 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535
L ++L G K +L+W ER+Q+AV+SAQGLEYLH+GC+PPIVHRDVKS+NILLNE+ QAK
Sbjct: 647 NLKEHLSGSKASVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAK 706
Query: 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRR 595
IADFGLS+ F ES ++T VAGT GYLDPEYY WL EKSDVYSFGV++LEI+T R
Sbjct: 707 IADFGLSKSFPTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTS-R 765
Query: 596 PV--ISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTS 653
PV I RA HISQWV ++ GDIR+IVD ++ NFD +SAWKAVE+A+ C S S
Sbjct: 766 PVLMIDRASSQKYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNS 825
Query: 654 SERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNL-DTESSPSAR 704
+RP M +V+ EL ECL+LE R + V+ N ++E +P AR
Sbjct: 826 IDRPNMKEVVSELSECLALEKARKRKNADTDMRKSNPVSRNFRESEVTPFAR 877
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | ||||||
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.984 | 0.791 | 0.535 | 5.8e-185 | |
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.448 | 0.353 | 0.570 | 9.2e-178 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.980 | 0.783 | 0.497 | 3.7e-174 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.974 | 0.783 | 0.505 | 3.1e-170 | |
| TAIR|locus:2066143 | 786 | AT2G28970 [Arabidopsis thalian | 0.947 | 0.848 | 0.451 | 3.6e-153 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.981 | 0.781 | 0.456 | 6.7e-152 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.978 | 0.775 | 0.444 | 4.7e-151 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.978 | 0.772 | 0.445 | 3.3e-150 | |
| TAIR|locus:2078176 | 878 | MEE39 "maternal effect embryo | 0.970 | 0.777 | 0.443 | 2.3e-149 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.941 | 0.756 | 0.459 | 5.2e-149 |
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1794 (636.6 bits), Expect = 5.8e-185, P = 5.8e-185
Identities = 381/712 (53%), Positives = 465/712 (65%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
+R LKN TY+T E+L L RR+DFG+ TN +RYKDD YDR+WMP P K L+TSL
Sbjct: 176 IRFLKNDTYDTPY--EALMLGRRWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSL 233
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID N N FRPA VM +A+ N S N L W P DP S++Y+YMHF EV L N+
Sbjct: 234 TIDETNHNGFRPASIVMRSAIAPGNES-NPLKFNWAPDDPRSKFYIYMHFAEVRELQRNE 292
Query: 121 TREFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIY 180
TREF+I N P YL+T T + PV E ++ T STL PI+NA+EIY
Sbjct: 293 TREFDIYINDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIY 352
Query: 181 MVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPS-RII 239
+ QL TD+ DV+A+ IK Y VK+NWQGDPCVP + W+GL C + DNN S + I
Sbjct: 353 QINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSI 412
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+LNLSSSGLTG+I P FANLT+I LDLSNNSL+G P+FL+ LP+L LNL+ NKLTGS
Sbjct: 413 ALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGS 472
Query: 300 LPADLVERSNNGSLTLSVDGNXXXXXXXXXXXXXXXXXXXXX--XXXXXXXXXXLFALAI 357
+PA L+E+S +GSL+L GN L ALA+
Sbjct: 473 IPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALAL 532
Query: 358 FCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHG 417
++R++R G R F YSE+ ITNNFERVLGKGGFG+VYHG
Sbjct: 533 IWHFKKRSRR-GTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHG 591
Query: 418 SLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472
L+ +Q VAVK+LS F+ +V+LLMRVHH NLT+LIGYC E N+M LIYEYM
Sbjct: 592 FLNGDQ-VAVKILSEESTQGYKEFRA-EVELLMRVHHTNLTSLIGYCNEDNHMALIYEYM 649
Query: 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
A+G L YL GK +L+W ERLQI++D+AQGLEYLHYGCKPPIVHRDVK +NILLNE L
Sbjct: 650 ANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENL 709
Query: 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
QAKIADFGLSR F +E S Q+ST VAGT GYLDPEYY +NEKSDVYSFGVVLLE+IT
Sbjct: 710 QAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVIT 769
Query: 593 GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHT 652
G+ P I + ++ H+S V SMLA GDI+ IVD L F+ SAWK ELALACAS +
Sbjct: 770 GK-PAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASES 828
Query: 653 SSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
S +RPTM+ V+MELK+ I + H+DP RMVT+NLDTE P AR
Sbjct: 829 SEQRPTMSQVVMELKQ----SIFGRVNNRSDHKDPVRMVTMNLDTEMVPRAR 876
|
|
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 9.2e-178, Sum P(2) = 9.2e-178
Identities = 186/326 (57%), Positives = 240/326 (73%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ----V 441
K+R+ Y ++ KITNNFERVLG+GGFG VY+G L+ N+ VAVKML+ S Q V
Sbjct: 572 KNRKLTYIDVVKITNNFERVLGRGGFGVVYYGVLN-NEPVAVKMLTESTALGYKQFKAEV 630
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVD 500
+LL+RVHH++LT L+GYC EG+ M LIYE+MA+G L ++L GK+ +L W RL+IA +
Sbjct: 631 ELLLRVHHKDLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAE 690
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
SAQGLEYLH GCKP IVHRD+K++NILLNEK QAK+ADFGLSR F + + +ST VAGT
Sbjct: 691 SAQGLEYLHNGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGT 750
Query: 561 PGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620
PGYLDPEYY NWL EKSDV+SFGVVLLE++T + PVI + + HI++WV ML+ GD
Sbjct: 751 PGYLDPEYYRTNWLTEKSDVFSFGVVLLELVTNQ-PVIDMKREKS-HIAEWVGLMLSRGD 808
Query: 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680
I +IVDP LQG+FD N+ WK VE A+ C + +SS RPTMT V+M+LKECL++E+ RN G
Sbjct: 809 INSIVDPKLQGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNMEMARNMGS 868
Query: 681 EK--GHRDPRRMVTLNLDTESSPSAR 704
D +++N TE +P AR
Sbjct: 869 RMTDSTNDSSIELSMNFTTELNPGAR 894
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1692 (600.7 bits), Expect = 3.7e-174, P = 3.7e-174
Identities = 356/716 (49%), Positives = 469/716 (65%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
+RLLK++TYET +SL L +R+D G + VRYKDD++DR+W+P +P + + SL
Sbjct: 180 IRLLKSNTYETPY--DSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASL 237
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
ID+ N F+PA VM+TA + E++S++ +I WEP DP +Y+VYMHF EV L +N+
Sbjct: 238 TIDSNNNEGFQPARFVMNTATSPEDLSQD-IIFSWEPKDPTWKYFVYMHFAEVVELPSNE 296
Query: 121 TREFNITQNGK-FYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEI 179
TREF + N K + P YLYT T PVSG ++E+ + T RSTL PI+NA+E
Sbjct: 297 TREFKVLLNEKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIET 356
Query: 180 YMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRII 239
Y V Q TD+ DV+A+ IKS YGVK++W GDPC P Y W +NCSY DN RII
Sbjct: 357 YRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRII 416
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
S+NLSSSGLTGEI F+NLT + LDLSNNSL+G P+FL L +L LNL+ NKL+G+
Sbjct: 417 SVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGA 476
Query: 300 LPADLVERSNNGSLTLSVDGN----XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLFAL 355
+P L+ERSN + L +DGN + A+
Sbjct: 477 IPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI 536
Query: 356 AIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVY 415
A+F ++R++R G R R + YSE+ K+TNNFERVLG+GGFG+VY
Sbjct: 537 ALFLLYKKRHRRGGSGGV-----RAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVY 591
Query: 416 HGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470
HG L+D+Q VAVK+LS S F+ +V+LL+RVHH+NLTALIGYC EG M LIYE
Sbjct: 592 HGVLNDDQ-VAVKILSESSAQGYKEFRA-EVELLLRVHHKNLTALIGYCHEGKKMALIYE 649
Query: 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
+MA+GTL YL G+K ++L+W ERLQI++D+AQGLEYLH GCKPPIV RDVK +NIL+NE
Sbjct: 650 FMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINE 709
Query: 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590
KLQAKIADFGLSR +++ ++Q +TAVAGT GYLDPEY++ L+EKSD+YSFGVVLLE+
Sbjct: 710 KLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEV 769
Query: 591 ITGRRPVISRAED--DTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALAC 648
++G+ PVI+R+ + HI+ V+ ML+ GDIR IVDP L FD SAWK E+A+AC
Sbjct: 770 VSGQ-PVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMAC 828
Query: 649 ASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
AS +S RPTM+ V+ ELKE +S DP +T N D+ P AR
Sbjct: 829 ASSSSKNRPTMSHVVAELKESVSRARAGGGSGASSVTDPA--MT-NFDSGMFPQAR 881
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1655 (587.6 bits), Expect = 3.1e-170, P = 3.1e-170
Identities = 362/716 (50%), Positives = 467/716 (65%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPG-WKKLSTS 59
+RLL N+TYET ++L LLRR D+ RYKDDIYDR+W P+ +K L+TS
Sbjct: 179 IRLLLNTTYETPY--DALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTS 236
Query: 60 LPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLAN 119
L +D N ++PA VMSTA T+ N S +L + + P DP +++YVYMHF E+EVL +N
Sbjct: 237 LTVDQFLNNGYQPASTVMSTAETARNESL-YLTLSFRPPDPNAKFYVYMHFAEIEVLKSN 295
Query: 120 QTREFNITQNGKFYIGPIVPT-YLYTTTALSSVPVSGARIEY-IINATERSTLQPILNAM 177
QTREF+I N + I P YL T T ++ PVSG I + ++ L PI+NA+
Sbjct: 296 QTREFSIWLN-EDVISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINAL 354
Query: 178 EIYMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDN--NP 235
E+Y V Q+ T DV+A+R IK+TY VK+NWQGDPCVP +Y W+G++C DN NP
Sbjct: 355 EVYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNP 414
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
R++SLN+S S L G+I P F+NLT+I LDLS N+L+G P FL+ LP+L LN++ NK
Sbjct: 415 -RVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNK 473
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNXXXXXXXXXXXXXXXXXXXXXX--XXXXXXXXXLF 353
LTG +P L ERS NGSL+L N L
Sbjct: 474 LTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLT 533
Query: 354 ALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGE 413
ALA+F RR K+ Q+ + RN R F YSE+ ITNNFERV+GKGGFG+
Sbjct: 534 ALALF----RRFKKKQQRGTLG--ERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGK 587
Query: 414 VYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468
VYHG ++ +QVAVK+LS F+ +V LLMRVHH NLT+L+GYC E N+M LI
Sbjct: 588 VYHGVIN-GEQVAVKVLSEESAQGYKEFRA-EVDLLMRVHHTNLTSLVGYCNEINHMVLI 645
Query: 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528
YEYMA+ L YL GK+ +L+W ERL+I++D+AQGLEYLH GCKPPIVHRDVK +NILL
Sbjct: 646 YEYMANENLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILL 705
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLL 588
NEKLQAK+ADFGLSR FS+E S QIST VAG+ GYLDPEYY +NEKSDVYS GVVLL
Sbjct: 706 NEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLL 765
Query: 589 EIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALAC 648
E+ITG+ P I+ ++ + HIS V S+LA GDIR IVD L+ +D SAWK E+ALAC
Sbjct: 766 EVITGQ-PAIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALAC 824
Query: 649 ASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESSPSAR 704
HTS++RPTM+ V+MELK+ + + E ++ D +M+T+NLDTE P AR
Sbjct: 825 TEHTSAQRPTMSQVVMELKQIVYGIVTDQENYD----DSTKMLTVNLDTEMVPRAR 876
|
|
| TAIR|locus:2066143 AT2G28970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1494 (531.0 bits), Expect = 3.6e-153, P = 3.6e-153
Identities = 315/698 (45%), Positives = 438/698 (62%)
Query: 28 SITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSLPIDAENPNAFRPAPAVMSTAVTSENVS 87
S ++ +RY DD YDR+W P + ++TSL I+ N + F A + +A T +N S
Sbjct: 99 STSDSEIRYDDDSYDRVWYPFFSSSFSYITTSLNIN--NSDTFEIPKAALKSAATPKNAS 156
Query: 88 ENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQTREFNITQNGKFYIGPIVPTYLYTTTA 147
LI+ W+P ++ Y Y+HF E++ L AN+TREF+I G F PT L T
Sbjct: 157 AP-LIITWKPRPSNAEVYFYLHFAEIQTLAANETREFDIVFKGNFNYSAFSPTKLELLTF 215
Query: 148 LSSVPVS----GARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTDEDDVNALRNIKS 203
+S PV G ++ + T STL P++NA+E Y + QL T DVNA++NIK+
Sbjct: 216 FTSGPVQCDSDGCNLQLV--RTPNSTLPPLINALEAYTIIEFPQLETSLSDVNAIKNIKA 273
Query: 204 TYGV-KRNWQGDPCVPKNYWWDGLNCSYEDNN-PSRIISLNLSSSGLTGEISPYFANLTA 261
TY + K +WQGDPC+P+ W+ L CSY +++ P +IISLNLS+SGLTG + F NLT
Sbjct: 274 TYRLSKTSWQGDPCLPQELSWENLRCSYTNSSTPPKIISLNLSASGLTGSLPSVFQNLTQ 333
Query: 262 IEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNX 321
I+ LDLSNNSL+G P FL+ + SL L+L N TGS+P L++R G L L ++GN
Sbjct: 334 IQELDLSNNSLTGLVPSFLANIKSLSLLDLSGNNFTGSVPQTLLDREKEG-LVLKLEGNP 392
Query: 322 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLFALAIFCGLRRR----NKRVGQKVEME-- 375
+ +A+F LR++ + + + +E
Sbjct: 393 ELCKFSSCNPKKKKGLLVPVIASISSVLIVIVVVALFFVLRKKKMPSDAQAPPSLPVEDV 452
Query: 376 --FENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS 433
++ SF K +FAY E+Q++TNNF+RVLG+GGFG VYHG ++ QQVAVK+LS S
Sbjct: 453 GQAKHSESSFVSKKIRFAYFEVQEMTNNFQRVLGEGGFGVVYHGCVNGTQQVAVKLLSQS 512
Query: 434 CC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE-H 487
F+ +V+LLMRVHH+NL +L+GYC EG+++ LIYEYM +G L Q+L GK+
Sbjct: 513 SSQGYKHFKA-EVELLMRVHHKNLVSLVGYCDEGDHLALIYEYMPNGDLKQHLSGKRGGF 571
Query: 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
+L+W RL++AVD+A GLEYLH GCKPP+VHRD+KS+NILL+E+ QAK+ADFGLSR F
Sbjct: 572 VLSWESRLRVAVDAALGLEYLHTGCKPPMVHRDIKSTNILLDERFQAKLADFGLSRSFPT 631
Query: 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH 607
E+ +ST VAGTPGYLDPEYY NWL EKSDVYSFG+VLLEIIT R P+I ++ + H
Sbjct: 632 ENETHVSTVVAGTPGYLDPEYYQTNWLTEKSDVYSFGIVLLEIITNR-PIIQQSREKP-H 689
Query: 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667
+ +WV ++ GDI NIVDP+L G +D S WKA+ELA++C + +S+ RP+M+ V+ +LK
Sbjct: 690 LVEWVGFIVRTGDIGNIVDPNLHGAYDVGSVWKAIELAMSCVNISSARRPSMSQVVSDLK 749
Query: 668 ECLSLEIVRN-EGHEKGHRDPRRMVTLNLDTESSPSAR 704
EC+ E R E E ++ +DTE P AR
Sbjct: 750 ECVISENSRTGESREMNSMSSIEF-SMGIDTEVIPKAR 786
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1482 (526.7 bits), Expect = 6.7e-152, P = 6.7e-152
Identities = 333/729 (45%), Positives = 452/729 (62%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPG-WKKLSTS 59
LR LK + Y T+S + L L R+Y F S + +++RY DDIYDR+W W ++ST+
Sbjct: 169 LRPLKKNVYVTESGSLKL-LFRKY-F-SDSGQTIRYPDDIYDRVWHASFLENNWAQVSTT 225
Query: 60 LPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLAN 119
L ++ + N + + VM+T T N SE L + W P ++ Y YMHF E+E L AN
Sbjct: 226 LGVNVTD-N-YDLSQDVMATGATPLNDSET-LNITWNVEPPTTKVYSYMHFAELETLRAN 282
Query: 120 QTREFNITQNGKFYIGPIVPTYLYTTTALSSVPVS---GARIEYIINATERSTLQPILNA 176
TREFN+ NG GP P L T T + P GA I ++ T +STL P+LNA
Sbjct: 283 DTREFNVMLNGNDLFGPYSPIPLKTETETNLKPEECEDGACILQLVK-TSKSTLPPLLNA 341
Query: 177 MEIYMVKNSSQLLTDEDDVNALRNIKSTYGV--KRNWQGDPCVPKNYWWDGLNCSYEDNN 234
+E + V + Q+ TDEDD A++N+++ YG+ + +WQGDPCVPK Y WDGL CSY D+
Sbjct: 342 IEAFTVIDFLQVETDEDDAAAIKNVQNAYGLINRSSWQGDPCVPKQYSWDGLKCSYSDST 401
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
P I L+LS+SGLTG I+P NLT +E L LSNN+L+G PEFL+ L S+ ++L+ N
Sbjct: 402 PPIINFLDLSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLADLKSIMVIDLRGN 461
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLFA 354
L+G +PA L+++ L L +D N L
Sbjct: 462 NLSGPVPASLLQKKG---LMLHLDDNPHILCTTGSCMHKGEGEKKSIIVPVVASIVSLAV 518
Query: 355 L--AIFCGLRRRNKRVGQKVE---MEFENRNDSFAPKS---------RQFAYSEIQKITN 400
+ A+ L R K+ KVE + +D +P+S ++F YS++ +TN
Sbjct: 519 IIGALILFLVFRKKKAS-KVEGTLPSYMQASDGRSPRSSEPAIVTKNKRFTYSQVVIMTN 577
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLS--SSCCFQLL--QVKLLMRVHHRNLTALI 456
NF+R+LGKGGFG VYHG ++ +QVAVK+LS SS ++ +V+LL+RVHH+NL L+
Sbjct: 578 NFQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLV 637
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEH-MLNWVERLQIAVDSAQGLEYLHYGCKPP 515
GYC EG NM LIYEYMA+G L +++ G + +LNW RL+I +DSAQGLEYLH GCKP
Sbjct: 638 GYCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCKPL 697
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
+VHRDVK++NILLNE +AK+ADFGLSR F I +ST VAGTPGYLDPEYY N L
Sbjct: 698 MVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLT 757
Query: 576 EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635
EKSDVYSFG+VLLE+IT R PVI ++ + +IS+WV ML +GDI +I+DPSL G++D+
Sbjct: 758 EKSDVYSFGIVLLEMITNR-PVIDQSREKP-YISEWVGIMLTKGDIISIMDPSLNGDYDS 815
Query: 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNL 695
S WKAVELA++C + +S+ RPTM+ VL+ L ECL E R V+L
Sbjct: 816 GSVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSENSRGGASRDMDSKSSLEVSLTF 875
Query: 696 DTESSPSAR 704
DT+ SP AR
Sbjct: 876 DTDVSPMAR 884
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1474 (523.9 bits), Expect = 4.7e-151, P = 4.7e-151
Identities = 323/727 (44%), Positives = 445/727 (61%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSV--RYKDDIYDRLWMPKNYPGWKKLST 58
LR L++ TY ++ SL L R G + + V RY DD+ DR W P +Y WK ++T
Sbjct: 177 LRPLRSDTY-ISAIGSSLLLYFR---GYLNDSGVVLRYPDDVNDRRWFPFSYKEWKIVTT 232
Query: 59 SLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVF-WEPTDPASQYYVYMHFCEVEVLL 117
+L ++ N F M++A T V++N F W D +++++Y+HF E++ LL
Sbjct: 233 TLNVNTSN--GFDLPQGAMASAAT--RVNDNGTWEFPWSLEDSTTRFHIYLHFAELQTLL 288
Query: 118 ANQTREFNITQNGKFYIGPIVPTYLYTTTALSSVPVS------GARIEYIINATERSTLQ 171
AN+TREFN+ NGK Y GP P L T +S P S G+ + ++ T +STL
Sbjct: 289 ANETREFNVLLNGKVYYGPYSPKMLSIDT-MSPQPDSTLTCKGGSCLLQLVKTT-KSTLP 346
Query: 172 PILNAMEIYMVKNSSQLLTDEDDVNALRNIKSTYGVKR-NWQGDPCVPKNYWWDGLNCS- 229
P++NA+E++ V Q T++D+V A++ I+ TYG+ R NWQGDPCVP+ + W GL CS
Sbjct: 347 PLINAIELFTVVEFPQSETNQDEVIAIKKIQLTYGLSRINWQGDPCVPEQFLWAGLKCSN 406
Query: 230 YEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRAL 289
+ P I LNLSSSGLTG ISP NLT ++ LDLSNN L+G PEFL+ + SL +
Sbjct: 407 INSSTPPTITFLNLSSSGLTGIISPSIQNLTHLQELDLSNNDLTGDVPEFLADIKSLLII 466
Query: 290 NLKRNKLTGSLPADLVERSNNGSLTLSVDGNXXXXXXXX-------XXXXXXXXXXXXXX 342
NL N +G LP L+++ L L+V+GN
Sbjct: 467 NLSGNNFSGQLPQKLIDKKR---LKLNVEGNPKLLCTKGPCGNKPGEGGHPKKSIIVPVV 523
Query: 343 XXXXXXXXXLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNF 402
+ AL +F LR++N ++ + K ++F Y E+ ++TNNF
Sbjct: 524 SSVALIAILIAALVLFLVLRKKNPSRSKENGRTSRSSEPPRITKKKKFTYVEVTEMTNNF 583
Query: 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCF---QL-LQVKLLMRVHHRNLTALIGY 458
VLGKGGFG VYHG ++ +QVAVK+LS + Q +V+LL+RVHH+NL +L+GY
Sbjct: 584 RSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHHKNLVSLVGY 643
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
C +G + L+YEYMA+G L ++ GK+ + +L W RLQIAV++AQGLEYLH GC+PPIV
Sbjct: 644 CEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYLHKGCRPPIV 703
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRDVK++NILL+E QAK+ADFGLSR F E +ST VAGT GYLDPEYY NWL EK
Sbjct: 704 HRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEYYRTNWLTEK 763
Query: 578 SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637
SDVYSFGVVLLEIIT +R VI R + HI++WVN M+ +GDIR IVDP+L+G++ ++S
Sbjct: 764 SDVYSFGVVLLEIITNQR-VIERTREKP-HIAEWVNLMITKGDIRKIVDPNLKGDYHSDS 821
Query: 638 AWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRMVTLNLDT 697
WK VELA+ C + +S+ RPTMT V+ EL EC++LE R + VT+ DT
Sbjct: 822 VWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLENSRGGKSQNMGSTSSSEVTMTFDT 881
Query: 698 ESSPSAR 704
E +P AR
Sbjct: 882 EVNPVAR 888
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1466 (521.1 bits), Expect = 3.3e-150, P = 3.3e-150
Identities = 324/727 (44%), Positives = 453/727 (62%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPK-NYPGWKKLSTS 59
LR L N TY TQS +L R Y F S + + +RY +D+ DR W P + W +L+T+
Sbjct: 181 LRPLINDTYNTQS-GSLKYLFRNY-F-STSRRIIRYPNDVNDRHWYPFFDEDAWTELTTN 237
Query: 60 LPIDAENPNAFRPAPAVMSTAVT--SENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLL 117
L +++ N + P VM++A T S+N NF W +++Y YMHF +++ L
Sbjct: 238 LNVNSSN--GYDPPKFVMASASTPISKNAPFNFT---WSLIPSTAKFYSYMHFADIQTLQ 292
Query: 118 ANQTREFNITQNGKFYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILN 175
AN+TREF++ NG + P T T P G + + T +STL P+ +
Sbjct: 293 ANETREFDMMLNGNLALERYRPKTFATGTIYFIKPQICEGGQCIIELLKTSKSTLPPLCS 352
Query: 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTYGV-KRNWQGDPCVPKNYWWDGLNC--SYED 232
A+E++ V + +L T++DDV A++NI++TYGV K +WQGDPCVPK + WDGLNC SY
Sbjct: 353 ALEVFTVIDFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKRFMWDGLNCNNSYIS 412
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
P+ I LNLSSS LTG I+ NLT ++ LDLSNN+L+G PEFL+ L SL +NL
Sbjct: 413 TPPT-ITFLNLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPEFLAGLKSLLVINLS 471
Query: 293 RNKLTGSLPADLVERSN-----NGSLTLSV-DGNXXXXXXXXXXXXXXXXXXXXXXXXXX 346
N L+GS+P L+++ G++ L+ DG+
Sbjct: 472 GNNLSGSVPQTLLQKKGLKLNLEGNIYLNCPDGSCVSKDGNGGAKKKNVVVLVVVSIALV 531
Query: 347 XXXXXLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVL 406
ALA+F R+R K +V + + + K+R+F YSE+ K+TNNFE++L
Sbjct: 532 VVLGS--ALALFLVFRKR-KTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMTNNFEKIL 588
Query: 407 GKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIE 461
GKGGFG VYHG+++D +QVAVKMLS S F+ +V+LL+RVHH+NL L+GYC E
Sbjct: 589 GKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKA-EVELLLRVHHKNLVGLVGYCDE 647
Query: 462 GNNMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRD 520
G N+ LIYEYMA G L +++ G + +L+W RL+I +SAQGLEYLH GCKPP+VHRD
Sbjct: 648 GENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRD 707
Query: 521 VKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDV 580
VK++NILL+E QAK+ADFGLSR F +E ++ T VAGTPGYLDPEYY NWLNEKSDV
Sbjct: 708 VKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDV 767
Query: 581 YSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWK 640
YSFG+VLLEIIT + VI+++ + HI++WV ML +GDI++I+DP G++D S W+
Sbjct: 768 YSFGIVLLEIITNQH-VINQSREKP-HIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWR 825
Query: 641 AVELALACASHTSSERPTMTDVLMELKECLSLEIVR---NEGHEKGHRDPRRMVTLNLDT 697
AVELA++C + +S+ RPTM+ V++EL ECL+ E R ++ E V+ N T
Sbjct: 826 AVELAMSCVNPSSTGRPTMSQVVIELNECLASENSRRGMSQNMESKGSIQYTEVSTNFGT 885
Query: 698 ESSPSAR 704
E +P AR
Sbjct: 886 EYTPEAR 892
|
|
| TAIR|locus:2078176 MEE39 "maternal effect embryo arrest 39" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1458 (518.3 bits), Expect = 2.3e-149, P = 2.3e-149
Identities = 320/722 (44%), Positives = 445/722 (61%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSV--RYKDDIYDRLWMPKNYPGWKKLST 58
LR L N TY +S + R Y ++N +V RY D+YDR W+P P W ++ST
Sbjct: 178 LRPLANDTYIAKS-GSLKYYFRMY----LSNATVLLRYPKDVYDRSWVPYIQPEWNQIST 232
Query: 59 SLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLA 118
+ + N N + P + A T N+ +V W +P Q Y+YMHF E++VL A
Sbjct: 233 TSNVS--NKNHYDPPQVALKMAATPTNLDAALTMV-WRLENPDDQIYLYMHFSEIQVLKA 289
Query: 119 NQTREFNITQNGK-FYIGPIVPTYLYTTTALSSVP--VSGARIEYIINATERSTLQPILN 175
N TREF+I NG+ + P YL T L++ P +G + T++STL P+LN
Sbjct: 290 NDTREFDIILNGETINTRGVTPKYLEIMTWLTTNPRQCNGGICRMQLTKTQKSTLPPLLN 349
Query: 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTYGVKR-NWQGDPCVPKNYWWDGLNCSYED-N 233
A E+Y V Q T+E +V A++NI++TYG+ R +WQGDPCVPK + WDGLNC+ D +
Sbjct: 350 AFEVYSVLQLPQSQTNEIEVVAIKNIRTTYGLSRISWQGDPCVPKQFLWDGLNCNITDIS 409
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
P RIISLNLSSSGL+G I F NL +E LDLSNNSLSG PEFL+ + SL +NL
Sbjct: 410 APPRIISLNLSSSGLSGTIVSNFQNLAHLESLDLSNNSLSGIVPEFLATMKSLLVINLSG 469
Query: 294 NKLTGSLPADLVERSNNGSLTLSVDGNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLF 353
NKL+G++P L +R G L L+V GN +
Sbjct: 470 NKLSGAIPQALRDREREG-LKLNVLGNKELCLSSTCIDKPKKKVAVKVVAPVASIAAIVV 528
Query: 354 ALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGE 413
+ +F ++ + R K E + K ++F YSE+ ++T N +R LG+GGFG
Sbjct: 529 VILLFVFKKKMSSR--NKPEPWIKT-------KKKRFTYSEVMEMTKNLQRPLGEGGFGV 579
Query: 414 VYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468
VYHG L+ ++QVAVK+LS + F+ +V+LL+RVHH NL L+GYC E ++ LI
Sbjct: 580 VYHGDLNGSEQVAVKLLSQTSAQGYKEFKA-EVELLLRVHHINLVNLVGYCDEQDHFALI 638
Query: 469 YEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527
YEYM++G L Q+L GK +LNW RLQIA+++A GLEYLH GCKP +VHRDVKS+NIL
Sbjct: 639 YEYMSNGDLHQHLSGKHGGSVLNWGTRLQIAIEAALGLEYLHTGCKPAMVHRDVKSTNIL 698
Query: 528 LNEKLQAKIADFGLSRIFSIESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVV 586
L+E+ +AKIADFGLSR F + Q+ST VAGT GYLDPEYY+ + L+EKSDVYSFG++
Sbjct: 699 LDEEFKAKIADFGLSRSFQVGGDQSQVSTVVAGTLGYLDPEYYLTSELSEKSDVYSFGIL 758
Query: 587 LLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELAL 646
LLEIIT +R VI + ++ +I++WV ++ +GD IVDP L GN+D +S W+A+E+A+
Sbjct: 759 LLEIITNQR-VIDQTRENP-NIAEWVTFVIKKGDTSQIVDPKLHGNYDTHSVWRALEVAM 816
Query: 647 ACASHTSSERPTMTDVLMELKECLSLEIVR----NEGHEKGHRDPRRMVTLNLDTESSPS 702
+CA+ +S +RP M+ V++ LKECL+ E R N+ + GH + VT+ DT+ P
Sbjct: 817 SCANPSSVKRPNMSQVIINLKECLASENTRISRNNQNMDSGHSSDQLNVTVTFDTDVKPK 876
Query: 703 AR 704
AR
Sbjct: 877 AR 878
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1436 (510.6 bits), Expect = 5.2e-149, Sum P(2) = 5.2e-149
Identities = 320/697 (45%), Positives = 426/697 (61%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSL 60
LR L N TY TQ SL R F T +RY DD+YDR+W+P + LST+L
Sbjct: 176 LRPLNNDTYVTQG--GSLMSFARIYFPK-TAYFLRYSDDLYDRVWVPFSQNETVSLSTNL 232
Query: 61 PIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQ 120
P+D + N++ V ++A+ + L ++W+ + + YVYMHF E++ L AN
Sbjct: 233 PVDTSS-NSYNVPQNVANSAIIPAEATHP-LNIWWDLQNINAPSYVYMHFAEIQNLKAND 290
Query: 121 TREFNITQNG-KFYIGPIVPTYLYTTTALSSVPVSGAR--IEYIINATERSTLQPILNAM 177
REFNIT NG + + I P L TT S ++ + + T STL P++NA+
Sbjct: 291 IREFNITYNGGQVWESSIRPHNLSITTISSPTALNSSDGFFNFTFTMTTTSTLPPLINAL 350
Query: 178 EIYMVKNSSQLLTDEDDVNALRNIKSTYGVKR--NWQGDPCVPKNYWWDGLNCSYEDNNP 235
E+Y + + L T +D+V+A+ NIK TYG+ + +WQGDPC P+ Y W+GLNC Y D++
Sbjct: 351 EVYTLVENLLLETYQDEVSAMMNIKKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQ 410
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN- 294
I SLNL +SGLTG I+ +NL + LDLS+N LSG P+FL+ + L +NLK N
Sbjct: 411 PLITSLNLRTSGLTGIITHDISNLIQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNP 470
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLFA 354
KL ++P + R NN SL L +D N L A
Sbjct: 471 KLNLTVPDSIKHRINNKSLKLIIDENQSSEKHGIKFPLVAILASVAGVIA-------LLA 523
Query: 355 LAIFCGLRRRNKR-VGQ---KVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGG 410
+ C + +R K+ G+ +V E + S K R+F YSEI K+TNNFERVLGKGG
Sbjct: 524 IFTICVIFKREKQGSGEAPTRVNTEIRSSYQSIETKDRKFTYSEILKMTNNFERVLGKGG 583
Query: 411 FGEVYHGSLDDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTALIGYCIEGNNM 465
+G VY+G LDD + VAVKML S Q +V+LL+RVHHR+L L+GYC +G+N
Sbjct: 584 YGRVYYGKLDDTE-VAVKMLFHSSAEQDYKHFKAEVELLLRVHHRHLVGLVGYCDDGDNF 642
Query: 466 GLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSS 524
LIYEYMA+G L + + G + H+L+W R+QIA+++AQGLEYLH G +PP+VHRDVK++
Sbjct: 643 ALIYEYMANGDLKENMSGNRSGHVLSWENRMQIAMEAAQGLEYLHNGSRPPMVHRDVKTT 702
Query: 525 NILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFG 584
NILLNE QAK+ADFGLSR ++ +ST VAGTPGYLDPE N L+EK+DVYSFG
Sbjct: 703 NILLNELYQAKLADFGLSRSSPVDGESYVSTIVAGTPGYLDPE---TNLLSEKTDVYSFG 759
Query: 585 VVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVEL 644
VVLLEIIT + PVI + HI+ WV L EGDIRNI+DP L FD N WKAVEL
Sbjct: 760 VVLLEIITNQ-PVIDTTREKA-HITDWVGFKLMEGDIRNIIDPKLIKEFDTNGVWKAVEL 817
Query: 645 ALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHE 681
AL+C + TS+ RPTM V+MELKECL EI R +G +
Sbjct: 818 ALSCVNPTSNHRPTMPHVVMELKECLDSEIARKQGSQ 854
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 704 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-49 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-23 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 402 FERVLGKGGFGEVYHGSLDDN-----QQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+ LG+G FGEVY G+L +VAVK L Q ++ +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L+G C E + ++ EYM G L YL+ + L+ + L A+ A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYV 570
+HRD+ + N L+ E L KI+DFGLSR + D P ++ PE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 571 LNWLNEKSDVYSFGVVLLEIIT-GRRP 596
KSDV+SFGV+L EI T G P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 6e-49
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 402 FERVLGKGGFGEVYHGSLDDN-----QQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+ LG+G FGEVY G L +VAVK L Q ++ +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L+G C E + ++ EYM G L YL+ + L+ + L A+ A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLE-- 119
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYV 570
+HRD+ + N L+ E L KI+DFGLSR + D P ++ PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 571 LNWLNEKSDVYSFGVVLLEIIT-GRRP 596
KSDV+SFGV+L EI T G +P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-48
Identities = 79/189 (41%), Positives = 112/189 (59%), Gaps = 12/189 (6%)
Query: 1 LRLLKNSTYETQSLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMP-KNYPGWKKLSTS 59
LR L +S Y + +++L L+ R +FG + ++RY DD+YDR+W P + PGW ++STS
Sbjct: 152 LRPLPDSLYPSSGGSQALKLVARLNFGG-SEGTIRYPDDVYDRIWEPFFSSPGWSQISTS 210
Query: 60 LPIDAENPNA-FRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLA 118
L +D + NA + P AV+ TAVT N S L W+ DP +YYVY+HF E++ L
Sbjct: 211 LSVDISSNNAPYIPPSAVLQTAVTPTNASAP-LNFTWDLVDPNFEYYVYLHFAEIQSL-- 267
Query: 119 NQTREFNITQNGKFYIGPIVPTYLYTTTALSSVP----VSGARIEYI-INATERSTLQPI 173
+TREF+I NGK G + P YL T T + VSG + I + T STL P+
Sbjct: 268 -ETREFDIYINGKTVYGDVSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPL 326
Query: 174 LNAMEIYMV 182
LNA+EI+ V
Sbjct: 327 LNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-47
Identities = 69/193 (35%), Positives = 110/193 (56%), Gaps = 14/193 (7%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTALIGYC 459
LG+GGFG VY ++VA+K++ LL+ +++L +++H N+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519
+ N++ L+ EY G+L LK + E L+ E L+I + +GLEYLH I+HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 520 DVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW-LNEK 577
D+K NILL+ + K+ADFGLS++ + S + + GTP Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 578 SDVYSFGVVLLEI 590
SD++S GV+L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 7e-46
Identities = 73/214 (34%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 402 FERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+ LG+G FGEVY G+L +VAVK L + + ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L+G C +G + ++ EYM G L +L+ E L + LQ+A+ A+G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE-- 119
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD-----P 566
VHRD+ + N L+ E L KI+DFGLSR I D G L P
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDD---YYRKRGGGKLPIKWMAP 173
Query: 567 E---YYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E KSDV+SFGV+L EI T G +P
Sbjct: 174 ESLKDGK---FTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-44
Identities = 74/215 (34%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 404 RVLGKGGFGEVYHGSLDDNQ----QVAVKML----SSSCCFQLLQ-VKLLMRVHHRNLTA 454
+ LG+G FGEVY G L +VAVK L S L+ +++ ++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-------LNWVERLQIAVDSAQGLEY 507
L+G C E + L+ EYM G L YL+ + L+ + L A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG----- 562
L VHRD+ + N L+ E L KI+DFGLSR + D T G
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDD---YYRKKTGGKLPIR 172
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE KSDV+SFGV+L EI T G P
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTAL 455
LG+G FG+VY + VA+K++ + + +K+L ++ H N+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+ + + L+ EY G L LK + L+ E LEYLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLH---SKG 117
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL- 574
IVHRD+K NILL+E K+ADFGL+R + T GTP Y+ PE VL
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPE--VLLGKG 172
Query: 575 -NEKSDVYSFGVVLLEIITGRRP 596
+ D++S GV+L E++TG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 92/275 (33%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLS----SSCCFQLLQ--VKLLMRVHHRNLTA 454
R LG G FG VY + VAVK+L S Q + +++L R+ H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
LI + +++ L+ EY G L YL L+ E +IA+ +GLEYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLH---SN 117
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I+HRD+K NILL+E KIADFGL++ S T GTP Y+ PE VL
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPE--VLLGG 173
Query: 575 NE---KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631
N K DV+S GV+L E++TG+ P D + IR I+ P L+
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL------------IRRILGPPLEF 221
Query: 632 NF---DNNSAWKAVELALACASHTSSERPTMTDVL 663
+ + S A +L C + S+RPT ++L
Sbjct: 222 DEPKWSSGSEE-AKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 9e-37
Identities = 121/453 (26%), Positives = 213/453 (47%), Gaps = 41/453 (9%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
+++SL+LS + L+G+I F+ + + LDLS N LSG P+ L + SL +N+ N L
Sbjct: 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
Query: 297 TGSLPADLVERSNNGSLTLSVDGNTSTTCSSES------CKK--KKHKFVVPVVVSVAAF 348
GSLP+ + N S +V GN C ++ CK+ K + + ++ AF
Sbjct: 584 HGSLPSTGAFLAINAS---AVAGNID-LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAF 639
Query: 349 STVLFALAIFCGLRRRN----KRVGQK---VEMEFENRNDSFAPKSRQFAYSEIQKITNN 401
+ F +R RN KRV + E++F + + S+ ++I
Sbjct: 640 LVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD-----SKVSKSITINDILSSLKE 694
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCI 460
E V+ +G G Y G S+ + Q VK ++ ++ + ++ H N+ LIG C
Sbjct: 695 -ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR 753
Query: 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRD 520
LI+EY+ L + L+ L+W R +IA+ A+ L +LH C P +V +
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 521 VKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDV 580
+ I+++ K + + L + ++ IS+A Y+ PE + EKSD+
Sbjct: 809 LSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKDITEKSDI 861
Query: 581 YSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN--FDNNSA 638
Y FG++L+E++TG+ P + + I +W ++ + +DPS++G+ + N
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920
Query: 639 WKAVELALACASHTSSERPTMTDVLMELKECLS 671
+ + LAL C + + RP DVL L+
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-----LLQ-VKLLMRVHHRNLTALI 456
+LG+G FG VY D + +AVK + S + L + +++L + H N+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 457 GYCI--EGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERL--QIAVDSAQGLEYLH 509
G E N + + EY++ G+L LK E + + + QI +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGTPGYLDPEY 568
IVHRD+K +NIL++ K+ADFG ++ + IE+ + + V GTP ++ PE
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMAPEV 174
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+D++S G ++E+ TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTALI 456
+ +GKG FG+VY D + +K + S + L +VK+L +++H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK-------EHM-LNWVERLQIAVDSAQGLEYL 508
E + ++ EY G L Q +K +K E L+W +Q+ + L+YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL----ALKYL 119
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE- 567
H I+HRD+K NI L K+ DFG+S++ S+ ++ V GTP YL PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPEL 174
Query: 568 -----YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y N KSD++S G VL E+ T + P
Sbjct: 175 CQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 68/196 (34%), Positives = 107/196 (54%), Gaps = 15/196 (7%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSS-SCCFQ--LLQVKLLMRVHHRNLTALIGYCIEG 462
+GKG FG+V G Q+VAVK L S Q L + ++ + H NL L+G ++G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 463 NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522
N + ++ EYMA G+L YL+ + ++ ++L A+D +G+EYL + VHRD+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLA 129
Query: 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNWLNEKSDVY 581
+ N+L++E L AK++DFGL++ P + PE + KSDV+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 582 SFGVVLLEIIT-GRRP 596
SFG++L EI + GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ----LLQVKLLMRVHHRNLTALIGY 458
+GKGGFGEVY ++VA+K++ + + ++++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCKPP 515
++ + + ++ E+ + G+L LK L E QIA + +GLEYLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTN-QTLT--ES-QIAYVCKELLKGLEYLH---SNG 118
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
I+HRD+K++NILL + K+ DFGLS S + + GTP ++ PE +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYD 175
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
K+D++S G+ +E+ G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 77/214 (35%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHH 449
EI + + ER LG G FGEV+ G+ + +VAVK L F L + +++ ++ H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAF-LQEAQIMKKLRH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL- 508
L L C E + ++ EYM+ G+L +LK + L + + +A A+G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 509 --HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT--P-GY 563
+Y +HRD+ + NIL+ E L KIADFGL+R+ IE D TA G P +
Sbjct: 121 SRNY------IHRDLAARNILVGENLVCKIADFGLARL--IE--DDEYTAREGAKFPIKW 170
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE KSDV+SFG++L EI+T GR P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 43/235 (18%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC------FQLLQV 441
+Q+ T +R LG+G FG+V+ G +D + VAVK L + F+ +
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER-EA 59
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLK------------GKKEHML 489
+LL H N+ G C EG+ +++EYM G L+++L+ L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 490 NWVERLQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546
+ LQIAV A G+ YL H+ VHRD+ + N L+ L KI DFG+SR
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSR--D 171
Query: 547 IESSDQISTAVAGTP----GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ ++D V G ++ PE + +SDV+SFGVVL EI T G++P
Sbjct: 172 VYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHH 449
EI + + R LG G FGEV+ G ++ VAVK L F L + +++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDF-LAEAQIMKKLRH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL- 508
L L C + ++ E M G+L +YL+G L + + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 509 --HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP---GY 563
+Y +HRD+ + N+L+ E K+ADFGL+R+ + I A G +
Sbjct: 121 AQNY------IHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKW 170
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + N + KSDV+SFG++L EI+T GR P
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 93/311 (29%), Positives = 146/311 (46%), Gaps = 47/311 (15%)
Query: 34 VRYKDDIY--DRLWMPKNYPGW---KKLSTSLPI-DAENPNAFRPAPAVMSTAVTSENVS 87
Y D + DR W G + +ST I A N F P S V+++
Sbjct: 207 EDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQP 266
Query: 88 ENFLIVFWEPTDPASQYYVYMHFCEVEV-LLANQTREFNITQNGK--FYIGPIVPTYLYT 144
+ + + DP Y V++HF E++ + A R F++ NG F IV
Sbjct: 267 D---LSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGER 323
Query: 145 TTAL---SSVPVSGARIEYIINATERSTLQPILNAMEIY-MVKNSSQLLTDEDDVNALRN 200
TAL +V VSG + ++ + + I+NA+E++ ++ S+ L +E V+AL+
Sbjct: 324 YTALVLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEE--VSALQT 379
Query: 201 IKSTYGV--KRNWQGDPCVPKNYWWDGLNCSYEDNNPSRII------------------- 239
+KS+ G+ + W GDPCVP+ + W G +C ++ I
Sbjct: 380 LKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDIS 439
Query: 240 ------SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
S+NLS + + G I P ++T++E LDLS NS +G+ PE L +L SLR LNL
Sbjct: 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 294 NKLTGSLPADL 304
N L+G +PA L
Sbjct: 500 NSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQL----LQVKLLMRVHHRNLTALIGY 458
ER LG G FGEV+ G + +VA+K+L S + +V+ L R+ H++L +L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
C G + +I E M G+L +L+ + +L + +A A+G+ YL + +H
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIF--SIESSDQISTAVAGTPGYLDPEYYVLNWLNE 576
RD+ + NIL+ E L K+ADFGL+R+ + S T PE +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFST 183
Query: 577 KSDVYSFGVVLLEIIT 592
KSDV+SFG++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 403 ERVLGKGGFGEVYHGSLDDNQQ----VAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLT 453
E+V+G G FGEV G L + VA+K L + + L + ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L G + + +I EYM +G+LD++L+ + + + + + A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-TP-GYLDPEYYVL 571
VHRD+ + NIL+N L K++DFGLSR +E S+ T G P + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 572 NWLNEKSDVYSFGVVLLEIIT-GRRP--------VISRAEDD 604
SDV+SFG+V+ E+++ G RP VI ED
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 3e-28
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 26/280 (9%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRV--------HHRNL 452
R LG+G FGEVY D + VA+K+L+ + +V+ +R H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLK-GKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
L + + ++ L+ EY+ G+L+ LK ++ L+ E L I LEYLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 512 CKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESS----DQISTAVAGTPGYLDP 566
I+HRD+K NILL+ K+ DFGL+++ S + + GTPGY+ P
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 567 EYYVLNWLNE---KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
E + L SD++S G+ L E++TG P E +++ SQ + +L
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG--EKNSSATSQTLKIILELPT--P 233
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ L + + A +L + R + + L
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 402 FERVLGKGGFGEVYHGSLD---DNQ--QVAVKMLSSSCCFQLL-----QVKLLMRVHHRN 451
F + LG+G FG+V D DN QVAVK L+ S Q ++++L + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 452 LTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ G C + G ++ LI EY+ SG+L YL+ ++ +N L + +G++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLG 126
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG-----YL 564
+HRD+ + NIL+ + KI+DFGL+++ E D PG +
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP-EDKDYY---YVKEPGESPIFWY 179
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE + + SDV+SFGV L E+ T P
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTALIG 457
++G+G FG VY G +L+ VA+K +S + + ++ LL + H N+ IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCKP 514
+++ +I EY +G+L Q +K K E L +AV Q GL YLH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK--KFGPFP--ESL-VAVYVYQVLQGLAYLH---EQ 118
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
++HRD+K++NIL + K+ADFG++ + S D +V GTP ++ PE ++
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGA 176
Query: 575 NEKSDVYSFGVVLLEIITGRRP 596
+ SD++S G ++E++TG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 406 LGKGGFGEVY---HGSLDDNQQVAVKMLSSSCCFQLLQV-------KLLMRVHHRNLTAL 455
LGKG FG+V D + A+K+L + +V +L R++H + L
Sbjct: 1 LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQ-IAVDSAQGLEYLH-YGCK 513
+ L+ EY G L +L KE + ER + A + LEYLH G
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFS-EERARFYAAEIVLALEYLHSLG-- 113
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
I++RD+K NILL+ K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNT-FCGTPEYLAPEV----- 164
Query: 574 LNEK-----SDVYSFGVVLLEIITGRRP 596
L K D +S GV+L E++TG+ P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 400 NNFERV--LGKGGFGEVYHGSLD-DNQQVAVKM--LSSSCCF--QLLQ-VKLLMRVHHRN 451
++ ERV LG+G G VY + A+K + F QLL+ +K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYL 508
+ G + + ++ EYM G+L LK E +L ++ R QI +GL+YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QIL----KGLDYL 115
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-DQISTAVAGTPGY---- 563
H I+HRD+K SN+L+N K + KIADFG+S++ +E++ DQ +T V GT Y
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFV-GTVTYMSPE 170
Query: 564 -LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ E Y +D++S G+ LLE G+ P
Sbjct: 171 RIQGESYSYA-----ADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKML---SSSCCFQLLQVKLLMRVHHR 450
E+ + T + LG G FGEV+ G + + +VA+K L S S L + L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + + +I EYM +G+L +LK + L + + +A A+G+ ++
Sbjct: 62 RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE- 119
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYY 569
+ +HRD++++NIL++E L KIADFGL+R+ IE ++ + A P + PE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
KSDV+SFG++L EI+T GR P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 85/298 (28%), Positives = 131/298 (43%), Gaps = 61/298 (20%)
Query: 402 FERVLGKGGFGEVYH----GSLDDNQQ--VAVKMLSSSCCFQLL-----QVKLLMRVHHR 450
+ R +G+G FG V+ G L VAVKML + + L+ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM--------------------LN 490
N+ L+G C G M L++EYMA G L+++L+ + L+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 491 WVERLQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
E+L IA A G+ YL + VHRD+ + N L+ E + KIADFGLSR +I
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR--NI 180
Query: 548 ESSD--QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDD 604
S+D + S A ++ PE N +SDV+++GVVL EI + G +P A ++
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 605 TTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDV 662
V + +G++ + D N + L C S S+RP+ +
Sbjct: 241 -------VIYYVRDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 70/206 (33%), Positives = 115/206 (55%), Gaps = 15/206 (7%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ--LLQVKLLMRVHHRN 451
+QK+T ++G+G FG V G Q+VAVK + Q L + ++ ++HH+N
Sbjct: 4 NLQKLT--LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN 60
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
L L+G I N + ++ E M+ G L +L+ + +++ ++ LQ ++D A+G+EYL
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
+VHRD+ + NIL++E AK++DFGL+R+ S D V T PE
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVKWTA----PEALKH 171
Query: 572 NWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+S+GV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQL----LQ-VKLLMRVHHRNLTALIGY 458
+GKG FG+VY G L N +VAVK S+ L LQ ++L + H N+ LIG
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
C++ + ++ E + G+L +L+ KK++ L + LQ+++D+A G+EYL +H
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP----GYLDPEYYVLNW- 573
RD+ + N L+ E KI+DFG+SR E I T G + PE LN+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPE--ALNYG 170
Query: 574 -LNEKSDVYSFGVVLLEIITG 593
+SDV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 25/206 (12%)
Query: 404 RVLGKGGFGEVY---HGSLDDNQQVAVKM----LSSSCCFQLLQ-VKLLMRVHHRNLTAL 455
LG G G V H + +AVK ++ + Q+L+ + +L + + +
Sbjct: 7 GELGAGNSGVVSKVLH--RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYG 511
G ++ + EYM G+LD+ LK + E +L +IAV +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
K I+HRDVK SNIL+N + Q K+ DFG+S + + ++ GT Y+ PE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQG 173
Query: 572 NWLNEKSDVYSFGVVLLEIITGRRPV 597
N + KSD++S G+ L+E+ TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 34/225 (15%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VK 442
EI F LG+G FG+VY G L VA+K L + ++ Q +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL--------------KGKKEHM 488
L+ + H N+ L+G C + +++EY+A G L ++L +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 489 LNWVERLQIAVDSAQGLEYL--HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IF 545
L+ + L IA+ A G+EYL H+ VHRD+ + N L+ E L KI+DFGLSR I+
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590
S + S ++ ++ PE + +SD++SFGVVL EI
Sbjct: 176 SADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 405 VLGKGGFGEVYHGSLDDNQQVAVK--------MLSSSCCFQLLQ--VKLLMRVHHRNLTA 454
VLGKG +G VY G + Q +AVK +L++ ++ LQ V LL + H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLK--GKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
+G C++ N + + E++ G++ L G + QI G+ YLH C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNNC 122
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE----SSDQISTAVAGTPGYLDPEY 568
+VHRD+K +N++L K+ DFG +R + + + ++ GTP ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628
+ KSD++S G + E+ TG+ P+ S + +M G R ++ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYIGAHRGLM-PR 229
Query: 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
L +F A++ +C + ERP+ +L
Sbjct: 230 LPDSFSAA----AIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 82/280 (29%), Positives = 119/280 (42%), Gaps = 46/280 (16%)
Query: 404 RVLGKGGFGEVYHGSLDD-------NQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRN 451
LG G FGEVY G+ D +VAVK L Q L + L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH-----MLNWVERLQIAVDSAQGLE 506
+ L+G C+ +I E M G L YL+ + +L E L I +D A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQA-----KIADFGLSRIFSIESSDQISTAVAG-- 559
YL + +HRD+ + N L++EK KI DFGL+R I SD G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLL 175
Query: 560 TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618
++ PE + +SDV+SFGV++ EI+T G++P + + A
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------AG 229
Query: 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT 658
G ++ N K +L C + SERPT
Sbjct: 230 GRLQK----------PENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 68/194 (35%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 406 LGKGGFGEVYHGSLDD-NQQVAVKMLSSSC--CFQLLQVKLLMR-VHHRNLTALIGYCIE 461
LG G +GEVY G + VAVK L + L+ +M+ + H NL L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 462 GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV 521
+I E+M G L YL+ +N V L +A + +EYL K +HRD+
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 130
Query: 522 KSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP---GYLDPEYYVLNWLNEKS 578
+ N L+ E K+ADFGLSR+ + TA AG + PE N + KS
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 579 DVYSFGVVLLEIIT 592
DV++FGV+L EI T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 401 NFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMR-------VHHR 450
+FE RV+GKG FG+V D +++ A+K ++ C + V+ ++ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + NM L+ + + G L +Y +K + + LEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKF-WICEIVLALEYLH- 117
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
I+HRD+K NILL+E+ I DF ++ + D ++T+ +GTPGY+ PE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLC 172
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRP 596
+ D +S GV E + G+RP
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 14/198 (7%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
F + LG G FG V+ G VA+KM+ + + + K++M++ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
C + + ++ EYMA+G L YL+ +++ L L + D + +EYL +H
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP---GYLDPEYYVLNWLN 575
RD+ + N L+ E K++DFGL+R + ++ DQ T+ GT + PE + + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLAR-YVLD--DQY-TSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 576 EKSDVYSFGVVLLEIITG 593
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 397 KITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVK--LLMR-VHHRNL 452
++ N E+ +G+G GEVY ++VA+K + + L + L+M+ H N+
Sbjct: 19 ELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 453 TALIGYCIEGNNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
+ G+ + ++ EYM G+L Q E + +V R + QGLEYL
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-----EVLQGLEYL 132
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
H ++HRD+KS NILL++ K+ADFG + + E S + S V GTP ++ PE
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRP 596
K D++S G++ +E+ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHG----SLDDNQ-QVAVKMLSSSCCFQ---- 437
R +E++KI +VLG G FG VY G + + VA+K+L +
Sbjct: 1 LRILKETELEKI-----KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 438 LLQVKLLM-RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK-----EHMLNW 491
+L +M V H ++ L+G C+ + + LI + M G L Y++ K +++LNW
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW 114
Query: 492 VERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
QIA +G+ YL + +VHRD+ + N+L+ KI DFGL+++ ++ +
Sbjct: 115 CV--QIA----KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
Query: 552 QISTAVAGTP-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ P ++ E + KSDV+S+GV + E++T G +P
Sbjct: 166 YHAEG-GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 404 RVLGKGGFGEVYH-GSLDDNQQVAVK------MLSSSCCFQLLQVKLLMRVHHRNLTALI 456
RV+G+G FG V+ D + V +K M + ++L + H N+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
+E + ++ EY GTL +Y++ + +L+ L V L ++H I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLI 122
Query: 517 VHRDVKSSNILLNE-KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
+HRD+K+ NILL++ K+ KI DFG+S+I S +S + V GTP Y+ PE N
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYN 179
Query: 576 EKSDVYSFGVVLLEIITGRR 595
+KSD+++ G VL E+ + +R
Sbjct: 180 QKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 70/209 (33%), Positives = 114/209 (54%), Gaps = 13/209 (6%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLS----SSCCFQLLQVKLLMRVHH 449
EI + + E LG+G FGEV+ G+ + +VA+K L S F L + +++ ++ H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMKKLRH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
L L E + ++ EYM+ G+L +LKG+ L + + +A A G+ Y+
Sbjct: 61 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEY 568
+ VHRD++++NIL+ E L K+ADFGL+R+ IE ++ + A P + PE
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+SFG++L E+ T GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHHRNLTALIGYCIE 461
LG+G +G VY + Q VA+K++ Q + + +L + + G +
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 462 GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCKPPIVH 518
++ ++ EY +G++ +K L E +IA + +GLEYLH +H
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMK-ITNKTLT--EE-EIAAILYQTLKGLEYLH---SNKKIH 122
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+K+ NILLNE+ QAK+ADFG+S ++ + +T V GTP ++ PE N K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKA 180
Query: 579 DVYSFGVVLLEIITGRRP 596
D++S G+ +E+ G+ P
Sbjct: 181 DIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 61/295 (20%)
Query: 404 RVLGKGGFGEVYHGSL----DDNQ--QVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNL 452
R LG G FGEVY G D QVAVK L SC Q L++ ++ + +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH-----MLNWVERLQIAVDSAQGLEY 507
LIG E ++ E MA G L +L+ + L + L A D A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 508 L---HYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSR-IFSIE---SSDQISTAV 557
L H+ +HRD+ + N LL K AKIADFG++R I+ + +
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSML 616
P PE ++ K+DV+SFGV+L EI + G P R +Q V +
Sbjct: 186 KWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-------NQEVMEFV 234
Query: 617 AEGD----IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667
G + P + + C HT +RP +L ++
Sbjct: 235 TGGGRLDPPKGCPGPVYR-------------IMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 68/216 (31%), Positives = 114/216 (52%), Gaps = 10/216 (4%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKML---SSSCCFQLLQVKLLMRVHHR 450
EI + + + LG G FGEV+ G +++ +VAVK L + S L + L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + + +I EYMA G+L +LK + + + + + A+G+ Y+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE- 120
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYY 569
+ +HRD++++N+L++E L KIADFGL+R+ IE ++ + A P + PE
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 176
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDD 604
KSDV+SFG++L EI+T G+ P + D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 402 FERV--LGKGGFGEVYHG-SLDDNQQVAVKM---------LSSSCCFQLLQVKLLMRVHH 449
+E++ LG+G +G VY + VA+K + S+ L ++ LL + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LREISLLKELKH 57
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-LNWVERL--QIAVDSAQGLE 506
N+ L+ + L++EY L +YL + + N ++ + Q+ +GL
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL----RGLA 112
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
Y H I+HRD+K NIL+N K+ADFGL+R F I V T Y P
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167
Query: 567 EYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
E +L L K D++S G + E+ITG+
Sbjct: 168 E--IL--LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRVH----------HRNLTA 454
+G G FG+VY +LD + +AVK + Q K + + H NL
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYG 511
G + + + EY + GTL++ L+ + EH++ V LQ+ GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR-VYTLQLLE----GLAYLH-- 116
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV---AGTPGYLDPEY 568
IVHRD+K +NI L+ K+ DFG + ++ + V AGTP Y+ PE
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 569 YVLNWLNEK---SDVYSFGVVLLEIITGRRP 596
+D++S G V+LE+ TG+RP
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGYCIEG 462
+G G FG V+ G + ++VA+K + + + + +++M++ H L L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 463 NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522
+ + L++E+M G L YL+ ++ + L + +D +G+ YL ++HRD+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYS 582
+ N L+ E K++DFG++R F ++ ST + PE + + + KSDV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 583 FGVVLLEIIT-GRRPVISRA 601
FGV++ E+ + G+ P +R+
Sbjct: 187 FGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 406 LGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQ------VKLLMRVHHRNLTALIGY 458
+GKG FG V+ +++V A+K + S + + ++L ++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN----WVERLQIAVDSAQGLEYLHYGCKP 514
++ + ++ EY +G L + LK ++ L W +QI + GL +LH
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH---SK 120
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I+HRD+KS N+ L+ KI D G++++ S + + + GTP YL PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 575 NEKSDVYSFGVVLLEIITGRRP 596
NEKSDV++ GVVL E TG+ P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCF---QLLQVKLLMRVH---H 449
F + LG G FG+V + D +VAVKML + + L +L + H H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
N+ L+G C G + +I EY G L +L+ K+E L + L + A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 510 Y-GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPE 567
C +HRD+ + N+LL KI DFGL+R + S+ + A P ++ PE
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGNARLPVKWMAPE 213
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIIT 592
+SDV+S+G++L EI +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 13/209 (6%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLS----SSCCFQLLQVKLLMRVHH 449
EI + + + LG G FGEV+ G+ + N +VAVK L S F L + +++ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESF-LEEAQIMKKLRH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
L L E + ++ EYM+ G+L +LK + L + +A A G+ Y+
Sbjct: 61 DKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEY 568
+ +HRD++S+NIL+ + L KIADFGL+R+ IE ++ + A P + PE
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+SFG++L E++T GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 50/231 (21%)
Query: 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVK-----------LLMRVHH 449
F +++G+G F V + N++ A+K+L QL++ K L H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR---QLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQ--- 503
+ L + N+ + EY +G L QY++ E + +A+
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY--------AAEILL 113
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA----- 558
LEYLH I+HRD+K NILL++ + KI DFG +++ SS + + A
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 559 -------------GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
GT Y+ PE + SD+++ G ++ +++TG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 68/270 (25%), Positives = 129/270 (47%), Gaps = 27/270 (10%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
F + LG G FG V+ G +VA+K ++ + + + K++M++ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
C + + ++ E+M +G L YL+ ++ + + L + D +G+EYL + +H
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM-LLSMCQDVCEGMEYLE---RNSFIH 123
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNWLNEK 577
RD+ + N L++ K++DFG++R + + S++ A P + PE + + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 578 SDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636
SDV+SFGV++ E+ T G+ P ++ + V M++ G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGF--RLYRPKLASMT--- 229
Query: 637 SAWKAVELALACASHTSSERPTMTDVLMEL 666
E+ +C RPT ++L +
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
F + LG G FG V +G VA+KM+ + + + K++M++ H L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
C + + ++ EYM++G L YL+ + + L++ D +G+ YL +H
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE---SKQFIH 123
Query: 519 RDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTA--VAGTPGYLDPEYYVLNWLN 575
RD+ + N L++++ K++DFGLSR + E + + + V +P PE + + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLLYSKFS 179
Query: 576 EKSDVYSFGVVLLEIIT-GRRPVISRAEDDTT-HISQ 610
KSDV++FGV++ E+ + G+ P +T +SQ
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 22/204 (10%)
Query: 404 RVLGKGGFGE--VYHGSLDDNQ----QVAVKMLSSSCCFQLL-QVKLLMRVHHRNLTALI 456
RVLGKG FGE +Y + DD+ +V + LS L ++ +L + H N+ A
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK-----EHMLNWVERLQIAVDSAQGLEYLHYG 511
+ ++ N + + EY GTL + +K E M+ W QI SA + Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-LFQIV--SA--VSYIH-- 118
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
K I+HRD+K+ NI L + K+ DFG+S+I E S ++ V GTP Y+ PE
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQG 175
Query: 572 NWLNEKSDVYSFGVVLLEIITGRR 595
N KSD+++ G VL E++T +R
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 404 RVLGKGGFGEVYHGSLDDN----QQVAVKMLSS----SCCFQLLQVKLLMR-VHHRNLTA 454
RV+GKG FG VYHG+L D+ AVK L+ Q L+ ++M+ H N+ +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 455 LIGYCI--EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
L+G C+ EG+ + ++ YM G L +++ + H + + + A+G+EYL
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIE-SSDQISTAVAGTPGYLDPEYYV 570
VHRD+ + N +L+E K+ADFGL+R I+ E S T ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 571 LNWLNEKSDVYSFGVVLLEIIT 592
KSDV+SFGV+L E++T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 39/221 (17%)
Query: 406 LGKGGFGEVY----HGSLDDNQQ--VAVKML-----SSSCCFQLLQVKLLMRVHHRNLTA 454
LG+G FG+V+ H L + + VAVK L S+ FQ + +LL + H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR-EAELLTVLQHQHIVR 71
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLK--GKKEHMLNWVE-----------RLQIAVDS 501
G C EG + +++EYM G L+++L+ G +L E L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 502 AQGLEY---LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--QISTA 556
A G+ Y LH+ VHRD+ + N L+ + L KI DFG+SR I S+D ++
Sbjct: 132 ASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGR 183
Query: 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE + +SD++SFGVVL EI T G++P
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ--LLQVKLLMRVHHRNLTALIGYC 459
+ +GKG FG+V G N+ VAVK + + Q L + ++ ++ H NL L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 460 IEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+E + ++ EYMA G+L YL+ + +L L+ ++D + +EYL VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+ + N+L++E AK++DFGL++ E+S T + PE + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPEALREKKFSTKS 180
Query: 579 DVYSFGVVLLEIIT-GRRP 596
DV+SFG++L EI + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 403 ERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLT 453
++V+G G FGEV+ G L VA+K L + L + ++ + H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L G + +I EYM +G LD+YL+ + + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR-DHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLN 572
VHRD+ + NIL+N L+ K++DFGLSR+ + +T+ P + PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 573 WLNEKSDVYSFGVVLLEIIT-GRRP 596
SDV+SFG+V+ E+++ G RP
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 399 TNNF--ERVLGKGGFGEVYHG-SLDDNQQVAVK------MLSSSC---CFQLLQVKLLMR 446
NF E+ +GKG F VY L D + VA+K M+ + C + ++ LL +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK--EIDLLKQ 58
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQG 504
+ H N+ + IE N + ++ E +G L + +K K+ ER + V
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
LE++H I+HRD+K +N+ + K+ D GL R FS +++ S + GTP Y+
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE N N KSD++S G +L E+ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 405 VLGKGGFGEVYHGSLDDNQQVAVKM----LSSSCCFQLLQ-VKLLMRVHHRNLTALIGYC 459
+LGKG FGEV+ G+L D VAVK L + L ++L + H N+ LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519
+ + ++ E + G +L+ KK+ L + ++ A+D+A G+ YL +HR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 520 DVKSSNILLNEKLQAKIADFGLSR-----IFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
D+ + N L+ E KI+DFG+SR I+S QI + PE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNYGRY 171
Query: 575 NEKSDVYSFGVVLLEIIT 592
+ +SDV+S+G++L E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKML---SSSCCFQLLQVKLLMRVHHR 450
EI + + E+ LG G FGEV+ + + + +VAVK + S S L + ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + + +I E+MA G+L +LK + + + + A+G+ ++
Sbjct: 62 KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 119
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYY 569
+ +HRD++++NIL++ L KIADFGL+R+ IE ++ + A P + PE
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
KSDV+SFG++L+EI+T GR P
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKML---SSSCCFQLLQ--VKLLMRVHHRNLTALI 456
+GKG FGEVY NQ VA+K++ + + +Q ++ L + +T
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCK 513
G ++G+ + +I EY G+ LK K ++ IA + GLEYLH K
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHEEGK 119
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
+HRD+K++NILL+E+ K+ADFG+S + + + +T V GTP ++ PE +
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 574 LNEKSDVYSFGVVLLEIITGRRP 596
+EK+D++S G+ +E+ G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 64/208 (30%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI + + + LG+G FGEV+ G+ + +VA+K L L + +++ ++ H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L E + ++ E+M G+L +LK L + + +A A G+ Y+
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYY 569
+ +HRD++++NIL+ + L KIADFGL+R+ IE ++ + A P + PE
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+SFG++L E++T GR P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGY 458
+G+G +G VY + VA+K + L ++KLL ++H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGLEYLHYGCKPP 515
++ L++E+M + L + +K ++ + + + Q+ QGL + H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFCH---SHG 118
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES---SDQISTAVAGTPGYLDPE----- 567
I+HRD+K N+L+N + K+ADFGL+R F + + T Y PE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGD 173
Query: 568 -YYVLNWLNEKSDVYSFGVVLLEIITGR 594
Y + D++S G + E+++ R
Sbjct: 174 KGY-----STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 402 FERVLGKGGFGEV---YHGSLDDN--QQVAVKMLSSSCCFQL----LQVKLLMRVHHRNL 452
F + LGKG FG V + L DN + VAVK L S L ++++L + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 453 TALIGYCIEG--NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
G C N+ L+ EY+ G+L YL+ K L+ + L A +G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYL-- 124
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY-LDPEYY 569
G K VHRD+ + NIL+ + + KI DFGL+++ + +P + PE
Sbjct: 125 GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT 592
+ + SDV+SFGVVL E+ T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 19/197 (9%)
Query: 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQL-----LQVKLLMRVHHRNLTALI 456
ER+ G+G FGEV+ G L DN VAVK + L + ++L + H N+ LI
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
G C + + ++ E + G +L+ + L E +Q+ ++A G+EYL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---C 115
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP----GYLDPEYYVLN 572
+HRD+ + N L+ EK KI+DFG+SR E D + + G + PE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 573 WLNEKSDVYSFGVVLLE 589
+ +SDV+SFG++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 402 FERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCCFQLL-----QVKLLMRVHHRN 451
F LG+ FG++Y G L D Q VA+K L Q + L+ +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM---------------LNWVERLQ 496
+ L+G + + +++EY+ G L ++L + H L+ + L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 497 IAVDSAQGLEYL--HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--Q 552
IA+ A G+EYL H+ VH+D+ + NIL+ E+L KI+D GLSR I S+D +
Sbjct: 129 IAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYR 181
Query: 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ ++ PE + + SD++SFGVVL EI + G +P
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 47/276 (17%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLS-----SSCCFQ--LLQVKLLMRVHHRNLTAL 455
R +G G FG VY + N+ VA+K +S S+ +Q + +V+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 456 IGYCIEGNNMGLIYEYM---ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
G + + L+ EY AS L+ + K +E VE I + QGL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE-----VEIAAICHGALQGLAYLHSHE 135
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
+ +HRD+K+ NILL E K+ADFG + + S +S GTP ++ PE V+
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE--VIL 184
Query: 573 WLNE-----KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627
++E K DV+S G+ +E+ + P+ + +N+M A I P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFN------------MNAMSALYHIAQNDSP 232
Query: 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+L N ++ V+ C +RP+ ++L
Sbjct: 233 TLSSNDWSDYFRNFVDS---CLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 390 FAYSEIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLL---- 439
F S +Q+IT LG+G FGEV+ V VK L + L
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 440 -QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL---KGKKEHM----LNW 491
++ + ++ H+N+ L+G C E +I EY G L Q+L K K E + L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 492 VERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
+++ + A G+++L VHRD+ + N L++ + + K++ LS+ + +S+
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSE 171
Query: 552 QISTAVAGTP-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
A P +L PE + + KSDV+SFGV++ E+ T
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 402 FERVLGKGGFGEVYHGS------LDDNQQVAVKML-----SSSCCFQLLQVKLLMRVHHR 450
+R LG+G FG+V+ D VAVK L ++ FQ + +LL + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR-EAELLTNLQHE 67
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKG--------------KKEHMLNWVERLQ 496
++ G C +G+ + +++EYM G L+++L+ + + L + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--QIS 554
IA A G+ YL VHRD+ + N L+ L KI DFG+SR + S+D ++
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVG 182
Query: 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE + +SDV+SFGV+L EI T G++P
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 405 VLGKGGFGEVY---HGSLDDNQQVAVKMLSSSC-----CFQLL-QVKLLMRVHHRNLTAL 455
+GKG FG V S D + + K + QL+ +V +L + H N+
Sbjct: 7 TIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 456 IGYCIEGNN--MGLIYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSAQGLEYLHYG 511
I+ +N + ++ EY G L Q ++ K+ E +I L H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 512 CKPP--IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
P ++HRD+K +NI L+ K+ DFGL++I + + GTP Y+ PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQL 182
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
+EKSD++S G ++ E+ P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 406 LGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ----LLQVKLLMRV--HHRNLT 453
LG+G FG+V ++ VAVKML + L+ +M++ H+N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAV 499
L+G C + + ++ EY A G L +L+ ++ E L + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
A+G+E+L +HRD+ + N+L+ E KIADFGL+R I D G
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194
Query: 560 -TP-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
P ++ PE +SDV+SFGV+L EI T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 406 LGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTALIGY 458
LGKG +G VY L DNQ A+K + Q + ++++L V+H N+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQGLEYLHYGCKPPI 516
++GN + ++ EY G L + + +K+ E+ +I + +GL+ LH + I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKI 124
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNE 576
+HRD+KS+NILL KI D G+S++ ++ GTP Y+ PE + +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 577 KSDVYSFGVVLLEIITGRRPVISRAEDD 604
KSD++S G +L E+ T P +R+ D
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 406 LGKGGFGEVYHG--SLDDNQQ--VAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTALI 456
LG G FG V G + ++ VAVK L L + ++ ++ H + LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKE----HMLNWVERLQIAVDSAQGLEYLHYGC 512
G C +G + L+ E G L +YLK ++E + Q+A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA--HQVA----MGMAYLE-SK 114
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVL 571
VHRD+ + N+LL + QAKI+DFG+SR S +T P + PE
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 572 NWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+S+GV L E + G +P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVK----------LLMRVHHRN 451
E+ +G+G F EVY + L D + VA+K + F+++ K LL +++H N
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQ---IFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQGLEYLH 509
+ + IE N + ++ E +G L Q +K K+ ER + V +E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
++HRD+K +N+ + K+ D GL R FS +++ + ++ GTP Y+ PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERI 178
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
N N KSD++S G +L E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 52/222 (23%)
Query: 402 FERV--LGKGGFGEVYHG-SLDDNQQVAVK---MLSSSCCFQLL---QVKLLMRVHHRNL 452
+E++ +G+G +G+VY + + VA+K M + F + ++KLL ++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 453 TALIGYCIE--GNNMGLIYEYMA---SGTLDQY--------LKGKKEHMLNWVERLQIAV 499
L ++ +++EYM +G LD +K + +L
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---------- 110
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+GL+YLH I+HRD+K SNIL+N K+ADFGL+R ++ +S + V
Sbjct: 111 ---EGLQYLH-SNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 560 TPGYLDPE-------YYVLNWLNEKSDVYSFGVVLLEIITGR 594
T Y PE Y + D++S G +L E+ G+
Sbjct: 164 TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHR 450
+R LG+G FG+V+ D VAVK L + F + +LL + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR-EAELLTNLQHE 67
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLK-----------GKKEHMLNWVERLQIAV 499
++ G C+EG+ + +++EYM G L+++L+ G + L + L IA
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--QISTAV 557
A G+ YL VHRD+ + N L+ E L KI DFG+SR + S+D ++
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHT 182
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE + +SDV+S GVVL EI T G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVK--------MLSSSCCFQLLQ-VKLLMRVHHRNLT 453
+LG G FG VY G +LDD AVK QL Q + LL ++ H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAVDSAQGLEYLHY 510
+G E +N+ + E + G+L + LK K V RL QI + GLEYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILL----GLEYLH- 119
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
VHRD+K +NIL++ K+ADFG+++ + + G+P ++ PE
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKS-FKGSPYWMAPEVIA 174
Query: 571 -LNWLNEKSDVYSFGVVLLEIITGRRP 596
+D++S G +LE+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 42/216 (19%)
Query: 405 VLGKGGFGEVYHGSLDD-----NQQVAVKML----SSSCCFQLLQVKLLMR-VHHRNLTA 454
+L +G FG +++G L D ++V VK + S LLQ L+ + H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 455 LIGYCIEGNNMGLI-YEYMASGTLDQYLK------GKKEHMLNWVERLQIAVDSAQGLEY 507
++ CIE + Y YM G L +L+ L+ + + +A+ A G+ Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGTPGYLDP 566
LH K ++H+D+ + N +++E+LQ KI D LSR +F D D
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLF---PMDYHCLG--------DN 178
Query: 567 EYYVLNWL----------NEKSDVYSFGVVLLEIIT 592
E + W+ + SDV+SFGV+L E++T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 404 RVLGKGGFGEVYHGSL--DDN--QQVAVKMLSSSCCFQ-----LLQVKLLMR-VHHRNLT 453
++LG+G FG V G L DD +VAVK + L M+ H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 454 ALIGYCIEGNNMG------LIYEYMASGTLDQYLKGKKEHMLNWVERLQ----IAVDSAQ 503
LIG C E +++ +I +M G L +L + L LQ VD A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGTP- 561
G+EYL +HRD+ + N +L E + +ADFGLS+ I+S + Q +A P
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ--GRIAKMPV 179
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ E KSDV++FGV + EI T G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTA 454
V+G G VY L +N++VA+K + C +V+ + + +H N+
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGK-KEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
+ G+ + L+ Y++ G+L +K L+ + + +GLEYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIF--SIESSDQISTAVAGTPGYLDPEYYVL 571
+HRD+K+ NILL E KIADFG+S + + ++ GTP ++ PE V+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE--VM 178
Query: 572 ---NWLNEKSDVYSFGVVLLEIITGRRP 596
+ + K+D++SFG+ +E+ TG P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 403 ERVLGKGGFGEVYHGSLDDNQQ----VAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLT 453
E+V+G G FGEV G L + VA+K L + + L + ++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L G + + ++ EYM +G+LD +L+ K + ++ + + A G++YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL---SD 124
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLN 572
VHRD+ + NIL+N L K++DFGLSR+ + +T P + PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 573 WLNEKSDVYSFGVVLLEIIT-GRRP 596
SDV+S+G+V+ E+++ G RP
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML-----SSSCCFQLLQVKLLMRV-HHRNLTALI 456
+ LG G FG VY + + + VA+K + S C L +VK L ++ H N+ L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHML------NWVERLQIAVDSAQGLEYLHY 510
E + + ++EYM G L Q +K +K + + QI QGL ++H
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSII--YQIL----QGLAHIH- 116
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
K HRD+K N+L++ KIADFGL+R I S + V T Y PE +
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYRAPE--I 169
Query: 571 L---NWLNEKSDVYSFGVVLLEIITGR 594
L + D+++ G ++ E+ T R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 404 RVLGKGGFGEV----YHGSLDDN-QQVAVKMLSSSCCFQLL-----QVKLLMRVHHRNLT 453
RVLG+G FG+V Y + D + VAVK L C Q ++ +L ++H N+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 454 ALIGYCIEGNNMG--LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
G C E G LI EY+ G+L YL +H LN + L A +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLH-- 124
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGTPGYLDPEYYV 570
+HRD+ + N+LL+ KI DFGL++ + ++ + E
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 571 LNWLNEKSDVYSFGVVLLEIIT 592
N + SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 403 ERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLT 453
E V+G G FGEV G L VA+K L S + L + ++ + H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L G + + +I E+M +G LD +L+ + + ++ + + A G++YL +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYL---SE 124
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP---GYLDPEYYV 570
VHRD+ + NIL+N L K++DFGLSR ++SD T+ G + PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 571 LNWLNEKSDVYSFGVVLLEIIT-GRRP 596
SDV+S+G+V+ E+++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 404 RVLGKGGFGEVYHGSLD---DN--QQVAVKMLSSSCCFQLL-----QVKLLMRVHHRNLT 453
R LG+G FG+V D DN +QVAVK L + ++++L ++H N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 454 ALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
G C E GN + LI E++ SG+L +YL K +N ++L+ AV +G++YL G
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL--G 126
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG---YLDPEY 568
+ VHRD+ + N+L+ + Q KI DFGL++ +IE+ + T + PE
Sbjct: 127 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT 592
+ + SDV+SFGV L E++T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 82/271 (30%), Positives = 121/271 (44%), Gaps = 41/271 (15%)
Query: 406 LGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-----FQ--LLQVKLLMRVHHRNLTALIG 457
+G G FG VY + N+ VAVK +S S +Q + +VK L ++ H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
++ + L+ EY D KK L VE I + QGL YLH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNM---I 143
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNE- 576
HRD+K+ NILL E Q K+ADFG + S +S GTP ++ PE V+ ++E
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPE--VILAMDEG 195
Query: 577 ----KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
K DV+S G+ +E+ + P+ + +N+M A I P+LQ N
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFN------------MNAMSALYHIAQNDSPTLQSN 243
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVL 663
+S V+ C ERP ++L
Sbjct: 244 EWTDSFRGFVDY---CLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 403 ERVLGKGGFGEVYHG--SLDDNQQ--VAVKMLSSSC------CFQLLQVKLLMRVHHRNL 452
ER+LG G FGE+ G L ++ VA+ L + C F L + L + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGF-LAEALTLGQFDHSNI 68
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
L G GN M ++ EYM++G LD +L+ K E L + + + A G++YL
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYL---S 124
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFG-LSRIFSIESSDQISTAVAGTPGYL--DPEYY 569
+ VH+ + + +L+N L KI+ F L + S+ I T ++G L PE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ + SDV+SFG+V+ E+++ G RP
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVK----------LLMRVHHRNL 452
+ +G+G FG++Y + D++ +K + + VK LL ++ H N+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEID----LTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
E + ++ EY G L + + ++ + + + L V + GL+++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118
Query: 513 KPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
I+HRD+KS NI L++ + AK+ DFG++R + S +++ GTP YL PE
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 572 NWLNEKSDVYSFGVVLLEIITGRRP 596
N K+D++S G VL E+ T + P
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 73/216 (33%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 404 RVLGKGGFGEVYHGSL--DDN--QQVAVKML-----SSSCCFQLLQVKLLMR-VHHRNLT 453
R+LGKG FG V L +D Q+VAVKML SSS + L+ M+ H N+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 454 ALIGYCIEGNNMG------LIYEYMASGTLDQYLK----GKKEHMLNWVERLQIAVDSAQ 503
LIG + G +I +M G L +L G++ L ++ +D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT-P- 561
G+EYL +HRD+ + N +LNE + +ADFGLS+ I S D A P
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCASKLPV 179
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+L E N SDV++FGV + EI+T G+ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 396 QKITNNFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQ-----VKLLMRVHH 449
+++ ER+ GKG FGEV+ G + QQV A+K++ ++ + +L +
Sbjct: 3 EELFTKLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLE 506
+T G ++G + +I EY+ G+ L+ + QIA + +GL+
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP------FDEFQIATMLKEILKGLD 115
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS-TAVAGTPGYLD 565
YLH K +HRD+K++N+LL+E+ K+ADFG++ + QI GTP ++
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNTFVGTPFWMA 169
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625
PE + + K+D++S G+ +E+ G P + ++ M I
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPP------------NSDMHPMRVLFLIPKNN 217
Query: 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
P+L G F E AC + S RPT ++L
Sbjct: 218 PPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 399 TNNFER-VLGKGGFGEVYHGSLDDNQ-QVAVKML--SSSCCFQLL--QVKLLMRVHHRNL 452
N ER VLGKG +G VY Q ++A+K + S Q L ++ L + HRN+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGK------KEHMLNWVERLQIAVDSAQGLE 506
+G E + E + G+L L+ K E + + + QI +GL+
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL----EGLK 122
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQA-KIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
YLH IVHRD+K N+L+N KI+DFG S+ + + + GT Y+
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMA 177
Query: 566 PEY--YVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE 602
PE +D++S G ++E+ TG+ P I E
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 45/222 (20%)
Query: 402 FERVLGKGGFGEVYHGSL--DDNQ-QVAVKMLSSSCCFQ-----LLQVKLLMRV-HHRNL 452
FE V+G+G FG+V + D + A+KML ++++L ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 453 TALIGYCIEGNNMGLIY---EYMASGTLDQYLKGK----------KEH----MLNWVERL 495
L+G C N G +Y EY G L +L+ KEH L + L
Sbjct: 66 INLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
Q A D A G++YL + +HRD+ + N+L+ E L +KIADFGLSR +++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVY- 172
Query: 556 AVAGTPGYLDPEYYVLNWLN-----EKSDVYSFGVVLLEIIT 592
V T G L + + LN KSDV+SFGV+L EI++
Sbjct: 173 -VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQVKLLM--R 446
Y IQ+I G G +G+VY + + VA+K+ L F+++Q ++ M
Sbjct: 5 YELIQRI--------GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE 56
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA---VDSAQ 503
H N+ A G + + + ++ EY G+L + + + LQIA ++ +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLK 112
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA----- 558
GL YLH K +HRD+K +NILL E K+ADFG+S Q++ +A
Sbjct: 113 GLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSA--------QLTATIAKRKSF 161
Query: 559 -GTPGYLDPEYYVLNWL---NEKSDVYSFGVVLLEIITGRRP 596
GTP ++ PE + + K D+++ G+ +E+ + P
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLL-----QVKLLMRVHHRNLTAL 455
++ +LG G G VY L + +AVK++ +L ++++L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
G N + + E+M G+LD Y K EH+L +IAV +GL YL + K
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRK-IPEHVLG-----RIAVAVVKGLTYL-WSLK-- 115
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
I+HRDVK SN+L+N + Q K+ DFG+S + + I+ GT Y+ PE
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
SDV+S G+ +E+ GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVK----------LLMRVHHRN 451
E+ +G+G F EVY + L D VA+K + F L+ K LL +++H N
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQGLEYLH 509
+ IE N + ++ E +G L + +K K+ E+ + V LE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
++HRD+K +N+ + K+ D GL R FS S + ++ GTP Y+ PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 178
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
N N KSD++S G +L E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 403 ERVLGKGGFGEVYHGSLDD------NQQVAVKMLSSSCCF----QLLQVKLLMR---VHH 449
R LG+G FG VY G +VA+K ++ + + L +M+ HH
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNW--------VERLQIAVDS 501
+ L+G G ++ E MA G L YL+ ++ N + +Q+A +
Sbjct: 71 --VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT- 560
A G+ YL VHRD+ + N ++ E L KI DFG++R I +D G
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL 183
Query: 561 P-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618
P ++ PE KSDV+SFGVVL E+ T +P + ++ V + +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVID 236
Query: 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
G ++ + N K +EL C + RPT +++ LK+
Sbjct: 237 GGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 406 LGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCF----QLL-QVKLLMRVHHRNLTALIGYC 459
LG+G G V L + + A+K +++ Q+L ++++ + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 460 IE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSAQGLEYLHYGCKPP 515
++ +++G+ EY G+LD K K+ E+ +IA +GL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRK 125
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE------YY 569
I+HRD+K SNILL K Q K+ DFG+S + S T GT Y+ PE Y
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFT---GTSFYMAPERIQGKPYS 181
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE 602
+ SDV+S G+ LLE+ R P E
Sbjct: 182 I------TSDVWSLGLTLLEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 80/245 (32%), Positives = 116/245 (47%), Gaps = 31/245 (12%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLS-----SSCCFQ--LLQVKLLMRVHHRNLTAL 455
R +G G FG VY + N+ VA+K +S S+ +Q + +VK L R+ H N
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
G + + L+ EY D KK L VE I + QGL YLH
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLH---SHN 145
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
++HRD+K+ NILL E Q K+ADFG + I S +S GTP ++ PE V+ ++
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE--VILAMD 197
Query: 576 E-----KSDVYSFGVVLLEIITGRRPVIS-RAEDDTTHISQWVNSMLAEGD----IRNIV 625
E K DV+S G+ +E+ + P+ + A HI+Q + L + RN V
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257
Query: 626 DPSLQ 630
D LQ
Sbjct: 258 DSCLQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 8/148 (5%)
Query: 463 NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522
NN+ + E+M G+LD+ K + + + IAV +GL YL+ I+HRD+K
Sbjct: 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYN--VHRIMHRDIK 131
Query: 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYS 582
SNIL+N + Q K+ DFG+S E + I+ GT Y+ PE KSDV+S
Sbjct: 132 PSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 583 FGVVLLEIITGRRPVISRAEDDTTHISQ 610
G+ ++E+ G+ P DD
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDP 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 73/245 (29%), Positives = 112/245 (45%), Gaps = 31/245 (12%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-------LLQVKLLMRVHHRNLTAL 455
R +G G FG VY + +++ VA+K +S S + +V+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
G + + L+ EY D KK L VE + + QGL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
++HRDVK+ NILL+E K+ DFG + I + + GTP ++ PE V+ ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPE--VILAMD 187
Query: 576 E-----KSDVYSFGVVLLEIITGRRPVIS-RAEDDTTHISQWVNSMLAEGD----IRNIV 625
E K DV+S G+ +E+ + P+ + A HI+Q + L G RN V
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 626 DPSLQ 630
D LQ
Sbjct: 248 DSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 406 LGKGGFGEVYHGS---LDDNQ-----QVAVKMLSSSCCFQ----LLQVKLLMRV--HHRN 451
LG+G FG+V LD + +VAVKML S + L+ +M++ H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQI 497
+ L+G C + + +I EY + G L +YL+ ++ E L++ + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
A A+G+EYL +HRD+ + N+L+ E KIADFGL+R I D
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTT 200
Query: 558 AG--TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
G ++ PE +SDV+SFGV+L EI T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 47/220 (21%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKML-----SSSCC---FQLL-QVKLLMRVHHRN 451
+ LG+G + VY + + VA+K + + F L ++KLL + H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK---------KEHMLNWVERLQIAVDSA 502
+ L+ +N+ L++E+M + L++ +K K K +ML
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYML------MTL---- 112
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
+GLEYLH I+HRD+K +N+L+ K+ADFGL+R F S ++ T T
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVVTRW 167
Query: 563 YLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y PE +Y D++S G + E++ R P
Sbjct: 168 YRAPELLFGARHY-----GVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML-------SSSCCFQLL--QVKLLMRVHHRNLT 453
++LG+G FG VY +D +++AVK + + L +++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLK--GKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
G + + + EYM G++ LK G + QI +G+EYLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH-- 121
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLS-RIFSIESSDQISTAVAGTPGYLDPEYYV 570
IVHRD+K +NIL + K+ DFG S R+ +I SS +V GTP ++ PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRP 596
K+DV+S G ++E++T + P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKML---SSSCCFQLLQ--VKLLMRVHH---RNLTAL 455
++G+G +G VY G + + VA+K++ + +Q V LL ++ N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGC 512
G ++G + +I EY G++ +K + I+V + L+Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGP------IAEKYISVIIREVLVALKYIH--- 118
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE----- 567
K ++HRD+K++NIL+ K+ DFG++ + + SS + + GTP ++ PE
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEG 176
Query: 568 -YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
YY + K+D++S G+ + E+ TG P
Sbjct: 177 KYY-----DTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 405 VLGKGGFGEVY------HGSLDDNQQVAVKMLSSSCC------FQLLQ--VKLLMRVHHR 450
++G G FG VY G L +QV + +S+S L + LL + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGT----LDQYLKGKKEHML--NWVERLQIAVDSAQG 504
N+ +G ++ +++ + EY+ G+ L+ Y G E L N+V ++ +G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQI------LKG 118
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST------AVA 558
L YLH I+HRD+K +NIL++ K KI+DFG+S+ +E++ + ++
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQ 173
Query: 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
G+ ++ PE K+D++S G +++E++TG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTALIG 457
LG G FG+VY +++ + + + ++++ +L H N+ L
Sbjct: 13 LGDGAFGKVY---KAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCKP 514
N + ++ E+ G LD + + E L QI Q L +LH
Sbjct: 70 AYFYENKLWILIEFCDGGALDS-IMLELERGLT---EPQIRYVCRQMLEALNFLH---SH 122
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL--- 571
++HRD+K+ NILL K+ADFG+S +S+ Q GTP ++ PE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSA--KNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 572 --NWLNEKSDVYSFGVVLLEIITGRRP 596
N + K+D++S G+ L+E+ P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 408 KGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIGYC 459
KG FG VY A+K+L S QV ++M A + Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 460 IE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+ + + L+ EY+ G +K +W + Q + G+E LH + I+H
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGIIH 120
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+K N+L+++ K+ DFGLSR + GTP YL PE + ++ S
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 579 DVYSFGVVLLEIITGRRP 596
D +S G V+ E + G P
Sbjct: 175 DWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 404 RVLGKGGFGEVYHGS------LDDNQQVAVKML----SSSCCFQLL-QVKLLMRVHHRNL 452
+ LG+G FG+V + VAVKML SSS LL + LL +V+H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK----------------------EHMLN 490
L G C + + LI EY G+L +L+ + E L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 491 WVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ + A ++G++YL + +VHRD+ + N+L+ E + KI+DFGLSR E S
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
+ ++ E + +SDV+SFGV+L EI+T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQ---------------VAVKMLSSSCCFQ-----LLQV 441
+ LG+G FGEV+ + + VAVKML + L ++
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH----------MLNW 491
K++ R+ + N+ L+G C+ + + +I EYM +G L+Q+L ++ ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 492 VERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
L +AV A G++YL VHRD+ + N L+ KIADFG+SR ++ S D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--NLYSGD 183
Query: 552 --QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
+I ++ E +L SDV++FGV L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 404 RVLGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTALI 456
+G+G G V+ + + VA+K ++ L ++K L H + L+
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCK 513
G+ L+ EYM S L + L+ +E L Q+ G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLR-DEERPLP---EAQVKSYMRMLLKGVAYMH---A 117
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE-YYVLN 572
I+HRD+K +N+L++ KIADFGL+R+FS E S VA T Y PE Y
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGAR 176
Query: 573 WLNEKSDVYSFGVVLLEIITGR 594
+ D+++ G + E++ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 48/128 (37%), Positives = 72/128 (56%), Gaps = 8/128 (6%)
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529
E+M G+LDQ LK N + ++ IAV +GL YL K I+HRDVK SNIL+N
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVN 134
Query: 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLE 589
+ + K+ DFG+S + D ++ + GT Y+ PE +SD++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 590 IITGRRPV 597
+ GR P+
Sbjct: 191 MAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 18/163 (11%)
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV 499
++++L V+H N+ + ++ E+M G+L+ E L V R QI
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD-EQFLADVAR-QIL- 178
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
G+ YLH + IVHRD+K SN+L+N KIADFG+SRI + ++ D +++V G
Sbjct: 179 ---SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA-QTMDPCNSSV-G 230
Query: 560 TPGYLDPEYYVLNWLNE------KSDVYSFGVVLLEIITGRRP 596
T Y+ PE + LN D++S GV +LE GR P
Sbjct: 231 TIAYMSPERINTD-LNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 404 RVLGKGGFGE---VYHGSLDDNQQVAVKMLSSSCCFQLLQVK-----LLMRVHHRNLTAL 455
RV+G+G FG V H + +Q+ A+K + ++ LL ++ H N+ A
Sbjct: 6 RVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
++ ++ EY G L Q +K ++ + LQ V G++++H +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKR 120
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
++HRD+KS NI L + + K+ DFG +R+ + S + GTP Y+ PE + N
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
KSD++S G +L E+ T + P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 68/247 (27%), Positives = 111/247 (44%), Gaps = 49/247 (19%)
Query: 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVK---MLSSSCCF---QLL 439
S+ Y + K LG+G FGEVY + + VA+K M + F L
Sbjct: 5 SKLRDYEILGK--------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 440 QVKLLMRVHHRNLTALIGYCIE-----GNNMGLIY---EYMA---SGTLD-QYLKGKKEH 487
++K+L ++ H N+ LI +E G +Y YM SG L+ +K +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
+ ++ +L +G+ YLH + I+HRD+K++NIL++ + KIADFGL+R +
Sbjct: 117 IKCYMLQL------LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 548 ES---------SDQISTAVAGTPGYLDPEYYVLNWLNEKS--DVYSFGVVLLEIITGRRP 596
+ T + T Y PE +L + D++ G V E+ T RRP
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPE-LLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
Query: 597 VISRAED 603
++ D
Sbjct: 226 ILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 73/234 (31%), Positives = 106/234 (45%), Gaps = 47/234 (20%)
Query: 401 NFERVLGKGGFGEVY-------------HGSLDDNQ----QVAVKMLSSSCCFQLLQ--- 440
NF LG+G FGEV+ + +DN VAVK+L +
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 441 --VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLK-----------GKKEH 487
VK+L R+ N+ L+G C + +I EYM +G L+Q+L+ K
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK-- 125
Query: 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
L++ L +A A G+ YL VHRD+ + N L+ + KIADFG+SR ++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NL 180
Query: 548 ESSDQISTAVAGTP----GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
SSD V G ++ E +L KSDV++FGV L EI+T R
Sbjct: 181 YSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 406 LGKGGFGEVY----HGSLDDNQQ----VAVKMLSSSCCFQ----LLQVKLLMRV--HHRN 451
LG+G FG+V +G VAVKML + + L+ LM++ H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQI 497
+ L+G C + + +I EY A G L ++L+ ++ E L++ + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTA 556
A A+G+EYL +HRD+ + N+L+ E KIADFGL+R + I+ + S
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
++ PE +SDV+SFG+++ EI T
Sbjct: 197 RLPVK-WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 406 LGKGGFGEVYHGS---LDDNQ-----QVAVKMLS--------SSCCFQLLQVKLLMRVHH 449
LG+G FG+V +D ++ VAVKML S ++ +K++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERL 495
+N+ L+G C + + +I EY + G L +YL+ ++ + + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
A+G+EYL +HRD+ + N+L+ E KIADFGL+R + + D
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKK 195
Query: 556 AVAG--TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
G ++ PE +SDV+SFGV++ EI T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHHRNL 452
F + LG G FG V + + A+K+LS + +L QV ++L + H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAVDSAQGLEYLH 509
L G + +N+ L+ EY+ G L +L+ K V R Q+ + LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAAQVVL----ALEYLH 118
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
IV+RD+K N+LL+ KI DFG F+ + T + GTP YL PE
Sbjct: 119 -SLD--IVYRDLKPENLLLDSDGYIKITDFG----FAKRVKGRTYT-LCGTPEYLAPEII 170
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ + D ++ G+++ E++ G P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 402 FERVLGKGGFGEV---YHGSLDDNQQVAVKMLSSSCCFQL------LQVKLLMRVHHRNL 452
F RV+GKG +GEV H + D +Q +K L+ + + +LL ++ H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 453 TALIGYCIEGNNMGLIYEYMA---SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
A EG + GL+Y M G L LK +K +L + ++ V A L+YLH
Sbjct: 62 VAY-RESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ I+HRD+K+ N+ L K+ D G++R+ +E+ +++ + GTP Y+ PE +
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELF 174
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT 592
N KSDV++ G + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 406 LGKGGFGEVYH------GSLDDNQQVAVKMLSSSCCFQ--LLQVKLLMRVHHRNLTALIG 457
LGKGGFGEV G L +++ K L ++ +++ ++L +VH R + +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 458 YCIEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI--AVDSAQGLEYLHYGCKP 514
Y + ++ L+ M G L ++ E + E GLE+LH +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I++RD+K N+LL+ +I+D GL+ ++ + AGTPG++ PE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISRAE 602
+ D ++ GV L E+I R P +R E
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 406 LGKGGFGEVYHGSLDDNQQV-AVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIG 457
LGKGGFGEV + ++ A K L L + K+L +V R + +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 458 YCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
Y E +++ L+ M G L ++ E + A GLE+LH + I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST-AVAGTPGYLDPEYYVLNWLN 575
V+RD+K N+LL++ +I+D GL ++E AGTPGY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGL----AVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 576 EKSDVYSFGVVLLEIITGRRPVISRAE 602
D ++ G L E+I GR P R E
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 406 LGKGGFGEVYHGS---LDDNQ-----QVAVKMLS--------SSCCFQLLQVKLLMRVHH 449
LG+G FG+V +D ++ VAVKML S ++ +K++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERL 495
+N+ L+G C + + ++ EY + G L +YL+ ++ E L + + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
A A+G+EYL +HRD+ + N+L+ E KIADFGL+R + + D
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKK 192
Query: 556 AVAG--TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
G ++ PE +SDV+SFGV+L EI T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 404 RVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSCCF----QLLQVKLLMR-VHHRNLTA 454
R +G+G FG+VY G ++ VAVK + + LQ +MR H ++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYG 511
LIG E N + ++ E G L YL+ K ++ + + S Q L YL
Sbjct: 72 LIGVITE-NPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE-- 124
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYV 570
VHRD+ + N+L++ K+ DFGLSR +E + P ++ PE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESIN 181
Query: 571 LNWLNEKSDVYSFGVVLLEIIT-GRRP--------VISRAE 602
SDV+ FGV + EI+ G +P VI R E
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 406 LGKGGFGEVY---HGSLDDNQQVAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTAL 455
+ KG +G V+ S D A+K++ + + QV +L +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVK 57
Query: 456 IGYCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLH-Y 510
+ Y +G N+ L+ EY+ G L L + ++ + A+ LEYLH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLL-----ENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA------VAGTPGYL 564
G I+HRD+K NIL++ K+ DFGLS++ + ++ + GTP Y+
Sbjct: 113 G----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE + ++ D +S G +L E + G P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 57/306 (18%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VK 442
EI T F LG+ FG+VY G L + Q VA+K L L +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH--------------M 488
+ R+ H N+ L+G + + +I+ Y + L ++L + H
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 489 LNWVERLQIAVDSAQGLEYL--HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IF 545
L + + I A G+E+L H+ +VH+D+ + N+L+ +KL KI+D GL R ++
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDD 604
+ + + ++ ++ PE + + SD++S+GVVL E+ + G +P + D
Sbjct: 176 AADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 605 TTHISQWVNSMLAEGDIRN---IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTD 661
+ IRN + P D+ AW L L C + S RP D
Sbjct: 235 VIEM------------IRNRQVLPCP------DDCPAW-VYTLMLECWNEFPSRRPRFKD 275
Query: 662 VLMELK 667
+ L+
Sbjct: 276 IHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML---------SSSCCFQLLQVKLLMRVHHRNLT 453
++LG+G FGEVY D +++AVK + S +++LL + H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 454 ALIGYCI---EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
G C+ E + + EYM G++ LK N R + QG+ YLH
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLHS 124
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLS-RIFSIESSDQISTAVAGTPGYLDPEYY 569
IVHRD+K +NIL + K+ DFG S RI +I S +V GTP ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
K+DV+S ++E++T + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLM---RV-----HHRNLTA 454
++LGKG FG+V+ L NQ A+K L V+ M RV H LT
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 455 LIGYCI--EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
L YC N+ + EY+ G L +++ H + A + GL++LH
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH--- 113
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
IV+RD+K NILL+ KIADFG+ + + D + GTP Y+ PE +
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQ 171
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH 607
N D +SFGV+L E++ G+ P E++
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 34/266 (12%)
Query: 406 LGKGGFGEVYHGSLDDNQQ--VAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTALIGY 458
+GKG FGEV+ G +D+ Q VA+K++ ++ + +L + +T G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 459 CIEGNNMGLIYEYMASGT-LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
++ + +I EY+ G+ LD G L+ + I + +GL+YLH K +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKK---I 123
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRD+K++N+LL+E + K+ADFG++ + + GTP ++ PE + + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 578 SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637
+D++S G+ +E+ G P ++ M I P+L+GN+
Sbjct: 182 ADIWSLGITAIELAKGEPP------------HSELHPMKVLFLIPKNNPPTLEGNYSK-- 227
Query: 638 AWKAVELALACASHTSSERPTMTDVL 663
E AC + S RPT ++L
Sbjct: 228 --PLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 45/219 (20%)
Query: 405 VLGKGGFGEVYHGSLDDN---QQVAVKMLSSSCCFQ-----LLQVKLLMRV-HHRNLTAL 455
V+G+G FG+V + + A+K + ++++L ++ HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 456 IGYCIEGNNMGLIY---EYMASGTLDQYLKGKK----------EH----MLNWVERLQIA 498
+G C + G +Y EY G L +L+ + + L+ + L A
Sbjct: 62 LGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
D A+G++YL + +HRD+ + NIL+ E AKIADFGLSR ++ V
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY--VK 167
Query: 559 GTPGYLDPEYYVLNWLN-----EKSDVYSFGVVLLEIIT 592
T G L + + LN SDV+S+GV+L EI++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQ-----------------VAVKMLSSSCCFQ-----LL 439
F+ LG+G FGEV+ + + Q VAVK+L L
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK--------------K 485
+VK+L R+ N+ L+G C++ + + +I EYM +G L+Q+L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 486 EHML---NWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542
H L ++ L +A+ A G++YL VHRD+ + N L+ E L KIADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEII 591
R +I ++ E ++ SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 46/241 (19%)
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNN----MGLIYEYMASGTLDQYLKGKKEHMLNWVERL 495
++K L R+ N+ + G+ I+ + + LI EY G L + L KE L++ +L
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKL 125
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
+A+D +GL L+ P ++++ S + L+ E + KI GL +I S ++
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183
Query: 556 AVAGTPGYLDPEYY--VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV- 612
V Y + + + K D+YS GVVL EI TG+ P T I +
Sbjct: 184 MV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF---ENLTTKEIYDLII 235
Query: 613 ---NSMLAEGD----IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665
NS+ D I+ IV+ AC SH S +RP + ++L
Sbjct: 236 NKNNSLKLPLDCPLEIKCIVE--------------------ACTSHDSIKRPNIKEILYN 275
Query: 666 L 666
L
Sbjct: 276 L 276
|
Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 11/160 (6%)
Query: 441 VKLLMRVHHRNLTALIGY---CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI 497
++ L +H N ++G+ + + E+M G+LDQ LK K + ++ I
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
AV +GL YL K I+HRDVK SNIL+N + + K+ DFG+S + D ++ +
Sbjct: 111 AV--LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSF 162
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPV 597
GT Y+ PE + +SD++S G+ L+E+ GR P+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 55/287 (19%)
Query: 405 VLGKGGFGEVY----------------------HGSLDDNQQVAVKMLSSSCCFQLLQVK 442
++GKG +G VY G D Q+ VK L S +++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS-------EIE 60
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLK--GK-KEHMLNWVERLQIAV 499
L + H N+ +G+ + + EY+ G++ L+ G+ +E ++ + Q+
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL- 118
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVA 558
+GL YLH I+HRD+K+ N+L++ KI+DFG+S+ I +DQ + ++
Sbjct: 119 ---EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQ 171
Query: 559 GTPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML 616
G+ ++ PE + K D++S G V+LE+ GRRP S E + +M
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--------IAAMF 222
Query: 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
G+ R+ P + + N + A++ AC + RPT ++L
Sbjct: 223 KLGNKRSA--PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 45/228 (19%)
Query: 399 TNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRV-HHRN 451
T FE V+G+G +G+VY Q VA+K++ + + +L + +H N
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 452 LTALIGYCIEGNNMG------LIYEYMASGTLDQYLKG-------KKEHMLNWVERLQIA 498
+ G I+ N G L+ E G++ +KG KE + ++ R
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR---- 120
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
++ +GL YLH + ++HRD+K NILL + + K+ DFG+S ++S+
Sbjct: 121 -ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFI 174
Query: 559 GTPGYLDPE----------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
GTP ++ PE Y + +SDV+S G+ +E+ G+ P
Sbjct: 175 GTPYWMAPEVIACDEQPDASY-----DARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 42/132 (31%), Positives = 75/132 (56%), Gaps = 1/132 (0%)
Query: 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSS 524
+ L+ +Y +G L Q +K + + + E + + Q L +H+ ++HRD+KS+
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 525 NILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFG 584
NILL K+ DFG S++++ SD + GTP Y+ PE + ++K+D++S G
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 585 VVLLEIITGRRP 596
V+L E++T +RP
Sbjct: 233 VLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 396 QKITNNFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQ-----VKLLMRVHH 449
+++ ER+ GKG FGEVY G + ++V A+K++ ++ + +L +
Sbjct: 3 EELFTKLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLE 506
+T G ++G + +I EY+ G+ LK +E IA + +GL+
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLD 115
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS-TAVAGTPGYLD 565
YLH K +HRD+K++N+LL+E+ K+ADFG++ + QI GTP ++
Sbjct: 116 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNTFVGTPFWMA 169
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE + + K+D++S G+ +E+ G P
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 45/217 (20%)
Query: 406 LGKGGFGEVY---HGSLDDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLT---- 453
LG+G +G V H +AVK + ++ Q L+ + + MR T
Sbjct: 9 LGRGAYGVVDKMRHVPTG--TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 454 -ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQGLEYLHY 510
AL EG+ + + E M + +LD++ K + L E + +IAV + LEYLH
Sbjct: 67 GALFR---EGD-VWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS-TAVAGTPGYLDPE-- 567
++HRDVK SN+L+N Q K+ DFG+S D ++ T AG Y+ PE
Sbjct: 122 KLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKPYMAPERI 175
Query: 568 --------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y V KSDV+S G+ ++E+ TGR P
Sbjct: 176 NPELNQKGYDV------KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 38/224 (16%)
Query: 402 FERVLGKGGFGEVY-------------HGSLDDNQQ----VAVKMLSSSCCFQ-----LL 439
F+ LG+G FGEV+ SLD + VAVKML L
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL-------KGKKEHM--LN 490
++K++ R+ N+ L+ CI + + +I EYM +G L+Q+L +K + ++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 491 WVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ + +A A G++YL VHRD+ + N L+ + KIADFG+SR ++ S
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYSG 183
Query: 551 D--QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
D +I ++ E +L SDV++FGV L EI+T
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 62/206 (30%), Positives = 85/206 (41%), Gaps = 23/206 (11%)
Query: 406 LGKGGFGEV----YHGSLDDNQQVAVKMLSS----SCCFQLLQ-VKLLMRVHHRNLTALI 456
LG G FG V + S VAVK L S L+ ++ + H NL L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 457 GYCIEGNNMGLIYEYMASGTL-DQYLKGKKEHMLNWVERL-QIAVDSAQGLEYLHYGCKP 514
G + + + ++ E G+L D+ K H L + L AV A G+ YL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL--ISTLCDYAVQIANGMRYLE---SK 116
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNW 573
+HRD+ + NILL + KI DFGL R + P + PE L
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SLRT 174
Query: 574 L--NEKSDVYSFGVVLLEIIT-GRRP 596
+ SDV+ FGV L E+ T G P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 47/232 (20%)
Query: 401 NFERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCCFQLL--------QVKLLMRVHHRN 451
+G G +G+V ++VA+K LS FQ +++LL + H N
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAKRTYRELRLLKHMDHEN 75
Query: 452 LTALIG-YCIEGNNMG-----LIYEYMASGTLDQYLKGKK---EHMLNWVERL--QIAVD 500
+ L+ + + L+ M + L+ +K +K +H ++ L QI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDH----IQFLVYQIL-- 128
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
+GL+Y+H I+HRD+K SNI +NE + KI DFGL+R + D+++ VA T
Sbjct: 129 --RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR----HTDDEMTGYVA-T 178
Query: 561 PGYLDPEYYVLNWL--NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610
Y PE +LNW+ N+ D++S G ++ E++TG+ + D HI Q
Sbjct: 179 RWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK--TLFPGSD---HIDQ 224
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 392 YSEIQKITNNFERVLGKGGFGE-VYHGSLDDNQQVAVKMLSSSCCFQ------LLQVKLL 444
Y +++KI G+G FG+ + S +D +Q +K ++ S +V +L
Sbjct: 2 YVKVKKI--------GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVL 53
Query: 445 MRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK------EHMLNWVERLQIA 498
+ H N+ E N+ ++ +Y G L + + ++ + +L+W ++ +A
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
L+++H I+HRD+KS NI L + K+ DFG++R+ + S+ +++
Sbjct: 114 ------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCI 162
Query: 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
GTP YL PE N KSD+++ G VL E+ T
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 404 RVLGKGGFGEVYHGSLDDNQ---QVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTA 454
+ LG+G FG V G L+ + +VAVK + + C + L + + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 455 LIGYCIEG-NNMG-----LIYEYMASGTLDQYLK----GKKEHMLNWVERLQIAVDSAQG 504
LIG C++ + G +I +M G L +L G L ++ D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA-VAGTP-G 562
+EYL +HRD+ + N +LNE + +ADFGLS+ I + D +A P
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK--KIYNGDYYRQGRIAKMPVK 179
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ E KSDV+SFGV + EI T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 400 NNFER--VLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHR 450
N +E V+G+G +G V + + VA+K S + L +VK+L ++ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAVDSAQGLEY 507
N+ L + L++EY+ TL + L+ + R Q+ Q + Y
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL----QAIAY 115
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
H I+HRD+K NIL++E K+ DFG +R + ++ VA T Y PE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 568 YYVLNWLNEKS-DVYSFGVVLLEIITGR 594
V + K DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 11/160 (6%)
Query: 441 VKLLMRVHHRNLTALIGY---CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI 497
++ L +H N ++G+ + + E+M G+LDQ LK + ++ I
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 110
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
AV +GL YL K I+HRDVK SNIL+N + + K+ DFG+S + D ++ +
Sbjct: 111 AV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSF 162
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPV 597
GT Y+ PE + +SD++S G+ L+E+ GR P+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 393 SEIQKITNNFERVLGKGGFGEVYHGSLDDNQQ-----VAVKMLSSSCCFQ-----LLQVK 442
+E +KI +VLG G FG VY G + VA+K L + + L +
Sbjct: 7 TEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE-----HMLNWVERLQI 497
++ V + ++ L+G C+ + + LI + M G L Y++ K+ ++LNW
Sbjct: 62 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 114
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
V A+G+ YL + +VHRD+ + N+L+ KI DFGL+++ + + +
Sbjct: 115 CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 558 AGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIIT-GRRP 596
++ E +L+ + +SDV+S+GV + E++T G +P
Sbjct: 172 KVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 43/294 (14%)
Query: 396 QKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ-----LLQVKLL 444
+KIT R LG+G FG VY G + +VA+K ++ + + L + ++
Sbjct: 6 EKIT--MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 445 MRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN--------WVERLQ 496
+ ++ L+G +G +I E M G L YL+ + M N + +Q
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556
+A + A G+ YL+ VHRD+ + N ++ E KI DFG++R I +D
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKG 178
Query: 557 VAG--TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS 614
G ++ PE SDV+SFGVVL EI T Q
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI--------------ATLAEQPYQG 224
Query: 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
M E +R +++ L DN EL C + RP+ +++ +KE
Sbjct: 225 MSNEQVLRFVMEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKML---SSSCCFQLL---QVKLLMRVHHRNLTALIG 457
+G+G +G+VY D + VA+K + + F + ++K+L +++HRN+ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 458 YCI----------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY 507
+ L++EYM D L G E L I Q LE
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
L+Y K +HRD+K SNILLN K Q K+ADFGL+R+++ E S + V T Y PE
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPE 187
Query: 568 YYVLNWLNEKS-----DVYSFGVVLLEIITGRRPV 597
L E+ DV+S G +L E+ T ++P+
Sbjct: 188 LL----LGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 405 VLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ---LLQVKLLMRV-HHRNLTALIGYC 459
++G G +G+VY G + Q A+K++ + + ++ +L + HHRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 460 IEGNNMG------LIYEYMASGTLDQYLKGKKEHMLN--WVERLQIAVDSAQGLEYLHYG 511
I+ N G L+ E+ +G++ +K K + L W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
+ ++HRD+K N+LL E + K+ DFG+S ++ + GTP ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 572 N-----WLNEKSDVYSFGVVLLEIITGRRPV 597
+ + KSD++S G+ +E+ G P+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRN 451
+ +G G +G V ++VA+K +S+ F L ++KLL + H N
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 452 LTAL--IGYCIEGNNMGLIY---EYMASGTLDQYLKGKK----EHMLNWVERL---QIAV 499
+ L I + +Y E M + L + +K + +H+ + QI
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHI-----QYFLYQILR 114
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS--DQISTAV 557
GL+YLH ++HRD+K SNIL+N KI DFGL+R + ++ V
Sbjct: 115 ----GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 558 AGTPGYLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
T Y PE +L+ + D++S G + E++T +
Sbjct: 168 V-TRWYRAPE-LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 67/247 (27%), Positives = 110/247 (44%), Gaps = 35/247 (14%)
Query: 467 LIYEYMASGTLDQYLKGK-KEHM-LNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSS 524
LI EY + G L++ +K + KEH+ E + L+ +H ++HRD+KS+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA 198
Query: 525 NILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFG 584
NI L K+ DFG S+ +S S ++++ GTP YL PE + ++K+D++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 585 VVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN-----NSAW 639
V+L E++T RP ++ R I+ L G +D +S
Sbjct: 259 VILYELLTLHRPFKGPSQ-------------------REIMQQVLYGKYDPFPCPVSSGM 299
Query: 640 KAVELALACASHTSSERPTMTDVL----MELKECLSLEIVRNEGHEKGHRDPRRMVTLNL 695
KA+ L S + RPT +L ++ L +IVR+ H + L
Sbjct: 300 KALLDPL--LSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQE 357
Query: 696 DTESSPS 702
E +P
Sbjct: 358 SGERAPP 364
|
Length = 478 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 404 RVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTA 454
+VLGKG FG+V L N+ A+K L C + + L + H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 455 LIGYCIEGNNMGLIY--EYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLHYG 511
L +C L + EY+ G L +++ R + A + GL++LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICGLQFLH-- 113
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
K I++RD+K N+LL++ KIADFG+ + + ++ GTP Y+ PE
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDYIAPEILKG 170
Query: 572 NWLNEKSDVYSFGVVLLEIITGRRPVISRAED--------DTTHISQWV 612
NE D +SFGV+L E++ G+ P ED D H +W+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 42/220 (19%)
Query: 406 LGKGGFGEVYHG---SLDDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTALIG 457
+G G FG+V G +V VK L +S L +V+ ++H N+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGLEYLHYGCKP 514
CIE L+ E+ G L YL+ + + ++ ++A + A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
+H D+ N L L KI D+GL+ D T D L WL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITK--------DCHAVPLRWL 169
Query: 575 -----------------NEKSDVYSFGVVLLEIIT-GRRP 596
+KS+++S GV + E+ T +P
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQVK 442
++ Q Y IQ++ G G +G+VY +L + AVK+ L F L+Q +
Sbjct: 5 RNPQHDYELIQRV--------GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE 56
Query: 443 LLM--RVHHRNLTALIGYCIEGNNMGLIYEYMASGTL-DQYLKGKKEHMLNWVERLQIAV 499
+ M H N+ A G + + + EY G+L D Y H+ + LQIA
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY------HVTGPLSELQIAY 110
Query: 500 ---DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556
++ QGL YLH K +HRD+K +NILL + K+ADFG++ I ++ +
Sbjct: 111 VCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKS 165
Query: 557 VAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEI 590
GTP ++ PE + N+ D+++ G+ +E+
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 406 LGKGGFGEVY---------HGSLDDNQQVAVKMLSSSCCFQL-LQVKLLMRVHHRNLTAL 455
LGKG FG VY L +++ V L+ + Q + +LL ++ H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKE--------HMLNWVERLQIAVDSAQGLEY 507
+E + +I EY LD L+ K + W +L + V Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------Y 121
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
+H + I+HRD+K+ NI L L KI DFG+SR+ + S ++T GTP Y+ PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPE 175
Query: 568 YYVLNWLNEKSDVYSFGVVLLEI 590
+ KSD++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 396 QKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQVKLLMRVHHRN- 451
+K FE++ G+G G VY + Q+VA++ L +L+ ++L+ ++N
Sbjct: 19 KKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 452 --LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ L Y + G+ + ++ EY+A G+L + E ++ + + + Q LE+LH
Sbjct: 78 NIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH 133
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
++HRD+KS NILL K+ DFG + E S + + + GTP ++ PE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVV 188
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
K D++S G++ +E+I G P ++
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDD------NQQVAVKMLSSSCCF----QLLQVKL 443
E+ + R LG+G FG VY G+ D +VAVK ++ S + L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 444 LMR---VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN--------WV 492
+M+ HH + L+G +G ++ E MA G L YL+ + N
Sbjct: 62 VMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 493 ERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552
E +Q+A + A G+ YL+ VHRD+ + N ++ KI DFG++R I +D
Sbjct: 120 EMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDY 174
Query: 553 ISTAVAG--TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
G ++ PE SD++SFGVVL EI +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 402 FERVLGKGGFGEVYHGSLDDN---QQVAVKMLSSSCCFQ-----LLQVKLLMRV-HHRNL 452
F+ V+G+G FG+V + + A+K + ++++L ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIA 498
L+G C + L EY G L +L+ + L+ + L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
D A+G++YL + +HRD+ + NIL+ E AKIADFGLSR + V
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVK 179
Query: 559 GTPGYLDPEYYVLNWLN-----EKSDVYSFGVVLLEIIT 592
T G L + + LN SDV+S+GV+L EI++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 51/209 (24%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 396 QKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKM--LSSSCCFQLL--QVKLLMRVHHR 450
+K +E++ G+G G V+ + Q+VA+K L +L+ ++ ++ + +
Sbjct: 18 KKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP 76
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
N+ + + G+ + ++ EY+A G+L + E ++ + + + Q LE+LH
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHA 133
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
++HRD+KS N+LL K+ DFG + E S + + + GTP ++ PE
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT 188
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
K D++S G++ +E++ G P ++
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 404 RVLGKGGFGEVYH------GSLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNL 452
+ LG G F Y G+L +QV +SS ++++ ++L+ R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKG----KKEHMLNWVERLQIAVDSAQGLEYL 508
++G E ++ L E+MA G++ L K+ ++N+ E+L +GL YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQ-AKIADFGLS-RIFS-IESSDQISTAVAGTPGYLD 565
H + I+HRDVK +N+L++ Q +IADFG + R+ + + + + GT ++
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE DV+S G V++E+ T + P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 396 QKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQVKLLMRVHHRN- 451
+K FE++ G+G G VY + Q+VA+K L +L+ ++L+ ++N
Sbjct: 18 KKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP 76
Query: 452 --LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ L Y + G+ + ++ EY+A G+L + E ++ + + + Q L++LH
Sbjct: 77 NIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLH 132
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
++HRD+KS NILL K+ DFG + E S + + + GTP ++ PE
Sbjct: 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVV 187
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
K D++S G++ +E++ G P ++
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNL------- 452
NF VLGKG FG+V ++ A+K+L Q V+ M V R L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTM-VEKRVLALPGKPP 61
Query: 453 --TALIGYCIEGNNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
T L + + + EY+ G L Q K K+ H + + A + A GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIGLF 115
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR--IFSIESSDQISTAVAGTPGYL 564
+LH I++RD+K N++L+ + KIADFG+ + IF + + GTP Y+
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----GGKTTRTFCGTPDYI 168
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
PE + D ++FGV+L E++ G+ P ED+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML---------SSSCCFQLLQVKLLMRVHHRNLT 453
++LG+G FG VY +D +++A K + S +++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 454 ALIGYCIEGN---NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
G C+ + + EYM G++ LK + V R + +G+ YLH
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTR-KYTRQILEGMSYLHS 124
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLS-RIFSIESSDQISTAVAGTPGYLDPEYY 569
IVHRD+K +NIL + K+ DFG S R+ +I S +V GTP ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
K+DV+S G ++E++T + P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVH-HRNLTALI 456
FE++ G+G G VY + Q+VA+K ++ + ++ L+MR + H N+ +
Sbjct: 24 FEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
+ G+ + ++ EY+A G+L + E ++ + + + Q LE+LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQV 136
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNE 576
+HRD+KS NILL K+ DFG + E S + + + GTP ++ PE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGP 194
Query: 577 KSDVYSFGVVLLEIITGRRP 596
K D++S G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLM---RV-----HHRNLTA 454
+VLGKG FG+V L ++ AVK+L Q V+ M RV H LT
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L + + + EY+ G L + + + + A + GL++LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVLGLQFLH- 113
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
+ I++RD+K N+LL+ + KIADFG+ + I ST GTP Y+ PE
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTST-FCGTPDYIAPEILS 169
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
D ++ GV+L E++ G+ P ED+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 55/226 (24%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQ----VAVKML---SSSCCFQL 438
+R +E++K+ ++LG G FG V+ G + + VA+K + S FQ
Sbjct: 1 ARILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE 55
Query: 439 LQVKLLM--RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK-----EHMLNW 491
+ +L + H + L+G C G ++ L+ + G+L +++ + + +LNW
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114
Query: 492 VERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
V A+G+ YL +VHR++ + NILL +IADFG++ + +
Sbjct: 115 ------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
Query: 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ ++ E + +SDV+S+GV + E+++ G P
Sbjct: 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC------FQLLQVKLLMRV---HHRNLTAL 455
+G+G +G VY L+ + VA+K + L ++ LL ++ H N+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 456 IGYCI-----EGNNMGLIYEYMASGTLDQYLK-----GKKEHMLNWVERLQIAVDSAQGL 505
+ C + L++E++ L YL G + + R Q+ +G+
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR-QLL----RGV 120
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
++LH IVHRD+K NIL+ Q KIADFGL+RI+S E + T+V T Y
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRA 174
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE + + D++S G + E+ RRP
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML---------SSSCCFQLLQVKLLMRVHHRNLT 453
++LG+G FG VY D +++AVK + S +++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 454 ALIGYCIEG---NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
G C+ + + E+M G++ LK N + + Q LE + Y
Sbjct: 68 QYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-----TRQILEGVSY 121
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLS-RIFSIESSDQISTAVAGTPGYLDPEYY 569
IVHRD+K +NIL + K+ DFG S R+ +I S +V GTP ++ PE
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
K+D++S G ++E++T + P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 404 RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ---LLQVKLLMRV-HHRNLTALIGY 458
V+G G +G+VY G + Q A+K++ + + L++ +L + HHRN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 459 CIEGNNMG------LIYEYMASGTLDQYLKGKKEHML--NWVERLQIAVDSAQGLEYLHY 510
I+ + G L+ E+ +G++ +K K + L +W+ I + +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH- 138
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
++HRD+K N+LL E + K+ DFG+S ++ + GTP ++ PE
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 571 LN-----WLNEKSDVYSFGVVLLEIITGRRPV 597
+ + +SD++S G+ +E+ G P+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 33/220 (15%)
Query: 404 RVLGKGGFGEVY-----HGSLDDNQQVAVKMLSSSCCFQLLQVK----------LLMRVH 448
+VLG+G FG+V+ G D Q A+K+L + L+V+ +L V+
Sbjct: 2 KVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKAT----LKVRDRVRTKMERDILAEVN 56
Query: 449 HRNLTAL-IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY 507
H + L + EG + LI +++ G D + + KE M + + A L++
Sbjct: 57 HPFIVKLHYAFQTEGK-LYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDH 113
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA--GTPGYLD 565
LH I++RD+K NILL+E+ K+ DFGLS+ ES D A + GT Y+
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMA 166
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
PE + +D +SFGV++ E++TG P + +T
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 37/217 (17%)
Query: 401 NFERV--LGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQVKLLMR--VHHRNLT 453
+FE + +G G +G+VY +++ + A+K+ L F ++Q +++M H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 454 ALIGYCIEGNNMGLIYEYMASGTL-DQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLH 509
A G + + + + E+ G+L D Y H+ + QIA ++ QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY------HVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA------GTPGY 563
K +HRD+K +NILL + K+ADFG+S QI+ +A GTP +
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSA--------QITATIAKRKSFIGTPYW 172
Query: 564 LDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRPV 597
+ PE + N+ D+++ G+ +E+ + P+
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 39/216 (18%)
Query: 401 NFERV--LGKGGFGEVYHG-SLDDNQQVAVKM-----------LSSSCCFQLLQVKLLMR 446
FE++ +G+G +G VY + VA+K +SS L ++ LL+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-----LREITLLLN 62
Query: 447 VHHRNLTALIGYCIEGN---NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
+ H N+ L + G ++ L+ EY +Q L ++M Q+ Q
Sbjct: 63 LRHPNIVELK-EVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 504 ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
GL+YLH I+HRD+K SN+LL +K KIADFGL+R + + + V T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--T 171
Query: 561 PGYLDPEYYVLNWLNEKS--DVYSFGVVLLEIITGR 594
Y PE +L + D+++ G +L E++ +
Sbjct: 172 LWYRAPE-LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQ-----VAVKMLSSS----CCFQLLQVKLLM-RVHHRNLT 453
+VLG G FG VY G + VA+K+L+ + + + L+M + H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH-----MLNWVERLQIAVDSAQGLEYL 508
L+G C+ + L+ + M G L Y+ K++ +LNW V A+G+ YL
Sbjct: 73 RLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
+ +VHRD+ + N+L+ KI DFGL+R+ + + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+SDV+S+GV + E++T G +P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 406 LGKGGFGEVYHG--SLDDNQ-QVAVKMLSS----SCCFQLL-QVKLLMRVHHRNLTALIG 457
LG G FG V G + Q VA+K+L + S +++ + +++ ++ + + +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHML--NWVERLQIAVDSAQGLEYLHYGCKPP 515
C E + L+ E + G L+++L GKK+ + N VE + + G++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---QVSMGMKYLE---GKN 115
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNWL 574
VHRD+ + N+LL + AKI+DFGLS+ + S + + P + PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 575 NEKSDVYSFGVVLLEIIT-GRRP 596
+ +SDV+S+G+ + E + G++P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNLTALIG-- 457
NF VLGKG FG+V ++ A+K+L Q V+ M V R L AL G
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVL-ALSGKP 60
Query: 458 -------YCIEG-NNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGL 505
C + + + + EY+ G L Q + K+ H + + A + A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAIGL 114
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-DQISTAV-AGTPGY 563
+LH I++RD+K N++L+ + KIADFG+ + E+ D ++T GTP Y
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
+ PE + D ++FGV+L E++ G+ P ED+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTA 454
+VLGKG FG+V L + AVK L C + + L + + LT
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L ++ + E++ G L +++ K L A + GL++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQFLH---SK 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSR--IFSIESSDQISTAVAGTPGYLDPEYYVLN 572
I++RD+K N++L+ KIADFG+ + +F D ++ GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----GDNRASTFCGTPDYIAPEILQGL 171
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAED--------DTTHISQWV 612
D +SFGV+L E++ G+ P ED DT H +W+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQ----VAVKML----SSSCCFQL 438
R +E++K+ +VLG G FG VY G + D + VA+K+L S ++
Sbjct: 2 RILKETELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI 56
Query: 439 LQVKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK-----EHMLNWV 492
L +M V + L+G C+ + + L+ + M G L Y++ K + +LNW
Sbjct: 57 LDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW- 114
Query: 493 ERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552
V A+G+ YL + +VHRD+ + N+L+ KI DFGL+R+ I+ ++
Sbjct: 115 -----CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166
Query: 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ ++ E + +SDV+S+GV + E++T G +P
Sbjct: 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 401 NFERV--LGKGGFGEVYHGSLDDN----QQVAVKMLSSSCCFQLLQVK-------LLMRV 447
+ ER+ +G G FG V+ L + A+K+++ +L Q + +L V
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY 507
H + L + + ++ EY+ G L YL+ + L A + LEY
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
LH IV+RD+K NILL+++ K+ DFG F+ + D+ T + GTP YL PE
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDRTWT-LCGTPEYLAPE 168
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
N+ D ++ G+++ E++ G P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 36/208 (17%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLL--------QVKLLMRVHHRNLTALI 456
+G G +G V Q+VAVK LS FQ L +++LL + H N+ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 457 -----GYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYL 508
IE N + + L+ +K +K EH+ + +L +GL+Y+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL------LRGLKYI 134
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
H I+HRD+K SN+ +NE + +I DFGL+R ++ D+++ VA T Y PE
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVA-TRWYRAPE- 185
Query: 569 YVLNWL--NEKSDVYSFGVVLLEIITGR 594
+LNW+ N+ D++S G ++ E++ G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLM---RV-----HHRNLTA 454
RVLGKG FG+V L ++ ++ AVK+L Q V+ M R+ +H LT
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 455 LIGYCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L C + + + + E++ G L +++ K + A + L +LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEITSALMFLH---D 114
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV-AGTPGYLDPEYYVLN 572
I++RD+K N+LL+ + K+ADFG+ + + +T+ GTP Y+ PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
D ++ GV+L E++ G P + EDD
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 406 LGKGGFGEVYHG--SLDDN----QQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYC 459
LG+G + V+ G L +N +++ ++ + C + +V LL + H N+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519
+ L++EY+ S L QYL ++ N + + + Q L L Y K I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 520 DVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS- 578
D+K N+L+NEK + K+ADFGL+R S+ + + V T Y P+ VL E S
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD--VLLGSTEYST 183
Query: 579 --DVYSFGVVLLEIITGR 594
D++ G +L E+ TGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 26/202 (12%)
Query: 406 LGKGGFGEVYHG--SLDDN----QQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYC 459
LG+G + VY G L DN +++ ++ + C + +V LL + H N+ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 460 IEGNNMGLIYEYMASGTLDQYLK--GKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
++ L++EY+ L QYL G +M N + + Q L L+Y + ++
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHN------VKLFLFQLLRGLNYCHRRKVL 126
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIES---SDQISTAVAGTPGYL--DPEYYVLN 572
HRD+K N+L+NE+ + K+ADFGL+R SI + S+++ T P L +Y
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY---- 182
Query: 573 WLNEKSDVYSFGVVLLEIITGR 594
+ + D++ G + E+ TGR
Sbjct: 183 --STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 9/105 (8%)
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
++ V + L YL K ++HRDVK SNILL+ K+ DFG+S ++S + T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDS--KAKT 172
Query: 556 AVAGTPGYLDPEYYVLNWLNEK----SDVYSFGVVLLEIITGRRP 596
AG Y+ PE N K +DV+S G+ L+E+ TG+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 40/210 (19%)
Query: 406 LGKGGFGEVYHGSLDDNQ--QVAVKMLSSSCCFQLL--------QVKLLMRVHHRNLTAL 455
+G G +G V + D +VAVK LS FQ + +++LL + H N+ L
Sbjct: 25 VGSGAYGSVC-AAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 456 IGYCI------EGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLE 506
+ E N++ L+ M + L+ +K +K +H+ + ++ +GL+
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI------LRGLK 134
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
Y+H I+HRD+K SN+ +NE + KI DFGL+R + D+++ VA T Y P
Sbjct: 135 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRAP 186
Query: 567 EYYVLNWL--NEKSDVYSFGVVLLEIITGR 594
E +LNW+ N+ D++S G ++ E++TGR
Sbjct: 187 E-IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 32/198 (16%)
Query: 420 DDNQQVAVKMLS----SSCCFQLLQVKLLM--RVHHRNLTALIGYCIEGNNMGLIYEYMA 473
N VAVK ++ S +LLQ +++ ++ H N+ + I + + ++ MA
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 474 SGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
G+ + LK H + L IA D L+Y+H +HR VK+S+ILL+
Sbjct: 83 YGSCEDLLK---THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSG 136
Query: 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL------------NEKS 578
+ ++ GL S+ + V P L WL NEKS
Sbjct: 137 DGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKS---SVKNLPWLSPEVLQQNLQGYNEKS 191
Query: 579 DVYSFGVVLLEIITGRRP 596
D+YS G+ E+ G P
Sbjct: 192 DIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAV-KMLSSSCCFQL----LQVKLLMRVHHRNLTALIGYCI 460
LG G FG+VY + +A K++ + +L +++ +L H N+ L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAVDSAQGLEYLHYGCKPPIV 517
NN+ ++ E+ A G +D ML L QI V Q LE L+Y + I+
Sbjct: 73 YENNLWILIEFCAGGAVDAV-------MLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 518 HRDVKSSNILLNEKLQAKIADFGLS--RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
HRD+K+ NIL K+ADFG+S +I+ D + GTP ++ PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWMAPEVVMCETSK 181
Query: 576 E-----KSDVYSFGVVLLEI 590
+ K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 28/201 (13%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAV-KMLSSSCCFQL----LQVKLLMRVHHRNLTALIGYCI 460
LG G FG+VY + +A K++ + +L +++++L +H + L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 461 EGNNMGLIYEYMASGTLDQYL----KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
+ ++ E+ G +D + +G E QI V Q LE L Y I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--------QIQVICRQMLEALQYLHSMKI 131
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLS--RIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
+HRD+K+ N+LL K+ADFG+S + +++ D + GTP ++ PE + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD----SFIGTPYWMAPEVVMCETM 187
Query: 575 NE-----KSDVYSFGVVLLEI 590
+ K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/266 (25%), Positives = 102/266 (38%), Gaps = 69/266 (25%)
Query: 400 NNFERV--LGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK-------LLMRVHH 449
++FE + +G+G FGEV+ D QV A+K+L S + Q+ +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK---KEHMLNW-VERLQIAVDSAQGL 505
+ L + ++ L+ EYM G L L K E + + L +A+DS L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS------------RIFSIESSDQ- 552
+ +HRD+K NIL++ K+ADFGL S +
Sbjct: 121 GF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 553 --------------ISTAVAGTPGYLDPE-----YYVLNWLNEKSDVYSFGVVLLEIITG 593
+ + GTP Y+ PE Y + D +S GV+L E++ G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-----GLECDWWSLGVILYEMLYG 226
Query: 594 RRPVISRAEDDTTH-----ISQWVNS 614
P S DT I W S
Sbjct: 227 FPPFYS----DTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 28/230 (12%)
Query: 401 NFE--RVLGKGGFGEVY----HGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTA 454
NFE RVLG G +G+V+ G D + A+K+L + Q + R + L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 455 LIG--------YCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
+ Y + + + LI +Y+ G L +L ++EH R+ IA + L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIA-EIVLAL 118
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
++LH + I++RD+K NILL+ + + DFGLS+ F E ++ + + GT Y+
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMA 174
Query: 566 PEYYVLN----WLNEKSDVYSFGVVLLEIITGRRP-VISRAEDDTTHISQ 610
PE V+ ++ D +S GV+ E++TG P + ++ + IS+
Sbjct: 175 PE--VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 399 TNNFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNLTAL-- 455
NF VLGKG FG+V ++ A+K+L Q V+ M V R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVLALQDK 59
Query: 456 ------IGYCIEG-NNMGLIYEYMASGTLDQYLK--GK-KEHMLNWVERLQIAVDSAQGL 505
+ C + + + + EY+ G L +++ GK KE + + A + + GL
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGL 114
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
+LH + I++RD+K N++L+ + KIADFG+ + ++ + GTP Y+
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIA 169
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
PE + D +++GV+L E++ G+ P ED+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTALI 456
+G G +G V ++VA+K LS FQ ++ LL + H N+ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--FQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 457 GY---CIEGNNMGLIYEYMASGTLD-QYLKGKKEHMLNWVERLQIAV-DSAQGLEYLHYG 511
+ G+ Y M D Q + G H L+ +++Q V GL+Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLS-EDKVQYLVYQMLCGLKYIH-- 134
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
I+HRD+K N+ +NE + KI DFGL+R +D T T Y PE +L
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPE-VIL 187
Query: 572 NWL--NEKSDVYSFGVVLLEIITGR 594
NW+ N+ D++S G ++ E++TG+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 36/228 (15%)
Query: 401 NFE--RVLGKGGFGEVYHGSLDDNQQV-AVKML--------SSSCCFQLLQVKLLMRVHH 449
+FE +V+G+G FGEV L + +V A+K+L + + CF+ + +L+ +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLVNGDN 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN-----WVERLQIAVDSAQG 504
+ +T L + NN+ L+ +Y G L L ++ + ++ + IA+DS
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L Y VHRD+K NIL++ ++ADFG + + Q S AV GTP Y+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 565 DPEYYVLNWLNE-------KSDVYSFGVVLLEIITGRRPVISRAEDDT 605
PE +L + + + D +S GV + E++ G P + + +T
Sbjct: 171 SPE--ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 50/219 (22%)
Query: 404 RVLGKGGFGEV---YHGSLDDNQQVAVKMLS-----SSCCFQLLQVKLLMRVHHRNLTAL 455
+G+G +G V H +VA+K +S + C L ++K+L R H N+ +
Sbjct: 11 SYIGEGAYGMVCSATH--KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 456 IGYCIEGN--NMGLIY---EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ------- 503
+ + + +Y E M + D Y K +H+ N D Q
Sbjct: 69 LDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSN---------DHIQYFLYQIL 116
Query: 504 -GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES--SDQISTAVAGT 560
GL+Y+H ++HRD+K SN+LLN KI DFGL+RI E + ++ VA T
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-T 172
Query: 561 PGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
Y PE LN K D++S G +L E+++ R
Sbjct: 173 RWYRAPEIM----LNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 404 RVLGK---GGFGEVYHG-SLDDNQQVAVKML-----SSSCCFQLLQVKLLMRV-HHRNLT 453
++LGK G F EV S + A+K + S L +++ L R+ H N+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 454 ALIG--YCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-----LNWVERLQIAVDSAQGLE 506
LI + + + L++E M L + +KG+K + +++ +L + L+
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLD 114
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
++H + I HRD+K NIL+ + + K+ADFG R I S T T Y P
Sbjct: 115 HMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCR--GI-YSKPPYTEYISTRWYRAP 167
Query: 567 E------YYVLNWLNEKSDVYSFGVVLLEIIT 592
E YY K D+++ G V EI++
Sbjct: 168 ECLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 47/135 (34%), Positives = 67/135 (49%), Gaps = 14/135 (10%)
Query: 172 PILNAMEIYMVKNSSQLLTDEDDVNALRNIKST----YGVKRNWQGDPCVPKNYWWDGLN 227
P L M ++ N S L +E + L + KS+ NW V W G+
Sbjct: 10 PYLIFMLFFLFLNFSMLHAEE--LELLLSFKSSINDPLKYLSNWNSSADVCL---WQGIT 64
Query: 228 CSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLP-SL 286
C NN SR++S++LS ++G+IS L I+ ++LSNN LSG P+ + SL
Sbjct: 65 C----NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSL 120
Query: 287 RALNLKRNKLTGSLP 301
R LNL N TGS+P
Sbjct: 121 RYLNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 406 LGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIG 457
LG GGFG V N+ A+K + + Q + +L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA-VDSAQGLEYLHYGCKPPI 516
+ + ++ EY G L L+ + + R IA V A EYLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLA--FEYLH---NRGI 114
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-WLN 575
++RD+K N+LL+ K+ DFG ++ ++S + T GTP Y+ PE +LN +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQKTWTFC-GTPEYVAPE-IILNKGYD 170
Query: 576 EKSDVYSFGVVLLEIITGRRPVISRAEDD 604
D +S G++L E++TGR P ED
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDP 199
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQ-------LLQVKLLMRVHHRNLTAL 455
++LGKG FG+V + A+K+L L + ++L H LTAL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+ + + EY G L +L +E + + + L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC---D 115
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
+V+RD+K N++L++ KI DFGL + I + T GTP YL PE N
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 576 EKSDVYSFGVVLLEIITGRRPVISRAED 603
D + GVV+ E++ GR P ++ +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 36/180 (20%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQ-VAVK---MLSSSCCF---QLLQVKLL 444
Y ++ KI G+G FGEV+ +Q VA+K M + F L ++K+L
Sbjct: 14 YEKLAKI--------GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKIL 65
Query: 445 MRVHHRNLTALIGYCIEGNNMG--------LIYEYMA---SGTLDQ-YLKGKKEHMLNWV 492
+ H N+ LI C L++E+ +G L +K + +
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 493 ERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552
+ L GL Y+H I+HRD+K++NIL+ + K+ADFGL+R FS+ + +
Sbjct: 126 KML------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKMLS-----SSCCFQLLQVKLLMRVHHRNLTALIGY 458
LG+G + VY G S Q VA+K + + + + LL + H N+ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 459 CIEGNNMGLIYEYMASGTLDQYLK--GKKEHMLNWVERL-QIAVDSAQGLEYLHYGCKPP 515
+ L++EY+ + L QY+ G M N L Q+ +GL Y H +
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH---QRR 123
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
++HRD+K N+L++E+ + K+ADFGL+R S+ S + V T Y P+ VL
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPD--VLLGST 179
Query: 576 EKS---DVYSFGVVLLEIITGRR--PVISRAEDDTTHI 608
E S D++ G + E+ TGR P + ED I
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 398 ITNNFERV--LGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQLL------QVKLLMR 446
ITN + + +G G FG V S D Q VA+K + +L ++KLL
Sbjct: 8 ITNRYVDLQPVGMGAFGLVC--SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 447 VHHRNLTALIGYCIEG-NNMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQG 504
+ H N+ +L I ++ + E + + L + L + E QI +G
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL----RG 120
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L+Y+H +VHRD+K SNIL+NE KI DFGL+RI D T T Y
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172
Query: 565 DPEYYVLNW--LNEKSDVYSFGVVLLEIITGR 594
PE +L W + + D++S G + E++ G+
Sbjct: 173 APE-IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 406 LGKGGFGEVYHGSLDDNQQ-VAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIG 457
+G+GG+G+V+ D + VA+K + S F+L +V+ +L L L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKG----KKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
+ + L EY+ G L ++H ++ + AVD+ L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGTPGYLDPEYYVLN 572
+HRD+K N L++ K+ DFGLS+ I + +S V G+P Y+ PE VL
Sbjct: 123 ---IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPE--VLR 171
Query: 573 --WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT-THISQW 611
+ D +S G +L E + G P ++T ++ W
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 22/183 (12%)
Query: 423 QQVAVKM--LSSSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478
+QVAVK L +LL +V ++ H N+ + + G+ + ++ E++ G L
Sbjct: 45 RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535
+ + + QIA L +LH ++HRD+KS +ILL + K
Sbjct: 105 DIVTHTRMN------EEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVK 155
Query: 536 IADFGLSRIFSIESSDQI--STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITG 593
++DFG F + S ++ ++ GTP ++ PE + D++S G++++E++ G
Sbjct: 156 LSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
Query: 594 RRP 596
P
Sbjct: 212 EPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 38/213 (17%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTALI 456
+G+G +G V + + N++VA+K ++++ F L ++KLL + H N+ A+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 457 GYCIEGNNMG------LIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLE 506
+ + ++YE M + L Q ++ + +H ++ +L +GL+
Sbjct: 71 D-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
Y+H ++HRD+K SN+LLN KI DFGL+R S E D ++ V T Y P
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVV-TRWYRAP 177
Query: 567 EYYVLNWLNEKS--DVYSFGVVLLEIITGRRPV 597
E +LN + DV+S G + E++ GR+P+
Sbjct: 178 E-LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 406 LGKGGFGEVYHG--SLDDN----QQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYC 459
LG+G + V+ G L +N +++ ++ + C + +V LL + H N+ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519
++ L++EY LD+ LK + N + + + Q L L Y + ++HR
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 520 DVKSSNILLNEKLQAKIADFGLSRIFSIES---SDQISTAVAGTPGYL--DPEYYVLNWL 574
D+K N+L+NE+ + K+ADFGL+R S+ + S+++ T P L EY
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY------ 182
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608
+ + D++ G + E+ +GR +D H+
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 403 ERVLGKGGFGEVYHGSLD--DNQQVAVKMLSSSCCFQLLQ--------VKLLMRVHHRNL 452
+G G +G V ++D ++VA+K + + F + +K+L H N+
Sbjct: 10 IENIGSGAYGVVCS-AIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKILRHFKHDNI 66
Query: 453 TALIGYCI------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QIAVDSAQG 504
A+ I + ++ ++ + M S L + + + Q+ +G
Sbjct: 67 IAIRD--ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL----RG 119
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTPG 562
L+Y+H ++HRD+K SN+L+NE + +I DFG++R S ++ T T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 563 YLDPE-YYVLNWLNEKSDVYSFGVVLLEIITGRRPV 597
Y PE L D++S G + E++ GRR +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
++ISL+LS + L+GEI L +E L L +N+ +G P L+ LP L+ L L NK
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 297 TGSLPADLVERSNNGSLTLSVDGNT----STTCSS 327
+G +P +L + +N L LS + T CSS
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 72/269 (26%), Positives = 109/269 (40%), Gaps = 72/269 (26%)
Query: 400 NNFE--RVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSCCF---QLLQVK----LLMR 446
++FE +V+G+G FGEV L D A+K L S Q+ V+ +L
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57
Query: 447 VHHRNLTALIGYCI--EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-----AV 499
+ + L Y + N + LI EY+ G + L KK+ R I A+
Sbjct: 58 ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAI 114
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS------------RIFS- 546
DS L Y +HRD+K N+LL+ K K++DFGL RI S
Sbjct: 115 DSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 547 -------------IESSDQIST----------AVAGTPGYLDPEYYVLNWLNEKSDVYSF 583
+ S + T + GTP Y+ PE ++ N++ D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 584 GVVLLEIITGRRPVISRAEDDTTH-ISQW 611
GV++ E++ G P S +T I W
Sbjct: 226 GVIMYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 68/260 (26%), Positives = 119/260 (45%), Gaps = 29/260 (11%)
Query: 406 LGKGGFGEVYHG---SLDDNQQVAVKMLSS-----SCCFQLL-QVKLLMRVHHRNLTALI 456
LG G FG V G + VAVK+L + + +LL + ++ ++ + + +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
G C E + L+ E G L+++L+ K + L V + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV--SMGMKYLE---ETNF 116
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN- 575
VHRD+ + N+LL + AKI+DFGLS+ +D+ + A T G ++Y +N
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL---GADE-NYYKAKTHGKWPVKWYAPECMNY 172
Query: 576 ----EKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGD----IRNIVD 626
KSDV+SFGV++ E + G++P ++ T + + M + +++
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK 232
Query: 627 PSLQGNFDNNSAWKAVELAL 646
D + VEL L
Sbjct: 233 LCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 36/208 (17%)
Query: 406 LGKGGFGEVYHGSLD--DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGN 463
+G G +G V +LD +VA+K L ++ Q +L + +R L L+ + N
Sbjct: 23 VGSGAYGTVCS-ALDRRTGAKVAIKKL-----YRPFQSELFAKRAYRELR-LLKHMKHEN 75
Query: 464 NMGLIYEYMASGTLDQ----YL----------KGKKEHMLNWVERLQIAV-DSAQGLEYL 508
+GL+ + +LD+ YL K K L+ +R+Q V +GL+Y+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLKGLKYI 134
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
H I+HRD+K N+ +NE + KI DFGL+R +D T T Y PE
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPE- 185
Query: 569 YVLNWLN--EKSDVYSFGVVLLEIITGR 594
+LNW++ + D++S G ++ E++TG+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 36/220 (16%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKML--------SSSCCFQLLQVKLLMRVH 448
++FE +V+G+G FGEV + + QV A+K+L + + CF+ + +L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE-ERDVLVNGD 59
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN-----WVERLQIAVDSAQ 503
R +T L + NN+ L+ +Y G L L ++ + ++ + +A+DS
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS-- 117
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
+ L Y VHRD+K N+LL++ ++ADFG + + Q + AV GTP Y
Sbjct: 118 -VHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDY 169
Query: 564 LDPEYYVLNWLNE-------KSDVYSFGVVLLEIITGRRP 596
+ PE +L + + + D +S GV + E++ G P
Sbjct: 170 ISPE--ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQ-VAVKMLSSS------CCFQLLQVKLL 444
Y ++ KI G+G +G V+ + Q VA+K S L ++++L
Sbjct: 3 YEKLSKI--------GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML 54
Query: 445 MRVHHRNLTALIGYCIEGNNMGLIYEYMAS---GTLDQYLKGKKEHMLNWVERLQIAVDS 501
++ H NL LI + L++EY L++ +G EH++ +I +
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQT 109
Query: 502 AQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
Q + + H + C +HRDVK NIL+ ++ Q K+ DFG +RI + D + VA T
Sbjct: 110 LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVA-T 163
Query: 561 PGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITG 593
Y PE V + DV++ G V E++TG
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556
IAV + + L YL K I+HRDVK SNILL+ K+ DFG+S ++S + T
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAK--TR 166
Query: 557 VAGTPGYLDPEYYVLNWLNE---KSDVYSFGVVLLEIITGRRP 596
AG Y+ PE + + +SDV+S G+ L E+ TG+ P
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLM---RV-----HHRNLTA 454
+VLGKG FG+V L +V A+K+L Q V M R+ H LTA
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L + + + EY+ G D + ++ + A + L +LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGG--DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
+++RD+K NILL+ + K+ADFG+ + + +T GTP Y+ PE
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
D ++ GV++ E++ G+ P + EDD
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK--------LLMRVHHRNLTA 454
+V+GKG FG+V + + AVK+L + + K LL V H L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L + + + +Y+ G L +L+ ++ R A + A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I++RD+K NILL+ + + DFGL + IE S ST GTP YL PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTST-FCGTPEYLAPEVLRKQPY 173
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISR 600
+ D + G VL E++ G P SR
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 404 RVLGKGGFGEVY-----HGSLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHR 450
+VLGKGG+G+V+ G+ D + A+K+L + + + +L V H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN----WVERLQIAVDSAQGLE 506
+ LI G + LI EY++ G L +L+ + M + ++ + +A LE
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LE 114
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
+LH + I++RD+K NILL+ + K+ DFGL + SI ++ GT Y+ P
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIH-EGTVTHTFCGTIEYMAP 169
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
E + + + D +S G ++ +++TG P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 12/181 (6%)
Query: 423 QQVAVKM--LSSSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478
+QVAVKM L +LL +V ++ H+N+ + + G + ++ E++ G L
Sbjct: 47 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538
+ + LN + + Q L YLH ++HRD+KS +ILL + K++D
Sbjct: 107 DIVS---QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVI 598
FG S + + S + GTP ++ PE + D++S G++++E++ G P
Sbjct: 161 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
Query: 599 S 599
S
Sbjct: 219 S 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 401 NFERV--LGKGGFGEVYHG-SLDDNQQVAVKML-----SSSCCFQLLQVKLLMRVHHRNL 452
NF+++ LG+G + VY G + + VA+K + + + ++ L+ + H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM---LNWVERLQIAVDSAQGLEYLH 509
L N + L++EYM L +Y+ N V+ + +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCH 117
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ ++HRD+K N+L+N++ + K+ADFGL+R F I + + V T Y P+
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVL 172
Query: 570 VLNWLNEKS-DVYSFGVVLLEIITGR 594
+ + S D++S G ++ E+ITGR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 12/178 (6%)
Query: 423 QQVAVKM--LSSSCCFQLL--QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478
+QVAVK L +LL +V ++ HH N+ + + G+ + ++ E++ G L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538
+ + +N + + + + L YLH ++HRD+KS +ILL + K++D
Sbjct: 108 DIVTHTR---MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
FG S E + S + GTP ++ PE + D++S G++++E+I G P
Sbjct: 162 FGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 44/225 (19%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQ 440
Y++I+KI G+G +G VY G + Q VA+K + S++ + +
Sbjct: 2 YTKIEKI--------GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA----IRE 49
Query: 441 VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL----KGKK-EHMLNWVERL 495
+ LL + H N+ L ++ + + LI+E++ S L +YL KG+ + L
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
QI QG+ + H ++HRD+K N+L++ K K+ADFGL+R F I ++ T
Sbjct: 109 QIL----QGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYT 159
Query: 556 AVAGTPGYLDPEYYVLNWLNEKS---DVYSFGVVLLEIITGRRPV 597
T Y PE VL S D++S G + E+ T ++P+
Sbjct: 160 HEVVTLWYRAPE--VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 50/281 (17%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKL---LMR--VHHRNLTALI---- 456
LGKG +G VY ++ V M +L + K +M + H+ ++ I
Sbjct: 9 LGKGNYGSVYKVL---HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 457 -GYCIEGNNMGLIYEYMASGTLDQ------YLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ IEG + + EYM +G+LD+ +G E +L +I +GL++L
Sbjct: 66 GAFFIEGA-VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLK 119
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ I+HRDVK +N+L+N Q K+ DFG+S ++ +S ++ G Y+ PE
Sbjct: 120 E--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERI 173
Query: 570 VLNWLNE------KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
N+ +SDV+S G+ +LE+ GR P E +Q S + +GD
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY--PPETYANIFAQL--SAIVDGD--- 226
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664
P+L + ++ A + C + + RPT +L
Sbjct: 227 --PPTLPSGYSDD----AQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIG 457
LG G FG V + A+K L ++ QV+ +LM + H + ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
+ N + + E++ G L +L+ K N V + A + EYLH I+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHA-ELVLAFEYLH---SKDII 140
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
+RD+K N+LL+ K K+ DFG F+ + D+ T + GTP YL PE +
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFT-LCGTPEYLAPEVIQSKGHGKA 195
Query: 578 SDVYSFGVVLLEIITGRRP 596
D ++ GV+L E I G P
Sbjct: 196 VDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKM---------LSSSCCFQLLQVKLLMRVHHRNLTAL 455
+G G +G VY VA+K L S ++ +K L H N+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 456 IGYCIEGNN-----MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ------- 503
+ C + L++E+ +DQ L+ L+ V + ++ +
Sbjct: 68 MDVCATSRTDRETKVTLVFEH-----VDQDLRT----YLDKVPPPGLPAETIKDLMRQFL 118
Query: 504 -GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
GL++LH C IVHRD+K NIL+ Q K+ADFGL+RI+S + + T V T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLW 172
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPV 597
Y PE + + D++S G + E+ R+P+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKML--------SSSCCFQLLQVKLLMRVH 448
++FE +V+G+G FGEV + +++ A+K+L + + CF+ + +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE-ERNVLVNGD 59
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA--VDSAQGLE 506
+ +T L + N + L+ +Y G L L ++ + + R IA V + +
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
LHY VHRD+K N+LL+ ++ADFG + + + Q S AV GTP Y+ P
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISP 172
Query: 567 EYYVLNWLNE-------KSDVYSFGVVLLEIITGRRP 596
E +L + + + D +S GV + E++ G P
Sbjct: 173 E--ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 404 RVLGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCF-------QLLQVKLLMRVHHRNLTAL 455
++LGKG FG+V + A+K+L L + ++L H LT+L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+ + + EY+ G L + +E + + + L+YLH G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
IV+RD+K N++L++ KI DFGL + I + + T GTP YL PE N
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
D + GVV+ E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSS-------SCCFQLLQVKLLMRVHHRNLTAL 455
RVLGKGGFGEV + + A K L L + ++L +V+ R + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 456 IGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWV------ERLQI-AVDSAQGLEY 507
Y E + + L+ M G L K H+ N ER A + GLE
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDL-------KFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
LH + IV+RD+K NILL++ +I+D GL+ I + I V GT GY+ PE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPE 171
Query: 568 YYVLNWLNEK----SDVYSFGVVLLEIITGRRPVISRAE 602
V+ NE+ D + G ++ E+I G+ P R E
Sbjct: 172 --VVK--NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 404 RVLGKGGFGEVY---HGSLDDNQQVAVKMLSSSCCFQLLQVK--------LLMRVHHRNL 452
+V+GKG FG+V H + + + AVK+L + + K LL V H L
Sbjct: 1 KVIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
L + + + +Y+ G L +L+ ++ L R A + A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLH--- 113
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
IV+RD+K NILL+ + + DFGL + +IE + ST GTP YL PE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISR 600
+ D + G VL E++ G P SR
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSC-------CFQLLQVKLLMRVHHRNLTAL 455
RVLGKGGFGEV + ++ A K L L + ++L +V+ + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 456 IGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
Y E + + L+ M G L ++ L A + GLE LH +
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RE 121
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
V+RD+K NILL++ +I+D GL+ I + I V GT GY+ PE VLN
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPE--VLN-- 174
Query: 575 NEK----SDVYSFGVVLLEIITGRRPVISRAE 602
N++ D + G ++ E+I G+ P R E
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSC-------CFQLLQVKLLMRVHHRNLTAL 455
RVLGKGGFGEV + ++ A K L L + ++L +V+ R + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 456 IGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
Y E + + L+ M G L ++ E + A + GLE LH +
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QE 121
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
IV+RD+K NILL++ +I+D GL+ Q GT GY+ PE
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISR 600
D ++ G +L E+I G+ P R
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 34/233 (14%)
Query: 406 LGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHHRNLTALIG 457
+GKG FG+VY D +++ A+K+LS +V +L+R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 458 YCIE---GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
+++ L+ +YM+ G L +L+ K+ + IA + LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLH---KY 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
IV+RD+K NILL+ + DFGLS+ + + ++ + GT YL PE VL L
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE--VL--L 169
Query: 575 NEKS-----DVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622
+EK D +S GV++ E+ G P AED +Q + +A G +R
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFY--AED-----TQQMYRNIAFGKVR 215
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSC-------CFQLLQVKLLMRVHHRNLTAL 455
RVLGKGGFGEV + ++ A K L L + ++L +V+ R + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 456 IGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
Y E + + L+ M G L ++ + + A + GLE L +
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
IV+RD+K NILL+++ +I+D GL+ I + + V GT GY+ PE V+N
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPE--VIN-- 174
Query: 575 NEK----SDVYSFGVVLLEIITGRRPVISRAE 602
NEK D + G ++ E+I G+ P R E
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 56/252 (22%)
Query: 401 NFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHHR 450
+FE +V+G+G FGEV D V A+K+L + + QV +L+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQGLE 506
+ + + N+ LI E++ G + L K +E ++ +A+DS L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG--------------------LSRIFS 546
+ +HRD+K N+LL+ K K++DFG L F+
Sbjct: 122 F---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 547 IESSD-------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITG 593
++ + Q++ + GTP Y+ PE ++ N+ D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 594 RRPVISRAEDDT 605
P S +T
Sbjct: 233 YPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 406 LGKGGFGEVYHGSLDDNQQ--VAVKMLS--------------SSCCFQLLQVKLLM-RVH 448
LG G FG VY +N Q +A+K ++ S + +V ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQY---LKGKKEHMLNWVERL-QIAVDSAQG 504
H N+ +E + + ++ + + L ++ LK KK+ ER+ I V
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVLA 125
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L YLH + IVHRD+ +NI+L E + I DFGL++ ES T+V GT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYS 180
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
PE EK+DV++FG +L ++ T + P S
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 58/254 (22%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNLTALI 456
++FE +V+G+G FGEV D + A+K+L + + QV + R L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI-RAERDILVEAD 59
Query: 457 GYCI--------EGNNMGLIYEYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQG 504
G + + N+ LI E++ G + L K +E ++ +A+D+
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL--------------------SRI 544
L + +HRD+K N+LL+ K K++DFGL
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 545 FSIESSD-------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEII 591
FS ++ + Q++ + GTP Y+ PE ++ N+ D +S GV++ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 592 TGRRPVISRAEDDT 605
G P S +T
Sbjct: 231 IGYPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 37/157 (23%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV 499
+V ++ H N+ + + G+ + ++ E++ G L + + +N + + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCL 123
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+ L LH ++HRD+KS +ILL + K++DFG S E + S + G
Sbjct: 124 AVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVG 178
Query: 560 TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
TP ++ PE + D++S G++++E++ G P
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS---IESSDQISTAVAGTP 561
L+Y+H G ++HRD+K SNILLN + K+ADFGL+R S + + T T
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 562 GYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGR 594
Y PE +L + D++S G +L E++ G+
Sbjct: 177 WYRAPE--ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 405 VLGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCFQLLQVKL----LMRVHHRNLTALI--G 457
++G+GGFGEVY D + A+K C ++K+ + ++ R + +L+ G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTG 54
Query: 458 YCI----------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY 507
C + + I + M G L +L + + + E A + GLE+
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEH 112
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
+H +V+RD+K +NILL+E +I+D GL+ FS + A GT GY+ PE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPE 165
Query: 568 YYVLN---WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618
VL + +D +S G +L +++ G P D I + ++ E
Sbjct: 166 --VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 37/171 (21%)
Query: 401 NFERVLGKGGFGEVYHG---SLDDNQQVAVKM----------LSSSCCFQLLQVKLLMRV 447
E +G+G +G VY + D ++ A+K +S S C ++ LL +
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC---REIALLREL 59
Query: 448 HHRNLTALIGYCIEGNNMG--LIYEYMASGTLDQYLK---GKKEHMLN--WVERL--QIA 498
H N+ +L+ +E + L+++Y A L Q +K K + V+ L QI
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIF 545
G+ YLH ++HRD+K +NIL+ E+ KI D GL+R+F
Sbjct: 119 ----NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLS---------SSCCFQLLQV 441
Y +++KI G+G +G V+ + + ++ VA+K + SS L ++
Sbjct: 2 YEKLEKI--------GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREI 50
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLK-------GKKEHMLNWVER 494
LL + H+N+ L + L++EY DQ LK G + +
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFM 105
Query: 495 LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
Q+ +GL + H ++HRD+K N+L+N+ + K+ADFGL+R F I S
Sbjct: 106 FQLL----KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS 157
Query: 555 TAVAGTPGYLDPEYYVLNWLNEKS-DVYSFGVVLLEIITGRRPV 597
V T Y P+ L S D++S G + E+ RP+
Sbjct: 158 AEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 401 NFERVLGKGGFGEVYH-GSLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLT 453
N V G+G +G V + Q VA+K S + ++++L ++ H NL
Sbjct: 5 NLGLV-GEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLD---QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
LI + L++E++ LD +Y G E + QI +G+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKY-LFQIL----RGIEFCH- 117
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
I+HRD+K NIL+++ K+ DFG +R ++ + ++ T T Y PE V
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 571 LNWLNEKS-DVYSFGVVLLEIITG 593
+ ++ D+++ G ++ E++TG
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 401 NFE--RVLGKGGFGEVY----HGSLDDNQQVAVKMLSSSCCFQLLQV--------KLLMR 446
NFE +VLG G +G+V+ D + A+K+L + Q + +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 447 VHHRNLTALIGYCIEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
V + Y + + LI +Y++ G + +L ++++ R + L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSG-EIILAL 118
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
E+LH K IV+RD+K NILL+ + + DFGLS+ F E ++ + + GT Y+
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMA 174
Query: 566 PEYYVLNWLNEKS-DVYSFGVVLLEIITGRRPVISRAEDDT 605
PE + K+ D +S G+++ E++TG P E +T
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 406 LGKGGFGEV----YHGSLDDNQQVAVKMLSS------SCCFQLLQVKLLMRVH-HRNLTA 454
LG+G +G V + ++ VA+K +++ L ++KLL H+N+T
Sbjct: 8 LGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 455 LIGYCI--EGNNMGL-IYEYMASGTLDQYLKGKKE----HMLNWVERLQIAVDSAQGLEY 507
L I GN L +YE + L Q ++ + H +++ QI GL+Y
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI--YQILC----GLKY 120
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI---ESSDQISTAVAGTPGYL 564
+H ++HRD+K N+L+N + KI DFGL+R FS E++ ++ VA T Y
Sbjct: 121 IH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYR 176
Query: 565 DPEYYVLNWLNEKS-DVYSFGVVLLEIITGRRPV 597
PE + K+ DV+S G +L E++ GR+PV
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 383 FAPKSRQFAYSEIQKITNNFERV--LGKGGFGEVYH-GSLDDNQQVAVKMLSS------- 432
F S + T+ +E + +GKG +G+VY + D AVK+L
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE 64
Query: 433 -SCCFQLLQVKLLMRVHHRNLTALIGYCIE-----GNNMGLIYEYMASGTLDQYLKGKKE 486
+ +LQ +H N+ G + G + L+ E G++ + +KG
Sbjct: 65 IEAEYNILQ----SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG--- 117
Query: 487 HMLNWVERLQIAVDS------AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540
+L +RL A+ S GL++LH I+HRDVK +NILL + K+ DFG
Sbjct: 118 -LLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW-----LNEKSDVYSFGVVLLEIITGRR 595
+S + S+ GTP ++ PE + + DV+S G+ +E+ G
Sbjct: 174 VSA--QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
Query: 596 PV 597
P+
Sbjct: 232 PL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 406 LGKGGFGEV------YHGSLDDNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTALIG 457
LGKGGFGEV G + +++ K L LL+ ++L +V+ + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 458 YCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
Y E ++ L+ M G L ++ E L + + G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD-QISTAVAGTPGYLDPEYYVLNWLN 575
V+RD+K N+LL+++ +++D GL ++E D + T AGT GY+ PE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGL----AVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
D ++ G + E++ GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-10
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 48/232 (20%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCC-FQLLQVKLLMRVH------HRNLT 453
R++GKGG GEVY D +++VA+K + LL+ + L H +
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKG-------KKEHMLNWVER------LQIAVD 500
+ C +G+ + Y+ TL LK KE E+ L I
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL----AEKTSVGAFLSIFHK 121
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA---- 556
+EY+H ++HRD+K NILL + I D+G + +E D +
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 557 ------------VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ GTP Y+ PE + +E +D+Y+ GV+L +++T P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 401 NFERVLGKGGFGEV----YHGSLDDNQQVAVKMLSSSCCFQLLQVKLLM----------R 446
VLG+G FG+V Y + + A+K L +V+ LM
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANS 58
Query: 447 VHHRNLTALIGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ-- 503
H L L C + + + + EY A G L M++ + + A
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL----------MMH-IHTDVFSEPRAVFY 106
Query: 504 ------GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
GL+YLH + IV+RD+K N+LL+ + KIADFGL + + D+ ST
Sbjct: 107 AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTST-F 161
Query: 558 AGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDD 604
GTP +L PE L E S D + GV++ E++ G P E++
Sbjct: 162 CGTPEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 402 FERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMRVH 448
+++V +G+G +G VY + VA+K + S++ + ++ LL ++
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IREISLLKELN 56
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
H N+ L+ N + L++E++ L +Y+ L+ I Q L+ +
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD---PPLIKSYLYQLLQGI 112
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
Y ++HRD+K N+L++ + K+ADFGL+R F +
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVK--------LLMRVHHRNLTA 454
+V+GKG FG+V D AVK+L + + LL + H L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L + + +Y+ G L + ++E A + A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I++RD+K NILL+ + + DFGL + +E + ST GTP YL PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTST-FCGTPEYLAPEVLRKEPY 173
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISR 600
+ D + G VL E++ G P SR
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 406 LGKGGFGEVYHG-SLDDNQQVAVKMLSSS--------------CC---FQLL-QVKLLMR 446
LG+G +G+V + VA+K + C F L ++K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVE--RLQIAVDSAQG 504
+ H N+ L+ +EG+ + L+ + MAS L + + K + V+ LQI G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQIL----NG 131
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF-----SIESSDQIS----- 554
L LH K +HRD+ +NI +N K KIADFGL+R + S S +
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 555 --TAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGR 594
T+ T Y PE + + D++S G + E++TG+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 401 NFERV--LGKGGFGEVYHG-SLDDNQQVA---VKMLSSSCCF---QLLQVKLLMRVHHRN 451
+E++ + +G +G VY + VA +KM F L ++ +L+++ H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 452 LTALIGYCIEGNNMGLIY---EYMASGTLDQYLKGKKEHM---LNWVERLQIAVDSAQGL 505
+ + + G+N+ IY EY+ + LK E M E + + G+
Sbjct: 66 IVT-VKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
+LH I+HRD+K+SN+LLN + KI DFGL+R + S + T + T Y
Sbjct: 120 AHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVTLWYRA 174
Query: 566 PEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
PE +L L K D++S G + E++T +
Sbjct: 175 PE--LL--LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 404 RVLGKGGFGEV----------YHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLT 453
++LGKG FG+V Y+ ++V V L + ++L H LT
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLT 58
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
AL + + + EY G L +L +E + + + L+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
+V+RD+K N++L++ KI DFGL + I+ + T GTP YL PE N
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 574 LNEKSDVYSFGVVLLEIITGRRP 596
D + GVV+ E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 8/108 (7%)
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
+GL++LH +VHRD+K NIL+ Q K+ADFGL+RI+S + T+V T
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 174
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610
Y PE + + D++S G + E+ R+P+ R D + +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF-RGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 16/206 (7%)
Query: 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVK--------LLMRVHHRNLTA 454
+V+GKG FG+V D + AVK+L + K LL V H L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L + + +++ G L +L+ +E A + A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLH---SI 115
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
IV+RD+K NILL+ + + DFGL + I SD +T GTP YL PE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDT-TTTFCGTPEYLAPEVIRKQPY 173
Query: 575 NEKSDVYSFGVVLLEIITGRRPVISR 600
+ D + G VL E++ G P R
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 420 DDNQQVAVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALI--GYCIEGNNMGLIYE 470
+VA+K+L + + Q L R++H N+ AL+ G G + ++E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59
Query: 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
Y+ TL + L + L E ++ + L H IVHRD+K NI++++
Sbjct: 60 YVPGRTLREVLAA--DGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 531 ---KLQAKIADFGLSRIFS-IESSDQI----STAVAGTPGYLDPEYYVLNWLNEKSDVYS 582
+ AK+ DFG+ + + +D +T V GTP Y PE + SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 583 FGVVLLEIITGRRPV 597
+G++ LE +TG+R V
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 505 LEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI-----------FSIESSDQ 552
LEYLH YG IVHRD+K N+L+ K+ DFGLS+I IE +
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 553 --ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ V GTP Y+ PE + + D ++ G++L E + G P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 405 VLGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCFQLLQVKL----LMRVHHRNLTALIG-- 457
++G+GGFGEVY D + A+K C ++K+ + ++ R + +L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTG 54
Query: 458 ---------YCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY 507
Y + + I + M G L +L + + + E A + GLE+
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEH 112
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
+H +V+RD+K +NILL+E +I+D GL+ FS + A GT GY+ PE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPE 165
Query: 568 YYVLN---WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618
VL + +D +S G +L +++ G P D I + +M E
Sbjct: 166 --VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 6/89 (6%)
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
+GL YLH I+HRDVK+ NI +N+ Q I D G ++ + + +AGT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF---LGLAGTVE 221
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEII 591
PE + N K+D++S G+VL E++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 404 RVLGKGGFGEV----------YHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLT 453
++LGKG FG+V Y+ ++V + + + ++L H LT
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLT 58
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
AL + + + EY G L +L +E + + LEYLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---S 113
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
+V+RD+K N++L++ KI DFGL + I + T GTP YL PE N
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISR 600
D + GVV+ E++ GR P ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 401 NFE--RVLGKGGFGEVYH----GSLDDNQQVAVKMLSSSCCFQLLQV--------KLLMR 446
NFE +VLG G +G+V+ D + A+K+L + Q + ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 447 VHHRNLTALIGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV-DSAQG 504
+ + Y + + + LI +Y+ G L +L ++ V QI +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEV---QIYSGEIVLA 117
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
LE+LH K I++RD+K NILL+ + DFGLS+ F E + + + GT Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYM 173
Query: 565 DPEYYV--LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
P+ ++ D +S GV++ E++TG P E ++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 51/224 (22%)
Query: 404 RVLGKGGFGEVYHGSLDDNQ---QVAVKMLS----SSCCFQLLQVKLLMRVHHRN----- 451
R LG G G V+ S D+ +VAVK + S L ++K++ R+ H N
Sbjct: 11 RPLGCGSNGLVF--SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 452 ---------LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
LT +G E N++ ++ EYM + + N +E+ ++ + A
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET------------DLANVLEQGPLSEEHA 116
Query: 503 --------QGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQ- 552
+GL+Y+H ++HRD+K +N+ +N E L KI DFGL+RI S +
Sbjct: 117 RLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 553 -ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGR 594
+S + T Y P + N + D+++ G + E++TG+
Sbjct: 174 YLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 406 LGKGGFGEVYHGSLDDN---QQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTALIG 457
+G G FG+V G ++ QV VK L S Q L + + + H NL +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKG--KKEHMLNWVERLQ-IAVDSAQGLEYLHYGCKP 514
C E L+ E+ G L YL+ K E M LQ +A + A GL +LH K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE----SSDQISTAVAG-TPGYLDPEYY 569
+H D+ N LL L KI D+GLS E + DQ+ + P +D +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 570 VLNWLNE--KSDVYSFGVVLLEIIT-GRRP 596
L +++ +S+V+S GV + E+ G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 47/246 (19%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQ------VAVKMLSSSCCFQL- 438
+SR Y I+KI G G FGEV+ Q+ ++ + L QL
Sbjct: 9 ESRLNEYEVIKKI--------GNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 439 LQVKLLMRVHHRNLTALIGYCIEGNNMGL--IYEYMASGTLDQYLKGKKEHMLNWVERLQ 496
++V ++ + H+N+ I + N L + E+ +G L + ++ K M +E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHA 119
Query: 497 IAVDSAQ---GLEYLHYGCKPP----IVHRDVKSSNILLNEKLQ---------------- 533
I + Q L Y H P ++HRD+K NI L+ ++
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 534 -AKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV--LNWLNEKSDVYSFGVVLLEI 590
AKI DFGLS+ IES ++ + GTP Y PE + ++KSD+++ G ++ E+
Sbjct: 180 IAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 591 ITGRRP 596
+G+ P
Sbjct: 237 CSGKTP 242
|
Length = 1021 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 406 LGKGGFGEVYHG----SLDDNQ----QVAVKMLSSS---CCFQLLQVKLLM-RVHHRNLT 453
LG+G F +++ G D + +V +K+L S + +M ++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
G C+ G+ ++ EY+ G+LD YLK K ++++N +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 514 PPIVHRDVKSSNILLNEKLQA--------KIADFGLSRIFSIESSDQISTAVAGTPGYL- 564
+ H +V + N+LL + K++D G+S ++ + + + P
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIPWVPPECI 176
Query: 565 -DPEYYVLNWLNEKSDVYSFGVVLLEIITG 593
+P+ L+ +D +SFG L EI +G
Sbjct: 177 ENPQN-----LSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNLTA-----LIG 457
RV+G+G + +V L N Q+ A+K++ + + H A L+G
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 458 Y--CIEGNN-MGLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHY 510
C + + + L+ EY+ G L +++ ++ EH + + IA L +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLH- 113
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
+ I++RD+K N+LL+ K+ D+G+ + + D ST GTP Y+ PE
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTST-FCGTPNYIAPEILR 169
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622
D ++ GV++ E++ GR P ++ + ++ ++ E IR
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 71/278 (25%), Positives = 110/278 (39%), Gaps = 61/278 (21%)
Query: 400 NNFE--RVLGKGGFGEV-YHGSLDDNQQVAVKMLSSSCCF---QLLQVK----LLMRVHH 449
+F +V+GKG FGEV D + A+K L S F QL VK +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ +L + + LI E++ G L L K + V R +A + +E +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMA-ECVLAIEAVH 118
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF------------------------ 545
K +HRD+K NIL++ K++DFGLS F
Sbjct: 119 ---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 546 -----------SIESSDQIST----------AVAGTPGYLDPEYYVLNWLNEKSDVYSFG 584
++ S DQI+T + GTP Y+ PE ++ ++ D +S G
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235
Query: 585 VVLLEIITGRRPVISRAEDDT-THISQWVNSMLAEGDI 621
++ E + G P S +T I W ++ DI
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 424 QVAVKMLSSSCC----FQLLQVKLLMR--VHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477
V V++ C + LQ ++++ H N+ G+ + +I +MA G+
Sbjct: 27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSA 86
Query: 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY-GCKPPIVHRDVKSSNILLNEKLQAKI 536
+ LK ++ I + +GL YLH G +HR++K+S+IL++ +
Sbjct: 87 NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVSL 142
Query: 537 ADFGLSRIFSIESSDQISTAVAGTPGY-------LDPEYYV--LNWLNEKSDVYSFGVVL 587
+ GLS ++S+ + Q + V P + L PE L N KSD+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200
Query: 588 LEIITGRRP 596
E+ TGR P
Sbjct: 201 CELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 401 NFERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSCCFQLLQV-------KLLMRVHHRN 451
NF R LG G FG V + +D VA+K S + QV K+L ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVD---SAQGLEYL 508
L G + + + L+ E++ G +L+ K R V +AQ +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--------RFPNDVGCFYAAQIVLIF 144
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
Y IV+RD+K N+LL++ K+ DFG +++ D + + GTP Y+ PE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEI 199
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ + +D ++ G+ + EI+ G P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 67/254 (26%), Positives = 109/254 (42%), Gaps = 43/254 (16%)
Query: 363 RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDN 422
R+NK + F +R + + + ++ + +V+G+G FGEV +
Sbjct: 16 RKNKNIDN-----FLSR---YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS 67
Query: 423 QQV-AVKMLSSSCCFQLL---------QVKLLMRVHHRNLTALIGYCIEGNNMGLIY--- 469
+QV A+K+LS F+++ + + +M H N ++ + +Y
Sbjct: 68 KQVYAMKLLSK---FEMIKRSDSAFFWEERDIMA--HANSEWIVQLHYAFQDDKYLYMVM 122
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILL 528
EYM G L L + W R A + L+ +H G +HRDVK N+LL
Sbjct: 123 EYMPGGDLVN-LMSNYDIPEKWA-RFYTA-EVVLALDAIHSMG----FIHRDVKPDNMLL 175
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL------NWLNEKSDVYS 582
++ K+ADFG + TAV GTP Y+ PE VL + + D +S
Sbjct: 176 DKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPE--VLKSQGGDGYYGRECDWWS 232
Query: 583 FGVVLLEIITGRRP 596
GV L E++ G P
Sbjct: 233 VGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQLL--------QVKLLMRVHHRNL 452
+ +G G G V + D Q VA+K LS FQ + ++ L+ V+H+N+
Sbjct: 22 KPIGSGAQGIVC--AAYDTVTGQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 453 TALIGYCI------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV-DSAQGL 505
L+ E ++ L+ E M L Q ++ +H ER+ + G+
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH-----ERMSYLLYQMLCGI 131
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
++LH I+HRD+K SNI++ KI DFGL+R + + T T Y
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 185
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
PE + E D++S G ++ E+I G V+ D HI QW
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGT--VLFPGTD---HIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGT 560
A+G+E+L +HRD+ + NILL+E KI DFGL+R I+ + D + A
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARL 237
Query: 561 P-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
P ++ PE +SDV+SFGV+L EI +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 40/212 (18%)
Query: 406 LGKGGFGEVYHGSLDDNQQVA---VKMLSSSCCF----QLLQVKLLMRV-HHRNLTALIG 457
+G G FG+V + + VA VK L ++ + LQ R+ H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN--WVERLQIAVDSAQGLEYLHYGCKPP 515
C+E L++EY G L YL ++ H N + ++A + A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL- 574
+H D+ N L L K+ D+G+ S D I T D + L WL
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETE--------DDKCVPLRWLA 169
Query: 575 ----------------NEKSDVYSFGVVLLEI 590
+ S+V++ GV L E+
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLS----SSCCFQLL-QVKLLMRVHHRNLTA 454
N E+ LG+G + VY G S + Q VA+K++S F + + LL + H N+
Sbjct: 9 NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
L + ++EYM + L QY+ + + RL +GL Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQ 122
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I+HRD+K N+L++ + K+ADFGL+R SI S S V T Y P+ VL
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD--VLLGA 178
Query: 575 NEKS---DVYSFGVVLLEIITGR 594
+ S D++ G + +E++ G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 31/248 (12%)
Query: 363 RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDN 422
R+NK + F NR + K R+ +++ + +V+G+G FGEV +
Sbjct: 16 RKNKNIDN-----FLNRYEKIVRKIRKL---QMKAEDYDVVKVIGRGAFGEVQLVRHKSS 67
Query: 423 QQV-AVKMLS-------SSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474
Q+V A+K+LS S F + ++ + + L + + ++ EYM
Sbjct: 68 QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127
Query: 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA 534
G L L + W + V A L+ +H ++HRDVK N+LL++
Sbjct: 128 GDLVN-LMSNYDVPEKWAKFYTAEVVLA--LDAIH---SMGLIHRDVKPDNMLLDKHGHL 181
Query: 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLL 588
K+ADFG + TAV GTP Y+ PE VL + + D +S GV L
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAV-GTPDYISPE--VLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 589 EIITGRRP 596
E++ G P
Sbjct: 239 EMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 406 LGKGGFGEVYH-GSLDDNQQVAVKMLSS--------SCCFQLLQVKLLMRVHHRNLTALI 456
+GKG +G+V+ + + + AVK+L + +L+ H N+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA----LSDHPNVVKFY 81
Query: 457 GY-----CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQ------IAVDSAQGL 505
G G+ + L+ E G++ +KG L ER++ I ++ GL
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG----FLKRGERMEEPIIAYILHEALMGL 137
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
++LH +HRDVK +NILL + K+ DFG+S + S+ GTP ++
Sbjct: 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGTPFWMA 192
Query: 566 PEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPV 597
PE + + + DV+S G+ +E+ G P+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 460 IEGNNMGLIYE---YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
IE +N Y+ A + + L++++ + + A G+E+L
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNC 260
Query: 517 VHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNWLN 575
VHRD+ + N+L+ E KI DFGL+R + S+ IS P ++ PE N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGSTFLPLKWMAPESIFNNLYT 319
Query: 576 EKSDVYSFGVVLLEIIT 592
SDV+SFG++L EI T
Sbjct: 320 TLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 46/219 (21%)
Query: 401 NFERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMRV 447
NF++V +G+G +G VY + + VA+K + S++ + ++ LL +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IREISLLKEL 56
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL-----KGKKEHML-NWVERLQIAVDS 501
+H N+ L+ N + L++E++ L +++ G ++ +++ +L
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL------ 109
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561
QGL + H ++HRD+K N+L+N + K+ADFGL+R F + V T
Sbjct: 110 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TL 164
Query: 562 GYLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGR 594
Y PE YY + D++S G + E++T R
Sbjct: 165 WYRAPEILLGCKYY-----STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
+GL+YLH I+HRD+K N+L+N KI DFGL+R+ + S ++ V T
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 563 YLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGR 594
Y PE +Y D++S G + E++ R
Sbjct: 170 YRAPEILMGSRHY-----TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 88/278 (31%)
Query: 402 FERVLGKGGFGEVYH------GSLDDNQQVAVKMLSSSCCFQ-----LLQVKLLMRV-HH 449
F + LG G FG+V G D+ +VAVKML +S + ++K+L + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 450 RNLTALIG-------------YCIEGN------------------------------NMG 466
+N+ L+G YC G+ N+
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 467 LIYEYM------ASGTLDQYLKGK-----------------KEHM--LNWVERLQIAVDS 501
L +Y+ +S D Y++ + E L+ + L+ +
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221
Query: 502 AQGLEYL-HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
AQG+++L C +HRDV + N+LL + AKI DFGL+R + S+ + A
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNARL 276
Query: 561 P-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
P ++ PE +SDV+S+G++L EI + G+ P
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 29/158 (18%)
Query: 463 NNMGLIYEYMASGTL----DQYLKGKKEHMLN-WVERLQIAVDSAQGLEYLHYGCKPPIV 517
+N+ L+ EY G L ++Y E M ++ L +A+ S + Y V
Sbjct: 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---------V 124
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRD+K N+L++ K+ADFG + + S GTP Y+ PE VL +N
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPE--VLTTMNGD 181
Query: 578 S--------DVYSFGVVLLEIITGRRPVISRAEDDTTH 607
D +S GV+ E+I GR P + T+
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPF----HEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 406 LGKGGFGEVYHGSLDDNQQV-AVKML-------SSSCCFQLLQVKLLMRVHHRNLTALIG 457
+GKG FG+V D Q++ A+K + S L + +L +V+ + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
+ L+ ++ G L +L+ +E + + LE LH K ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDLSRARFYTAELLCALENLH---KFNVI 115
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
+RD+K NILL+ + + DFGL ++ +++ D+ +T GTP YL PE + + +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNT-FCGTPEYLAPELLLGHGYTKA 173
Query: 578 SDVYSFGVVLLEIITGRRP 596
D ++ GV+L E++TG P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 24/179 (13%)
Query: 440 QVKLLMRVHHRNLTALIGYCI------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVE 493
++ LL V+H+N+ +L+ E ++ L+ E M L Q + + +H E
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDH-----E 123
Query: 494 RLQ-IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552
R+ + G+++LH I+HRD+K SNI++ KI DFGL+R ++
Sbjct: 124 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNF 177
Query: 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
+ T T Y PE + E D++S G ++ E++ G VI + D HI QW
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS--VIFQGTD---HIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 28/74 (37%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 243 LSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA 302
L + +GE+ F L + FLD+SNN+L G +PSL+ L+L RNK G LP
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP- 469
Query: 303 DLVERSNNGSLTLS 316
D +L LS
Sbjct: 470 DSFGSKRLENLDLS 483
|
Length = 968 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLL---------QVKLLMRVHHRNLT 453
+V+G+G FGEV ++V A+K+LS F+++ + + +M +
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSK---FEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 454 ALIGYCIEGNN-MGLIYEYMASGTLDQYLKG---KKEHMLNWVERLQIAVDSAQGLEYLH 509
+ Y + + + ++ EYM G L + ++ + + +A+D+ + +
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF-- 163
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+HRDVK N+LL++ K+ADFG + E + TAV GTP Y+ PE
Sbjct: 164 -------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE-- 213
Query: 570 VLN------WLNEKSDVYSFGVVLLEIITGRRP 596
VL + + D +S GV L E++ G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGT 560
A+G+E+L +HRD+ + NILL+E KI DFGL+R I+ + D + A
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGSARL 238
Query: 561 P-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
P ++ PE +SDV+SFGV+L EI +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 400 NNFE--RVLGKGGFGEVYH-GSLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHR 450
N FE V+G+G +G V + + VA+K S + L ++K+L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
N+ L + L++EY+ L+ E M N V ++ Q ++ +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
K IVHRD+K N+L++ K+ DFG +R S E S+ T T Y PE +
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLL 174
Query: 571 LNWLNEKSDVYSFGVVLLEIITGR 594
+ D++S G +L E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 36/125 (28%), Positives = 58/125 (46%), Gaps = 5/125 (4%)
Query: 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528
Y+ + L L ++ L A+G+E+L VHRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEYYVLNWLNEKSDVYSFGVVL 587
+ KI DFGL+R + S+ +S P ++ PE N SDV+S+G++L
Sbjct: 271 AQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 588 LEIIT 592
EI +
Sbjct: 330 WEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQISTAVAGT 560
A+G+E+L +HRD+ + NILL+E KI DFGL+R I+ + D + A
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARL 243
Query: 561 P-GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592
P ++ PE +SDV+SFGV+L EI +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 27/80 (33%), Positives = 45/80 (56%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S + L+L + L G+I NLT++EFL L++N L G P L ++ SL+ + L N
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 296 LTGSLPADLVERSNNGSLTL 315
L+G +P ++ ++ L L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDL 243
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 56/246 (22%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK-------LLMRVHHRNLTAL 455
++LGKG G V+ L ++ A+K+L + +VK +L + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ--------GLEY 507
+ L+ +Y G L + L+ + L + + A+ LEY
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCL--------SEEVARFYAAEVLLALEY 118
Query: 508 LH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS------------------------ 542
LH G IV+RD+K NILL+E ++DF LS
Sbjct: 119 LHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 543 ---RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
E S + GT Y+ PE + D ++ G++L E++ G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 600 RAEDDT 605
D+T
Sbjct: 235 SNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 27/64 (42%), Positives = 37/64 (57%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L L + L+G I P +L + LDLS+NSLSG PE + +L +L L+L N TG +
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 301 PADL 304
P L
Sbjct: 325 PVAL 328
|
Length = 968 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 403 ERVLGKGGFGEVYHGSLDDN---QQVAVKMLS------SSCCFQLLQVKLLMRVHHRNLT 453
+ V+GKG +G V S D ++VA+K ++ S L ++KLL + H ++
Sbjct: 5 QEVIGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 454 ALIGYCI-----EGNNMGLIYEYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQG 504
+ + E ++ +++E M S L Q +K EH ++ +L +
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQL------LRA 115
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS-TAVAGTPGY 563
L+Y+H + HRD+K NIL N + KI DFGL+R+ ++ I T T Y
Sbjct: 116 LKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 564 LDPEY--YVLNWLNEKSDVYSFGVVLLEIITGR 594
PE + D++S G + E++TG+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 467 LIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522
+ EY+ G L +++ ++ EH + + +A L YLH + I++RD+K
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLH---ERGIIYRDLK 123
Query: 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYS 582
N+LL+ + K+ D+G+ + + D S GTP Y+ PE D ++
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 583 FGVVLLEIITGRRP--VISRAEDDTTHISQWVNSMLAEGDIR 622
GV++ E++ GR P ++ +++ + ++ ++ E IR
Sbjct: 182 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 400 NNFERV--LGKGGFGEVYHGSLDDNQQ-VAVKML-----SSSCCFQLLQVKLLMRVHHRN 451
+++E++ LG+G + VY G N + VA+K++ + + + LL + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L + L++EY+ + L QY+ K L+ +GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMD-KHPGGLHPENVKLFLFQLLRGLSYIH-- 120
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
+ I+HRD+K N+L+++ + K+ADFGL+R S+ S + V T Y P+ VL
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPD--VL 175
Query: 572 NWLNEKS---DVYSFGVVLLEIITG 593
E S D++ G + +E+I G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 57/262 (21%), Positives = 101/262 (38%), Gaps = 55/262 (20%)
Query: 404 RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQV-------KLLMRVHHRNLTAL 455
+ +G G FGEV +D N A+K L + Q +L + + L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+ +N+ + +Y+ G + L + + R IA + +E +H K
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIA-ELTCAIESVH---KMG 121
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGL------------------SRIFSIESSDQIST-- 555
+HRD+K NIL++ K+ DFGL R S+E S++ S
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 556 ---------------------AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR 594
++ GTP Y+ PE + + D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 595 RPVISRAEDDTTH-ISQWVNSM 615
P ++ +T + W ++
Sbjct: 242 PPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 25/65 (38%), Positives = 39/65 (60%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+L+LS++ L+GEI + ++++ LDL N L G P L+ L SL L L N+L G
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 300 LPADL 304
+P +L
Sbjct: 204 IPREL 208
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 27/58 (46%), Positives = 36/58 (62%), Gaps = 2/58 (3%)
Query: 240 SLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
SL+LS++ LT I F L ++ LDLS N+L+ PE S LPSLR+L+L N L
Sbjct: 4 SLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 31/81 (38%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S + LNLS++ TG I +E LDLSNN LSG P + SL+ L+L N
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 296 LTGSLPADLVERSNNGSLTLS 316
L G +P L ++ LTL+
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLA 196
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-LNWVERLQIAVDS 501
L+ +V H +L + G C+ G+ ++ E++ G LD L+ +K + + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA-------KIADFGLSRIFSIESSDQIS 554
A L YL +VH +V + NILL A K++D G+S F+ S ++
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREE-- 179
Query: 555 TAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEI-ITGRRPVISRAEDDTTHISQWV 612
V P ++ PE N L+ +D +SFG LLEI G P+ R + +
Sbjct: 180 -RVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-- 235
Query: 613 NSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666
+ +PS + + L C ++ ++RP+ +L +L
Sbjct: 236 -------KKHRLPEPSCK---------ELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 39/224 (17%)
Query: 406 LGKGGFGEV---YHGSLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTA 454
+G G G V Y LD N VA+K LS FQ ++ L+ V+H+N+ +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 455 LIGYCI------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQ-IAVDSAQGLEY 507
L+ E ++ L+ E M L Q ++ + +H ER+ + G+++
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLCGIKH 134
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
LH I+HRD+K SNI++ KI DFGL+R + + T T Y PE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
+ E D++S G ++ E++ R ++ D +I QW
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRD---YIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 40/211 (18%)
Query: 406 LGKGGFGEVYHGSLDDNQ-----------QVAVKMLSS----SCCFQLLQVKLLMRVHHR 450
LG+G F +Y G L V +K+L S S F L+ ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61
Query: 451 NLTALIGYCI-EGNNMGLIYEYMASGTLDQYLKGKKEHM-LNWVERLQIAVDSAQGLEYL 508
+L L G C+ + N M EY+ G LD +L +K ++ L+W +L +A A L YL
Sbjct: 62 HLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 509 HYGCKPPIVHRDVKSSNILL-----NEKLQ--AKIADFGLSRIFSIESSDQISTAVAGTP 561
+VH +V NIL+ NE K++D G+ + V P
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIP 169
Query: 562 GYLDPEYY--VLNWLNEKSDVYSFGVVLLEI 590
++ PE L +D +SFG LLEI
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVHHRNLTA-----LIG 457
RV+G+G + +V L +++ A+K++ + + H TA L+G
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 458 Y--CIEG-NNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
C + + + + E+++ G L + K +EH + + +A L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHE 114
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
I++RD+K N+LL+ + K+ D+G+ + I D ST GTP Y+ PE
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTST-FCGTPNYIAPEILR 169
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRP 596
D ++ GV++ E++ GR P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 46/172 (26%), Positives = 87/172 (50%), Gaps = 30/172 (17%)
Query: 408 KGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLMRVH-HRNLTAL--------IG 457
+G FG+VY G +N ++ AVK++ + ++ ++ +V R+ AL +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKA---DMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 458 YCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV----DSAQGLEYLHYGC 512
Y ++ NN+ L+ EY+ G + L H+ + + ++AV + A L+YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLL-----HIYGYFDE-EMAVKYISEVALALDYLH--- 121
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF---SIESSDQISTAVAGTP 561
+ I+HRD+K N+L++ + K+ DFGLS++ + D ++T P
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 36/219 (16%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHR 450
+ +E++ +G+G +G+VY + + VA+K L ++ LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 451 N-LTALIGYCIEG--NNMG-----LIYEYMASGT---LDQYLKGKKEHM-LNWVERLQIA 498
+ L+ +E G L++EY+ S +D +G + ++
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAV 557
+ +G+ + H K ++HRD+K N+L++ +K KIAD GL R FSI V
Sbjct: 119 L--LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 558 AGTPGYLDPEYYVLNWLNEKS---DVYSFGVVLLEIITG 593
T Y PE VL S D++S G + E+
Sbjct: 174 --TLWYRAPE--VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 24/137 (17%)
Query: 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526
LI +Y+ G L LK KE L+ E +I + L LH K I+H D+K N+
Sbjct: 86 LIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENV 140
Query: 527 LLNE-KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE------YYVLNWLNEKSD 579
L + K + + D+GL +I S GT Y PE Y + D
Sbjct: 141 LYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGHNY------DVSFD 188
Query: 580 VYSFGVVLLEIITGRRP 596
++ GV+ E++TG+ P
Sbjct: 189 WWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 4/106 (3%)
Query: 495 LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
L I + ++YLH + I+HRD+K+ NI +N + DFG + F ++ +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240
Query: 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISR 600
AGT PE + D++S G+VL E+ T + +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 3/105 (2%)
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
+ L YLH I+HRDVK+ NI L+E A + DFG + +GT
Sbjct: 196 EALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH 607
PE L+ K+D++S G+VL E+ + + ++
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 55/246 (22%), Positives = 110/246 (44%), Gaps = 27/246 (10%)
Query: 367 RVGQKV-EMEFENRND-SFAPKSRQFAYSEIQKITN---NFERVLGKGGFGEVYHG-SLD 420
+K+ E E + N+ + ++I + N ++G G FG VY +D
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID 89
Query: 421 DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGY----CIEGNN----MGLIYEYM 472
+++VA+K + ++ ++ ++ ++H N+ L Y C + N + ++ E++
Sbjct: 90 TSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 473 ASGTLDQYLK--GKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
T+ +Y+K + H L + + L Y+H I HRD+K N+L++
Sbjct: 150 PQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDP 205
Query: 531 KLQA-KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS--DVYSFGVVL 587
K+ DFG ++ + Q S + + Y PE +L N + D++S G ++
Sbjct: 206 NTHTLKLCDFGSAKNL---LAGQRSVSYICSRFYRAPE-LMLGATNYTTHIDLWSLGCII 261
Query: 588 LEIITG 593
E+I G
Sbjct: 262 AEMILG 267
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA---VDSAQG 504
+H N+ I N + ++ +MA G+ + H ++ + L IA +
Sbjct: 57 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC---THFMDGMSELAIAYILQGVLKA 113
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L+Y+H+ VHR VK+S+IL++ + K+ GL S+ + Q V P Y
Sbjct: 114 LDYIHH---MGYVHRSVKASHILIS--VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY- 167
Query: 565 DPEYYVLNWL------------NEKSDVYSFGVVLLEIITGRRP 596
VL WL + KSD+YS G+ E+ G P
Sbjct: 168 --SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQ------VAVKML-----SSSCCFQLLQVKLLMRV-HH 449
+ LG+G FG+V S ++ VAVKML +S + ++K+L+ + HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 450 RNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKE 486
N+ L+G C + G + +I EY G L YL+ K+E
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRE 108
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
G+++LH I+HRD+K SNI++ KI DFGL+R + + T T Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
PE + E D++S G ++ E+I G V+ D HI QW
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTD---HIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/270 (21%), Positives = 106/270 (39%), Gaps = 67/270 (24%)
Query: 404 RVLGKGGFGEV-YHGSLDDNQQVAVKMLSSSCCF---QLLQVK----LLMRVHHRNLTAL 455
+ LG G FGEV +D + A+K L Q+ VK +L + + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLN-WVERLQIAVDSAQGLEYLHYG 511
+ +N+ + +Y+ G + L + E + ++ L +A++S + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---- 122
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF------------------SIESSDQ- 552
+HRD+K NIL++ K+ DFGL F S+E SD
Sbjct: 123 -----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 553 --------------------------ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVV 586
++ ++ GTP Y+ PE + + D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 587 LLEIITGRRPVISRAEDDTT-HISQWVNSM 615
L E++ G+ P ++ +T + W N++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/129 (34%), Positives = 56/129 (43%), Gaps = 20/129 (15%)
Query: 404 RVLGKGGFGEVY----HGSLDDNQ---QVAVKMLSS---SCCFQLLQVKLLMRVH---HR 450
R LG G FG V HG L +Q +VAVKML S S Q L +L + H H
Sbjct: 43 RTLGSGAFGRVVEATAHG-LSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHL 101
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
N+ L+G C +G + +I EY G L YL K LQ +D + L
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF------LQYYLDKNRDDGSLIS 155
Query: 511 GCKPPIVHR 519
G P+ R
Sbjct: 156 GGSTPLSQR 164
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 67/270 (24%)
Query: 404 RVLGKGGFGEV-YHGSLDDNQQVAVKMLSSSCCF---QLLQVK----LLMRVHHRNLTAL 455
+ LG G FGEV +D A+K L Q+ VK +L + + L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYL--KGKKEHMLN--WVERLQIAVDSAQGLEYLHYG 511
+ +N+ + +Y+ G + L G L ++ L AV+S + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF---- 122
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGL----------------------SRIFSIES 549
+HRD+K NIL++ K+ DFGL S FS E
Sbjct: 123 -----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 550 SDQ-----------------------ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVV 586
D ++ ++ GTP Y+ PE + + D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 587 LLEIITGRRPVISRAEDDT-THISQWVNSM 615
L E++ G+ P +++ +T + W S+
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 44/189 (23%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTL----DQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
N+ L Y + +++ L+ ++ G L ++L +E + W + +A+D+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS---DQISTAVAGTPGY 563
LH + IV RD+ +NILL+++ ++ F R +E S + + Y
Sbjct: 101 -LH---REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM------Y 148
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
PE ++ E D +S G +L E++TG+ V TH + + ++E + R+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE-EARS 207
Query: 624 IVDPSLQGN 632
++ LQ N
Sbjct: 208 LLQQLLQFN 216
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 28/74 (37%), Positives = 40/74 (54%)
Query: 243 LSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA 302
L + L+GEI LT++ LDL N+L+G P L L +L+ L L +NKL+G +P
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 303 DLVERSNNGSLTLS 316
+ SL LS
Sbjct: 279 SIFSLQKLISLDLS 292
|
Length = 968 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 28/163 (17%)
Query: 402 FERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMRVH 448
+E+V +G+G +G VY N+ +A+K + S++ + ++ LL +
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA----IREISLLKEMQ 59
Query: 449 HRNLTALIGYCIEGNNMGLIYEYM---ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
H N+ L + L++EY+ +D K L QI +G+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGI 115
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQA-KIADFGLSRIFSI 547
Y H ++HRD+K N+L++ + A K+ADFGL+R F I
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 74/317 (23%), Positives = 136/317 (42%), Gaps = 45/317 (14%)
Query: 406 LGKGGFGEVYHGSLDDNQ--------QVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIG 457
+G+G +G VY D + Q+ +S S C ++ LL + H N+ AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIALQK 65
Query: 458 YCIEGNN--MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY-----LHY 510
+ ++ + L+++Y A L +K + N + +Q+ + L Y +HY
Sbjct: 66 VFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHY 123
Query: 511 GCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFS--IESSDQISTAVAGTPGYL 564
++HRD+K +NIL+ E+ + KIAD G +R+F+ ++ + V T Y
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 182
Query: 565 DPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT----HISQWVNSMLAEG 619
PE + + D+++ G + E++T R ED T H Q G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 620 --------DIRNIVD-PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
DIR + + P+LQ +F + + L H +P + V + L++ L
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDF-RRTTYANSSLIKYMEKHKV--KPD-SKVFLLLQKLL 298
Query: 671 SLEIVRNEGHEKGHRDP 687
+++ + E+ +DP
Sbjct: 299 TMDPTKRITSEQALQDP 315
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561
A+G+ +L +HRD+ + NILL KI DFGL+R +S+ +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE +SDV+S+G++L EI + G P
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 23/99 (23%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF--------------------- 279
L++S++ L G I+ ++ +++ L L+ N G P+
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVP 492
Query: 280 --LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316
L L L L L NKL+G +P +L SL LS
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531
|
Length = 968 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 13/104 (12%)
Query: 404 RVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRV-HHRN 451
+VLG G FG+V S VAVKML + ++K+L+ + +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 452 LTALIGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVER 494
+ L+G C + N + +I E+ G L +L+ K+E + E+
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 404 RVLGKGGFGEVYHGS---LDDNQ---QVAVKML---SSSCCFQLLQVKLLMRVH---HRN 451
R+LG G FG+V G+ L +Q +VAVKML + S Q L +L + H H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN 490
+ L+G C + + +I EY G L YL +++ L+
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L+L S+ TG+I +L ++ L L +N SG P+ L K +L L+L N LTG +
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 301 PADLVERSNNGSLTL---SVDGN---TSTTCSS 327
P L N L L S++G + C S
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 406 LGKGGFGEVYHGSLDDNQ--------QVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIG 457
+G+G +G VY D + Q+ +S S C ++ LL + H N+ +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQK 65
Query: 458 YCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLN----WVERLQIAVDSAQGLEYLHYG 511
+ + L+++Y A L +K + N + R + Q L+ +HY
Sbjct: 66 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 512 CKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFS--IESSDQISTAVAGTPGYLD 565
++HRD+K +NIL+ E+ + KIAD G +R+F+ ++ + V T Y
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRA 183
Query: 566 PEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606
PE + + D+++ G + E++T R ED T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 16/209 (7%)
Query: 404 RVLGKGGFGEVYHGSLDD-NQQVAVKM---LSSSCCFQLLQVKLLMRVHHRNLTALIGYC 459
R L G G V+ S D Q+V VK SS + +LL R+ H + AL+
Sbjct: 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWYASSV-----HEARLLRRLSHPAVLALLDVR 229
Query: 460 IEGNNMGLIY-EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+ G L+ +Y + L YL + L + Q+ + Q L + Y I+H
Sbjct: 230 VVGGLTCLVLPKYRSD--LYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+K+ N+L+N + DFG + S +AGT PE +
Sbjct: 284 RDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV 343
Query: 579 DVYSFGVVLLEIITGRRPVISRAEDDTTH 607
D++S G+V+ E + S + D
Sbjct: 344 DIWSAGLVIFEAAVHTASLFSASRGDERR 372
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 18/129 (13%)
Query: 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527
+Y +M D K +L + + A +EY+H ++HRD+K NI
Sbjct: 249 LYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIF 299
Query: 528 LNEKLQAKIADFGLSRIFSIESSDQ----ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSF 583
LN + + DFG + F E + T +P L + Y E +D++S
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-----EITDIWSC 354
Query: 584 GVVLLEIIT 592
G++LL++++
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 404 RVLGKGGFGEVYHGS---LDDN---QQVAVKMLSSSCCFQ-----LLQVKLLMRV-HHRN 451
+ LG+G FG+V +D + VAVKML + ++K+L+ + HH N
Sbjct: 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 72
Query: 452 LTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKK 485
+ L+G C + G + +I E+ G L YL+ K+
Sbjct: 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 262 IEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
++ LDLSNN L+ LP+L+ L+L N LT
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT 37
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRV-HH 449
F + LG G FG+V + D VAVKML S + ++K+L + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE 486
N+ L+G C G +I EY G L +L+ K++
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 24/63 (38%), Positives = 36/63 (57%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L+LS++ LTGEI + + L L +NSL G P+ L SLR + L+ N +G L
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 301 PAD 303
P++
Sbjct: 421 PSE 423
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 21/140 (15%)
Query: 406 LGKGGFGEVYHGSL---DDNQ----------QVAVKMLSSS---CCFQLLQVKLLMR-VH 448
LG+G ++Y G L DD++ +V +K+L S + +MR V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
H+++ L G C+ ++ E++ G LD ++ +K +L + ++A A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 509 HYGCKPPIVHRDVKSSNILL 528
+VH +V + NILL
Sbjct: 122 E---DKDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 25/68 (36%), Positives = 33/68 (48%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
R+ L L S+ +GEI + LDLS N+L+G PE L +L L L N L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 297 TGSLPADL 304
G +P L
Sbjct: 393 EGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 20/67 (29%), Positives = 32/67 (47%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ + L L S+ L GEI ++ + L +NS SG P +KLP + L++
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 294 NKLTGSL 300
N L G +
Sbjct: 438 NNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 57/239 (23%), Positives = 87/239 (36%), Gaps = 60/239 (25%)
Query: 406 LGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCI----- 460
LG+G FG VY SL + Q + V++ M + R A C
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM--NERVRRACPNSCADFVYG 197
Query: 461 --------EGNNMGLIYEYMASGTL-------------DQYLKGKKEHMLNWVERLQIAV 499
+ + L++ Y TL + YL GK + + +ER +
Sbjct: 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 500 DS--AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA-KIADFGLSR------------- 543
+ Q L L IVHRDVK NI+ +E + KI D G +
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 544 ------------IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590
I S ++ S VA L P + LN L ++ D+YS G++ L++
Sbjct: 318 LLDPRYAAPEQYIMSTQTPSAPSAPVATA---LSPVLWQLN-LPDRFDIYSAGLIFLQM 372
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.34 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.34 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.18 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.17 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.89 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.8 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.72 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.44 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.43 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=505.00 Aligned_cols=424 Identities=27% Similarity=0.454 Sum_probs=311.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+++|.+|..|++|++|++|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..+..++.|+.|
T Consensus 497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l 576 (968)
T PLN00113 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576 (968)
T ss_pred hhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEE
Confidence 45678888999999999999999999999999999999999999999999999999999999999999999888888888
Q ss_pred ccccCC---------------------CCccccCCc------ccccccCcce-eeeeehhhHHHHHH-HHHHhhhhcccc
Q 037258 314 TLSVDG---------------------NTSTTCSSE------SCKKKKHKFV-VPVVVSVAAFSTVL-FALAIFCGLRRR 364 (704)
Q Consensus 314 ~l~~~~---------------------n~s~~c~~~------~c~~~~~~~v-i~viv~v~~~~~vl-~~~~i~~~~~rr 364 (704)
+++.|. |+ .+|+.. .|........ ..++++++++++++ +++++++++++|
T Consensus 577 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~-~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (968)
T PLN00113 577 NISHNHLHGSLPSTGAFLAINASAVAGNI-DLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655 (968)
T ss_pred eccCCcceeeCCCcchhcccChhhhcCCc-cccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence 887653 33 345432 3432211111 11222222222222 222222222322
Q ss_pred ccccCccchhhhccCC-CCCC-CCCcccCHHHHHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHH
Q 037258 365 NKRVGQKVEMEFENRN-DSFA-PKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQV 441 (704)
Q Consensus 365 ~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~ 441 (704)
+....++.+.+..... .... .....+++.++... ....+.||+|+||.||+|.. .++..||||+++........|+
T Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~ 734 (968)
T PLN00113 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734 (968)
T ss_pred hcccccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHH
Confidence 2111111110000000 0000 11123445554432 23467899999999999976 5789999999976655556789
Q ss_pred HHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 037258 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV 521 (704)
Q Consensus 442 ~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 521 (704)
+.+++++||||++++++|.+++..++||||+++|+|.++++. ++|..+.+++.|+++||+|||+.++.+|+||||
T Consensus 735 ~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred HHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 999999999999999999999999999999999999999963 889999999999999999999777889999999
Q ss_pred CCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 522 KSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 522 kp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
||+||+++.++..++. ||...... ......++..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 810 kp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 810 SPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 9999999999888875 66554321 1122367899999999999999999999999999999999999995433
Q ss_pred CCCcccHHHHHHHHHhcCCcccccCCcCCCC--CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 602 EDDTTHISQWVNSMLAEGDIRNIVDPSLQGN--FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
. ....+.+|++...........+|+.+... .+..+..++.+++.+||+.+|++||+|+|++++|+++...
T Consensus 883 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 883 G-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred C-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 2 33467777776655555566667666432 3456677889999999999999999999999999987653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=444.75 Aligned_cols=286 Identities=50% Similarity=0.848 Sum_probs=253.7
Q ss_pred CCcccCHHHHHHHHhhhc--ccccccCceEEEEEEeCCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEE
Q 037258 386 KSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 386 ~~~~~~~~el~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
..+.|++.|+..+|++|. +.||+|+||.||+|.+++|+.||||++.... .+|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567899999999999996 7999999999999999999999999986533 4699999999999999999999999
Q ss_pred EeCC-eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 460 IEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 460 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
.+.+ +.+||||||++|+|.++|+......++|..|++||.++|+||+|||+.+..+||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999986643689999999999999999999998888999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
||+++..... .........||.+|+|||++..+..+.|+|||||||+++||+||+.|.+.........+.+|+...+..
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999654321 111111118999999999999999999999999999999999999998776555555699999999999
Q ss_pred CCcccccCCcCC-CCCCh-hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 619 GDIRNIVDPSLQ-GNFDN-NSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 619 ~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+.+.+++|+.+. +.++. .+..++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 56664 6888899999999999999999999999999665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=449.55 Aligned_cols=313 Identities=25% Similarity=0.427 Sum_probs=236.4
Q ss_pred CccCCCCCcccCC---ccceeeeeeeeccCCCC-CCceecCCCCC--CceeecCCC---CCceeccccccccCCCCCCCC
Q 037258 1 LRLLKNSTYETQS---LAESLWLLRRYDFGSIT-NKSVRYKDDIY--DRLWMPKNY---PGWKKLSTSLPIDAENPNAFR 71 (704)
Q Consensus 1 lr~l~~~~y~~~~---~~~~l~l~~R~~~g~~~-~~~~ryp~D~~--dR~W~~~~~---~~~~~~~t~~~~~~~~~~~~~ 71 (704)
||||++++|+... .+.+|.++.|.|+|..+ ...+|||||+| ||+|.|++. ..|..++|...|...++..+.
T Consensus 170 v~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~ 249 (623)
T PLN03150 170 ILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNF 249 (623)
T ss_pred EEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCcc
Confidence 6899999997542 23469999999999643 23589999999 999999654 568899988877754455678
Q ss_pred ChHHHHhhcccccCCCcceEEEeeCCCCCCCceEEEEEeeeeec-cCCCceeEEEEEEcCeeeccCccc-----ccceee
Q 037258 72 PAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEV-LLANQTREFNITQNGKFYIGPIVP-----TYLYTT 145 (704)
Q Consensus 72 ~p~~v~~ta~~~~~~~~~~~~~~~~~~~~~~~~~v~l~Fae~~~-~~~~~~R~F~i~lng~~~~~~~~p-----~~~~~~ 145 (704)
+|..|||||+++.++...+.+ .|+ .++...|+|+|||||++. ....++|+|+|++||+.....+.+ ......
T Consensus 250 ~P~~VyqTA~~~~~~~~~lty-~~~-v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~ 327 (623)
T PLN03150 250 YPESLYQSALVSTDTQPDLSY-TMD-VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTAL 327 (623)
T ss_pred ChHHHhhhhccccCCCCceEE-Eee-cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccce
Confidence 899999999998875444433 354 567889999999999984 446689999999999876544322 111111
Q ss_pred eEEeeeecCCceEEEEEeccCCCchhhHHHHHHHhhhhccCCCcCChhhHHHHHHhhhhcCCC--CCCCCCCCCCCCCce
Q 037258 146 TALSSVPVSGARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTDEDDVNALRNIKSTYGVK--RNWQGDPCVPKNYWW 223 (704)
Q Consensus 146 ~~~~~~~~~~~~~~~~l~~t~~S~lpPllna~e~~~~~~~~~~~~~~~~~~al~~~~~~~~~~--~~w~~~~c~~~~~~w 223 (704)
..-......++.++++|.++..+ ||+|||+|||.+.+. +..|.+.|+.||+.+|..++.. .+|.||||+|..+.|
T Consensus 328 ~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~-~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w 404 (623)
T PLN03150 328 VLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITA-ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPW 404 (623)
T ss_pred EEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeecccc-ccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCccccc
Confidence 11112233457899999998655 799999999999985 4568999999999999988653 389999999988899
Q ss_pred eeeecCCCCC-CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCccc
Q 037258 224 DGLNCSYEDN-NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA 302 (704)
Q Consensus 224 ~gv~c~~~~~-~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~ 302 (704)
.||.|+.... ....++.|+|++|+|+|.+|+.|++|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|+
T Consensus 405 ~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~ 484 (623)
T PLN03150 405 SGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484 (623)
T ss_pred ccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCch
Confidence 9999963321 223577777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccCCCccccccC
Q 037258 303 DLVERSNNGSLTLSVD 318 (704)
Q Consensus 303 ~~~~~~~l~~l~l~~~ 318 (704)
.++++++|+.|+|+.|
T Consensus 485 ~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 485 SLGQLTSLRILNLNGN 500 (623)
T ss_pred HHhcCCCCCEEECcCC
Confidence 7777777777766554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=384.35 Aligned_cols=250 Identities=38% Similarity=0.548 Sum_probs=210.0
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC-eEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN-NMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~~~g 475 (704)
.+.||+|+||+||+|.+.....||||++.... ..+.+|+.+|.+++|||||+++|+|.++. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45599999999999999755559999997543 37889999999999999999999999887 799999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCcc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP-IVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.++++......+++..+++++.|||+||+||| +.+ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 9999998854455999999999999999999999 777 99999999999999997 99999999998753211 33
Q ss_pred cccccCCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 554 STAVAGTPGYLDPEYYV--LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.+...||..|||||++. ...|+.|+|||||||++|||+||+.||...... +.+......+ .+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~---------~Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGG---------LRP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcC---------CCC
Confidence 44478999999999999 569999999999999999999999999766541 1111222121 222
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..+...+..++.+||..||..||++.|++..|+.+...
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 33334667899999999999999999999999999988763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=366.01 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=210.6
Q ss_pred cccCHHHHHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe
Q 037258 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE 461 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~ 461 (704)
..++.+|++.. +.||+|..|+||++.++ +++.+|+|++.... .+..+|++++++.+||+||.++|.|..
T Consensus 74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34667777655 67999999999999775 78899999983222 256889999999999999999999999
Q ss_pred CC-eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 462 GN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 462 ~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
++ ...++||||++|||++++...++ +++....+|+.++++||.|||+ +++||||||||+|||++..|++||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 98 59999999999999999987654 9999999999999999999994 4999999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.++.+.. .......||..|||||.+.+..|+.++||||||++++|+.+|+.||....+. .....+.+..+..+.
T Consensus 225 VS~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv~~p- 298 (364)
T KOG0581|consen 225 VSGILVN----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIVDEP- 298 (364)
T ss_pred ccHHhhh----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHhcCC-
Confidence 9987642 2567789999999999999999999999999999999999999999775221 112222222222111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.|.++.. ..+.++.+++..||++||.+||+++|+++
T Consensus 299 -----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 -----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222211 36678999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.37 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=207.8
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+|...++||+|||+.+|.++. ..|+.||+|++.+.. .....|+++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3456678999999999999976 899999999986532 25578999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
|+|+.++|..+++..+ .+++.++..+..||+.||.||| +++|+|||||..|+|+++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-- 170 (592)
T ss_pred EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecC--
Confidence 9999999999998544 4999999999999999999999 99999999999999999999999999999998743
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
......+.+||+.|+|||++.....+..+||||+|||+|.|+.|++||....-.+ -...+. ..+.
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik-~~~Y-------- 235 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIK-LNEY-------- 235 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHH-hcCc--------
Confidence 3345567899999999999999999999999999999999999999996543221 111111 1111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+||.++|+.+|.+|||+++|+.
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 123345567899999999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.79 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=218.2
Q ss_pred HHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+....+.+.||+|-||.||.|.++....||+|.++... ..+.+|+++|++++|+|||+++|+|..++.++||||||+
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 33445678899999999999999888899999987633 377899999999999999999999999889999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
.|+|.++|+...+..+...+.+.++.|||+||+||+ ++++|||||.++|||++++..+||+|||+|+... ++....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTA 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccC-CCceee
Confidence 999999999866667999999999999999999999 9999999999999999999999999999999543 222233
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.||..+...+. .+.++...+-.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcCC
Confidence 334445678999999999999999999999999999999 8999876654321 11222333334
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.+..++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 4667788999999999999999999999999999887654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.01 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=205.2
Q ss_pred HHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh-----------hHHHHHHHHHhhcccceeEEEEEEEeCCeE
Q 037258 398 ITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC-----------FQLLQVKLLMRVHHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 465 (704)
-.|-..+.||+|+||.|-+| ...+|+.||||++++... ...+|+++|++++|||||+++++++..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 34556899999999999999 566899999999864321 336899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLS 542 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla 542 (704)
|+||||++||+|.+.+-.++. +.+.....++.|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999987765 777788999999999999999 9999999999999999765 78999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWL---NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
+..+ ....+.+.+||+.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.+...+. .+. ..+..|
T Consensus 327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~~G 397 (475)
T KOG0615|consen 327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQILKG 397 (475)
T ss_pred hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHhcC
Confidence 9764 4566778999999999999986543 347899999999999999999997655432 111 122222
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .......+.+++.+++|.+||..||++|||+.|+++
T Consensus 398 ~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 221 111234567889999999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=352.99 Aligned_cols=192 Identities=29% Similarity=0.555 Sum_probs=173.4
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.||+|+||+||+|++. ++..||||.+.... .....|+++|+.++|||||.+++++..++..++|||||.|
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 4566999999999999765 68999999986542 1347799999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC------CcEEEEeccCccccccC
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK------LQAKIADFGLSRIFSIE 548 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kL~DfGla~~~~~~ 548 (704)
|+|.++++..+. +++..+..++.|+|.||++|| +++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 94 GDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-- 166 (429)
T KOG0595|consen 94 GDLSDYIRRRGR--LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-- 166 (429)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--
Confidence 999999998765 999999999999999999999 9999999999999999764 468999999999875
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
........+|++.|||||++..++|+.|+|+||+|+++|+|++|+.||....
T Consensus 167 -~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 -PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred -chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 4556677899999999999999999999999999999999999999996544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.62 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=206.8
Q ss_pred HhhhcccccccCceEEEEE-EeCCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEE-EEEeCCe-EEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIG-YCIEGNN-MGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lV~ 469 (704)
.+.+.++||+|.||+||++ ...+|..||.|.+.-. ...-..|+.+|++++|||||++++ .+.++++ +.|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 3456789999999999999 5678999999987522 224577999999999999999998 4455555 88999
Q ss_pred eecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 470 EYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
|+|..|+|...++..+ .+.+++..+++++.|++.||.++|... .+ |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999997543 556999999999999999999999421 44 899999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
. .........+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+.. +.+ ....+..++...+
T Consensus 179 ~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-L~~KI~qgd~~~~- 248 (375)
T KOG0591|consen 179 S--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-LCKKIEQGDYPPL- 248 (375)
T ss_pred c--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-HHHHHHcCCCCCC-
Confidence 4 34455667899999999999999999999999999999999999999997652 222 2233333332211
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+.-.+..+.+||..|+..||+.||+...++..++.-
T Consensus 249 -------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 249 -------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred -------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1255677899999999999999999977777766653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=375.60 Aligned_cols=254 Identities=31% Similarity=0.513 Sum_probs=215.2
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
..+.+.||+|+||+||+|+.. +.+.||||.++.... +|++|++++..++|||||+++|.|.+++.+++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 346788999999999999643 356799999986543 789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccc--------CC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEE
Q 037258 469 YEYMASGTLDQYLKGKK--------EH----MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
+|||..|||.++|.... .. .++..+.+.||.|||.||+||- ++.+|||||..+|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEe
Confidence 99999999999997543 12 2888999999999999999999 999999999999999999999999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
+|||+++.....+.........-..+|||||.+..++++.+||||||||+|||+++ |+.||.+...++ +...
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~ 717 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIEC 717 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHH
Confidence 99999987643333332323445679999999999999999999999999999999 999998877544 2233
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
++.+.+. ..++.++.++.+|+..||+.+|.+||+++||-..|+.....
T Consensus 718 i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 4444331 34667788999999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.36 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=204.9
Q ss_pred hhcccccccCceEEEEEE-eCCCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.|.+.||+|+|++|++|+ .+.++.+|||++.+... ....|-.+|.+| .||.|++++-.|.++..+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 468899999999999994 55899999999865432 446688889999 899999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.++|+..+. +++.....++.+|+.||+||| ++|||||||||+|||||++|+++|+|||.|+.+......
T Consensus 156 A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred cCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999998765 999999999999999999999 999999999999999999999999999999988543222
Q ss_pred ---------cc--cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 552 ---------QI--STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 552 ---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.. ....+||..|.+||++.....++.+|||+||||+|+|+.|++||....+-. .+++++.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFqkI~~--- 301 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQKIQA--- 301 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHHHHHH---
Confidence 11 145889999999999999999999999999999999999999997655311 1111111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
++- .+++..++.+.+|+.+.|..||.+|++++||.+.
T Consensus 302 ----l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 ----LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 112 3344445688999999999999999999998763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=337.98 Aligned_cols=233 Identities=24% Similarity=0.362 Sum_probs=197.3
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.||+|+||+||.++. ++++.+|+|++++... ....|..+|.+++||.||+++-.|++.+.+|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 468999999999999954 5789999999975433 45778999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
||.|..+|++... +++..+.-++..|+.||.||| +.+||||||||+|||+|++|+++|+|||+++.. ......
T Consensus 109 GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~--~~~~~~ 181 (357)
T KOG0598|consen 109 GGELFYHLQREGR--FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED--LKDGDA 181 (357)
T ss_pred CccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc--ccCCCc
Confidence 9999999987665 899999999999999999999 999999999999999999999999999999863 223344
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+. ..+........ . ...
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k-~---------~~~ 245 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK-L---------PLP 245 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc-C---------CCC
Confidence 4568999999999999999999999999999999999999999966542 22333333222 0 011
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCC
Q 037258 634 DNNSAWKAVELALACASHTSSERP 657 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RP 657 (704)
+.-.+.+.++++.++|..||++|.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 222445788999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=353.83 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=206.8
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.||+|+||+||+|.+.+ .||||++.... ..|..|+..+++-+|.||+-+.|||..+.. .||+.+|+|-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 46889999999999999853 59999996543 267889999999999999999999998877 9999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|+.+++..+. .++..+.+.|+.||++||.||| .++|||||||..|||+.+++.|||+|||++..-..-.......
T Consensus 473 SLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 473 SLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred hhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 99999997764 4899999999999999999999 9999999999999999999999999999997654444444455
Q ss_pred cccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 556 AVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
...|...|||||+++. ..|++.+||||||||+|||++|..||.....+... | ++..|.+. .|.. .
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----f---mVGrG~l~--pd~s---~ 616 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----F---MVGRGYLM--PDLS---K 616 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----E---EecccccC--ccch---h
Confidence 6678899999999984 47899999999999999999999999733322110 0 11111110 1111 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
....++.++.+|+..||..++++||.+.+|+..|++++.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 234567789999999999999999999999999998876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.81 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=208.3
Q ss_pred HHhhhcccccccCceEEEEEE-eCCCcEEEEEecccchh-----hHHHHHHHHHhhc-ccceeEEEEEEEeCC-eEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVH-HRNLTALIGYCIEGN-NMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lV~ 469 (704)
.+|...++||.|.||.||+|. ..+|+.||||.++.... -..+|++.|+++. ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 356667899999999999994 56899999999875432 4578999999998 999999999999888 999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
|||+. +|.++++.+ ++.+++..+..|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--- 161 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR--- 161 (538)
T ss_pred Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc---
Confidence 99975 999999988 667999999999999999999999 9999999999999999988899999999999764
Q ss_pred CCcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc-------
Q 037258 550 SDQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI------- 621 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 621 (704)
.....+.++.|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+..+-+...- +..++.....
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccchhHH
Confidence 344556788899999999976 67899999999999999999999999987765433211 1111211110
Q ss_pred --ccccCCcCC---C----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 622 --RNIVDPSLQ---G----NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 622 --~~~~d~~l~---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+.-.+. + ..-...+.++.+++.+|+.+||.+||||+|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111111 0 1112366789999999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.74 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=202.3
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccc----hhhHHHHHHHHHhhcccceeEEEEEEEeCC--eEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS----CCFQLLQVKLLMRVHHRNLTALIGYCIEGN--NMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~e~~~~ 474 (704)
..+.||+|+||.||++... +|+..|||..... .....+|+.+|++++|||||+++|...... .+++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4688999999999999665 4899999998765 334688999999999999999999855544 68999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCcccccc-CCCCc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIFSI-ESSDQ 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~-~~~~~ 552 (704)
|+|.+++...+. .+++..+..+..||++||+||| +++||||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999998776 5999999999999999999999 999999999999999999 79999999999987643 11222
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|||||++..+ ....++|||||||++.||+||+.||.... ....++......... |
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~-----P---- 242 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSL-----P---- 242 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCC-----C----
Confidence 34457899999999999953 34469999999999999999999996531 111222222222111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
..+...+.+..+++.+|+..+|++||||+|+++.---
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 3344456688999999999999999999999986543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.10 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=201.4
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeC-CeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEG-NNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~ 465 (704)
.+.+.+.||+|+||.||+|.. .+++.||||+++... ..+..|+.++.++ +||||++++++|... +..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 455678999999999999963 235689999986432 2467899999999 899999999998764 458
Q ss_pred EEEEeecCCCCHHHHhhccc------------------------------------------------------------
Q 037258 466 GLIYEYMASGTLDQYLKGKK------------------------------------------------------------ 485 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 485 (704)
++||||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999987532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccC
Q 037258 486 EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565 (704)
Q Consensus 486 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~a 565 (704)
...+++..+..++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 124778899999999999999999 89999999999999999999999999999986532222222233456678999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHH
Q 037258 566 PEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVEL 644 (704)
Q Consensus 566 PE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 644 (704)
||++.+..++.++|||||||++|||++ |..||....... . ....+..+... ..+...+..+.++
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~---------~~~~~~~~~l~~l 309 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRM---------RAPENATPEIYRI 309 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCC---------CCCCCCCHHHHHH
Confidence 999999999999999999999999997 999996543221 1 11122222111 1122344578899
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 645 ALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 645 i~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.+||+.||.+||++.|+++.|++++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=333.80 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=206.5
Q ss_pred HhhhcccccccCceEEEEEE-eCCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.|.+.+.||.|..++||+|. ...++.||||++.-+.+ ...+|++.++.++||||++++..|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 35677899999999999994 55789999999864433 5578999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
.+|++.++++..-...+++..+..|.+++++||.||| ++|.||||||+.||||+++|.+||+|||.+..+......
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 9999999999887777999999999999999999999 999999999999999999999999999988666332211
Q ss_pred ccc-ccccCCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QIS-TAVAGTPGYLDPEYYV--LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~-~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
... ....||++|||||+++ ...|+.|+|||||||+..||.+|..||....+-. .....++.. .....-..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~-pp~~~t~~ 256 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQND-PPTLLTSG 256 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCC-CCCccccc
Confidence 111 4568999999999965 3479999999999999999999999997665421 111122211 11111111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..+........+.+++..||+.||.+|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111222334457899999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.82 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=202.9
Q ss_pred cccccccCceEEEEE-EeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEeecC
Q 037258 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEYMA 473 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~~~ 473 (704)
.++||+|.||.||+| +..+|+.||+|++.-.. ....+|+.+|+++.||||+++.+...+. ..+|+|+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 468999999999999 56789999999986443 2558999999999999999999999876 78999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.-++.... -.+++.++..++.|++.||+|+| .++|+|||||.+|||||.+|.+||+|||+|+++... ....
T Consensus 202 h-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~-~~~~ 275 (560)
T KOG0600|consen 202 H-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS-GSAP 275 (560)
T ss_pred c-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC-CCcc
Confidence 8 9988887643 23999999999999999999999 999999999999999999999999999999987533 3344
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc-------ccc
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR-------NIV 625 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 625 (704)
.+..+-|..|.|||.+.|. .|+.+.|+||.||||.||++|++.|.+..+-+..+.+..+.....+..+. ..+
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 6677889999999999865 79999999999999999999999998776544332222111111111111 111
Q ss_pred CCcCCCCCC-------hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFD-------NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+. ..+. ...+...++|+..+|..||.+|.|+.++++
T Consensus 356 kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 356 KPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 0111 123456789999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.19 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=200.0
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.-++|+|+||+||+++.+ +|+.||||++..+.. -..+|+++|++++|+|+|.++++|.....++||+|||+.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 357999999999999665 799999999965443 458899999999999999999999999999999999988
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
++.+-|..... .++...+.+++.|++.|+.|+| ++++|||||||+|||++.++.+||||||+|+.+.. .....+
T Consensus 86 TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YT 159 (396)
T KOG0593|consen 86 TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYT 159 (396)
T ss_pred HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhh
Confidence 55555554432 3889999999999999999999 99999999999999999999999999999998753 344556
Q ss_pred cccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHHhcCCcc-ccc
Q 037258 556 AVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV--------NSMLAEGDIR-NIV 625 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~ 625 (704)
....|..|+|||.+.+ .+|+...||||+||++.||++|.+-|.+..+-+........ .+.+....+. -+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 7788999999999997 68999999999999999999999999776654332221111 1111111111 111
Q ss_pred CCcCC--CC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQ--GN---FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~--~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
-|... .. --...+.-+++++..||+.||.+|++-+|++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11110 00 01223446889999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=313.35 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=202.3
Q ss_pred hhhcccccccCceEEEEE-EeCCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.-.++||+|.||.||+| +.++|+.||||+++.... ...+|++.|+.++|+||+.++++|...+.+.||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 444678999999999999 456899999999865432 5689999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+. +|...++... ..+...++..++.++++||+||| .+.|+||||||.|+|++++|.+||+|||+++.+.... .
T Consensus 84 ~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~ 156 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--R 156 (318)
T ss_pred cc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--c
Confidence 87 9999998765 34888999999999999999999 9999999999999999999999999999999875433 2
Q ss_pred ccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CCccc-----
Q 037258 553 ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GDIRN----- 623 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 623 (704)
..+...-|..|.|||.+.| ..|+...||||.|||+.||+.|.+-|.+..+-+ ++...+ +.+.. ..+.+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If-~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIF-RALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHH-HHcCCCCcccCccccccc
Confidence 3334478899999999986 479999999999999999999887776554322 121111 11111 11111
Q ss_pred -------ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 624 -------IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 624 -------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.-.+.+..-| ...+..+.+|+.+|+..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111112 2344566999999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.02 Aligned_cols=240 Identities=25% Similarity=0.442 Sum_probs=203.7
Q ss_pred cccccccCceEEEEE-EeCCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
-++||+|+.|.||.| +..+++.||||++..... -...|+.+|+..+|+|||++++.|..++++++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 367999999999999 556889999999854332 457899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.|.+.... +++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+.... ......
T Consensus 358 TDvVt~~~---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~Tm 429 (550)
T KOG0578|consen 358 TDVVTKTR---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTM 429 (550)
T ss_pred hhhhhccc---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Cccccc
Confidence 99998765 899999999999999999999 9999999999999999999999999999998874332 245678
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.||+.|||||+.....|++|.||||||++++||+-|++||.....-. . + ..+.... .+.+ ..++..
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----A--l-yLIa~ng-----~P~l--k~~~kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----A--L-YLIATNG-----TPKL--KNPEKL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----H--H-HHHhhcC-----CCCc--CCcccc
Confidence 99999999999999999999999999999999999999997533211 1 1 1111111 1111 234556
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..+.+++.+||+.|+++||++.|+|+
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 778999999999999999999999996
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.68 Aligned_cols=250 Identities=30% Similarity=0.449 Sum_probs=210.8
Q ss_pred CcccCHHHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 387 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.-++.+++|.+. +-||+|+.|.||+|+++ ++.||||+++. ....+++-|++|+|+||+.+.|+|....-++
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhh---hhhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 345667777655 56999999999999995 68899998763 2356788999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
||||||..|-|...|+.... +.......|..+||.||.||| .+.|||||||.-||||+.+..+||+|||-++.+.
T Consensus 189 IiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred EeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999987654 778888999999999999999 9999999999999999999999999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
. ......+.||..|||||+++....++|.||||||||||||+||..||..-+.... +.-+-.
T Consensus 264 ~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGs 325 (904)
T KOG4721|consen 264 D---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGS 325 (904)
T ss_pred h---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccC
Confidence 2 2344568899999999999999999999999999999999999999965432111 011111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
..+.-..+..++..++-|++.||+..|..||++.+++..|+-
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 223334566777889999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=356.88 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=215.1
Q ss_pred hcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 402 FERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
++++||.|.||.||+|+++ ....||||.++... .+|+.|..||.++.||||+++.|+.......+||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 3689999999999999775 24579999997543 37889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|+.+|+.+.++ +.+.+..-++++||.||+||. +.++|||||.++|||++.+..+|++|||+++.+.++....
T Consensus 713 ENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999999988765 999999999999999999999 9999999999999999999999999999999885544222
Q ss_pred ccc-cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 553 IST-AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 553 ~~~-~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
..+ .-.-..+|.|||.+..++++.++|||||||++||.++ |..||.++...+.. ..++..++
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----------------kaIe~gyR 852 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----------------KAIEQGYR 852 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------------HHHHhccC
Confidence 221 2223568999999999999999999999999999988 99999887754321 12223333
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
-..+.+++..+.+|++.||++|-.+||.+.||+..|.+++..
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 345678889999999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.18 Aligned_cols=239 Identities=30% Similarity=0.436 Sum_probs=205.8
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|.||.||||+. .+.+.||+|.+.+... ...+|++++++++||||+.++++|+...++++|.||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 3457899999999999954 4789999999865433 35789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
| +|..++..... ++++.+..++.+++.||.||| +.+|+|||+||+|||++..+.+|++|||+|+.+. .....
T Consensus 85 g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~v 156 (808)
T KOG0597|consen 85 G-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSV 156 (808)
T ss_pred h-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc--cCcee
Confidence 7 99999987665 999999999999999999999 9999999999999999999999999999999864 34556
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.+...||+.|||||.+.++.|+..+|+||+||++||+++|++||... .+.+.++.++.+.. ..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v-----------~~ 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPV-----------KP 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCC-----------CC
Confidence 67789999999999999999999999999999999999999999542 33334444333221 11
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+...+..+..++...|.+||.+|.+..+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2345668899999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.35 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=202.2
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccc---------hhhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---------CCFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 466 (704)
..|.+.+.||+|+||+|+.|.. .+++.||+|++... .....+|+.++++++ ||||+++++++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3456688999999999999954 57899999987553 113457999999999 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCcccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIF 545 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~ 545 (704)
+||||+.+|+|.+++....+ +.+..+.+++.|++.|++|+| +++|+||||||+|||++.+ +++||+|||++...
T Consensus 97 ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999998443 888999999999999999999 9999999999999999999 99999999999875
Q ss_pred ccCCCCcccccccCCCCccCccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNW-LN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
. ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ...... +..+.+
T Consensus 172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~~-- 240 (370)
T KOG0583|consen 172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGEF-- 240 (370)
T ss_pred C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCCc--
Confidence 3 2344566789999999999999877 75 889999999999999999999976322 111111 222211
Q ss_pred ccCCcCCCCCChhH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNS-AWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++... +.++..++.+||..+|.+|+++.|+++
T Consensus 241 --------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 --------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 122222 668899999999999999999999993
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.46 Aligned_cols=240 Identities=26% Similarity=0.364 Sum_probs=205.3
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+.|.|-.|++ .+|+.+|||++... .....+|+-+|+.+.|||++++++++++..++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 4568899999999999954 58999999999765 235688999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|-|++++-.++. +.+.++.+++.||+.|+.|+| ..+|+|||+||+|+|||..+++||+|||+|..- ....
T Consensus 95 ~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk 166 (786)
T KOG0588|consen 95 PGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK 166 (786)
T ss_pred CCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence 99999999987765 899999999999999999999 999999999999999999999999999999753 3445
Q ss_pred ccccccCCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
...+.+|++.|.|||++.|.+|. .++||||+|||||.|+||+.||++++- ..+. ..++.|.+
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LL----lKV~~G~f---------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLL----LKVQRGVF---------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHH----HHHHcCcc----------
Confidence 56678999999999999999875 799999999999999999999974321 1111 12222322
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.+...+.++.+|+.+|+..||++|.|++||++.
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1234556688999999999999999999999984
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.11 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=200.4
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.. +++..||||+++... ....+|++++..+ +||||++++++|.+++..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 355679999999999999953 346689999986432 1456799999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc-------------------------------------------------------------
Q 037258 467 LIYEYMASGTLDQYLKGKK------------------------------------------------------------- 485 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 485 (704)
+||||+++|+|.++++...
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999986432
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 486 ------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 486 ------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 124788899999999999999999 89999999999999999999999999999986543222222
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .+..+... .
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~---------~ 337 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEGYRM---------L 337 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhCccC---------C
Confidence 223345678999999999999999999999999999998 888886543221 1111 12211100 0
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1112245788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.39 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=202.5
Q ss_pred cccCHHHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEE
Q 037258 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCI 460 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~ 460 (704)
..++..++...+ ...||+|++|.||+|.+ +|+.||||+++... ..+.+|+.++++++||||+++++++.
T Consensus 13 ~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 13 KCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred eecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 344555552211 25799999999999988 68899999986432 24468999999999999999999987
Q ss_pred e----CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEE
Q 037258 461 E----GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAK 535 (704)
Q Consensus 461 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~k 535 (704)
+ ....++||||+++|+|.+++.... .+++.....++.+++.||.||| + .+++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEE
Confidence 7 356889999999999999998654 3889999999999999999999 5 4889999999999999999999
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN 613 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 613 (704)
|+|||+++.+... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +...
T Consensus 164 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~ 232 (283)
T PHA02988 164 IICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYD 232 (283)
T ss_pred EcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence 9999998765321 123467889999999976 68899999999999999999999999654321 1111
Q ss_pred HHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 614 SMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 614 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.....+. ....+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 233 ~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2111111 01122234567999999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=363.96 Aligned_cols=261 Identities=31% Similarity=0.483 Sum_probs=212.9
Q ss_pred HHHHHhhhcccccccCceEEEEEEeC--CCc----EEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCC
Q 037258 395 IQKITNNFERVLGKGGFGEVYHGSLD--DNQ----QVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGN 463 (704)
Q Consensus 395 l~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 463 (704)
+......+.+.||+|.||.||.|... +|. .||||.++.... +|..|..+|+.++||||++++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 33444556789999999999999654 233 489999876533 7788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 464 NMGLIYEYMASGTLDQYLKGKK-----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
..+|++|||++|+|..+|+..+ ...+.....+.++.|||+|+.||+ ++++|||||..+|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999998763 345889999999999999999999 99999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||+|+.+.............-...|||||.+..+.++.|+|||||||++||++| |..||......+. +.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHh
Confidence 999996533222222222234568999999999999999999999999999999 8899966554321 111222
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.++ -..+..++..+.+++..||+.+|++||++..+++++..+...-.
T Consensus 920 ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 920 GGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 221 12355677789999999999999999999999999988776433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.23 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=200.4
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.. .++..||||+++... .....|+++++.+ +|+||++++++|...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 445678999999999999853 234579999986432 2456799999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc-------------------------------------------------------------
Q 037258 467 LIYEYMASGTLDQYLKGKK------------------------------------------------------------- 485 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 485 (704)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999986431
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 486 -------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 486 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
...+++..+++++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.+.............
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 124788899999999999999999 8999999999999999999999999999997653222222222334
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .....+. ....+...
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~---------~~~~~~~~ 340 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY---------QMSRPDFA 340 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHccc---------CccCCCCC
Confidence 5678999999998899999999999999999997 999996543221 111 1111110 00111123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
+.++.+++.+||+.||.+||++.|+++.|++++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.52 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=198.7
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
...+.||+|+||.||+|.. .+++.||+|.+.... ..+..|++++.+++|+||+++++++.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4468899999999999965 578999999875432 13567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.++|+|||++...... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 156 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---E 156 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---C
Confidence 9999998887655445899999999999999999999 999999999999999999999999999999765321 1
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... +-+....... ...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~~~ 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED----------QEE 223 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc----------ccc
Confidence 223456899999999999999999999999999999999999999765432211 1111111111 011
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
++...+..+.+|+.+||+.||.+||+ ++|+++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22334557889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.28 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=201.4
Q ss_pred HHHhhhcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
...+.+.+.||+|+||.||+|.+. .+..||+|+++... ..+..|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344567889999999999999653 45789999987542 245779999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997653 24899999999999999999999 99999999999999999999999999998765321
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+ .. . .+..+..
T Consensus 160 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~---~-~~~~~~~----- 226 (266)
T cd05064 160 EA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI---K-AVEDGFR----- 226 (266)
T ss_pred cc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH---H-HHHCCCC-----
Confidence 11 111112334678999999999999999999999999999875 999996543221 11 1 1111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
...+...+..+.+++.+||+.+|.+||+++|+++.|+++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011233456788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.47 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=199.9
Q ss_pred HhhhcccccccCceEEEEEEeCC-----------------CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD-----------------NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALI 456 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~ 456 (704)
.+.+.+.||+|+||.||++.+.+ +..||+|++.... ..+.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 45567899999999999996532 3469999986532 2567899999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHhhccc-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceec
Q 037258 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK-----------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHR 519 (704)
Q Consensus 457 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 519 (704)
+++.+.+..++||||+++|+|.+++.... ...+++..+++++.|++.||+||| +.+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 99999999999999999999999986532 123678899999999999999999 8999999
Q ss_pred CCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 037258 520 DVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT--GRRPV 597 (704)
Q Consensus 520 Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~Pf 597 (704)
||||+|||+++++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999976533222222233455788999999998899999999999999999987 56677
Q ss_pred CCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 598 ISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...... .....+............ ...+...+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 243 ~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDE---QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHH---HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 654321 222222222211111000 01122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.56 Aligned_cols=239 Identities=26% Similarity=0.431 Sum_probs=202.5
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.++||+|.||.||+|. ...++.||+|++.-... +.+.|+.+|.+++++||.++++.+..+..++++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 4789999999999994 45789999999864333 55789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
+.+.++.... +++..+.-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+..+... ......
T Consensus 98 v~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~t 170 (467)
T KOG0201|consen 98 VLDLLKSGNI--LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKT 170 (467)
T ss_pred hhhhhccCCC--CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech--hhcccc
Confidence 9999987653 478888889999999999999 999999999999999999999999999999876432 223367
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.. ..-++.....+.....
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGD 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccccc
Confidence 899999999999999899999999999999999999999997655421 1112222222233335
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+..+.+++..||..||+.||+|.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 5668999999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=304.08 Aligned_cols=235 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred cCHHHHHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEe
Q 037258 390 FAYSEIQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIE 461 (704)
Q Consensus 390 ~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~ 461 (704)
+++++.+ +.+.||.|+||+|.+++.+ +|..+|+|+++.... ....|..+|+.+.||.++++.+.+.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 6666654 3578999999999999655 688999999976543 34568889999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 462 GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 462 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
.+..++||||++||.|..+++..++ +++..+.-++.||+.||+||| +.+|++|||||+|||+|.+|.+||+|||.
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccc
Confidence 9999999999999999999998766 999999999999999999999 99999999999999999999999999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
|+.+. ......+||+.|+|||.+....+..++|-|||||++|||+.|.+||....... +...+.++++
T Consensus 191 AK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v 258 (355)
T KOG0616|consen 191 AKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV 258 (355)
T ss_pred eEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc
Confidence 99864 22456899999999999999999999999999999999999999997765411 1122222221
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCC
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSER 656 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 656 (704)
.++...+..+.+|+...|+.|-.+|
T Consensus 259 ----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2344445678899999999999998
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=322.02 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=203.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|++|.||+|... .++.||+|++..... .+..|++++++++|+||+++++++..++..++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 445788999999999999654 688999999875433 5678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||++....... .....
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~~~~ 163 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHA 163 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce-eeccC
Confidence 9999998766556899999999999999999999 8999999999999999999999999999997653221 11111
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.... +..+ .....+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~~~---------~~~~~~ 227 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-LEKG---------YRMERP 227 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHCC---------CCCCCC
Confidence 2234568999999999999999999999999999998 89998643321 11111 1111 111222
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 33456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.83 Aligned_cols=246 Identities=36% Similarity=0.582 Sum_probs=193.5
Q ss_pred hcccccccCceEEEEEEeC-----CCcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 402 FERVLGKGGFGEVYHGSLD-----DNQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.||.|.||.||+|.+. .+..|+||+++.. ...+..|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999775 3578999999542 23678899999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.......+++..+..|+.|+++||+||| +.+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999875555999999999999999999999 889999999999999999999999999999876322222
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
...........|+|||.+....++.++||||||+++|||++ |+.||..... .++.... ..+...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~~-------- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQRL-------- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEET--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccc--------
Confidence 23334556778999999999999999999999999999999 7888855422 1122222 222111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11223355788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.02 Aligned_cols=249 Identities=29% Similarity=0.519 Sum_probs=201.8
Q ss_pred hhcccccccCceEEEEEEeCC------CcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLDD------NQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.||+|+||.||+|.... ...||+|.+..... .+.+|++++.+++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 456889999999999996532 25799999864322 4577999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEE
Q 037258 470 EYMASGTLDQYLKGKKE--------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 535 (704)
||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence 99999999999975421 45888999999999999999999 89999999999999999999999
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNS 614 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 614 (704)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~---- 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE---- 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----
Confidence 999999976532222222334456788999999998899999999999999999998 99999764432 1111
Q ss_pred HHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 615 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.+..+... ..+...+.++.+|+.+||+.||.+||+++||++.|+.
T Consensus 238 ~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 12222111 1223455689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.16 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=204.6
Q ss_pred HHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
...+.+.+.||+|++|.||+|...+++.||+|.++... ..+.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34456789999999999999988778899999987532 356789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.......+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||+++...... ...
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 160 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEA 160 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-ccc
Confidence 999999998766556899999999999999999999 8999999999999999999999999999998764211 111
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .... ...... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~---------~~~ 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGY---------RMP 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCC---------CCC
Confidence 112223457999999999899999999999999999999 99998654321 1111 111110 001
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.....+..+.+++.+|++.+|.+||++.++++.|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 122344678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.07 Aligned_cols=237 Identities=25% Similarity=0.358 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||++.. .+|+.||+|+++... .....|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999987432 14467889999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence 9999997654 3899999999999999999999 99999999999999999999999999999875321 122233
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..+.. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~-~~~~~~----------~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL-ILMEEI----------RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHH-HHcCCC----------CCCC
Confidence 457999999999999999999999999999999999999999653321 11111 111110 1223
Q ss_pred hHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
..+.++.+++.+||+.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3456788999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.16 Aligned_cols=249 Identities=28% Similarity=0.437 Sum_probs=203.3
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.++||+|+||.||+|...+++.||+|.+.... ..+..|+.++++++|+||+++++++.+++..++||||+++|+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 34578999999999999988888899999886432 356789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++....... ......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 163 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREG 163 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-eeccCC
Confidence 999998765556899999999999999999999 8999999999999999999999999999998653221 111223
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... +..+.. . ....
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~----~~~~ 227 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYR-----M----PRME 227 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCC-----C----CCCC
Confidence 345678999999998889999999999999999998 99999653321 11111 111110 0 1112
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
..+.++.+++.+|+..+|++||+++++.+.|++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 234578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=326.64 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.||+|+||.||+++ ..+|..+|+|+++++.. ....|-.+|....+|.||+++-.|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 4789999999999995 45799999999987655 345677788888999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC------
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE------ 548 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~------ 548 (704)
|++..+|..... +++..+..++.+++.|++.|| +.|+|||||||+|+|||..|++||+|||++..+...
T Consensus 226 GD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 226 GDMMTLLMRKDT--LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred ccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999999987665 999999999999999999999 999999999999999999999999999998543110
Q ss_pred ---------------CCCc------------------------ccccccCCCCccCccccccCCCCcchhHHHHHHHHHH
Q 037258 549 ---------------SSDQ------------------------ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLE 589 (704)
Q Consensus 549 ---------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~e 589 (704)
.... .....+|||.|+|||++.+..|+..+|.||+|||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 0000 0112479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcc-cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 037258 590 IITGRRPVISRAEDDTT-HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT---MTDVL 663 (704)
Q Consensus 590 lltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 663 (704)
|+.|.+||......+.. .+..|...... ......+.++.+||.+|+. ||++|.. ++||.
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999887764432 33333221111 1112233688999999999 9999986 55554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.04 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCC-----eEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGN-----NMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~e~~~~gs 476 (704)
.+++|+|+||.||+|... +++.||||+.-.......+|+++|+.+.|||||++.-+|.... ...+|||||+. +
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-t 107 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-T 107 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-H
Confidence 578999999999999654 5799999998877778889999999999999999999887542 23489999987 9
Q ss_pred HHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCCCCcc
Q 037258 477 LDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 477 L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~~~~~ 553 (704)
|.+.++.. .+..++...+.-+..||++||.||| ..+|+||||||+|+|+|.+ |.+||||||.|+.+.. ...
T Consensus 108 L~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~---~ep 181 (364)
T KOG0658|consen 108 LYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK---GEP 181 (364)
T ss_pred HHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeecc---CCC
Confidence 99999853 1334888888999999999999999 8999999999999999976 8999999999998743 233
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-------------
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------------- 619 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------- 619 (704)
......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+ .+++.++ .+...
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik-~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIK-VLGTPTREDIKSMNPNYT 258 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHH-HhCCCCHHHHhhcCcccc
Confidence 3567788999999999865 79999999999999999999999997754332 2333222 11111
Q ss_pred --CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 --DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...++....+..-+....+.++.+++.++|+.+|.+|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111111111133456678999999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.34 Aligned_cols=266 Identities=28% Similarity=0.392 Sum_probs=202.5
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHH--hhcccceeEEEEEEEeCC----eEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLM--RVHHRNLTALIGYCIEGN----NMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~--~l~h~nIv~l~~~~~~~~----~~~lV~e~~~~ 474 (704)
+.++||+|+||.||+|.+. ++.||||++..... .+..|-++.+ .++|+||++++++-.... +++||++|.+.
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 4578999999999999985 59999999976544 5566666655 568999999999987665 89999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC------KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|+|.++|+.+. ++|....+|+..+++||+|||++. +++|+|||||++|||+..|+++.|+|||+|..+...
T Consensus 293 GsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 293 GSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred CcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 99999999776 999999999999999999999643 678999999999999999999999999999988655
Q ss_pred CCCcccccccCCCCccCccccccCC-CC-----cchhHHHHHHHHHHHHhCCCCCCC-CCCCCc----------ccHHHH
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNW-LN-----EKSDVYSFGVVLLEIITGRRPVIS-RAEDDT----------THISQW 611 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDVwSlGvvl~elltG~~Pf~~-~~~~~~----------~~~~~~ 611 (704)
......-..+||.+|||||++.+.. +. .+.||||+|.|||||+++..-+.. ..++-. ..+.+.
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 5444455689999999999997642 22 468999999999999996544421 111110 111111
Q ss_pred HHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 037258 612 VNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIV 675 (704)
Q Consensus 612 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 675 (704)
-.-.+.+.....+.+ ... ....+..+.+.+..||..||+-|.|+.=+-+++.++..+...
T Consensus 450 q~~VV~kK~RP~~p~-~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 450 QELVVRKKQRPKIPD-AWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHhhccCCCChh-hhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111111111111 111 123456789999999999999999999999999887766553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.36 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=196.6
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------------------hHHHHHHHHHhhcccceeEEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------------------FQLLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
.|.+.+.||+|.||.|-+|.. .+++.||||++.+... ...+|+.+|++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 455678899999999999954 4799999999864322 347899999999999999999999
Q ss_pred EeC--CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 460 IEG--NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 460 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
.+. +.+|||+|||..|.+...=..... +++.++++++.+++.||+||| .++||||||||+|+||+++|++||+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~e--ls~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPE--LSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCccc--ccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEee
Confidence 865 679999999998877654333222 899999999999999999999 9999999999999999999999999
Q ss_pred eccCccccccC---CCCcccccccCCCCccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 037258 538 DFGLSRIFSIE---SSDQISTAVAGTPGYLDPEYYVLNW----LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610 (704)
Q Consensus 538 DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 610 (704)
|||.+...... ..........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+...-+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------ 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH------
Confidence 99999765221 1222233478999999999998632 4578899999999999999999996654311
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
... .++...+.-....+..+.+.+||+++|++||++|.+..+|....-
T Consensus 327 l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111 122222221222345678999999999999999999999976543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.10 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=209.9
Q ss_pred hhhcccccccCceEEEEEEeCCC-cEEEEEecccchh----hHHHHHHHHHhhc-ccceeEEEEE-EEe------CCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDN-QQVAVKMLSSSCC----FQLLQVKLLMRVH-HRNLTALIGY-CIE------GNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~----~~~~E~~~l~~l~-h~nIv~l~~~-~~~------~~~~~ 466 (704)
..+++.|.+|||+.||.|....+ ..||+|++-.... ...+|+++|++|+ |+|||.+++. ... .-+++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34578999999999999977655 9999998754433 4578999999997 9999999993 221 13688
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
|+||||++|.|-|++..+....+++.++++|+.|+++|+++||. ++.+|||||||-+||||+.+++.||||||.+....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999999987766669999999999999999999994 47889999999999999999999999999986542
Q ss_pred cCCCCc-c------cccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH
Q 037258 547 IESSDQ-I------STAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML 616 (704)
Q Consensus 547 ~~~~~~-~------~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 616 (704)
...... . .-....|+.|+|||++. +..+++|+|||+|||+||-|+....||+....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------- 263 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------- 263 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------------
Confidence 222111 0 11245799999999874 77899999999999999999999999965432
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCC
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 680 (704)
..+++....-.....++..+.+||+.||+.||.+||++-+|+..+.++......-....
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 22333333322235678899999999999999999999999999999887655444333
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.23 Aligned_cols=246 Identities=26% Similarity=0.459 Sum_probs=198.9
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
..+.+.||+|+||.||++.+.++..+|+|.+.... ..+..|++++++++||||+++++++.+++..++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 34568899999999999998888899999876432 366789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.++++.... .+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||.++...... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05114 86 LLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccCC
Confidence 9999976443 3889999999999999999999 8999999999999999999999999999987653211 111122
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. +... ..+.. .. .+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~---~~~i-~~~~~--~~-------~~~ 224 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EV---VEMI-SRGFR--LY-------RPK 224 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHHH-HCCCC--CC-------CCC
Confidence 345568999999998889999999999999999999 89998654321 11 1111 11111 00 111
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..+..+.+++.+||+.+|.+||+++|+++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 2345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.36 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=202.2
Q ss_pred hhhcccccccCceEEEEEEeC----CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|.+. +...||||.++.... .+..|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 456789999999999999764 245799999864322 45679999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++..... .+++..+..++.|++.||+||| +.+|+|+||||+||++++++.++|+|||++..+.....
T Consensus 86 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 86 YMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred cCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999976543 4899999999999999999999 89999999999999999999999999999987642222
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+.. ....+...
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~------- 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIK----AVEDGYRL------- 227 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 222223345678999999998899999999999999999998 99998554321 1111 11111100
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
..+...+..+.+++.+|++.+|++||++.|+++.|++++
T Consensus 228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 112234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.99 Aligned_cols=251 Identities=29% Similarity=0.461 Sum_probs=205.1
Q ss_pred hcccccccCceEEEEEEeCC--C---cEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 402 FERVLGKGGFGEVYHGSLDD--N---QQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.++||+|+||.||+|.+.. + ..||||..+... .++..|.+++++++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45899999999999996643 2 238999987422 26788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
|+|.||+|.++|+..+. .++..++..++.+.|.||+||| +.++|||||-++|+|++.++.+||+|||+++.-.
T Consensus 241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--- 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--- 313 (474)
T ss_pred EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence 99999999999998765 4899999999999999999999 9999999999999999999999999999987532
Q ss_pred CCcccc-cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 SDQIST-AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
...... ...-...|+|||.+....++.++|||||||++||+++ |..||.+....+ +.. .....+
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~---kI~~~~-------- 379 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKA---KIVKNG-------- 379 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHH---HHHhcC--------
Confidence 111111 2235679999999999999999999999999999999 888997655321 111 111221
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.+...+...+..+..++.+|+..+|++||+|.++.+.|+.+.....
T Consensus 380 -~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 -YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1112233456678899999999999999999999999998876544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.35 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=202.8
Q ss_pred HHhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.++.+.+.||+|+||.||+|... +++.||||.++... ..+.+|++++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 44567789999999999999653 34789999986532 25678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcE
Q 037258 467 LIYEYMASGTLDQYLKGKK------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA 534 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 534 (704)
+||||+++++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 234788999999999999999999 8999999999999999999999
Q ss_pred EEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 037258 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVN 613 (704)
Q Consensus 535 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 613 (704)
+|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence 9999999876432222122233445778999999999999999999999999999998 999986543321 1111
Q ss_pred HHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 614 SMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 614 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...+... ..+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 237 --~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 --ITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111 1122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.70 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=202.1
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEeecC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEYMA 473 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~~~ 473 (704)
.+.|++|.||.||+|+. .+++.||+|+++-... ...+|+.+|.+++|||||.+.++.... +.+|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 36799999999999954 4789999999975443 458999999999999999999988754 67999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
. +|..++...+ +.+...++..+..|+++|++||| ...|+|||||++|+|++..|.+||+|||+|+.++.. ...
T Consensus 161 h-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~ 233 (419)
T KOG0663|consen 161 H-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKP 233 (419)
T ss_pred h-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC--ccc
Confidence 8 9999998766 45899999999999999999999 999999999999999999999999999999987533 334
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc--------
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI-------- 624 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 624 (704)
.+..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.+..+-+..+..-.......+..+..+
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 5667789999999999865 6899999999999999999999999877654432221111111111111111
Q ss_pred ------cCCcCCCCCChh-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 625 ------VDPSLQGNFDNN-SAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 625 ------~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+...|... .++.-.+|+..+|..||.+|.|+.|.|+.
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 001111222222 34677899999999999999999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.68 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=201.2
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.++||+|+||.||+|... .+..||||+++... ..+..|+++++++. ||||++++++|.+.+..+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445689999999999999642 23479999986432 24677999999996 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc-------------------------------------------------------------
Q 037258 467 LIYEYMASGTLDQYLKGKK------------------------------------------------------------- 485 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 485 (704)
+||||+++|+|.+++....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999999886531
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC
Q 037258 486 ---------------------------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532 (704)
Q Consensus 486 ---------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 532 (704)
...+++..+..++.|+++||+||| +.+|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCC
Confidence 123778888999999999999999 89999999999999999999
Q ss_pred cEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 037258 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQW 611 (704)
Q Consensus 533 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 611 (704)
.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------ 348 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------ 348 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------
Confidence 999999999986533222222233456788999999999899999999999999999997 9999865432111
Q ss_pred HHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 612 VNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 612 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.......+. ....+...+..+.+++.+||+.+|++||++.+|.+.|+++..
T Consensus 349 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111111 001122345678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.90 Aligned_cols=235 Identities=23% Similarity=0.350 Sum_probs=191.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||.||+|... +++.||+|+++... .....|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999664 68899999986432 2446789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.... ........
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 153 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF 153 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence 999976543 899999999999999999999 99999999999999999999999999999875321 12223445
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ..++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~-~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQE-P----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC-C----------CCCCCcC
Confidence 789999999999999999999999999999999999999965332 1222222211 1 0122334
Q ss_pred HHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 037258 638 AWKAVELALACASHTSSERPT---MTDVLM 664 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs---~~evl~ 664 (704)
+..+.+++.+||+.||.+||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 457889999999999999985 556553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.13 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=201.0
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeC-CeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEG-NNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~ 465 (704)
.+.+.+.||+|+||.||+|... +++.||+|+++... .....|++++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4567899999999999999532 35789999986432 1346789999999 899999999988754 568
Q ss_pred EEEEeecCCCCHHHHhhcccC-----------------------------------------------------------
Q 037258 466 GLIYEYMASGTLDQYLKGKKE----------------------------------------------------------- 486 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 486 (704)
++++||+++|+|.+++.....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 899999999999999864321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCc
Q 037258 487 HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566 (704)
Q Consensus 487 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 566 (704)
..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++..+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25789999999999999999999 899999999999999999999999999999876332222222334566789999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHH
Q 037258 567 EYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELA 645 (704)
Q Consensus 567 E~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 645 (704)
|++.+..++.++|||||||++|||++ |+.||......+ . ....+..+... ..+.....++.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~---------~~~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRM---------RAPEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCC---------CCCccCCHHHHHHH
Confidence 99999999999999999999999998 999996533221 1 11122221111 11223345789999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 646 LACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 646 ~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+||+.+|++||++.|+++.|++++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.09 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=205.9
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.+.||+|+||.||+|...+++.+++|++..... ....|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 3556789999999999999888899999999875433 567789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||.+...... ....
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~~~ 161 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VYLS 161 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc--cccc
Confidence 99999998766666899999999999999999999 899999999999999999999999999999765322 1112
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+ ... ... .+ .....
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~-~~---------~~~~~ 225 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYD---QIT-AG---------YRMPC 225 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HHH-hC---------CcCCC
Confidence 23445678999999998889999999999999999998 899996543211 111 111 11 01111
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 233456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.10 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.||+|+||.||+|.. .+++.||+|.+.... ..+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999966 478999999875332 2567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997543 24889999999999999999999 999999999999999999999999999998754321111111112
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..+..|+|||.+.++.++.++||||||+++|||++ |..||....... ........ .....+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCCCCccc
Confidence 23457999999998889999999999999999998 888885433211 11111111 11112233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.+..+.+++.+||+.+|++||++.|++++|++
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 45678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.58 Aligned_cols=239 Identities=24% Similarity=0.336 Sum_probs=196.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999665 78999999985422 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 83 VPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999976543 889999999999999999999 999999999999999999999999999999765321
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~-~~~~---------- 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKIL-AGKL---------- 215 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCc----------
Confidence 12346899999999999988999999999999999999999999654321 1111111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPT-----MTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 665 (704)
.++......+.+++.+||+.||.+||+ ++|+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 122223457889999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.25 Aligned_cols=237 Identities=26% Similarity=0.371 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||++.. .+|+.||+|+++... .....|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999986432 13457899999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccc
Confidence 9999887654 3899999999999999999999 99999999999999999999999999999875321 112223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .... .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~-~~~~----------~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL-MEEI----------RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCC----------CCCC
Confidence 4568999999999999999999999999999999999999996543211 111111 1110 1222
Q ss_pred hHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
..+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3455788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.56 Aligned_cols=253 Identities=29% Similarity=0.441 Sum_probs=204.6
Q ss_pred HHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 395 IQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 395 l~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+....+.+.++||+|+||.||+|...+++.||+|.+.... ..+..|+.++++++|+||+++++++. .+..++||||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3445667789999999999999998889999999987533 35678999999999999999999874 4568999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.......+++.++..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence 99999999998766556899999999999999999999 8999999999999999999999999999997653211 1
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +..+. .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~---------~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN----LERGY---------R 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH----HHcCC---------C
Confidence 11223345678999999998889999999999999999999 99999654321 11111 11110 0
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...+...+.++.+++.+|+..+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01112234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.75 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=194.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|... +++.||+|+++... ....+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 445689999999999999654 78999999886322 245689999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 87 ~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~~ 159 (288)
T cd07871 87 S-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TKT 159 (288)
T ss_pred c-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Ccc
Confidence 5 9999887543 23788999999999999999999 999999999999999999999999999998764321 112
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc------------CC
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE------------GD 620 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------~~ 620 (704)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.. ..+...... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhccccchh
Confidence 234567899999999875 56899999999999999999999999654432211 111111100 00
Q ss_pred cccccCCcCCCC----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGN----FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..... .....+.++++++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 011111111000 01123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.82 Aligned_cols=238 Identities=25% Similarity=0.370 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||++.. .+++.||+|++.... .....|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999986432 24567889999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccc
Confidence 9999987654 3899999999999999999999 99999999999999999999999999999875321 112223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... .. . .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~-~~------~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-ED------I----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhcc-CC------c----cCCC
Confidence 456899999999999989999999999999999999999999654321 11111111 10 1 1223
Q ss_pred hHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
..+..+.+++.+||+.||.+|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3455788999999999999997 89998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.15 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=199.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||||+++... .....|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 345789999999999999765 68999999986432 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 83 VPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 99999999997654 3889999999999999999999 99999999999999999999999999999976532
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ........ ..+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~---~~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWK---ETLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcc---ccccCCCCC
Confidence 23445789999999999999999999999999999999999999965432211 11111100 001000000
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
......+.++.+++.+||..+|.+||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0012345678899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.76 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=199.5
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
..+...+.||+|+||.||+|.+. +++ .||+|+++... ..+..|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 33455689999999999999753 333 48999986432 2556788999999999999999999865 5679
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|+||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999999986542 3889999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~---- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERL---- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCC----
Confidence 322222223344678999999999999999999999999999998 99998653221 11 1112211110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+......+.+++.+||+.+|.+||++.+++..|..+...
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11122345688999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.18 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+...+.||+|+||.||++... ++..||+|++.... ..+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 445688999999999999665 68899999886432 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+|+|.+++..... +++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||++..+.. .
T Consensus 87 ~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 87 GGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 9999999976543 889999999999999999999 5 4699999999999999999999999999876532 1
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC--cc--------
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD--IR-------- 622 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 622 (704)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+......+. ..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccc
Confidence 2234568999999999999999999999999999999999999996543211 1111100000000 00
Q ss_pred ------------------------cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 ------------------------NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 ------------------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+.............+.++.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000011245678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.13 Aligned_cols=250 Identities=28% Similarity=0.488 Sum_probs=199.6
Q ss_pred hhhcccccccCceEEEEEEe-----CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
..+.+.||+|+||.||+|.. .++..|++|.+.... ..+..|++++++++||||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 35678999999999999964 356789999986422 24567999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcE
Q 037258 470 EYMASGTLDQYLKGKK---------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA 534 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 534 (704)
||+++++|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence 9999999999985332 234788999999999999999999 8999999999999999999999
Q ss_pred EEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 037258 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVN 613 (704)
Q Consensus 535 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 613 (704)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .+.+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~--- 237 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE--- 237 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 9999999976533222222233445678999999998889999999999999999998 99998653321 1111
Q ss_pred HHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 614 SMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 614 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
........ ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 238 -~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 1122334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.10 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=202.4
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|...+...||+|+++... ..+..|++++++++|+||+++++++.+ ...++||||+++|
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 85 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCC
Confidence 466788999999999999988777789999987532 256789999999999999999998754 5678999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+..+.... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~~~~~ 161 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ 161 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc-ccccc
Confidence 9999998655555899999999999999999999 8999999999999999999999999999997653222 11222
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||+..+..++.++||||||+++|||++ |+.||....... . ... ...+. .....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~---~~~-~~~~~---------~~~~~ 225 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQ-VERGY---------RMPCP 225 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H---HHH-HhcCC---------CCCCc
Confidence 3446678999999988889999999999999999999 888885543211 1 111 11110 00112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
...+..+.+++.+|++.+|++||++.++++.|++..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.22 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=196.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... +++.||+|+++... ....+|++++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 445788999999999999765 68899999986432 24567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+++.+..+.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+.... ..
T Consensus 83 ~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (287)
T cd07848 83 EKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NA 156 (287)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cc
Confidence 987776554432 34899999999999999999999 9999999999999999999999999999998753221 12
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH---------HHHHHhcCCccc
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW---------VNSMLAEGDIRN 623 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 623 (704)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....... ............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22345689999999999988899999999999999999999999976442211000000 000000000000
Q ss_pred ccCCcCCC------CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQG------NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+.... ......+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010000 011123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=342.50 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=198.9
Q ss_pred hhhcccccccCceEEEEEEeC-C-CcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-D-NQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|... + ++.||+|.+..... .+..|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566889999999999999543 4 67889987643322 45679999999999999999999999999999999999
Q ss_pred CCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 2335889999999999999999999 899999999999999999999999999999876433222
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +...
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~-~~~~--------- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY-GKYD--------- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC---------
Confidence 233456799999999999999999999999999999999999999964332 111222111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+..+.+++.+||+.+|++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112233457899999999999999999999874
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=314.21 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=200.9
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccc---hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|...++..||+|.+... ...+.+|+.++++++|+|++++++++. ....++||||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 35567899999999999998888889999998653 235678999999999999999999885 45678999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++..+.... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccccc
Confidence 9999998765555899999999999999999999 8999999999999999999999999999997653221 11112
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... .... .. ..+ .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~-~~~---------~~~~~~ 225 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE---QV-ERG---------YRMPCP 225 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HH-HcC---------CCCCCC
Confidence 2335668999999988889999999999999999999 88998653321 1111 11 111 011112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.62 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=202.6
Q ss_pred hhhcccccccCceEEEEEEe------CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||++.. .++..+|+|.+..... .+..|++++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 34578899999999999964 2345689999865432 4678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccc-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 470 EYMASGTLDQYLKGKK-----------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEecc
Confidence 9999999999997543 234899999999999999999999 89999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+ . . ....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~---~-~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---I-ECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HHHH
Confidence 999976532222122223445778999999999999999999999999999998 899986543211 1 1 1111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.+.... .+...+..+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus 237 ~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 221111 1112345789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.49 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=198.0
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|... .+..||||++.... ..+..|+.+++.++|+||+++++++.++...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 3556789999999999998643 35679999885432 245678999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 468 IYEYMASGTLDQYLKGKKE--------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCC
Confidence 9999999999999975321 23678889999999999999999 899999999999999999999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... . ... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~---~~~-~~~~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---Q---VLR-FVME 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H---HHH-HHHc
Confidence 99876532222111222345678999999998889999999999999999999 78888654321 1 111 1111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
+... ..+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 237 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 1122334578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.30 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=196.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||+|+++... .....|++++++++||||+++++++.+++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 456789999999999999765 68999999986432 2456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 100 VVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred CCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 999999999986543 888999999999999999999 999999999999999999999999999999865321
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +... .+..+..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~-~i~~~~~---------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYE-KILAGRL---------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHH-HHhcCCc----------
Confidence 12356899999999999999999999999999999999999999653321 1111 1111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||+ ++|++.
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112223456889999999999999997 677774
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.34 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=199.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|...++..+|+|.+.... ..+..|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 34678899999999999988777789999887542 256789999999999999999999999889999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++..... .+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||.++...... ......
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVG 160 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCC
Confidence 9999976443 4899999999999999999999 9999999999999999999999999999987653221 111222
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++.+..++.++|||||||++|||++ |+.||......+ . ..... .+... ..+.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~-~~~~~---------~~~~ 224 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T---VEKVS-QGLRL---------YRPH 224 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHHHh-cCCCC---------CCCC
Confidence 345678999999998889999999999999999998 999986443211 1 11111 11100 0111
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
..+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 23467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=313.77 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
..+.+.||+|+||.||+|...++..+|+|++.... ..+..|++++++++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 34678899999999999988777889999986432 256789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++..... .......
T Consensus 86 L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 160 (256)
T cd05059 86 LLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQG 160 (256)
T ss_pred HHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccc-cccccCC
Confidence 9999976543 4899999999999999999999 899999999999999999999999999998765321 1111112
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. .. ...+ .. ...+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~~~~-----~~----~~~~~ 224 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ES-VSAG-----YR----LYRPK 224 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HH-HHcC-----Cc----CCCCC
Confidence 233457999999998899999999999999999999 899986543211 11 11 1111 00 11122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..+.++.+++.+||..+|++||++.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3456899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=321.41 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=202.5
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.. ..+..||||+++... ..+..|+++++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 345678999999999999963 234579999886432 2456799999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++|+|.++++......+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++.+.
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999998655445899999999999999999999 8999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .. ......+.
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~----~~~~~~~~----- 261 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF----YKLIKEGY----- 261 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH----HHHHHcCC-----
Confidence 3222112223445778999999998899999999999999999998 999986543221 11 11111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
....+...+.++.+++.+||..+|++||++.|+++.|+++
T Consensus 262 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.87 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=204.2
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... ++..+++|.++.... .+.+|++++++++|+||+++++++..++..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 345688999999999999642 356799999875432 4678899999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEE
Q 037258 470 EYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 535 (704)
||+++++|.+++.... ...+++..++.++.|++.||+||| +++++||||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999997542 134789999999999999999999 99999999999999999999999
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNS 614 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 614 (704)
|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .. .
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI----E 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----H
Confidence 999999976532222222334456788999999999999999999999999999999 999986543211 11 1
Q ss_pred HHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 615 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
....+.... .....+..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 112221111 1122345788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.81 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=200.2
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEe-----CCeEEEEEe
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIE-----GNNMGLIYE 470 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lV~e 470 (704)
.+.||+|++|.|+.+.. .+|+.||||++... .....+|+++|+.++|+||+.+++.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 46799999999999954 58899999998622 2366899999999999999999999865 357999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
+|+ -+|...++.+.. ++...+..++.|+++||+|+| +.+|+||||||+|++++.+..+||+|||+|+.......
T Consensus 107 lMe-tDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred HHh-hHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 995 499999987654 899999999999999999999 99999999999999999999999999999998754434
Q ss_pred CcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHHhcCCc
Q 037258 551 DQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN--------SMLAEGDI 621 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~ 621 (704)
....+....|..|.|||.+. ...|+.+.||||.|||+.||++|+.-|.+.+.-+...+...+. ..+.....
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 45567788999999999986 5689999999999999999999999997765432211111100 00000000
Q ss_pred ccccC---C----cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 622 RNIVD---P----SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 622 ~~~~d---~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+. . .+...+ .......++|+.+||..||.+|+|++|+++.
T Consensus 261 r~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 0 000111 1344578899999999999999999999973
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=327.55 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=209.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCe-EEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNN-MGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lV~e~ 471 (704)
|...+.+|+|+||.++..+++ ++..+++|.+.-.. .....|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 455689999999999999654 67889999874322 256789999999999999999999999888 9999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
++||+|.+.+...++..++++.+..++.|++.|+.||| +.+|+|||||+.|||++.+..++|+|||+|+.+..+.
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 99999999999888777999999999999999999999 9999999999999999999999999999999875332
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|++||.+.+..|..|+|||||||++|||++-+++|...+-. ..+.+.... ...
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~----------~~~ 224 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRG----------LYS 224 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhc----------cCC
Confidence 3566789999999999999999999999999999999999999999654421 122222211 112
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+.++..++..||+.+|..||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2345567789999999999999999999999975
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=321.70 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=206.8
Q ss_pred HHHHhhhcccccccCceEEEEEEe--------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEe
Q 037258 396 QKITNNFERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIE 461 (704)
Q Consensus 396 ~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 461 (704)
....+.+.+.||+|+||.||+|.. .++..||+|.+.... .....|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 344456678999999999999963 134579999986432 2467789999999 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 462 GNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 462 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
....++||||+++|+|.+++.... ...+++..+..++.|+++||+||| +.+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 999999999999999999997642 234788899999999999999999 899999999999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTT 606 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~ 606 (704)
+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999987643222222233445678999999998889999999999999999998 7888754321
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIV 675 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 675 (704)
.++... +..+... ..+...+..+.+++.+||+.+|.+||++.|+++.|++++.++..
T Consensus 246 --~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 --EELFKL-LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred --HHHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 122221 1111110 11223456788999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=308.55 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=206.4
Q ss_pred HHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
-+|.|.+.||+|.||.|-+| ....|+.||||.+++... ...+|+++|+.++||||+.++++|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 45677889999999999999 457899999998865433 4578999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||..+|.|.+++...+. +++.++..++.||..|+.|+| +++++|||||.+|||+|.++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~--- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--- 204 (668)
T ss_pred EecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc---
Confidence 99999999999998766 999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCcccccccCCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.......++|++-|.+||++.+..|. +..|-|||||+||.|+.|..||++.+. ...+ +.+..|...+
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lv-rQIs~GaYrE----- 272 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLV-RQISRGAYRE----- 272 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHH-HHhhcccccC-----
Confidence 34556778999999999999998874 789999999999999999999976542 1112 2233333221
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
...+....-||++||..+|++|.|+.+|...-
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12223466799999999999999999998654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.76 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=216.2
Q ss_pred HHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 394 el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
|+-+-.-.|.++||+|-||.|.++....+..||||+++.... ++..|+++|.+++||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 444444456799999999999999998889999999976543 788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+|||++|+|.+++..+....+.-....+|+.||+.||+||. +.++|||||.++|+|++.++++||+|||+++-+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999876444566677889999999999999 999999999999999999999999999999876444
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT--GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
+.........-..+|||||.+..++++.++|||+||+++||+++ ...||.....++ .++-....+..+.....+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l- 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVL- 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceec-
Confidence 44444445566789999999999999999999999999999876 788987665432 222222222222111111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
..+.-++.++.+++.+||..+-.+||+++++...|++.
T Consensus 767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12345667889999999999999999999999998764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.58 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=200.4
Q ss_pred hhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.||+|+||.||+|... ....+++|.+..... .+..|+.+++.++||||+++++.+..++..++|+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 34678999999999999642 235799998864332 4567999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 470 EYMASGTLDQYLKGKK----------------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
||+.+|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEE
Confidence 9999999999986421 134789999999999999999999 999999999999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTT 606 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~ 606 (704)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--- 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 99999999999999976532222112223345678999999988889999999999999999998 99998554321
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+.. ....+ .....+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 ~~~~----~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFN----LLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH----HHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111 11111 0111122344578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.51 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=201.3
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||++... ....+|+|.+.... .....|++++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3455789999999999999653 23679999886432 1456789999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC
Q 037258 467 LIYEYMASGTLDQYLKGK--------------KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 532 (704)
+||||+++|+|.++++.. ....+++..++.++.|++.||+||| +.+|+||||||+||++++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCC
Confidence 999999999999999652 2345889999999999999999999 89999999999999999999
Q ss_pred cEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 037258 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQW 611 (704)
Q Consensus 533 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 611 (704)
.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------- 242 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 242 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------
Confidence 999999999987643222122222345678999999998899999999999999999998 999986433211
Q ss_pred HHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 612 VNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 612 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
+......+. ....+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 243 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111 11122234557889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.21 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=192.4
Q ss_pred hhhcccccccCceEEEEEEe--CCCcEEEEEecccch------hhHHHHHHHHHhh---cccceeEEEEEEEe-----CC
Q 037258 400 NNFERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSC------CFQLLQVKLLMRV---HHRNLTALIGYCIE-----GN 463 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 463 (704)
|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+|+.+++.+ +||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 45678899999999999975 246889999875322 1345677776665 69999999999862 35
Q ss_pred eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..++||||+. ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 59999998766556899999999999999999999 8999999999999999999999999999997
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CC
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GD 620 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~ 620 (704)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+.. +...... ..
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~-i~~~~~~~~~~~ 232 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGK-ILDVIGLPGEED 232 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHH-HHHHhCCCChhh
Confidence 65322 22334568999999999998899999999999999999999999997654321 1111 1111100 00
Q ss_pred cc-------cccCCcCCC---CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IR-------NIVDPSLQG---NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. ..+.+.... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.25 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=200.7
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|++|.||+|....+..+|+|.+.... ..+..|++++++++|+|++++++++. .+..++||||+++|
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 355678999999999999988777789999876432 25678999999999999999999875 45678999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccC
Confidence 9999998765556899999999999999999999 8999999999999999999999999999997653221 11122
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||...+..++.++||||||+++|||++ |+.||......+ ...+ ...+. ....+
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~---------~~~~~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQ----VERGY---------RMPCP 225 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC---------CCCCC
Confidence 3345678999999998889999999999999999999 899986543211 1111 11110 00112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...+..+.+++.+||..+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.49 Aligned_cols=244 Identities=20% Similarity=0.334 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||++... +++.||+|+++.... ....|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999654 688999999875321 345678888888 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 99999887554 3899999999999999999999 99999999999999999999999999999874211 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD--TTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+ ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34678999999999999999999999999999999999999996432211 11222333333322221 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPT------MTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 664 (704)
.+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12233457889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.67 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=203.8
Q ss_pred HHHhhhcccccccCceEEEEEEeC--------CCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeC
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEG 462 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 462 (704)
...+.+.+.||+|+||.||++... +...+|+|.++... .....|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345667899999999999999642 23579999987532 1456789999999 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 463 NNMGLIYEYMASGTLDQYLKGKKE--------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 463 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 999999999999999999976431 34889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTH 607 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 607 (704)
++++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999876532111111122234568999999998889999999999999999998 8888854321
Q ss_pred HHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.+... .+..+.. ...+...+.++.+++.+||..+|.+||++.|+++.|++++....
T Consensus 249 -~~~~~-~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 -EELFK-LLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred -HHHHH-HHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111 1111111 11222345688899999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.65 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=199.7
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|... .++.||+|+++.... .+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999653 357899999874432 45678889999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc
Q 037258 468 IYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ 533 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 533 (704)
++||+++++|.+++.... ...+++..+..++.|++.||+||| +++++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 999999999999985321 234788899999999999999999 999999999999999999999
Q ss_pred EEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 037258 534 AKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWV 612 (704)
Q Consensus 534 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 612 (704)
+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ++.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 99999999876532222222233456778999999988889999999999999999998 88888653321 111
Q ss_pred HHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 613 NSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 613 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.. +..+... ..+...+..+.+++.+||+.+|.+||+++||++.|+.
T Consensus 237 ~~-i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 1111111 1223345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.51 Aligned_cols=234 Identities=24% Similarity=0.387 Sum_probs=195.8
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.|.++||+|.||+|+++..+ +++.+|||++++... ....|..++... +||.+++++..+...++++.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 35789999999999999765 688999999987543 335566666655 599999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.||++..+.+. ..+++..+.-++..|+.||+||| +++||+||||.+|||||.+|++||+|||+++... ...
T Consensus 451 ~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g 522 (694)
T KOG0694|consen 451 VAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQG 522 (694)
T ss_pred cCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC--CCC
Confidence 999995444443 33999999999999999999999 9999999999999999999999999999998632 234
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
....+..||+.|||||++.+..|+.+.|-|||||+||||+.|..||.+.++++. ...++.+. .
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~-----------~ 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDE-----------V 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCC-----------C
Confidence 456788999999999999999999999999999999999999999987766442 11111111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+.+.++|++++|..+|++|..+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2455567789999999999999999977
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.01 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=200.0
Q ss_pred hhcccccccCceEEEEEEe-----CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLI 468 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 468 (704)
.+.+.||+|+||+||++.. .+++.||+|+++... ..+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4568899999999988642 367889999986432 2557799999999999999999998753 458899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.... +++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999997643 899999999999999999999 899999999999999999999999999999865422
Q ss_pred CCCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SSDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhc
Confidence 2111 11223456679999999988899999999999999999999999855332100 000000000000011111122
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
......+...+.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222223345568999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.92 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=200.9
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 466 (704)
...+.+.||+|+||.||+|.+. .++.||||+++.... .+..|++++.++. ||||++++++|...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 3445689999999999999753 346899999974321 4567999999997 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccC------------------------------------------------------------
Q 037258 467 LIYEYMASGTLDQYLKGKKE------------------------------------------------------------ 486 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 486 (704)
+|+||+++|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999965321
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 487 ------------------------------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 487 ------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
..+++..++.++.|++.||+||| +.+++||||||+|||+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeC
Confidence 23677888999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----- 349 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----- 349 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-----
Confidence 99999999999976532222112223456788999999998889999999999999999998 889986543211
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.....+..+. ....+...+.++.+++.+||..+|.+||+++||++.|++++
T Consensus 350 -~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 11112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.41 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=193.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++.++...++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 455789999999999999765 78999999986432 245789999999999999999999999999999999996
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++...... ...
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 159 (303)
T cd07869 87 -TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHT 159 (303)
T ss_pred -cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--Ccc
Confidence 58888876543 33888999999999999999999 999999999999999999999999999998754221 122
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---ccc-----c
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRN-----I 624 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~ 624 (704)
.....+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....+........ ... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhccc
Confidence 234567899999999875 457899999999999999999999997543211 11111111111000 000 0
Q ss_pred cCC-cCCCCCC---------hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDP-SLQGNFD---------NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~-~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++ ......+ ......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0000000 011246789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.29 Aligned_cols=239 Identities=21% Similarity=0.344 Sum_probs=190.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||+|+++.... ....|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 678999999875321 345677777766 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCcc
Confidence 99999887654 3899999999999999999999 89999999999999999999999999999875321 11223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD--TTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34678999999999999999999999999999999999999996422111 11222233332222211 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
++...+..+.+++.+||+.||.+||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.42 Aligned_cols=238 Identities=25% Similarity=0.364 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||++.. .+++.||+|+++... .....|++++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999986432 24466888999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
+|.+++.... .+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 9999887654 3899999999999999999999 6 79999999999999999999999999998753211 1222
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...... .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~-i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL-ILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHH-HhcCCC----------CCC
Confidence 34568999999999999999999999999999999999999996543211 1111 111110 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
...+..+.+++.+||+.||++|+ ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23345788999999999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.12 Aligned_cols=256 Identities=19% Similarity=0.221 Sum_probs=195.8
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.|.+.+.||+|+||.||++.. .+++.||+|.... ....+|++++++++||||+++++++..+...++|+|++. ++|
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 355678999999999999955 5789999998653 346789999999999999999999999999999999995 689
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++..... +++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ........
T Consensus 170 ~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~~ 243 (391)
T PHA03212 170 YCYLAAKRN--IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKYYGW 243 (391)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccccccc
Confidence 988876543 889999999999999999999 899999999999999999999999999999753211 12223345
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc-----ccHHHHHHHHHhcC--C--------cc
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT-----THISQWVNSMLAEG--D--------IR 622 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~--~--------~~ 622 (704)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+. ..... . +.
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~-~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR-RSGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH-HhcCChhhcCcchhHHHH
Confidence 799999999999999999999999999999999999988765432111 01111110 00000 0 00
Q ss_pred c---------ccCCcCCCCC--ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 N---------IVDPSLQGNF--DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~---------~~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ...+...... ....+.++.+++.+||+.||.+|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000000 0123557889999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.90 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.||+|+||.||++.. .+++.||||+++... .....|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 367899999986432 1346789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 999999999976543 788899999999999999999 99999999999999999999999999999875321 11
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~---------- 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL---------- 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC----------
Confidence 2223457899999999999888999999999999999999999999654321 1111111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
..+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222345788999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.18 Aligned_cols=243 Identities=26% Similarity=0.431 Sum_probs=194.0
Q ss_pred cccccCceEEEEEEe---CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 405 VLGKGGFGEVYHGSL---DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.||+|+||.||+|.+ .++..+|+|+++... ..+..|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 357889999986432 24577899999999999999999885 45678999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc-c
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI-S 554 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-~ 554 (704)
+|.+++.... .+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||++..+........ .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997544 3899999999999999999999 89999999999999999999999999999987643221111 1
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .... .+..+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~---------~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGER---------MEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCC---------CCC
Confidence 22234578999999988889999999999999999998 99999654321 1111 1222111 112
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=293.28 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=209.4
Q ss_pred CcccCHHHHHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEE
Q 037258 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 387 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
...++.+++ ++.+.||+|-||.||.|+.+ ++-.||+|++.++.. +..+|+++-+.++||||++++++
T Consensus 16 ~~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 16 TKTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred ccccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 345565554 35789999999999999654 678899999865432 45678889999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
+.+....||++||..+|+|...|.......+++.....++.|+|.||.|+| .++|+||||||+|+|++.++.+||+|
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999999999777777999999999999999999999 99999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
||-+..- .........||..|.+||...+...+.+.|+|++|++.||++.|.+||.....++. +. + +..
T Consensus 168 fGwsV~~----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et--Yk----r-I~k 236 (281)
T KOG0580|consen 168 FGWSVHA----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET--YK----R-IRK 236 (281)
T ss_pred CCceeec----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--HH----H-HHH
Confidence 9988542 23445678899999999999999999999999999999999999999976653221 11 1 111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.++ .++...+..+.++|.+|+..+|.+|.+..|+++.
T Consensus 237 ---~~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ---VDL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---ccc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 1234455678899999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.99 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred HHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
...|.+.+.||+|+||.||++... +++.+|+|++.... ..+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 344566789999999999999765 68889999876432 246789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..+..++.|++.||.|||+ ..+++|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999976543 8899999999999999999992 247999999999999999999999999998755321
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc-------
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN------- 623 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 623 (704)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ...... ...+....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---ELMFGC-PVEGDPAESETSPRP 231 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH---HHHhcC-cccCCccccccCccc
Confidence 22335688999999999998999999999999999999999999965432111 000000 00000000
Q ss_pred ----------------------ccCC---cCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 ----------------------IVDP---SLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ----------------------~~d~---~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+. ...... ....+.++.+|+.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 000000 0113456889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.61 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=194.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||.||++... +|+.||+|.+.... .....|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999654 68999999885322 1335689999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 99987666556899999999999999999999 999999999999999999999999999998765321 122345
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........... ... .. .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~----~~-----~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE-DEV----KF-----EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc-ccc----cc-----ccccC
Confidence 68899999999998889999999999999999999999996543211 11111111111 110 00 01123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
+.++.+++.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 457889999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.30 Aligned_cols=243 Identities=27% Similarity=0.432 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
++||+|+||.||+|...+++.+|+|.+..... .+..|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999888899999999865432 4567999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++..... .+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++...... .........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD-ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCC
Confidence 99875442 4789999999999999999999 999999999999999999999999999998654211 111112223
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
++..|+|||++.+..++.++||||||+++||+++ |..||....... . ......+. ....+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~----~~~~~~~~---------~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A----REQVEKGY---------RMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcCC---------CCCCCCCC
Confidence 4567999999998889999999999999999998 999996543211 1 11111111 11112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
+..+.+++.+|+..+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=326.64 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=196.2
Q ss_pred HhhhcccccccCceEEEEEEeCC--CcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|.... +..||+|++.... .....|+.+++.++||||+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 35567899999999999996542 3689999885322 24567999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 111 Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred eCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 99999999999976543 899999999999999999999 99999999999999999999999999999976531
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~-------- 245 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII-------- 245 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC--------
Confidence 123457899999999999988999999999999999999999999654321 11111111111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
.++...+..+.+++.+||+.||++|+ +++|+++.
T Consensus 246 --~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222345678999999999999995 88888764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.28 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=189.0
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.||+|+||.||+|... +++.||||++.... ..+.+|+++++.++|+||+++++++.+++..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999654 78999999985432 24678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+.. ...+..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+... .....
T Consensus 158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 226 (353)
T PLN00034 158 SLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCN 226 (353)
T ss_pred cccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--ccccc
Confidence 986542 2567788899999999999999 899999999999999999999999999999865321 11223
Q ss_pred cccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 556 AVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
...|+..|+|||++.. ...+.++|||||||++|||++|+.||......+. ........ ... .
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~-~~~---------~ 293 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAIC-MSQ---------P 293 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHh-ccC---------C
Confidence 4578999999998743 3345789999999999999999999974332211 11111110 000 0
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.......+.++.+++.+||+.||++||++.|+++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345578999999999999999999999974
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.51 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+...+.||+|+||.||++... +++.||+|++.... ..+.+|+.++++++|+||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345688999999999999654 68999999986432 1346799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.......+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 155 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC---
Confidence 99999999987655455899999999999999999999 899999999999999999999999999998765311
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||........ .+.+...+... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~----------~~ 222 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED----------QE 222 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc----------cc
Confidence 122344689999999999988899999999999999999999999975432211 11111111111 01
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
.++...+..+.+++.+||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 12233456788999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.27 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=197.3
Q ss_pred hhcccccccCceEEEEEEeCC----CcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCe------
Q 037258 401 NFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNN------ 464 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 464 (704)
.+.+.||+|+||.||+|.... +..||+|+++... ..+..|++.++.++|+||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999996542 3679999986432 245778999999999999999999876554
Q ss_pred EEEEEeecCCCCHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 465 MGLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
.++|+||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999985432 235899999999999999999999 8999999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.++ . ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~---~-~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDY---L-RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H-HcC
Confidence 9987643222222222345678999999988889999999999999999999 88888543321 11111 1 111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
... ..+...+..+.+++.+||+.||.+||++.|+++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.98 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=194.1
Q ss_pred hcccccccCceEEEEEEeCCC-c--EEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 402 FERVLGKGGFGEVYHGSLDDN-Q--QVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
+.+.||+|+||.||+|..... + .||+|.++... ..+..|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 467899999999999976543 2 68999875431 2456789999999999999999987532 2468
Q ss_pred EEEeecCCCCHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 467 LIYEYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
+|+||+++|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+||++++++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999987432 2334889999999999999999999 899999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
+.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+. ..+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----DYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcCCC
Confidence 87632221111223345678999999999999999999999999999999 78888543221 111 11222211
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
. ......+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 233 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 L---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 11123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.42 Aligned_cols=245 Identities=26% Similarity=0.321 Sum_probs=204.8
Q ss_pred hcccccccCceEEEEEEeCC-CcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 402 FERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.||+|.-|+||++++.+ +..+|+|++.+... ..+.|-+||+.+.||.++.+++.++.+...++|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 35789999999999998764 58999999976543 45678899999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc------
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI------ 547 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~------ 547 (704)
||+|..+.+.+..+.+++..+.-++.+++-||+||| -.|||.|||||+||||.++|++.|+||.++.....
T Consensus 161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999999999999889999999999999999999999 99999999999999999999999999998643210
Q ss_pred ------------------------------------------------CCCCcccccccCCCCccCccccccCCCCcchh
Q 037258 548 ------------------------------------------------ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSD 579 (704)
Q Consensus 548 ------------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD 579 (704)
+.........+||-.|+|||++.+...+.+.|
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 00001123457899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC-
Q 037258 580 VYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT- 658 (704)
Q Consensus 580 VwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 658 (704)
.|+|||++|||+.|+.||.+...++. +..++...+.-......+..+.+||++.|.+||.+|..
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 99999999999999999988776443 12222222221122356678999999999999999998
Q ss_pred ---HHHHHH
Q 037258 659 ---MTDVLM 664 (704)
Q Consensus 659 ---~~evl~ 664 (704)
++||-+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 777764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.84 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=194.5
Q ss_pred hhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.||+|+||.||++.. .+++.||+|++.... .....|++++..+ +|+||+++++++..++..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4578999999999999864 368899999986432 1346788899999 59999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999976543 899999999999999999999 89999999999999999999999999999976532
Q ss_pred CCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.. ........||..|+|||++.+. .++.++|||||||++|||++|+.||........ ........... +
T Consensus 158 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~-------~ 227 (332)
T cd05614 158 EE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKC-------D 227 (332)
T ss_pred cC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcC-------C
Confidence 21 2222345789999999999865 478899999999999999999999965433221 11111111111 1
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
+ .++...+..+.+++.+||+.||++|| +++++++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 12223445788999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.76 Aligned_cols=250 Identities=31% Similarity=0.474 Sum_probs=196.9
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|++|.||+|... .+..|++|.+.... ..+..|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 345689999999999999664 35689999876332 2567789999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEecc
Q 037258 469 YEYMASGTLDQYLKGKKE-----HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFG 540 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfG 540 (704)
|||+++++|.+++..... ..+++..++.++.||+.||+||| +.+++||||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999976531 24899999999999999999999 89999999999999998654 59999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....... + ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~~~~~~~~ 238 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---MEFVTGGG 238 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHHcCC
Confidence 9986532211111122233568999999998999999999999999999997 999986543221 1 11111111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
. ...+...+..+.+++.+|++.+|++||++.||++.|++
T Consensus 239 ~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 R----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred c----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 11122335678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.44 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=203.4
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|..++++.||||.+.... ..+..|+.++++++|+||+++++++......++||||++++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 445678999999999999988888899999987532 36778999999999999999999999889999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..+..++.+++.||+||| +.+++|+||||+||++++++.++|+|||++..+... ......
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~ 162 (261)
T cd05034 87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTARE 162 (261)
T ss_pred CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch-hhhhhh
Confidence 9999998766556899999999999999999999 899999999999999999999999999998765321 111112
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ... .+ . ....+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~~~-~~-~--------~~~~~ 226 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE---QVE-RG-Y--------RMPRP 226 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHH-cC-C--------CCCCC
Confidence 2334568999999998889999999999999999998 99998543321 1111 111 11 0 00111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.55 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=200.2
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|... .+..||+|.+..... .+..|+.+++.++|+||+++++++..+...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 3445789999999999999653 246899999864432 45678999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 468 IYEYMASGTLDQYLKGKK--------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
||||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCc
Confidence 999999999999997533 123788999999999999999999 999999999999999999999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FVID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HHhc
Confidence 99876543222222233456788999999998889999999999999999998 99998543321 1111 1111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 1122235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.08 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=203.2
Q ss_pred HHhhhcccccccCceEEEEEEeCC-----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 466 (704)
..+.+.+.||+|+||.||+|.... +..|++|++.... .....|+.++++++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 445567899999999999997755 7889999886432 245678999999999999999998876 46789
Q ss_pred EEEeecCCCCHHHHhhcccC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 467 LIYEYMASGTLDQYLKGKKE------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
+++||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 99999999999999976432 45899999999999999999999 8999999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~ 235 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL----KDG 235 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH----HcC
Confidence 9986533222222223456778999999998889999999999999999999 9999965332 1122211 111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
. ........+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 236 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 Y---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 001112234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.93 Aligned_cols=236 Identities=28% Similarity=0.424 Sum_probs=188.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHh-hcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||||+++.... ....|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 678999999865321 23445556654 4899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSGR--FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKA 153 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCcc
Confidence 999999976543 899999999999999999999 899999999999999999999999999999754211 1233
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... . ...++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~----------~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILN-D----------RPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc-C----------CCCCC
Confidence 4457899999999999999999999999999999999999999654321 11111111 1 01122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT-DVL 663 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl 663 (704)
...+..+.+++.+||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23345788999999999999999976 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.69 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=195.5
Q ss_pred hhcccccccCceEEEEEEeC-CCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||+|.+. +++ .|++|.+.... ..+..|+..+++++||||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 34578999999999999763 344 47888875332 134556778889999999999998754 55788999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.+.....
T Consensus 89 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 89 LSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred eCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 9999999999976442 3899999999999999999999 89999999999999999999999999999986643322
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........++..|+|||.+.++.++.++|||||||++|||++ |+.||....... .. ..+..+.... .
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~--~--- 232 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VP----DLLEKGERLA--Q--- 232 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcCC--C---
Confidence 222334557788999999998899999999999999999998 999996543211 11 1222221111 1
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+......+.+++.+|+..+|++|||+.|+++.|+.+..
T Consensus 233 ----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11123467889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.16 Aligned_cols=232 Identities=25% Similarity=0.408 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||||+++... .....|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 68899999986432 1345677777766 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR--FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT 153 (320)
T ss_pred chHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence 999999876543 899999999999999999999 99999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+.. .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~-~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL-NDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHh-cCCC----------CCC
Confidence 3457899999999999999999999999999999999999999654321 1111111 1111 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 635 NNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
...+..+.+++.+||+.||.+||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.16 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=192.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 467 (704)
|.+.+.||+|+||.||+|.. .+++.||||++... .....+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 45678999999999999965 47899999988632 12457899999999999999999988643 35899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+. ++|.+++..... +++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 82 VFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999995 699999876543 899999999999999999999 99999999999999999999999999999976432
Q ss_pred CCC-CcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH--------
Q 037258 548 ESS-DQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML-------- 616 (704)
Q Consensus 548 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 616 (704)
... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSPETI 232 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCHHHH
Confidence 221 112234578999999999875 6789999999999999999999999965432111 00110000
Q ss_pred ---hcCCcccc---cCCcCCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 617 ---AEGDIRNI---VDPSLQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 617 ---~~~~~~~~---~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
........ +.......+ .......+.+++.+||+.||++||+++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 000000000 01224567899999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.30 Aligned_cols=240 Identities=21% Similarity=0.328 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||+|+++.... ....|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999654 678999999975321 345678888887 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQRK--LPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTT 153 (327)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCce
Confidence 999998875543 899999999999999999999 89999999999999999999999999999875321 11223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.......... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3467899999999999999999999999999999999999999654433222223333333322211 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
...+..+.+++.+||+.||.+|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 22345688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.04 Aligned_cols=244 Identities=30% Similarity=0.488 Sum_probs=201.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|++|.||+|... |+.||+|.++.... .+..|+.++++++|+||+++++++.+.+..++||||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 356789999999999999774 78999999976644 56789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.++...... ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~ 158 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DS 158 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----cc
Confidence 999998766556999999999999999999999 9999999999999999999999999999998653211 12
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+. .....+. ....+.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~---------~~~~~~ 222 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PHVEKGY---------RMEAPE 222 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhcCC---------CCCCcc
Confidence 334568999999998889999999999999999997 99998544321 111 1111111 011122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
..+..+.+++.+||..+|++||++.|++++|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=291.94 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=202.4
Q ss_pred HhhhcccccccCceEEEEEE-eCCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV 468 (704)
+|.+.+.||+|||+-||.+. ..+++.+|+|++.-.. ....+|++..++++|||++++++++..+ ...|++
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 46678999999999999995 6688999999875333 2567899999999999999999887643 348999
Q ss_pred EeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 469 YEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
++|...|+|.+.+.... +..+++.+++.|+.++++||++||.. ..+++||||||.|||+++++.++|.|||.+....
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 99999999999997654 44699999999999999999999932 3359999999999999999999999999987653
Q ss_pred cCCCCc-------ccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH
Q 037258 547 IESSDQ-------ISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML 616 (704)
Q Consensus 547 ~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 616 (704)
..-... .......|..|+|||.+. +...++++|||||||+||+|+.|..||....+..+
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg----------- 249 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG----------- 249 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-----------
Confidence 221111 112346789999999986 55678999999999999999999999965433111
Q ss_pred hcCCcc-cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 617 AEGDIR-NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 617 ~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.+. .+....+...-....++.+.++++.|++.||.+||++.|++..++...
T Consensus 250 ---SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ---SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 111112211122336778999999999999999999999999988754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.10 Aligned_cols=244 Identities=24% Similarity=0.430 Sum_probs=193.7
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 405 VLGKGGFGEVYHGSLD---DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.||+|+||.||+|.+. .+..||+|++..... .+..|+.++++++|+||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999653 455799999865432 4568899999999999999999885 457899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc-cc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI-ST 555 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-~~ 555 (704)
|.+++.... ..+++..+++++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..+........ ..
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999997543 34899999999999999999999 89999999999999999999999999999976532222111 11
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||......+ .. ..+..+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQGK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCCC---------CCCCC
Confidence 2233568999999988889999999999999999996 999996543211 11 1111111 11122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
...+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 33456888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.03 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=192.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeC--------CeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEG--------NNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|.. .+++.||||++........+|+.+++.++||||+++++++... ...++|||
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE 147 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence 45678999999999999965 4689999999876655667899999999999999999887532 24678999
Q ss_pred ecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCcccccc
Q 037258 471 YMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSI 547 (704)
Q Consensus 471 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~ 547 (704)
|+++ +|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.+..
T Consensus 148 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 148 FIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred cCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 9985 787776532 2345899999999999999999999 99999999999999999665 799999999986532
Q ss_pred CCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-------
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------- 619 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 619 (704)
. .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+ .+...+ ..+...
T Consensus 224 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~~~~~~~ 297 (440)
T PTZ00036 224 G---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPTEDQLKE 297 (440)
T ss_pred C---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCCHHHHHH
Confidence 1 222345689999999998754 68999999999999999999999997644321 111111 111000
Q ss_pred --------CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 --------DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 --------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.......+...++...+.++++|+.+||+.||.+|||+.|+++
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000111111122334567899999999999999999999984
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.70 Aligned_cols=238 Identities=26% Similarity=0.402 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||||+++.... ....|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999664 678999999865321 345677787765 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+.+..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..... .....
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTT 153 (321)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccc
Confidence 999999876543 889999999999999999999 99999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ....... +.. .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~-~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILH-DDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CCC----------CCC
Confidence 34568999999999999899999999999999999999999996543211 1111111 110 111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERP-------TMTDVLME 665 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 665 (704)
...+.++.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22345788999999999999999 77888743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.66 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=202.5
Q ss_pred HHhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
..+.+.+.||+|+||.||+|...++..+|+|.+.... ..+.+|++++++++|+||+++++++.+ ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4456789999999999999988788889999886543 256789999999999999999999887 778999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+..+... .....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC-Ccccc
Confidence 99999998765556899999999999999999999 899999999999999999999999999998765321 11112
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....++..|+|||++....++.++|||||||++|++++ |+.||...... ....+ +..+.. ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~---------~~~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYR---------MPR 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCC---------CCC
Confidence 22345677999999998889999999999999999999 89998654321 11111 111110 011
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
....+.++.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12344578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.61 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=198.9
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC--------
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN-------- 463 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 463 (704)
.|.+.+.||+|+||.||+|.. .+++.||||++.... .....|+.++..++|+||+++.+.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 456688999999999999954 578999999985431 24567889999999999999988775432
Q ss_pred eEEEEEeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 464 NMGLIYEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3679999999999999997543 345889999999999999999999 99999999999999999999999999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..... +..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~-~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA-GRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCC
Confidence 9876433223333456799999999999999999999999999999999999999964321 222222221 111
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. ..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 263 ~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 D---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1223345678999999999999999999999863
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.42 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred HHhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..+.+.+.||+|+||.||+|... .+..||+|.+..... .+..|+.++++++|+||+++++++.+++..+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34556789999999999999543 245899998764321 4567889999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 467 LIYEYMASGTLDQYLKGKK--------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
+||||+++|+|.+++.... .....+..+..++.|++.||.||| +++|+||||||+||++++++.++|+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999997532 123567788999999999999999 99999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... +......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~- 235 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVM- 235 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-
Confidence 999876532222111222345678999999998899999999999999999998 78888653321 1111111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.+... ..+...+..+.+++.+||+.+|++||++.|+++.|++.+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111 112233467999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.44 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=197.7
Q ss_pred hhcccccccCceEEEEEEe------CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||++.. .++..+|+|.+..... .+..|+++++.++|+||+++++++.+++..++|||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 3468899999999999953 2456899998864332 56788999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 471 YMASGTLDQYLKGKKE-------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
|+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.++|+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEEC
Confidence 9999999999976432 34789999999999999999999 9999999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHH
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSML 616 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 616 (704)
|||++..+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ . .....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~ 238 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A---IECIT 238 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H---HHHHH
Confidence 9999876532221111223345678999999999999999999999999999998 899985543211 1 11111
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.+... ..+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus 239 -~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 -QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11100 1112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.84 Aligned_cols=239 Identities=24% Similarity=0.354 Sum_probs=190.0
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHH---HHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKL---LMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~---l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.||+|+||.||+|... +++.||||+++.... ....|.++ ++.++||||+++++++..++..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 35688999999999999654 689999999864321 22344444 45668999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|..++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05589 82 EYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-- 153 (324)
T ss_pred cCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--
Confidence 999999999888653 3899999999999999999999 99999999999999999999999999999865321
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +....... +..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~-~~~-------- 218 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVN-DEV-------- 218 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC--------
Confidence 122233467899999999999999999999999999999999999999654321 11111111 110
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11223345788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.95 Aligned_cols=237 Identities=28% Similarity=0.438 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHh-hcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||||+++... .....|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 57899999986542 134556777765 4899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCce
Confidence 99999997643 3889999999999999999999 89999999999999999999999999999875321 11223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ ... +.... +. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~---~~~-i~~~~------~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL---FQS-IRMDN------PC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH---HHH-HHhCC------CC----CC
Confidence 3456899999999999999999999999999999999999999654321 11 111 11110 11 11
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT-DVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 664 (704)
......+.+++.+||+.||++||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=329.20 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=199.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||||+++... ..+..|++++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 345789999999999999765 78999999986432 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC-
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS- 550 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~- 550 (704)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 83 MPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999998763 4899999999999999999999 89999999999999999999999999999986543220
Q ss_pred --------------------------CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037258 551 --------------------------DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604 (704)
Q Consensus 551 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~ 604 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 012234578999999999999999999999999999999999999996644211
Q ss_pred cccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 037258 605 TTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT-MTDVLME 665 (704)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 665 (704)
......... .. +........+..+.+++.+|+. +|.+||+ ++|+++.
T Consensus 238 ------~~~~i~~~~--~~-----~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 ------TYNKIINWK--ES-----LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHhccC--Cc-----ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111100 00 0000011135678899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.01 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=192.3
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||+||++... +++.||+|++..... .+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999654 788999999864321 345689999999999999999999999999999999999999
Q ss_pred HHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 478 DQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 478 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
.+++... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--Ccccc
Confidence 9887542 2345899999999999999999999 899999999999999999999999999999765322 12223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...|++.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ... ..++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~---------~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL---------NDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc---------ccC--CCCcc
Confidence 45789999999999999999999999999999999999999965433211 111111111 000 01223
Q ss_pred hHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
..+..+.+++.+||+.||++|| +++|+++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3456788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.76 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=196.3
Q ss_pred hhhcccccccCceEEEEEEe-----CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 468 (704)
+.+.+.||+|+||.||++.. .+++.||+|.++.... .+..|++++++++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 34568899999999999964 3578999999865432 45789999999999999999998754 3468899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++..+...
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 86 MEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999997543 23899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCCcc-cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc---------ccHHHHHHHHHhc
Q 037258 549 SSDQI-STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT---------THISQWVNSMLAE 618 (704)
Q Consensus 549 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~---------~~~~~~~~~~~~~ 618 (704)
..... .....++..|+|||++.+..++.++|||||||++|||++|..|+........ .............
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 22111 1112234569999999988899999999999999999998877643221100 0000000111111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
..........+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 242 ---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 ---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.77 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=204.1
Q ss_pred HHHHhhhcccccccCceEEEEEEeC--------CCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEe
Q 037258 396 QKITNNFERVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIE 461 (704)
Q Consensus 396 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 461 (704)
....+.+.+.||+|+||.||+|... .+..||+|.++... ..+..|+++++++ +|+||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3345677899999999999999542 12368999886432 2567789999999 79999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 462 GNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 462 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
++..++++||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence 999999999999999999997532 234788999999999999999999 899999999999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTT 606 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~ 606 (704)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 99999999999999976532221111222334567999999999999999999999999999998 8888854332
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.++.... ..+... ..+...+..+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 243 --~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 --EELFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1222211 111111 1122334578899999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.23 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=192.3
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||+||+|.. .+++.||||++.... ..+..|++++++++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 3467899999999999955 478899999986432 14567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 84 PGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999976543 889999999999999999999 999999999999999999999999999997643110000
Q ss_pred --------------------------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHH
Q 037258 552 --------------------------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVL 587 (704)
Q Consensus 552 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 587 (704)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234699999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHh--ccCCCCCCCCCHHHHHHH
Q 037258 588 LEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALA--CASHTSSERPTMTDVLME 665 (704)
Q Consensus 588 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~~ 665 (704)
|||++|+.||......+. .......... +........+.++.+++.+ |+..+|..||++.|+++.
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTET------QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHH------HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999976443211 1111110000 0000111234577888887 556666679999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.84 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=198.4
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh--hHHHHHHHHHhhcccceeEEEEEEE-eCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTALIGYCI-EGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||++... +..||+|.++.... .+..|+.++++++|+|++++++++. .++..++|+||+++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 455789999999999999764 78899999865433 5678999999999999999999765 4567899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++....... ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~ 158 (256)
T cd05082 87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT 158 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CC
Confidence 999998766556899999999999999999999 8999999999999999999999999999987543211 22
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... +..+. ......
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~~~---------~~~~~~ 222 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR-VEKGY---------KMDAPD 222 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HhcCC---------CCCCCC
Confidence 334568999999998889999999999999999998 9999854321 111111 11111 111122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
..+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 3456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.82 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=202.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+++.||||.++... ..+..|+++++.++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 34578899999999999965 478999999764311 1457799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+++|+|.+++.... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..+...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 99999999886432 334789999999999999999999 999999999999999999999999999998765321
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+... +..... +
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~-----~-- 226 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCDY-----P-- 226 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCCC-----C--
Confidence 11223456888999999999888999999999999999999999998653321 1122211 111111 1
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.......+..+.+++.+||..+|++||++.|+++.|+++
T Consensus 227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.83 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=198.0
Q ss_pred HHhhhcccccccCceEEEEEEeCC---------------CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDD---------------NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIG 457 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~ 457 (704)
..+.+.+.||+|+||.||++.... ...||+|.++... ..+..|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345667899999999999986532 2358999986532 24667999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhhccc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 458 YCIEGNNMGLIYEYMASGTLDQYLKGKK----------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 458 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986532 123688999999999999999999 999999999999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT--GRRPVISRAEDDT 605 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~Pf~~~~~~~~ 605 (704)
+++++.+||+|||++..+.............++..|+|||++.++.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976532222222223345678999999998889999999999999999998 667775433211
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
................. ...+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 241 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111100000 01112234589999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.89 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=200.6
Q ss_pred HhhhcccccccCceEEEEEEeC--------CCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCCe
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGNN 464 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 464 (704)
.+.+.+.||+|+||.||+|... ....+|+|+++.... .+..|+++++++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3456789999999999999642 345799999874322 456789999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 465 MGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcC
Confidence 999999999999999997532 234889999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .+.
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~ 246 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---ELF 246 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 99999999999976532221111122234467999999998899999999999999999999 88888543321 111
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.....+... ..+...+.++.+++.+||..+|++||++.|+++.|+++...
T Consensus 247 ----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 247 ----KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111111111 11223345788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.31 Aligned_cols=237 Identities=26% Similarity=0.411 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||||+++... .....|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999665 57899999987532 1345677788777 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTT 153 (318)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcc
Confidence 999999876543 899999999999999999999 99999999999999999999999999999864311 11222
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....... .... .++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~-~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSIL-EDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHH-cCCC----------CCC
Confidence 3456899999999999999999999999999999999999999654321 1111111 1110 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTM-----TDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 664 (704)
...+..+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334578899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.83 Aligned_cols=234 Identities=26% Similarity=0.349 Sum_probs=190.8
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 404 RVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.||+|+||.||++.. .+|+.||+|++.... .....|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 368899999987532 134668999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 999999997644 3899999999999999999999 999999999999999999999999999998764321 122
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ........ ... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~-~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILK-AKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHc-CCC----------CC
Confidence 33457899999999999888999999999999999999999999654321 11111111 110 11
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTD 661 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~e 661 (704)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233457889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=301.57 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccchh------hHHHHHHHHHhhcccc-eeEEEEEEEeCC------eEEEE
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRN-LTALIGYCIEGN------NMGLI 468 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~~~lV 468 (704)
.++||+|+||+||+|+ ..+|+.||+|++.-... ...+|+.++++++|+| |+.+++++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 4569999999999995 45789999999864432 4589999999999999 999999999877 78999
Q ss_pred EeecCCCCHHHHhhcccC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 469 YEYMASGTLDQYLKGKKE--HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||++. +|.+++..... ..++...+..++.||++||+||| +++|+||||||+|||++++|.+||+|||+|+.+.
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999976 99999987663 35777889999999999999999 9999999999999999999999999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CCcc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GDIR 622 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 622 (704)
.. ....+...+|..|+|||++.+. .|+...||||+|||+.||++++.-|.+..+.+. +.. +-..+.. ..+.
T Consensus 172 ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~-If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 172 IP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFR-IFRLLGTPNEKDWP 246 (323)
T ss_pred CC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHH-HHHHcCCCCccCCC
Confidence 22 2234566789999999999876 799999999999999999999999977665221 111 1111111 1111
Q ss_pred ccc-CCcCCCCCC------------hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 NIV-DPSLQGNFD------------NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 ~~~-d~~l~~~~~------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
... -+.....+. ........+++.+||+.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 110 000100110 1111468899999999999999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.53 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=199.1
Q ss_pred HHhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeC-Ce
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEG-NN 464 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~ 464 (704)
..+.+.+.||+|+||.||+|.. .+++.||||+++... .....|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3466789999999999999953 357889999986432 2456799999999 689999999988654 56
Q ss_pred EEEEEeecCCCCHHHHhhccc-----------------------------------------------------------
Q 037258 465 MGLIYEYMASGTLDQYLKGKK----------------------------------------------------------- 485 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 485 (704)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccC
Q 037258 486 ------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559 (704)
Q Consensus 486 ------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~g 559 (704)
...+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678888999999999999999 99999999999999999999999999999876532222122223345
Q ss_pred CCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHH
Q 037258 560 TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638 (704)
Q Consensus 560 t~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 638 (704)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... . .......+.... .+...+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~---------~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMR---------APDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCC---------CCCCCC
Confidence 678999999998899999999999999999997 999986533211 1 111122221110 111123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 639 WKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 639 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+.+++.+||+.+|++||++.|+++.|+.++.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=293.61 Aligned_cols=241 Identities=26% Similarity=0.398 Sum_probs=200.0
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccchh------------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEE
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 468 (704)
.+.||.|..++|-+... .+|+..|+|++..... ....|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 57899999999998844 5788999998743221 335688999998 699999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+|.|+.|.|.|+|...-. +++....+|+.|+.+|++||| ..+||||||||+|||++++.++||+|||+++.+.
T Consensus 102 Fdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~-- 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE-- 174 (411)
T ss_pred hhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccC--
Confidence 999999999999987655 899999999999999999999 9999999999999999999999999999999774
Q ss_pred CCCcccccccCCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVL------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
........+||++|+|||.+.. ..|+...|+||+||++|.|+.|.+||..... -.+.+++.+|...
T Consensus 175 -~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGkyq 246 (411)
T KOG0599|consen 175 -PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKYQ 246 (411)
T ss_pred -CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhcccc
Confidence 3344567899999999999863 3578899999999999999999999954221 1122344444332
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+......+.+....+||.+||+.||.+|.|++|+++
T Consensus 247 ------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 112223456778899999999999999999999996
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.98 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=196.5
Q ss_pred hhcccccccCceEEEEEEe-CCCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||+|.+ .+++ .||+|+++... .....|+.++..++|+||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence 4468899999999999964 3444 48999886432 2456788899999999999999999754 5679999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.+.....
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 89 LMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999997643 24899999999999999999999 99999999999999999999999999999987643222
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+ +..+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~------- 230 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERL------- 230 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcC-------
Confidence 222223345678999999998899999999999999999998 89998543321 12221 1111111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 231 --~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 --PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112234578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.34 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=196.0
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.+.||+|+||.||++... +++.||+|++.... ..+..|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3456789999999999999664 68899999986421 134678999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++.... +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++...... .
T Consensus 124 y~~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~-~ 196 (370)
T cd05596 124 YMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-G 196 (370)
T ss_pred CCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC-C
Confidence 999999999997543 788899999999999999999 999999999999999999999999999999765322 1
Q ss_pred CcccccccCCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN----WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............ .
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~--~-- 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS--L-- 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc--C--
Confidence 1222345799999999998753 4789999999999999999999999654321 111111111100 0
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
... .....+..+.+++.+||+.+|.+ ||++.|+++.
T Consensus 267 -~~~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 -TFP--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CCC--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 11124567889999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=306.49 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=200.0
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||+|... +++.|++|.+... ...+..|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45688999999999999664 6899999987532 2256778999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.++++......+++..++.++.|++.||.||| +.+++|+||||+||++++++.++|+|||+++.+... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 999999998765556899999999999999999999 899999999999999999999999999998865322 222
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||++.+..++.++||||||+++|||++|+.||...... .. ... ...+... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~-~~~~~~~---------~~ 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL---ILK-IIRGVFP---------PV 221 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHH-HHcCCCC---------CC
Confidence 23456788999999999988999999999999999999999999654321 11 111 1111111 11
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.43 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHh-hcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +|+.||+|+++... .....|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 68899999986532 134556667665 4899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++... ......
T Consensus 81 g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV--FGDNRA 153 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecc--cCCCce
Confidence 999999876543 889999999999999999999 9999999999999999999999999999986431 112223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ ... +... .+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~---~~~-~~~~------~~----~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL---FES-IRVD------TP----HYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHH-HHhC------CC----CCC
Confidence 4567899999999999999999999999999999999999999654321 11 111 1111 01 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT-DVL 663 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl 663 (704)
...+.++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.24 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=188.8
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhccc-ceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHR-NLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.+.+.||+|+||.||+|... +++.||||++.... .....|.+++..++|+ +|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45789999999999999654 67899999986432 1346678888888664 588899999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..... ..
T Consensus 83 ~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GG 155 (324)
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CC
Confidence 999999999976543 889999999999999999999 89999999999999999999999999999864321 11
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......+ . ..... ... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~-~~~----------~ 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---FQSIM-EHN----------V 218 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-cCC----------C
Confidence 22334568999999999999999999999999999999999999996543211 1 11111 111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+..+.+++.+||..||.+|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1222344578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=312.63 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=200.5
Q ss_pred HhhhcccccccCceEEEEEEeCC-----------------CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD-----------------NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALI 456 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~ 456 (704)
.+.+.+.||+|+||.||+|.... +..||+|++.... ..+..|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34567899999999999986542 2468999986542 2556799999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHhhccc---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK---------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 457 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
+++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhcee
Confidence 99999999999999999999999997654 124899999999999999999999 899999999999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT--GRRPVISRAEDDT 605 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~Pf~~~~~~~~ 605 (704)
++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-- 240 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-- 240 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH--
Confidence 99999999999999876532222222334456778999999998889999999999999999998 67777543321
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.....+............ ...+...+.++.+++.+||+.||.+||++.||++.|++
T Consensus 241 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 -QVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111110 01122334679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=308.70 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=199.0
Q ss_pred hhhcccccccCceEEEEEEeC-CC---cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DN---QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+...+.||+|+||.||+|... ++ ..+|+|.++... ..+..|++++++++|+|++++++++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 345789999999999999764 33 379999986442 245678999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 87 YMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999997643 34899999999999999999999 89999999999999999999999999999876532221
Q ss_pred Cccc-ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 551 DQIS-TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 551 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...... +...... .+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~~~-------- 227 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-DGF-------- 227 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-cCC--------
Confidence 1111 11223457999999998889999999999999999997 99999654321 1111111 110
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
........+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00112234457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.73 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|++|.||+|.. .+++.+|||.+.... ..+..|+.+++.++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 44568899999999999964 588999999875321 2556789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999998742 2345899999999999999999999 9999999999999999999999999999987653221
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.......++..|+|||++.+..++.++||||||+++|||++|..||...... ........ .. ...+..
T Consensus 161 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~-----~~~~~~ 228 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQ-----CDYPPL 228 (267)
T ss_pred --cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-hc-----CCCCCC
Confidence 1223356888999999999888999999999999999999999999653321 11111111 11 111111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.....+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 12234568999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=308.29 Aligned_cols=245 Identities=29% Similarity=0.446 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEeC-CCc--EEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQ--QVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... ++. .+++|.++... ..+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999764 343 57889886422 2456799999999 899999999999999999999999999
Q ss_pred CCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 475 GTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 475 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
|+|.+++.... ...+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997543 124789999999999999999999 8999999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
++.... ..........+..|+|||++....++.++||||||+++|||++ |..||...... ...... ..+
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~-~~~ 227 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL-PQG 227 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH-hCC
Confidence 985321 1111112233567999999988889999999999999999997 99999553321 111111 111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
. ....+...+..+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 00111223457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.22 Aligned_cols=252 Identities=30% Similarity=0.458 Sum_probs=197.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCc--EEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQ--QVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... ++. .+++|.++... ..+..|++++.++ +||||+++++++.+.+..++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 345789999999999999764 333 47888876421 2467799999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEE
Q 037258 471 YMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
|+++|+|.+++.... ...+++..++.++.|++.||+||| +++++||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEE
Confidence 999999999997532 124888999999999999999999 899999999999999999999999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||......+ .....
T Consensus 161 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~~ 231 (297)
T cd05089 161 ADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEKL 231 (297)
T ss_pred CCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH
Confidence 99999864211 111111223457999999998889999999999999999997 999996543211 11111
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+ .....+...+..+.+++.+||+.+|.+||++.++++.|++++...
T Consensus 232 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 -PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 111112234457889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.39 Aligned_cols=244 Identities=28% Similarity=0.436 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEeC-C---CcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-D---NQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... . +..+|+|.+..... .+..|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999543 2 26899999874433 5577899999999999999999876 4568999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc-
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI- 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~- 553 (704)
|+|.+++.... .+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998655 4899999999999999999999 89999999999999999999999999999987643222111
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+..++ ...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~---------~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERL---------P 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcC---------C
Confidence 112223467999999998899999999999999999998 9999865432 1222221 111100 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+...+..+.+++.+||..+|.+||++.++++.|+++
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.79 Aligned_cols=233 Identities=26% Similarity=0.373 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHH-HHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVK-LLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +|+.||+|++..... ....|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999764 789999999864321 2233333 46778999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 99999997654 3889999999999999999999 89999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.. . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~----~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN-KPL------R----LK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc-CCC------C----CC
Confidence 345689999999999999999999999999999999999999965432 111222211 110 1 11
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22355788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.23 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=190.0
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||+|...+ +..+|+|.++... ..+..|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997543 4579999886432 25667999999999999999999999999999999999999
Q ss_pred CHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 476 TLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 476 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+|.+++.... ....++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997543 223677788899999999999999 8999999999999999999999999999987543222112
Q ss_pred ccccccCCCCccCccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-------WLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 22334567889999998642 35789999999999999996 999996543221 1111 111 111122
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
.++.+. ......+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222221 123346788999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.64 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=174.0
Q ss_pred HhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh---hHHHHHHHHHhhc-c-----cceeEEEEEEEeCCeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVH-H-----RNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lV 468 (704)
+|.+.+.||+|.||.|-+| +.++++.||||+++.... +...|+.+|..++ | -|+|++++++...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6677899999999999999 566899999999987665 5567899999986 3 5899999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC--cEEEEeccCccccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL--QAKIADFGLSRIFS 546 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfGla~~~~ 546 (704)
+|.+.. +|.++++.+....++...+..++.||+.||.+|| +.+|||+||||+||||.+.. .+||+|||.+....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999965 9999999999888999999999999999999999 99999999999999997544 69999999998753
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED 603 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~ 603 (704)
. .......+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+..+.
T Consensus 343 q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 343 Q-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred C-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 1 222667788999999999999999999999999999999998888776653
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.05 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEeCC--C--cEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLDD--N--QQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|++|.||+|.+.+ + ..||||.+..... .+..|++++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 3 3699999876443 56779999999999999999999988 889999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc-c
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ-I 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-~ 553 (704)
|+|.+++.......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765345899999999999999999999 9999999999999999999999999999998764322211 1
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +............ .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~---------~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGERL---------E 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCcC---------C
Confidence 223456788999999998899999999999999999999 99998543321 1111111111100 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
.+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11233457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.71 Aligned_cols=251 Identities=30% Similarity=0.458 Sum_probs=213.7
Q ss_pred hhcccccccCceEEEEEEeCC-CcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 401 NFERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
...++||-|-||.||.|.|+. .-.||||.++.... +|+.|..+|+.++|||+|+++|+|..+..+|||+|||.+|+
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 346899999999999998864 45799999987654 78999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.++|+...+..++....+.++.||+.||+||. .+++|||||..+|+|+.++..+|++|||+++++..+... ....
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAG 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAG 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cccC
Confidence 999999988777888899999999999999999 999999999999999999999999999999988533221 1122
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..-...|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+. .+ +.. ++....+-+.++
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------Sq-VY~---------LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQ-VYG---------LLEKGYRMDGPE 489 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HH-HHH---------HHhccccccCCC
Confidence 334568999999999999999999999999999998 8888855432 11 122 223333445567
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.++..+.+|+++||+.+|.+||++.|+-+.++.+..
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 788899999999999999999999999999987764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=309.02 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=199.0
Q ss_pred HhhhcccccccCceEEEEEEeC-CC---cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DN---QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|... ++ ..||||+++... ..+..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 3567889999999999999764 23 369999986532 25677999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++..... .+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999976543 4899999999999999999999 8999999999999999999999999999987653222
Q ss_pred CCccccc-cc--CCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 550 SDQISTA-VA--GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 550 ~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
....... .. .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....++ ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~----- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDY----- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCC-----
Confidence 1111111 11 2357999999998899999999999999999886 99999654321 122221 1110
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
....+.+.+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=323.69 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=194.3
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||+|... +++.||||++.... .....|+.++..++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 44689999999999999664 68999999986432 13467999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.+.......
T Consensus 84 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 84 PGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999997654 3899999999999999999999 9999999999999999999999999999987642211000
Q ss_pred ------------------------------------ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 037258 553 ------------------------------------ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596 (704)
Q Consensus 553 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 596 (704)
......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 01124589999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 037258 597 VISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT---MTDVLM 664 (704)
Q Consensus 597 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 664 (704)
|......+ .......... .+........+..+.+++.+|+. +|.+|++ +.|+++
T Consensus 239 f~~~~~~~------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQE------TYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHH------HHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 96543211 1111111110 00000011234578899999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.65 Aligned_cols=245 Identities=33% Similarity=0.513 Sum_probs=200.5
Q ss_pred ccccccCceEEEEEEeCC----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|.... +..|++|+++... .....|++++..++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 7899999987543 2556789999999999999999999999999999999999
Q ss_pred CCHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 475 GTLDQYLKGKK-------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 475 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
++|.+++.... ...+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 245899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
...........++..|+|||.+....++.++||||+|+++|||++ |..||...... .+. .. ...+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~-~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVL---EY-LRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HH-HHcCCC-----
Confidence 322223344567889999999998889999999999999999999 69998665321 111 11 111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
...+...+.++.+++.+||+.+|.+||++.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=323.27 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=190.8
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||++... +++.||||++.... .....|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 34688999999999999654 68999999986532 13466889999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 84 PGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999997654 3899999999999999999999 999999999999999999999999999998764321100
Q ss_pred --------------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 037258 552 --------------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599 (704)
Q Consensus 552 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~ 599 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999965
Q ss_pred CCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 037258 600 RAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACAS--HTSSERPTMTDVLME 665 (704)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 665 (704)
....+ ........ ...-.+.+. ...+..+.+++.+++. .++..||+++|+++.
T Consensus 239 ~~~~~------~~~~i~~~-~~~~~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQE------TYKKVMNW-KETLIFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHH------HHHHHHcC-cCcccCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 43211 11111110 000001111 1123467778877554 233456899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.00 Aligned_cols=265 Identities=20% Similarity=0.265 Sum_probs=202.3
Q ss_pred HHHHHHhhhcccccccCceEEEEEEeC---CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 394 EIQKITNNFERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 394 el~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+....+.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 334456777899999999999999643 4578999998654 345689999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
++. ++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 167 ~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 996 6899888543 34899999999999999999999 89999999999999999999999999999976643333
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc--c-----
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR--N----- 623 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~----- 623 (704)
........||..|+|||++.+..++.++|||||||++|||++|+.||.............-+...+...... .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 333345679999999999999999999999999999999999999997655432111111111111110000 0
Q ss_pred ------ccCCcCCCCC-------ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 624 ------IVDPSLQGNF-------DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 624 ------~~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.........+ .......+.+++.+||..||++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 01224567899999999999999999999875
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.13 Aligned_cols=235 Identities=26% Similarity=0.418 Sum_probs=189.1
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.+.+.||+|+||.||+|... +++.||+|+++.... ....|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45688999999999999655 678999999865321 234566677666 589999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.... ..
T Consensus 83 ~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~ 155 (323)
T cd05616 83 VNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DG 155 (323)
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CC
Confidence 999999999876543 889999999999999999999 89999999999999999999999999999875321 12
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ..... ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~---~~~i~-~~~~---------- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQSIM-EHNV---------- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH---HHHHH-hCCC----------
Confidence 2233457899999999999999999999999999999999999999654321 11 11111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+.++.+++.+||+.+|.+|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.84 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=203.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|++|.||+|... +|+.||+|.++.. ......|++++++++|+|++++++++.+++..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456789999999999999765 8899999987521 22456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+++|+|.+++.... ...+++.+++.++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999986532 344889999999999999999999 9999999999999999999999999999987653221
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........ ...+...
T Consensus 161 --~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~------- 226 (267)
T cd08224 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCDYP------- 226 (267)
T ss_pred --cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCCCC-------
Confidence 112334678899999999988899999999999999999999999854432 11111111 1111111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.......+..+.+++.+||..+|++||++.+|+++|+++.
T Consensus 227 -~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 -PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111234557889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=312.79 Aligned_cols=250 Identities=32% Similarity=0.511 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||.||+|... ++..||+|++.... ..+..|++++++++||||+++++++.+++..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 345688999999999999753 46789999986432 2467799999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccc--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 469 YEYMASGTLDQYLKGKK--------------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
+||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEe
Confidence 99999999999997432 124788899999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTH 607 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 607 (704)
++++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---- 239 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---- 239 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999876532221112223344667999999998899999999999999999998 88888644321
Q ss_pred HHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
+... .+..+.... .+...+.++.+++.+||+.+|.+||++.|+++.|++
T Consensus 240 --~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 122222111 122334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.83 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=198.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCc--EEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQ--QVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... ++. .+++|.++... ..+.+|++++.++ +|+||+++++++.+++..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 346789999999999999754 444 46888765422 2456799999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEE
Q 037258 471 YMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
|+++|+|.++++... ...+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence 999999999997542 124789999999999999999999 999999999999999999999999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
+|||++..... .........+..|+|||++.+..++.++|||||||++|||+| |..||......+ .....
T Consensus 166 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~ 236 (303)
T cd05088 166 ADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL 236 (303)
T ss_pred CccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHHH
Confidence 99999864211 111112234567999999988889999999999999999998 999996543211 11111
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
..+ .....+...+..+.+++.+||+.+|++||++.++++.|++++..+.
T Consensus 237 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 -PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111 0001112234578899999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=308.57 Aligned_cols=246 Identities=32% Similarity=0.477 Sum_probs=195.2
Q ss_pred ccccccCceEEEEEEeCC-------CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDD-------NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.||+|+||.||+|...+ ++.+|+|.+.... ..+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999996542 2579999875432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-----cEEEEeccC
Q 037258 472 MASGTLDQYLKGKK-----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-----QAKIADFGL 541 (704)
Q Consensus 472 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~DfGl 541 (704)
+++++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234788999999999999999999 89999999999999999877 899999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
+................++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----HhcCC
Confidence 876532222222223345678999999999999999999999999999998 99998543221 11111 11111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
....+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011123345678999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.38 Aligned_cols=244 Identities=29% Similarity=0.454 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
++||+|++|.||++...+++.||+|.+.... ..+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4699999999999987779999999876432 25677999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++..... .+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++................
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99976432 4789999999999999999999 8999999999999999999999999999987643111111111223
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.+..|+|||.+.++.++.++||||||+++|||++ |..||....... ... ...... ....+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~----~~~~~~---------~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRE----RIESGY---------RMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHH----HHhcCC---------CCCCCccC
Confidence 3567999999998899999999999999999999 888885543211 111 111110 01112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 557999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.56 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=196.4
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch---------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
...+.||+|++|.||+|.. .+++.||+|.+.... ....+|++++++++||||+++++++.+++..++|+|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 3468999999999999965 478999999875321 245678999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++..... +++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++.......
T Consensus 85 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 85 YMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred ECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 9999999999976543 888999999999999999999 89999999999999999999999999999876532111
Q ss_pred Cc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ........ .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~---------~ 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQP---------T 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH-HHHHhccC---------C
Confidence 11 112345778999999999988999999999999999999999998643221 11 11111110 1
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+......+.+++.+||..+|.+||++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 112233345578899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.99 Aligned_cols=240 Identities=27% Similarity=0.373 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHH-HHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQV-KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||+|++..... ....|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999665 678899999864321 222333 346778999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~ 153 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT 153 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence 999999976543 788889999999999999999 99999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... ... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN-KPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh-CCc----------CCC
Confidence 3457899999999999999999999999999999999999999654321 11111111 110 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
...+..+.+++.+||+.+|.+||++.+.+..+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 233457889999999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.84 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=199.5
Q ss_pred HhhhcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|... .+..+|+|.++... ..+..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456789999999999999653 23479999886432 25677899999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++++|.+++..... .+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+....
T Consensus 85 e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 85 EYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999976543 4899999999999999999999 9999999999999999999999999999998764322
Q ss_pred CCcc-cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 SDQI-STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ....+ ..+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC-------
Confidence 1111 112223568999999998889999999999999999887 999996543221 11111 1110
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
........+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=324.81 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=194.1
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.+.||+|+||.||++... +++.||+|++.... .....|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3556789999999999999765 68899999985421 235678999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..+.. ..
T Consensus 124 y~~gg~L~~~l~~~~---~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~-~~ 196 (370)
T cd05621 124 YMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TG 196 (370)
T ss_pred CCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc-CC
Confidence 999999999997543 788999999999999999999 99999999999999999999999999999986532 11
Q ss_pred CcccccccCCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN----WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~----- 265 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNS----- 265 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcc-----
Confidence 2223356799999999998754 3788999999999999999999999654321 111111111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
+........+..+.+++.+|+..++.+ |+++.|+++.
T Consensus 266 --~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 --LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000111233557889999999865543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.33 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=196.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||++... +++.||+|+++.... .+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 345789999999999999654 789999999875322 456788899999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.... .
T Consensus 83 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~ 157 (330)
T cd05601 83 QPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-M 157 (330)
T ss_pred CCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-c
Confidence 99999999998653 24899999999999999999999 9999999999999999999999999999998653221 2
Q ss_pred cccccccCCCCccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 552 QISTAVAGTPGYLDPEYYV------LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~- 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF- 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC-
Confidence 2233457899999999987 456789999999999999999999999654321 112222211111110
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++..|++ +|.+||++.++++
T Consensus 231 ------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 ------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0111234578899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.10 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=209.1
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV 468 (704)
..|.+.+.||+|.||.||++... +|+.+|+|++.+... ...+|+++|+++. ||||+.+.+.+++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34566789999999999999765 599999999865433 5688999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC----CcEEEEeccCccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK----LQAKIADFGLSRI 544 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~ 544 (704)
||++.||.|.+.+... . +++..+..++.|++.+++||| +.+|+||||||+|+|+... +.+|++|||++..
T Consensus 115 mEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999877 2 999999999999999999999 9999999999999999643 4799999999988
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
... ........||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+..+.+
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC---
Confidence 643 456677899999999999999999999999999999999999999997766433211 2222222
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..........+..+.+++..|+..||.+|+++.++++.
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22223344567789999999999999999999999983
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.77 Aligned_cols=247 Identities=31% Similarity=0.519 Sum_probs=196.9
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|+||+||++... +++.||+|++..... ....|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 46789999999999999765 567899999876543 12348899999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.... .+++..+..++.|+++||++|| +.+++|+||||+||++++++.++|+|||.+... ......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred cccccccccccc--cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence 999999998333 3899999999999999999999 899999999999999999999999999998754 122334
Q ss_pred cccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....++..|+|||++. +..++.++||||+|+++|+|++|+.||......+... ......... ... . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~-~~~---~-~~-- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILKRP-LPS---S-SQ-- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHHTH-HHH---H-TT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhccccc-ccc---c-cc--
Confidence 44567889999999998 8889999999999999999999999997652111111 111111100 000 0 00
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
........+.+++.+||+.||++||++.|+++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.78 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=197.0
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
...+.||+|+||.||++.. .+++.||||.+.... .....|+.++++++|++++++++.+.+++..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3457899999999999965 478999999875432 13457899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++...... .
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---~ 156 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---Q 156 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---c
Confidence 9999999997655556899999999999999999999 999999999999999999999999999998754311 1
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ....... .. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~--~~--------~~ 223 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE--VQ--------EE 223 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh--hh--------hh
Confidence 22334689999999999998999999999999999999999999975432211110 1111110 00 01
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
+.......+.+++.+||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12223456889999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.78 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=191.6
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||++.. .+++.||||++.... .....|++++++++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 4568999999999999965 478999999885432 14467899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 84 PGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999997654 3889999999999999999999 999999999999999999999999999998643211000
Q ss_pred --------------------------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHH
Q 037258 552 --------------------------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVL 587 (704)
Q Consensus 552 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 587 (704)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 000124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 037258 588 LEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSER---PTMTDVLM 664 (704)
Q Consensus 588 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 664 (704)
|||++|+.||......+ ............. +.. ....+.++.+++.+||. +|.+| +++.|+++
T Consensus 239 ~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 239 FECLIGWPPFCSENSHE------TYRKIINWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhcCCCCCCCCCHHH------HHHHHHccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999996543211 1111111000000 000 11234578899999997 66665 59999886
Q ss_pred H
Q 037258 665 E 665 (704)
Q Consensus 665 ~ 665 (704)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.44 Aligned_cols=246 Identities=26% Similarity=0.510 Sum_probs=198.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
..+.+.||+|+||.||+|...+++.+|+|.++... ..+..|++++++++|||++++++++......++|+||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34578899999999999988778899999987542 367789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++..... .+++..+..++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++....... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence 9999976543 3789999999999999999999 8999999999999999999999999999987553211 111122
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++.++.++.++||||||+++|||++ |+.||...... ..... +..+. ....+ .
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~--~~~~~-------~ 224 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVET-INAGF--RLYKP-------R 224 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHH-HhCCC--CCCCC-------C
Confidence 335678999999998889999999999999999998 99998543321 11111 11110 11111 1
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..+..+.+++.+||+.+|++||++.|+++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1245789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.10 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=193.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ....+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 34568899999999999965 468999999986432 2456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC-
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS- 550 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~- 550 (704)
+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 83 IPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999997654 3788999999999999999999 99999999999999999999999999999753311000
Q ss_pred ----------------------------------------CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHH
Q 037258 551 ----------------------------------------DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590 (704)
Q Consensus 551 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~el 590 (704)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001234689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 037258 591 ITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERP---TMTDVLME 665 (704)
Q Consensus 591 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 665 (704)
++|+.||......+. ......... .+........+..+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 238 l~G~~Pf~~~~~~~~------~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAET------QLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHH------HHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999976543211 111111000 0000111223456778888876 5999999 88999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.45 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=198.9
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|+||.||++... +++.+|+|.++... .....|+.+++.++|+||+++++.+.+++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45689999999999999654 78899999874321 2456788999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.......+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||.+..+... ....
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYA 157 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cccc
Confidence 99999987655556899999999999999999999 999999999999999999999999999998765321 2223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ...... ...+... ..+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~---------~~~ 221 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILK-VCQGSYK---------PLP 221 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHH-HhcCCCC---------CCC
Confidence 345688899999999988899999999999999999999999965332 111111 1111111 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+..+.+++.+||+.||++||++.|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.37 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=195.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
+.+.+.||+|+||.||+|... .++.||||.... ....+|++++++++|+||+++++++..++..++|||++. ++|.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~ 247 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY 247 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence 445689999999999999665 578999997432 245789999999999999999999999999999999995 6999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.............
T Consensus 248 ~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 323 (461)
T PHA03211 248 TYLGARLR-PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323 (461)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence 88865432 4899999999999999999999 8999999999999999999999999999998754322222233457
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHHHhcCCc-----cccc-------
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED-DTTHISQWVNSMLAEGDI-----RNIV------- 625 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~------- 625 (704)
||..|+|||++.+..++.++|||||||++|||++|..|+...... ........+.+.+..... ....
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 999999999999999999999999999999999988776443221 111111111111111110 0000
Q ss_pred ---------CCcCCCCCC---hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 626 ---------DPSLQGNFD---NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 626 ---------d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+....... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 0123367899999999999999999999874
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.93 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=197.8
Q ss_pred hhhcccccccCceEEEEEEeC-----------------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-----------------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIG 457 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~ 457 (704)
+.+.+.||+|+||.||++... ++..||+|++.... ..+..|+++++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456789999999999998532 23468999987432 25678999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhhcccC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKE---------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 458 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
++..++..++||||+++|+|.+++..... ..+++.++..++.|++.||+||| +.+++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence 99999999999999999999999976431 23778899999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCcc
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT--GRRPVISRAEDDTT 606 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~Pf~~~~~~~~~ 606 (704)
++++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-- 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-- 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--
Confidence 9999999999999976532222122223344678999999888889999999999999999998 778885443221
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.................. ..+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus 242 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 -VIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111000000 0112234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.58 Aligned_cols=255 Identities=23% Similarity=0.390 Sum_probs=194.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|... +++.||+|.++... ....+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 445688999999999999654 67889999886332 245689999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 160 (309)
T cd07872 88 K-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KT 160 (309)
T ss_pred C-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--cc
Confidence 5 8888886543 23789999999999999999999 8999999999999999999999999999987543221 12
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC------------C
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------------D 620 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------~ 620 (704)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... +...+... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhh
Confidence 233467889999999865 4688999999999999999999999976543221111 11111000 0
Q ss_pred cccccCCcCCC----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQG----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....-.+.... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=317.48 Aligned_cols=238 Identities=25% Similarity=0.349 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHH-HHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVK-LLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|.. .+|+.||+|++..... ....|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999965 4789999999864321 2233443 46778999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 99999887544 3899999999999999999999 99999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... +....... ... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc----------cCC
Confidence 3457899999999999999999999999999999999999999654321 11112111 111 011
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+..+.+++.+|++.+|.+||++.+.++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1234568899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=324.24 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=191.0
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||+|.. .+++.||+|++.... .....|++++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 3468899999999999965 478899999986432 24567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC--
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-- 550 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-- 550 (704)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 84 PGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999997654 3888999999999999999999 89999999999999999999999999999753311000
Q ss_pred -------------------------------------------CcccccccCCCCccCccccccCCCCcchhHHHHHHHH
Q 037258 551 -------------------------------------------DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVL 587 (704)
Q Consensus 551 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 587 (704)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 037258 588 LEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT---MTDVLM 664 (704)
Q Consensus 588 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 664 (704)
|||++|+.||......+. ........ ..+........+.++.+++.+|+ .+|.+|++ +.|+++
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHH------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999975432111 11111100 00000111223456778888876 59999997 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.49 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=199.6
Q ss_pred HhhhcccccccCceEEEEEEe-----CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 466 (704)
++...+.||+|+||.||++.. .++..||+|.++... ..+.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 345568899999999999964 357889999986432 2567799999999999999999999875 5688
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++++|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999975432 4899999999999999999999 9999999999999999999999999999998664
Q ss_pred cCCCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------CcccHHHHHHHHH
Q 037258 547 IESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED---------DTTHISQWVNSML 616 (704)
Q Consensus 547 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~ 616 (704)
..... .......++..|+|||++.+..++.++||||||+++|||++++.|....... .......++ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence 22221 1122345677899999999888999999999999999999988765332110 000111111 111
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
..+.. .......+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 011223456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.40 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=213.7
Q ss_pred HHHHHhhhcccccccCceEEEEEEeCC---C--cEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCe
Q 037258 395 IQKITNNFERVLGKGGFGEVYHGSLDD---N--QQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNN 464 (704)
Q Consensus 395 l~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 464 (704)
+.+....+.++||.|-||.||+|.+.+ | -.||||..+..+. .|..|..+++.++||||++++|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 344444457899999999999996532 3 3588998876443 67889999999999999999999986 46
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++|||.++.|.|.++|+.++.. ++......++.||..||+||| +.++|||||..+|||+.....+||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 79999999999999999987643 888999999999999999999 99999999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
+.++. .+..+...-...|||||.+.-..++.++|||.|||.+||++. |..||.+-...+. .-
T Consensus 541 ~ed~~-yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~ 603 (974)
T KOG4257|consen 541 LEDDA-YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IG 603 (974)
T ss_pred ccccc-hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EE
Confidence 85433 333344455678999999999999999999999999999987 9999977554332 11
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.+...-+...++.++..+..|+.+||.++|.+||.+.|+...|.+++..+.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 122222334567788899999999999999999999999999999887444
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.63 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=191.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhh---cccceeEEEEEEEe-----CCe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRV---HHRNLTALIGYCIE-----GNN 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~ 464 (704)
|.+.+.||+|+||.||+|... +++.||+|.++... .....|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345688999999999999654 78999999886421 1345677766665 69999999998864 245
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+++ +|.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 8899999975 8999987765555899999999999999999999 89999999999999999999999999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CCc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GDI 621 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~ 621 (704)
.... .......++..|+|||++.+..++.++||||+||++|||++|+.||......+ .+.... ..... ...
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~-~~~~~~~~~~~ 231 (288)
T cd07863 158 YSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIF-DLIGLPPEDDW 231 (288)
T ss_pred ccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHH-HHhCCCChhhC
Confidence 5321 12234567899999999998899999999999999999999999996543221 111111 11100 000
Q ss_pred c-------cccCCcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 R-------NIVDPSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ....+... .......+..+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011234457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.46 Aligned_cols=233 Identities=26% Similarity=0.361 Sum_probs=186.1
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHH-HHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQV-KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|... +++.||+|++..... ....|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 688999999864321 223343 357788999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCcc
Confidence 99998887543 3888999999999999999999 89999999999999999999999999999875321 11223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILH-KP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhc-CC----------CCCC
Confidence 345689999999999998999999999999999999999999965432 111111111 11 0122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23345788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=303.57 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=193.4
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|+||.||+|.. .+++.||+|++.... ..+..|++++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3567899999999999964 578999999975431 2456799999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|..+. .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++..+.. ...
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 9997653 2678889999999999999999 99999999999999999999999999999976532 122
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ............ . .+.+.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~--- 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVLP--- 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCCC---
Confidence 3457889999999999889999999999999999999999999654332211 111111111111 0 01110
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+.++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11234578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.14 Aligned_cols=243 Identities=22% Similarity=0.386 Sum_probs=196.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|++|.||+|.. .+++.|++|.+.... ..+..|+.+++.++|+|++++++.+..+...++||||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 44567899999999999964 578899999886432 2556789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++... .+++.++..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++...... ....
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~ 173 (296)
T cd06654 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173 (296)
T ss_pred CCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--cccc
Confidence 9999998654 2789999999999999999999 899999999999999999999999999998764321 1122
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... . +. .....+ . +.+ ..+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~---~~-~~~~~~-~-----~~~--~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A---LY-LIATNG-T-----PEL--QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--h---HH-HHhcCC-C-----CCC--CCc
Confidence 33468889999999998889999999999999999999999996543211 1 11 111111 0 000 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+.+++.+||..+|++||++.|+++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 334567889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.04 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||+|...+ ...+++|.+..... .+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996543 35788998754321 4567899999999999999999999999999999999999
Q ss_pred CHHHHhhcccC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 476 TLDQYLKGKKE---HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 476 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+|.+++..... ...++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976542 23567888999999999999999 8999999999999999999999999999986532221111
Q ss_pred ccccccCCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 553 ISTAVAGTPGYLDPEYYVL-------NWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence 1223345678999998753 356789999999999999999 788885443211 1111122211 112
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
.++.. +...+..+.+++..|+ .||++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222 2233456778889998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=289.93 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=198.2
Q ss_pred HhhhcccccccCceEEEEE-EeCCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 399 TNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.+.+.+.||+|.|+.||+. ...+|+.+|+|++... ..+..+|+.+-+.++||||+++.+.+.+....++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3455678999999999998 4457899998876432 22557889999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccccC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSIE 548 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~~~~ 548 (704)
|.|++|..-+-.+ ..+++..+-..+.||+++|.|+| .++|||||+||+|+++... --+||+|||++..++
T Consensus 92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999997555433 23788889999999999999999 9999999999999999543 358999999998875
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
+........||++|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.. .+.+ .+..+.. .
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~y------d 230 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAY------D 230 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhcccc------C
Confidence 455566789999999999999999999999999999999999999999764321 1111 1112211 1
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+.......++..+|+++||..||.+|.|+.|.+.
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 122233455678899999999999999999999863
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.47 Aligned_cols=249 Identities=21% Similarity=0.368 Sum_probs=196.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.+.||+|+||.||+|.. .+++.||+|++.... .....|+.++++++||||+++++++..++..++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 345678999999999999975 578899999986432 245678999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.++++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++..+... ...
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06646 90 GGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAK 162 (267)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc--ccc
Confidence 999999987544 3899999999999999999999 899999999999999999999999999999865321 111
Q ss_pred cccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 554 STAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||.......... ...... ...+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCCc
Confidence 23346788999999884 3457889999999999999999999985443211100 000000 0011111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
.....+..+.+++.+||+.+|++||+++++++.|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1122346789999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.43 Aligned_cols=248 Identities=28% Similarity=0.423 Sum_probs=190.5
Q ss_pred ccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEEeecC
Q 037258 404 RVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMA 473 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~~~ 473 (704)
+.||+|+||.||+|... ++..||+|.+.... ..+..|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999653 24579999885321 255678899999999999999998764 556889999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC--
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD-- 551 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-- 551 (704)
+|+|.+++..... ..++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976543 3677888999999999999999 899999999999999999999999999998755321111
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR-RPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......++..|+|||.+.+..++.++|||||||++|||++|. .||..... ..+ ...... +.. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~---~~~~~~-~~~-----~--- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDI---TVYLLQ-GRR-----L--- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH---HHHHhc-CCC-----C---
Confidence 1112334567899999998888999999999999999999954 55533221 111 111111 110 0
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1112234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.84 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=199.9
Q ss_pred HHhhhcccccccCceEEEEEEeCC----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
..+.+.+.||+|+||.||+|...+ ...|+||...... ..+..|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 345567899999999999996543 3468999876443 156779999999999999999999875 457899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++..... .+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976443 4899999999999999999999 899999999999999999999999999998765322
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.........++..|+|||.+....++.++||||||+++||+++ |..||......+ .... +..+...
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~----- 227 (270)
T cd05056 161 -SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----IENGERL----- 227 (270)
T ss_pred -cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HHcCCcC-----
Confidence 1111223334568999999988889999999999999999986 999996554321 1111 1111100
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+...+..+.+++.+|+..+|.+||++.|+++.|+++...
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223455789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.85 Aligned_cols=245 Identities=24% Similarity=0.408 Sum_probs=193.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc---hhhHHHHHHHHHhh-cccceeEEEEEEEeC------CeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS---CCFQLLQVKLLMRV-HHRNLTALIGYCIEG------NNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~~lV 468 (704)
+.+.+.||+|+||.||+|... +++.||+|++... ......|+.++.++ +|+||+++++++... ...++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 445678999999999999654 6889999998543 23567788899988 799999999998753 468899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+|+||||+||++++++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999999998765556899999999999999999999 899999999999999999999999999998765321
Q ss_pred CCCcccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
........|+..|+|||++. ...++.++|||||||++|||++|+.||....... ... .........
T Consensus 165 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~--~~~~~~~~~ 235 (272)
T cd06637 165 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--LIPRNPAPR 235 (272)
T ss_pred --cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH--HHhcCCCCC
Confidence 12233456889999999986 3457889999999999999999999996433211 110 011111111
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. .....+..+.+++.+||..+|.+||++.|+++
T Consensus 236 ~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 236 L--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 11223457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.14 Aligned_cols=195 Identities=24% Similarity=0.374 Sum_probs=160.6
Q ss_pred cccccccCceEEEEEEeC---CCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~~~g 475 (704)
.++||+|+||.||+|... +++.||+|.+.... ....+|++++++++||||+++++++.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 468999999999999754 56789999986543 356789999999999999999998864 4568899999864
Q ss_pred CHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe----CCCCcEEEEeccCccc
Q 037258 476 TLDQYLKGKK-------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRI 544 (704)
Q Consensus 476 sL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla~~ 544 (704)
+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ +..+.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 8888875321 224889999999999999999999 9999999999999999 4567899999999987
Q ss_pred cccCCC-CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 545 FSIESS-DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 545 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 642221 112234678999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.51 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=195.6
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
..+.||+|+||+||+|.. .+++.||+|.+.... .....|++++++++|+|++++.+++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 457899999999999965 478899999986432 134679999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ES 157 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Cc
Confidence 999999987655556999999999999999999999 999999999999999999999999999998754311 12
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... +........ ..+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~-~~~~~~~~~----------~~~ 224 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REE-VDRRVLETE----------EVY 224 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhhhccc----------ccc
Confidence 2345689999999999988999999999999999999999999965432111 111 111111110 011
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
....+..+.+|+.+|++.||++||+ +.|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2233456789999999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=337.20 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=199.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.++||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 345689999999999999654 68999999986431 2467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccc---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 472 MASGTLDQYLKGKK---------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 472 ~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
+++|+|.+++.... ....++..++.++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999986421 123567788999999999999999 899999999999999999999999999999
Q ss_pred cccccCCC----------------CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037258 543 RIFSIESS----------------DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606 (704)
Q Consensus 543 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~ 606 (704)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki- 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI- 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence 86521110 0011234689999999999999999999999999999999999999965332111
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhh
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERP-TMTDVLMELKECLSL 672 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 672 (704)
. . .... .++... ......+..+.+++.+|++.||++|| +++++++.|+..+..
T Consensus 240 --~---~----~~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 --S---Y----RDVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --h---h----hhhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0 0000 011000 00123345788999999999999996 677788888877653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.23 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=192.8
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC-----eEEEEE
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN-----NMGLIY 469 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~ 469 (704)
..+.||+|+||.||++.. .+++.||||++.... ....+|+++++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999965 578999999886421 24578999999999999999999998776 789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+. ++|.+.+.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 84 e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~- 156 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD- 156 (372)
T ss_pred eccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccC-
Confidence 9997 58888876543 3899999999999999999999 899999999999999999999999999999765322
Q ss_pred CCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH----------H------HH
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS----------Q------WV 612 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~----------~------~~ 612 (704)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||......+..... . ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 12223344678899999998864 5789999999999999999999999765432111000 0 00
Q ss_pred HHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 613 NSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 613 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+............+ .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000000 01112235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.55 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=208.1
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..|++++.||+|.|+.|-+|++ -+|+.||||++.+... ....|+..|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466788999999999999954 4899999999976543 55789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe-CCCCcEEEEeccCccccccCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL-NEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DfGla~~~~~~~ 549 (704)
.-++|+|+++|-.+.. .+.+.-+.+++.||+.|+.|+| +..+|||||||+||.+ ..-|-+||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 9999999999976653 3899999999999999999999 9999999999999866 566889999999997664
Q ss_pred CCcccccccCCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....+..+|+..|-|||++.+..|+ ++.||||||||||-|++|+.||....+.+. +..++|..
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK 235 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK 235 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence 33445677899999999999998886 678999999999999999999987765443 23344543
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ..+...+.++.+||..||..||.+|.+.+||+.
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3 346677889999999999999999999999874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.13 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=199.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... +|+ .+|+|.+.... ..+..|+.++++++|+||+++++++.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 456689999999999999754 333 68999886543 255678999999999999999999987 7889999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++..... .+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++.+....
T Consensus 88 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred ecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999986543 3899999999999999999999 8999999999999999999999999999998764322
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........++..|+|||.+....++.++||||||+++||+++ |+.||...... .+.. .+..+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~------ 230 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGERL------ 230 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCCC------
Confidence 2222222334568999999988889999999999999999998 99999654321 1111 11111110
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+...+..+.+++.+||..+|.+||++.++++.|+++..
T Consensus 231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1112233568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.13 Aligned_cols=235 Identities=25% Similarity=0.424 Sum_probs=188.8
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
++.+.||+|+||.||+|.. .+++.||+|++..... ....|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 4678999999999999965 4789999999864321 3456777777775 57788899999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~ 155 (323)
T cd05615 83 VNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--G 155 (323)
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--C
Confidence 999999999876543 899999999999999999999 899999999999999999999999999998753211 1
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... . ....... ...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~---~~~~i~~-~~~---------- 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---E---LFQSIME-HNV---------- 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---H---HHHHHHh-CCC----------
Confidence 2233456899999999999989999999999999999999999999654321 1 1111111 111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+..+.+++.+||+.+|.+|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=310.03 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=192.8
Q ss_pred hccccccc--CceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 402 FERVLGKG--GFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 402 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.++||+| +|++||++.. .+|+.||+|++.... .....|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999955 578999999986432 14456889999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655445899999999999999999999 899999999999999999999999999865433211110
Q ss_pred ----cccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 552 ----QISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 552 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... +.....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-----~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN-----GTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc-----CCccccc
Confidence 01122346778999999976 468899999999999999999999996533211 0000000 0000000
Q ss_pred C-------------------Cc-----------------CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 D-------------------PS-----------------LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d-------------------~~-----------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ .. ............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 00 000112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.95 Aligned_cols=243 Identities=28% Similarity=0.479 Sum_probs=196.9
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.+.+.||+|+||.||++.. .++.||+|.++... ..+..|+.++++++|||++++++++..+ ..++||||+++++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 45678999999999999975 67889999986432 2567899999999999999999998764 47899999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.......+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~ 157 (254)
T cd05083 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNS 157 (254)
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCC
Confidence 99998766556899999999999999999999 899999999999999999999999999998754211 1122
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..+..|+|||.+.+..++.++||||||+++|||++ |+.||...... +... ....+. .......
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~---------~~~~~~~ 221 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKE-CVEKGY---------RMEPPEG 221 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHH-HHhCCC---------CCCCCCc
Confidence 34568999999998889999999999999999998 99998654321 1111 111111 1111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.+..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 45678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.83 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=201.2
Q ss_pred hhhcccccccCceEEEEEEeC-----CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEe--CCeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-----DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 467 (704)
+.+.+.||+|+||.||+|.+. +++.||||+++.... .+..|+++++.++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999753 468899999875433 56789999999999999999999987 567899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++++|.+++..... .+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 86 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999976543 3899999999999999999999 89999999999999999999999999999987642
Q ss_pred CCCCcc-cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHHHHhc
Q 037258 548 ESSDQI-STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT--------HISQWVNSMLAE 618 (704)
Q Consensus 548 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~--------~~~~~~~~~~~~ 618 (704)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 222111 11234456799999999889999999999999999999999998654322110 001111111111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
+. ....+...+.++.+++.+||+.+|++||++.||+++|+++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 1111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.39 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=196.7
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+...+.||+|+||.||+|.. .+++.||+|.++... ..+..|++++++++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 344567899999999999965 467899999976332 14577999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++... .+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++..+... ..
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QI 156 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc--ch
Confidence 999999998653 3889999999999999999999 899999999999999999999999999999765321 11
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......++..|+|||++.+..++.++|||||||++|||++|+.||........ .. ....+ ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~---------~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKN---------SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcC---------CCCC
Confidence 22334678899999999988899999999999999999999999864332110 00 01111 1111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+..+.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22334567889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=298.21 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=202.4
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHh--hcccceeEEEEEEEeC----CeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMR--VHHRNLTALIGYCIEG----NNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~lV~e~~~ 473 (704)
.+.+.||+|.||.||+|.+. |+.||||+|..... ...+|.++.+. ++|+||+.+++.-..+ .+++||++|.+
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 34789999999999999995 88999999975543 55666666654 6999999999886543 46899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY-----GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
.|||+|+|.... ++....++++..+|.||+|||. ..++.|.|||||+.|||+..++.+.|+|+|+|......
T Consensus 293 ~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 293 HGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred CCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999998754 8999999999999999999994 34788999999999999999999999999999876433
Q ss_pred CC--CcccccccCCCCccCccccccCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCcccHHH
Q 037258 549 SS--DQISTAVAGTPGYLDPEYYVLNW----L--NEKSDVYSFGVVLLEIITG----------RRPVISRAEDDTTHISQ 610 (704)
Q Consensus 549 ~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDVwSlGvvl~elltG----------~~Pf~~~~~~~~~~~~~ 610 (704)
.+ ........||.+|||||++...- + -..+||||||.|+||+... +.||.+..+.+.. +.
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~e- 447 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-FE- 447 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-HH-
Confidence 22 12245678999999999986431 1 1458999999999999863 5677665544332 11
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
-++..+...+++..++.... ..+....+.++++.||..+|.-|-|+--+-+.|.++..
T Consensus 448 eMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 12222222233323332222 34567788999999999999999999999999988764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=299.61 Aligned_cols=235 Identities=23% Similarity=0.392 Sum_probs=184.9
Q ss_pred ccccccCceEEEEEEeCC-------------CcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 404 RVLGKGGFGEVYHGSLDD-------------NQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
+.||+|+||.||+|.... ...|++|.+..... .+..|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996532 23589998764332 4566788999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc-------EEEEec
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ-------AKIADF 539 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kL~Df 539 (704)
+||||+++|+|..++..... .+++..++.++.|+++||+||| +.+|+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999998875432 3899999999999999999999 999999999999999987654 899999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEII-TGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+. .. ..
T Consensus 157 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~-~~ 222 (262)
T cd05077 157 GIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ER-FY 222 (262)
T ss_pred CCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HH-HH
Confidence 99865421 12345778899999887 567899999999999999998 58888754322111 00 01
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
.+.. .. .......+.+|+.+||+.||.+||++.+|++.|
T Consensus 223 ~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1110 00 111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=300.86 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=196.1
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccch----------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC----------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
..+.||+|+||.||+|...+++.+|+|.+.... ....+|++++++++|+||+++++++.+.+..++|+||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 457899999999999988889999999875321 2356789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC--
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES-- 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~-- 549 (704)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 84 VPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999997654 3789999999999999999999 8999999999999999999999999999987642111
Q ss_pred --CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 --SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.........++..|+|||++.+..++.++||||||+++|||++|+.||....... ........... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-----~~ 228 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGL-----MP 228 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCC-----CC
Confidence 1112233568889999999998889999999999999999999999996543211 11000000011 11
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. .+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 229 ~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 12234557889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=301.90 Aligned_cols=234 Identities=26% Similarity=0.397 Sum_probs=183.7
Q ss_pred cccccCceEEEEEEeCC-------------------------CcEEEEEecccchh----hHHHHHHHHHhhcccceeEE
Q 037258 405 VLGKGGFGEVYHGSLDD-------------------------NQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTAL 455 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l 455 (704)
.||+|+||.||+|.+.. ...|++|++..... .+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13589999865432 45677889999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---
Q 037258 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL--- 532 (704)
Q Consensus 456 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 532 (704)
+++|.++...++||||+++|+|..++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999987543 24889999999999999999999 89999999999999997643
Q ss_pred ----cEEEEeccCccccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCcc
Q 037258 533 ----QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEII-TGRRPVISRAEDDTT 606 (704)
Q Consensus 533 ----~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~ell-tG~~Pf~~~~~~~~~ 606 (704)
.++++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 389999998754321 122356788999998875 56899999999999999995 69999865433211
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..+ .... ... +......+.+++.+||+.+|++||++.++++.|
T Consensus 231 --~~~----~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 --ERF----YEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHH----HHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 1110 001 111223688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.48 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=198.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+...+.||+|+||.||+|... +++.||+|+++... ..+..|+++++++.|+||+++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 344578999999999999764 68899999886432 245778999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++..+... ...
T Consensus 86 ~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~ 157 (277)
T cd06640 86 GGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIK 157 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--ccc
Confidence 99999998753 3888999999999999999999 899999999999999999999999999999765322 112
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||++.+..++.++|||||||++|||++|+.||........ .. .. ........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~---------~~~~~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LF-LI---------PKNNPPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hh-hh---------hcCCCCCC
Confidence 2334678899999999988899999999999999999999999965432111 00 00 11111223
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 44566789999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=307.82 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=196.4
Q ss_pred hcccccccCceEEEEEEe-CCCc----EEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQ----QVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
..+.||+|+||.||+|.. .+++ .||+|.+..... .+..|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 357899999999999965 3444 578998865432 456788999999999999999998754 46799999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+++.+......
T Consensus 90 ~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 90 MPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 999999999876532 3789999999999999999999 899999999999999999999999999999876432222
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+ ...+...
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~-------- 230 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGERL-------- 230 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCCC--------
Confidence 22223445678999999998999999999999999999997 89998654321 12221 1111110
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
......+..+.+++.+||..+|++||++.|+++.|+++...
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112345788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.22 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=191.8
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
..+.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++..++..++|+|++. ++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 34666899999999999999765 5788999986543 34679999999999999999999999999999999995 58
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 143 l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~ 215 (357)
T PHA03209 143 LYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAFLG 215 (357)
T ss_pred HHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cccccc
Confidence 988886543 34899999999999999999999 89999999999999999999999999999875321 122234
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH----HHHHHHHHhc-C----Ccc-----
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI----SQWVNSMLAE-G----DIR----- 622 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~----~~~~~~~~~~-~----~~~----- 622 (704)
..||..|+|||++.+..++.++|||||||++|||+++..|+........... ...+...+.. + .+.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 5689999999999999999999999999999999997666543322211100 0001111100 0 000
Q ss_pred ----cccCC--cCCCCC-------ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 ----NIVDP--SLQGNF-------DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ----~~~d~--~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..++. .....+ ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 000000 0112335667999999999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=306.86 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|+||.||++... ++..+|+|.+.... .....|++++++++||||+++++++.+++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 45688999999999999654 67889999876432 2456899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.++++... .+++..+..++.|+++||.||| + .+++|+||||+||+++.++.++|+|||++...... .
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 84 GSLDQVLKKAG--RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 99999997653 3889999999999999999999 5 58999999999999999999999999998754221 2
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc-----------
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR----------- 622 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 622 (704)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 234568899999999988889999999999999999999999986443211 111111000000000
Q ss_pred -------------cccCCcCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 -------------NIVDPSLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 -------------~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...... .... ....+..+.+++.+||..+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000 01234568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.28 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=194.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +++.||+|.++... .....|+.++++++|+||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 445688999999999999664 68899999875332 245679999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++..... .+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||++....... ..
T Consensus 88 -~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 160 (301)
T cd07873 88 -KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KT 160 (301)
T ss_pred -cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Cc
Confidence 599998875432 4889999999999999999999 9999999999999999999999999999987543211 12
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CCcccccC---
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GDIRNIVD--- 626 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d--- 626 (704)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+...+.. .......+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcccc
Confidence 2234568899999998754 57889999999999999999999996543221 11111111100 00000000
Q ss_pred ------CcCCC----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 ------PSLQG----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10000 011223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.42 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEeCCC---cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLDDN---QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||+|...++ ..+++|.++... ..+.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999965433 346677665332 25677888999999999999999999999999999999999
Q ss_pred CHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 476 TLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 476 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.++++... ....++..+..++.|++.||+||| +.+++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997643 233667788899999999999999 89999999999999999999999999999864321111112
Q ss_pred cccccCCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 554 STAVAGTPGYLDPEYYVL-------NWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+........ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 234567889999998753 245789999999999999997 5667744322 1122222222 122233
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
++.+... ....+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333322 3456788999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.82 Aligned_cols=241 Identities=27% Similarity=0.412 Sum_probs=199.6
Q ss_pred cccccCceEEEEEEeC-CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 405 VLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
+||+|.+|+||.|+.. +...+|||-+..... ....|+.+-++++|.|||+++|.|.+++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999654 566899999865443 33678999999999999999999999999999999999999999
Q ss_pred HhhcccCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccccCCCCcccccc
Q 037258 480 YLKGKKEH-MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 480 ~l~~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
+++..-+. .=++.++-.+.+||++||.||| ...|||||||-+|||++ -.|.+||+|||-++.+.. -.......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 99876532 2377888889999999999999 99999999999999996 578999999999988642 23345567
Q ss_pred cCCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 558 AGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
.||..|||||++..+ .|+.++|||||||++.||.||++||......... +++-|- -...+..++
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGm------yKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGM------YKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcc------eecCCCCcH
Confidence 899999999999754 6899999999999999999999999766543221 111110 112234577
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.+.++..+|.+|+.+||.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 88899999999999999999999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.35 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=202.6
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEee
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.|...++||+||.+.||++...+.+.+|+|++.... ..+..|+++|.+++ |.+||++++|-..++.+|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 345568999999999999998888889988764322 25688999999994 99999999999999999999998
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
-+ .+|..+|+........| .+..+..|++.|+.++| ++||||.||||.|+|+-.. .+||+|||+|..+..+...
T Consensus 442 Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 442 GD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEee-eEEeeeechhcccCccccc
Confidence 74 49999999887655555 77889999999999999 9999999999999998764 8999999999998777777
Q ss_pred cccccccCCCCccCccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLN-----------WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
......+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..... .|. .
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-------K 581 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-------K 581 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-------H
Confidence 777889999999999998633 256899999999999999999999953221 111 2
Q ss_pred cccccCCcCCCCCChh-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNN-SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..+.||.-..+|+.- ...+++++++.||..||.+||+..|+|+
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3445566544444321 2234999999999999999999999986
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.35 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=199.3
Q ss_pred hhhcccccccCceEEEEEEeCC-CcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|...+ ++.+++|.++... ..+.+|++++++++|+||+++++++.++...++++||+++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4456789999999999997764 7899999987543 367789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....... .....
T Consensus 85 L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 158 (256)
T cd06612 85 VSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNT 158 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--ccccc
Confidence 999997543 34899999999999999999999 8999999999999999999999999999988653221 12234
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... . .. .....+.+ ..+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~-----~~-----~~~~~~~~--~~~~~ 224 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F-----MI-----PNKPPPTL--SDPEK 224 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h-----hh-----ccCCCCCC--Cchhh
Confidence 45788999999999889999999999999999999999999654322110 0 00 00000111 11223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.45 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=187.3
Q ss_pred cccccccCceEEEEEEeC---CCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~~~g 475 (704)
..+||+|+||.||+|... ++..||+|.+.... ....+|++++++++||||+++++++.. +...++|+||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 357999999999999764 45789999987543 256789999999999999999999854 4678899999875
Q ss_pred CHHHHhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe----CCCCcEEEEeccCccc
Q 037258 476 TLDQYLKGK-------KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRI 544 (704)
Q Consensus 476 sL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla~~ 544 (704)
+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 888777532 1234889999999999999999999 8999999999999999 5667899999999987
Q ss_pred cccCCCC-cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-------cHHHHHHHH
Q 037258 545 FSIESSD-QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-------HISQWVNSM 615 (704)
Q Consensus 545 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-------~~~~~~~~~ 615 (704)
....... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||.....+... .+..... .
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS-V 240 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH-h
Confidence 6422211 12234568899999999876 45889999999999999999999999754432110 0000000 0
Q ss_pred Hhc------------CCcccccCC---------cC---CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 616 LAE------------GDIRNIVDP---------SL---QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 616 ~~~------------~~~~~~~d~---------~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.. ......... .+ ...........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000000 00 00001112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.40 Aligned_cols=244 Identities=20% Similarity=0.349 Sum_probs=197.1
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.+.||+|++|.||+|.. .+++.||+|.+.... .....|+.+++.++|+||+++++++..++..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 345578899999999999965 578999999986432 245678899999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.... +++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ...
T Consensus 100 ~~~L~~~~~~~~---~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~ 171 (297)
T cd06656 100 GGSLTDVVTETC---MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 171 (297)
T ss_pred CCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--ccC
Confidence 999999986533 789999999999999999999 899999999999999999999999999998765322 122
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .... ........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~--------~~~~~~~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPELQN 237 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eecc--------CCCCCCCC
Confidence 234568889999999998889999999999999999999999996543311100 0000 00000111
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+...+..+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2334456889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.55 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=193.9
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
..+.+.+.||+|+||.||++... +++.||+|++.... .....|+.+++.++||||+++++.+.+++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34556789999999999999765 68899999985422 13457888999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus 123 Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 123 EYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred cCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 9999999999997543 788899999999999999999 999999999999999999999999999999865322
Q ss_pred CCcccccccCCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLN----WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ................
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~- 268 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLTF- 268 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcccC-
Confidence 12223356799999999998754 378999999999999999999999965432 1111222211111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
......+..+.+++.+||..++.+ |+++.|+++.
T Consensus 269 ------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 269 ------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 011234557889999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.95 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=200.5
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
-.+.+.+.||+|+||.||++... +++.||+|++.... ..+..|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34556789999999999999654 68899999875332 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.... .+++..+..++.+++.||.|||+ .++++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999987644 38999999999999999999993 368999999999999999999999999998654211
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-----cccHHHHHHHHHhcCCcccccC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD-----TTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~d 626 (704)
......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...+..+........ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence 1223568899999999988889999999999999999999999997654321 111222222222111 0
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
+.+. ....+..+.+++.+|++.||++||++.|+++..
T Consensus 231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 112445788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.46 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=191.0
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||++... +++.||+|++.... .....|+.++..++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34688999999999999654 68999999986432 14466889999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+......
T Consensus 84 ~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 84 PGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999999976543 899999999999999999999 999999999999999999999999999998754211100
Q ss_pred --------------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 037258 552 --------------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599 (704)
Q Consensus 552 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~ 599 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001234689999999999999999999999999999999999999965
Q ss_pred CCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 037258 600 RAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT---MTDVLM 664 (704)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 664 (704)
..... .......... ...+.+. ...+.++.+++.+|+. +|.+|++ +.|+++
T Consensus 239 ~~~~~------~~~~i~~~~~-~~~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQE------TYRKVMNWKE-TLVFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHH------HHHHHHcCCC-ceecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 44321 1111111000 0001110 1134567888888764 9999995 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.88 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=197.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~ 471 (704)
|.+.+.||+|++|.||++... +++.||+|.+.... .....|++++++++|+|++++++.+.. +...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999654 67899999975321 245678899999999999999998764 4467899999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.......+++.+++.++.+++.||++|| +.+++|+||||+||+++.++.++|+|||++..+... .
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--C 156 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc--C
Confidence 99999999998765556899999999999999999999 899999999999999999999999999999765322 1
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......+++.|+|||++.+..++.++||||||++++||++|+.||..... ....... ..+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~--------- 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-IEGKLP--------- 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhcCCC---------
Confidence 223345688899999999999999999999999999999999999864321 1111111 111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.54 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=192.9
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||+|... +++.||+|+++... .....|+.++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 35678999999999999764 78999999875321 245779999999999999999999999999999999997
Q ss_pred CCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|.+++.... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 68998886543 245899999999999999999999 999999999999999999999999999998765322 11
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh--c---------CC
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA--E---------GD 620 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~---------~~ 620 (704)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+. .......... . ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence 22234568899999988754 578999999999999999999999975432110 0000000000 0 00
Q ss_pred cccccCCcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+.... .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001123457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.90 Aligned_cols=235 Identities=25% Similarity=0.406 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEeCCCc-----------EEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 404 RVLGKGGFGEVYHGSLDDNQ-----------QVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.||+|+||.||+|...+.. .|++|.+.... ..+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999765432 58888876443 366788999999999999999999988 7789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-------cEEEEeccCc
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-------QAKIADFGLS 542 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kL~DfGla 542 (704)
||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .++|+|||++
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999986553 4899999999999999999999 99999999999999999887 7999999998
Q ss_pred cccccCCCCcccccccCCCCccCccccccC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+. ...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~----~~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY----QDQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH----hcC
Confidence 76532 2234466789999999876 78999999999999999999 577775543211 11111 000
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
.. . +......+.+++.+||..+|.+||++.|+++.|+
T Consensus 223 ~~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 0011157889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.08 Aligned_cols=256 Identities=23% Similarity=0.253 Sum_probs=190.9
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCC------eE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGN------NM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 465 (704)
.|.+.+.||+|+||.||++.. .+|+.||||++... .....+|+.+++.++||||+++++++...+ ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 345578999999999999965 46899999998642 224567999999999999999999986543 57
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 102 YLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999999975 67666643 2788899999999999999999 999999999999999999999999999999754
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc------------cH----H
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT------------HI----S 609 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~------------~~----~ 609 (704)
.. ........+|..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. .
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 21 22233457899999999999999999999999999999999999999754321100 00 0
Q ss_pred HHHHHHHhcC-Cc-----ccccCCcC-C--CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 610 QWVNSMLAEG-DI-----RNIVDPSL-Q--GNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 610 ~~~~~~~~~~-~~-----~~~~d~~l-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+....... .. .+...... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 00 00000000 0 00111234568899999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.39 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=184.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh---cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV---HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
||+|+||.||+|... +++.||||++..... ....|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999654 689999999864321 233455666555 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++..... +++..+..++.||++||+||| +.+|+||||||+|||++.++.++|+|||+++.... .....
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~ 153 (330)
T cd05586 81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTT 153 (330)
T ss_pred ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCc
Confidence 999999876543 899999999999999999999 99999999999999999999999999999875321 12223
Q ss_pred ccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....||..|+|||++.+. .++.++|||||||++|||++|+.||...... +... .+..+... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~-~i~~~~~~------~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYR-NIAFGKVR------FP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHH-HHHcCCCC------CC---
Confidence 345789999999998754 4789999999999999999999999654321 1111 11111110 11
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERP----TMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 664 (704)
....+..+.+++.+||+.||.+|| ++.|+++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112345678999999999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.55 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=192.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||++... +++.+|+|++.... ..+..|+.++..++|++|+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345689999999999999765 57889999986422 1356678889999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+... ..
T Consensus 83 ~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GT 157 (332)
T ss_pred cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Cc
Confidence 999999999976432 3889999999999999999999 999999999999999999999999999998765321 12
Q ss_pred cccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 552 QISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~--- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ--- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc---
Confidence 2223457899999999986 34678999999999999999999999965432 112222221110000
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
.. ......+..+.+++.+|+..++.+ |++++|+++.
T Consensus 229 --~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --FP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 111234567889999988655444 7899999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=327.22 Aligned_cols=255 Identities=19% Similarity=0.272 Sum_probs=187.1
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch---hhHHHHHHHHHhhccc------ceeEEEEEEEeC-CeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHR------NLTALIGYCIEG-NNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------nIv~l~~~~~~~-~~~~l 467 (704)
.+.+.+.||+|+||+||+|.. ..++.||||+++... .....|++++.+++|. +++++++++..+ .+.++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 355678999999999999965 468899999986432 2446678888877654 588999988764 57889
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCC--------------
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKL-------------- 532 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~-------------- 532 (704)
|||++ +++|.+++.... .+++..+..++.||+.||+||| . .+||||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 99988 678998887654 3899999999999999999999 6 5999999999999998765
Q ss_pred --cEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 037258 533 --QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610 (704)
Q Consensus 533 --~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 610 (704)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 284 ~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 284 PCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 49999999875421 22335678999999999999999999999999999999999999997644322111110
Q ss_pred ---------HHHH--------HHh-cCCcccccCCcC-----C--CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 611 ---------WVNS--------MLA-EGDIRNIVDPSL-----Q--GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 611 ---------~~~~--------~~~-~~~~~~~~d~~l-----~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
|... ... .+.+....++.. . ..........+.+|+.+||+.||.+|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 000 000000000000 0 0000112346789999999999999999999997
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.95 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=191.2
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
...||+|+||.||+|.. .++..|++|.+..... .+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 46899999999999965 4678899998764432 567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccccCCCCcccc
Q 037258 478 DQYLKGKKEH-MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 478 ~~~l~~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
.+++...... ..++..+..++.|++.||+||| +.+|+||||||+||+++. ++.++|+|||++...... .....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 9999864321 1378888999999999999999 899999999999999976 678999999998765321 11222
Q ss_pred cccCCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
...++..|+|||++... .++.++||||||+++|+|++|+.||........ ..+..... ......
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~-----------~~~~~~ 233 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF-----------KIHPEI 233 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-----------ccCCCC
Confidence 34578899999998754 378899999999999999999999965332111 11110000 001112
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.....++.+++.+||+.+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3334567889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.48 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=191.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||++... +++.||+|++.... ..+..|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 345789999999999999754 68999999986421 1356788899999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..+... ..
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GT 157 (331)
T ss_pred CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-CC
Confidence 99999999997533 23889999999999999999999 999999999999999999999999999998765322 12
Q ss_pred cccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.............+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF-- 229 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC--
Confidence 22233568999999999873 4578899999999999999999999965432 1112222211111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSS--ERPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 665 (704)
. ......+..+.+++.+|+..++. .||++.++++.
T Consensus 230 ---~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ---P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01112455788899988765443 37899999865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.63 Aligned_cols=242 Identities=29% Similarity=0.446 Sum_probs=197.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||.|++|.||+|... +++.||+|++.... ..+..|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 445688999999999999654 68999999986432 245778999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++.+.... ..
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 83 GGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 99999999865 4899999999999999999999 8999999999999999999999999999998764321 22
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....... ... ....... +.+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-~~~~~~~-----~~~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-LIPKNNP-----PSLEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-HhhhcCC-----CCCccc-
Confidence 334567889999999998889999999999999999999999996543211 111 1111111 111110
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+..+.+++.+||..+|++||+++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.98 Aligned_cols=247 Identities=21% Similarity=0.360 Sum_probs=195.1
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.+.||+|+||.||+|.. .+++.||+|.++.... ....|+.+++.++||||+++++.+..++..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 345668899999999999965 4688999999864322 45678999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.... .+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..+... ...
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 90 GGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999987654 3899999999999999999999 899999999999999999999999999998765321 122
Q ss_pred cccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 554 STAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||........ + .... ..... .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~-~~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMT-KSNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhhh-ccCCC---CCccc
Confidence 23456889999999874 45688999999999999999999999865432111 0 0000 01110 11111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ....+..+.+++.+||+.+|++||+++++++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 0122346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.66 Aligned_cols=245 Identities=28% Similarity=0.385 Sum_probs=200.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||.|+||.||.+.. .+++.+++|.+.... ..+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 44568999999999999854 468899999865322 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++.......+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 156 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--S 156 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--c
Confidence 9999999998765556899999999999999999999 8999999999999999999999999999997653222 1
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... .+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~--------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTP--------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCC---------
Confidence 23345688999999999988889999999999999999999999954332 11122221 111111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....+.++.+++.+||+.+|.+||++.|+++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112334578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.59 Aligned_cols=243 Identities=24% Similarity=0.431 Sum_probs=195.3
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.||+|++|.||+|.. .+++.+|+|.+.... ..+..|++++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 3567899999999999965 468899999875321 13567889999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+|+||+++++|.+++..... +++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||.++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999976543 788999999999999999999 8999999999999999999999999999988764
Q ss_pred cCCCC----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 547 IESSD----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 547 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... . +.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~-~---- 226 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A----IFKIG-E---- 226 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H----HHHHh-c----
Confidence 21111 11123457889999999998889999999999999999999999996543211 0 11100 0
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+ ..+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 227 -~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 122334567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.85 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=205.5
Q ss_pred hcccccccCceEEEEEEeC--CC--cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 402 FERVLGKGGFGEVYHGSLD--DN--QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.++||+|.||.|++|.|. +| ..||||+++... .+|.+|+.+|.+|+|+|++++||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999775 34 368999987543 378999999999999999999999987 6788999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+.|+|.+.|+......+-......++.|||.||.||. .+++|||||..+|+|+-....+||+|||+.+.+....+.+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999866666888899999999999999999 9999999999999999999999999999999886444443
Q ss_pred ccc-cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 553 IST-AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 553 ~~~-~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.+. ...-...|+|||.+....++.++|||+|||++|||+| |+.||.+-.... +.+.+|..-+
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccccc
Confidence 332 3445678999999999999999999999999999999 889996654321 1222333223
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
-.-++.+++.+.++++.||..+|++||++..|.+.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 344677889999999999999999999999997433
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.53 Aligned_cols=255 Identities=23% Similarity=0.269 Sum_probs=190.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
+...+.||+|+||.||++.. ..++.||||++.... ....+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 44578999999999999965 468899999986431 2456789999999999999999988643 3579
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 99 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred EEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 99999975 67776653 2788999999999999999999 9999999999999999999999999999997643
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc-H--------H-------H
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH-I--------S-------Q 610 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~-~--------~-------~ 610 (704)
. ........+|..|+|||++.+..++.++|||||||++|||++|+.||......+... . . .
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 1 222334578999999999999999999999999999999999999996543211100 0 0 0
Q ss_pred HHHHHHhcC-CcccccCC-----cCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 611 WVNSMLAEG-DIRNIVDP-----SLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 611 ~~~~~~~~~-~~~~~~d~-----~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+....... .......+ ... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000 000 01112234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.13 Aligned_cols=245 Identities=32% Similarity=0.518 Sum_probs=197.3
Q ss_pred hcccccccCceEEEEEEeCC-----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 402 FERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.||.|+||.||++...+ +..||+|++.... .....|+.++..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999997653 4889999986543 2567789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY- 158 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc-
Confidence 99999999998765444899999999999999999999 99999999999999999999999999999977643211
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......++..|+|||.+.+..++.++||||+|+++++|++ |+.||..... ..+.. . ...+...
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~-~~~~~~~-------- 223 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE---Y-LKKGYRL-------- 223 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---H-HhcCCCC--------
Confidence 11112336789999999988889999999999999999998 7888755322 11111 1 1111111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
......+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122456789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.15 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=196.5
Q ss_pred hcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 402 FERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..+.||+|+||.||+|... +.+.|++|.+.... ..+..|++++++++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4578999999999999753 34679999886433 246789999999999999999999999899999999
Q ss_pred ecCCCCHHHHhhcccC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 471 YMASGTLDQYLKGKKE-------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
|+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccccccc
Confidence 9999999999976551 24899999999999999999999 8999999999999999999999999999986
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
..... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. +. ....+...
T Consensus 166 ~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~---~~-~~~~~~~~ 237 (275)
T cd05046 166 DVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV---LN-RLQAGKLE 237 (275)
T ss_pred ccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH---HH-HHHcCCcC
Confidence 54211 1112223355678999999988888999999999999999999 78888543321 11 11 11111111
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
. ......+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 238 ~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 L--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 111233457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.90 Aligned_cols=243 Identities=20% Similarity=0.371 Sum_probs=196.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||.|++|.||+|.. .+++.|++|.+.... .....|+.+++.++|+||+++++++..++..++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 34567899999999999964 578999999885432 2456789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... +++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 101 ~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 172 (296)
T cd06655 101 GSLTDVVTETC---MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (296)
T ss_pred CcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccC
Confidence 99999987543 899999999999999999999 9999999999999999999999999999987653221 122
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...... ..... + ..+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~-~~~~~-----~--~~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIAT-NGTPE-----L--QNP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-cCCcc-----c--CCc
Confidence 334688899999999988899999999999999999999999965443111 111111 11000 0 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+++.+||..+|.+||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 233457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.14 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred hhcccccccCceEEEEEEeCC--CcEEEEEecccch--------------hhHHHHHHHHHh-hcccceeEEEEEEEeCC
Q 037258 401 NFERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSC--------------CFQLLQVKLLMR-VHHRNLTALIGYCIEGN 463 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~ 463 (704)
.+.+.||+|+||.||+|.... ++.+|+|.+.... .....|+.++.+ ++||||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456789999999999997654 6889999874221 134567777764 79999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 464 NMGLIYEYMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988542 23458999999999999999999992 26899999999999999999999999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ..+..
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~-~~~~~ 230 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI-VEAVY 230 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH-hhccC
Confidence 97653221 334556888999999999888999999999999999999999998543221 111111 11111
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
... .....+..+.+++.+||+.||++||++.|+.+++++
T Consensus 231 ~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 111234578899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.08 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=193.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... ++..+++|.+..... .+..|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345678999999999999765 577889998864332 456789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|..++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 99999886533 34899999999999999999999 899999999999999999999999999998754221 1222
Q ss_pred ccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 555 TAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
....++..|+|||++. +..++.++|||||||++|||++|+.||......+ .+....... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-PPTL----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcC-CCCC-----
Confidence 3456889999999984 4457789999999999999999999986533211 111111110 0000
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234578999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=311.24 Aligned_cols=235 Identities=31% Similarity=0.468 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEE-eCCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||.|+||.||.|. ..+.+.||||++.-+.. +...|+..|++++|||++.+.|+|..+...+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 569999999999995 45788999999853322 66889999999999999999999999999999999995 4
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+-.|++.-.+ +++.+.++..|..+.++||+||| +++.||||||..|||+++.|.|||+|||.+.... ...
T Consensus 111 SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAn 180 (948)
T KOG0577|consen 111 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PAN 180 (948)
T ss_pred cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC------chh
Confidence 8888887554 34888999999999999999999 9999999999999999999999999999997653 345
Q ss_pred cccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 556 AVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.++||+.|||||++. .+.|+-|+||||+||+..||.-.++|+..++.-. -+.. +.+.-.|.+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYH----------IAQNesPtLq-- 246 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----------IAQNESPTLQ-- 246 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHH----------HHhcCCCCCC--
Confidence 678999999999986 5689999999999999999999999987665311 1111 1111223333
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+-+..+++++..||++-|.+|||.+++++
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3456778999999999999999999998863
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=300.22 Aligned_cols=236 Identities=23% Similarity=0.396 Sum_probs=185.8
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDD--------NQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.||+|+||.||+|.... ...|++|.+..... .+..|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 23588888764332 456788999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc--------EEEEeccCcc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--------AKIADFGLSR 543 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~DfGla~ 543 (704)
+++|+|.++++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999986543 4889999999999999999999 999999999999999987765 6999999886
Q ss_pred ccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGR-RPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|. .||....... .. ..... .
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~-~- 221 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYED-R- 221 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHc-c-
Confidence 5421 123457889999999986 45789999999999999999995 5553322111 00 01110 0
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
...+.....++.+++.+||+.+|++|||++|+++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0112223357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.27 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=189.9
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLI 468 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 468 (704)
...+.||+|+||.||+|.. .++..|++|++... .....+|+.++++++||||+++++++.+ +...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 3468899999999999965 46899999987532 1245678999999999999999999875 3678899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+||+++++|.+++..... +++...+.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+...
T Consensus 85 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999999976543 789999999999999999999 899999999999999999999999999998765321
Q ss_pred CC-CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SS-DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+....... ..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----~~~ 228 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----TNP 228 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----CCC
Confidence 11 11122345788999999999888999999999999999999999999643221 1111111111 111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++......+.+++ +||..+|++||+++|+++
T Consensus 229 ----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 22233344566777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.06 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=194.2
Q ss_pred hhcccccccCceEEEEEEeC----CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC------e
Q 037258 401 NFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN------N 464 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 464 (704)
.+.+.||+|+||.||+|... +++.||||++.... ..+..|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34678999999999999643 46889999886432 14567899999999999999999886542 2
Q ss_pred EEEEEeecCCCCHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 465 MGLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
.++++||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999998875322 224788999999999999999999 8999999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
+++...............++..|++||.+....++.++||||||+++|||++ |+.||...... .+..+. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~---~~~~ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL---IKGN 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH---HcCC
Confidence 9986532222122223345678999999998889999999999999999999 88888644321 111111 1111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.. ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 01122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.15 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=199.1
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||++.. .+++.||+|.+... ......|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 34578999999999999955 47899999987532 125677899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++.......+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~ 156 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VE 156 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hh
Confidence 9999999998655545889999999999999999999 899999999999999999999999999999765321 11
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......++..|+|||++.+...+.++|||||||++++|++|+.||..... ...+..... +... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~---------~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYP---------P 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCC---------C
Confidence 22334578899999999988899999999999999999999999864321 112222211 1111 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+...+..+.+++.+||+.+|.+||++.||++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122335578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.39 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=191.1
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 465 (704)
.+.+.+.||+|+||.||++.. ..++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 345578999999999999965 468899999986421 2456789999999999999999987543 357
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 999999975 77777753 2788999999999999999999 999999999999999999999999999999764
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH------------
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN------------ 613 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~------------ 613 (704)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||......+. ....+.
T Consensus 177 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 177 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHh
Confidence 32 1222345789999999999999999999999999999999999999965432111 000000
Q ss_pred ------HHHhcC-Ccc-----cccCCcC---CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 614 ------SMLAEG-DIR-----NIVDPSL---QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 614 ------~~~~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...... ... ....... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 0000000 001111234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.67 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=193.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch---hhHHHHHHHHHhh-cccceeEEEEEEEe------CCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---CFQLLQVKLLMRV-HHRNLTALIGYCIE------GNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~l 467 (704)
.+.+.+.||+|+||.||+|.. .+++.+|+|++.... .....|+.++.++ +|+||+++++++.. ....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 344568999999999999965 468899999885443 2456788888888 69999999999853 457899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
+|||+++|+|.+++.......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 999999999999998766556889999999999999999999 89999999999999999999999999999875421
Q ss_pred CCCCcccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
. ........++..|+|||.+. ...++.++|||||||++|||++|+.||.......... . ....
T Consensus 174 ~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~--- 241 (282)
T cd06636 174 T--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRN--- 241 (282)
T ss_pred c--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------h-HhhC---
Confidence 1 11223456888999999986 3467889999999999999999999996543211100 0 0000
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+.. .....+..+.+++.+||+.||.+||++.|+++
T Consensus 242 --~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 --PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 01111 11234557899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=291.30 Aligned_cols=242 Identities=22% Similarity=0.381 Sum_probs=204.3
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh--hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
++..+||+|+||.||+|.+ +.|+.||||.+..... +...|+.++++++.|++|+++|.|.....+++|||||..|++
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 3457899999999999954 5899999999876544 678899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+.++.+. +.+.+.++..++.+.+.||+||| ...-||||||..|||++.+|.+||+|||.+..+.+ ........
T Consensus 116 SDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNTV 189 (502)
T KOG0574|consen 116 SDIMRARR-KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNTV 189 (502)
T ss_pred HHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhCcc
Confidence 99998654 45999999999999999999999 88889999999999999999999999999977632 23334568
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC--Ch
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF--DN 635 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~ 635 (704)
.||+.|||||++..-.|..++||||+|++..||..|++||....+-.. +. .+.......| ++
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IF-MIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IF-MIPTKPPPTFKKPE 253 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eE-eccCCCCCCCCChH
Confidence 899999999999999999999999999999999999999965433111 10 1111222233 35
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.-+.++-++++.||-..|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 55778999999999999999999998875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.29 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=195.9
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch---------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
...+.||+|++|.||+|... +++.|++|.+.... ..+..|+++++.++|+||+++++++.++...++|+|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34578999999999999765 78999999875422 246778999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 83 LVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999997654 3889999999999999999999 8999999999999999999999999999987653221
Q ss_pred CcccccccCCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-------- 220 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL-------- 220 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC--------
Confidence 233456888999999988766 899999999999999999999999654311 111111110111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+......+.+++.+||+.+|.+||++.|+++
T Consensus 221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122234457889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.98 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=192.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||++... +++.||+|++.... ..+..|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345789999999999999764 67889999986422 1345678889999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..+.... .
T Consensus 83 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 157 (331)
T cd05624 83 YVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-T 157 (331)
T ss_pred CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence 99999999997643 23889999999999999999999 9999999999999999999999999999997653221 1
Q ss_pred cccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......|++.|+|||++.+ +.++.++|||||||++|||++|+.||...... +............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~---- 227 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF---- 227 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc----
Confidence 22234568999999999875 46789999999999999999999999654321 1111111111000
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
.+. ......+..+.+++.+|+..++.+ |++++++++.
T Consensus 228 -~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 011123567889999999876554 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.39 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=194.5
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch--------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..+.||+|+||.||+|.. .+++.||+|.++... ..+..|++++++++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 357899999999999954 478999999875311 13456889999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999998763 4889999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCCCcccccccCCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
............++..|+|||.+.... ++.++||||||+++||+++|+.||...... ... ..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~-~~~~~~ 232 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM-FKLGN-KRSAPP 232 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH-HHhhc-cccCCc
Confidence 222222233456788999999987654 789999999999999999999998533211 111 11110 111111
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.. ......+..+.+++.+||..+|.+||++.|+++.
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111 1122345688999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.94 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=194.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... +++.|++|++..... .+..|+++++.++|+||+++++.+..++..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 456688999999999999765 588999999865433 456789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|..++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..... .....
T Consensus 94 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~~~ 167 (292)
T cd06644 94 GAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQRR 167 (292)
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccccc
Confidence 99998876543 24899999999999999999999 89999999999999999999999999998865321 11222
Q ss_pred ccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 555 TAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... ........ ... +..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~~ 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SEP-----PTL 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhc-CCC-----ccC
Confidence 3456788999999985 345678999999999999999999998653321 11111111 110 100
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+.++.+++.+||+.+|++||++.|+++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112233457889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=293.59 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=199.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||.|+||.||+|.. .++..+++|++.... ....+|+++++.++|+|++++++.+..++..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 34578899999999999975 468899999986432 356788999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+++|.++++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++..+.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999976543 45899999999999999999999 9999999999999999999999999999987764332221
Q ss_pred --ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 553 --ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 553 --~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
......++..|+|||++... .++.++|+|||||++|||++|+.||....... ... ...... .+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~~------~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQND------PPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcCC------CCCc
Confidence 22345688899999998876 78999999999999999999999996543321 111 111111 1111
Q ss_pred CCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNF-DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... ....+..+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 1234567899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.12 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=194.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|++|.||+|... +++.||+|++.... ..+..|++++++++|+|++++++++..+...++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999999765 68999999875332 23567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|..++.... .+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 83 DHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred CccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 9998888876543 3899999999999999999999 89999999999999999999999999999987632221
Q ss_pred ccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh-----------cCC
Q 037258 553 ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA-----------EGD 620 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~~ 620 (704)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. +.. ...... ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL-IRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChHHhhhccccc
Confidence 1223457789999999876 4578999999999999999999999975443211 111 111000 000
Q ss_pred c-ccccCCcCCCCC-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 I-RNIVDPSLQGNF-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~-~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. .....+...... ....+..+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000001000000 0123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.84 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=196.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|++|.||+|... +++.||+|.+.... .....|+++++.++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44678999999999999665 58999999986432 24567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
.+++|.+++.......+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999999998665556899999999999999999999 899999999999999999999999999998754221110
Q ss_pred --------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 037258 552 --------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605 (704)
Q Consensus 552 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~ 605 (704)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 01113467889999999998889999999999999999999999996544321
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT----MTDVLM 664 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 664 (704)
. ...... ...........+..+.+++.+||+.+|++||+ ++|+++
T Consensus 240 -~----~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 -T----FSNILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -H----HHHHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 111111 11100111124568999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.15 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=191.0
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch---hhHHHHHHHHHhh-cccceeEEEEEEE-----eCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---CFQLLQVKLLMRV-HHRNLTALIGYCI-----EGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~~lV~e 470 (704)
.+.+.||+|+||.||++.. .+++.+|+|+++... .....|+.+++++ +|+||+++++++. .++..++|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 3468899999999999965 468899999876432 2456788999999 6999999999884 3456899999
Q ss_pred ecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 471 YMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 471 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|+++++|.+++... ....+++..+..++.|+++||.||| +.+++||||||+||++++++.++|+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 99999999988642 2345889999999999999999999 899999999999999999999999999998765321
Q ss_pred CCCcccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
........|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ... . ........
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~~-~-~~~~~~~~ 248 (286)
T cd06638 178 --RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----ALF-K-IPRNPPPT 248 (286)
T ss_pred --CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HHh-h-ccccCCCc
Confidence 122234568899999999853 457889999999999999999999996543211 000 0 00000001
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+ +......+.+++.+||+.+|++||++.|+++.
T Consensus 249 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 249 LHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111 11223468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.88 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=209.0
Q ss_pred hhcccccccCceEEEEEEe-CCC----cEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDN----QQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.-.++||+|+||+||+|.+ ..| -+||+|++... ..++..|+-+|.+++|||+++++|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999954 334 46899987532 337788999999999999999999998766 889999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
||+.|+|.++++.++. .+.....+.|..|||+||.||| .+++|||||-.+|||+.+...+||.|||+++.+..+..
T Consensus 778 ~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999998664 3788899999999999999999 99999999999999999999999999999999876666
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........-.+.|||-|.+....++.++|||||||++||++| |..|+++...++..+ .++.+.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-------lle~ge--------- 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-------LLEKGE--------- 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-------HHhccc---------
Confidence 665556666788999999999999999999999999999999 999997766544322 222221
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
+-.-++-++..+.-++.+||..|+..||+++++...+.++.
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 12234556678889999999999999999999998887654
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=294.52 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=196.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|.. .+++.||+|++.... ..+..|++++.+++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 44567899999999999965 478899999875332 245678999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+... ...
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~ 157 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIK 157 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhh
Confidence 99999998753 3889999999999999999999 899999999999999999999999999998765321 112
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||.+.+...+.++|||||||++|+|++|..||...... ..... ...... ...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~---------~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-IPKNNP---------PTL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-HhcCCC---------CCC
Confidence 23346788999999998888899999999999999999999998643321 11111 111111 112
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=293.01 Aligned_cols=247 Identities=23% Similarity=0.406 Sum_probs=198.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... +++.+++|++.... .....|++++++++||||+++++++.+++..+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 345788999999999999664 67889999986432 3567889999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++...... ....
T Consensus 85 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~ 158 (262)
T cd06613 85 GSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKR 158 (262)
T ss_pred CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhcc
Confidence 99999987652 23889999999999999999999 899999999999999999999999999998765321 1122
Q ss_pred ccccCCCCccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 555 TAVAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .. . ...... ..+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~----~-~~~~~~---~~~~~-- 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF----L-ISKSNF---PPPKL-- 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H-HHhccC---CCccc--
Confidence 345678899999999876 889999999999999999999999965432111 10 0 111100 00111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=293.34 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=197.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|++|.||++.. .+++.+|+|.+.... ..+..|++++++++|||++++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 34568899999999999965 478899999875432 24567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCCCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~~~ 551 (704)
++++|.+++.......+++..+..++.++++||+||| +.+++|+||+|+||+++++ +.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--- 155 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--- 155 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---
Confidence 9999999998765556899999999999999999999 8999999999999999865 46899999999865322
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+..... +...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~--------- 219 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFA--------- 219 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCC---------
Confidence 1223356788999999999888999999999999999999999998654321 11111111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.29 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=198.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|++|.||++... +++.||+|.+.... ..+.+|++++++++||||+++++.+..++..++|+||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34678999999999999765 68999999876542 2457789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.... ..+++..+..++.|++.||+||| + .+++|+||||+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999998653 34889999999999999999999 7 999999999999999999999999999987653211
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+........ +.+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~~--- 225 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRLP--- 225 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCCC---
Confidence 112668889999999999999999999999999999999999996553211 122222222221110 1111
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+..+.+++.+||..+|++||++.|++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1114557899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.09 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=195.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|++|.||+|... +++.||+|+++.... .+..|++++++++|+||+++++++..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 456688999999999999764 688999999864332 466799999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~ 160 (280)
T cd06611 87 GALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKR 160 (280)
T ss_pred CcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cccc
Confidence 99999987643 24899999999999999999999 899999999999999999999999999988654221 1222
Q ss_pred ccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 555 TAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...... ..+.. +.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEP-----PTL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCC-----CCc
Confidence 3456888999999975 345678999999999999999999999654321 111111 11111 111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122334578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.52 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=188.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
|...+.||+|+||.||+|.. .+++.||||++.... ....+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 44568899999999999965 578899999986432 2456799999999999999999987543 4578
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+++|++ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 97 ~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 97 LVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 999988 77999888643 3899999999999999999999 9999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------ 619 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 619 (704)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..+. ......
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~ 241 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIM-EVVGTPSPEVLK 241 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCCHHHHH
Confidence 2 1234568999999999876 568899999999999999999999996543211 111110 000000
Q ss_pred -----C-------cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 620 -----D-------IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 620 -----~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. +.......+.. ........+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000 001123457899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.75 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=192.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... +|+.||+|.++... .....|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345688999999999999664 78999999885321 24567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+ ++|.+++.... ..+++..++.++.||++||.||| +.+++||||||+||+++.++.++|+|||+++.+.... .
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 82 D-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 7 58888876543 23899999999999999999999 8999999999999999999999999999997653221 1
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC------ccccc
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD------IRNIV 625 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 625 (704)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+....... .............. .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 22334578899999998764 46899999999999999999999975433211 11111111100000 00000
Q ss_pred CC----cCCC-----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DP----SLQG-----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~----~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+. .... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000 011123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=294.07 Aligned_cols=246 Identities=22% Similarity=0.392 Sum_probs=196.8
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch----------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..+.||+|++|.||+|.. .+++.||+|++.... ..+..|++++++++|+||+++++++.+++..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 457899999999999964 578999999986422 255779999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIES 549 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~ 549 (704)
|+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++ .++|+|||.+..+....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 84 WMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred ccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999997654 3889999999999999999999 89999999999999998776 59999999987664321
Q ss_pred C--CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 S--DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. ........++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~--------- 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASA--------- 226 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhcc---------
Confidence 1 1112234678899999999888899999999999999999999999964432211 1111111100
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+......+.+++.+|+..+|.+||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111233445568899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=329.38 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=191.7
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 468 (704)
..|.+.+.||+|+||.||++... +++.||+|++... ...+..|+.++.+++||||+++++++.+ ...+++|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 34567889999999999999654 6778999987632 1256779999999999999999998864 3568999
Q ss_pred EeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCceecCCCCCCEEeCCC-----------
Q 037258 469 YEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGC----KPPIVHRDVKSSNILLNEK----------- 531 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~Dlkp~NIll~~~----------- 531 (704)
|||+++|+|.++|.... ...+++..++.|+.||+.||+|||... ..+||||||||+||||+.+
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999997532 235899999999999999999999321 1469999999999999642
Q ss_pred ------CcEEEEeccCccccccCCCCcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037258 532 ------LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAED 603 (704)
Q Consensus 532 ------~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~ 603 (704)
..+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred cccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 35899999999765322 12234578999999999864 4588999999999999999999999964332
Q ss_pred CcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 604 DTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+. .+.... .+. ....+..+.+||..||+.+|.+||++.|++.
T Consensus 249 ----~~qli~-~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 ----FSQLIS-ELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----HHHHHH-HHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111111 111111 110 0122457889999999999999999999984
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=292.72 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=190.6
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEE
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIY 469 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~ 469 (704)
..+.||+|+||.||+|.. .+++.||||.+... ......|++++++++||||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 468899999999999965 46899999987421 11446689999999999999999998764 4678999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++++|.+++..... +++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 86 EHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 99999999999976543 788899999999999999999 8999999999999999999999999999987653211
Q ss_pred C-CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 S-DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. ........
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~--------- 225 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQP--------- 225 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCC---------
Confidence 1 11122345888999999999888999999999999999999999999643211 11 11111100
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0112234455678899999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=297.18 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=194.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+++.+.||+|+||.||++... +++.||+|.++... ..+.+|++++++++|+||+++++.+..++..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456688999999999999765 78999999876421 256679999999999999999999999999999999999
Q ss_pred CCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+++|.+++.... ...+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.++|+|||++..+.. .
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 156 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----S 156 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC----C
Confidence 999999987642 2348999999999999999999993 35999999999999999999999999999876521 1
Q ss_pred ccccccCCCCccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 553 ISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....... ...+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~~~~~~----- 227 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA-IVDGDP----- 227 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH-HhhcCC-----
Confidence 22334578899999998654 34789999999999999999999996533211 1111111 111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1122335567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.70 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|++|.||+|... +++.||+|+++... .....|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456788999999999999765 68899999886432 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+++.+..+..... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 83 ERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 9877776655433 3899999999999999999999 89999999999999999999999999999887643222 1
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh------------cC
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA------------EG 619 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------~~ 619 (704)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. +. ....... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LY-LIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHHhCCCCHHHhhhcccCc
Confidence 22345678899999999888 889999999999999999999999965432111 00 0000000 00
Q ss_pred Ccc--cccCCc----CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIR--NIVDPS----LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~--~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... +..+.. ....++...+.++.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 000112223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.33 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=200.6
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|++|.||+|... +++.|+||++.... ..+..|++.+.+++|+|++++++++..++..++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 35689999999999999765 58999999986542 3667889999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.... .+++..++.++.|+++||+||| + .+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 84 ~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 84 GSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999998653 4899999999999999999999 8 999999999999999999999999999988653222 11
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ ..... ... + ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~-~~~-----~----~~ 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICD-GPP-----P----SL 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhc-CCC-----C----CC
Confidence 22456788999999999889999999999999999999999999665431111111 11111 111 1 11
Q ss_pred Chh-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNN-SAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.. .+..+.+++.+||..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222 45689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.19 Aligned_cols=241 Identities=25% Similarity=0.436 Sum_probs=193.5
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhc---ccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVH---HRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.+.+.||+|+||.||+|.. .+++.||+|.+.... .....|++++++++ |||++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 4467899999999999975 578999999875321 24567888999987 99999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence 9999999998754 4899999999999999999999 9999999999999999999999999999998764222
Q ss_pred cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... .. .....+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~-----~~~~~~~~~ 223 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LI-----PKSKPPRLE 223 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-cc-----ccCCCCCCC
Confidence 22234468889999999875 456899999999999999999999996543211 110 00 000111111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ...+.++.+++.+||+.||++||++.|+++
T Consensus 224 ~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 D---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 114457889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.27 Aligned_cols=240 Identities=30% Similarity=0.486 Sum_probs=191.1
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEE---Ee---cccch--hhHHHHHHHHHhhcccceeEEEEEEEeCCe--EEEEEe
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAV---KM---LSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEGNN--MGLIYE 470 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vav---K~---~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lV~e 470 (704)
|...||+|+|-+||+|-. .+|..||- |. .+... ..+..|+.+|+.|+||||++++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 467899999999999944 46777763 22 22222 367889999999999999999999987654 779999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIES 549 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~ 549 (704)
.|..|+|..|++..+. ++...+..|++||++||.|||.. .++|||||||.+||||+.+ |.+||+|+|+|..+..
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 9999999999988776 88899999999999999999954 7899999999999999864 7999999999988642
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.......|||.|||||++. ..|++..||||||+.++||+|+..||..-.. ..+..++ +..|.....+
T Consensus 199 --s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKK-V~SGiKP~sl---- 265 (632)
T KOG0584|consen 199 --SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKK-VTSGIKPAAL---- 265 (632)
T ss_pred --cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHH-HHcCCCHHHh----
Confidence 2334479999999999887 7899999999999999999999999955432 2222222 2222211111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..-...++++||.+|+.. ..+|||+.|+|+
T Consensus 266 ----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 ----SKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----hccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111234688999999999 999999999996
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=296.89 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=191.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|++|.||+|... +++.||||.+.... .....|++++++++|+||+++++++.+++..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 345688999999999999765 68999999985432 245679999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.+++..... .+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~ 159 (291)
T cd07844 87 T-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KT 159 (291)
T ss_pred C-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--cc
Confidence 5 99998876543 4889999999999999999999 8999999999999999999999999999987542211 11
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---Cccc------
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DIRN------ 623 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 623 (704)
.....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... .........+... ....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122346788999999875 457899999999999999999999996543211 1111011110000 0000
Q ss_pred cc--------CCcCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IV--------DPSLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~--------d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. ...+.... .......+.+++.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0111257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.14 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=197.4
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~ 471 (704)
.+.+.||.|+||.||++.. .+++.||+|++.... .....|++++++++|+||+++++++.. +...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 4567899999999999954 478899999885322 145668999999999999999998764 4568899999
Q ss_pred cCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 472 MASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGC--KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 472 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
+++++|.+++.... ...+++..++.++.|++.||+|||..+ +.+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999997542 345899999999999999999999554 67899999999999999999999999999987642
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .+. .....+..
T Consensus 163 ~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~------ 227 (265)
T cd08217 163 DS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGKF------ 227 (265)
T ss_pred Cc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCCC------
Confidence 22 1123456889999999999888999999999999999999999999654311 111 11111111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...+...+..+.+++.+|++.+|++||++.||++.
T Consensus 228 ---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12233445688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=297.30 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=191.0
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch---hhHHHHHHHHHhh-cccceeEEEEEEEeC-----CeEEEEEee
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---CFQLLQVKLLMRV-HHRNLTALIGYCIEG-----NNMGLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-----~~~~lV~e~ 471 (704)
+.+.||+|+||.||++.. .+++.+|+|++.... .....|+.++.++ +|||++++++++... +..++|+||
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 467899999999999966 478899999986432 2456788899988 899999999998754 358999999
Q ss_pred cCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+++|+|.++++.. ....+++..++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 9999999988642 2345899999999999999999999 8999999999999999999999999999987653211
Q ss_pred CCcccccccCCCCccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLN-----WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
.......++..|+|||.+... .++.++|||||||++|||++|+.||....... .+. .. ........
T Consensus 183 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~----~~-~~~~~~~~ 253 (291)
T cd06639 183 --LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF----KI-PRNPPPTL 253 (291)
T ss_pred --ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH----HH-hcCCCCCC
Confidence 122334678899999998643 36889999999999999999999996543211 111 11 11111111
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. ........+.+++.+||+.+|++||++.|+++.
T Consensus 254 ~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 L-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred C-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 112234578899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.79 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=185.8
Q ss_pred cccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHH---hhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 405 VLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLM---RVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.||+|+||.||++.. .+++.+|+|.+..... ....|..+++ ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4689999998754321 2233333333 3479999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++..... +++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 9999999876543 899999999999999999999 899999999999999999999999999998754321 1
Q ss_pred cccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....|+..|+|||.+. +..++.++|||||||++|||++|+.||.......... ....... ... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~----~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNV----E 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCc----C
Confidence 22346899999999986 4568899999999999999999999996544322111 1111100 111 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
.+...+..+.+++.+||+.||.+|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233456788999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.65 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=196.1
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||++... .++.|++|.+.... .....|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 45688999999999999654 67899999886432 14457889999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC--
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-- 550 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-- 550 (704)
++++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999997654 3889999999999999999999 89999999999999999999999999998864211000
Q ss_pred -----------CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 551 -----------DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 551 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
........++..|+|||.+.+..++.++||||||+++|||++|+.||.+.... ++...... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~-~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS-D 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-c
Confidence 00112245788999999999888999999999999999999999999643321 11221111 1
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.. ..+.. ....+..+.+++.+||+.+|++||++.++.+.|+.-
T Consensus 232 ~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 232 DI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred cc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11 01111 112345688999999999999999977777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.97 Aligned_cols=240 Identities=27% Similarity=0.366 Sum_probs=191.7
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||+||++.. .+|+.||+|.+.... ..+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 478999999885422 1346789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99998766556899999999999999999999 89999999999999999999999999999876532 1222334
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.++..|+|||++.+..++.++||||||+++|+|++|+.||.......... . +.... .. .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~~----~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRRT----LE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhcc----cc------ccccCCccC
Confidence 67889999999988889999999999999999999999996554321110 1 00000 00 011122233
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 638 AWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
+..+.+++.+||+.+|.+|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56788999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.26 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=196.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|++|.||+|.. .+|+.||+|++.... ..+..|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 34568899999999999976 478999999986432 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 999999987544 44899999999999999999999 89999999999999999999999999999987643221 1
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC------------
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------------ 619 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------ 619 (704)
......++..|+|||.+.+. .++.++||||+|+++|||++|..||...... ....++.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22345688899999998754 4689999999999999999998777543321 1111111111100
Q ss_pred CcccccCCcCC----CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 620 DIRNIVDPSLQ----GNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 620 ~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+... .....+....+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00112334788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.67 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=195.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|++|.||++... +++.||+|++.... .....|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345789999999999999654 68999999986432 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 83 VPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999997654 3899999999999999999999 899999999999999999999999999999765322
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... . .......+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~---------- 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q----IYEKILEGKV---------- 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHhcCCc----------
Confidence 23446889999999998888899999999999999999999999654311 1 1111111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+++.+||..+|.+|+ +++|+++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11222345788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.40 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
..||+|+||.||+|... +++.||+|++.... ....+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999654 78999999985322 24567889999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++... .+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..+... ........
T Consensus 107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~ 178 (297)
T cd06659 107 DIVSQT---RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLV 178 (297)
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccccee
Confidence 988653 3889999999999999999999 899999999999999999999999999998754322 12223456
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 638 (704)
++..|+|||++.+..++.++|||||||++|||++|+.||......+ . ... +...... .. .......
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~---~~~-~~~~~~~-----~~--~~~~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A---MKR-LRDSPPP-----KL--KNAHKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HhccCCC-----Cc--cccCCCC
Confidence 8899999999998889999999999999999999999996533211 1 111 1111100 00 0111234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 639 WKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 639 ~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+.+++.+||+.+|++||++.|+++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.96 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=193.6
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+..+.||+|++|.||+|... +++.||||+++... ..+..|++++++++||||+++++++.+++..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 34678999999999999654 78999999886432 246789999999999999999999999999999999996
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.......+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++..+.... ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 68999987765556899999999999999999999 8999999999999999999999999999987653211 11
Q ss_pred cccccCCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc--------------
Q 037258 554 STAVAGTPGYLDPEYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE-------------- 618 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 618 (704)
.....++..|+|||++.+.. ++.++||||||+++|||+||+.||......+ .........-..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22345678999999887644 5889999999999999999999996543211 111111100000
Q ss_pred -CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 -GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 -~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
............ .........+.+++.+||+.||.+||+++|+++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 001122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=297.83 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=194.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+..|+++++.++||||+++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345689999999999999775 58999999875432 24567899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.++...... +++..++.++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++..+.... .
T Consensus 83 ~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 155 (286)
T cd07846 83 DHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 155 (286)
T ss_pred CccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--c
Confidence 99999887765433 899999999999999999999 8999999999999999999999999999987653222 2
Q ss_pred ccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHH-------HHHhcCCc-c
Q 037258 553 ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HISQWVN-------SMLAEGDI-R 622 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~-------~~~~~~~~-~ 622 (704)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .+..+.. .......+ .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233457889999999875 45788999999999999999999998643321100 0000000 00000000 0
Q ss_pred cccCCcCCC-----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQG-----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+.... ......+..+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001233567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.94 Aligned_cols=238 Identities=25% Similarity=0.348 Sum_probs=193.3
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||.|++|.||++... +++.||+|++.... .....|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 58899999986432 2456789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++..... +++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999976543 889999999999999999999 8999999999999999999999999999998764221 22334
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....+. .+....... ......++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc---------cCCCCCCCccc
Confidence 67889999999988889999999999999999999999997654311 111111111 00111222333
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 638 AWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
+..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 568899999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.22 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=194.2
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhh-cccceeEEEEEEEeCC------eEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRV-HHRNLTALIGYCIEGN------NMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------~~~l 467 (704)
.+.+.+.||+|++|.||+|... +++.+++|++.... ..+..|+.+++++ .|+||+++++++.... ..++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 3455789999999999999764 67899999986543 2567799999998 6999999999997644 4899
Q ss_pred EEeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 468 IYEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
||||+++++|.+++.... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 999999999999987543 445899999999999999999999 999999999999999999999999999998764
Q ss_pred ccCCCCcccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
... ........++..|+|||++.. ..++.++|||||||++|+|++|+.||....... .+ .... ...
T Consensus 164 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~-~~~ 234 (275)
T cd06608 164 DST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL----FKIP-RNP 234 (275)
T ss_pred ccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH----HHhh-ccC
Confidence 321 222234568889999998753 346789999999999999999999996432211 11 1111 111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. +.. ......+..+.+++.+||..||++|||+.|+++
T Consensus 235 ~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 P-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 111 112224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.42 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
..||+|+||.||++.. .++..||||.+..... .+..|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999965 4688999998854322 4567899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++...... ........
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~ 179 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLV 179 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCceee
Confidence 998643 3889999999999999999999 899999999999999999999999999998754322 11223456
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 638 (704)
++..|+|||.+.+..++.++||||||+++|||++|+.||....... . +.. ... ...+.... ....+
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~-~~~-----~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MRR-IRD-----NLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHh-----cCCCcccc--ccccC
Confidence 8899999999988889999999999999999999999996533211 1 111 110 11111111 11234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 639 WKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 639 ~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+.+++.+|+..||.+|||++|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 468899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.46 Aligned_cols=245 Identities=21% Similarity=0.355 Sum_probs=196.9
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.+.||+|+||.||++.. .+++.||+|.+.... ..+..|+.++++++|||++++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 445578899999999999964 478899999975322 245778899999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.... +++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 100 ~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~ 171 (293)
T cd06647 100 GGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 171 (293)
T ss_pred CCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--cc
Confidence 999999997543 789999999999999999999 9999999999999999999999999999887653221 12
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||.+.+..++.++||||||+++|++++|+.||.......... .... ........
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~~~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPELQN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCCCCC
Confidence 233468889999999988889999999999999999999999996543321100 0000 00000011
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+.+++.+||..+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22345578899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=289.89 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=194.9
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEeecC
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEYMA 473 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~~~ 473 (704)
+.+.||.|++|.||++.. .+++.+|+|.+.... ....+|++++++++||||+++++++.+. +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 457899999999999976 468899999886432 2567899999999999999999998653 46899999999
Q ss_pred CCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|.+++... ....+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--- 158 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--- 158 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc---
Confidence 99999987642 2344889999999999999999999 899999999999999999999999999998754321
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+....... ...... ....
T Consensus 159 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~-~~~~-- 232 (287)
T cd06621 159 -LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVN-MPNPEL-KDEP-- 232 (287)
T ss_pred -ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhc-CCchhh-ccCC--
Confidence 11234578899999999988999999999999999999999999976533111 11111111111 111111 1000
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||+.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001234567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.59 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|...+.||+|+||.||+|... +++.|++|.++... ..+..|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345688999999999999654 78899999986432 25578899999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++..... +++..+..++.++++||+||| +.+++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 82 SGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999986543 788999999999999999999 9999999999999999999999999999998764322211
Q ss_pred c--cccccCCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 553 I--STAVAGTPGYLDPEYYVLNW---LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 553 ~--~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. .....++..|+|||++.+.. .+.++||||||+++||+++|+.||....... .. ... ...+. .+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~---~~~-~~~~~-----~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QI---MFH-VGAGH-----KP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HH---HHH-HhcCC-----CC
Confidence 1 12356788999999998766 8899999999999999999999996543211 11 111 11110 11
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.. .......+.+++.+||+.+|.+||++.|++.
T Consensus 226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1123557889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.72 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=194.3
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh---------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|++|.||+|... +++.||||.+..... ....|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 45678999999999999754 689999999864422 34568999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+ +|+|.+++.... ..+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 156 (298)
T cd07841 83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN- 156 (298)
T ss_pred cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-
Confidence 99 899999997654 34899999999999999999999 8999999999999999999999999999997653221
Q ss_pred CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---------CC
Q 037258 551 DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---------GD 620 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~ 620 (704)
.......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+ .+.... ..... ..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIF-EALGTPTEENWPGVTS 232 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHH-HHcCCCchhhhhhccc
Confidence 12223356778999998864 467899999999999999999977775433211 111111 10000 00
Q ss_pred cccccCCcCCCC-----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 IRNIVDPSLQGN-----FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
............ .....+..+.+++.+||+.+|++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 112335678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.61 Aligned_cols=243 Identities=27% Similarity=0.375 Sum_probs=187.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHH-HHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKL-LMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|+||.||+|... +|+.||+|+++... .....|+.. ++..+||||+++++++..++..++||||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 35678999999999999664 68999999886432 133445554 566789999999999999999999999997
Q ss_pred CCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 474 SGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 474 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+|.+++.... ...+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+|||++..+...
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 157 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-- 157 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--
Confidence 68988876532 345899999999999999999999 76 9999999999999999999999999998765321
Q ss_pred CcccccccCCCCccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 551 DQISTAVAGTPGYLDPEYYVL----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... .. ........ ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~~~~~~~~-~~----- 225 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQ-QLKQVVEE-PS----- 225 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HH-HHHHHHhc-CC-----
Confidence 12233467889999998864 45688999999999999999999999543221 11 11111111 11
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+... ....+..+.+++.+||..+|.+||++.++++
T Consensus 226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1123457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=290.25 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=189.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+|+++++.++|+||+++++++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 34568899999999999965 478899999985432 145679999999999999999999999999999999996
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.... ..+.+..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||+++..... ...
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 159 (291)
T cd07870 87 -TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQT 159 (291)
T ss_pred -CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CCC
Confidence 68877765443 23778889999999999999999 899999999999999999999999999998754221 111
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh------------cCC
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA------------EGD 620 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------~~~ 620 (704)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .+.+. ...+. ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKI-WTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHH-HHHcCCCChhhhhhhhhccc
Confidence 2334568899999998754 578899999999999999999999965432111 11110 00000 000
Q ss_pred c-ccccCCcCCCCC-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 I-RNIVDPSLQGNF-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~-~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ............ .......+.+++.+|+..||.+|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 000000000000 0012457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.39 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=194.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.+++|.++.... ...+|+.++++++||||+++++++... +..++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 445688999999999999765 688999999864321 346799999999999999999999877 88999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++ +|.+++..... .+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..+....
T Consensus 87 ~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 87 YVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred hcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9975 99998876443 4899999999999999999999 8999999999999999999999999999988664321
Q ss_pred CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh------------
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA------------ 617 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 617 (704)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. +.. +.....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNK-IFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCchHHHHHhhc
Confidence 122334578899999998754 468999999999999999999999965432111 100 000000
Q ss_pred -----cCCcccccCCcCCCCCChh-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 -----EGDIRNIVDPSLQGNFDNN-SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 -----~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111111122222 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.90 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=189.6
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.||+|+||.||++... +++.||+|.+.... .....|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999654 68999999886432 24567888999996 99999999999999999999999864
Q ss_pred CHHHHh---hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 476 TLDQYL---KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 476 sL~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++.++. .......+++..+..++.+++.||+|||+ +.+++||||||+||+++.++.++|+|||++..+... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---I 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC---C
Confidence 655543 32333458999999999999999999993 359999999999999999999999999998765321 1
Q ss_pred ccccccCCCCccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 553 ISTAVAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+..... + ..+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~-----~~~~~ 231 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-G-----DPPIL 231 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-C-----CCCcC
Confidence 12334678899999998865 68999999999999999999999996433 11111111111 1 11122
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
........+.++.+++.+||+.+|++||++.||++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222223456689999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=295.61 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=193.5
Q ss_pred hhhcccccccCceEEEEEEeC---CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 467 (704)
+.+.+.||+|++|.||+|... +++.||+|.+.... .....|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345678999999999999664 47899999987632 2457799999999999999999999988 88999
Q ss_pred EEeecCCCCHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC----CCcEEEEecc
Q 037258 468 IYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE----KLQAKIADFG 540 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~DfG 540 (704)
||||+++ +|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 7777765332 225889999999999999999999 999999999999999999 8999999999
Q ss_pred CccccccCCC-CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-------cHHHH
Q 037258 541 LSRIFSIESS-DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-------HISQW 611 (704)
Q Consensus 541 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-------~~~~~ 611 (704)
++..+..... ........++..|+|||++.+. .++.++|||||||++|||++|+.||......... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986533222 1122345678899999988764 5789999999999999999999999765543210 01111
Q ss_pred HHHHHhc------------CCcccccCCcCCCCCC---------h--hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 612 VNSMLAE------------GDIRNIVDPSLQGNFD---------N--NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 612 ~~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+. .+.. .......+......++ . .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000 0000000000000111 0 23457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=284.62 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=200.0
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEeec
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEYM 472 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~~ 472 (704)
..+.||+|++|.||+|... +++.|++|++.... .....|++++++++|+||+++++.+.+. +..++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4578999999999999765 78999999986543 2567889999999999999999999988 8899999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 84 SGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999998765 4899999999999999999999 8999999999999999999999999999998764332211
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......++..|+|||.+.+...+.++||||||+++++|++|+.||..... .......... ......
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~~ 224 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SGEPPE 224 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cCCCcC
Confidence 23445688899999999988899999999999999999999999966541 1111111110 011112
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+...+..+.+++.+|++.+|.+||++.|+++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 23334568999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.16 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=190.7
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh-----hHHHHHHHHHhhc-ccceeEEEEEEEeC--CeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-----FQLLQVKLLMRVH-HRNLTALIGYCIEG--NNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~e~ 471 (704)
.+.+.||+|+||.||+|.. .+++.||+|+++.... ....|+.++.++. |+|++++++++.++ +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4567899999999999965 4789999999865321 3356888888885 99999999999987 889999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
++ |+|.+.+.... ..+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++..+....
T Consensus 82 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 82 MD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred CC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 97 58888887543 34899999999999999999999 899999999999999999 999999999998653221
Q ss_pred cccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH-----------hcC
Q 037258 552 QISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML-----------AEG 619 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------~~~ 619 (704)
......++..|+|||++. +..++.++|||||||++|||++|+.||......+ ...+..... ...
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence 122345788999999765 4567899999999999999999999996544211 111111111 111
Q ss_pred CcccccCCcCCC----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIRNIVDPSLQG----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.......+.... ......+..+.+++.+||+.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 101000000000 001234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=297.22 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=190.5
Q ss_pred cccccc--CceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKG--GFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
..||+| +||+||++.. .+|+.||+|++.... ..+..|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999965 479999999986432 2446678888889999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc--
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ-- 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-- 552 (704)
|+|.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556899999999999999999999 8999999999999999999999999998654321111100
Q ss_pred ---ccccccCCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-------------
Q 037258 553 ---ISTAVAGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS------------- 614 (704)
Q Consensus 553 ---~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~------------- 614 (704)
......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence 01112345679999999764 47899999999999999999999996543211 11110000
Q ss_pred -------------------HHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 615 -------------------MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 615 -------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000111111111223345678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=283.05 Aligned_cols=243 Identities=25% Similarity=0.445 Sum_probs=198.3
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
...+.||+|++|.||++... +++.+++|++.... ....+|++++++++|+|++++++++..+...++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34578999999999999765 78899999986554 36678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.... ..+++..+..++.|++.||++|| ..+++||||+|+||++++++.++|+|||.+........ ..
T Consensus 83 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 83 SLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred cHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9999998753 34899999999999999999999 89999999999999999999999999999877643221 34
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ........ ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~-------~~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIAT-NGPPGLRN-------PE 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHh-cCCCCcCc-------cc
Confidence 4568889999999998889999999999999999999999986543211 1111111 11111111 11
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12457899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.83 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=193.8
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.||+|++|.||+|.. .+|+.||+|++.... ..+..|++++++++|+|++++++++.+++..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 457899999999999965 479999999886332 246779999999999999999999999999999999995
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.......+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++..+.... ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~ 156 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTY 156 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--ccc
Confidence 69999998766455899999999999999999999 8999999999999999999999999999997653221 112
Q ss_pred ccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-----------C--
Q 037258 555 TAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG-----------D-- 620 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------~-- 620 (704)
....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+........... .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 233568899999988754 56899999999999999999999996543211 1111111000000 0
Q ss_pred --cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 --IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 --~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......... .......+..+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0111233457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.47 Aligned_cols=240 Identities=29% Similarity=0.433 Sum_probs=191.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+..|+++++.++||||+++++++.+++..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 455688999999999999664 68999999875321 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+. |+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 97 57877775433 24899999999999999999999 89999999999999999999999999999875421
Q ss_pred cccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....++..|+|||++. ...++.++||||||+++|||++|+.||....... .... ...... +.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~-----~~ 233 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNDS-----PT 233 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCCC-----CC
Confidence 12345788999999874 4568899999999999999999999986543211 0111 111100 11
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. .....+..+.+++.+||+.+|++||++.+++..
T Consensus 234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 112345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.88 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=197.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|+||.||+|... +|..||+|.+... ......|++++++++|+||+++++.+..+...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45688999999999999664 6889999998542 2245689999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~ 552 (704)
+++|.+++.......+++..+..++.|+++||.||| +.+++|+||||+||++++++ .++|+|||.+...... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 999999998765556899999999999999999999 89999999999999999885 4699999998765322 12
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..+++..... +... +
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~----~----- 221 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFA----P----- 221 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCC----C-----
Confidence 2233468889999999988889999999999999999999999985432 1222222221 1111 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....+..+.+++.+|+..+|++|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=290.15 Aligned_cols=244 Identities=24% Similarity=0.394 Sum_probs=197.8
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.+.+.||+|++|.||+|... +++.|++|++.... ..+..|++++++++|+|++++++++...+..++|+||+++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 34578999999999999776 68899999987543 356789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~ 175 (286)
T cd06614 102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNS 175 (286)
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhcc
Confidence 999998765 34899999999999999999999 8999999999999999999999999999886543221 12233
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ........ ....
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~-------~~~~ 241 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLIT-TKGIPPLK-------NPEK 241 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCCCCc-------chhh
Confidence 457889999999998889999999999999999999999986433211 111111 11111100 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+..+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.95 Aligned_cols=240 Identities=21% Similarity=0.349 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.+.||+|++|.||++.. .+++.+++|++.... ....+|+.+++.++|+||+++++++..++..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999965 478899999875322 2456789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++... .+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+....... ......
T Consensus 104 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 175 (285)
T cd06648 104 TDIVTHT---RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSL 175 (285)
T ss_pred HHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccc
Confidence 9999873 3889999999999999999999 8999999999999999999999999999887543221 122335
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .... +... .....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~-~~~~-----~~~~--~~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIR-DNLP-----PKLK--NLHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHH-hcCC-----CCCc--ccccC
Confidence 688999999999988899999999999999999999999865332 11111111 1110 1111 11123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..+.+++.+||+.+|++||++.|+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.82 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=204.0
Q ss_pred CHHHHHHHHhhhcccccccCceEEEEE-EeCCCcEEEEEecccch----hhHHHHHHHHHhh-cccceeEEEEEEEeCCe
Q 037258 391 AYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNN 464 (704)
Q Consensus 391 ~~~el~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 464 (704)
++.|+.+.|. +.||+|+++.|-.+ ...+|.++|||++.+.. ....+|++++.+. .|+||++++++|+++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 4567766665 78999999999988 67789999999997543 3668899999988 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEeccC
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGL 541 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGl 541 (704)
+|||||-|.||+|..+|+.+.. +++.++.++.++|+.||.+|| .+||.|||+||+|||..+.. -+||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 9999999999999999987665 999999999999999999999 99999999999999997665 489999988
Q ss_pred ccccccCC-----CCcccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-cc----
Q 037258 542 SRIFSIES-----SDQISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD-TT---- 606 (704)
Q Consensus 542 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~-~~---- 606 (704)
..-+.... .........|+..|||||+.. ...|+.++|.||||||+|-|+.|.+||.+.=..+ +.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 75442211 122233567888999999874 3478999999999999999999999997643211 11
Q ss_pred ---cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 607 ---HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 607 ---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.-.+..-..+++|... ++..-....+.+..+++...+..|+.+|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0111111223333221 111122456778899999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.56 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=197.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||.|+||.||+|... +++.||+|++... ......|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345789999999999999765 6899999988643 22567789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 9999999999765 34889999999999999999999 8999999999999999999999999999987653221
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..+....... ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------ADV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------ccc
Confidence 2234567889999999998889999999999999999999999997654321 1111111111 011
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM--TDVL 663 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 663 (704)
..+...+..+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1223344688899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.49 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=194.2
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~ 471 (704)
.+.+.||+|++|.||+|... +++.+|+|++.... ..+..|++++++++|+|++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 34678999999999999765 58899999987542 2456799999999999999999999988 889999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 82 MDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred ccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 975 8998887653 34899999999999999999999 89999999999999999999999999999987643221
Q ss_pred cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc---CCcccc---
Q 037258 552 QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE---GDIRNI--- 624 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 624 (704)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+...... ......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 12233456788999998765 4578999999999999999999999965443211 1111111100 000000
Q ss_pred -----------cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 -----------VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 -----------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.97 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=186.7
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHH-HHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKL-LMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|++|.||+|.. .+++.||+|++..... ....|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999965 4689999999865321 12333333 3445899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997654 3889999999999999999999 89999999999999999999999999999875421 2
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....++..|+|||.+.+..++.++||||||+++|||++|..||...... ..... ...+... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDN-ILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhcccC------CCCccc
Confidence 2345788999999999888899999999999999999999999654321 11111 1111110 011111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
...+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23456789999999999999999876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=287.42 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=185.6
Q ss_pred cccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHH---HHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 405 VLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQV---KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.||+|+||.||+|.. .+++.||+|.+..... ....|. +.++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 4688999998754321 122333 33444579999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 999999987543 4899999999999999999999 899999999999999999999999999998755321 1
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... ...... ....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~---- 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVE---- 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCC----
Confidence 2234689999999998754 688999999999999999999999976533221111 011100 1111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.+...+..+.+++.+|+..+|.+|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222356789999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.31 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=204.6
Q ss_pred cCHHHHHHHHhhh---cccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEE
Q 037258 390 FAYSEIQKITNNF---ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 390 ~~~~el~~~~~~~---~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
+.+-|.+..+.+- -++||+||||.||.+.. .+|+.+|.|.+.+... -...|-++|.+++.+.||.+--.
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 3444444444332 57999999999999954 4799999998754332 45778999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
|+..+.+++|+..|.||+|.-+|.+.....+++..+.-++.+|+.||++|| +.+||.||+||+|||+|+.|+++|+|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeec
Confidence 999999999999999999999998888777999999999999999999999 99999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
+|+|..+. ........+||.+|||||++.++.|+...|-||+||++|||+.|+.||....+..... -+.+....
T Consensus 331 LGLAvei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~ 404 (591)
T KOG0986|consen 331 LGLAVEIP---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLE 404 (591)
T ss_pred cceEEecC---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhc
Confidence 99998764 3334445689999999999999999999999999999999999999996544322110 01111111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
-...+++..++++.+|.+..|+.||.+|..-.
T Consensus 405 ----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 ----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ----------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11234555667899999999999999997543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.24 Aligned_cols=242 Identities=29% Similarity=0.407 Sum_probs=191.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+...+.||+|+||.||+|.. .+++.||+|++.... ..+..|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 34467899999999999965 468899999985321 1456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+ +|.+.+.... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 974 8888776443 34899999999999999999999 89999999999999999999999999998865421
Q ss_pred cccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||....... . .......+.
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~----~~~~~~~~~-------- 241 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----LYHIAQNES-------- 241 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--H----HHHHHhccC--------
Confidence 22346788999999974 4568899999999999999999999986542111 1 111111110
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
........+..+.+++.+||+.+|.+||++.|+++.+-
T Consensus 242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00111234457899999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.75 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=193.3
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||.||++... +|+.+++|++..... ....|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999776 589999999864432 456788999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC------C
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS------D 551 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~------~ 551 (704)
.+++.... .+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998654 4899999999999999999999 89999999999999999999999999999875432211 1
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......++..|+|||.......+.++||||||+++|||++|+.||...... ........ +... ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~------~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKIE------WPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCcC------CCc
Confidence 1223456788999999998888899999999999999999999999654321 11111111 1110 000
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
....+..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0112567889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.05 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=189.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC--------e
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN--------N 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~ 464 (704)
+.+.+.||+|+||.||+|... +++.||||.+.... ....+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 456789999999999999654 68999999875322 13457999999999999999999987654 4
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 5999999975 8888876543 24899999999999999999999 89999999999999999999999999999976
Q ss_pred cccCCCC--cccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 545 FSIESSD--QISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 545 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+.........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6322211 112234577889999988764 4688999999999999999999998654432111111111100000000
Q ss_pred ccc-----cCC-cCCCCC---------ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 RNI-----VDP-SLQGNF---------DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ~~~-----~d~-~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .+. ...... .......+.+++.+||..||.+|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000 000000 0011345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=329.74 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=198.0
Q ss_pred cccccccCceEEEEE-EeCCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
..+||.|.||.||-| ..++|+..|+|-++-. .....+|..++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 468999999999999 5678999999976422 225578999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC--Ccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS--DQI 553 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~--~~~ 553 (704)
+|.+.+...+- .++.....+..|++.|+.||| ++|||||||||.||+++.+|.+|++|||.|..+..... ...
T Consensus 1320 sLa~ll~~gri--~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1320 SLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999987653 566666778899999999999 99999999999999999999999999999988753321 122
Q ss_pred cccccCCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-HHHhcCCcccccCCcC
Q 037258 554 STAVAGTPGYLDPEYYVLNW---LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN-SMLAEGDIRNIVDPSL 629 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l 629 (704)
.....||+.|||||++.+.. -.-++||||+|||++||+||+.||...+.+ |.. -.+..|..
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~-------- 1459 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK-------- 1459 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC--------
Confidence 34578999999999998543 457899999999999999999999766542 221 22233332
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.+++..+.+-.+++.+||+.||++|+++.|+++.
T Consensus 1460 -Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 23455577788999999999999999999877753
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=288.39 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=193.7
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|++|.||+|... +|+.||||+++... .....|++++++++|+||+++++++.+.+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 45688999999999999764 68999999886432 2456799999999999999999999999999999999985
Q ss_pred CCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++....... ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~ 156 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NT 156 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cc
Confidence 8988887544 345899999999999999999999 8999999999999999999999999999997653211 11
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----------HHhcCCc
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS-----------MLAEGDI 621 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-----------~~~~~~~ 621 (704)
.....++..|++||++.+. .++.++||||||+++|+|++|+.||......+. ....... .......
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCchh
Confidence 2234568899999988654 568899999999999999999999976543211 1110000 0000000
Q ss_pred ccccCCcC---CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 RNIVDPSL---QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
........ ........+..+.+++.+|++.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00011223457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.11 Aligned_cols=239 Identities=25% Similarity=0.395 Sum_probs=202.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|.|+.|.+|.+ .++..||||.+.+... ...+|++++..++|||||+++.+.+....+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 44578999999999999965 4799999999876543 4578999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
.+|.+++++....+ ..+..+..++.|+.+|++|+| ++.|||||||++||||+.++++||+|||++..+. ...
T Consensus 138 ~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~ 209 (596)
T KOG0586|consen 138 SGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGL 209 (596)
T ss_pred cCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---ccc
Confidence 99999999988776 666888999999999999999 9999999999999999999999999999998874 345
Q ss_pred ccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.+ .-++.+.+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl~g 270 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVLRG 270 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchheee
Confidence 5667889999999999998765 589999999999999999999997654322 11111222
Q ss_pred CC--ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NF--DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+ +.....++.++++++|..+|.+|++++++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 22234467799999999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=290.71 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=191.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|++|.||+|... +++.||+|.+.... ..+..|++++++++|+||+++++++.+++..++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345678999999999999764 78999999885432 24567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccccCCCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~~~ 551 (704)
+ ++|.+++.......+++..+..++.||+.||+||| +.+++|+||+|+||+++. ++.+||+|||++...... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~ 157 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--V 157 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--c
Confidence 6 58888887655545688889999999999999999 899999999999999985 557999999999764321 1
Q ss_pred cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc-----
Q 037258 552 QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV----- 625 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 625 (704)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+ .+.... ...... .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTP-NEETWPGVTS 233 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCC-Chhhcccccc
Confidence 11233456889999998876 457899999999999999999999996543211 111100 000000 00000
Q ss_pred --C-----CcCCC----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 --D-----PSLQG----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 --d-----~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ +.... ......+.++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 011223456889999999999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.66 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=201.4
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCC------eEEEEEe
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGN------NMGLIYE 470 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~e 470 (704)
.+.||+|+||.||+|+ ..+|+.||||.+... .....+|+++|++++|+|||++++.-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 5789999999999997 568999999998653 235678999999999999999999866543 5679999
Q ss_pred ecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CCC--cEEEEeccCcccc
Q 037258 471 YMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EKL--QAKIADFGLSRIF 545 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DfGla~~~ 545 (704)
||.+|||...|..-. ...+++.+.+.+..+++.||.||| .++|+||||||.||++- ++| .-||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999998654 345999999999999999999999 99999999999999983 334 4699999999987
Q ss_pred ccCCCCcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
++ ........||..|.+||.+. .+.|+..+|.|||||++||++||..||..........-..|....-....+...
T Consensus 175 ~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 43 33667889999999999999 588999999999999999999999999765543221112222111111111111
Q ss_pred cCCcCCC------------CCChhHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHhhhhhh
Q 037258 625 VDPSLQG------------NFDNNSAWKAVELALACASHTSSERP--TMTDVLMELKECLSLE 673 (704)
Q Consensus 625 ~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~~ 673 (704)
..+...+ .........+-..+..+|..+|.+|. ...+....+..++...
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 1111111 11223344566788888899999999 7667766666666543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=314.18 Aligned_cols=262 Identities=18% Similarity=0.228 Sum_probs=184.0
Q ss_pred HHhhhcccccccCceEEEEEEeCC--CcEEEEE------------------ecccc---hhhHHHHHHHHHhhcccceeE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDD--NQQVAVK------------------MLSSS---CCFQLLQVKLLMRVHHRNLTA 454 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~---~~~~~~E~~~l~~l~h~nIv~ 454 (704)
..|.+.+.||+|+||.||++.... +..+++| .+... ...+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 456678999999999999985432 2222222 11111 124568999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 455 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
+++++...+..++|+|++. ++|.+++.... ........+..++.|++.||+||| +++|+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 9999999999999999985 57877775432 112345677889999999999999 8999999999999999999
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CCCcccHHH
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA-EDDTTHISQ 610 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~-~~~~~~~~~ 610 (704)
+.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||++|+.++.... ......+.+
T Consensus 304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999876322 2222334678999999999999999999999999999999999886543322 221112221
Q ss_pred HHHHHH-hcCCcc-------cccCCc-C---CCCC-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 611 WVNSML-AEGDIR-------NIVDPS-L---QGNF-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 611 ~~~~~~-~~~~~~-------~~~d~~-l---~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.... ....+. +.++.. . .... .......+.+++.+||+.||.+|||+.|+++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111000 000000 000000 0 0000 0012345678899999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=293.63 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=191.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +|+.||+|+++.... ...+|+.++++++|+||+++++++.+. +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 345678999999999999764 689999999863321 345799999999999999999998765 56899999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+.+ +|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 89 YCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred cCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 9975 8988887543 34899999999999999999999 8999999999999999999999999999998764221
Q ss_pred CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC--Cc-c----
Q 037258 551 DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG--DI-R---- 622 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~-~---- 622 (704)
.......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ....+....... .. .
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhc
Confidence 11223345778999999875 457899999999999999999999996543221 111111111000 00 0
Q ss_pred ----ccc--CCcCCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 ----NIV--DPSLQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 ----~~~--d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
... ........ ....+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000 01135677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.59 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.-.||.|+||.||+|..+ .+-..|-|++..... ++..|+++|..+.||+|+++++.|...+.++++.|||.||-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 356899999999999654 444566787754433 667899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
+..+-.-. ..+.+.++..+++|++.||.||| +.+|||||||+.|||++-+|.++|+|||.+... .........+
T Consensus 117 DaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRDsF 190 (1187)
T KOG0579|consen 117 DAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRDSF 190 (1187)
T ss_pred hHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc--hhHHhhhccc
Confidence 88876544 34999999999999999999999 999999999999999999999999999988643 2223344568
Q ss_pred cCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 558 AGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 558 ~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.||+.|||||+.. ..+|+.++||||||++|.||..+.+|......- ..+.. +....- |.+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllK-iaKSeP-----PTLl-- 256 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEP-----PTLL-- 256 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHH-HhhcCC-----Cccc--
Confidence 9999999999976 568999999999999999999999997554321 11111 111111 1111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
-+...+..+.+++.+||..||..||++.++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 13344567889999999999999999999974
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=290.17 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=189.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhc-ccceeEEEEEEEeCCe-----EE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVH-HRNLTALIGYCIEGNN-----MG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~-----~~ 466 (704)
+...+.||+|+||.||+|... +++.||||.++... .....|+.+++.++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999754 78999999875432 24577999999995 6999999999987665 89
Q ss_pred EEEeecCCCCHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCc
Q 037258 467 LIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLS 542 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla 542 (704)
+||||+++ +|.+++.... ...+++..++.++.||++||+||| +.+++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 8988886543 235899999999999999999999 899999999999999998 889999999998
Q ss_pred cccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD- 620 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 620 (704)
..+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..... .+....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~ 233 (295)
T cd07837 159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLGTPTE 233 (295)
T ss_pred eecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhCCCCh
Confidence 76532211 1123356788999998865 457899999999999999999999996543211 1111110 000000
Q ss_pred --cccccC-------CcCC----CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 --IRNIVD-------PSLQ----GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 --~~~~~d-------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...... +... .......+.++.+++.+||..+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0001234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.38 Aligned_cols=234 Identities=21% Similarity=0.292 Sum_probs=185.0
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhc
Q 037258 406 LGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKG 483 (704)
Q Consensus 406 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 483 (704)
||+|+||.||++.. .+++.+|+|.+...... ..|+.....+ +|+||+++++++..++..++||||+++|+|.+++..
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~ 102 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK 102 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh
Confidence 59999999999965 47888999998654221 1233333222 799999999999999999999999999999999986
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCcccccccCCCC
Q 037258 484 KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQISTAVAGTPG 562 (704)
Q Consensus 484 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~gt~~ 562 (704)
.. .+++..+..++.|+++||+||| +.+++||||||+||+++.++ .++|+|||++...... ....++..
T Consensus 103 ~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~ 171 (267)
T PHA03390 103 EG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLD 171 (267)
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCc
Confidence 64 4899999999999999999999 89999999999999999998 9999999998765321 22457889
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHH
Q 037258 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAV 642 (704)
Q Consensus 563 y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 642 (704)
|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... ... .......+..+.
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~----------~~~~~~~~~~~~ 238 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QKK----------LPFIKNVSKNAN 238 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--ccc----------CCcccccCHHHH
Confidence 999999998889999999999999999999999997443322 1222222111 000 011123456789
Q ss_pred HHHHhccCCCCCCCCC-HHHHHH
Q 037258 643 ELALACASHTSSERPT-MTDVLM 664 (704)
Q Consensus 643 ~li~~cl~~dP~~RPs-~~evl~ 664 (704)
+++.+||+.+|.+||+ ++|+++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 9999999999999996 588874
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=284.30 Aligned_cols=242 Identities=26% Similarity=0.415 Sum_probs=197.7
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||++.. .+++.+++|.+.... .....|++++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 4567899999999999954 478899999986432 145678899999999999999999999999999999999
Q ss_pred CCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 999999987632 345899999999999999999999 999999999999999999999999999999876432
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .+. .....+...
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR----YKVQRGKYP--------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCCCC---------
Confidence 222345788999999999988999999999999999999999999654321 111 111111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
........++.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1223445679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.87 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=192.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 467 (704)
+.+.+.||+|+||.||+|.. .+++.||+|.+... ...+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 34578999999999999965 46899999986421 11456789999999999999999998764 46889
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|+||+++++|.+++..... +++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 9999999999999976543 788999999999999999999 89999999999999999999999999999976532
Q ss_pred CCC-CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESS-DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. +.......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IFKIATQP------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HHHHHcCC-------
Confidence 111 11122356888999999999888999999999999999999999999643211 11 11111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+......+.+++.+|+. +|..||++.+++.
T Consensus 226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112234455678999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.30 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=191.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
+...+.||+|+||.||+|.. .+++.||+|++... ......|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 44568999999999999965 47899999998632 12455799999999999999999988643 3579
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+.+ +|.+.+... +++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 98 lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 98 LVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 99999964 888887643 788999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cH--------HHH------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HI--------SQW------ 611 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~--------~~~------ 611 (704)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+ .++
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 170 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 21 1223346788999999999999999999999999999999999999654321100 00 000
Q ss_pred -HHHHHhcCC------cccccCCcC----CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 612 -VNSMLAEGD------IRNIVDPSL----QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 612 -~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
......... +.+...... ........+..+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 001111000 000112345678899999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.47 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=181.4
Q ss_pred HhhhcccccccCceEEEEEEeCC----CcEEEEEecccchhhH---------------HHHHHHHHhhcccceeEEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSCCFQ---------------LLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~---------------~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
.+.+.++||+|+||.||+|...+ +..+|+|+........ ..+...+..+.|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 45667899999999999997654 4566777643222111 1122334456899999999977
Q ss_pred EeCC----eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEE
Q 037258 460 IEGN----NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535 (704)
Q Consensus 460 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 535 (704)
.... ..++++|++.. ++.+.+..... .++..+..++.|++.||+||| +.+|+||||||+|||++.++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eEecCCceEEEEEEehhcc-CHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 6543 34677787643 67776654332 578888999999999999999 89999999999999999999999
Q ss_pred EEeccCccccccCCCC-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cH-
Q 037258 536 IADFGLSRIFSIESSD-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HI- 608 (704)
Q Consensus 536 L~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~- 608 (704)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999876322111 1122346999999999999999999999999999999999999999765322110 00
Q ss_pred -HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 609 -SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 609 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
.++... +..+.. . ....+..+.+++..|++.+|++||++.++++.|
T Consensus 247 ~~~~~~~-~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKR-LHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHH-hhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111 111111 0 112245788999999999999999999999876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.19 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=191.5
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC--------
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN-------- 463 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 463 (704)
.+.+.+.||+|+||.||+|... +++.||+|+++... .....|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 4456789999999999999765 68899999986432 14467899999999999999999987654
Q ss_pred --eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 464 --NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 464 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999986 7777776542 34899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG- 619 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 619 (704)
+..+..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.. +.......
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~-~~~~~~~~~ 238 (302)
T cd07864 163 ARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLEL-ISRLCGSPC 238 (302)
T ss_pred cccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-HHHHhCCCC
Confidence 986632221 12223345778999998864 35789999999999999999999999653321 11111 11111110
Q ss_pred --Cccccc--------CC------cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 --DIRNIV--------DP------SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 --~~~~~~--------d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+. +. ..... ....+..+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00 00000 1123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=283.72 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=192.7
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhh---cccceeEEEEEEEeCCe-----E
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRV---HHRNLTALIGYCIEGNN-----M 465 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----~ 465 (704)
.+.+.||+|+||.||+|... +++.||+|+++... .....|+.+++++ .|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 35678999999999999876 58999999986321 1345677777666 59999999999988776 9
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
+++|||+.+ +|.+++.......+++..++.++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++..+
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999975 8999987755445899999999999999999999 899999999999999999999999999999775
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc--c-
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI--R- 622 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~- 622 (704)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..+.......... .
T Consensus 158 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 158 SFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 3221 1123347889999999999899999999999999999999999986543221 111111111000000 0
Q ss_pred ------cccCCcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 ------NIVDPSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
........ ..........+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.10 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=192.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV 468 (704)
+.+.+.||+|+||.||+|.. .+|+.||||+++... .....|+.++++++|+||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 44578999999999999964 578999999986321 2456799999999999999999987654 357999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+||+.+ +|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 87 QELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 999975 888887653 3899999999999999999999 999999999999999999999999999998765322
Q ss_pred CCC-cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---ccc
Q 037258 549 SSD-QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRN 623 (704)
Q Consensus 549 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~ 623 (704)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+...+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHH
Confidence 111 11233567899999998764 568899999999999999999999996533211 1111111111000 000
Q ss_pred ccCCc-------CC--CC-----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhhh
Q 037258 624 IVDPS-------LQ--GN-----FDNNSAWKAVELALACASHTSSERPTMTDVLME--LKECL 670 (704)
Q Consensus 624 ~~d~~-------l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 670 (704)
+.+.. .. .. .....+.++.+++.+||+.+|++||++.|+++. ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 00 00 001234578899999999999999999999985 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.11 Aligned_cols=243 Identities=29% Similarity=0.428 Sum_probs=199.0
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||++... +++.|++|++.... .....|++++++++|+|++++++.+..++..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 45678999999999999664 68899999986432 245778999999999999999999999999999999999
Q ss_pred CCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|.+++.... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999998753 355899999999999999999999 8899999999999999999999999999997653221
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......++..|+|||.+.+..++.++||||+|+++++|++|+.||..... ......... ....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~--------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQYP--------- 221 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCCC---------
Confidence 223345688899999999988899999999999999999999999854431 111222111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+..+.+++.+||..+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112234457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=288.34 Aligned_cols=256 Identities=19% Similarity=0.254 Sum_probs=190.3
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.+.+|.|+++.||++.. +++.||||++.... .....|++++++++|+||+++++++.+++..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666554 68999999975431 256788999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC-----C
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-----D 551 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-----~ 551 (704)
|.+++.......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||.+..+..... .
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999998765555889999999999999999999 89999999999999999999999999998875532111 1
Q ss_pred cccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH----hcC------
Q 037258 552 QISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML----AEG------ 619 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~----~~~------ 619 (704)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+...... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 11223456778999999875 357899999999999999999999997543211 1111111000 000
Q ss_pred -Cccc----ccCCc----CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 -DIRN----IVDPS----LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 -~~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... ..++. ...........++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000 001112334567889999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.09 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=194.5
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||+|... +++.|+||++..... ...+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999775 578999999764322 3456888999999 999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++.......+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++...... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 789999998765455899999999999999999999 899999999999999999999999999999765321 11
Q ss_pred cccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc-H---------HHHHHHHHhcCCcc
Q 037258 554 STAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH-I---------SQWVNSMLAEGDIR 622 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~-~---------~~~~~~~~~~~~~~ 622 (704)
.....++..|+|||++. ...++.++||||||++++||++|+.||......+... . ..|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23345788999999885 4567899999999999999999999996554321100 0 00111110001111
Q ss_pred cccCCcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+..... ..........+.+++.+||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001112467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.35 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=199.9
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhh-cccceeEEEEEEEeC----CeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYCIEG----NNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~lV~e~~~~gsL 477 (704)
++||-|-.|.|-.+.. .+++.+|+|++... ....+|+++--.. .|||||.++++|+.. ..+.+|||.|+||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeL 146 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGEL 146 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHH
Confidence 7899999999999854 47899999999743 4567788875554 699999999998743 457799999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
.+.++.++...+.+.++..|+.||..|+.||| +.+|.||||||+|+|... +-.+||+|||+|+.-. .....
T Consensus 147 fsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~---~~~~L 220 (400)
T KOG0604|consen 147 FSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ---EPGDL 220 (400)
T ss_pred HHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC---CCccc
Confidence 99999998888999999999999999999999 999999999999999964 4469999999998532 23445
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
.....|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +..-++..+..+.. .+.....
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy------~FP~pEW 291 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQY------EFPEPEW 291 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCc------cCCChhH
Confidence 56778999999999999999999999999999999999999997765421 11122333333321 1112223
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...++...++|+.+|..+|.+|.|+.|+++
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 466788999999999999999999999985
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=295.59 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=192.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhh-cccceeEEEEEEEeC--CeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRV-HHRNLTALIGYCIEG--NNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~lV 468 (704)
.+.+.+.||+|+||.||+|... +++.+|+|++... ......|+.+++++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 3455789999999999999764 6889999987432 12456799999999 999999999998653 468999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||++ ++|.+++... .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++..+...
T Consensus 88 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 88 FEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99997 5999988765 4889999999999999999999 899999999999999999999999999999866432
Q ss_pred CCC---cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH--------
Q 037258 549 SSD---QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML-------- 616 (704)
Q Consensus 549 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 616 (704)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHH
Confidence 211 22234568899999998764 4678899999999999999999999965432211 00000000
Q ss_pred ---hcCCcccccC----CcC--CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 617 ---AEGDIRNIVD----PSL--QGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 617 ---~~~~~~~~~d----~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.......+++ ... ........+.++.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 000 000111245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.89 Aligned_cols=254 Identities=25% Similarity=0.317 Sum_probs=191.6
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccchh------------------hHHHHHHHHHhhcccceeEEEEEEEeC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------------------FQLLQVKLLMRVHHRNLTALIGYCIEG 462 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~~~~~~~ 462 (704)
+.+.||+|+||.||+|... +++.||||+++.... ....|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3577999999999999654 789999998754321 246799999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 463 NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 463 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
+..++||||+. |+|.+++..... +++.....++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccce
Confidence 99999999997 599999875443 899999999999999999999 899999999999999999999999999998
Q ss_pred cccccCC------------CCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 037258 543 RIFSIES------------SDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS 609 (704)
Q Consensus 543 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 609 (704)
....... .........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~ 243 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QL 243 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 7653111 01111223467889999998764 46899999999999999999999996554321 11
Q ss_pred HHHHHHHhcCC---ccccc--------CCcCCC---CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 610 QWVNSMLAEGD---IRNIV--------DPSLQG---NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 610 ~~~~~~~~~~~---~~~~~--------d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+........ +.... ...... ......+..+.+++.+||+.+|++||+++|++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111100 00000 000000 001123457889999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.29 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
..||+|+||.||++.. .+++.||||++.... .....|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6799999999999966 478999999875322 24567899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
+++... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 988643 2789999999999999999999 8999999999999999999999999999887653221 1223356
Q ss_pred CCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHH
Q 037258 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638 (704)
Q Consensus 559 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 638 (704)
++..|+|||.+.+..++.++||||||+++|||++|+.||....... .... .... ..+.+.. ....+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~----~~~~-----~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDN-----LPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhh-----CCcccCC--cccCC
Confidence 7889999999988888999999999999999999999986533211 1111 1110 0111110 11234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 639 WKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 639 ~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+.+++.+||+.+|.+||++.|+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 46789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=288.21 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=194.8
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
..+.||+|++|.||+|... +++.+++|.+..... ....|++++++++|+||+++++++..++..++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4578999999999999664 789999998864432 456789999999999999999999999999999999975
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
+|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+....... ...
T Consensus 83 -~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 83 -DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred -CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 8988887643 34899999999999999999999 8999999999999999999999999999987664322 122
Q ss_pred ccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---CcccccC----
Q 037258 555 TAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DIRNIVD---- 626 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---- 626 (704)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. + ......+... ......+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--L-FKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHcCCCchHhcccchhhhhh
Confidence 334578899999998876 789999999999999999999999965442111 0 0011110000 0000000
Q ss_pred -------CcCC--CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 -------PSLQ--GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 -------~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... .......+.++.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0111234668999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=279.47 Aligned_cols=241 Identities=26% Similarity=0.413 Sum_probs=196.9
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||++... +++.|++|.+..... ....|++++++++|+|++++++++.+++..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 45688999999999999654 678999999865432 45788999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (254)
T cd06627 83 NGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--D 155 (254)
T ss_pred CCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--c
Confidence 999999997653 4899999999999999999999 99999999999999999999999999999987642221 1
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ... ..... ... ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~-~~~---------~~~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AAL-FRIVQ-DDH---------PPL 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHH-HHHhc-cCC---------CCC
Confidence 23456788999999998888899999999999999999999998643311 111 11110 100 112
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+...+..+.+++.+||..+|++||++.|++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2233557889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.78 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=192.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV 468 (704)
+.+.+.||+|++|.||+|.. .+++.||+|++.... .....|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 34467899999999999965 468999999986532 245678999999999999999988763 3568999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+||+. |+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 87 ~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 87 MDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred Eehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99996 599999875543 899999999999999999999 899999999999999999999999999999765322
Q ss_pred CC--CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh--------
Q 037258 549 SS--DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA-------- 617 (704)
Q Consensus 549 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 617 (704)
.. ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVLN 237 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhhh
Confidence 21 112234568889999999865 4688999999999999999999999965432111 011110000
Q ss_pred ---cCCcccccCC-cCCCC-----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 ---EGDIRNIVDP-SLQGN-----FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ---~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+....+. ..... .....+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 00000 01223567999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=283.40 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=192.0
Q ss_pred hhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.||+|+||.||++.. .+|+.||+|++.... .....|++++.++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999965 478999999986432 2456789999999 59999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 83 ILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999997654 3888999999999999999999 89999999999999999999999999999976532
Q ss_pred CCCCcccccccCCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.. ........|+..|+|||.+... .++.++||||||+++|+|++|+.||....... ....+........
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~------ 228 (290)
T cd05613 158 DE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE------ 228 (290)
T ss_pred cc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC------
Confidence 21 1222235688899999998753 46789999999999999999999996432211 1222222211111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
+ .++......+.+++.+||+.+|++|| ++.+++.
T Consensus 229 -~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 11223345788999999999999997 6666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=284.86 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=196.0
Q ss_pred hhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.||+|++|.||++.. .+++.||||+++... ..+..|++++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4568899999999999854 357889999986422 1456789999999 59999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++|+|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++..+..
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999987543 3889999999999999999999 89999999999999999999999999999876532
Q ss_pred CCCCcccccccCCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.. ........++..|+|||.+.+.. .+.++||||||+++|||++|..||....... ............
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------- 227 (288)
T cd05583 158 EE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------- 227 (288)
T ss_pred cc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-------
Confidence 21 11222345788999999987654 7889999999999999999999996432211 111222221111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01 11222345688999999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=296.46 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=193.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 467 (704)
+...+.||+|+||.||+|.. .+++.||||.+... ......|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 34467899999999999965 47899999987542 22456789999999999999999988644 35799
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 999996 68999887654 3899999999999999999999 89999999999999999999999999999986532
Q ss_pred CCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc--------
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE-------- 618 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 618 (704)
.. .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhh
Confidence 21 22234567889999998864 468899999999999999999999996543211 00000000000
Q ss_pred ---CCcc-------cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhh
Q 037258 619 ---GDIR-------NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME--LKEC 669 (704)
Q Consensus 619 ---~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 669 (704)
.... ...++... ......+..+.+++.+||+.+|++|||++|+++. ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 00000000 0012345678999999999999999999999975 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=287.12 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=187.8
Q ss_pred hhcccccccCceEEEEEEeCC-CcEEEEEecccchh-----hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC-----FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|++|.||+|...+ ++.||||.++.... ....|+.++.+.. |+||+++++++.++...++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 457899999999999998764 89999999864321 3455666666664 9999999999999999999999985
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|.+++..... .+++..+..++.|++.||+||| + .+|+||||+|+||++++++.++|+|||++..+....
T Consensus 98 -~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--- 169 (296)
T cd06618 98 -TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169 (296)
T ss_pred -cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence 477777665332 5899999999999999999999 5 599999999999999999999999999987653211
Q ss_pred ccccccCCCCccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 553 ISTAVAGTPGYLDPEYYVLNW----LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+......... .. .
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~-----~ 238 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PP-----S 238 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CC-----C
Confidence 122335778999999987553 788999999999999999999999543211 11111111111 00 0
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.. .....+.++.+++.+||+.||.+||++.++++.
T Consensus 239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=287.32 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=190.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+...+.||+|+||.||+|... +++.||+|.+... ...+..|+++++.++|+|++++++++..+...++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444578999999999999754 6788999987532 11456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+. |+|.+.+.... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 96 58888775443 34889999999999999999999 89999999999999999999999999999876431
Q ss_pred cccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ..... ..+.. +.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~-----~~ 233 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNES-----PA 233 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHH-hhcCC-----CC
Confidence 12345788999999975 3567889999999999999999999986533211 11111 11111 11
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
. .....+..+.+++.+||+.+|++||++.++++.-
T Consensus 234 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1 1123445788999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=264.91 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=192.5
Q ss_pred cccCHHHHHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEE
Q 037258 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCI 460 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~ 460 (704)
.+....|++.. ..||.|..|.|++++.. .|...|||.+..... .....+.++... ..|.||+.+|||.
T Consensus 87 ~~~dindl~~l-----~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 87 YQADINDLENL-----GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cccChHHhhhH-----HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 34455666544 56999999999999765 688999999865433 223344444444 3899999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 461 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
.+...++.||.|.. -++.+++.-. +++++..+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence 99999999999854 4555555433 348888888999999999999996 8899999999999999999999999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
++..+-+ ....+...|.+.|||||.+. ...|+.++||||||++++||.||+.||..-..+- +.+...+.
T Consensus 238 IsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln 309 (391)
T KOG0983|consen 238 ISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLN 309 (391)
T ss_pred ccceeec---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHh
Confidence 9987642 23344567899999999987 3478899999999999999999999997644321 11112222
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+. .|.+.+. ...+..+.+++..||+.|+.+||...++++
T Consensus 310 ~e------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 EE------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cC------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 1333321 125668999999999999999999999885
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=276.00 Aligned_cols=233 Identities=27% Similarity=0.370 Sum_probs=196.1
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+|.++||+|.||.|-+++- .+++.+|+|++++... ....|-++|+..+||.+..+.-.+...+.+|+||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 3568999999999999954 4789999999986543 3456778999999999999998999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
.||.|.-+|.+.+. +++....-+...|+.||.||| +++||.||||.+|.|+|.+|++||+|||+++. .-....
T Consensus 251 nGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKYGD 323 (516)
T ss_pred cCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh--cccccc
Confidence 99999999877543 888888899999999999999 99999999999999999999999999999985 233445
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....+||+.|+|||++....|+.+.|.|.+||++|||++|+.||...+.+. +.+ .+..++ -.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFe----LIl~ed----------~k 386 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFE----LILMED----------LK 386 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHH----HHHhhh----------cc
Confidence 5677899999999999999999999999999999999999999997654321 111 111111 12
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCC
Q 037258 633 FDNNSAWKAVELALACASHTSSERP 657 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RP 657 (704)
|+...+.+...|+...|..||.+|.
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhc
Confidence 4455566888999999999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=271.45 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred hhhcccccccCceEEEEEEeC---C--CcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD---D--NQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l 467 (704)
|+....||+|.+|.||+|.-. + ...+|||+++.+. ....+|+.+++.++|||++.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 445678999999999999432 2 2378999998663 366899999999999999999999877 788999
Q ss_pred EEeecCCCCHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC----CcEEEEecc
Q 037258 468 IYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK----LQAKIADFG 540 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG 540 (704)
++||.+. +|.+.|+-++ .+.++...+..|+.||+.|+.||| +.-|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999988 9999887543 456889999999999999999999 9999999999999999877 899999999
Q ss_pred CccccccCCCCc-ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc----cH--HHHH
Q 037258 541 LSRIFSIESSDQ-ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT----HI--SQWV 612 (704)
Q Consensus 541 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~----~~--~~~~ 612 (704)
+++.+...-... .....+-|..|.|||.+.+. .|+++.||||.|||+.||+|-++.|.+..+.-.. +. ...+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999875433222 33456779999999999865 7999999999999999999998888765432111 11 1111
Q ss_pred HHHHhc---CCcccc---cCC-----cCC-CCCCh-----------hHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 613 NSMLAE---GDIRNI---VDP-----SLQ-GNFDN-----------NSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 613 ~~~~~~---~~~~~~---~d~-----~l~-~~~~~-----------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
-..+.. .++..+ .+- ..+ ..++. ..+....+|+.++|..||.+|.|++++++.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111 011000 000 000 00000 011237799999999999999999999874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=283.77 Aligned_cols=237 Identities=30% Similarity=0.425 Sum_probs=188.0
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.||+|+||.||+|.. .+++.|++|++.... .....|+++++.++|+|++++++++.++...++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 46799999999999965 468899999985321 145678999999999999999999999999999999996
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... ..+++.++..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.... ..
T Consensus 105 ~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 105 GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 58888776543 34899999999999999999999 8999999999999999999999999999886431 12
Q ss_pred ccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 555 TAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
....++..|+|||++. ...++.++|||||||++|||++|..||....... ........ .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~-~~~~~------- 240 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-DSPTL------- 240 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc-CCCCC-------
Confidence 2356788999999984 4568889999999999999999999986543211 11111111 11111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....+..+.+++.+||+.+|.+||++.+++..
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=292.74 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=198.1
Q ss_pred HhhhcccccccCceEEEEEE-eCCCcEEEEEecccchhhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.|.+...+|.|+|+.|-.+. ..+++..+||++.....+..+|+.++... +||||+++.+.+.++.+.++|||.+.++-
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 34566789999999998884 45788999999988866777788666655 79999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe-CCCCcEEEEeccCccccccCCCCcccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL-NEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+.+.+...+. ....+..|+.+|+.|+.||| .+|+|||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 403 ll~ri~~~~~---~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~ 471 (612)
T KOG0603|consen 403 LLRRIRSKPE---FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CD 471 (612)
T ss_pred HHHHHHhcch---hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hc
Confidence 8888876553 23677789999999999999 8999999999999999 68999999999999876432 33
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..+-|..|.|||++....|++++|+||||++||+|++|+.||.....+. -+...+.. +.+..
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~------------~~~s~ 533 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQM------------PKFSE 533 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcC------------Ccccc
Confidence 4466889999999999999999999999999999999999997655431 12222222 23345
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+..+++|+.+||+.||.+||+|.++...
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 667789999999999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=281.41 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=196.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 470 (704)
|.+.+.||+|++|.||+|... +++.||+|++.... .....|.+++++++ |+||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345688999999999999664 78999999986421 24567889999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 83 YAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999998654 3899999999999999999999 89999999999999999999999999999876543221
Q ss_pred C------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 037258 551 D------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV 612 (704)
Q Consensus 551 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~ 612 (704)
. .......++..|+|||......++.++||||||++++++++|+.||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HH
Confidence 1 12223457889999999988889999999999999999999999996544210 01
Q ss_pred HHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 037258 613 NSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTM----TDVLM 664 (704)
Q Consensus 613 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 664 (704)
..... . ...++...+..+.+++.+||+.+|.+||++ +|+++
T Consensus 232 ~~~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILK-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHh-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 011222335578899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=291.48 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC-----eEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN-----NMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l 467 (704)
+.+.+.||+|++|.||+|... +++.||||++.... ..+..|+.+++.++|+||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345688999999999999765 58999999886532 25677999999999999999999998775 7899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++ +|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 82 VTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred Eecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999984 8999887654 4899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCC-cccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC------
Q 037258 548 ESSD-QISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------ 619 (704)
Q Consensus 548 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 619 (704)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhh
Confidence 2210 122345678899999999887 889999999999999999999999966542111 00011100000
Q ss_pred -----CcccccC---CcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhhh
Q 037258 620 -----DIRNIVD---PSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLME--LKECL 670 (704)
Q Consensus 620 -----~~~~~~d---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 670 (704)
.....+. .... .......+..+.+++.+||+.+|.+||+++++++. +++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000 0000 00011235678899999999999999999999974 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=273.66 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=203.5
Q ss_pred hhcccccccCceEEEEEEe------CCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeC-CeEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEG-NNMGLI 468 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lV 468 (704)
....++-+|.||.||.|.+ .+.+.|-||.++.... .+..|--++..+.|||+.++.+.+.+. ...+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 3456889999999999944 3456677887765443 335566677778999999999998764 567888
Q ss_pred EeecCCCCHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 469 YEYMASGTLDQYLKGKK------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
|.++.-|+|..++...+ .+.+.-.+...++.|++.|++||| ++++||.||..+|.+||+..++||+|=.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhc
Confidence 99999999999998322 344777888999999999999999 999999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
+.+-..+.............||+||.+....|+.++|||||||++|||+| |+.|+..-++.+. ...+.+|.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ylkdGy- 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYLKDGY- 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHHhccc-
Confidence 88755554444555667789999999999999999999999999999999 9999976554332 22233321
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+-..+.+++.++..++.-||...|++||+.+|++.-|.+.-.
T Consensus 516 --------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 516 --------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred --------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 112345678899999999999999999999999999987643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=275.23 Aligned_cols=232 Identities=27% Similarity=0.371 Sum_probs=190.6
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 406 LGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
||+|+||.||++... +++.+|+|++..... ....|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 589999999864322 567788999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.... .+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99998664 3899999999999999999999 8999999999999999999999999999987653221 223445
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.++..|+|||...+...+.++|+||||+++||+++|+.||..... ......... .. ..++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~----------~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DP----------LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CC----------CCCCCCC
Confidence 678899999999888889999999999999999999999955432 111111111 10 1122223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTD 661 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~e 661 (704)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=279.77 Aligned_cols=243 Identities=25% Similarity=0.383 Sum_probs=190.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
|.+.+.||+|+||.||++... .+..+++|+++.. ......|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 456788999999999999654 3445666655421 114456888999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 470 EYMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 470 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988642 2345899999999999999999999 899999999999999986 4699999999876532
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+. .+
T Consensus 158 ~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~-----~~ 223 (260)
T cd08222 158 S--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGP-----TP 223 (260)
T ss_pred C--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCC-----CC
Confidence 2 122234567889999999988888999999999999999999999985322 111111111 111 11
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+..+.+++.+||+.+|++||++.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 123345568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=306.97 Aligned_cols=249 Identities=31% Similarity=0.435 Sum_probs=186.8
Q ss_pred HHHhhh--cccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC------
Q 037258 397 KITNNF--ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG------ 462 (704)
Q Consensus 397 ~~~~~~--~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 462 (704)
+...+| .+.||+||||.||+++.+ ||+.+|||++.-.. ....+|+++|.+++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 444455 368999999999999765 89999999986442 2567899999999999999987532100
Q ss_pred --------------------------------------------------------------------------------
Q 037258 463 -------------------------------------------------------------------------------- 462 (704)
Q Consensus 463 -------------------------------------------------------------------------------- 462 (704)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Q 037258 463 ---------------------------------NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509 (704)
Q Consensus 463 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH 509 (704)
..+||=||||+..+|.++++.+.... .....++++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 01456789998888888887665211 35778999999999999999
Q ss_pred cCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc----------------cCCCCcccccccCCCCccCccccccC-
Q 037258 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS----------------IESSDQISTAVAGTPGYLDPEYYVLN- 572 (704)
Q Consensus 510 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~- 572 (704)
+.|||||||||.|||++++..+||+|||+|+... ........+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999998721 00111234567899999999999855
Q ss_pred --CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccC
Q 037258 573 --WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACAS 650 (704)
Q Consensus 573 --~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 650 (704)
.|+.|+|+||+|||++||+. ||....+. ..+...++.+.+..- ..+.......-.++|++|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 56433221 011222333333221 23344445566799999999
Q ss_pred CCCCCCCCHHHHHH
Q 037258 651 HTSSERPTMTDVLM 664 (704)
Q Consensus 651 ~dP~~RPs~~evl~ 664 (704)
.||.+||||.|+|.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999984
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=286.53 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=188.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC--------e
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN--------N 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~ 464 (704)
+.+.+.||+|++|.||+|... +++.||||++.... ....+|++++++++|+||+++++++.+.. .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 445788999999999999754 68999999874321 24577999999999999999999875433 4
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++|+||+.+ +|.+.+.... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||++..
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 6899999975 7777776533 34899999999999999999999 89999999999999999999999999999976
Q ss_pred cccCCCCc---------ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 037258 545 FSIESSDQ---------ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS 614 (704)
Q Consensus 545 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 614 (704)
........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ... +..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~--~~~-~~~ 241 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ--LHL-IFK 241 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHH
Confidence 53222111 11234567889999988654 578999999999999999999999965443211 111 000
Q ss_pred HHhc---------CCccccc----CCcCCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 615 MLAE---------GDIRNIV----DPSLQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 615 ~~~~---------~~~~~~~----d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... ..+.... ........ .......+.+++.+||+.+|.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0000000 00000000 0112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=279.38 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=193.4
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.||+|++|.||+|... +++.||+|++.... .....|++++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999765 58999999987542 245678999999999999999999999999999999998
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 59999998753 23899999999999999999999 89999999999999999999999999999876532211 22
Q ss_pred ccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---------Cc---
Q 037258 555 TAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---------DI--- 621 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~--- 621 (704)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+....... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 234457789999998766 78999999999999999999999996543211 111111111000 00
Q ss_pred ccccCCcCCC---CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 RNIVDPSLQG---NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.......... .........+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 001122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=284.06 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=189.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+++.||||++... ......|++++++++||||+++++++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 34468999999999999964 47899999987431 2355679999999999999999999875 5678899999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+ +++|.++++... +++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 92 ~-~~~L~~~~~~~~---~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 92 L-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred h-ccCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 8 568998887533 788888999999999999999 89999999999999999999999999999875421
Q ss_pred cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc-H--------HHHHHHHHhcCCc
Q 037258 552 QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH-I--------SQWVNSMLAEGDI 621 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~-~--------~~~~~~~~~~~~~ 621 (704)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... + .++..........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 1123456788999998765 568999999999999999999999996543211000 0 0011100000000
Q ss_pred ccccCCcCCCCCC-----hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 622 RNIVDPSLQGNFD-----NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 622 ~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.-..........+ ...+..+.+++.+||+.+|++||++.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000011 1234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=290.36 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=190.1
Q ss_pred HHHHHHHhhh--cccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC-
Q 037258 393 SEIQKITNNF--ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG- 462 (704)
Q Consensus 393 ~el~~~~~~~--~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 462 (704)
.++...+.++ .+.||+|+||.||+|.. .+++.||+|+++... ....+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3444444444 67899999999999964 578999999986432 2456789999999999999999988643
Q ss_pred -----CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 463 -----NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 463 -----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
...+++++++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 78999888654 3899999999999999999999 8999999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM- 615 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~- 615 (704)
|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 163 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~ 235 (345)
T cd07877 163 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVG 235 (345)
T ss_pred cccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 9999875421 1233467889999999876 567899999999999999999999995433211 111100000
Q ss_pred ---------HhcCCcc---cccCCcCCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 616 ---------LAEGDIR---NIVDPSLQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 616 ---------~~~~~~~---~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+...... ..+.......+ .......+.+++.+|++.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000000000 01234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=290.24 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=189.2
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEEEE
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMGLI 468 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV 468 (704)
..+.||+|+||.||+|.. .+|+.||||++.... .....|++++++++|+||+++++++... ..+++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 468999999999999965 478999999986421 2456799999999999999999998754 356899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+||+.. +|.+++. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++....
T Consensus 99 ~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 99 MPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 999964 7777653 23889999999999999999999 89999999999999999999999999999875421
Q ss_pred CCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH----------HHHh
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN----------SMLA 617 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~----------~~~~ 617 (704)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..... ....
T Consensus 170 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 170 ----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred ----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHhc
Confidence 1223456888999999876 468899999999999999999999997543211 1110000 0000
Q ss_pred cCCcccccC--Cc-CCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhhhhh
Q 037258 618 EGDIRNIVD--PS-LQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLM--ELKECLSL 672 (704)
Q Consensus 618 ~~~~~~~~d--~~-l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 672 (704)
......... +. ..... .......+.+++.+||+.||.+||+++|++. .++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000 00 00000 0123456889999999999999999999995 47666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=283.11 Aligned_cols=239 Identities=25% Similarity=0.361 Sum_probs=195.8
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
++.||+|-||+||-|.+ ++|+.||||++.+.. ....+|+.+|..++||.||.+--.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 68999999999999955 589999999986432 3567899999999999999999999999999999999965
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccccCCCCc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~~~~~~~~ 552 (704)
+..+.+-......+++..-.-++.||+.||.||| .++|+|+||||+|||+.+. -++||+|||+|+.+. ...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc---hhh
Confidence 6555554444445888888899999999999999 9999999999999999654 379999999999875 334
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|+|||+++...|...-|+||.|||+|--++|..||....+ +.+ .++... ++ ....
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind----QIQNAa---FM---yPp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND----QIQNAA---FM---YPPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH----Hhhccc---cc---cCCC
Confidence 45678999999999999999999999999999999999999999965432 111 111111 11 1122
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVL 663 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 663 (704)
...+.+...++||...|+..-.+|-|....+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 3456677899999999999999999988765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.78 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=186.9
Q ss_pred hhcccccccCceEEEEEEeC-C--CcEEEEEecccc------hhhHHHHHHHHHhh-cccceeEEEEEEEeC----CeEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD-D--NQQVAVKMLSSS------CCFQLLQVKLLMRV-HHRNLTALIGYCIEG----NNMG 466 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~ 466 (704)
.+.+.||+|+||.||++... . +..||+|++... ......|+.+++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45688999999999999764 3 778999987642 12456789999999 599999999976432 4578
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+++||+. ++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++.+.
T Consensus 83 ~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 8888886 69999987544 3899999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCC--CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh------
Q 037258 547 IESS--DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA------ 617 (704)
Q Consensus 547 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------ 617 (704)
.... ........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....+...+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 2211 111233568899999998765 468899999999999999999999986543211 0000000000
Q ss_pred -----cCC-------cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 -----EGD-------IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 -----~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... ........+. .........+.+++.+||+.+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0000000000 001122457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.85 Aligned_cols=221 Identities=19% Similarity=0.152 Sum_probs=177.4
Q ss_pred cCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCC
Q 037258 409 GGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH 487 (704)
Q Consensus 409 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 487 (704)
|.+|.||++.. .+++.+|+|++.... ....|...+....||||+++++++.+.+..++||||+++|+|.+++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~- 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN- 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC-
Confidence 89999999955 578999999997654 233455555566799999999999999999999999999999999876543
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCcc
Q 037258 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567 (704)
Q Consensus 488 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 567 (704)
+++..+..++.|+++||+||| +.+++||||||+||+++.++.++++|||.+..+... .....++..|+|||
T Consensus 82 -l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE 152 (237)
T cd05576 82 -IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPE 152 (237)
T ss_pred -CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCc
Confidence 899999999999999999999 899999999999999999999999999987654321 12334567899999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHh
Q 037258 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALA 647 (704)
Q Consensus 568 ~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~ 647 (704)
.+.+..++.++||||+|+++|||++|+.|+....... ..... ...+...+..+.+++.+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEARSLLQQ 211 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHHHHHHHH
Confidence 9988888999999999999999999998874321100 00000 01122234578899999
Q ss_pred ccCCCCCCCCCHHH
Q 037258 648 CASHTSSERPTMTD 661 (704)
Q Consensus 648 cl~~dP~~RPs~~e 661 (704)
|++.||++||++.+
T Consensus 212 ~l~~dp~~R~~~~~ 225 (237)
T cd05576 212 LLQFNPTERLGAGV 225 (237)
T ss_pred HccCCHHHhcCCCc
Confidence 99999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=276.95 Aligned_cols=264 Identities=28% Similarity=0.434 Sum_probs=207.4
Q ss_pred CcccCHHHHHHHHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh-----------hHHHHHHHHHhhcccceeE
Q 037258 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC-----------FQLLQVKLLMRVHHRNLTA 454 (704)
Q Consensus 387 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-----------~~~~E~~~l~~l~h~nIv~ 454 (704)
..+|.-.-+.+.+|-+..+||+|||+.||+| ++...+.||||+-.-... ...+|..+-+.+.||.||+
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 4455555566667777899999999999999 677789999998642211 3467889999999999999
Q ss_pred EEEEEE-eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---
Q 037258 455 LIGYCI-EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE--- 530 (704)
Q Consensus 455 l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 530 (704)
+++|+. +.+.+|-|+|||+|.+|+-+|+.++. +++.++..|+.||+.||.||.+ .+.+|||-||||.|||+..
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcc
Confidence 999996 55779999999999999999987765 8999999999999999999994 4889999999999999954
Q ss_pred CCcEEEEeccCccccccCCCCc-----ccccccCCCCccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 531 KLQAKIADFGLSRIFSIESSDQ-----ISTAVAGTPGYLDPEYYVL----NWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
-|.+||.|||+++.+..+.... ......||..|++||.+.- .+++.|.||||+|||+|+++.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 4689999999999986554432 2345789999999999863 367889999999999999999999996544
Q ss_pred CCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 602 EDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .++.+..+...-.-.++ ..+..+.+...+|++||++.-++|....++..
T Consensus 689 sQQ---------dILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 689 SQQ---------DILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hHH---------HHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 321 22333333222221111 12345567889999999999999988777653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.01 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=190.9
Q ss_pred hhhcccccccCceEEEEEE-eCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC------eEE
Q 037258 400 NNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN------NMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 466 (704)
+...+.||+|+||.||+|. ..+++.||||++.... .....|++++++++|+||+++++++..+. .++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 3446789999999999995 4578999999885321 14567999999999999999999987543 468
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 97 lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 97 LVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999999 77999888643 3899999999999999999999 9999999999999999999999999999987643
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH----------HH
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN----------SM 615 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~----------~~ 615 (704)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....... ..
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHh
Confidence 2 1223457889999999875 458899999999999999999999996543211 0000000 00
Q ss_pred HhcCCcccccC--CcCC----CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhhh
Q 037258 616 LAEGDIRNIVD--PSLQ----GNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKECL 670 (704)
Q Consensus 616 ~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 670 (704)
+.......... +... ..........+.+++.+|++.||.+|||+.++++ .++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00000000000 0000 0011233456889999999999999999999994 455443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=305.38 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=202.0
Q ss_pred hhcccccccCceEEEEEEeC--------CCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.||+|.||.|++|... ....||||.++.... ....|+++++.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 35569999999999999542 145799999875433 567789999988 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC
Q 037258 467 LIYEYMASGTLDQYLKGKK------------E--HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 532 (704)
+|+||+..|+|.++++..+ . ..+.....+.++.|||.|++||+ +.++|||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998766 0 13888999999999999999999 99999999999999999999
Q ss_pred cEEEEeccCccccccCCCCccccccc--CCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 533 QAKIADFGLSRIFSIESSDQISTAVA--GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 533 ~~kL~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
.+||+|||+++....... ....... -...|||||.+....++.++|||||||+||||+| |..||.+.... ..+
T Consensus 456 ~~kIaDFGlar~~~~~~~-y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l- 531 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDY-YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EEL- 531 (609)
T ss_pred EEEEccccceeccCCCCc-eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHH-
Confidence 999999999986532222 2212222 2456999999999999999999999999999999 88998652211 111
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
...+..|.. ...+..+..++.++++.||+.+|++||++.|+.+.++..+
T Consensus 532 ---~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 532 ---LEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ---HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 123333322 2234455678889999999999999999999999999954
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=287.64 Aligned_cols=180 Identities=38% Similarity=0.632 Sum_probs=148.2
Q ss_pred CccCCCCCcccC--CccceeeeeeeeccCCCCCCceecCCCCCCceeecCC-CCCceecccccccc-CCCCCCCCChHHH
Q 037258 1 LRLLKNSTYETQ--SLAESLWLLRRYDFGSITNKSVRYKDDIYDRLWMPKN-YPGWKKLSTSLPID-AENPNAFRPAPAV 76 (704)
Q Consensus 1 lr~l~~~~y~~~--~~~~~l~l~~R~~~g~~~~~~~ryp~D~~dR~W~~~~-~~~~~~~~t~~~~~-~~~~~~~~~p~~v 76 (704)
||||++++|+.. ..+.+|.++.|.|+|...+ .||||||+|||+|.|+. .+.|.+++|+.+++ ....+.|.||.+|
T Consensus 158 l~~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V 236 (347)
T PF12819_consen 158 LRPLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAV 236 (347)
T ss_pred EEECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHH
Confidence 699999999644 4446799999999997544 39999999999999974 68899999988776 4456679999999
Q ss_pred HhhcccccCCCcceEEEeeCCCCCCCceEEEEEeeeeeccCCC-ceeEEEEEEcCeeeccCcccccceeeeE--Eee--e
Q 037258 77 MSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLAN-QTREFNITQNGKFYIGPIVPTYLYTTTA--LSS--V 151 (704)
Q Consensus 77 ~~ta~~~~~~~~~~~~~~~~~~~~~~~~~v~l~Fae~~~~~~~-~~R~F~i~lng~~~~~~~~p~~~~~~~~--~~~--~ 151 (704)
||||+++.+++..+.+ .|..+++..+|||+|||||+|.+..+ ++|+|+|++||+.+.+++.|.++..... +.. .
T Consensus 237 ~~TA~~~~~~s~~~nl-tw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~ 315 (347)
T PF12819_consen 237 YQTARTPSNSSDPLNL-TWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVV 315 (347)
T ss_pred HHhhhcccccccceEE-EeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEE
Confidence 9999999998756555 59888899999999999999988644 4899999999998877888877655433 221 2
Q ss_pred ecC-CceEEEEEeccCCCchhhHHHHHHHhhh
Q 037258 152 PVS-GARIEYIINATERSTLQPILNAMEIYMV 182 (704)
Q Consensus 152 ~~~-~~~~~~~l~~t~~S~lpPllna~e~~~~ 182 (704)
... ++.++++|.++.+|+|||||||+|||.+
T Consensus 316 ~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 316 NVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 222 3478999999999999999999999964
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=287.59 Aligned_cols=256 Identities=24% Similarity=0.312 Sum_probs=185.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeC------------
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEG------------ 462 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~------------ 462 (704)
+.+.+.||+|+||.||+|.. .+++.||+|++.... .....|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 44578999999999999965 468999999875432 2457799999999999999999776543
Q ss_pred --CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEec
Q 037258 463 --NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADF 539 (704)
Q Consensus 463 --~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Df 539 (704)
...++|+||++ ++|.+++... .+++..+..++.|+++||+||| +.+++||||||+||+++. ++.++|+||
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 5998888643 3889999999999999999999 899999999999999974 557899999
Q ss_pred cCccccccCCCC-cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 540 GLSRIFSIESSD-QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 540 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|++..+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ..........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 237 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVPV 237 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCC
Confidence 999765321111 11123457889999998754 5678899999999999999999999965432111 0000000000
Q ss_pred -----cC----CcccccC-CcCCC-----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 -----EG----DIRNIVD-PSLQG-----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 -----~~----~~~~~~d-~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. ....... ..... ........++.+++.+||+.||.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0000000 00000 001123457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=277.15 Aligned_cols=268 Identities=17% Similarity=0.278 Sum_probs=205.1
Q ss_pred cccCHHHHHHHHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh---hHHHHHHHHHhhcc--c----ceeEEEE
Q 037258 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHH--R----NLTALIG 457 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h--~----nIv~l~~ 457 (704)
-.|...|.....+.+...+|+|.||.|-.. +.+.+..||||+++.... ...-|+++|.++.+ | -++++.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 345566666677777899999999999999 444578999999976544 45678999999932 2 3788889
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-------
Q 037258 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE------- 530 (704)
Q Consensus 458 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------- 530 (704)
++.-.++.++|+|.+ |-|+.+++..+...+++...+..|+.|+++++++|| +.+++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEe
Confidence 999999999999998 559999999988888999999999999999999999 999999999999999932
Q ss_pred -------------CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 037258 531 -------------KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPV 597 (704)
Q Consensus 531 -------------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf 597 (704)
+..++|+|||.|..-.. .....+.|..|.|||++.+-.++.++||||+||||+|+.||...|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 23589999999986421 225567899999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHH--------------HHHhcCCc-----------ccccCCcCC----CCCChhHHHHHHHHHHhc
Q 037258 598 ISRAEDDTTHISQWVN--------------SMLAEGDI-----------RNIVDPSLQ----GNFDNNSAWKAVELALAC 648 (704)
Q Consensus 598 ~~~~~~~~~~~~~~~~--------------~~~~~~~~-----------~~~~d~~l~----~~~~~~~~~~l~~li~~c 648 (704)
...+..+...+.+.+. +....+.+ ....++... -.....+..++++|+++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 7665332211111110 00111100 000000000 001234556799999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 037258 649 ASHTSSERPTMTDVLM 664 (704)
Q Consensus 649 l~~dP~~RPs~~evl~ 664 (704)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=301.72 Aligned_cols=139 Identities=26% Similarity=0.391 Sum_probs=124.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +++.||||+++... ..+..|+.++..++|+||+++++++...+..++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 345789999999999999765 78999999986532 3567788999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
+.+++|.+++.... .+++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999997644 3788999999999999999999 8899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=239.81 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
-++||+|.+|+||+|+ .++++.||+|...-... ...+|+-+++.++|+|||++++....++..-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 3679999999999995 55789999998753322 568999999999999999999999999999999999965
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|..+.....+. ++.+.+..++.|+++||.+.| ++++.|||+||+|.+|+.+|++|++|||+++.++.. .....
T Consensus 86 dlkkyfdslng~-~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vrcys 159 (292)
T KOG0662|consen 86 DLKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYS 159 (292)
T ss_pred HHHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeee
Confidence 888888765443 889999999999999999999 999999999999999999999999999999877422 12233
Q ss_pred cccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcc---cccCCcCC
Q 037258 556 AVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIR---NIVDPSLQ 630 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~l~ 630 (704)
...-|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+.++...-..|......+..+. .+.|....
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 45678999999999876 57899999999999999998 555555444333222222222222332222 22232222
Q ss_pred CCCChh---------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNN---------SAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~---------~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..++.. ....-.+++...+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 223221 1123468899999999999999998876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.37 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=188.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCe------EE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNN------MG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~ 466 (704)
+.+.+.||+|++|.||+|... +++.||||++.... ....+|+.++++++|+|++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345688999999999999765 68899999986421 234578999999999999999988766554 89
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+|+||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+|+||||+||++++++.++|+|||++....
T Consensus 97 lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 97 LVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 999998 56999998753 3899999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc-------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE------- 618 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------- 618 (704)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .+ .........
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~-~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QL-KRIMNLVGTPDEELLQ 241 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHhcCCCCHHHHh
Confidence 21 233467889999999865 367899999999999999999999996543211 01 100000000
Q ss_pred ----CCcccccC---CcCCCCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 ----GDIRNIVD---PSLQGNF---DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 ----~~~~~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+. ......+ ....+..+.+++.+||+.+|++|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 0000000 0122567899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=273.55 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=197.3
Q ss_pred HHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeE
Q 037258 395 IQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 395 l~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 465 (704)
+.....+|..+||+|+||.|.+|.. .+.+.+|||++++... ....|-++|..- +-|.++++..++..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3344457899999999999999954 4677899999986543 224455566554 567889999999999999
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
+.||||+.||+|--++++-.. +.+..+.-+|..||-||-+|| +++||.||||.+|||+|.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999987665 788899999999999999999 999999999999999999999999999999752
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
-..........||+.|+|||++..++|+...|.|||||+||||+.|+.||++.++++. .. .+.
T Consensus 501 --i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~---------aI~ 563 (683)
T KOG0696|consen 501 --IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQ---------AIM 563 (683)
T ss_pred --ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HH---------HHH
Confidence 2234445678999999999999999999999999999999999999999987665431 11 111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPT 658 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 658 (704)
+.. -.++...+.+.+.+....|...|.+|..
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 221 1356667778999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=302.74 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=198.0
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.++||+|+||.|..++++ +++.+|.|++++. ...|..|-.+|..-..+=|++++-.|.++.++|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 44689999999999999765 6888999998652 236777888888888899999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+||+|-.++.... .+++..+.-++..|+-||.-|| +.|+|||||||+|||||..|++||+|||.+-.+. .++..
T Consensus 158 pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~-~dG~V 231 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD-ADGTV 231 (1317)
T ss_pred cCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcC-CCCcE
Confidence 9999999998776 4899999999999999999999 9999999999999999999999999999998774 34455
Q ss_pred ccccccCCCCccCccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 553 ISTAVAGTPGYLDPEYYV----L-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~----~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.+...+|||.|++||++. + +.|+..+|.||+||++|||+.|..||....- ++-...++ +.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm---------~h 296 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIM---------NH 296 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHh---------ch
Confidence 566789999999999996 3 5789999999999999999999999965432 21111111 11
Q ss_pred cCCCCCC--hhHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 037258 628 SLQGNFD--NNSAWKAVELALACASHTSSERPT---MTDVLM 664 (704)
Q Consensus 628 ~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 664 (704)
.-.-.|+ ...+.+..+||.+.+. +|+.|.. ++++-.
T Consensus 297 k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111222 3467789999999886 6777887 888763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=261.41 Aligned_cols=257 Identities=25% Similarity=0.335 Sum_probs=194.8
Q ss_pred cccCHHHHHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-----hHHHHHHHH-HhhcccceeEEEEEEE
Q 037258 388 RQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-----FQLLQVKLL-MRVHHRNLTALIGYCI 460 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~E~~~l-~~l~h~nIv~l~~~~~ 460 (704)
..|+-++++.. ..||.|+||+|++-.+ +.|+..|||++..... +...|.+.. +.-+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 45666666654 4599999999999855 4799999999865432 334455443 3346899999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhh---cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 461 EGNNMGLIYEYMASGTLDQYLK---GKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 461 ~~~~~~lV~e~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
.++..++.||.|.- ||..+.+ ......+++...-+|....+.||.||.+ ...|||||+||+|||++..|.+|||
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence 99999999999964 7765543 2334458888889999999999999996 7889999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV--LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
|||++..+. .....+...|...|||||.+. +..|+-++||||||++|+|+.||+.|+..... +.+.+.+.
T Consensus 211 DFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V 282 (361)
T KOG1006|consen 211 DFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV 282 (361)
T ss_pred cccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH
Confidence 999997653 233445667889999999997 33588999999999999999999999955432 22222222
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.. ++...+..+ ......+..++.++.-||.+|-..||...++++.
T Consensus 283 v~-gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VI-GDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Hc-CCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 222111111 1123456789999999999999999999998763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.07 Aligned_cols=245 Identities=26% Similarity=0.441 Sum_probs=201.9
Q ss_pred hhcccccccCceEEEEEE-eCCCcEEEEEecccchh---hHHHHHHHHHhh-cccceeEEEEEEEe-----CCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC---FQLLQVKLLMRV-HHRNLTALIGYCIE-----GNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~E~~~l~~l-~h~nIv~l~~~~~~-----~~~~~lV~e 470 (704)
.|.+.||.|.+|.||+++ .++++.+|+|++..... +...|.++++.. .|||++.++|++.. +++++||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 357899999999999994 55789999999865433 556677788877 69999999999863 578999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
||.+||.-|+++...+..+.|..+..|++.++.||.+|| +..++|||||-.|||++.++.+||+|||.+..+. ..
T Consensus 102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld--sT 176 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--ST 176 (953)
T ss_pred ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee--cc
Confidence 999999999999887778999999999999999999999 9999999999999999999999999999998753 33
Q ss_pred CcccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 551 DQISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
........||+.|||||++.. ..|+..+|+||||++..||.-|.+|+.++.+... ++ .+...-
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------LF---~IpRNP 244 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LF---LIPRNP 244 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---------hc---cCCCCC
Confidence 444566789999999999973 3577889999999999999999999976654211 11 111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.|.+ .-+..-.+++.++|..||..|-++||++.++++
T Consensus 245 PPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Cccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1222 235566789999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=259.68 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEeccc--ch----hhHHHHHHHHHhhcccceeEEEEEEEe--------CCeEEE
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSS--SC----CFQLLQVKLLMRVHHRNLTALIGYCIE--------GNNMGL 467 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~l 467 (704)
..+||+|.||.||+|+.+ +|+.||+|+.-- +. ....+|+++|..++|+|++.+++.|.. ...+++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 468999999999999654 678889886421 11 156889999999999999999998863 235899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||.+|+. +|..++.... ..++..++.+++.++..||.|+| ...|+|||+|+.|+||+.++.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999987 9999987654 23889999999999999999999 99999999999999999999999999999987753
Q ss_pred CCC--CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 548 ESS--DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 548 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
... ....+...-|..|++||.+.+ ..|+++.|||+.|||+.||+||.+-+.+..+....++.......+....+.+.
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 332 222345667999999999886 47899999999999999999999988776654433333222222111111111
Q ss_pred --------c--CCcCCCCCC--hhH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 --------V--DPSLQGNFD--NNS------AWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 --------~--d~~l~~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ .|-..+.+. ++. ..+..+|+..++..||.+|+.+.+++.
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1 111111110 111 236789999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=291.22 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=165.8
Q ss_pred hhhcccccccCceEEEEEEeC-C----CcEEEEEecccchhhHHHHHHHHHhh---cccceeEEEEE------EEeCCeE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-D----NQQVAVKMLSSSCCFQLLQVKLLMRV---HHRNLTALIGY------CIEGNNM 465 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~------~~~~~~~ 465 (704)
+.+.+.||+|+||.||+|... + +..||||++..... .|..+..++ .+.++..++.. +..+...
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence 345789999999999999765 4 68999998764322 222222222 22222222111 2456789
Q ss_pred EEEEeecCCCCHHHHhhcccCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 466 GLIYEYMASGTLDQYLKGKKEH------------------MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
++|+||+.+++|.+++...... ......+..++.|++.||+||| +++|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence 9999999999999998754310 0122345679999999999999 899999999999999
Q ss_pred eCC-CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccC----------------------CCCcchhHHHHH
Q 037258 528 LNE-KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN----------------------WLNEKSDVYSFG 584 (704)
Q Consensus 528 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDVwSlG 584 (704)
+++ ++.+||+|||+++.+... .........+++.|+|||.+... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 579999999999865322 22333456789999999976422 234567999999
Q ss_pred HHHHHHHhCCCCCCCCCC-------CCcccHHHHHHHHHhcCCcccccCCcCCCCC--ChhHHHHHHHHHHhccCCCCCC
Q 037258 585 VVLLEIITGRRPVISRAE-------DDTTHISQWVNSMLAEGDIRNIVDPSLQGNF--DNNSAWKAVELALACASHTSSE 655 (704)
Q Consensus 585 vvl~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~ 655 (704)
|++|||+++..|+..... ........|....... ..+.+...+ .........+|+.+||+.||.+
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999997766432110 0001112221111000 000000000 0011224568999999999999
Q ss_pred CCCHHHHHHH
Q 037258 656 RPTMTDVLME 665 (704)
Q Consensus 656 RPs~~evl~~ 665 (704)
|||++|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=287.88 Aligned_cols=240 Identities=29% Similarity=0.438 Sum_probs=188.3
Q ss_pred cccccccCceE-EEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 403 ERVLGKGGFGE-VYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 403 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
.+++|.|+.|+ ||+|.+ +|+.||||++-.... ...+|++.|+.- .|||||++++.-.+....||..|.|.. +|.+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d 591 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD 591 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence 46799999875 799988 478999999876665 668899999887 699999999999999999999999965 9999
Q ss_pred Hhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---C--CcEEEEeccCccccccCCCC-
Q 037258 480 YLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---K--LQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 480 ~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~DfGla~~~~~~~~~- 551 (704)
++... ..........+.+..|++.||++|| +.+||||||||+||||+. + ..++|+|||+++.+......
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99874 2111222455788999999999999 999999999999999975 3 47999999999998544332
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITG-RRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......||-+|+|||++....-+.+.||||+||++|+.++| .+||......+.. ++ .+... +. .+.
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il-~~~~~-L~--~L~ 736 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------IL-TGNYT-LV--HLE 736 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hh-cCccc-ee--eec
Confidence 224567899999999999988888899999999999999996 9999765433211 01 01000 00 001
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVL 663 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 663 (704)
. ..++ +..+||.+|+.++|..||++.+|+
T Consensus 737 ~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 P--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 1111 788999999999999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=256.85 Aligned_cols=234 Identities=28% Similarity=0.397 Sum_probs=190.2
Q ss_pred CceEEEEEEeC-CCcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhc
Q 037258 410 GFGEVYHGSLD-DNQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKG 483 (704)
Q Consensus 410 ~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 483 (704)
+||.||+|... +++.+++|++... ...+..|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999776 5899999998654 34667899999999999999999999999999999999999999999976
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCc
Q 037258 484 KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563 (704)
Q Consensus 484 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y 563 (704)
... +++..+..++.++++++.+|| +.+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 554 889999999999999999999 8899999999999999999999999999998764221 23345678899
Q ss_pred cCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHH
Q 037258 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVE 643 (704)
Q Consensus 564 ~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 643 (704)
++||.+.+..++.++||||||+++++|++|..||...... ....+ .......... ......+.++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK----KIGKPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH----HHhccCCCCc-------cccccCCHHHHH
Confidence 9999999888899999999999999999999998653211 11111 1111111100 000013457889
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 037258 644 LALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 644 li~~cl~~dP~~RPs~~evl~ 664 (704)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=271.30 Aligned_cols=244 Identities=23% Similarity=0.373 Sum_probs=200.4
Q ss_pred CcccCHHHHHHHHhhhcccccccCceEEEEEEeCCCc-EEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEE
Q 037258 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQ-QVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 387 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
..+..+++++.. ..||-||||.|=++..+... .+|+|++++... ....|-.+|...+.|.||+++..
T Consensus 414 ~a~v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT 488 (732)
T KOG0614|consen 414 FAQVKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT 488 (732)
T ss_pred hcccchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence 345556666544 46999999999999775433 388888865432 34567889999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
|.++...|++||-|-||.|...|+.+.. ++.....-++..+++|++||| .++||.|||||+|.+++.+|-+||.|
T Consensus 489 frd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 489 FRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred hccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEee
Confidence 9999999999999999999999998765 888899999999999999999 99999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
||+|+.+. ........+||+.|.|||++.....+.+.|.||||+++|||++|.+||.+.++.....+ +..
T Consensus 564 FGFAKki~---~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILk 633 (732)
T KOG0614|consen 564 FGFAKKIG---SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILK 633 (732)
T ss_pred hhhHHHhc---cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHh
Confidence 99999875 33445678999999999999999999999999999999999999999977654322111 111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT 658 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 658 (704)
| +| ...++........+++++....+|.+|..
T Consensus 634 G-----id---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 G-----ID---KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred h-----hh---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1 11 11344555667889999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=272.93 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=175.3
Q ss_pred hhhcccccccCceEEEEEEe-----------------CCCcEEEEEecccchh------------------hHHHHHHHH
Q 037258 400 NNFERVLGKGGFGEVYHGSL-----------------DDNQQVAVKMLSSSCC------------------FQLLQVKLL 444 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~------------------~~~~E~~~l 444 (704)
+.+.++||+|+||.||+|.. ..++.||||++..... ....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 34578999999999999953 2456899999854321 223466677
Q ss_pred Hhhcccce-----eEEEEEEEe--------CCeEEEEEeecCCCCHHHHhhccc----------------------CCCC
Q 037258 445 MRVHHRNL-----TALIGYCIE--------GNNMGLIYEYMASGTLDQYLKGKK----------------------EHML 489 (704)
Q Consensus 445 ~~l~h~nI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l 489 (704)
.+++|.++ ++++++|.. .+..++||||+++|+|.++++... ...+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77776654 677787753 356899999999999999987431 1124
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCcccc
Q 037258 490 NWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569 (704)
Q Consensus 490 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 569 (704)
++..+..++.|++.+|.||| +.+|+||||||+|||++.++.+||+|||++..+.... ........+++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhh
Confidence 67788999999999999999 8999999999999999999999999999997653211 1111223347899999988
Q ss_pred ccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCCCC------cccHHHHHHHHHhcCC
Q 037258 570 VLNWL----------------------NEKSDVYSFGVVLLEIITGRR-PVISRAEDD------TTHISQWVNSMLAEGD 620 (704)
Q Consensus 570 ~~~~~----------------------~~~sDVwSlGvvl~elltG~~-Pf~~~~~~~------~~~~~~~~~~~~~~~~ 620 (704)
..... ..+.||||+||+++||++|.. ||....... ...+..|.. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC
Confidence 64321 134799999999999999885 664321100 111112211 11111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTS---SERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 664 (704)
.+- ...........+++.+||..+| .+|+|++|+++
T Consensus 461 ----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 ----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 1112335678899999999766 68999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=263.08 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=169.2
Q ss_pred cccccccCceEEEEEE-eCCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.||-|+||.|.+++ .++...+|.|.+.+... ....|-.||.....+=||+++-.|.+++.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 4679999999999994 45667789998865433 446688899999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC---
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--- 551 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~--- 551 (704)
|++-.+|.+.+- +.+..+.-++..+..|+++.| +.|+|||||||+|||||.+|++||.|||++.-+....+.
T Consensus 714 GDmMSLLIrmgI--FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 714 GDMMSLLIRMGI--FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred ccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999877653 778888888999999999999 999999999999999999999999999998654211000
Q ss_pred -------------------------------------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC
Q 037258 552 -------------------------------------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR 594 (704)
Q Consensus 552 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~ 594 (704)
......+||+.|+|||++....++..+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0011346999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcc
Q 037258 595 RPVISRAEDDTT 606 (704)
Q Consensus 595 ~Pf~~~~~~~~~ 606 (704)
.||......+.+
T Consensus 869 ~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 869 PPFLADTPGETQ 880 (1034)
T ss_pred CCccCCCCCcce
Confidence 999887765543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.30 Aligned_cols=240 Identities=21% Similarity=0.341 Sum_probs=192.2
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeec
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.++||+|++++|-.+++. +.+.+|+|++++... ..+.|-.+..+. +||.+|-+..++..+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3588999999999999765 678899999875432 223444444444 7999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+||+|--++++++. ++++.+.-+...|.-||.||| ++|||.||||.+|||+|..|++||.|+|+++.- -....
T Consensus 334 ~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~--l~~gd 406 (593)
T KOG0695|consen 334 NGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LGPGD 406 (593)
T ss_pred cCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC--CCCCc
Confidence 99999888876654 999999999999999999999 999999999999999999999999999999753 23344
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED-DTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||.+++..|....|.|++||+++||+.|+.||+--..+ ....-.++.-+.+.+..++
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------- 477 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------- 477 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---------
Confidence 566789999999999999999999999999999999999999999643211 1223344444444443322
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCC
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPT 658 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs 658 (704)
.+...+.+...+++.-|.+||.+|..
T Consensus 478 -iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 -IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 12223345668899999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=228.37 Aligned_cols=252 Identities=20% Similarity=0.358 Sum_probs=192.9
Q ss_pred hhhcccccccCceEEEEE-EeCCCcEEEEEecccchh-hHHHHHHHHHhhc-ccceeEEEEEEEeC--CeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC-FQLLQVKLLMRVH-HRNLTALIGYCIEG--NNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~e~~~~ 474 (704)
|.+.+++|+|-++.||.| ...+++.++||+++.... ...+|+++|..++ ||||+++++...++ ....||+||+.+
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 456789999999999999 456889999999987655 6789999999997 99999999999875 457899999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~~~~~ 553 (704)
.+...+... +....+...+.+++.||.|+| +.||.|||+||.|++||.. -.++|+|+|+|.++.... .
T Consensus 120 ~Dfk~ly~t-----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---e 188 (338)
T KOG0668|consen 120 TDFKQLYPT-----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 188 (338)
T ss_pred ccHHHHhhh-----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc---e
Confidence 887776543 667788899999999999999 9999999999999999965 469999999998874322 2
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-------ccccc
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD-------IRNIV 625 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 625 (704)
......+..|.-||.+.. +.|+..-|+|||||++..|+..+.||.......+ +++..++ .+.... ..-.+
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIak-VLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAK-VLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHH-HhChHHHHHHHHHHccCC
Confidence 234456778899999874 5688999999999999999999999976554322 2222221 111000 00012
Q ss_pred CCcCCC---C--------C-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQG---N--------F-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~---~--------~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
|+.+.. . | ..-...++++++.+.|..|-.+|+|++|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 222111 0 0 1112467899999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=231.80 Aligned_cols=206 Identities=34% Similarity=0.609 Sum_probs=181.2
Q ss_pred ccccCceEEEEEEeCC-CcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 406 LGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
||+|++|.||++...+ ++.+++|++..... .+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997754 89999999986643 57889999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccccCCCCccccccc
Q 037258 480 YLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIFSIESSDQISTAVA 558 (704)
Q Consensus 480 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~ 558 (704)
++.... ..+++..+..++.++++++++|| +.+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 998653 23889999999999999999999 889999999999999999 89999999999976532211 233355
Q ss_pred CCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 559 GTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 559 gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
+...|++||..... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77899999999877 788999999999999999
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=226.37 Aligned_cols=192 Identities=31% Similarity=0.411 Sum_probs=157.0
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccchh-----hHHHHHHHHHh-hcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-----FQLLQVKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
..||+|++|.|-+-++ .+|+..|+|.+..... ....|+.+..+ ..+|.+|.++|...+....++.||.|.. |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 5699999999988855 4899999999865433 23445554433 3699999999999999999999999965 8
Q ss_pred HHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 477 LDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 477 L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|..+-+.. .+..+++...-+|+..+.+||.|||+ +..+||||+||+|||++.+|++|+||||++..+.+ .-..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHH
Confidence 87765532 23458899999999999999999996 77899999999999999999999999999977632 2223
Q ss_pred ccccCCCCccCccccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYV----LNWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
+...|...|||||.+. ...|+-++||||||+++.||.+++.||....
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 3467888999999986 3378999999999999999999999996543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=242.18 Aligned_cols=135 Identities=25% Similarity=0.382 Sum_probs=115.1
Q ss_pred CHHHHHH-HHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh---hHHHHHHHHHhhc--------ccceeEEEE
Q 037258 391 AYSEIQK-ITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVH--------HRNLTALIG 457 (704)
Q Consensus 391 ~~~el~~-~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~--------h~nIv~l~~ 457 (704)
...|..+ .+|-+.++||=|.|++||++ +..+.+.||+|+.+.... ....|+++|++++ ..+||++++
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 3344444 67778899999999999999 556788999999986544 4577999999984 346999999
Q ss_pred EEEe----CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 458 YCIE----GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 458 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
.|.. +.++++|+|++ |.+|..+|.....+.++...+..|+.||+.||.|||. ..+|||.||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 9974 56899999999 5699999988877779999999999999999999997 5599999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=242.57 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=191.5
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEeccc------chhhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEEEEe
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSS------SCCFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGLIYE 470 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~e 470 (704)
++-||-|+||.||.... .+|+.||+|++.. .+....+|+++|.-++|.|++..+++..-. .+.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46799999999999854 5899999999854 234678999999999999999988877543 35678888
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
.|.. +|...+-.- +.++...+.-+..||++||+||| +.+|.||||||.|.|++.+..+||+|||+++....+ .
T Consensus 138 LmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~ 210 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-D 210 (449)
T ss_pred HHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh-h
Confidence 8854 787777543 34888888999999999999999 999999999999999999999999999999876432 3
Q ss_pred CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHHHHhcCCc
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW--------VNSMLAEGDI 621 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 621 (704)
...++...-|..|.|||.+++. .|+.+.||||.|||+.||+..+..|.....-+..++..- ..+.-.+|.-
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 3344556678899999999864 799999999999999999999998876554322211110 0011111111
Q ss_pred ccccCC-----cCCCCC----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 622 RNIVDP-----SLQGNF----DNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 622 ~~~~d~-----~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
..++.. .+.--+ +.....+.+.+...++..||.+|.+..+.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111 111000 123334677889999999999999999988754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=255.24 Aligned_cols=187 Identities=23% Similarity=0.349 Sum_probs=164.8
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchh------------hHHHHHHHHHhhc---ccceeEEEEEEEeCCeEE
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------------FQLLQVKLLMRVH---HRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------------~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+|+|+||.|+.+.++ +...|+||.+.++.. ..-.|+++|..++ |+||++++++|++++.++
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 478999999999999765 567899999876543 2356899999997 999999999999999999
Q ss_pred EEEeec-CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 467 LIYEYM-ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 467 lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
|+||-. ++.+|++++..+.+ +++.++..|+.|++.|+++|| +.+|||||||-+||.++.+|-+||+|||.+...
T Consensus 646 l~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred EEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999964 56799999987766 999999999999999999999 999999999999999999999999999998764
Q ss_pred ccCCCCcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVI 598 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~ 598 (704)
. ........||..|.|||++.+.+| +...|||++|++||.++....||.
T Consensus 721 k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 K----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred c----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 2 334556789999999999998876 567899999999999999999984
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=253.22 Aligned_cols=270 Identities=22% Similarity=0.243 Sum_probs=209.0
Q ss_pred CcccCHHHHHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh---hHHHHHHHHHhhc------ccceeEEE
Q 037258 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC---FQLLQVKLLMRVH------HRNLTALI 456 (704)
Q Consensus 387 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~E~~~l~~l~------h~nIv~l~ 456 (704)
.-.+.+.|+....|.+.-..|+|-|++|.+|.. ..|+.||||++..... .-+.|+++|++|. .-|+++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 345677888888898889999999999999954 4578999999976654 5578999999995 45788999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cE
Q 037258 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QA 534 (704)
Q Consensus 457 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~ 534 (704)
..|...+++|||+|-+. .+|.++|+..+ ...+....+..++.|+.-||..|- +.+|+|+||||+|||+++.- .+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence 99999999999999885 49999998765 334888899999999999999999 99999999999999998764 68
Q ss_pred EEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--
Q 037258 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV-- 612 (704)
Q Consensus 535 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~-- 612 (704)
||||||.|.... ....+.+.-+..|.|||++.|-.|+...|+||.||+||||.||+..|.+....+...+..-+
T Consensus 577 KLCDfGSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFAS----ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccc----cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999997653 22233444566899999999999999999999999999999999999877654432221111
Q ss_pred ---HHHHhcCCcc-cccCCcC--------------------------------CC--CC---ChhHHHHHHHHHHhccCC
Q 037258 613 ---NSMLAEGDIR-NIVDPSL--------------------------------QG--NF---DNNSAWKAVELALACASH 651 (704)
Q Consensus 613 ---~~~~~~~~~~-~~~d~~l--------------------------------~~--~~---~~~~~~~l~~li~~cl~~ 651 (704)
..++..+.+. +-+|..+ .+ .+ ......++.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 1122222111 1111111 00 01 123456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 037258 652 TSSERPTMTDVLM 664 (704)
Q Consensus 652 dP~~RPs~~evl~ 664 (704)
||++|.|..++|+
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999999886
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=227.39 Aligned_cols=247 Identities=18% Similarity=0.302 Sum_probs=183.2
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhh-cccceeEEEEE-EEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRV-HHRNLTALIGY-CIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lV~e~~ 472 (704)
.+++.+.||+|.||.+-+++++ ..+.+++|.+..... +|.+|...--.+ .|.||+.-++. |+..+.+.+++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 3556789999999999999765 678899998875433 666666544344 58999877654 56677888999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccccCCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfGla~~~~~~~~ 550 (704)
+.|+|.+-+...+ +.+....+++.|+++|+.||| +.++||||||.+||||- +..++||||||.....+
T Consensus 105 P~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g---- 174 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG---- 174 (378)
T ss_pred ccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC----
Confidence 9999999987754 788899999999999999999 99999999999999993 33479999999987542
Q ss_pred CcccccccCCCCccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN-----WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
........+..|.+||.+... ...+.+|||.||+++|.++||+.||...... .....+|.. +..+..
T Consensus 175 -~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~--w~~rk~---- 246 (378)
T KOG1345|consen 175 -TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ--WLKRKN---- 246 (378)
T ss_pred -ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH--HhcccC----
Confidence 223334456789999987532 3567899999999999999999999844433 233444432 111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.++..|. ..+..+.++.++-+..+|++|=-..++.++
T Consensus 247 -~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 -PALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -ccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 12222221 234467889999999999999555555544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=233.50 Aligned_cols=245 Identities=26% Similarity=0.311 Sum_probs=187.8
Q ss_pred ccccccCceEEEEE-EeCCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeC------CeEEEEEe
Q 037258 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMGLIYE 470 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~e 470 (704)
+.+|.|.- .|..+ +.-.+++||+|++... .....+|..++..+.|+||++++.++.-. .+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 55555 3336889999987533 23668899999999999999999998643 46899999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
+|.. +|.+.+.-. ++-..+..|..|++.|++||| +.+|+||||||+||++..+..+||.|||+++.-. .
T Consensus 102 ~m~~-nl~~vi~~e----lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~---~ 170 (369)
T KOG0665|consen 102 LMDA-NLCQVILME----LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED---T 170 (369)
T ss_pred hhhh-HHHHHHHHh----cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccC---c
Confidence 9965 999888722 778899999999999999999 9999999999999999999999999999997532 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC----------
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---------- 620 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------- 620 (704)
....+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.. ++.+|.+..-..|.
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHhh
Confidence 245667888999999999999889999999999999999999999986433 33333321111110
Q ss_pred -----------------cccc-cCCcCCCC--CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 -----------------IRNI-VDPSLQGN--FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 -----------------~~~~-~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+.+. -|..++.. .+.-....+.+++.+||..+|++|.|++++|+.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0011 11111111 112334567899999999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=222.58 Aligned_cols=194 Identities=35% Similarity=0.508 Sum_probs=167.4
Q ss_pred hhcccccccCceEEEEEEeCC-CcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLDD-NQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|++|.||++...+ ++.+++|.+... ......|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999997764 889999998754 33667789999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++...... +++..+..++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 82 ~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~ 156 (225)
T smart00221 82 GDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALL 156 (225)
T ss_pred CCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cccc
Confidence 9999999865432 789999999999999999999 8899999999999999999999999999998764322 1122
Q ss_pred ccccCCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 037258 555 TAVAGTPGYLDPEYY-VLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG~~Pf~~ 599 (704)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345677889999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=248.43 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=194.6
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+|+|.+|.|||++. ..++..|||+++-... -...|+-+++..+||||+.++|.+...+..++.||||.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 3457899999999999954 5789999999875433 3467888999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|++.-+.... +++.++..+++..++||+||| +.+=+|||||-.||++++.|.+|++|||.+..+. ..-....
T Consensus 98 slQdiy~~Tgp--lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit--ati~Krk 170 (829)
T KOG0576|consen 98 SLQDIYHVTGP--LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--ATIAKRK 170 (829)
T ss_pred cccceeeeccc--chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh--hhhhhhh
Confidence 99999876654 899999999999999999999 9999999999999999999999999999987653 2223345
Q ss_pred cccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC-CcCCC
Q 037258 556 AVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD-PSLQG 631 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~l~~ 631 (704)
...||+.|||||+.. .+.|..++|||++|+...|+---+.|........ +...... ..++ +.+..
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk----S~~qpp~lkD 239 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK----SGFQPPTLKD 239 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc----cCCCCCcccC
Confidence 678999999999875 5678999999999999999988777754332211 0111111 1111 11211
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...-.+.+.++++.|+..+|++||+++.++.
T Consensus 240 --k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 --KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233557889999999999999999988763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=227.96 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=190.5
Q ss_pred hcccccccCceEEEEEEeC----CCcEEEEEecccchh--hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 402 FERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCC--FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
..++||+|.|++||++... ..+.||+|.+..... ....|+++|..+ .+.||+++.+++..+++..+|+||++.
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 3689999999999999443 467899998865443 678899999998 599999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCC----
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIES---- 549 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~---- 549 (704)
..-.++... ++...+..++..++.||+++| ..|||||||||+|+|.+.. +.-.|.|||+|.......
T Consensus 120 ~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 120 DRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred cCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 999998876 778899999999999999999 9999999999999999854 568999999997321000
Q ss_pred ----------------------------CC----------cccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHH
Q 037258 550 ----------------------------SD----------QISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEI 590 (704)
Q Consensus 550 ----------------------------~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~el 590 (704)
.. .......||++|.|||++.. ..-+++.||||.|||++-+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 00 00113569999999999874 4568899999999999999
Q ss_pred HhCCCCCCCCCCCCcccHHHHHH---------HHHhcCC--ccc---------------ccC-CcCC---------CCCC
Q 037258 591 ITGRRPVISRAEDDTTHISQWVN---------SMLAEGD--IRN---------------IVD-PSLQ---------GNFD 634 (704)
Q Consensus 591 ltG~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~--~~~---------------~~d-~~l~---------~~~~ 634 (704)
++++.||.....+-. .+.+.+. .....+. +.+ -++ ..+. ....
T Consensus 272 ls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 272 LSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 999999976554322 2222110 0001111 000 000 0000 0111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+++.+|++.||.+|.|++|+|+
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 223347889999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=206.00 Aligned_cols=169 Identities=23% Similarity=0.260 Sum_probs=127.0
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.++++... ..+++.+++.++.|++.||+||| +.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999998643 34999999999999999999999 555 999999999999999 9998765321
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+..... .. ++... ...
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-~~------~~~~~-~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-AD------DPRDR-SNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-cC------Ccccc-ccH
Confidence 1257899999999999999999999999999999999999996443211 11111111111 00 00000 011
Q ss_pred hhHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 635 NNSAW--KAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 635 ~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..... ++.+++.+||..+|.+||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 22222 68999999999999999999999999876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=262.87 Aligned_cols=196 Identities=20% Similarity=0.225 Sum_probs=138.6
Q ss_pred hhcc-cceeEEEEEEE-------eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 037258 446 RVHH-RNLTALIGYCI-------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517 (704)
Q Consensus 446 ~l~h-~nIv~l~~~~~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 517 (704)
.++| +||.+++++|. +...++.++|++ +++|.+++.... ..+++.+++.++.||++||+||| +++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 4556 68888888772 334567888987 559999997543 34899999999999999999999 99999
Q ss_pred ecCCCCCCEEeCCCC-------------------cEEEEeccCccccccCCC--------------CcccccccCCCCcc
Q 037258 518 HRDVKSSNILLNEKL-------------------QAKIADFGLSRIFSIESS--------------DQISTAVAGTPGYL 564 (704)
Q Consensus 518 H~Dlkp~NIll~~~~-------------------~~kL~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~ 564 (704)
||||||+||||+..+ .+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455556665543210000 00011235788899
Q ss_pred CccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHH
Q 037258 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVEL 644 (704)
Q Consensus 565 aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 644 (704)
|||++.+..++.++|||||||+||||++|..|+..... ..... ... ...+.. ........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-----~~~----~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-----RHR----VLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-----HHh----hcChhh-----hhcCHHHHHH
Confidence 99999999999999999999999999999888642110 11111 000 011111 1112345688
Q ss_pred HHhccCCCCCCCCCHHHHHH
Q 037258 645 ALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 645 i~~cl~~dP~~RPs~~evl~ 664 (704)
+.+||+++|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 99999999999999999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=208.20 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=192.5
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
++..+|.+...|..|+|+++ |..+++|++... +.+|..|.-.|+.+.||||++++|.|..+.+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 45567899999999999996 455677777532 23778888899999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|+..++....-..+..++.+++.++|+|++|||+. .+-|.---|.+..|++|++.+++|+- +-+++ ....
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQE 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeec
Confidence 9999999998877788899999999999999999942 33444557899999999999888751 11111 1112
Q ss_pred ccccCCCCccCccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLN---EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~---~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
....-.+.|++||.++..+-+ .++|+|||++++|||.|...||.....-+-. ..+.-..++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccc
Confidence 234457899999999866433 5799999999999999999999765542211 1111123334
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
..+...+..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 455566778899999999999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-21 Score=204.48 Aligned_cols=270 Identities=19% Similarity=0.235 Sum_probs=200.3
Q ss_pred HhhhcccccccCceEEEEEEeCC--CcEEEEEecccchh----hHHHHHHHHHhhcc----cceeEEEEEE-EeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSCC----FQLLQVKLLMRVHH----RNLTALIGYC-IEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 467 (704)
.+.+.+.||+|+||.||.+.... ...+|+|....... ....|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45568899999999999997654 35789998754322 46678888888863 6888999888 47778899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-----CcEEEEeccCc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-----LQAKIADFGLS 542 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~DfGla 542 (704)
||+.+ |.+|.++........++..++++|+.|++.+|++|| +.|++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 779999887666566999999999999999999999 9999999999999999765 46999999999
Q ss_pred c--ccccCCCCc-----c-cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 037258 543 R--IFSIESSDQ-----I-STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS 614 (704)
Q Consensus 543 ~--~~~~~~~~~-----~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 614 (704)
+ .+....... . .....||..|++++...+...+.+.|+||++.++.|++.|..||......... ..+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHH
Confidence 8 332222110 1 23456999999999999999999999999999999999999999655432211 11111
Q ss_pred HHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCCCC
Q 037258 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGH 684 (704)
Q Consensus 615 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 684 (704)
...... ... +....+..+.++...+-..+..++|....+...|++.............++.
T Consensus 252 ~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 252 DPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred Hhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 111110 100 1122234566666666668999999999999999888776644444444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=208.50 Aligned_cols=157 Identities=18% Similarity=0.167 Sum_probs=122.6
Q ss_pred hhhcccccccCceEEEEEEeC--CCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD--DNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
|.+.+.||+|+||+||+|... +++.||||++... ...+.+|++++++++|+|+++.+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 556789999999999999664 5778899986422 2246889999999999999853322 2467999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCEEeCCCCcEEEEeccCcccccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV-KSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|||+++++|... .. .. ...++.+++++|.||| +.+|+|||| ||+|||++.++.+||+|||+++.+..
T Consensus 97 mE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 97 RGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999732 11 11 1467889999999999 999999999 99999999999999999999987754
Q ss_pred CCCCcc------cccccCCCCccCcccccc
Q 037258 548 ESSDQI------STAVAGTPGYLDPEYYVL 571 (704)
Q Consensus 548 ~~~~~~------~~~~~gt~~y~aPE~~~~ 571 (704)
...... .....+++.|.|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 332211 135678889999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=187.63 Aligned_cols=274 Identities=16% Similarity=0.195 Sum_probs=206.7
Q ss_pred HhhhcccccccCceEEEEE-EeCCCcEEEEEeccc--chhhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSS--SCCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.++||+|.||.++.| .+-++++||||.-.. ...+...|....+.| ..++|...+-+-.++.+-.||+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 3556899999999999999 456899999998643 344667788888877 4788988888878888889999988 7
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-----cEEEEeccCccccccCC
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-----QAKIADFGLSRIFSIES 549 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~DfGla~~~~~~~ 549 (704)
.||.|+..-..+. ++..++..+|+|++.-++|+| .+.+|.|||||+|+||...+ .+.++|||+|+.+.+..
T Consensus 108 PSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 108 PSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred cCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 7999998766543 999999999999999999999 99999999999999997543 58999999999875443
Q ss_pred CC-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 550 SD-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 550 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
.. .......||.+||+-....+..-+..-|+=|+|-++.+.+-|..||.+........-.+.+...-+...+.+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~- 262 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV- 262 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH-
Confidence 32 223457899999999999999999999999999999999999999988765433221111111111111111
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCCCCCC
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRD 686 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 686 (704)
+ .+..+.++..-+.-.-..+-.+-|..+-+...+..++........++.+|...
T Consensus 263 ----L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l 316 (449)
T KOG1165|consen 263 ----L----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL 316 (449)
T ss_pred ----H----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 1 11223344444444445577788998888888888887777666777776653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=225.12 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=185.3
Q ss_pred hcccccccCceEEEEEEe-CCCcEEEEEecc----cchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLS----SSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
...++|.|++|.|+.... ...+..+.|.+. .... ....|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 357899999998877733 333434444332 1111 12334555566799999888877777666666699
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++ +|..++..... +...++..++.|+..|++||| ..||.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 99999987633 788899999999999999999 99999999999999999999999999999987754444
Q ss_pred C--cccccccCCCCccCccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 551 D--QISTAVAGTPGYLDPEYYVLNWLNE-KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 551 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. .......|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... ......+......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~-- 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFE-- 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccccc--
Confidence 4 5667788999999999999988875 5799999999999999999997766544321 0000000000000
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
-........+.+...++.+||+.+|.+|.|+++|++
T Consensus 549 -~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 -GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000112344567789999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-19 Score=190.54 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=193.9
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccch-------hhHHHHHHHHHhhccc-ceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHR-NLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
...+.||.|+||.||++... ..+++|.+.... ..+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34678999999999999776 788999885433 2467788899999988 7999999998777789999999
Q ss_pred CCCCHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCC
Q 037258 473 ASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESS 550 (704)
Q Consensus 473 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~ 550 (704)
.++++.+++..... ..+.......++.|++.+++|+| ..+++|||+||+||+++..+ .++++|||.+..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999977765532 14888999999999999999999 89999999999999999988 799999999986533222
Q ss_pred Cc----ccccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHHHhcCCcc
Q 037258 551 DQ----ISTAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAED-DTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 551 ~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 622 (704)
.. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ...... ..+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH----HHHHhcCCc
Confidence 21 3466789999999999987 57889999999999999999999997554431 011111 111111111
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001000002223568899999999999999999988764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=219.97 Aligned_cols=240 Identities=22% Similarity=0.253 Sum_probs=178.6
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh--------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||++.|=+|.+|+.+.|. |+||++-+... +...|++ ...++|||.+++.-+...+...|+|-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 345688999999999999988887 99999854332 2234444 5566999999998887777777888888
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC-
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS- 550 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~- 550 (704)
..+ +|+|.+..+.- +...+.+-|+.|++.||..+| +.||+|||||.+||||+.-.-+.|+||..-+..-...+
T Consensus 103 vkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 876 99999987654 777888899999999999999 99999999999999999999999999987765321111
Q ss_pred ----CcccccccCCCCccCccccccC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 037258 551 ----DQISTAVAGTPGYLDPEYYVLN----------W-LNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNS 614 (704)
Q Consensus 551 ----~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 614 (704)
.........-.+|+|||.+... . .+++.||||+||++.||++ |++||.- .+...-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhH
Confidence 1112233445589999988631 2 6788999999999999998 6777732 111110
Q ss_pred HHhcCC-----cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 615 MLAEGD-----IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 615 ~~~~~~-----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.-.... +..+-| ..+++++..|++.||.+|.++++.|+.-++
T Consensus 248 r~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 000000 111111 146799999999999999999999987443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=175.98 Aligned_cols=202 Identities=22% Similarity=0.313 Sum_probs=167.1
Q ss_pred HHhhhcccccccCceEEEEE-EeCCCcEEEEEecccchh--hHHHHHHHHHhhcc-cceeEEEEEEEeCCeEEEEEeecC
Q 037258 398 ITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCC--FQLLQVKLLMRVHH-RNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
..+.+.++||+|+||.+|.| ...+|++||||+-+.... ....|.++.+.+++ ..|..+..+..+...-.+||+.+
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 34567899999999999999 567899999999876554 55778899998875 56777777778888889999988
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccccCCC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~~~~~~ 550 (704)
|.+|.+++.-..+. ++..+++-++-|++.-++|+| .+++|||||||+|+|..-+ ..+.++|||+++.+.+...
T Consensus 94 GPsLEdLfnfC~R~-ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRR-FTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred CccHHHHHHHHhhh-hhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 77999988755432 889999999999999999999 9999999999999999643 4689999999988743222
Q ss_pred -----CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037258 551 -----DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604 (704)
Q Consensus 551 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~ 604 (704)
........||.+|.+-....+..-+...|+-|+|.+|..+-.|..||.+.....
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 122345679999999888877777889999999999999999999998866543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=179.33 Aligned_cols=135 Identities=16% Similarity=0.185 Sum_probs=106.7
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh-------------h-----------------HHHHHHHHHhhcccce
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-------------F-----------------QLLQVKLLMRVHHRNL 452 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~-----------------~~~E~~~l~~l~h~nI 452 (704)
...||+|+||.||+|...+|+.||||+++.... . ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999887899999999864421 1 1238899999988776
Q ss_pred eEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCEEeCCC
Q 037258 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-HYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 453 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
.....+.. ...++||||++++++....... ..++......++.|++.+|.++ | +.+|+||||||+||++++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEEC-
Confidence 43333222 2238999999998776553222 2388999999999999999999 7 789999999999999984
Q ss_pred CcEEEEeccCcccc
Q 037258 532 LQAKIADFGLSRIF 545 (704)
Q Consensus 532 ~~~kL~DfGla~~~ 545 (704)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=195.75 Aligned_cols=218 Identities=27% Similarity=0.413 Sum_probs=165.7
Q ss_pred HHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eecCCC
Q 037258 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPI-VHRDVK 522 (704)
Q Consensus 444 l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~Dlk 522 (704)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.... ..+++.-...++++++.||+||| ..+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence 356789999999999999999999999999999999998743 34899999999999999999999 4444 999999
Q ss_pred CCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccC-------CCCcchhHHHHHHHHHHHHhCCC
Q 037258 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-------WLNEKSDVYSFGVVLLEIITGRR 595 (704)
Q Consensus 523 p~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvvl~elltG~~ 595 (704)
+.|.++|....+||+|||+....................-|.|||.+.+. ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998775321111111222344579999999853 14678999999999999999999
Q ss_pred CCCCCCCCCcc-cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 596 PVISRAEDDTT-HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 596 Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
||......... .+..++.. .....+.|.+... .+....+..++..||..+|.+||+++++-..++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99775543322 22222222 1112222222211 13344789999999999999999999999888876553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.6e-20 Score=179.49 Aligned_cols=171 Identities=15% Similarity=0.164 Sum_probs=131.3
Q ss_pred HHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchh----h---------HHHHHHHHHhhcccceeEEEEEE
Q 037258 393 SEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----F---------QLLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 393 ~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~---------~~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
.++.+..++..+++|.|+||.||.+.. ++..+|||++..... . +.+|++.+.++.|++|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 344555666689999999999999866 577899999964321 1 46788899999999999999886
Q ss_pred EeC--------CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 460 IEG--------NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 460 ~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
... +..++||||++|.+|.++.. ++. ....+++.+|..+| ..|++|||+||+||+++++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 643 35789999999999988742 232 24568999999999 9999999999999999998
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 592 (704)
+ ++|+|||.......+... ..+.....+..++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988654211110 013344456679999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=172.18 Aligned_cols=135 Identities=19% Similarity=0.236 Sum_probs=108.3
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh------------------------------hHHHHHHHHHhhcccce
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC------------------------------FQLLQVKLLMRVHHRNL 452 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~nI 452 (704)
...||+|++|.||+|...+|+.||||++..... ....|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 367999999999999877899999999864321 12467888999999987
Q ss_pred eEEEEEEEeCCeEEEEEeecCCCCHHHH-hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCC
Q 037258 453 TALIGYCIEGNNMGLIYEYMASGTLDQY-LKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNE 530 (704)
Q Consensus 453 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~ 530 (704)
.....+... ..++||||++++++... +... .++......++.|++.++.++| . .||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 544443332 24899999998865443 4322 3778899999999999999999 7 9999999999999999
Q ss_pred CCcEEEEeccCccccc
Q 037258 531 KLQAKIADFGLSRIFS 546 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~ 546 (704)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=168.32 Aligned_cols=184 Identities=17% Similarity=0.137 Sum_probs=141.3
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh--------hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecC
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
...|++|+||+||.+.. .+.+++.+.++.... .+.+|+++|+++. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999998866 678888887765544 3578999999995 5889999886 44699999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCEEeCCCCcEEEEeccCccccccCCCC-
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV-KSSNILLNEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
|.+|.+.+.. ....++.|++++|+++| ..||+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998765421 11357789999999999 999999999 799999999999999999999865322210
Q ss_pred ---cc-------cccccCCCCccCccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037258 552 ---QI-------STAVAGTPGYLDPEYYVLN-WLN-EKSDVYSFGVVLLEIITGRRPVISRAED 603 (704)
Q Consensus 552 ---~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~ 603 (704)
.. ......++.|++|+..... ..+ ...+.++-|.-+|.++|++.+...+.+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 00 1123467788888865432 223 5678899999999999999998766543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=204.45 Aligned_cols=253 Identities=17% Similarity=0.188 Sum_probs=188.8
Q ss_pred HHHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhhc---ccceeEEEEEEEeCCeEEE
Q 037258 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRVH---HRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 392 ~~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 467 (704)
.-++....+.+.+.||+|+||+||+|...+|+.||+|+-+.... ++.--.+++.+|+ -+.|..+...+.-.+.-+|
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 33444555666899999999999999888899999999876554 4544456666666 2334445555556778899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-------CCcEEEEecc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-------KLQAKIADFG 540 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kL~DfG 540 (704)
|+||.+.|+|.+++... +.++|.-+..++.|++..+++|| ..+||||||||+|+||.. ..-++|+|||
T Consensus 772 v~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999999844 44999999999999999999999 999999999999999942 2358999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.+-.+..-..........+|-.+-.+|+..|..++..+|.|.++.+++-|+.|+.-= ...+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g~ 908 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNGS 908 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCCc
Confidence 997776555566677788999999999999999999999999999999999997521 11111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
...++..++. +....+ .-+++..+|..|-..=|...++...+++++.
T Consensus 909 -~~~~~~~~~R-y~~~~~--W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 909 -SWMVKTNFPR-YWKRDM--WNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -ceeccccchh-hhhHHH--HHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111221111 111122 2356666666555555777888888877665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=176.85 Aligned_cols=224 Identities=18% Similarity=0.235 Sum_probs=140.1
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh----------cccceeEEEEEEE----
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV----------HHRNLTALIGYCI---- 460 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l----------~h~nIv~l~~~~~---- 460 (704)
.+.||.|+++.||.++.. +|+++|||++..... ...+|.-....+ .|-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999665 689999998743222 122222122111 1323332222221
Q ss_pred -----eC---C-----eEEEEEeecCCCCHHHHhhc---ccC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 037258 461 -----EG---N-----NMGLIYEYMASGTLDQYLKG---KKE--HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVK 522 (704)
Q Consensus 461 -----~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 522 (704)
.. . +.+++|+-+. +||.+++.. ... ..+....++.+..|+++.+++|| ..|++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence 11 1 2467888874 599888653 211 12445566777899999999999 9999999999
Q ss_pred CCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCcccccc--------CCCCcchhHHHHHHHHHHHHhCC
Q 037258 523 SSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL--------NWLNEKSDVYSFGVVLLEIITGR 594 (704)
Q Consensus 523 p~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlGvvl~elltG~ 594 (704)
|+|++++.+|.++|+||+.....+ ..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999998776532 11111 345578999997753 25788999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCC
Q 037258 595 RPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSER 656 (704)
Q Consensus 595 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 656 (704)
.||........... .+. ... +.++.+..||..+|+.+|.+|
T Consensus 248 lPf~~~~~~~~~~~-------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW-------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG-------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc-------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99976543221110 111 122 667789999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-19 Score=190.93 Aligned_cols=221 Identities=26% Similarity=0.292 Sum_probs=178.2
Q ss_pred cccccCceEEEEEE----eCCCcEEEEEecccchh------hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecC
Q 037258 405 VLGKGGFGEVYHGS----LDDNQQVAVKMLSSSCC------FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+|+|.||.|++++ .+.|..+|.|+++.... ....|..++..++ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999862 34567788888754322 3355777888887 9999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.|...+..... +.+.........++-+++++| +.+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999998876554 777778888889999999999 99999999999999999999999999999986532211
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
..||..|||||++. ....++|.||||++++||+||..||.. +.+..++.. ....
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 17899999999998 456889999999999999999999965 111222211 1123
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
+.+....+.+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 55566678899999999999999866
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-17 Score=159.09 Aligned_cols=130 Identities=18% Similarity=0.196 Sum_probs=102.0
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccc----hhhHHHHHHHHHhh-----cccceeEEEEEEEeCC---e-EEEEE
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS----CCFQLLQVKLLMRV-----HHRNLTALIGYCIEGN---N-MGLIY 469 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~lV~ 469 (704)
.+.||+|+||.||. ...++.. +||+.... .....+|+++++.+ .||||++++|++.++. . +.+|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 3334444 69987643 33678899999999 5799999999998863 3 33789
Q ss_pred ee--cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCEEeCC----CCcEEEEeccCc
Q 037258 470 EY--MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL-EYLHYGCKPPIVHRDVKSSNILLNE----KLQAKIADFGLS 542 (704)
Q Consensus 470 e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~DfGla 542 (704)
|| +.+|+|.+++.... +++. ..++.+++.++ +||| +++|+||||||+|||++. +..++|+||+.+
T Consensus 85 e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 55799999997632 5554 35677888777 9999 999999999999999974 347999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=164.44 Aligned_cols=198 Identities=23% Similarity=0.283 Sum_probs=141.8
Q ss_pred cccceeEEEEEEEe---------------------------CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHH
Q 037258 448 HHRNLTALIGYCIE---------------------------GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVD 500 (704)
Q Consensus 448 ~h~nIv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 500 (704)
+|||||++.++|.+ +..+|+||..++. +|.+++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 69999999887653 2357899998865 9999998665 566777889999
Q ss_pred HHHHHHHHhcCCCCCceecCCCCCCEEe--CCCC--cEEEEeccCccccccCC----CCcccccccCCCCccCccccccC
Q 037258 501 SAQGLEYLHYGCKPPIVHRDVKSSNILL--NEKL--QAKIADFGLSRIFSIES----SDQISTAVAGTPGYLDPEYYVLN 572 (704)
Q Consensus 501 ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 572 (704)
+++|+.||| ++||.|||+|++|||+ |+|+ .+.|+|||++-.-.... .....-...|...-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 9999999999999999 3443 57899999874311100 01112235677889999998643
Q ss_pred C-----C-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHH
Q 037258 573 W-----L-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELAL 646 (704)
Q Consensus 573 ~-----~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 646 (704)
. . -.|+|.|+.|.+.||+++...||....+..- +... .++..+ | ..+..++..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~-----Yqe~qL-----P----alp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT-----YQESQL-----P----ALPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh-----hhhhhC-----C----CCcccCChHHHHHHH
Confidence 2 1 2589999999999999999999976332110 1000 111111 1 234455667889999
Q ss_pred hccCCCCCCCCCHHHHHHHHH
Q 037258 647 ACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 647 ~cl~~dP~~RPs~~evl~~L~ 667 (704)
..|+.||.+|++..-....|+
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 999999999999776655543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=160.19 Aligned_cols=136 Identities=19% Similarity=0.219 Sum_probs=107.2
Q ss_pred hhhcccccccCceEEEEEE--eCCCcEEEEEecccch----------------------------hhHHHHHHHHHhhcc
Q 037258 400 NNFERVLGKGGFGEVYHGS--LDDNQQVAVKMLSSSC----------------------------CFQLLQVKLLMRVHH 449 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~----------------------------~~~~~E~~~l~~l~h 449 (704)
+.+.+.||+|++|.||+|. ..+|+.||||++.... .....|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3457899999999999997 5689999999886431 013568889999976
Q ss_pred cc--eeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCE
Q 037258 450 RN--LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP-IVHRDVKSSNI 526 (704)
Q Consensus 450 ~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NI 526 (704)
.. +.+++++ ...++||||+++++|........ .........++.|++.++++|| ..+ ++||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 33 4445543 23589999999988876653222 2556667899999999999999 899 99999999999
Q ss_pred EeCCCCcEEEEeccCcccc
Q 037258 527 LLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~ 545 (704)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=156.81 Aligned_cols=130 Identities=19% Similarity=0.372 Sum_probs=111.4
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.||+|++|.||+|.. .|..|++|+..... .....|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67789999764321 1346788999999999988877777777888999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
++|++|.+++.... . .+..++.+++.+|.+|| +.+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 78899999999999999 99999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-16 Score=152.54 Aligned_cols=132 Identities=17% Similarity=0.159 Sum_probs=106.0
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch--------------------------hhHHHHHHHHHhhcccc--
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--------------------------CFQLLQVKLLMRVHHRN-- 451 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~n-- 451 (704)
+.+.+.||+|+||.||++...+|+.||||++.... .....|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55678999999999999988889999999864321 02456788888888874
Q ss_pred eeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 452 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
+...++ ....++||||+++++|.+.... .....++.+++.++.++| ..+++||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 444443 2345899999999999776431 234678899999999999 8999999999999999999
Q ss_pred CcEEEEeccCccccc
Q 037258 532 LQAKIADFGLSRIFS 546 (704)
Q Consensus 532 ~~~kL~DfGla~~~~ 546 (704)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-16 Score=152.64 Aligned_cols=126 Identities=21% Similarity=0.372 Sum_probs=104.6
Q ss_pred cccccCceEEEEEEeCCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 405 VLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.||+|++|.||+|.+ ++..|++|+..... .....|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 57889999854321 13457899999999887665555666667789999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
+|++|.+++..... .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 78999999999999 99999999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-17 Score=172.45 Aligned_cols=173 Identities=25% Similarity=0.331 Sum_probs=129.6
Q ss_pred eEEEEEeecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
..++.|++|...+|.++|.+.. ....++...+.++.|++.|++| ++.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 4779999999999999997544 4457888999999999999998 67999999999999999999999999998
Q ss_pred cccccCC----CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 543 RIFSIES----SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 543 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
....... .....+...||..||+||.+.+..|+.|+||||||++|+|++. -..++... -....++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 7764333 1234456789999999999999999999999999999999997 22222100 0111112
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTD 661 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 661 (704)
.+.+ ...+..+. ..-..|+.+++.+.|.+||++.+
T Consensus 474 ~g~i--------p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII--------PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC--------ChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 2222 11111111 13348999999999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.7e-15 Score=170.09 Aligned_cols=128 Identities=20% Similarity=0.350 Sum_probs=106.4
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEe-cccc-----------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKM-LSSS-----------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
..+.||+|+||.||+|.+.+.. +++|+ .... ...+..|++++..++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3689999999999999875443 44443 2111 123567999999999999998888888777889999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
||+++++|.+++. ....++.+++++|.+|| +.+++||||||+||++ +++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999885 34678999999999999 9999999999999999 677999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-16 Score=175.17 Aligned_cols=207 Identities=24% Similarity=0.374 Sum_probs=142.5
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHh
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL 481 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 481 (704)
.++|..|++|.||..+++ ..+.+|+|+-+.. -+++ ||..+- +..+.| |+-...+
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~--------lilR-----nilt~a------~npfvv------gDc~tll 142 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILR-----NILTFA------GNPFVV------GDCATLL 142 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc--------hhhh-----cccccc------CCccee------chhhhhc
Confidence 478999999999999765 4677888654422 1121 111111 112222 4555555
Q ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC------------
Q 037258 482 KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES------------ 549 (704)
Q Consensus 482 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~------------ 549 (704)
+..+. ++. +++.+++||| +.+|+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 143 k~~g~--lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~ 209 (1205)
T KOG0606|consen 143 KNIGP--LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD 209 (1205)
T ss_pred ccCCC--Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHH
Confidence 54333 221 2277899999 9999999999999999999999999999987642111
Q ss_pred -CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-CcccccCC
Q 037258 550 -SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG-DIRNIVDP 627 (704)
Q Consensus 550 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~ 627 (704)
.........||+.|+|||++..+.|....|.|++|+|+||.+-|+.||.+...++- +...+... .+.+
T Consensus 210 t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i~wpE---- 279 (1205)
T KOG0606|consen 210 THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDIEWPE---- 279 (1205)
T ss_pred HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhccccc----
Confidence 11123356899999999999999999999999999999999999999988765432 11111111 1111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDV 662 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 662 (704)
-++....++.+++.++|+.+|.+|--....
T Consensus 280 -----~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 280 -----EDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred -----cCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 123334578899999999999999744433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=139.99 Aligned_cols=131 Identities=21% Similarity=0.230 Sum_probs=96.4
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh------hH----------------------HHHHHHHHhhcccc--e
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC------FQ----------------------LLQVKLLMRVHHRN--L 452 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~----------------------~~E~~~l~~l~h~n--I 452 (704)
.+.||+|+||.||+|...+++.||||++..... .. ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999888899999998764321 00 23445555554432 3
Q ss_pred eEEEEEEEeCCeEEEEEeecCCCCHHH-HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCC
Q 037258 453 TALIGYCIEGNNMGLIYEYMASGTLDQ-YLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNE 530 (704)
Q Consensus 453 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~ 530 (704)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++| . .+|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 444443 24589999999954421 121111 11 567889999999999999 7 9999999999999999
Q ss_pred CCcEEEEeccCcccc
Q 037258 531 KLQAKIADFGLSRIF 545 (704)
Q Consensus 531 ~~~~kL~DfGla~~~ 545 (704)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-14 Score=131.77 Aligned_cols=132 Identities=21% Similarity=0.188 Sum_probs=112.3
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcc--cceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHH--RNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
.+.||+|.++.||++...+ ..+++|...... ..+..|+.++..++| .++++++++...++..++++||++++.+.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 3679999999999998754 789999987654 367889999999987 58999999988888899999999987776
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 4466678899999999999943335799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=139.33 Aligned_cols=131 Identities=18% Similarity=0.216 Sum_probs=103.3
Q ss_pred ccccc-ccCceEEEEEEeCCCcEEEEEecccc-----------------hhhHHHHHHHHHhhcccce--eEEEEEEEeC
Q 037258 403 ERVLG-KGGFGEVYHGSLDDNQQVAVKMLSSS-----------------CCFQLLQVKLLMRVHHRNL--TALIGYCIEG 462 (704)
Q Consensus 403 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 462 (704)
...|| .||.|+||++... +..++||.+... .....+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999775 678899877431 1135679999999998885 6777765433
Q ss_pred C----eEEEEEeecCC-CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 463 N----NMGLIYEYMAS-GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 463 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
. ..++|+|++++ .+|.+++.... ++.. .+.+++.+|.+|| +.||+|+||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~---l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP---LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC---CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 69999886532 4443 3568999999999 9999999999999999998899999
Q ss_pred eccCccc
Q 037258 538 DFGLSRI 544 (704)
Q Consensus 538 DfGla~~ 544 (704)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.7e-15 Score=166.92 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=187.3
Q ss_pred hhhcccccccCceEEEEEEe--CCCcEEEEEecccchh------hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSCC------FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+|+.|-.... .....+|+|.+..... ....|..+-..+. |+|++.+++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 44556799999999988854 3345567776654321 1123555555565 9999999999999999999999
Q ss_pred ecCCCCHHHHh-hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCcccccc-
Q 037258 471 YMASGTLDQYL-KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSI- 547 (704)
Q Consensus 471 ~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~- 547 (704)
|..++++.+.+ .... ...+......++.|+..++.|+|. ..++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCc-cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999988 4332 135667778899999999999995 67899999999999999999 999999999988765
Q ss_pred CCCCcccccccC-CCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 548 ESSDQISTAVAG-TPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 548 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+. ....|.... +
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~------ 248 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---G------ 248 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---c------
Confidence 444555556678 9999999999884 567889999999999999999999976654432 112221111 0
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...............+++.+++..+|..|.+.+++..
T Consensus 249 --~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 --RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001112233446678999999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-12 Score=142.86 Aligned_cols=136 Identities=18% Similarity=0.164 Sum_probs=97.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchh--------------------------------------------hHHH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------------------------------------------FQLL 439 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~~ 439 (704)
+.||.|++|.||+|++.+|+.||||+.+.... ++..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421 1122
Q ss_pred HHHHHHhh----cccceeEEEEEE-EeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 037258 440 QVKLLMRV----HHRNLTALIGYC-IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ-GLEYLHYGCK 513 (704)
Q Consensus 440 E~~~l~~l----~h~nIv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~~~ 513 (704)
|.+.+.++ +|.+-+.+-..+ ......++||||++|++|.++....... . .+..++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHH---h
Confidence 33333333 222223332233 2234578999999999999876542211 2 23456666666 478889 8
Q ss_pred CCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 514 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
.|++|+|+||.||+++++++++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=134.22 Aligned_cols=200 Identities=24% Similarity=0.368 Sum_probs=140.8
Q ss_pred HHHHhhcccceeEEEEEEEeC-----CeEEEEEeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 037258 442 KLLMRVHHRNLTALIGYCIEG-----NNMGLIYEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKP 514 (704)
Q Consensus 442 ~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 514 (704)
.-|-++.|.||++++.|+.+. ....++.|||..|++.++|++.+ ...+......+++-||+.||.||| .|..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCC
Confidence 345567899999999998754 34778999999999999998654 344777788899999999999999 5699
Q ss_pred CceecCCCCCCEEeCCCCcEEEEeccCccccc--cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh
Q 037258 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFS--IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT 592 (704)
Q Consensus 515 ~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 592 (704)
+|+|+++..+-|++..++-+|+.--.-..... ............+-++|.+||+-.....+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888875321111000 0000111122346789999999888888899999999999999988
Q ss_pred CCCCCCCCCCCCcccHHHHHHHHHhcCCccc---ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 593 GRRPVISRAEDDTTHISQWVNSMLAEGDIRN---IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 593 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..--..... . .. .+..+.. .+...+ -.+++..|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS--~-~~--------~ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSES--K-VE--------VEENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcc--e-ee--------hhhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 7753211110 0 00 0001111 011111 126788999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.4e-12 Score=152.46 Aligned_cols=122 Identities=31% Similarity=0.571 Sum_probs=82.2
Q ss_pred CChhhHHHHHHhhhhcC----CCCCCC-CCCCCCCCCceeeeecCCCCCCCCceEEEEcCCCCCcccCchhhccccccce
Q 037258 190 TDEDDVNALRNIKSTYG----VKRNWQ-GDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEF 264 (704)
Q Consensus 190 ~~~~~~~al~~~~~~~~----~~~~w~-~~~c~~~~~~w~gv~c~~~~~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~ 264 (704)
+.++|..||.++|+.+. .+.+|+ ++.|| .|.||+|+. ..+++.|+|++|+++|.+|+.|..|++|+.
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~----~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNN----SSRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCC----CCcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 57899999999999873 356896 45565 699999973 235666666666666666666666666666
Q ss_pred EeccCCcccCCCCcccC-C----------------------CCCCCeEeccCCCCCCCcccccccccCCCccccccCC
Q 037258 265 LDLSNNSLSGTFPEFLS-K----------------------LPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 265 L~l~~N~l~g~iP~~~~-~----------------------l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
|+|++|+++|.+|..+. . +++|++|+|++|.++|.+|..++++++|+.|+|+.|.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 66666666666665433 4 4455555555555556666667777777777777664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=116.18 Aligned_cols=124 Identities=17% Similarity=0.165 Sum_probs=95.0
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhccccee-EEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLT-ALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
+.|+.|.++.||+++.. ++.|++|+..... .....|++++..+.+.+++ +++.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 56889999999999875 7789999986553 2467899999998766654 444433 334579999999988764
Q ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 480 YLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP-----IVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 480 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
. . . ....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~----~---~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E----D---F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c----c---c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 3 0 1 11345678999999999 666 59999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7e-12 Score=135.64 Aligned_cols=245 Identities=20% Similarity=0.178 Sum_probs=178.9
Q ss_pred HHhhhcccccc--cCceEEEEEEe---CCCcEEEEEeccc------chhhHHHHHHHHHhh-cccceeEEEEEEEeCCeE
Q 037258 398 ITNNFERVLGK--GGFGEVYHGSL---DDNQQVAVKMLSS------SCCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 398 ~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~------~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 465 (704)
.+..+.+.+|. |.+|.||.+.. .++..+|+|.-+. ......+|+...+++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34445678999 99999999965 4788899987332 122445666666666 499999988888899999
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEecc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ----GLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFG 540 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfG 540 (704)
++-+|++. .+|.++.+.... .++....+....+..+ ||.++| ..+++|-|+||.||+..++ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence 99999985 688888765432 2666777788888888 999999 9999999999999999999 889999999
Q ss_pred CccccccCCCCcc---cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 541 LSRIFSIESSDQI---STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 541 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
+...+....-... .....|...|++||...+ -++.+.|||++|.++.+..++..+........ |.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~----- 336 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS----- 336 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc-----
Confidence 9988754332211 122367788999997654 46889999999999999999877654331111 10
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+... .++.++...-..++...+..|++.+|-.|++.+++..
T Consensus 337 --~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 --QLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --ccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00111 1222233333345566899999999999999888764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.6e-10 Score=123.51 Aligned_cols=134 Identities=13% Similarity=0.177 Sum_probs=88.6
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEecccchh--------------------------------------------hHH
Q 037258 404 RVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC--------------------------------------------FQL 438 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------------------------------------------~~~ 438 (704)
+.||+|++|.||+|.+.+ |+.||||+...... ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999887 99999999864421 112
Q ss_pred HHHHHHHhh----cccceeEEEEEEEe-CCeEEEEEeecCCCCHHHHh--hcccCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 037258 439 LQVKLLMRV----HHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYL--KGKKEHMLNWVERLQIAVDSAQ-GLEYLHY 510 (704)
Q Consensus 439 ~E~~~l~~l----~h~nIv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 510 (704)
.|..-+.++ .+.+.+.+-..+.+ ....++||||++|+.+.++- ...+ .+... ++...++ -+..++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~---la~~~v~~~~~Qif- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKL---LAERGVEVFFTQVF- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHH---HHHHHHHHHHHHHH-
Confidence 233333333 23333444344432 45678999999999998753 2221 22211 2221111 123334
Q ss_pred CCCCCceecCCCCCCEEeCCCC----cEEEEeccCccccc
Q 037258 511 GCKPPIVHRDVKSSNILLNEKL----QAKIADFGLSRIFS 546 (704)
Q Consensus 511 ~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla~~~~ 546 (704)
..|++|+|+||.||+++.++ +++++|||++..++
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 68999999999999999888 99999999987653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.2e-10 Score=123.93 Aligned_cols=164 Identities=20% Similarity=0.181 Sum_probs=124.7
Q ss_pred EeCCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHH
Q 037258 418 SLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVE 493 (704)
Q Consensus 418 ~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~ 493 (704)
+..++.+|.|...+.... ...+.++.|+.++||||++++..++..+..|+|+|.+. .|..++... ....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHH
Confidence 445778888887765433 24556788999999999999999999999999999884 677777653 3566
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCC
Q 037258 494 RLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573 (704)
Q Consensus 494 ~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 573 (704)
....+.||+.||.+||+ +.+++|++|.-+.|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 77788999999999986 67899999999999999999999999998765321111 112222233566676543222
Q ss_pred CCcchhHHHHHHHHHHHHhCC
Q 037258 574 LNEKSDVYSFGVVLLEIITGR 594 (704)
Q Consensus 574 ~~~~sDVwSlGvvl~elltG~ 594 (704)
-..|.|.|||+++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3569999999999999993
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=134.04 Aligned_cols=120 Identities=36% Similarity=0.607 Sum_probs=93.3
Q ss_pred CCCCCCCCCC--CCc--eeeeecCCCC---------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCC
Q 037258 210 NWQGDPCVPK--NYW--WDGLNCSYED---------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTF 276 (704)
Q Consensus 210 ~w~~~~c~~~--~~~--w~gv~c~~~~---------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~i 276 (704)
.|.|--|... ... -.++..++.. ..+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+
T Consensus 403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i 482 (623)
T PLN03150 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482 (623)
T ss_pred ccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence 7999888421 111 2333332211 35689999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCeEeccCCCCCCCccccccccc-CCCccccccCCCCccccCC---ccccc
Q 037258 277 PEFLSKLPSLRALNLKRNKLTGSLPADLVERS-NNGSLTLSVDGNTSTTCSS---ESCKK 332 (704)
Q Consensus 277 P~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~-~l~~l~l~~~~n~s~~c~~---~~c~~ 332 (704)
|.++++|++|+.|+|++|+|+|.+|..+..+. ++.. +...+|+ .+|+. ..|..
T Consensus 483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~--l~~~~N~-~lc~~p~l~~C~~ 539 (623)
T PLN03150 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS--FNFTDNA-GLCGIPGLRACGP 539 (623)
T ss_pred chHHhcCCCCCEEECcCCcccccCChHHhhccccCce--EEecCCc-cccCCCCCCCCcc
Confidence 99999999999999999999999999987643 3443 4455665 56763 45653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-10 Score=108.89 Aligned_cols=131 Identities=16% Similarity=0.165 Sum_probs=96.5
Q ss_pred ccccccCceEEEEEEeCC-------CcEEEEEecccchh------------------------------hHHHHHHHHHh
Q 037258 404 RVLGKGGFGEVYHGSLDD-------NQQVAVKMLSSSCC------------------------------FQLLQVKLLMR 446 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~------------------------------~~~~E~~~l~~ 446 (704)
..||.|--+.||.|...+ +..+|||+++.... ....|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47999998642110 11368888888
Q ss_pred hcc--cceeEEEEEEEeCCeEEEEEeecCCCCHH-HHhhcccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCC
Q 037258 447 VHH--RNLTALIGYCIEGNNMGLIYEYMASGTLD-QYLKGKKEHMLNWVERLQIAVDSAQGLEYL-HYGCKPPIVHRDVK 522 (704)
Q Consensus 447 l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk 522 (704)
+.. -++.+++++ ...++||||+.+..+. ..++.. .++..+...+..+++.+|..| | +.++|||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 854 455566654 4568999999775442 223221 245556677889999999999 7 8899999999
Q ss_pred CCCEEeCCCCcEEEEeccCcccc
Q 037258 523 SSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 523 p~NIll~~~~~~kL~DfGla~~~ 545 (704)
+.||++++ +.+.|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=101.77 Aligned_cols=127 Identities=22% Similarity=0.302 Sum_probs=101.0
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
..+++|+-+.+|.+.+. |.++++|.-.+.. ....+|+.++.+++--.|.-..-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 4457777532211 1346789999998877776666677788888999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
++|-.|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888754 2456677777788899 99999999999999998875 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-09 Score=99.29 Aligned_cols=138 Identities=20% Similarity=0.248 Sum_probs=104.6
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecc-cch-----------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLS-SSC-----------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~-----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..+|-+|+-+.|+++.+ .|+..+||.-. +.. ....+|.++|.+++--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 36788999999999988 47777777532 111 134678899998876666655556667777789999
Q ss_pred ecCC-CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEeccCccc
Q 037258 471 YMAS-GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGLSRI 544 (704)
Q Consensus 471 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~ 544 (704)
|+++ .++.+++...-...........++..|-+.+.-|| ..+|+||||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 47888887655433444444788899999999999 99999999999999997655 458999998853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-09 Score=107.40 Aligned_cols=138 Identities=18% Similarity=0.222 Sum_probs=108.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch-----hhHHHHHHHHHhhccc--ceeEEEEEEEeC---CeEEEEEeecC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHR--NLTALIGYCIEG---NNMGLIYEYMA 473 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~lV~e~~~ 473 (704)
+.|+.|..+.||++...+|+.+++|+..... .....|++++..+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999988777899999976532 3668899999998763 456777777654 25689999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG------------------------------------------ 511 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 511 (704)
|.++.+.+.. ..++......++.+++++|..||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988776542 1267778888888899999888842
Q ss_pred -----------CCCCceecCCCCCCEEeCC--CCcEEEEeccCccc
Q 037258 512 -----------CKPPIVHRDVKSSNILLNE--KLQAKIADFGLSRI 544 (704)
Q Consensus 512 -----------~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~ 544 (704)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-10 Score=122.40 Aligned_cols=238 Identities=21% Similarity=0.187 Sum_probs=168.7
Q ss_pred cccccccCceEEEEEEe--CCCcEEEEEecccchhhH------HHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecC
Q 037258 403 ERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSCCFQ------LLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~------~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
...||.|.|+.|++... .++..+++|.+......+ ..|+.+...+ .|.+++.....+....+.++=-||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 57899999999999843 467889999876554422 4455555554 58888887777766677778899999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++...+.- ...+++..++++..|++.++.++| +..++|+|+||+||++..+ +..+++|||.+..+...
T Consensus 350 ~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 350 GGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred CcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee----
Confidence 9998776632 234778889999999999999999 9999999999999999886 78899999998643211
Q ss_pred ccccccCCCCc-cCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGY-LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y-~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......+..| .+++......+..+.|+||||..+.|.+++..--..... |. .+..-.-+...
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------~i~~~~~p~~~- 484 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------TIRSGDTPNLP- 484 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------eeecccccCCC-
Confidence 11111223334 355555677788999999999999999998754322111 00 01111111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.....+..+.+.+...++..||.+.++....+..
T Consensus 485 ----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 485 ----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1225677889999999999999999987765543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.4e-10 Score=103.92 Aligned_cols=85 Identities=36% Similarity=0.500 Sum_probs=80.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++++.|.||+|+|+ .+|+.|+.|.+|+.|+++||+++ .+|.++++|++|+.|+++-|+|. .+|..|+.++.|..|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4578899999999999 99999999999999999999999 99999999999999999999999 899999999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+|.+|+..
T Consensus 108 dltynnl~ 115 (264)
T KOG0617|consen 108 DLTYNNLN 115 (264)
T ss_pred hccccccc
Confidence 99998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5e-08 Score=99.76 Aligned_cols=137 Identities=15% Similarity=0.108 Sum_probs=100.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchh---------------hHHHHHHHHHhhcccce--eEEEEEEEe-----
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---------------FQLLQVKLLMRVHHRNL--TALIGYCIE----- 461 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~E~~~l~~l~h~nI--v~l~~~~~~----- 461 (704)
+.+-.-....|++..+ +|+.+.||....... .+.+|...+.++...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 577899997643221 26788888888854443 344555543
Q ss_pred CCeEEEEEeecCCC-CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-------CCc
Q 037258 462 GNNMGLIYEYMASG-TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-------KLQ 533 (704)
Q Consensus 462 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~ 533 (704)
....++|+|++++. +|.+++........+...+..++.+++..+.-|| ..||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999986 8999986432233566778899999999999999 999999999999999975 468
Q ss_pred EEEEeccCccc
Q 037258 534 AKIADFGLSRI 544 (704)
Q Consensus 534 ~kL~DfGla~~ 544 (704)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1e-08 Score=98.80 Aligned_cols=121 Identities=25% Similarity=0.324 Sum_probs=80.0
Q ss_pred EEEEEEeCCCcEEEEEecccchh------------------------------hHHHHHHHHHhhccc--ceeEEEEEEE
Q 037258 413 EVYHGSLDDNQQVAVKMLSSSCC------------------------------FQLLQVKLLMRVHHR--NLTALIGYCI 460 (704)
Q Consensus 413 ~Vy~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~--nIv~l~~~~~ 460 (704)
.||.|...+|..+|||+.+.... ...+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999888999999998743211 235688899998765 456666442
Q ss_pred eCCeEEEEEeecC--CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 461 EGNNMGLIYEYMA--SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEY-LHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 461 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
...+||||++ |..+..+.... ++......++.+++..+.. +| ..||+|||+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 55554443322 1123445677777775554 57 8999999999999999988 99999
Q ss_pred eccCcccc
Q 037258 538 DFGLSRIF 545 (704)
Q Consensus 538 DfGla~~~ 545 (704)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=100.27 Aligned_cols=164 Identities=16% Similarity=0.213 Sum_probs=126.8
Q ss_pred CceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEE----eCCeEEEEEeecCC-CCHHH
Q 037258 410 GFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCI----EGNNMGLIYEYMAS-GTLDQ 479 (704)
Q Consensus 410 ~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lV~e~~~~-gsL~~ 479 (704)
...+.|++.. -+|..+++|+++.... ....-++.++++.|.|+|++.+++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467899944 4899999999943332 3345588999999999999999887 34568999999986 56776
Q ss_pred Hhhccc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 480 YLKGKK-------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 480 ~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+.-... +...++...|.++.|+..||.++| +.|+.-+-|.+.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543211 234778999999999999999999 8999999999999999999999999998877654
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRR 595 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 595 (704)
.+.. |-+.+ -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3220 11111 246799999999999999965
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.8e-07 Score=95.61 Aligned_cols=257 Identities=16% Similarity=0.214 Sum_probs=157.5
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhh-cccceeEEEEEE----E--e-CCeEEEEEeecC
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRV-HHRNLTALIGYC----I--E-GNNMGLIYEYMA 473 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~nIv~l~~~~----~--~-~~~~~lV~e~~~ 473 (704)
.+.||+|+.+.+|-.- .-...+-|++..... .....+..|... .||-+..-+.+= . + +....++|..+.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~ 93 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVS 93 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCC
Confidence 5679999999999652 112235577654322 222333334333 454333212211 1 1 223667888776
Q ss_pred CCC-HHHHhhc----ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 474 SGT-LDQYLKG----KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 474 ~gs-L~~~l~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+.- +.+++.. +.-...+|.-.++++..++.+.+.|| ..|.+-||+.++|+|+++++.+.|.|=..-...
T Consensus 94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--- 167 (637)
T COG4248 94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--- 167 (637)
T ss_pred CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec---
Confidence 642 3333321 11234789999999999999999999 999999999999999999999999986543321
Q ss_pred CCCcccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCc--ccHHHHHHHHHhcCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITG-RRPVISRAEDDT--THISQWVNSMLAEGD 620 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG-~~Pf~~~~~~~~--~~~~~~~~~~~~~~~ 620 (704)
..........|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+...... ..+. ..+..+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia~g~ 243 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIAHGR 243 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhhcce
Confidence 2233334467888999999765 33456789999999999999986 999976432111 1111 0011111
Q ss_pred cccccCCc--CC---CCCC-hhHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHHhhhh
Q 037258 621 IRNIVDPS--LQ---GNFD-NNSAWKAVELALACASHT--SSERPTMTDVLMELKECLS 671 (704)
Q Consensus 621 ~~~~~d~~--l~---~~~~-~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~ 671 (704)
+...-+.. +. ...+ .-.+..+.-+..+|+... +.-|||++..+..|.+...
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 11111110 00 0111 122345667788888643 5689999999888776554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.7e-09 Score=81.80 Aligned_cols=61 Identities=44% Similarity=0.603 Sum_probs=54.5
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCC
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l 296 (704)
++|+.|+|++|+|+...+..|.++++|++|+|++|+++..-|..|..|++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999966667899999999999999999966667899999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.3e-08 Score=97.83 Aligned_cols=131 Identities=20% Similarity=0.210 Sum_probs=97.2
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh--------------------------hHHHHHHHHHhhccc--c
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------------------------FQLLQVKLLMRVHHR--N 451 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~E~~~l~~l~h~--n 451 (704)
+.+.+.||-|--+.||.|....|.++|||.-+.... ...+|+++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999997432111 346788899988655 6
Q ss_pred eeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 452 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
+.+.+++ +..++|||+++|--|...- ++......++..|++-+..+- ..||||||+++-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence 6666654 5678999999986554332 123334445555555555555 6789999999999999999
Q ss_pred CcEEEEeccCccc
Q 037258 532 LQAKIADFGLSRI 544 (704)
Q Consensus 532 ~~~kL~DfGla~~ 544 (704)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-09 Score=121.17 Aligned_cols=237 Identities=19% Similarity=0.240 Sum_probs=160.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+-+-+|.++.++.+.-. .|...++|+..... .....+-.++-..+||-++...--+.-....+||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 46778888888877432 33333444332211 11122222222234565555444434456788999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC-----C-
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE-----S- 549 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~-----~- 549 (704)
+|...++.... .+.......+..+.+++++|| ...+.|+|++|.|++...++..++.|||........ .
T Consensus 890 ~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 890 DLPSKLHNSGC--LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred CchhhhhcCCC--cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 99999987663 455555666777889999999 888999999999999999999999999844322100 0
Q ss_pred -----------------------CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037258 550 -----------------------SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606 (704)
Q Consensus 550 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~ 606 (704)
.........+|+.|.+||...+......+|.|++|++++|.++|..||........
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~- 1043 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI- 1043 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh-
Confidence 00112345689999999999999999999999999999999999999966554321
Q ss_pred cHHHHHHHHHhcCCcccccCCcCC-CCCChhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQ-GNFDNNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
+ ..+...... ...+........+++...+..+|.+|-.|.
T Consensus 1044 -----f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 -----F---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -----h---------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 111111111 112334455677889999999999998776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-08 Score=111.44 Aligned_cols=152 Identities=21% Similarity=0.261 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC-------CcccccccCCCCccCccccc
Q 037258 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS-------DQISTAVAGTPGYLDPEYYV 570 (704)
Q Consensus 498 ~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~ 570 (704)
+.+++.||.|+|. +.++||++|.|++|.++..+..||+.|+.+........ ............|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999996 78999999999999999999999999998765422111 11111223456899999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhcc
Q 037258 571 LNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACA 649 (704)
Q Consensus 571 ~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 649 (704)
....+.++|+||+|+++|.+.. |+.-+.......... .....+..-...+....+.++++=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999994 444443222111100 00011111111223556678899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 037258 650 SHTSSERPTMTDVLM 664 (704)
Q Consensus 650 ~~dP~~RPs~~evl~ 664 (704)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.6e-08 Score=107.14 Aligned_cols=166 Identities=21% Similarity=0.267 Sum_probs=100.9
Q ss_pred EEEcCeeeccCcccccceeeeEEeeeecCCceEEEEEeccCCCchhhHHHHHHHhhhhccC-CC-cCChhhHHHHHHhhh
Q 037258 126 ITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIYMVKNSS-QL-LTDEDDVNALRNIKS 203 (704)
Q Consensus 126 i~lng~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~l~~t~~S~lpPllna~e~~~~~~~~-~~-~~~~~~~~al~~~~~ 203 (704)
|.+.|+.++|..-|.-...++....+.+ ..|.-..+|-.+.++..+.-+... |. .+.-.++..|-.+++
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkL---------nrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKL---------NRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRS 82 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEe---------chhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHH
Confidence 4566777777666766655554333333 333335667777766655433222 22 122233333333332
Q ss_pred ---hcCCCCCCCCCCCCCCCCceeeeecCCCCCCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcc-
Q 037258 204 ---TYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF- 279 (704)
Q Consensus 204 ---~~~~~~~w~~~~c~~~~~~w~gv~c~~~~~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~- 279 (704)
.-+.+.+ .|-|- . .-.+..|+.||||+|+|. ..|..+-+-+++-.|+||+|++. +||..
T Consensus 83 v~~R~N~LKn-sGiP~------------d--iF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~l 145 (1255)
T KOG0444|consen 83 VIVRDNNLKN-SGIPT------------D--IFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSL 145 (1255)
T ss_pred Hhhhcccccc-CCCCc------------h--hcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchH
Confidence 2222222 12221 1 124567888888888888 78888888888888888888888 77764
Q ss_pred cCCCCCCCeEeccCCCCCCCcccccccccCCCccccccC
Q 037258 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVD 318 (704)
Q Consensus 280 ~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~ 318 (704)
+.+|+.|-+||||+|+|. .+|+.+..+..|++|.|+.|
T Consensus 146 finLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 146 FINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred HHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCC
Confidence 557888888888888888 77777777777777776655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.7e-07 Score=97.78 Aligned_cols=135 Identities=16% Similarity=0.148 Sum_probs=90.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchh--------------------------------------------hHHH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------------------------------------------FQLL 439 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~~ 439 (704)
+-|+.++-|.||+|++++|+.||||+...... +...
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999754322 1122
Q ss_pred HHHHHHhh----c-ccceeEEEEEE-EeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHH-HHHHhcCC
Q 037258 440 QVKLLMRV----H-HRNLTALIGYC-IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQG-LEYLHYGC 512 (704)
Q Consensus 440 E~~~l~~l----~-h~nIv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~ 512 (704)
|..-+.++ + .+++ ++=..| +-.+...|+|||++|-.+.+...-.. ...+... ++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~--- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHH---
Confidence 22223333 1 2333 222333 33466789999999998888743222 1244333 33333322 23333
Q ss_pred CCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 513 ~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
..|+.|+|.+|.||+++.++++.+.|||+...++
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 5689999999999999999999999999987764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.5e-06 Score=82.91 Aligned_cols=134 Identities=13% Similarity=0.095 Sum_probs=101.5
Q ss_pred ccccCceEEEEEEeCCCcEEEEEecc----------cchhhHHHHHHHHHhhcccc--eeEEEEEEE-e----CCeEEEE
Q 037258 406 LGKGGFGEVYHGSLDDNQQVAVKMLS----------SSCCFQLLQVKLLMRVHHRN--LTALIGYCI-E----GNNMGLI 468 (704)
Q Consensus 406 lG~G~~g~Vy~~~~~~~~~vavK~~~----------~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~----~~~~~lV 468 (704)
-|+||-+-|+...+++. .+-+|.-. .....+.+|+..+.++...+ +.+.. ++. . .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999877544 68888753 12236788999999886433 34444 332 1 1246799
Q ss_pred EeecCC-CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc--EEEEeccCccc
Q 037258 469 YEYMAS-GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--AKIADFGLSRI 544 (704)
Q Consensus 469 ~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~ 544 (704)
+|-+.+ -+|.+++........+...+..++.++++.+.-|| ..|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997763 58999987655445678888999999999999999 999999999999999986666 99999987654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-08 Score=92.80 Aligned_cols=147 Identities=20% Similarity=0.282 Sum_probs=92.5
Q ss_pred EeeeecCCceEEEEEeccCCCchhhHHHHHHHhhhhccCCCcCC--hhhHHHHHHhhhhcCCCCC-CCCCCCCCCCCcee
Q 037258 148 LSSVPVSGARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTD--EDDVNALRNIKSTYGVKRN-WQGDPCVPKNYWWD 224 (704)
Q Consensus 148 ~~~~~~~~~~~~~~l~~t~~S~lpPllna~e~~~~~~~~~~~~~--~~~~~al~~~~~~~~~~~~-w~~~~c~~~~~~w~ 224 (704)
++.+.++.+++ +.+||=|.-+.-+.+.++.+.... |.....|..+|-. ++-.+ .+.-|-
T Consensus 35 ITrLtLSHNKl---------~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~l-nvgmnrl~~lpr-------- 96 (264)
T KOG0617|consen 35 ITRLTLSHNKL---------TVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRIL-NVGMNRLNILPR-------- 96 (264)
T ss_pred hhhhhcccCce---------eecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhhe-ecchhhhhcCcc--------
Confidence 34455566655 567776665555555555544332 5555666555531 11000 000111
Q ss_pred eeecCCCCCCCCceEEEEcCCCCCcc-cCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccc
Q 037258 225 GLNCSYEDNNPSRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303 (704)
Q Consensus 225 gv~c~~~~~~~~~l~~l~L~~n~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~ 303 (704)
.-+.++.|..|||+.|+|.. .+|..|..|+.|+-|+|++|.|. .+|..+++|++|+.|.|..|.|- ++|..
T Consensus 97 ------gfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke 168 (264)
T KOG0617|consen 97 ------GFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE 168 (264)
T ss_pred ------ccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH
Confidence 02356778888888877764 56777777777777778888777 77777888888888888888777 67888
Q ss_pred cccccCCCccccccCCC
Q 037258 304 LVERSNNGSLTLSVDGN 320 (704)
Q Consensus 304 ~~~~~~l~~l~l~~~~n 320 (704)
++.++.|+.|++..|..
T Consensus 169 ig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 169 IGDLTRLRELHIQGNRL 185 (264)
T ss_pred HHHHHHHHHHhccccee
Confidence 88777777777665543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.1e-08 Score=99.09 Aligned_cols=84 Identities=25% Similarity=0.364 Sum_probs=70.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCccc----------------------CCCCcc-cCCCCCCCeEe
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS----------------------GTFPEF-LSKLPSLRALN 290 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~----------------------g~iP~~-~~~l~~L~~l~ 290 (704)
.+++|+.|+|++|-|. .+|.+++.+..|+.||||+|+|. |.+|.+ +.+|.+|++||
T Consensus 433 ~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 433 QLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD 511 (565)
T ss_pred hhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence 4688999999998888 89999999999999999988775 344433 77889999999
Q ss_pred ccCCCCCCCcccccccccCCCccccccCC
Q 037258 291 LKRNKLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 291 l~~N~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
|.+|.+. .||+.++++.++++|.++.|.
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCc
Confidence 9999999 899999999999988876553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.7e-06 Score=83.51 Aligned_cols=136 Identities=17% Similarity=0.227 Sum_probs=84.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcccc--eeEEEEEEEeCCeEEEEEeecCCCC-HH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRN--LTALIGYCIEGNNMGLIYEYMASGT-LD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gs-L~ 478 (704)
..||+|..+.||+. .+..+++|...... ....+|.++++.+..-. +.+.+++....+...+|||+++|.+ +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 46899999999984 24567889876533 24578999999887544 4677888877888899999999863 22
Q ss_pred HHh---------------------hcccCCCCCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCceecCCCCC
Q 037258 479 QYL---------------------KGKKEHMLNWVERLQ-IAV----------DSAQ-GLEYLHY-GCKPPIVHRDVKSS 524 (704)
Q Consensus 479 ~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~LH~-~~~~~ivH~Dlkp~ 524 (704)
..+ +.............. +.. .+.+ ...+|.. .....++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111 111000011111000 000 0011 1111110 12345789999999
Q ss_pred CEEeCCCCcEEEEeccCcc
Q 037258 525 NILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 525 NIll~~~~~~kL~DfGla~ 543 (704)
||++++++ +.++||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.4e-06 Score=83.37 Aligned_cols=104 Identities=21% Similarity=0.219 Sum_probs=83.2
Q ss_pred hHHHHHHHHHhhcccc--eeEEEEEEEeC----CeEEEEEeecCCC-CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH
Q 037258 436 FQLLQVKLLMRVHHRN--LTALIGYCIEG----NNMGLIYEYMASG-TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508 (704)
Q Consensus 436 ~~~~E~~~l~~l~h~n--Iv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L 508 (704)
...+|...+.++.... ..+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence 4577888877775433 45666666543 2457999999884 79999986443 56677889999999999999
Q ss_pred hcCCCCCceecCCCCCCEEeCCCC---cEEEEeccCccc
Q 037258 509 HYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGLSRI 544 (704)
Q Consensus 509 H~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~ 544 (704)
| ..||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9 99999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-07 Score=72.23 Aligned_cols=60 Identities=38% Similarity=0.500 Sum_probs=52.9
Q ss_pred cccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCC
Q 037258 260 TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 260 ~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
++|++|+|++|+|+..-+..|..+++|++|+|++|+++...|..|..+++|+.|+++.|.
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 478999999999994444689999999999999999997777799999999999988763
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.5e-08 Score=104.64 Aligned_cols=91 Identities=25% Similarity=0.343 Sum_probs=71.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCC-CCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT-GSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~~~~l~~ 312 (704)
++.+|+.||||+|+|+ .+.-..+...+|++|+||+|+|+ .+|+.+++|++|+.|.+.+|+|+ .-||..++.+.+|..
T Consensus 243 ~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev 320 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV 320 (1255)
T ss_pred hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence 4567888888888888 77777777888888888888888 88888889999999999888765 238888888888888
Q ss_pred cccccCCC---CccccC
Q 037258 313 LTLSVDGN---TSTTCS 326 (704)
Q Consensus 313 l~l~~~~n---~s~~c~ 326 (704)
+..++|.. |.++|-
T Consensus 321 f~aanN~LElVPEglcR 337 (1255)
T KOG0444|consen 321 FHAANNKLELVPEGLCR 337 (1255)
T ss_pred HHhhccccccCchhhhh
Confidence 87776653 334554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.4e-07 Score=95.29 Aligned_cols=81 Identities=27% Similarity=0.396 Sum_probs=62.3
Q ss_pred CCceEEEEcCCCCCcccCchhhc-cccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
++.|..|.++.|+|. .+|.+.+ +|.+|..|||.+|+|. ..|++++-|.+|..||||+|.++ .+|.+++++ .|+.|
T Consensus 227 cs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L 302 (565)
T KOG0472|consen 227 CSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL 302 (565)
T ss_pred cHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh
Confidence 456777788888887 7777766 8888888888888888 88888888888888888888888 577788777 66654
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
. ..|||
T Consensus 303 ~--leGNP 308 (565)
T KOG0472|consen 303 A--LEGNP 308 (565)
T ss_pred h--hcCCc
Confidence 3 44555
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=79.58 Aligned_cols=131 Identities=22% Similarity=0.232 Sum_probs=89.9
Q ss_pred cccccCceEEEEEEeCCCcEEEEEecccchhhH----------------------------HHHHHHHHhhc--ccceeE
Q 037258 405 VLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ----------------------------LLQVKLLMRVH--HRNLTA 454 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~--h~nIv~ 454 (704)
.|..|--+.||+|...++..+|||+++.....+ ..|+.-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577788889999988889999999986543322 34555555553 233344
Q ss_pred EEEEEEeCCeEEEEEeecCCCC-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc
Q 037258 455 LIGYCIEGNNMGLIYEYMASGT-LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ 533 (704)
Q Consensus 455 l~~~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 533 (704)
.+++. +-.|||||+.... -.-.|+... +.......+..++++.+.-|-. ..++||+||+.-|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 44443 3469999986531 111222211 2233566777888888888872 48999999999999999 779
Q ss_pred EEEEeccCcccc
Q 037258 534 AKIADFGLSRIF 545 (704)
Q Consensus 534 ~kL~DfGla~~~ 545 (704)
+.++|||-+...
T Consensus 205 p~iID~~QaV~~ 216 (268)
T COG1718 205 PYIIDVSQAVTI 216 (268)
T ss_pred EEEEECcccccc
Confidence 999999988654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.1e-06 Score=83.59 Aligned_cols=82 Identities=33% Similarity=0.476 Sum_probs=35.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCccc-CCCCCCCeEeccCCCCCCCcc--cccccccCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFL-SKLPSLRALNLKRNKLTGSLP--ADLVERSNN 310 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~-~~l~~L~~l~l~~N~l~g~~p--~~~~~~~~l 310 (704)
.+.+|+.|+|++|+|+ .++ .+..|+.|+.|+|++|+++ .++..+ ..+++|+.|+|++|++.. +- ..+..+++|
T Consensus 40 ~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L 115 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKL 115 (175)
T ss_dssp T-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT-
T ss_pred hhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCc
Confidence 3578999999999998 554 5888999999999999999 676545 468999999999999873 22 245556667
Q ss_pred CccccccCCCC
Q 037258 311 GSLTLSVDGNT 321 (704)
Q Consensus 311 ~~l~l~~~~n~ 321 (704)
..|+|. |||
T Consensus 116 ~~L~L~--~NP 124 (175)
T PF14580_consen 116 RVLSLE--GNP 124 (175)
T ss_dssp -EEE-T--T-G
T ss_pred ceeecc--CCc
Confidence 766554 555
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-06 Score=62.37 Aligned_cols=37 Identities=46% Similarity=0.709 Sum_probs=24.3
Q ss_pred cccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCC
Q 037258 260 TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297 (704)
Q Consensus 260 ~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~ 297 (704)
++|++|+|++|+|+ .||..+++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35667777777777 56666777777777777777766
|
... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.9e-07 Score=100.90 Aligned_cols=81 Identities=35% Similarity=0.499 Sum_probs=40.9
Q ss_pred CceEEEEcCCCCCcccCch-hhccccccceEeccCCcccCCCCcc----------------------cCCCCCCCeEecc
Q 037258 236 SRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEF----------------------LSKLPSLRALNLK 292 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~iP~~----------------------~~~l~~L~~l~l~ 292 (704)
.+|+.|+|+.|+|. .+|. .+.+|..|+.|+||+|+|+ .||+. +.++++|+.+|||
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS 460 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLS 460 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecc
Confidence 45555555555555 3332 3455555555555555555 44444 5555556666666
Q ss_pred CCCCCC-CcccccccccCCCccccccCC
Q 037258 293 RNKLTG-SLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 293 ~N~l~g-~~p~~~~~~~~l~~l~l~~~~ 319 (704)
.|+|+- .+|..+- -++|++|+|+.|-
T Consensus 461 ~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 461 CNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred cchhhhhhhhhhCC-CcccceeeccCCc
Confidence 665542 2222221 1556666555443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.6e-05 Score=76.11 Aligned_cols=127 Identities=15% Similarity=0.118 Sum_probs=82.3
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccchhhH-------------HHHHHHHHhhcc---cceeEEEEEEE-----
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ-------------LLQVKLLMRVHH---RNLTALIGYCI----- 460 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------~~E~~~l~~l~h---~nIv~l~~~~~----- 460 (704)
..+.+-......|.+-.. +|+.+++|......... .+.+..+.+++. .....++.+..
T Consensus 35 ~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~ 113 (229)
T PF06176_consen 35 IIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFR 113 (229)
T ss_pred EEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecc
Confidence 345565556666666665 46889999876543311 222333333332 22233232222
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 461 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
-....++||||++|..|.++.. ++. .++..+++++.-|| +.|++|+|.+|.|++++++ .++++||+
T Consensus 114 ~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 114 YTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred ceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 1245678999999988876643 222 24566778899999 9999999999999999966 49999998
Q ss_pred Ccc
Q 037258 541 LSR 543 (704)
Q Consensus 541 la~ 543 (704)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.1e-07 Score=84.41 Aligned_cols=83 Identities=33% Similarity=0.517 Sum_probs=29.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhc-cccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccc-cccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLV-ERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~l~ 311 (704)
++.+++.|+|.+|+|+ .|. .++ .|.+|+.|||++|.++ .++. +..|+.|++|+|++|+++ .+++.+. .+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 4568899999999999 564 566 6899999999999999 6764 888999999999999999 6765553 689999
Q ss_pred ccccccCCCC
Q 037258 312 SLTLSVDGNT 321 (704)
Q Consensus 312 ~l~l~~~~n~ 321 (704)
.|.|+.|.-.
T Consensus 92 ~L~L~~N~I~ 101 (175)
T PF14580_consen 92 ELYLSNNKIS 101 (175)
T ss_dssp EEE-TTS---
T ss_pred EEECcCCcCC
Confidence 9999877543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.7e-05 Score=86.16 Aligned_cols=153 Identities=19% Similarity=0.235 Sum_probs=97.0
Q ss_pred CCcccCHHHHHHHHh------------hh-cccccccCceEEEEEEeCCCcEEEEEecccchh-----------------
Q 037258 386 KSRQFAYSEIQKITN------------NF-ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----------------- 435 (704)
Q Consensus 386 ~~~~~~~~el~~~~~------------~~-~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------- 435 (704)
..+.++++|+.+.-. .| .+.||.-+.|.||+|++++|+.||||+-+....
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l 215 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVL 215 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHH
Confidence 345666666554432 23 378999999999999999999999998654322
Q ss_pred ------------------------hHHHHHH----HHHhhcccce---eEEEEEEE-eCCeEEEEEeecCCCCHHHH--h
Q 037258 436 ------------------------FQLLQVK----LLMRVHHRNL---TALIGYCI-EGNNMGLIYEYMASGTLDQY--L 481 (704)
Q Consensus 436 ------------------------~~~~E~~----~l~~l~h~nI---v~l~~~~~-~~~~~~lV~e~~~~gsL~~~--l 481 (704)
++..|.+ +.+.++|-+. |.+=.++. -.....|+||||+|.-+.|. |
T Consensus 216 ~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i 295 (538)
T KOG1235|consen 216 QKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI 295 (538)
T ss_pred HHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH
Confidence 1122222 2223345551 11222222 23567899999999887665 3
Q ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC----CCcEEEEeccCccccc
Q 037258 482 KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE----KLQAKIADFGLSRIFS 546 (704)
Q Consensus 482 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~DfGla~~~~ 546 (704)
...+ ++...+..-+.+...-+-+ ..|++|+|-+|.||+++. ++.+.+.|||+...+.
T Consensus 296 ~~~g---i~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 296 DKRG---ISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHcC---CCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3333 5555443333332221211 568999999999999984 6789999999987653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.2e-05 Score=72.51 Aligned_cols=102 Identities=24% Similarity=0.228 Sum_probs=81.7
Q ss_pred HHHHHHHHhhcc-cceeEEEEEEEeCCeEEEEEeecCCCCHHHH---hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 037258 438 LLQVKLLMRVHH-RNLTALIGYCIEGNNMGLIYEYMASGTLDQY---LKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513 (704)
Q Consensus 438 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 513 (704)
..|.-+++.+++ +++.+++|+|-. ++|.||...+++... +... ...+|..+.+||.++++.+++|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357778888876 699999999943 678999987766422 1111 126899999999999999999997655
Q ss_pred CCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 514 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
..+..+|++++|+-+++++++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 67888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-06 Score=93.09 Aligned_cols=86 Identities=26% Similarity=0.262 Sum_probs=72.5
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+..+..|+|+.|+++..-...+.+|++|+.|+||+|.+...-++.+..+++|+.|+||+|+++..-|.+|..++.|+.|+
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 56788899999999877777888999999999999999977788888889999999999999966667788888888888
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
|+.|.-
T Consensus 348 Ls~Nsi 353 (873)
T KOG4194|consen 348 LSHNSI 353 (873)
T ss_pred ccccch
Confidence 877753
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-05 Score=76.79 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=83.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccc--hhhHHHHHHHHHhhcccc--eeEEEEEEEe---CCeEEEEEeecCCCC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSS--CCFQLLQVKLLMRVHHRN--LTALIGYCIE---GNNMGLIYEYMASGT 476 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~---~~~~~lV~e~~~~gs 476 (704)
+.|+.|..+.||+....+ ..+++|..... ......|..+++.+.... +.+++.++.. ....+++|+++++..
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 568999999999998877 68999998765 235567888888885443 4567765533 345789999999988
Q ss_pred HHH----------------Hh---hccc--CCCCCHHH---------HHHH------------HHHHHH-HHHHHhc---
Q 037258 477 LDQ----------------YL---KGKK--EHMLNWVE---------RLQI------------AVDSAQ-GLEYLHY--- 510 (704)
Q Consensus 477 L~~----------------~l---~~~~--~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~--- 510 (704)
+.. .+ +... ........ .... ...+.+ .++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 777 11 1110 00011110 0000 111222 2333331
Q ss_pred -CCCCCceecCCCCCCEEeC-CCCcEEEEeccCccc
Q 037258 511 -GCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRI 544 (704)
Q Consensus 511 -~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~~ 544 (704)
.....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1356799999999999999 666668999997753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=8e-07 Score=78.51 Aligned_cols=79 Identities=28% Similarity=0.406 Sum_probs=68.6
Q ss_pred CCCceEEEEcCCCCCcccCchhhccc-cccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANL-TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
...+|+.++|++|.|. .+|+.|... +.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..+.++-.
T Consensus 51 ~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~ 127 (177)
T KOG4579|consen 51 KGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDM 127 (177)
T ss_pred CCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence 4568999999999999 777777654 69999999999999 99999999999999999999999 78888887777766
Q ss_pred ccc
Q 037258 313 LTL 315 (704)
Q Consensus 313 l~l 315 (704)
|+.
T Consensus 128 Lds 130 (177)
T KOG4579|consen 128 LDS 130 (177)
T ss_pred hcC
Confidence 554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=71.62 Aligned_cols=128 Identities=21% Similarity=0.360 Sum_probs=93.5
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccch--------------------hhHHHHHHHHHhhc------ccceeEEE
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--------------------CFQLLQVKLLMRVH------HRNLTALI 456 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------------~~~~~E~~~l~~l~------h~nIv~l~ 456 (704)
...||+|+.-.||. +.+....+||+..... .+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999997 5566778899987665 35567777666665 88999999
Q ss_pred EEEEeCCeEEEEEeecCC------CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 457 GYCIEGNNMGLIYEYMAS------GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 457 ~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
|+.+++....+|+|.+.+ .+|.+++.... ++. ...+.+.++ .+||- ..+|+.+|++|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEe
Confidence 999999999999998754 35888885543 554 444444444 45555 777999999999999953
Q ss_pred C--C--cEEEEe-ccCc
Q 037258 531 K--L--QAKIAD-FGLS 542 (704)
Q Consensus 531 ~--~--~~kL~D-fGla 542 (704)
. + .+.|+| ||..
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 2 2 577777 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-05 Score=75.56 Aligned_cols=137 Identities=15% Similarity=0.082 Sum_probs=83.8
Q ss_pred ccccCc-eEEEEEEeCCCcEEEEEecccch-hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCCCHHHHh-
Q 037258 406 LGKGGF-GEVYHGSLDDNQQVAVKMLSSSC-CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYL- 481 (704)
Q Consensus 406 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l- 481 (704)
|-.|.. ..||+.... +..+.||+..... .....|+++++.+. +--+.+++++...++..++|||+++|.+|....
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 84 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE 84 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence 344444 889999765 4788999876531 24567888888874 344567788777666788999999998776432
Q ss_pred ------------------hcccC--CCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CCCCC
Q 037258 482 ------------------KGKKE--HMLN--WVERLQIAV--------------------DSAQGLEYLHY----GCKPP 515 (704)
Q Consensus 482 ------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~~L~~LH~----~~~~~ 515 (704)
+.... ..+. ......... .+...+..|-. .....
T Consensus 85 ~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 164 (244)
T cd05150 85 ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV 164 (244)
T ss_pred ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence 11100 0011 000000000 01111222210 11456
Q ss_pred ceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 516 IVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 516 ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
++|+|+.|.|||++++..+.|+||+.+.
T Consensus 165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 165 VTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EECCCCCCccEEEeCCcEEEEEEccccc
Confidence 8999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.5e-06 Score=59.87 Aligned_cols=40 Identities=35% Similarity=0.598 Sum_probs=34.6
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP 277 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP 277 (704)
++|+.|+|++|+|+ .+|+.|++|++|+.|+|++|+|+ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 36899999999999 78999999999999999999999 554
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.7e-06 Score=87.63 Aligned_cols=89 Identities=29% Similarity=0.382 Sum_probs=72.7
Q ss_pred eecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccC-CCCCC
Q 037258 226 LNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR-NKLTG 298 (704)
Q Consensus 226 v~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~-N~l~g 298 (704)
|.|+..+ +.+...+.|+|..|+|+-..|..|+.|++|+.||||+|+|+-.-|+.|..|++|..|-|-+ |+|+
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~- 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT- 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence 8897544 4567889999999999966667899999999999999999977799999999988777655 9999
Q ss_pred Cccc-ccccccCCCcccc
Q 037258 299 SLPA-DLVERSNNGSLTL 315 (704)
Q Consensus 299 ~~p~-~~~~~~~l~~l~l 315 (704)
.+|. .|..+..++.|.+
T Consensus 130 ~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred hhhhhHhhhHHHHHHHhc
Confidence 6665 5677777665544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.3e-06 Score=93.47 Aligned_cols=182 Identities=20% Similarity=0.203 Sum_probs=131.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchhhHHHHHHHHHhhcccc-eeEEEEEEEeCCeEEEEEeecCCC-CHHHHh
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRN-LTALIGYCIEGNNMGLIYEYMASG-TLDQYL 481 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l 481 (704)
+-+++|+.+++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~ 326 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM 326 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC
Confidence 457889999999986544444445655433 35566889999999999 666677777777888999999877 222221
Q ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCC
Q 037258 482 KGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561 (704)
Q Consensus 482 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~ 561 (704)
... ...+...+...+...-.+++++|| +..=+|+| ||+..+ +..+..||+....+.... ......+++
T Consensus 327 ~~s-e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~ 394 (829)
T KOG0576|consen 327 TVS-EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTP 394 (829)
T ss_pred Chh-hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCC
Confidence 111 111333444556667788999999 55558888 777666 578999999887664322 345577899
Q ss_pred CccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 037258 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVI 598 (704)
Q Consensus 562 ~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~ 598 (704)
.++|||+.....+..+.|+|+.|+-..++.-|-+|-.
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999988888877777653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.5e-05 Score=86.10 Aligned_cols=85 Identities=27% Similarity=0.356 Sum_probs=73.6
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
++..+.|||++|+|+-.-+..|-+|.+|+.++|.+|.|+ .||.+.....+|+.|+|.+|.++..--+++..++.|++|+
T Consensus 77 p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 77 PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 456788999999999888889999999999999999999 9999877777899999999999865566788888888888
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
|+-|--
T Consensus 156 LSrN~i 161 (873)
T KOG4194|consen 156 LSRNLI 161 (873)
T ss_pred hhhchh
Confidence 887743
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.6e-05 Score=86.99 Aligned_cols=45 Identities=9% Similarity=0.083 Sum_probs=29.3
Q ss_pred HHHHhhhhccCCCcCChhhHHHHHHhhhhc---CCCCC----CCC--CCCCCCC
Q 037258 176 AMEIYMVKNSSQLLTDEDDVNALRNIKSTY---GVKRN----WQG--DPCVPKN 220 (704)
Q Consensus 176 a~e~~~~~~~~~~~~~~~~~~al~~~~~~~---~~~~~----w~~--~~c~~~~ 220 (704)
|++-...+.+....|.++++..+.++.+.+ +.+.+ |+| +.|.-..
T Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~ 99 (754)
T PRK15370 46 AQNCIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSE 99 (754)
T ss_pred HHHHHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCC
Confidence 344333445566678899999999888876 33444 875 6786444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=9.9e-06 Score=93.87 Aligned_cols=75 Identities=28% Similarity=0.389 Sum_probs=54.4
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
..|..|+|++|+|++ +|..+ ++|+.|+|++|+|+ .||... .+|+.|+|++|+|+ .+|..+.++++|..|+|
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 467788888888873 66543 56778888888887 477533 46777888888887 77888888888887777
Q ss_pred ccCC
Q 037258 316 SVDG 319 (704)
Q Consensus 316 ~~~~ 319 (704)
+.|.
T Consensus 453 s~N~ 456 (788)
T PRK15387 453 EGNP 456 (788)
T ss_pred CCCC
Confidence 6654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=6.6e-06 Score=84.88 Aligned_cols=90 Identities=22% Similarity=0.276 Sum_probs=79.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|||++|+|++.-+..|..+..|+.|.|..|+|.-.--..|..|..|+.|+|.+|+++-.-|..|..+..|..|
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l 351 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL 351 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence 67899999999999999999999999999999999999984444568899999999999999998899999999999988
Q ss_pred ccccCCCCccccC
Q 037258 314 TLSVDGNTSTTCS 326 (704)
Q Consensus 314 ~l~~~~n~s~~c~ 326 (704)
+|-.| | +.|.
T Consensus 352 ~l~~N--p-~~Cn 361 (498)
T KOG4237|consen 352 NLLSN--P-FNCN 361 (498)
T ss_pred ehccC--c-ccCc
Confidence 77644 4 4553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00025 Score=84.83 Aligned_cols=75 Identities=11% Similarity=0.219 Sum_probs=55.9
Q ss_pred cccccccCceEEEEEEeCCC---cEEEEEecccc-----hhhHHHHHHHHHhhc-ccce--eEEEEEEEeC---CeEEEE
Q 037258 403 ERVLGKGGFGEVYHGSLDDN---QQVAVKMLSSS-----CCFQLLQVKLLMRVH-HRNL--TALIGYCIEG---NNMGLI 468 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lV 468 (704)
.+.++.|.+..+|+....++ ..+++|+.... .....+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35688999999999877654 46788876432 235678999999995 6665 7888888764 467899
Q ss_pred EeecCCCCH
Q 037258 469 YEYMASGTL 477 (704)
Q Consensus 469 ~e~~~~gsL 477 (704)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00019 Score=67.05 Aligned_cols=126 Identities=20% Similarity=0.183 Sum_probs=87.0
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccchh--hHHHHHHHHHhhcccceeE-EEEEEEeCCeEEEEEeecCCCCHH
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTA-LIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
..+.||+|.+|.||+|.+. |..+|+|+-...+. ....|+++|..+...++.+ ++.|-. -.+.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchh
Confidence 3578999999999999986 45889998765544 6678999999988776654 444422 23559999998887
Q ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC-CCEEeCCCCcEEEEeccCccc
Q 037258 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKS-SNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp-~NIll~~~~~~kL~DfGla~~ 544 (704)
+.-... +-.+ ...+++.---|- ..||-|+.|.- ...++..+..+.|+||..|+.
T Consensus 101 ~~~~~~-----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG-----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc-----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 765432 1122 333444444455 77888888864 444444444899999998874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.72 E-value=7.1e-06 Score=81.54 Aligned_cols=77 Identities=27% Similarity=0.319 Sum_probs=50.3
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
+.|+.||||+|.|+ .|..++.-++.++.|+||+|.+. .+-. +..|++|+.||||+|.|+ .+-..-..+.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45777777777777 77777777777777777777777 4444 677777777777777776 33333233333444444
Q ss_pred c
Q 037258 316 S 316 (704)
Q Consensus 316 ~ 316 (704)
+
T Consensus 360 a 360 (490)
T KOG1259|consen 360 A 360 (490)
T ss_pred h
Confidence 3
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=1.1e-05 Score=91.65 Aligned_cols=80 Identities=34% Similarity=0.461 Sum_probs=57.3
Q ss_pred ceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccc
Q 037258 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~ 316 (704)
+|.+|||++|+++ ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|+|.+|++. .+|.++..+.+|+.|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3777777777776 67777777777777777777777 67777777777777777777777 677777777777777776
Q ss_pred cCC
Q 037258 317 VDG 319 (704)
Q Consensus 317 ~~~ 319 (704)
+|.
T Consensus 123 ~N~ 125 (1081)
T KOG0618|consen 123 FNH 125 (1081)
T ss_pred hhc
Confidence 664
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00064 Score=71.17 Aligned_cols=74 Identities=8% Similarity=0.004 Sum_probs=56.7
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccc--hhhHHHHHHHHHhhcc---cceeEEEEEEEeC---CeEEEEEeecCC
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS--CCFQLLQVKLLMRVHH---RNLTALIGYCIEG---NNMGLIYEYMAS 474 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lV~e~~~~ 474 (704)
.+.||.|..+.||+....++ .+.+|..+.. ...+..|.+.|+.+.. -.+.+++++|..+ +..++|||++++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 35799999999999876656 4677876542 2377889999988853 3678888887643 668999999998
Q ss_pred CCH
Q 037258 475 GTL 477 (704)
Q Consensus 475 gsL 477 (704)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00078 Score=67.94 Aligned_cols=70 Identities=19% Similarity=0.246 Sum_probs=48.4
Q ss_pred ccccccCceEEEEEEeCC--CcEEEEEecccchh---hHHHHHHHHHhhccccee-EEEEEEEeCCeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLT-ALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.|..|-...+|+....+ ++.|++|+...... ....|+.++..+...+++ ++++.+. -.+||||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999997764 67899998765332 335788888888644443 4444332 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00047 Score=69.64 Aligned_cols=71 Identities=14% Similarity=0.197 Sum_probs=45.2
Q ss_pred ccccccCce-EEEEEEeCCCcEEEEEecccc--hhhHHHHHHHHHhhccc---ceeEEEEEEEeC---CeEEEEEeecCC
Q 037258 404 RVLGKGGFG-EVYHGSLDDNQQVAVKMLSSS--CCFQLLQVKLLMRVHHR---NLTALIGYCIEG---NNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~---~~~~lV~e~~~~ 474 (704)
+.|+.|+.. .||+. +..+++|..+.. ......|.+++..+... .+.++++..... ...++||++++|
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 457777766 58975 235778886653 22567888888887532 344445443332 234789999998
Q ss_pred CCHH
Q 037258 475 GTLD 478 (704)
Q Consensus 475 gsL~ 478 (704)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=5.8e-05 Score=87.63 Aligned_cols=51 Identities=31% Similarity=0.361 Sum_probs=26.5
Q ss_pred ccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCC
Q 037258 261 AIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 261 ~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|... .+|..|+|+.|.
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~Nq 433 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQ 433 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCc
Confidence 4555666666665 35532 245566666666666 355432 234445555444
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0012 Score=63.98 Aligned_cols=131 Identities=24% Similarity=0.327 Sum_probs=90.1
Q ss_pred CCCcccCHHHHHHHHhhhcccccccCc-eEEEEEEeCCCcEEEEEeccc---c----------------------hhhHH
Q 037258 385 PKSRQFAYSEIQKITNNFERVLGKGGF-GEVYHGSLDDNQQVAVKMLSS---S----------------------CCFQL 438 (704)
Q Consensus 385 ~~~~~~~~~el~~~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~----------------------~~~~~ 438 (704)
|+...|+.. .....|.+.||.|.. |.||+++. +|+.+|+|+++. . ...+.
T Consensus 27 PKL~~F~~h---~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 27 PKLEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CCcCCcCCC---CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 344455551 134456789999999 99999998 467999999321 0 01345
Q ss_pred HHHHHHHhh---cccce--eEEEEEEEeC------------------CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHH
Q 037258 439 LQVKLLMRV---HHRNL--TALIGYCIEG------------------NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL 495 (704)
Q Consensus 439 ~E~~~l~~l---~h~nI--v~l~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~ 495 (704)
.|.+...++ .+.++ ++++||..-. ..+.||.||++... .+. .
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~ 167 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----I 167 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----h
Confidence 666666665 45566 8999998422 12468888876533 122 2
Q ss_pred HHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 496 ~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
+-+.+|.+-|..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 23456777788899 999999999999986 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00065 Score=69.58 Aligned_cols=134 Identities=13% Similarity=0.078 Sum_probs=78.8
Q ss_pred cccccCceEEEEEEeCCCcEEEEEecccchh----hHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 405 VLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
.+..|-.+.+|+... +++.+++|+...... ....|.++++.+....+ .+++.... -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356678889999874 567888998654322 35778889988865434 33444332 368999999866532
Q ss_pred H-----------------hhccc--CCCCCHHHH-HHHHHH---------HHHHHHHHhc-----CCCCCceecCCCCCC
Q 037258 480 Y-----------------LKGKK--EHMLNWVER-LQIAVD---------SAQGLEYLHY-----GCKPPIVHRDVKSSN 525 (704)
Q Consensus 480 ~-----------------l~~~~--~~~l~~~~~-~~i~~~---------ia~~L~~LH~-----~~~~~ivH~Dlkp~N 525 (704)
. ++... ...++.... .....+ +...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 111222111 111111 1111222211 113468999999999
Q ss_pred EEeCCCCcEEEEeccCccc
Q 037258 526 ILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 526 Ill~~~~~~kL~DfGla~~ 544 (704)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00015 Score=89.86 Aligned_cols=79 Identities=22% Similarity=0.287 Sum_probs=34.5
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
.+|+.|+|++|+|. .+|..+..|++|+.|+|++|...+.+|. ++.+++|+.|+|++|...+.+|.++.++.+|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 34444444444444 3444444444444444444333334442 444444444444444333344444444444444444
Q ss_pred c
Q 037258 316 S 316 (704)
Q Consensus 316 ~ 316 (704)
+
T Consensus 689 ~ 689 (1153)
T PLN03210 689 S 689 (1153)
T ss_pred C
Confidence 3
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0002 Score=88.92 Aligned_cols=84 Identities=24% Similarity=0.224 Sum_probs=72.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++++..+.+| .++++++|+.|+|++|...+.+|..+++|++|+.|+|++|..-+.+|..+ ++++|+.|
T Consensus 632 ~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L 709 (1153)
T PLN03210 632 SLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRL 709 (1153)
T ss_pred cCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEE
Confidence 47899999999987666887 48999999999999988777999999999999999999987666899876 78899988
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.+.
T Consensus 710 ~Lsgc~ 715 (1153)
T PLN03210 710 NLSGCS 715 (1153)
T ss_pred eCCCCC
Confidence 887653
|
syringae 6; Provisional |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 704 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-53 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-148
Identities = 112/303 (36%), Positives = 172/303 (56%), Gaps = 13/303 (4%)
Query: 380 NDSFAPKSRQFAYSEIQKITNNF--ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ 437
+ +S + ++++ TNNF + ++G G FG+VY G L D +VA+K + Q
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQ 77
Query: 438 -----LLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM--LN 490
+++ L H +L +LIG+C E N M LIY+YM +G L ++L G ++
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 491 WVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
W +RL+I + +A+GL YLH I+HRDVKS NILL+E KI DFG+S+ +
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610
+ST V GT GY+DPEY++ L EKSDVYSFGVVL E++ R ++ + ++++
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
W G + IVDP+L S K + A+ C + +S +RP+M DVL +L+ L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
Query: 671 SLE 673
L+
Sbjct: 315 RLQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-121
Identities = 113/292 (38%), Positives = 178/292 (60%), Gaps = 14/292 (4%)
Query: 388 RQFAYSEIQKITNNF--ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC------FQLL 439
++F+ E+Q ++NF + +LG+GGFG+VY G L D VAVK L FQ
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT- 76
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH--MLNWVERLQI 497
+V+++ HRNL L G+C+ L+Y YMA+G++ L+ + E L+W +R +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
A+ SA+GL YLH C P I+HRDVK++NILL+E+ +A + DFGL+++ + + ++TAV
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 195
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISR--AEDDTTHISQWVNSM 615
GT G++ PEY +EK+DV+ +GV+LLE+ITG+R A DD + WV +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667
L E + +VD LQGN+ + + +++AL C + ERP M++V+ L+
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-117
Identities = 95/305 (31%), Positives = 157/305 (51%), Gaps = 26/305 (8%)
Query: 385 PKSRQFAYSEIQKITNNFER--------VLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCF 436
+ F++ E++ +TNNF+ +G+GGFG VY G +++ VAVK L++
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDI 68
Query: 437 QLLQ--------VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH- 487
+ +K++ + H NL L+G+ +G+++ L+Y YM +G+L L
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
L+W R +IA +A G+ +LH + +HRD+KS+NILL+E AKI+DFGL+R
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH 607
+ +++ + GT Y+ PE + + KSD+YSFGVVLLEIITG V E
Sbjct: 186 FAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L 242
Query: 608 ISQWVNSMLAE-GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666
+ + E I + +D + + D+ S +A C ++RP + V L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 667 KECLS 671
+E +
Sbjct: 302 QEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-85
Identities = 77/314 (24%), Positives = 125/314 (39%), Gaps = 31/314 (9%)
Query: 387 SRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQV 441
+ + + V +G FG V+ L N+ VAVK+ +V
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEV 69
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMG----LIYEYMASGTLDQYLKGKKEHMLNWVERLQI 497
L + H N+ IG G ++ LI + G+L +LK ++++W E I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHI 126
Query: 498 AVDSAQGLEYLH-------YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
A A+GL YLH G KP I HRD+KS N+LL L A IADFGL+ F S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 551 DQISTAVAGTPGYLDPEY-----YVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
+ GT Y+ PE + D+Y+ G+VL E+ + ++
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 606 THISQWVNSMLAEGDIRNIV-----DPSLQGNFDNNSAWKAV-ELALACASHTSSERPTM 659
+ + + D++ +V P L+ + ++ + E C H + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 660 TDVLMELKECLSLE 673
V + + L
Sbjct: 307 GCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-66
Identities = 80/287 (27%), Positives = 139/287 (48%), Gaps = 37/287 (12%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQ-----VKLLM 445
+ ++ + +G G FG V+ VAVK+L + + V ++
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 446 RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-LNWVERLQIAVDSAQG 504
R+ H N+ +G + N+ ++ EY++ G+L + L L+ RL +A D A+G
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
+ YLH PPIVHR++KS N+L+++K K+ DFGLSR+ S+ S + AGTP ++
Sbjct: 150 MNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWM 206
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DI 621
PE NEKSDVYSFGV+L E+ T ++P + +Q V ++ + +I
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFKCKRLEI 260
Query: 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
++P + + C ++ +RP+ ++ L+
Sbjct: 261 PRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKML------SSSCCFQLLQ---- 440
+EI+ +E+ +GKGGFG V+ G + D VA+K L + + Q
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 441 -VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV 499
V ++ ++H N+ L G M + E++ G L L K H + W +L++ +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL-DKAHPIKWSVKLRLML 129
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-----LQAKIADFGLSRIFSIESSDQIS 554
D A G+EY+ PPIVHRD++S NI L + AK+ADFGLS+ S
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSV 183
Query: 555 TAVAGTPGYLDPEYYVLNWL----NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610
+ + G ++ PE + EK+D YSF ++L I+TG P D+ ++
Sbjct: 184 SGLLGNFQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKI 236
Query: 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
+M+ E +R P++ + + + C S +RP + ++ EL E
Sbjct: 237 KFINMIREEGLR----PTIPEDCP--PRLR--NVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-64
Identities = 75/322 (23%), Positives = 123/322 (38%), Gaps = 42/322 (13%)
Query: 389 QFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ---VKL 443
+ A SE +N + ++G+G +G VY GSLD + VAVK+ S + + +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINEKNIYR 60
Query: 444 LMRVHHRNLTALIGYCIEGNNMG-----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIA 498
+ + H N+ I G L+ EY +G+L +YL H +WV ++A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLA 117
Query: 499 VDSAQGLEYLH------YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS------ 546
+GL YLH KP I HRD+ S N+L+ I+DFGLS +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 547 IESSDQISTAVAGTPGYLDPEY-------YVLNWLNEKSDVYSFGVVLLEIITGRRPVIS 599
D + + GT Y+ PE ++ D+Y+ G++ EI +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 600 RAEDDTTHI--SQWVNSMLAEGDIRNIVD-----PSLQGNFDNNSAWKAV--ELALACAS 650
+ V + D++ +V P + NS E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 651 HTSSERPTMTDVLMELKECLSL 672
+ R T + E + +
Sbjct: 298 QDAEARLTAQXAEERMAELMMI 319
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-63
Identities = 55/293 (18%), Positives = 116/293 (39%), Gaps = 50/293 (17%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQ-----VKLLM 445
+ ++ F L + GE++ G + VK+L + + L
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 446 RVHHRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
H N+ ++G C + LI +M G+L L +++ + ++ A+D A+
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
G+ +LH +P I + S +++++E + A+I+ + F S P +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAW 174
Query: 564 LDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618
+ PE L + +D++SF V+L E++T P D +++ + + E
Sbjct: 175 VAPE--ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADLSNM-EIGMKVALE 226
Query: 619 G---DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
G I + P + +L C + ++RP ++ L++
Sbjct: 227 GLRPTIPPGISPHVS------------KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-62
Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 44/293 (15%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ--------VKL 443
++E+ E ++G GGFG+VY +VAVK + Q KL
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
+ H N+ AL G C++ N+ L+ E+ G L++ L GK+ + + AV A+
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--------AKIADFGLSRIFSIESSDQIST 555
G+ YLH PI+HRD+KSSNIL+ +K++ KI DFGL+R E
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKM 172
Query: 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615
+ AG ++ PE + ++ SDV+S+GV+L E++TG P D ++ V
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---RGIDGLAVAYGV--- 226
Query: 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
A + + + +L C + RP+ T++L +L
Sbjct: 227 -AMNKLA----LPIPSTCP--EPFA--KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-62
Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 37/287 (12%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHH 449
Y EI+ E V+G+G FG V + VA+K + S + ++ L RV+H
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-LNWVERLQIAVDSAQGLEYL 508
N+ L G C+ N + L+ EY G+L L G + + + +QG+ YL
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQ-AKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
H ++HRD+K N+LL KI DFG + T G+ ++ PE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DIRNI 624
+ + +EK DV+S+G++L E+IT R+P D+ + + + G +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671
+ + L C S S+RP+M +++ + +
Sbjct: 229 LPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-62
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 35/295 (11%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGY 458
+ +GKG +GEV+ G ++VAVK+ ++ F+ ++ + + H N+ I
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 459 CIEGN----NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH----- 509
I+G + LI +Y +G+L YLK L+ L++A S GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS--DQISTAVAGTPGYLDPE 567
KP I HRD+KS NIL+ + IAD GL+ F +++ D GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 568 YYVLNWL--------NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619
VL+ +D+YSFG++L E+ R E+ V S +
Sbjct: 217 --VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 620 DIRNIVD-----PSLQGNFDNNSAWKAV-ELALACASHTSSERPTMTDVLMELKE 668
D+R IV PS + ++ + + +L C +H + R T V L +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 32/286 (11%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ------VKLLM 445
+I + +G G FG VY G + VAVKML+ + V +L
Sbjct: 23 DGQIT-----VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 446 RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
+ H N+ +GY + ++ ++ +L +L E + + IA +A+G+
Sbjct: 76 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGM 133
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
+YLH I+HRD+KS+NI L+E KI DFGL+ S S ++G+ ++
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 566 PE---YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622
PE N + +SDVY+FG+VL E++TG+ P + + Q + M+ G +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQ-IIEMVGRGSLS 244
Query: 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
+ + K L C ERP+ +L E++E
Sbjct: 245 PDLSKVRS---NCPKRMK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-61
Identities = 61/297 (20%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLS-SSCCFQLLQ-----VKLLM 445
+ +++ ++GKG FG+VYHG + +VA++++ L+ V
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 446 RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
+ H N+ +G C+ ++ +I TL ++ K L+ + QIA + +G+
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGM 143
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS---TAVAGTPG 562
YLH I+H+D+KS N+ + + I DFGL I + + + G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 563 YLDPEYYVLNWL-----------NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
+L PE ++ L ++ SDV++ G + E+ P I
Sbjct: 200 HLAPE--IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQPAEAIIWQ 254
Query: 612 VNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
+ + + + + + ++ L C + ERPT T ++ L++
Sbjct: 255 MGTGMKPNLSQIGMGKEIS------------DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-61
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 31/293 (10%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGY 458
+GKG +GEV+ GS + VAVK+ SS F+ ++ + + H N+ I
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 459 CIEGNNMG----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH----- 509
+ + LI Y G+L YL+ L+ V L+I + A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS--DQISTAVAGTPGYLDPE 567
KP I HRD+KS NIL+ + Q IAD GL+ + S ++ D + GT Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 568 ------YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621
++ D+++FG+VL E+ R ED V + + D+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 622 RNIVD-----PSLQGNFDNNSAWKAV-ELALACASHTSSERPTMTDVLMELKE 668
R +V P++ + ++ ++ +L C S R T + L +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-58
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 35/295 (11%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ---VKLLMRVHHRNLTALIGY 458
+ +GKG FGEV+ G ++VAVK+ SS + + + + H N+ I
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 459 CIEGNNMG----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH----- 509
+ N L+ +Y G+L YL + + +++A+ +A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS--DQISTAVAGTPGYLDPE 567
KP I HRD+KS NIL+ + IAD GL+ + D GT Y+ PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 568 YYVLNWL--------NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619
VL+ +++D+Y+ G+V EI R + ED V S +
Sbjct: 222 --VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 620 DIRNIVD-----PSLQGNFDNNSAWKAV-ELALACASHTSSERPTMTDVLMELKE 668
++R +V P++ + + A + + ++ C + R T + L +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-58
Identities = 75/304 (24%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKML---SSSCCFQLLQ- 440
R F S++ VLGKG FG+ + + + + +K L L+
Sbjct: 3 PHRIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 441 VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVD 500
VK++ + H N+ IG + + I EY+ GTL +K + W +R+ A D
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKD 116
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD--------- 551
A G+ YLH I+HRD+ S N L+ E +ADFGL+R+ E +
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 552 ---QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608
+ V G P ++ PE +EK DV+SFG+VL EII D
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------DPDYLP 227
Query: 609 SQWVNSMLAEGDIRNIV----DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664
+ G + PS + + C +RP+ +
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEH 275
Query: 665 ELKE 668
L+
Sbjct: 276 WLET 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTAL 455
+G+G FGEV+ G L DN VAVK + L + ++L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
IG C + + ++ E + G +L+ + L LQ+ D+A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPGYLDPEYY 569
+HRD+ + N L+ EK KI+DFG+SR ++ T PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ +SDV+SFG++L E + G P
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
I F + +G G FG V+ G + +VA+K + + + + +++M++ H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L G C+E + L+ E+M G L YL+ + + L + +D +G+ YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------T 560
+HRD+ + N L+ E K++DFG++R D T+ G
Sbjct: 123 ACV------IHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPVKWA 172
Query: 561 PGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + + + KSDV+SFGV++ E+ + G+ P
Sbjct: 173 S----PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI + + E LG+G FGEV+ G+ + +VA+K L L + +++ ++ H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L E ++ EYM+ G+L +LKG+ L + + +A A G+ Y+
Sbjct: 240 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDP 566
+Y VHRD++++NIL+ E L K+ADFGL+R+ IE ++ + A P + P
Sbjct: 299 MNY------VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAP 350
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E + KSDV+SFG++L E+ T GR P
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI F + LG G FG V +G VA+KM+ + + + K++M + H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L G C + + +I EYMA+G L YL+ + H + L++ D + +EYL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------T 560
+ +HRD+ + N L+N++ K++DFGLSR D T+ G +
Sbjct: 139 KQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 188
Query: 561 PGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
P PE + + + KSD+++FGV++ EI + G+ P
Sbjct: 189 P----PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVK-----MLSSSCCFQLLQ-VKLLMRVHHRNLTA 454
F+ +G+G F VY G + +VA L+ S + + ++L + H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 455 LIGYCI----EGNNMGLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLE 506
+ L+ E M SGTL YLK K + + +W QI +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC--RQIL----KGLQ 143
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
+LH PPI+HRD+K NI + KI D GL+ + + AV GTP ++
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMA 198
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE Y +E DVY+FG+ +LE+ T P
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
+ LG G FG V G VAVKM+ + + + +M++ H L G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYGCKPP 515
C + + ++ EY+++G L YL+ + L + L++ D +G+ +L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQF----- 125
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGYLDPEY 568
+HRD+ + N L++ L K++DFG++R D + G + PE
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSA----PEV 176
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ + KSDV++FG+++ E+ + G+ P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI + + E LG+G FGEV+ G+ + +VA+K L L + +++ ++ H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L E ++ EYM+ G+L +LKG+ L + + +A A G+ Y+
Sbjct: 323 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDP 566
+Y VHRD++++NIL+ E L K+ADFGL+R+ IE ++ + A P + P
Sbjct: 382 MNY------VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAP 433
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E + KSDV+SFG++L E+ T GR P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-40
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHH 449
E+++ + LG G +GEVY G + VAVK L L + ++ + H
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
NL L+G C +I E+M G L YL+ ++ V L +A + +EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE---SSDQISTAVAGTPGYLDP 566
K +HR++ + N L+ E K+ADFGLSR+ + + + + T P
Sbjct: 336 ---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----P 388
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E N + KSDV++FGV+L EI T G P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI + + E+ LG G FGEV+ + + + +VAVK + L + ++ + H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L + +I E+MA G+L +LK + + + + A+G+ ++
Sbjct: 244 KLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------T 560
+Y +HRD++++NIL++ L KIADFGL+R+ D TA G T
Sbjct: 303 RNY------IHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWT 352
Query: 561 PGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE KSDV+SFG++L+EI+T GR P
Sbjct: 353 A----PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
LG G FGEV+ G + + +VAVK L L + L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYGCKPP 515
+ +I EYM +G+L +LK L + L +A A+G+ ++ +Y
Sbjct: 77 VTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY----- 130
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGYLDPEY 568
+HRD++++NIL+++ L KIADFGL+R+ D TA G T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTA----PEA 181
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
KSDV+SFG++L EI+T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 402 FERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIG 457
+ LG G +GEVY G + VAVK L L + ++ + H NL L+G
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYGCKP 514
C +I E+M G L YL+ ++ V L +A + +EYL ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---- 132
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGYLDPE 567
+HRD+ + N L+ E K+ADFGLSR+ + TA AG T PE
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTA----PE 182
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
N + KSDV++FGV+L EI T G P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 27/214 (12%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ--LLQVKLLMRVHHRN 451
+ + +GKG FG+V G +VAVK + + Q L + ++ ++ H N
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 247
Query: 452 LTALIGYCIEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
L L+G +E + ++ EYMA G+L YL+ + +L L+ ++D + +EYL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR-IFSIESSDQIS---TAVAGTPGY 563
++ VHRD+ + N+L++E AK++DFGL++ S + + ++ TA
Sbjct: 308 NNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------- 354
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + KSDV+SFG++L EI + GR P
Sbjct: 355 --PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ--LLQVKLLMRVHHRNLTALIGYC 459
+ +GKG FG+V G +VAVK + + Q L + ++ ++ H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 460 IEGN-NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYGCKPP 515
+E + ++ EYMA G+L YL+ + +L L+ ++D + +EYL ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----- 138
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPGYLDPEYY 569
VHRD+ + N+L++E AK++DFGL++ + ST G T PE
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PEAL 186
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ KSDV+SFG++L EI + GR P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 374 MEFENRNDSFAPKSRQFAYSEIQKITN-----NFE--RVLGKGGFGEVYHG-SLDDNQQV 425
M+ +++ P + ++ NF + +G+G F EVY L D V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 426 AVK------MLSSSCCFQLLQ-VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478
A+K ++ + ++ + LL +++H N+ IE N + ++ E +G L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 479 QYLKGKKEHMLNWVER--LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536
+ +K K+ ER + V LE++H ++HRD+K +N+ + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 177
Query: 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
D GL R FS + + V GTP Y+ PE N N KSD++S G +L E+ + P
Sbjct: 178 GDLGLGRFFS-SKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 402 FERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRN 451
E+++G G GEV +G L + VA+K L + F L + ++ + H N
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF-LSEASIMGQFDHPN 111
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL--- 508
+ L G G ++ EYM +G+LD +L+ + ++ + + G+ YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPG 562
Y VHRD+ + N+L++ L K++DFGLSR+ + D T G T
Sbjct: 171 GY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTA- 222
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + SDV+SFGVV+ E++ G RP
Sbjct: 223 ---PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 403 ERVLGKGGFGEVYHGSL---DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTA 454
+ LG G FG V G VA+K+L + + +++ ++ + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYG 511
LIG C M L+ E G L ++L GK+E + ++ + G++YL ++
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGYL 564
VHRD+ + N+LL + AKI+DFGLS+ + + D TA +
Sbjct: 132 -----VHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYA--- 181
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + +SDV+S+GV + E ++ G++P
Sbjct: 182 -PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVK-----MLSSSCCFQLLQ-VKLLMRVHHR 450
+ + +G+G FG+ S +D +Q +K +SS + + V +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
N+ E ++ ++ +Y G L + + +K + + L V L+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE--- 567
I+HRD+KS NI L + ++ DFG++R+ + + + + GTP YL PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICE 198
Query: 568 ---YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y N KSD+++ G VL E+ T +
Sbjct: 199 NKPY------NNKSDIWALGCVLYELCTLKHA 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 396 QKITNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSCCFQ----LLQVKLLMR- 446
+++ + +RV+GKG FG VYHG D Q A+K LS Q L+ LLMR
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 447 VHHRNLTALIGYCIEGNNMGLI-YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
++H N+ ALIG + + + YM G L Q+++ + + + + A+G+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGM 137
Query: 506 EYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
EYL + VHRD+ + N +L+E K+ADFGL+R I + +
Sbjct: 138 EYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARD--ILDRE-YYSVQQHRHA 188
Query: 563 YL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L E KSDV+SFGV+L E++T G P
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 402 FERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRN 451
+VLG G FG VY G VA+K L + + L + ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL--- 508
+ L+G C+ LI + M G L Y++ K++ + L V A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR 136
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPG 562
VHRD+ + N+L+ KI DFGL+++ + + ++ A G
Sbjct: 137 RL------VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMA- 187
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E + +SDV+S+GV + E++T G +P
Sbjct: 188 ---LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 58/243 (23%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLD-----DNQQVAVKMLSSSCCFQLLQ-----VKL 443
+K R LG+G FG+V D +QVAVK L + +++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 444 LMRVHHRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDS 501
L ++H N+ G C E GN + LI E++ SG+L +YL K +N ++L+ AV
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQI 135
Query: 502 AQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
+G++YL Y VHRD+ + N+L+ + Q KI DFGL++
Sbjct: 136 CKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAI------------- 176
Query: 559 GTPGYLDPEYYVLN--------W-----LNE-----KSDVYSFGVVLLEIIT-GRRPVIS 599
D EYY + W L + SDV+SFGV L E++T
Sbjct: 177 ----ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 600 RAE 602
A
Sbjct: 233 MAL 235
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 61/298 (20%), Positives = 124/298 (41%), Gaps = 58/298 (19%)
Query: 391 AYSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRV 447
A++ ++ +F+ ++G GGFG+V+ D + +K + + +VK L ++
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL 61
Query: 448 HHRNLTALIGYCIEGNNMG----------------LIYEYMASGTLDQYLKGKKEHMLNW 491
H N+ G + + E+ GTL+Q+++ ++ L+
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 492 VERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
V L++ +G++Y+H +++RD+K SNI L + Q KI DFGL +++
Sbjct: 122 VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 552 QISTAVAGTPGYLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
+ + + GT Y+ PE Y ++ D+Y+ G++L E++ ++
Sbjct: 177 KRTRSK-GTLRYMSPEQISSQDY------GKEVDLYALGLILAELLHVCDTAFETSK--- 226
Query: 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
++ D + FD K L S +RP +++L
Sbjct: 227 --------------FFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSEIL 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 402 FERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRN 451
++V+G G FGEV G L VA+K L F L + ++ + H N
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF-LGEASIMGQFDHPN 107
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL--- 508
+ L G + + ++ EYM +G+LD +L+ K + ++ + + A G++YL
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL---- 564
Y VHRD+ + NIL+N L K++DFGL R+ D A G +
Sbjct: 167 GY------VHRDLAARNILINSNLVCKVSDFGLGRVL----EDDPEAAYTTRGGKIPIRW 216
Query: 565 -DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE SDV+S+G+VL E+++ G RP
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVK-----MLSSSCCFQLLQ-VKLLMRVHHR 450
++E +G G +G D + + K ++ + L+ V LL + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 451 NLTALIGYCIEGNNMGL--IYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSAQGLE 506
N+ I+ N L + EY G L + + E L++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 507 YLHYGCKPP--IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
H ++HRD+K +N+ L+ K K+ DFGL+RI + + T V GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-GTPYYM 183
Query: 565 DPE------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE Y NEKSD++S G +L E+ P
Sbjct: 184 SPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSCCFQLLQVKLLM---- 445
I + ++LG+G FG V G+L + +VAVK + Q + L
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 446 --RVHHRNLTALIGYCIEGNNMG-----LIYEYMASGTLDQYLKGKK----EHMLNWVER 494
H N+ L+G CIE ++ G +I +M G L YL + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 495 LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
L+ VD A G+EYL ++ +HRD+ + N +L + + +ADFGLS+ I S D
Sbjct: 150 LKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGD 201
Query: 552 QISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
G + E KSDV++FGV + EI T G P
Sbjct: 202 ---YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 58/225 (25%), Positives = 84/225 (37%), Gaps = 36/225 (16%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSCCFQ-------LLQVK 442
I + LG G FG V G VAVK L Q + +V
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
+ + HRNL L G + ++ E G+L L+ + H + AV A
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVA 131
Query: 503 QGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+G+ YL + +HRD+ + N+LL + KI DFGL R + +D
Sbjct: 132 EGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHYVMQEH 183
Query: 560 -------TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + SD + FGV L E+ T G+ P
Sbjct: 184 RKVPFAWCA----PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 69/224 (30%), Positives = 111/224 (49%), Gaps = 34/224 (15%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCCFQ-----LLQVKL 443
EI ++V+G G FGEVY G L VA+K L + + L + +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
+ + H N+ L G + M +I EYM +G LD++L+ +K+ + ++ + + A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAA 158
Query: 504 GLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG- 559
G++YL +Y VHRD+ + NIL+N L K++DFGLSR+ +E + + +G
Sbjct: 159 GMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGG 210
Query: 560 ------TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
T PE SDV+SFG+V+ E++T G RP
Sbjct: 211 KIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSCCFQ----LLQVKLLM 445
+ +F V+G+G FG VYHG+L DN AVK L+ L ++M
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 446 R-VHHRNLTALIGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
+ H N+ +L+G C+ ++ YM G L +++ + + + + + A+
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 139
Query: 504 GLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
G++YL + VHRD+ + N +L+EK K+ADFGL+R + + + T
Sbjct: 140 GMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKE-YYSVHNKT 190
Query: 561 PGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L E KSDV+SFGV+L E++T G P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 62/243 (25%), Positives = 94/243 (38%), Gaps = 60/243 (24%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSCCFQLLQ-----VKL 443
K R LG+G FG+V D + VAVK L + Q + +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 444 LMRVHHRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDS 501
L ++H ++ G C + ++ L+ EY+ G+L YL H + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQI 143
Query: 502 AQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
+G+ YL HY +HRD+ + N+LL+ KI DFGL++
Sbjct: 144 CEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAV------------- 184
Query: 559 GTPGYLDPEYYVLN--------W-----LNE-----KSDVYSFGVVLLEIIT-GRRPVIS 599
EYY + W L E SDV+SFGV L E++T
Sbjct: 185 ----PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240
Query: 600 RAE 602
+
Sbjct: 241 PTK 243
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 403 ERVLGKGGFGEVYHGSL---DDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLT 453
++ LG G FG V G + VAVK+L + L + ++ ++ + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HY 510
+IG C + M L+ E G L++YL+ + + +++ + G++YL ++
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 138
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGY 563
VHRD+ + N+LL + AKI+DFGLS+ + + + A
Sbjct: 139 ------VHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA-- 188
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + KSDV+SFGV++ E + G++P
Sbjct: 189 --PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 65/224 (29%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 402 FERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSCCFQ------LLQVKLLMRVHHRN 451
R+LGKG FG V L +VAVKML + L + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 452 LTALIGYCIEGNNMG------LIYEYMASGTLDQYLK----GKKEHMLNWVERLQIAVDS 501
+ L+G + G +I +M G L +L G+ L ++ VD
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 502 AQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
A G+EYL ++ +HRD+ + N +L E + +ADFGLSR I S D
Sbjct: 147 ACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGD---YYRQ 195
Query: 559 GTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
G L E N SDV++FGV + EI+T G+ P
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 29/245 (11%)
Query: 378 NRNDSFAPKSRQFAYSEIQKITNN-----FERVLGKGGFGEVYHG-SLDDNQQVAVK--M 429
+ + R+ Y + + + F + LG+GGF V L D A+K +
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 430 LSSSCCFQLLQ--VKLLMRVHHRNLTALIGYCIEGNNMG----LIYEYMASGTLDQYLKG 483
+ Q + +H N+ L+ YC+ L+ + GTL ++
Sbjct: 64 CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 484 KKEHMLNWVER--LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541
K+ E L + + +GLE +H HRD+K +NILL ++ Q + D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 542 SRIFSIESSD-------QISTAVAGTPGYLDPE---YYVLNWLNEKSDVYSFGVVLLEII 591
I Q A T Y PE ++E++DV+S G VL ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 592 TGRRP 596
G P
Sbjct: 241 FGEGP 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSCCFQ----LLQVKLLM 445
+ +F V+G+G FG VYHG+L DN AVK L+ L ++M
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 446 R-VHHRNLTALIGYCIEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
+ H N+ +L+G C+ ++ YM G L +++ + + + + + A+
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 203
Query: 504 GLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
G+++L + VHRD+ + N +L+EK K+ADFGL+R + + S T
Sbjct: 204 GMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSV-HNKT 254
Query: 561 PGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L E KSDV+SFGV+L E++T G P
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 402 FERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNL 452
R +G+G FG+V+ G + VA+K + L + + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---H 509
LIG E +I E G L +L+ +++ L+ + A + L YL
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEY 568
+ VHRD+ + N+L++ K+ DFGLSR +E S + P ++ PE
Sbjct: 137 F------VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPES 188
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
SDV+ FGV + EI+ G +P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 63/223 (28%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ----LLQ-VKLLMRVHHR 450
R LG+G FG VY G + +VA+K ++ + + L ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--------LQIAVDSA 502
++ L+G +G +I E M G L YL+ + M N +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 503 QGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
G+ YL + VHRD+ + N ++ E KI DFG++R I +D G
Sbjct: 149 DGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD---YYRKG 197
Query: 560 TPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
G L PE SDV+SFGVVL EI T +P
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHR 450
F LG+ FG+VY G L + Q VA+K L L + L R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM--------------LNWVERLQ 496
N+ L+G + + +I+ Y + G L ++L + H L + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 497 IAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553
+ A G+EYL H VH+D+ + N+L+ +KL KI+D GL R + ++D
Sbjct: 133 LVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFRE--VYAAD-- 182
Query: 554 STAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L PE + + SD++S+GVVL E+ + G +P
Sbjct: 183 -YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLD-----DNQQVAVKMLSSSCCFQ---LLQ-VKLL 444
++ + LGKG FG V D VAVK L S Q + +++L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 445 MRVHHRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
+H + G ++ L+ EY+ SG L +L+ + L+ L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQIC 137
Query: 503 QGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+G+EYL VHRD+ + NIL+ + KIADFGL+++ ++ V
Sbjct: 138 KGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVR 187
Query: 560 TPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PG PE N + +SDV+SFGVVL E+ T +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQ----VAVKMLSSSCCFQ-----LLQVKLLMRVHHRNL 452
R+LG+G FGEVY G +++ VAVK C + + ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---H 509
LIG E +I E G L YL+ + ++ L + + ++ + + YL +
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP-GYLDPEY 568
VHRD+ NIL+ K+ DFGLSR IE D +V P ++ PE
Sbjct: 134 C------VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPES 185
Query: 569 YVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
SDV+ F V + EI++ G++P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 44/228 (19%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKML---SSSCCFQLLQ-VKLLMRVHHRN 451
+R LG+G FG+V+ D VAVK L + + + +LL + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--------------LQI 497
+ G C +G+ + +++EYM G L+++L+ + V+ L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 498 AVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
A A G+ YL H+ VHRD+ + N L+ L KI DFG+SR + S+D
Sbjct: 139 ASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTD--- 187
Query: 555 TAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
G L PE + +SDV+SFGV+L EI T G++P
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQ-----VAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+VLG G FG V+ G + V +K++ Q Q + + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL--- 508
+ L+G C + L+ +Y+ G+L +++ + L L V A+G+ YL
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEH 134
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPG 562
VHR++ + N+LL Q ++ADFG++ + + D+
Sbjct: 135 GM------VHRNLAARNVLLKSPSQVQVADFGVADL--LPPDDKQLLYSEAKTPIKWMA- 185
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E +SDV+S+GV + E++T G P
Sbjct: 186 ---LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 56/231 (24%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLD-----DNQQVAVKML---SSSCCFQLLQ-VKLL 444
+ ++ F + LGKG FG V D + VAVK L + + +++L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 445 MRVHHRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
+ H N+ G C N+ LI EY+ G+L YL+ KE ++ ++ LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQIC 124
Query: 503 QGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+G+EYL Y +HRD+ + NIL+ + + KI DFGL+++
Sbjct: 125 KGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVL-------------- 164
Query: 560 TPGYLDPEYYVLN--------W-----LNE-----KSDVYSFGVVLLEIIT 592
D E++ + W L E SDV+SFGVVL E+ T
Sbjct: 165 ---PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 27/246 (10%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-S 418
+ + +RV + E ++ + P + + + +F+ LG G +GEV+ S
Sbjct: 25 QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ------SFQRLSRLGHGSYGEVFKVRS 78
Query: 419 LDDNQQVAVKML-----SSSCCFQLLQ-VKLLMRV-HHRNLTALIGYCIEGNNMGLIYEY 471
+D + AVK + L V +V H L EG + L E
Sbjct: 79 KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531
+L Q+ + L + D+ L +LH +VH DVK +NI L +
Sbjct: 139 -CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR 193
Query: 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEI 590
+ K+ DFGL + ++ G P Y+ PE +L +DV+S G+ +LE+
Sbjct: 194 GRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE--LLQGSYGTAADVFSLGLTILEV 248
Query: 591 ITGRRP 596
Sbjct: 249 ACNMEL 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSCCFQ----LLQV 441
+I+ F LG+G F +++ G +V +K+L +
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDS 501
++ ++ H++L G C+ G+ L+ E++ G+LD YLK K +N + +L++A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122
Query: 502 AQGLEYL---HYGCKPPIVHRDVKSSNILLN--------EKLQAKIADFGLSRIFSIESS 550
A + +L +H +V + NILL K++D G+S +
Sbjct: 123 AAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPK 174
Query: 551 DQISTAVAGTPGYLDPE---YYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
D + + P PE LN +D +SFG L EI + G +P
Sbjct: 175 DILQERIPWVP----PECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 402 FERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+VLG G FG VY G VA+K L + + + ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL--- 508
+ L+G C+ LI + M G L Y++ K++ + L V A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR 136
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG------TPG 562
VHRD+ + N+L+ KI DFGL+++ + + ++ A G
Sbjct: 137 RL------VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMA- 187
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
E + +SDV+S+GV + E++T G +P
Sbjct: 188 ---LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 56/223 (25%)
Query: 402 FERVLGKGGFGEVYHGSLD-----DNQQVAVKML---SSSCCFQLLQ-VKLLMRVHHRNL 452
F + LGKG FG V D + VAVK L + + +++L + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 453 TALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL-- 508
G C N+ LI EY+ G+L YL+ KE ++ ++ LQ +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 163
Query: 509 -HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
Y +HRD+ + NIL+ + + KI DFGL+++ D E
Sbjct: 164 KRY------IHRDLATRNILVENENRVKIGDFGLTKVL-----------------PQDKE 200
Query: 568 YYVLN--------W-----LNE-----KSDVYSFGVVLLEIIT 592
YY + W L E SDV+SFGVVL E+ T
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 70/252 (27%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 377 ENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKML 430
EN +I + LG+G FG+V+ D VAVK L
Sbjct: 25 ENPQYFSDACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 431 SSSCCFQLLQ----VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKE 486
+ +LL + H+++ G C EG + +++EYM G L+++L+
Sbjct: 80 KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 139
Query: 487 HMLNWVER-------------LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNE 530
L +A A G+ YL H+ VHRD+ + N L+ +
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQ 193
Query: 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGV 585
L KI DFG+SR I S+D G L PE + +SDV+SFGV
Sbjct: 194 GLVVKIGDFGMSR--DIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248
Query: 586 VLLEIIT-GRRP 596
VL EI T G++P
Sbjct: 249 VLWEIFTYGKQP 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-35
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 403 ERVLGKGGFGEVYHGSL---DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHRNLTA 454
+ LG G FG V G VA+K+L + + +++ ++ + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL---HYG 511
LIG C M L+ E G L ++L GK+E + ++ + G++YL ++
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG-------TPGYL 564
VHR++ + N+LL + AKI+DFGLS+ + + D TA +
Sbjct: 458 -----VHRNLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYA--- 507
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE + +SDV+S+GV + E ++ G++P
Sbjct: 508 -PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 63/305 (20%)
Query: 397 KITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQ-VKLLMRVHHR 450
+ ++FE VLG+G FG+V + D++ A+K + +L V LL ++H+
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 451 NLTALIGYCIEGNNMGL----------IY---EYMASGTLDQYLKGKKEHMLNWVERLQI 497
+ +E N ++ EY +GTL + + E ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRL 121
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS----------- 546
+ L Y+H I+HRD+K NI ++E KI DFGL++
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 547 --IESSDQISTAVAGTPGYLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGRRPVI 598
SSD +++A+ GT Y+ E +Y NEK D+YS G++ E+I +
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 599 SRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPT 658
R +L +R++ +FD+N ++ H ++RP
Sbjct: 233 ERVN------------ILK--KLRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 659 MTDVL 663
+L
Sbjct: 278 ARTLL 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ-----LLQVKLLMRVHHR 450
R LG G FGEVY G + QVAVK L C Q L++ ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYL-----KGKKEHMLNWVERLQIAVDSAQGL 505
N+ IG ++ ++ E MA G L +L + + L ++ L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 506 EYL---HYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+YL H+ +HRD+ + N LL AKI DFG++R I + G
Sbjct: 154 QYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR---KG 202
Query: 560 TPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L PE ++ K+D +SFGV+L EI + G P
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 47/296 (15%)
Query: 332 KKKHKFVVPVVVSVAAFSTVLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFA 391
H + +P ++ + L + ++ M N N FA K+ +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQ---SPEYKLSKLRTSTIMTDYNPNYCFAGKTSSIS 63
Query: 392 YS-EI--QKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ----- 437
E+ + IT R LG G FGEVY G + QVAVK L C Q
Sbjct: 64 DLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 438 LLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM-----LNWV 492
L++ ++ + +H+N+ IG ++ ++ E MA G L +L+ + L +
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 493 ERLQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFS 546
+ L +A D A G +YL H+ +HRD+ + N LL AKI DFG++R
Sbjct: 182 DLLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR--D 233
Query: 547 IESSDQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
I + G L PE ++ K+D +SFGV+L EI + G P
Sbjct: 234 IYRAGYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 69/237 (29%), Positives = 102/237 (43%), Gaps = 53/237 (22%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHR 450
+ R +G+G FG V+ + VAVKML + L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---------------- 494
N+ L+G C G M L++EYMA G L+++L+ H + +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 495 ------LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545
L IA A G+ YL + VHRD+ + N L+ E + KIADFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR-- 222
Query: 546 SIESSDQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+I S+D A + PE N +SDV+++GVVL EI + G +P
Sbjct: 223 NIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 395 IQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ-VKLLMRV-HHRNL 452
+ KI+ + VLG G G + + + DN+ VAVK + C + V+LL H N+
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 80
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
+ + E A TL +Y++ +K+ +E + + + GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 513 KPPIVHRDVKSSNILLNEK-----LQAKIADFGLSRIFSI-ESSDQISTAVAGTPGYLDP 566
IVHRD+K NIL++ ++A I+DFGL + ++ S + V GT G++ P
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 567 EYYVLNW-----LNEKSDVYSFGVVLLEIITGRRP 596
E +L+ D++S G V +I+
Sbjct: 196 E--MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-34
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL----DDNQQVAVKML----SSSCCFQLLQ-VKLL 444
EIQ+ R +G+G FG+V+ G + VA+K S S + LQ +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 445 MRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQG 504
+ H ++ LIG E +I E G L +L+ ++ L+ + A +
Sbjct: 446 RQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTA 503
Query: 505 LEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561
L YL + VHRD+ + N+L++ K+ DFGLSR +E S + P
Sbjct: 504 LAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP 555
Query: 562 -GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
++ PE SDV+ FGV + EI+ G +P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 63/301 (20%), Positives = 110/301 (36%), Gaps = 64/301 (21%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKML----SSSCCFQLLQ-VKLLMRVHHRN 451
+FE + LG+GGFG V+ + D+ A+K + ++++ VK L ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 452 LTALIGYCIEGNNM---------GLIY---EYMASGTLDQYLKGKKE-HMLNWVERLQIA 498
+ +E N +Y + L ++ G+ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ------ 552
+ A+ +E+LH ++HRD+K SNI K+ DFGL + +Q
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 553 ----ISTAVAGTPGYLDPE------YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE 602
T GT Y+ PE Y + K D++S G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY-------PFS 228
Query: 603 DDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDV 662
+ D+RN+ P L F + S + ERP ++
Sbjct: 229 TQMERVRTL-------TDVRNLKFPPL---FTQKYP-CEYVMVQDMLSPSPMERPEAINI 277
Query: 663 L 663
+
Sbjct: 278 I 278
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 402 FERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSCCFQ----LLQVKLLMR--V 447
+ LG+G FG+V + VAVKML + L+ +M+
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------------- 494
H+N+ L+G C + + +I EY + G L +YL+ ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 495 -LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ A+G+EYL +HRD+ + N+L+ E KIADFGL+R I +
Sbjct: 159 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR--DINNI 210
Query: 551 DQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
D T G L PE +SDV+SFGV++ EI T G P
Sbjct: 211 D---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ----LLQ-VKLLMRV-HH 449
F + LG G FG+V + D +VAVKML S+ L+ +K++ + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM------------LNWVERLQI 497
N+ L+G C G + +I EY G L +L+ K + + + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 498 AVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
+ AQG+ +L + +HRDV + N+LL AKI DFGL+R I +
Sbjct: 170 SSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARD--IMNDS--- 218
Query: 555 TAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ L PE +SDV+S+G++L EI + G P
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 72/240 (30%)
Query: 402 FERVLGKGGFGEVYHGSLDDN---QQVAVKMLSSSCCFQLLQ-----VKLLMRV-HHRNL 452
F+ V+G+G FG+V + + A+K + + +++L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIA 498
L+G C + L EY G L +L+ + L+ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 499 VDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
D A+G++YL + +HRD+ + NIL+ E AKIADFGLSR
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR------------ 190
Query: 556 AVAGTPGYLDPEYYVLN--------W-----LNE-----KSDVYSFGVVLLEIIT-GRRP 596
E YV W LN SDV+S+GV+L EI++ G P
Sbjct: 191 ---------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 55/308 (17%), Positives = 118/308 (38%), Gaps = 44/308 (14%)
Query: 378 NRNDSFAPKSRQFAYSEIQKITNNFER--VLGKGGFGEVYHGSLDDNQQVAVKM-----L 430
+ + + + + + +G GG +V+ + Q A+K
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 431 SSSCCFQLLQ-VKLLMRVHHRNLT--ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEH 487
+ + L ++ + L Y I + ++ E + L+ +LK KK
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS- 123
Query: 488 MLNWVERLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546
++ ER + + + +H +G IVH D+K +N L+ + K+ DFG++
Sbjct: 124 -IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177
Query: 547 IESSDQISTAVAGTPGYLDPE-----------YYVLNWLNEKSDVYSFGVVLLEIITGRR 595
+++ + + GT Y+ PE + ++ KSDV+S G +L + G+
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 596 PVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSE 655
P + IS+ + I+DP+ + F + ++ C +
Sbjct: 238 PF----QQIINQISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283
Query: 656 RPTMTDVL 663
R ++ ++L
Sbjct: 284 RISIPELL 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 402 FERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSCCFQ----LLQVKLLMR--V 447
+ LG+G FG+V + VAVKML + L+ +M+
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------------- 494
H+N+ L+G C + + +I EY + G L +YL+ ++ + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 495 -LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ A+G+EYL +HRD+ + N+L+ E KIADFGL+R I +
Sbjct: 205 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARD--INNI 256
Query: 551 DQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
D T G L PE +SDV+SFGV++ EI T G P
Sbjct: 257 D---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 53/237 (22%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHR 450
+ LG+G FG+V + VAVKML + L+ +L +V+H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---------------- 494
++ L G C + + LI EY G+L +L+ ++ ++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 495 ------LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545
+ A +QG++YL VHRD+ + NIL+ E + KI+DFGLSR
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 546 SIESSDQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
+ D + V + G + E + +SDV+SFGV+L EI+T G P
Sbjct: 199 DVYEED---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 402 FERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSCCFQ----LLQVKLLMR--V 447
+ LG+G FG+V + +VAVKML S + L+ +M+
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------------- 494
H+N+ L+G C + + +I EY + G L +YL+ ++ L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 495 -LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ A A+G+EYL +HRD+ + N+L+ E KIADFGL+R I
Sbjct: 193 LVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARD--IHHI 244
Query: 551 DQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
D T G L PE +SDV+SFGV+L EI T G P
Sbjct: 245 D---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 47/231 (20%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQ----LLQVKLLMRV--HH 449
+ LG+G FG+V + VAVKML L+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 450 RNLTALIGYC-IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-------------- 494
N+ L+G C G + +I E+ G L YL+ K+ + +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 495 LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551
+ + A+G+E+L +HRD+ + NILL+EK KI DFGL+R I
Sbjct: 151 ICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP 202
Query: 552 QISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
V L PE +SDV+SFGV+L EI + G P
Sbjct: 203 ---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 32/226 (14%)
Query: 396 QKITNNF---ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMR 446
Q +N+ +LG+G V+ G A+K+ ++ + + ++L +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 447 VHHRNLTALIGYCIEGNNMGLIY---EYMASGTLDQYL-KGKKEHMLNWVERLQIAVDSA 502
++H+N+ L E E+ G+L L + + L E L + D
Sbjct: 64 LNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFSIESSDQISTAVA 558
G+ +L + IVHR++K NI+ + + K+ DFG +R E +Q +
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLY- 176
Query: 559 GTPGYLDPEYYVLNWL--------NEKSDVYSFGVVLLEIITGRRP 596
GT YL P+ Y L D++S GV TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVK--MLSSSCCFQLLQ--VKLLMRVHHRNLTALIGY 458
VLGKG +G VY G L + ++A+K S Q L + L + H+N+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCKPP 515
E + + E + G+L L+ K L E+ I + Q GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQ--- 142
Query: 516 IVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
IVHRD+K N+L+N KI+DFG S+ + + + GT Y+ PE +++
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE--IIDKG 198
Query: 575 NE----KSDVYSFGVVLLEIITGRRP 596
+D++S G ++E+ TG+ P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 48/232 (20%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VKLLMRV-HH 449
F + LG G FG+V + D VAVKML S + +K+L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--------------- 494
N+ L+G C G +I EY G L +L+ K++ +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 495 -LQIAVDSAQGLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
L + A+G+ +L + +HRD+ + NILL KI DFGL+R I++
Sbjct: 147 LLSFSYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLARD--IKND 198
Query: 551 DQISTAVAGTPGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
V L PE +SDV+S+G+ L E+ + G P
Sbjct: 199 SNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 76/282 (26%), Positives = 116/282 (41%), Gaps = 60/282 (21%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYS---EI--QKITNNFERVLGKGGFGEVYH 416
+ R + Q V++ + N+ F R++ Y E + + F +VLG G FG+V +
Sbjct: 6 QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLE--FGKVLGSGAFGKVMN 63
Query: 417 GSL------DDNQQVAVKMLSSSCCFQ----LLQ-VKLLMRV-HHRNLTALIGYCIEGNN 464
+ + QVAVKML L+ +K++ ++ H N+ L+G C
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVER---------------------LQIAVDSAQ 503
+ LI+EY G L YL+ K+E L A A+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 504 GLEYL---HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
G+E+L VHRD+ + N+L+ KI DFGL+R I S V
Sbjct: 184 GMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLAR--DIMSDSNY---VVRG 232
Query: 561 PGYL-----DPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
L PE KSDV+S+G++L EI + G P
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 55/280 (19%), Positives = 113/280 (40%), Gaps = 42/280 (15%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQVAVKM-----LSSSCCFQLLQ-VKLLMRVHHRNLT--AL 455
+ +G GG +V+ + Q A+K + + L ++ + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH-YGCKP 514
Y I + ++ E + L+ +LK KK ++ ER + + + +H +G
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE------- 567
IVH D+K +N L+ + K+ DFG++ +++ + + GT Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 568 ----YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
+ ++ KSDV+S G +L + G+ P + IS+ +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISK----------LHA 232
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
I+DP+ + F + ++ C +R ++ ++L
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 396 QKITNNF---ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMR 446
Q +N+ +LG+G V+ G A+K+ ++ + + ++L +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 447 VHHRNLTALIGYCIEGNNMGLIY---EYMASGTLDQYLKGKKEHMLNWVER--LQIAVDS 501
++H+N+ L E E+ G+L L+ + + E L + D
Sbjct: 64 LNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDV 121
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFSIESSDQISTAV 557
G+ +L + IVHR++K NI+ + + K+ DFG +R E +Q +
Sbjct: 122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLY 176
Query: 558 AGTPGYLDPEYYVLNWL--------NEKSDVYSFGVVLLEIITGRRP 596
GT YL P+ Y L D++S GV TG P
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTAL 455
+ LG GGFG V D +QVA+K + + ++++ +++H N+ +
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 456 I------GYCIEGNNMGLIYEYMASGTLDQYL-KGKKEHMLNWVERLQIAVDSAQGLEYL 508
+ L EY G L +YL + + L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 509 HYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
H + I+HRD+K NI+L ++L KI D G ++ + + + V GT YL
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV-GTLQYLA 191
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISR 600
PE D +SFG + E ITG RP +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 58/325 (17%), Positives = 123/325 (37%), Gaps = 42/325 (12%)
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFER--VLGKGGFGEVYHG 417
G++ ++ M+ + K+ A I + +G GG +V+
Sbjct: 16 GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75
Query: 418 SLDDNQQVAVKM-----LSSSCCFQLLQ-VKLLMRVHHRNLT--ALIGYCIEGNNMGLIY 469
+ Q A+K + + L ++ + L Y I + ++
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529
E + L+ +LK KK ++ ER + + + +H + IVH D+K +N L+
Sbjct: 136 EC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV 189
Query: 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE-----------YYVLNWLNEKS 578
+ K+ DFG++ +++ + + G Y+ PE + ++ KS
Sbjct: 190 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 579 DVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638
DV+S G +L + G+ P + IS+ + I+DP+ + F +
Sbjct: 249 DVWSLGCILYYMTYGKTPF----QQIINQISK----------LHAIIDPNHEIEFPDIPE 294
Query: 639 WKAVELALACASHTSSERPTMTDVL 663
++ C +R ++ ++L
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPELL 319
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 44/233 (18%), Positives = 79/233 (33%), Gaps = 35/233 (15%)
Query: 393 SEIQKITNNFE--RVLGKGGFGEVYHGSLDDN------QQVAVKMLSSSCCFQLLQVKLL 444
+E Q + +LG+G F +VY + D Q+ +K+ + ++ L
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 445 MR----VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQI 497
M + N L+ E + GTL + K E ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA-----------KIADFGLSRIFS 546
A+ +E +H I+H D+K N +L + D G S
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 547 IESSDQISTAVAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
+ I TA T G+ E +L+ W N + D + + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE--MLSNKPW-NYQIDYFGVAATVYCMLFGTYM 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 35/266 (13%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKM----LSSSCCFQLLQ 440
K + + +KI LG G G V+ S +A K+ + + Q+++
Sbjct: 26 KVGELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 441 -VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQ 496
+++L + + G + + E+M G+LDQ LK E +L +
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 135
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556
+++ +GL YL K I+HRDVK SNIL+N + + K+ DFG+S + D ++ +
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANS 189
Query: 557 VAGTPGYLDPE-----YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW 611
GT Y+ PE +Y + +SD++S G+ L+E+ GR P+ + +
Sbjct: 190 FVGTRSYMSPERLQGTHY-----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244
Query: 612 VNSMLAEGDIRNIVDPSLQGNFDNNS 637
A P N
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMD 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 48/237 (20%)
Query: 396 QKITNNFE--RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ------------- 440
K N++ R L +G F ++ DN+ A+K S +
Sbjct: 27 DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 441 --------VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWV 492
++++ + + G + + +IYEYM + ++ ++ + N+
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 493 ERLQIAVDS------AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546
+ I V Y+H + I HRDVK SNIL+++ + K++DFG S
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202
Query: 547 IESSDQISTAVAGTPGYLDPE-------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+I + GT ++ PE Y K D++S G+ L + P
Sbjct: 203 --VDKKIKGS-RGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVP 251
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 46/234 (19%), Positives = 78/234 (33%), Gaps = 45/234 (19%)
Query: 397 KITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVK-----MLSSSCCFQLLQ-VKLLMRV 447
+ T F +G G FG V+ D A+K + S L+ V +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 448 -HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSAQG 504
H ++ E ++M + EY G+L + M + E + + +G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNE-------------------KLQAKIADFGLSRIF 545
L Y+H +VH D+K SNI ++ K+ KI D G
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 546 SIESSDQISTAVAGTPGYLDPEYYVLNWL---NEKSDVYSFGVVLLEIITGRRP 596
S G +L E VL K+D+++ + ++
Sbjct: 185 SSPQV------EEGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 28/221 (12%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLS--SSCCFQLLQ--VKLLMRV-HHRNLTALI 456
RVL +GGF VY + ++ A+K L + + V + ++ H N+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 457 GYCIEGNNMG-------LIYEYMASGTLDQYLKGKKEH-MLNWVERLQIAVDSAQGLEYL 508
G L+ + G L ++LK + L+ L+I + + ++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA---------- 558
H KPPI+HRD+K N+LL+ + K+ DFG + S S
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 559 GTPGYLDPE---YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
TP Y PE Y + EK D+++ G +L + + P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 403 ERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSCC--------FQLLQVKLLMRVHHRNL 452
LG GG VY D N +VA+K + F+ +V ++ H+N+
Sbjct: 16 VDKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFER-EVHNSSQLSHQNI 73
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
++I E + L+ EY+ TL +Y++ L+ + G+++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
IVHRD+K NIL++ KI DFG+++ S S Q + V GT Y PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGE 187
Query: 573 WLNEKSDVYSFGVVLLEIITGRRP 596
+E +D+YS G+VL E++ G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKL----------LMR 446
+FE R LGKG FG VY +A+K+L + QL + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA---QLEKAGVEHQLRREVEIQSH 65
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
+ H N+ L GY + + LI EY GT+ + L+ K + A L
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTA-TYITELANALS 123
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
Y H ++HRD+K N+LL + KIADFG S+ + T + GT YL P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPP 176
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
E +EK D++S GV+ E + G+ P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 403 ERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSCC--------FQLLQVKLLMRVHHRNL 452
+LG GG EV+ D ++ VAVK+L + F+ + + ++H +
Sbjct: 17 GEILGFGGMSEVHLA-RDLRDHRDVAVKVLRADLARDPSFYLRFRR-EAQNAAALNHPAI 74
Query: 453 TALIGYCIEGNNMGLIY----EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
A+ G + EY+ TL + E + +++ D+ Q L +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFS 132
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST-AVAGTPGYLDPE 567
H + I+HRDVK +NI+++ K+ DFG++R + + T AV GT YL PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ ++ +SDVYS G VL E++TG P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 393 SEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--------- 440
+ I + +F+ +LGKG F VY S+ +VA+KM+ + +
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK---AMYKAGMVQRVQN 60
Query: 441 -VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQ 496
VK+ ++ H ++ L Y + N + L+ E +G +++YLK + + R Q
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556
I G+ YLH I+HRD+ SN+LL + KIADFGL+ ++ +
Sbjct: 121 II----TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ--LKMPHEKHYT 171
Query: 557 VAGTPGYLDPE-----YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ GTP Y+ PE + +SDV+S G + ++ GR P
Sbjct: 172 LCGTPNYISPEIATRSAH-----GLESDVWSLGCMFYTLLIGRPP 211
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 21/246 (8%)
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITN-NFERVLGKGGFGEVYHG- 417
+ +R+G + E +N K + Y +++ + +G+G FGEV+
Sbjct: 22 SGSAKLQRLGPETE---DNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78
Query: 418 SLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477
Q AVK + F++ ++ + + L G EG + + E + G+L
Sbjct: 79 DKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 478 DQYLK--GK-KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQ 533
Q +K G E + Q +GLEYLH I+H DVK+ N+LL+ +
Sbjct: 138 GQLIKQMGCLPEDRALYYLG-QAL----EGLEYLHTRR---ILHGDVKADNVLLSSDGSR 189
Query: 534 AKIADFGLSRIFSIESSDQISTA---VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEI 590
A + DFG + + + + GT ++ PE + + K D++S ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
Query: 591 ITGRRP 596
+ G P
Sbjct: 250 LNGCHP 255
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 51/335 (15%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ-VKLLMRV-HHRNLTALIGY 458
E++LG G G V + VAVK + C L +KLL H N+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKK-----EHMLNWVERLQIAVDSAQGLEYLHYGCK 513
+ + E L ++ K + + + A G+ +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133
Query: 514 PPIVHRDVKSSNILLNEK-------------LQAKIADFGLSRIFSIESSDQISTA--VA 558
I+HRD+K NIL++ L+ I+DFGL + S + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 559 GTPGYLDPE-------YYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQ 610
GT G+ PE L D++S G V I++ G+ P + ++
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES----- 248
Query: 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM-----E 665
N + + ++ D + +A +L H +RPT VL
Sbjct: 249 --NIIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
Query: 666 LKECLSLEIVRNEGHEKGHRDPRRMVTLNLDTESS 700
+ L + ++ E +RDP + + D S
Sbjct: 302 KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSD 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 29/215 (13%)
Query: 403 ERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSCCFQLLQV-----KLLMRVHHRNLTA 454
+ + GG G +Y LD + + V +K L S + + + L V H ++
Sbjct: 85 KGCIAHGGLGWIYLA-LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 455 LIGYCIEGNNMG-----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ + + G ++ EY+ +L + K L E + ++ L YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH 199
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+V+ D+K NI+L E+ Q K+ D G + + GTPG+ PE
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINS-FGYLYGTPGFQAPEI- 248
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD 604
V +D+Y+ G L + R D
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 403 ERVLGKGGFGEVY---HGSLDDNQQVAVKMLSSSCC--------FQLLQVKLLMRVHHRN 451
R++G+GG G+VY + + VA+K++S + Q + + R+ +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRE--RIVALKLMSETLSSDPVFRTRMQR-EARTAGRLQEPH 95
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH-Y 510
+ + + + + + L L+ ++ L + I L+ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
G HRDVK NIL++ A + DFG++ + E Q+ V GT Y+ PE +
Sbjct: 154 G----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFS 208
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRP 596
+ ++D+Y+ VL E +TG P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----------VKLLMRVHHRNL 452
R LGKGGF + + D + A K++ S LL+ + + + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS---LLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGLEYLH 509
G+ + + + ++ E +L + K +K + R QI G +YLH
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIV----LGCQYLH 132
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ ++HRD+K N+ LNE L+ KI DFGL+ +E + + GTP Y+ PE
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAPE-- 185
Query: 570 VLN--WLNEKSDVYSFGVVLLEIITGRRP 596
VL+ + + DV+S G ++ ++ G+ P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----------VKLLMRVHHRNL 452
R LGKGGF + + D + A K++ S LL+ + + + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS---LLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGLEYLH 509
G+ + + + ++ E +L + K +K + R QI G +YLH
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIV----LGCQYLH 158
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ ++HRD+K N+ LNE L+ KI DFGL+ +E + + GTP Y+ PE
Sbjct: 159 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAPE-- 211
Query: 570 VLN--WLNEKSDVYSFGVVLLEIITGRRP 596
VL+ + + DV+S G ++ ++ G+ P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKL----------LMR 446
++F+ R LGKG FG VY + +A+K+L S QL + +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS---QLEKEGVEHQLRREIEIQSH 70
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAVDSAQ 503
+ H N+ + Y + + L+ E+ G L + L+ K ++A
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELA----D 125
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
L Y H + ++HRD+K N+L+ K + KIADFG S+ + + GT Y
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRTMCGTLDY 178
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
L PE +EK D++ GV+ E + G P
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKML---SSSCCFQLLQ--VKLLMRVHHRNLTALIGY 458
V+G G V ++VA+K + L ++ + + HH N+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---QIAV---DSAQGLEYLHYGC 512
+ + + L+ + ++ G++ +K + L IA + +GLEYLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFG----LSRIFSIESSDQISTAVAGTPGYLDPE- 567
K +HRDVK+ NILL E +IADFG L+ I + T V GTP ++ PE
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 568 -----YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y + K+D++SFG+ +E+ TG P
Sbjct: 198 MEQVRGY-----DFKADIWSFGITAIELATGAAP 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 405 VLGKGGFGEVYHG-SLDDNQQVAVKML---SSSCCFQLLQ--VKLLMRVHHRNLTALIGY 458
+GKG FGEV+ G + VA+K++ + + +Q + +L + +T G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCKPP 515
++ + +I EY+ G+ L+ ++ QIA + +GL+YLH
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLH---SEK 139
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
+HRD+K++N+LL+E + K+ADFG++ + + GTP ++ PE + +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 576 EKSDVYSFGVVLLEIITGRRP 596
K+D++S G+ +E+ G P
Sbjct: 198 SKADIWSLGITAIELARGEPP 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKM----LSSSCCFQLLQ- 440
S + +++ I LG+G +G V + Q +AVK ++S +LL
Sbjct: 1 SMEVKADDLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD 55
Query: 441 VKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL--QI 497
+ + MR V G ++ + E M +LD++ K + E + +I
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
AV + LE+LH ++HRDVK SN+L+N Q K+ DFG+S +
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDI-D 169
Query: 558 AGTPGYLDPE----------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
AG Y+ PE Y + KSD++S G+ ++E+ R P
Sbjct: 170 AGCKPYMAPERINPELNQKGY------SVKSDIWSLGITMIELAILRFP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 386 KSRQFAYSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCF----QLLQ 440
+ Q ++++ + +G G G+V+ +AVK + S ++L
Sbjct: 18 QRYQAEINDLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72
Query: 441 -VKLLMR-VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERL 495
+ ++++ + G I ++ + E M + + + E +L
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG----- 127
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
++ V + L YL ++HRDVK SNILL+E+ Q K+ DFG+S ++ +
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAK--D 182
Query: 556 AVAGTPGYLDPEYYVLNWL-------NEKSDVYSFGVVLLEIITGRRP 596
AG Y+ PE ++ + ++DV+S G+ L+E+ TG+ P
Sbjct: 183 RSAGCAAYMAPE--RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 29/238 (12%), Positives = 64/238 (26%), Gaps = 50/238 (21%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMR---------------- 446
VLG+ + + V + + +K +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 447 -------------VHHRNLTALIGYCIEGNNMGLIYEYM----ASGTLDQYLK-----GK 484
V +I ++ +M ++ + L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 485 KEHMLNWVERLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543
L RLQ+ + + L LH YG +VH ++ +I+L+++ + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 544 IFSIESSDQISTAVAGTPGYLDPE-----YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
S+ P + + D ++ G+ + I P
Sbjct: 260 RDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/213 (24%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVH 448
+ ++K+ G+G +G VY + Q VA+K + Q + + ++ +
Sbjct: 31 FDVLEKL--------GEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD 82
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGL 505
++ G + ++ ++ EY +G++ ++ + + + +IA + +GL
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TEDEIATILQSTLKGL 138
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTPGY 563
EYLH +HRD+K+ NILLN + AK+ADFG + + +D ++ V GTP +
Sbjct: 139 EYLH---FMRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFW 191
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ PE N +D++S G+ +E+ G+ P
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 26/279 (9%), Positives = 62/279 (22%), Gaps = 54/279 (19%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNF--ERVLGKGGFGEVYHG-S 418
R + + + M + + S + + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 419 LDDNQQVAVKML------SSSCCFQLLQ-VKLLMRVHHRNLTALIGYC------------ 459
++ + A+K+ S S +L + R+ +
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 460 --------------IEGNNMGLIYEYMASGTLDQYLK-----GKKEHMLNWVERLQIAVD 500
N L+ + L+ + +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 501 SAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+ L G +VH N+ + + + D A +
Sbjct: 203 LIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSV 253
Query: 560 TPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRP 596
Y E+ + + + G+ + + P
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQ--VKLLMRVHHRNLTALIGY 458
LG G FG+VY + + A K+ S + +++L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGCKPP 515
+ ++ E+ G +D + + QI V + L +LH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFLH---SKR 137
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTPGYLDPEYYVLNW 573
I+HRD+K+ N+L+ + ++ADFG S ++ + + GTP ++ PE +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 574 L-----NEKSDVYSFGVVLLEIITGRRP 596
+ + K+D++S G+ L+E+ P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQ--VKLLMR 446
Y+ +KI G+G G VY + Q+VA++ L +L+ + ++
Sbjct: 22 YTRFEKI--------GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQ 503
+ N+ + + G+ + ++ EY+A G+L + ++ QIA + Q
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQ 127
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTP 561
LE+LH ++HRD+KS NILL K+ DFG F + + + S + + GTP
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTP 180
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
++ PE K D++S G++ +E+I G P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 405 VLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCF----QLLQ-VKLLMR-VHHRNLTALIG 457
+G+G +G V Q +AVK + S+ QLL + ++MR + G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA---VDSAQGLEYLHYGCKP 514
+ + E M+ + D++ K + + + + + + + L +L K
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
I+HRD+K SNILL+ K+ DFG+S ++S + T AG Y+ PE ++
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAK--TRDAGCRPYMAPE--RIDPS 200
Query: 575 ------NEKSDVYSFGVVLLEIITGRRP 596
+ +SDV+S G+ L E+ TGR P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 63/278 (22%)
Query: 377 ENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS 433
+ + S ++ F + ++ + +G+G +G V A+K+++ +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 434 CCFQLLQ---------VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK 484
Q+ V+L+ ++HH N+ L + + L+ E G L L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 485 KEHMLNWVERLQIAVDSA--------------------------------------QGLE 506
+ + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQA--KIADFGLSRIFSIESSDQIS--TAVAGTPG 562
YLH I HRD+K N L + K+ DFGLS+ F ++ + T AGTP
Sbjct: 183 YLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 563 YLDPEYYVLNWL----NEKSDVYSFGVVLLEIITGRRP 596
++ PE VLN K D +S GV+L ++ G P
Sbjct: 240 FVAPE--VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 392 YSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQLLQ--VKLLMR 446
KI G+G G V +QVAVKM L +LL V ++
Sbjct: 47 LDSYVKI--------GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQ 503
H N+ + + G + ++ E++ G L + + + QIA Q
Sbjct: 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQ 152
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTP 561
L YLH ++HRD+KS +ILL + K++DFG F + S + ++ GTP
Sbjct: 153 ALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTP 205
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
++ PE + + D++S G++++E++ G P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 44/216 (20%), Positives = 77/216 (35%), Gaps = 35/216 (16%)
Query: 405 VLGKG--GFGEVYHG-SLDDNQQVAVKMLS----SSCCFQLLQ--VKLLMRVHHRNLTAL 455
V+GKG V + V V+ ++ S+ LQ + + +H N+
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGC 512
I N + ++ +MA G+ + + L IA + L+Y+H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGM---NELAIAYILQGVLKALDYIH--- 145
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE-----SSDQISTAVAGTPGYLDPE 567
VHR VK+S+IL++ + ++ + +L PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 568 -------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y + KSD+YS G+ E+ G P
Sbjct: 206 VLQQNLQGY-----DAKSDIYSVGITACELANGHVP 236
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 378 NRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKM----- 429
F S+ ++ ++ + LG G +GEV + + A+K+
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 430 LSSSCCFQLLQ-VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM 488
+S+S +LL+ V +L + H N+ L + + N L+ E G L + +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--- 131
Query: 489 LNWVER--LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSR 543
+ E I G+ YLH K IVHRD+K N+LL + KI DFGLS
Sbjct: 132 -KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 544 IFSIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAE 602
+F + + GT Y+ PE VL +EK DV+S GV+L ++ G P + +
Sbjct: 188 VF---ENQKKMKERLGTAYYIAPE--VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 603 DDT 605
+
Sbjct: 243 QEI 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKML-----SSSCCFQLLQ--VKLLMRVHHRNLTAL 455
R +G G FG VY + +++ VA+K + S+ +Q + V+ L ++ H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLHYGC 512
G + + L+ EY D KK ++ ++IA + QGL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLH--- 171
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGTPGYLDPEYYV 570
++HRDVK+ NILL+E K+ DFG S+ ++ + GTP ++ PE V
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFG--------SASIMAPANSFVGTPYWMAPE--V 221
Query: 571 LNWL-----NEKSDVYSFGVVLLEIITGRRP 596
+ + + K DV+S G+ +E+ + P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 30/244 (12%), Positives = 64/244 (26%), Gaps = 61/244 (25%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC---------------------------- 434
VLG+ + + V + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 435 ----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM-ASGTLDQYL-----KGK 484
+ L+ + + + + + + Y L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 485 KEHMLNWVERLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543
L RLQ+ + + L LH YG +VH ++ +I+L+++ + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 544 IFSIESSDQISTAVAGTPGYLDPEY-----------YVLNWLNEKSDVYSFGVVLLEIIT 592
D + + G+ PE + D ++ G+V+ I
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 593 GRRP 596
P
Sbjct: 309 ADLP 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 381 DSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKM-----LSS 432
D F ++ ++ RVLGKG FGEV Q+ AVK+ +
Sbjct: 7 DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66
Query: 433 SCCFQLLQ--VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EH 487
+ L V+LL ++ H N+ L + + L+ E G L + +K E
Sbjct: 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 488 MLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRI 544
+ R Q+ G+ Y+H K IVHRD+K N+LL ++ +I DFGLS
Sbjct: 127 DAARIIR-QV----LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 545 FSIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRP 596
F + + GT Y+ PE VL+ +EK DV+S GV+L +++G P
Sbjct: 179 F---EASKKMKDKIGTAYYIAPE--VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLS---------------SSCCFQLLQ--VKL 443
R LG G +GEV + + + A+K++ + + + L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVD 500
L + H N+ L + L+ E+ G L + + + E + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QIL-- 156
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAV 557
G+ YLH K IVHRD+K NILL N L KI DFGLS F S D
Sbjct: 157 --SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDR 208
Query: 558 AGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRP 596
GT Y+ PE VL NEK DV+S GV++ ++ G P
Sbjct: 209 LGTAYYIAPE--VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 382 SFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLS---SSCC 435
S + I + F R LG G FG+V+ + +K ++ S
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 436 FQLLQ--VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVE 493
+ ++ +++L + H N+ + + +NM ++ E G L + + + E
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 494 R------LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRI 544
Q+ L Y H +VH+D+K NIL + KI DFGL+ +
Sbjct: 124 GYVAELMKQMM----NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 545 FSIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRP 596
F SD+ ST AGT Y+ PE V + K D++S GVV+ ++TG P
Sbjct: 177 F---KSDEHSTNAAGTALYMAPE--VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLS----SSCCFQLLQ--VKLLMRVHHRNLT 453
N +LGKG FGEV Q+ AVK+++ + + V+LL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEY 507
L + ++ ++ E G L + +K + E Q+ G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQV----FSGITY 136
Query: 508 LHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
+H K IVHRD+K NILL + KI DFGLS F + GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYI 190
Query: 565 DPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRP 596
PE VL +EK DV+S GV+L +++G P
Sbjct: 191 APE--VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLS-SSCCFQLLQ--VKLLMRV-HHRNLTALIG- 457
++G G +G+VY G + Q A+K++ + + ++ + +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 458 -----YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV---DSAQGLEYLH 509
+ + L+ E+ +G++ +K K + L E IA + +GL +LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EE-WIAYICREILRGLSHLH 146
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE-- 567
+ ++HRD+K N+LL E + K+ DFG+S ++ + GTP ++ PE
Sbjct: 147 ---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 568 --------YYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y + KSD++S G+ +E+ G P
Sbjct: 202 ACDENPDATY-----DFKSDLWSLGITAIEMAEGAPP 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 31/215 (14%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLS----SSCCFQLLQVK----LLMRVHHRNL 452
+LG+G +G+V + + AVK+L VK LL R+ H+N+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 453 TAL--IGYCIEGNNMGLIYEYMASGTLD--QYLKGKKEHMLNWVER---LQIAVDSAQGL 505
L + Y E M ++ EY G + + K+ Q+ GL
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLI----DGL 122
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
EYLH IVH+D+K N+LL KI+ G++ ++D G+P +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 566 PEYYVLNWLNE----KSDVYSFGVVLLEIITGRRP 596
PE + N L+ K D++S GV L I TG P
Sbjct: 180 PE--IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHH 449
++FE R +GKG FG+V +D +++ A+K ++ C + +V +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 450 RNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA-VDSAQGLEY 507
L L Y + +M ++ + + G L +L+ + H +L I + A L+Y
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMA--LDY 130
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
L I+HRD+K NILL+E I DF ++ + + T +AGT Y+ PE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAPE 184
Query: 568 YYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610
+ + D +S GV E++ GRRP R+ + I
Sbjct: 185 --MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 52/233 (22%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------------------------- 437
+GKG +G V + +DN A+K+LS +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 438 -LLQVK----LLMRVHHRNLTALIGYC-IEGNNMGLIY---EYMASGTLDQYLKGKKEHM 488
+ QV +L ++ H N+ L ++ N +Y E + G + + K
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133
Query: 489 LNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548
L+ + D +G+EYLHY I+HRD+K SN+L+ E KIADFG+S F +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF--K 188
Query: 549 SSDQISTAVAGTPGYLDPEYYVLNWLNE-----KSDVYSFGVVLLEIITGRRP 596
SD + + GTP ++ PE L+ + DV++ GV L + G+ P
Sbjct: 189 GSDALLSNTVGTPAFMAPE--SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCF--QLLQ--VKLLMRVHHRNLTAL 455
F VLG G F EV+ + A+K + S F L+ + +L ++ H N+ L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 456 IGYCIEGNNMGLIYEYMASGTL-DQYL-KGK-KEHMLNWVERLQIAVDSAQGLEYLHYGC 512
+ L+ + ++ G L D+ L +G E + V + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QVL----SAVKYLH--- 123
Query: 513 KPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
+ IVHRD+K N+L E + I DFGLS++ + I + GTPGY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPE-- 177
Query: 570 VLNW--LNEKSDVYSFGVVL 587
VL ++ D +S GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 55/256 (21%), Positives = 101/256 (39%), Gaps = 48/256 (18%)
Query: 363 RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGS-L 419
K + + S P+ ++ ++ ++ V+G+G V
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 420 DDNQQVAVKMLSSSCCFQLLQ------------VKLLMRVH-HRNLTALIGYCIEGNNMG 466
+ AVK++ + + +L +V H ++ LI + M
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 467 LIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEYLHY-GCKPPIVHR 519
L+++ M G L YL K E+ + + + +LH IVHR
Sbjct: 177 LVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLL----EAVSFLHANN----IVHR 224
Query: 520 DVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL----- 574
D+K NILL++ +Q +++DFG S E +++ GTPGYL PE +L
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELC-GTPGYLAPE--ILKCSMDETH 279
Query: 575 ---NEKSDVYSFGVVL 587
++ D+++ GV+L
Sbjct: 280 PGYGKEVDLWACGVIL 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC----FQLLQ--VKLLMRVHHRNLT 453
+ + LGKG F V + A K++++ FQ L+ ++ ++ H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEY 507
L E + L+++ + G L + + ++ + E QI + + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQIL----ESIAY 120
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQA---KIADFGLSRIFSIESSDQISTAVAGTPGYL 564
H IVHR++K N+LL K + K+ADFGL+ + + AGTPGYL
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYL 174
Query: 565 DPEYYVL--NWLNEKSDVYSFGVVL 587
PE VL + ++ D+++ GV+L
Sbjct: 175 SPE--VLKKDPYSKPVDIWACGVIL 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ------------VKLLMRV 447
+ LG G GEV ++VA++++S +++L ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDS 501
+H + + + + + ++ E M G L + G K E Q+
Sbjct: 198 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQML--- 249
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSIESSDQISTAVA 558
++YLH + I+HRD+K N+LL+ + KI DFG S+I + + T
Sbjct: 250 -LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC- 302
Query: 559 GTPGYLDPEYYVLNWLNEKS-----DVYSFGVVL 587
GTP YL PE VL + D +S GV+L
Sbjct: 303 GTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 49/244 (20%), Positives = 100/244 (40%), Gaps = 38/244 (15%)
Query: 366 KRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE------RVLGKGGFGEVYHG-S 418
K G+ + + + + +++ ++ + LG G FG V+
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 419 LDDNQQVAVKMLSSSCCFQLLQVK----LLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474
+ K +++ VK ++ ++HH L L + M LI E+++
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 475 GTL-DQYLKGKKEHMLNWVER------LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527
G L D+ +++ ++ E Q +GL+++H + IVH D+K NI+
Sbjct: 133 GELFDRIAA--EDYKMS--EAEVINYMRQAC----EGLKHMH---EHSIVHLDIKPENIM 181
Query: 528 LNEKLQA--KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN--WLNEKSDVYSF 583
K + KI DFGL+ + D+I T + PE +++ + +D+++
Sbjct: 182 CETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE--IVDREPVGFYTDMWAI 236
Query: 584 GVVL 587
GV+
Sbjct: 237 GVLG 240
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC----FQLLQ--VKLLMRVHHRNLT 453
N +LGKG FGEV Q+ AVK+++ + + V+LL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEY 507
L + ++ ++ E G L + +K + E Q+ G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVF----SGITY 136
Query: 508 LHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
+H K IVHRD+K NILL + KI DFGLS F + GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYI 190
Query: 565 DPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRP 596
PE VL +EK DV+S GV+L +++G P
Sbjct: 191 APE--VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 53/280 (18%), Positives = 96/280 (34%), Gaps = 32/280 (11%)
Query: 395 IQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTA 454
I + N + + E+ L D S ++++ + +N
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLK-GKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
+ + + + L ++ L I + A+ +E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ----------ISTAVAGTPGY 563
++HRD+K SNI K+ DFGL + +Q T GT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
+ PE N + K D++S G++L E++ + R D+RN
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--------------IITDVRN 288
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ P L F + + S + +ERP TD++
Sbjct: 289 LKFPLL---FTQKYP-QEHMMVQDMLSPSPTERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 8/81 (9%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+FE + +G+GGFG V+ + D+ A+K + + VK L ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 452 LTALIGYCIEGNNMGLIYEYM 472
+ +E E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMD 86
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ------------VKLLMRV 447
+ LG G GEV ++VA+K++S +++L ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDS 501
+H + + + + + ++ E M G L + G K E Q+
Sbjct: 73 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQML--- 124
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVA 558
++YLH + I+HRD+K N+LL E KI DFG S+I + + T
Sbjct: 125 -LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC- 177
Query: 559 GTPGYLDPEYYVLNWL-----NEKSDVYSFGVVL 587
GTP YL PE VL + N D +S GV+L
Sbjct: 178 GTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 45/215 (20%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ-------------VKLLMRV 447
+ +LG+G V ++ AVK++ + V +L +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 448 -HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVD 500
H N+ L L+++ M G L YL K E+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALL-- 134
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
+ + LH K IVHRD+K NILL++ + K+ DFG S + +++ GT
Sbjct: 135 --EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVC-GT 186
Query: 561 PGYLDPEYYVLNWL--------NEKSDVYSFGVVL 587
P YL PE ++ ++ D++S GV++
Sbjct: 187 PSYLAPE--IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 36/233 (15%)
Query: 377 ENRNDSFAPKSRQFAYSEIQKITNNFE---RVLGKGGFGEVYHG-SLDDNQQVAVKM--- 429
+ + + + ++ N + + LG+G F V S Q+ A K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK 64
Query: 430 --LSSSCCFQLLQ-VKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK 485
C ++L + +L + L + + LI EY A G + +
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 486 EHMLNWVER------LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKI 536
M++ E QI +G+ YLH + IVH D+K NILL KI
Sbjct: 125 AEMVS--ENDVIRLIKQIL----EGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
DFG+SR + ++ + GTP YL PE +LN+ + +D+++ G++
Sbjct: 176 VDFGMSRKI--GHACELREIM-GTPEYLAPE--ILNYDPITTATDMWNIGIIA 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 394 EIQKITN-NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMR 446
+ + + + + LG+G +GEV + + VAVK++ + + +
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ--- 503
++H N+ G+ EGN L EY + G L + + + AQ
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFF 111
Query: 504 -----GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
G+ YLH I HRD+K N+LL+E+ KI+DFGL+ +F + +++ +
Sbjct: 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 559 GTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
GT Y+ PE +L + E DV+S G+VL ++ G P
Sbjct: 169 GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 44/245 (17%)
Query: 389 QFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLL 444
Q+ + E Q + + F RVLG+GGFGEV+ + ++ A K L+ + +
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 445 M-------RVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQ 496
M +VH R + +L Y E ++ L+ M G + + H+ N E
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI-------RYHIYNVDEDNP 284
Query: 497 I---------AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
GLE+LH + I++RD+K N+LL++ +I+D GL+
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-K 340
Query: 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAE 602
+ GTPG++ PE L + D ++ GV L E+I R P +R E
Sbjct: 341 AGQTKTKGYA-GTPGFMAPEL-----LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 603 DDTTH 607
Sbjct: 395 KVENK 399
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 393 SEIQKITNNFE------RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLM 445
++ + + F +G G + N + AVK++ S ++++L+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILL 70
Query: 446 R-VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSA 502
R H N+ L +G + ++ E M G L + +K + ER +
Sbjct: 71 RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTIT 126
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA----KIADFGLSRIFSIESSDQISTAVA 558
+ +EYLH +VHRD+K SNIL ++ +I DFG ++ + + +
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPC 181
Query: 559 GTPGYLDPEYYVLNWL--NEKSDVYSFGVVL 587
T ++ PE VL + D++S GV+L
Sbjct: 182 YTANFVAPE--VLERQGYDAACDIWSLGVLL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 386 KSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC----FQL 438
+ +F + K ++N++ LGKG F V + A K++++ FQ
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74
Query: 439 LQ--VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-- 494
L+ ++ ++ H N+ L E + L+++ + G L + + ++ + E
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADA 130
Query: 495 ----LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA---KIADFGLSRIFSI 547
QI + + Y H IVHR++K N+LL K + K+ADFGL+
Sbjct: 131 SHCIQQIL----ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-- 181
Query: 548 ESSDQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVL 587
+ + AGTPGYL PE VL + ++ D+++ GV+L
Sbjct: 182 -NDSEAWHGFAGTPGYLSPE--VLKKDPYSKPVDIWACGVIL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 41/211 (19%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLS--------SSCCFQLLQ--VKLLMRVHH 449
LG G F V ++ A K + + ++ V +L + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTL-DQYLKGKKEHMLNWVER------LQIAVDSA 502
N+ L ++ LI E ++ G L D +KE + E QI
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLA--EKESL---TEDEATQFLKQI----L 118
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA----KIADFGLSRIFSIESSDQISTAVA 558
G+ YLH I H D+K NI+L +K K+ DFG++ + +
Sbjct: 119 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIF 172
Query: 559 GTPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
GTP ++ PE ++N+ L ++D++S GV+
Sbjct: 173 GTPEFVAPE--IVNYEPLGLEADMWSIGVIT 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 32/207 (15%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKM-----LSSSCCFQLLQVK----LLMRVHHRN 451
V+GKG F V + QQ AVK+ +SS +K + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGL 505
+ L+ + +++E+M L + + + + E QI + L
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----EAL 143
Query: 506 EYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
Y H I+HRDVK +LL K+ FG++ S ++ GTP
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198
Query: 563 YLDPEYYVLNW--LNEKSDVYSFGVVL 587
++ PE V+ + DV+ GV+L
Sbjct: 199 FMAPE--VVKREPYGKPVDVWGCGVIL 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 31/254 (12%)
Query: 370 QKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLDDNQQV-A 426
+K +E+ F K +Q +FE +V+G+G FGEV L + +V A
Sbjct: 49 EKNILEYLEWAKPFTSKVKQMRLH-----REDFEILKVIGRGAFGEVAVVKLKNADKVFA 103
Query: 427 VKMLSSSCCFQLLQV-------KLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLD 478
+K+L+ + + +L+ + +T L Y + NN+ L+ +Y G L
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLL 162
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538
L ++ + + R +A + ++ +H + VHRD+K NIL++ ++AD
Sbjct: 163 TLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVY-------SFGVVLLEII 591
FG + + Q S AV GTP Y+ PE +L + Y S GV + E++
Sbjct: 219 FGSCLKLMEDGTVQSSVAV-GTPDYISPE--ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 592 TGRRPVISRAEDDT 605
G P + + +T
Sbjct: 276 YGETPFYAESLVET 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 39/210 (18%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLS--------SSCCFQLLQ--VKLLMRVHH 449
+ LG G F V + A K + + ++ V +L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQ 503
N+ L ++ LI E ++ G L +L +KE + E QI
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLA-QKESL---SEEEATSFIKQI----LD 126
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEK----LQAKIADFGLSRIFSIESSDQISTAVAG 559
G+ YLH I H D+K NI+L +K K+ DFGL+ + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 560 TPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
TP ++ PE ++N+ L ++D++S GV+
Sbjct: 181 TPEFVAPE--IVNYEPLGLEADMWSIGVIT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTAL 455
+ LG+G +GEV + + VAVK++ + + + ++H N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ--------GLEY 507
G+ EGN L EY + G L + + + AQ G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
LH I HRD+K N+LL+E+ KI+DFGL+ +F + +++ + GT Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 568 YYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
+L + E DV+S G+VL ++ G P
Sbjct: 178 --LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC----FQLLQ--VKLLMRVHHRNLTA 454
LGKG F V + Q+ A ++++ Q L+ ++ + H N+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEYL 508
L E + LI++ + G L + + ++ + E QI + + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQIL----EAVLHC 126
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQA---KIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
H + +VHR++K N+LL KL+ K+ADFGL+ E Q AGTPGYL
Sbjct: 127 H---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLS 181
Query: 566 PEYYVL--NWLNEKSDVYSFGVVL 587
PE VL + + D+++ GV+L
Sbjct: 182 PE--VLRKDPYGKPVDLWACGVIL 203
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 371 KVEMEFENRNDSFAPKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-A 426
V + + + + Q+ + E Q +T N F RVLGKGGFGEV + ++ A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 427 VKMLSSSCCFQLLQV-------KLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLD 478
K L + ++L +V+ R + +L Y E + + L+ M G L
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLK 272
Query: 479 QYLKGKKEHMLNWVERLQI-AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537
++ + R A + GLE LH + IV+RD+K NILL++ +I+
Sbjct: 273 FHIYHMGQAGFP-EARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRIS 328
Query: 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIIT 592
D GL+ + I V GT GY+ PE + + D ++ G +L E+I
Sbjct: 329 DLGLAV--HVPEGQTIKGRV-GTVGYMAPEV-----VKNERYTFSPDWWALGCLLYEMIA 380
Query: 593 GRRPVISRAEDDTTH 607
G+ P R +
Sbjct: 381 GQSPFQQRKKKIKRE 395
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 31/250 (12%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLD 420
R V + + + P+ + + + + LG G FG V+
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRVTERA 180
Query: 421 DNQQVAVKMLS--SSCCFQLLQ--VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476
A K + + ++ ++ + + H L L + N M +IYE+M+ G
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 477 LDQYLKGKKEHMLNWVER------LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
L + + + M E Q+ +GL ++H + VH D+K NI+
Sbjct: 241 LFEKVADEHNKM---SEDEAVEYMRQV----CKGLCHMH---ENNYVHLDLKPENIMFTT 290
Query: 531 KLQA--KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVV 586
K K+ DFGL+ Q GT + PE V + +D++S GV+
Sbjct: 291 KRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPE--VAEGKPVGYYTDMWSVGVL 345
Query: 587 LLEIITGRRP 596
+++G P
Sbjct: 346 SYILLSGLSP 355
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 52/239 (21%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 373 EMEFENRNDSFAPKSRQFAYSEIQKITNNFE--------RVLGKGGFGEVYHG-SLDDNQ 423
F + + +LG G FG+V+
Sbjct: 56 SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115
Query: 424 QVAVKML--SSSCCFQLLQ--VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL-D 478
++A K++ + ++ + ++ ++ H NL L N++ L+ EY+ G L D
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 479 QYLKGKKEHMLNWVER------LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
+ + + + L E QI +G+ ++H + I+H D+K NIL +
Sbjct: 176 RIID--ESYNLT--ELDTILFMKQIC----EGIRHMH---QMYILHLDLKPENILCVNRD 224
Query: 533 QA--KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
KI DFGL+R + + +++ GTP +L PE V+N+ ++ +D++S GV+
Sbjct: 225 AKQIKIIDFGLARRY--KPREKLKVNF-GTPEFLAPE--VVNYDFVSFPTDMWSVGVIA 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 46/208 (22%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 401 NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC--FQLLQ--VKLLMRVHHRNLTAL 455
E +G+G +GEV + A K + + ++++ + H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGC 512
+ ++ L+ E G L + + K+ E + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DVL----SAVAYCH--- 123
Query: 513 KPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
K + HRD+K N L + K+ DFGL+ F ++ GTP Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQ-- 178
Query: 570 VLNWL-NEKSDVYSFGVVLLEIITGRRP 596
VL L + D +S GV++ ++ G P
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLS----SSCCFQLLQ--VKLLMRVHHRNLTA 454
+ +GKG F +V + ++VA+K++ + Q L V+++ ++H N+
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 455 LIGY-CIEGNNMG-LIYEYMASGTLDQYL--KGK-KEHMLNWVERLQIAVDSAQGLEYLH 509
L + IE LI EY + G + YL G+ KE R QI ++Y H
Sbjct: 79 L--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIV----SAVQYCH 131
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
IVHRD+K+ N+LL+ + KIADFG S F+ ++ G P Y PE
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFC-GAPPYAAPE-- 183
Query: 570 VLNWLN---EKSDVYSFGVVLLEIITGRRP 596
+ + DV+S GV+L +++G P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 45/220 (20%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 396 QKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLS-SSCCFQLLQ--VKLLMRVHH 449
+++ + LG+G FG V+ + K + L++ + +L H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQ 503
RN+ L + +I+E+++ + + + + ER Q+ +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL---NEREIVSYVHQV----CE 113
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQA--KIADFGLSRIFSIESSDQISTAVAGTP 561
L++LH I H D++ NI+ + + KI +FG +R + D P
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAP 167
Query: 562 GYLDPEYYVLNW--LNEKSDVYSFGV---VLLEIITGRRP 596
Y PE V ++ +D++S G VLL +G P
Sbjct: 168 EYYAPE--VHQHDVVSTATDMWSLGTLVYVLL---SGINP 202
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 374 MEFENRNDSFAPKSRQFAYSEIQKIT---NNFE--RVLGKGGFGEVYHG-SLDDNQQVAV 427
M+ S Q A Q +F+ ++LG+G F V L +++ A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 428 KMLSSSCCFQLLQVK-------LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQY 480
K+L + +V ++ R+ H L + + Y +G L +Y
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 481 LKGKKEHMLNWVERLQIA-VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539
++ K R A + SA LEYLH I+HRD+K NILLNE + +I DF
Sbjct: 121 IR-KIGSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDF 174
Query: 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL--NEKSDVYSFGVVLLEIITGRRP 596
G +++ S ES + + GT Y+ PE +L + SD+++ G ++ +++ G P
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPE--LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 41/211 (19%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----------VKLLMRVHH 449
+ LG G F V Q A K + + V +L + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTL-DQYLKGKKEHMLNWVER------LQIAVDSA 502
N+ L ++ LI E +A G L D + KE + E QI
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESL---TEEEATEFLKQIL---- 124
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA----KIADFGLSRIFSIESSDQISTAVA 558
G+ YLH I H D+K NI+L ++ KI DFGL+ +
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIF 178
Query: 559 GTPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
GTP ++ PE ++N+ L ++D++S GV+
Sbjct: 179 GTPEFVAPE--IVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 39/210 (18%)
Query: 401 NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----------VKLLMRVHH 449
+ LG G F V + A K + + V +L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQ 503
N+ L ++ LI E ++ G L +L +KE + E QI
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLS---EEEATSFIKQI----LD 126
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEK----LQAKIADFGLSRIFSIESSDQISTAVAG 559
G+ YLH I H D+K NI+L +K K+ DFGL+ + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 560 TPGYLDPEYYVLNW--LNEKSDVYSFGVVL 587
TP ++ PE ++N+ L ++D++S GV+
Sbjct: 181 TPEFVAPE--IVNYEPLGLEADMWSIGVIT 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 23/196 (11%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-VKLLMRV-HHRNLTALIGYC 459
++ LG+G F NQ AVK++S + + L H N+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPI 516
+ + L+ E + G L + +K KK E +++ R ++ + ++H +
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KLV----SAVSHMH---DVGV 127
Query: 517 VHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
VHRD+K N+L N+ L+ KI DFG +R+ + +Q T Y PE +LN
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPE--LLNQ 183
Query: 574 L--NEKSDVYSFGVVL 587
+E D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHHRNLTALIGY 458
E LG+G VY + A+K+L + ++++ + +L+R+ H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+ L+ E + G L + K E + QI + + YLH +
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-QIL----EAVAYLH---ENG 168
Query: 516 IVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
IVHRD+K N+L KIADFGLS+I + V GTPGY PE +L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPE--ILR 223
Query: 573 WLN--EKSDVYSFGVVL 587
+ D++S G++
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 41/215 (19%)
Query: 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVKLLMRV----------HHRN 451
LG G FG+V G +VAVK+L+ ++ + ++ ++ H +
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 452 LTALIGY-CIEGNNMGLIY---EYMASGTLDQYL--KGK-KEHMLNWVERLQIAVDSAQG 504
+ L Y I + EY++ G L Y+ G+ +E + + QI
Sbjct: 73 IIKL--YQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QIL----SA 123
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
++Y H + +VHRD+K N+LL+ + AKIADFGLS + + + T+ G+P Y
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYA 177
Query: 565 DPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
PE V++ + + D++S GV+L ++ G P
Sbjct: 178 APE--VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVK----LLMRV-HHRNLTALI 456
E VLG+G V +L +Q+ AVK++ +V +L + HRN+ LI
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER--LQIAVDSAQGLEYLHYGCKP 514
+ E + L++E M G++ ++ ++ ++ E + D A L++LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLH---NK 130
Query: 515 PIVHRDVKSSNILL---NEKLQAKIADFGLSRIF------SIESSDQISTAVAGTPGYLD 565
I HRD+K NIL N+ KI DF L S S+ ++ T G+ Y+
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMA 189
Query: 566 PEYYVLNWL-------NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618
PE V+ +++ D++S GV+L +++G P + R D
Sbjct: 190 PE--VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 619 GDIRNIVDPSLQGNFD-NNSAWKAV 642
+I +G ++ + W +
Sbjct: 248 MLFESI----QEGKYEFPDKDWAHI 268
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 37/251 (14%)
Query: 363 RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLD 420
R+NK + F +R K R ++E +V+G+G FGEV
Sbjct: 42 RKNKNID-----NFLSRYKDTINKIRDLRMK-----AEDYEVVKVIGRGAFGEVQLVRHK 91
Query: 421 DNQQV-AVKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472
++V A+K+LS + ++ + + L + + ++ EYM
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151
Query: 473 ASGTLDQYLKGKKEHMLNWVERLQIA-VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531
G L + + R A V A L+ +H +HRDVK N+LL++
Sbjct: 152 PGGDLVNLMS--NYDVPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKS 204
Query: 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS------DVYSFGV 585
K+ADFG + E + TAV GTP Y+ PE VL D +S GV
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE--VLKSQGGDGYYGRECDWWSVGV 261
Query: 586 VLLEIITGRRP 596
L E++ G P
Sbjct: 262 FLYEMLVGDTP 272
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 48/214 (22%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 385 PKSRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKL 443
P+ +++A ++ +++ ++VLG G G+V Q+ A+K+L S + +V
Sbjct: 19 PEPKKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDH 74
Query: 444 LMRV-HHRNLTALIGYCIEGNNMG----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIA 498
+ ++ ++ ++ +I E M G L ++ + + E +I
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSDQIST 555
D +++LH I HRDVK N+L + K+ DFG ++ + + + T
Sbjct: 135 RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQT 188
Query: 556 AVAGTPGYLDPEYYVLNWLN--EKSDVYSFGVVL 587
TP Y+ PE VL + D++S GV++
Sbjct: 189 PC-YTPYYVAPE--VLGPEKYDKSCDMWSLGVIM 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 9e-21
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 27/251 (10%)
Query: 377 ENRNDSFAPKSRQFAYSEIQ-KIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLS 431
+ + Q+ E+ +T N+F R++G+GGFGEVY D ++ A+K L
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 432 SSCCFQLLQVKLLM----------RVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQY 480
L + + + Y + + I + M G L +
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYH 282
Query: 481 LKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540
L + R A + GLE++H +V+RD+K +NILL+E +I+D G
Sbjct: 283 LS-QHGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-DVYSFGVVLLEIITGRRPVIS 599
L+ + S + A GT GY+ PE + S D +S G +L +++ G P
Sbjct: 338 LAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 600 RAEDDTTHISQ 610
D I +
Sbjct: 394 HKTKDKHEIDR 404
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 61/257 (23%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 370 QKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGSLDDNQQV-A 426
K +F + + ++ ++FE +V+G+G F EV + QV A
Sbjct: 36 DKYVADFLQWAEPIVVRLKEVRLQR-----DDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 427 VKMLSSSCCFQLLQVK-------LLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLD 478
+K+++ + +V +L+ R +T L + + N + L+ EY G L
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIA 537
L E + + R +A + ++ +H G VHRD+K NILL+ ++A
Sbjct: 150 TLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLA 204
Query: 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS---------DVYSFGVVLL 588
DFG + + + AV GTP YL PE +L + D ++ GV
Sbjct: 205 DFGSCLKLRADGTVRSLVAV-GTPDYLSPE--ILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 589 EIITGRRPVISRAEDDT 605
E+ G+ P + + +T
Sbjct: 262 EMFYGQTPFYADSTAET 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 387 SRQFAYSEIQKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLM 445
Q + I +VLG G G+V + ++ A+KML + +V+L
Sbjct: 51 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHW 109
Query: 446 RV-HHRNLTALIGYC----IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVD 500
R ++ ++ + ++ E + G L ++ + + E +I
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 501 SAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA---KIADFGLSRIFSIESSDQISTAV 557
+ ++YLH I HRDVK N+L K K+ DFG ++ S + ++T
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPC 224
Query: 558 AGTPGYLDPEYYVLNWLN--EKSDVYSFGVVL 587
TP Y+ PE VL + D++S GV++
Sbjct: 225 -YTPYYVAPE--VLGPEKYDKSCDMWSLGVIM 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 42/215 (19%)
Query: 403 ERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVKLLMRV----------HHRN 451
LG+G FG+V + Q+VA+K +S L + + MRV H +
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPH 70
Query: 452 LTALIGY-CIEGNNMGLIY---EYMASGTLDQYL--KGK-KEHMLNWVERLQIAVDSAQG 504
+ L Y I I EY A G L Y+ K + E + QI
Sbjct: 71 IIKL--YDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQ-QII----CA 120
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
+EY H + IVHRD+K N+LL++ L KIADFGLS I + + T+ G+P Y
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS-CGSPNYA 174
Query: 565 DPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
PE V+N + + DV+S G+VL ++ GR P
Sbjct: 175 APE--VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 41/238 (17%)
Query: 384 APKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGS-LDDNQQVAVKML--------SS 432
+ + + + + LG G FG V+ + N++V VK +
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 433 SCCFQLLQVKL----LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT-LDQYLKGKKEH 487
+L +V L L RV H N+ ++ L+ E SG L ++ +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-RHPR 126
Query: 488 MLNWVERL------QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541
+ E L Q+ + YL I+HRD+K NI++ E K+ DFG
Sbjct: 127 L---DEPLASYIFRQLV----SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176
Query: 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
+ E T GT Y PE VL + + +++S GV L ++ P
Sbjct: 177 AAYL--ERGKLFYTFC-GTIEYCAPE--VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 40/165 (24%)
Query: 189 LTDEDDVNALRNIKSTYG---VKRNWQG--DPCVPKNYWWDGLNCSYEDNNPSRIISLNL 243
L + D AL IK G +W D C N W G+ C D R+ +L+L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC---NRTWLGVLCD-TDTQTYRVNNLDL 57
Query: 244 SSSGL---------------------------TGEISPYFANLTAIEFLDLSNNSLSGTF 276
S L G I P A LT + +L +++ ++SG
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 277 PEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
P+FLS++ +L L+ N L+G+LP + S+ +L ++ DGN
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSI---SSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 19/69 (27%), Positives = 40/69 (57%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+++ L ++ + ++G I + + + + LD S N+LSGT P +S LP+L + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 296 LTGSLPADL 304
++G++P
Sbjct: 161 ISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 20/85 (23%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
++L+ + L ++ + LDL NN + GT P+ L++L L +LN+ N
Sbjct: 221 KNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 296 LTGSLPADLVERSNNGSLTLSVDGN 320
L G +P + + + N
Sbjct: 280 LCGEIPQGGNLQRFD---VSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 21/79 (26%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 238 IISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
+ ++LS + L G+ S F + + + L+ NSL+ + + +L L+L+ N++
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY 257
Query: 298 GSLPADLVERSNNGSLTLS 316
G+LP L + SL +S
Sbjct: 258 GTLPQGLTQLKFLHSLNVS 276
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 1/69 (1%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ S+ +S + LTG+I P FANL + F+DLS N L G + + ++L
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 293 RNKLTGSLP 301
+N L L
Sbjct: 230 KNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 19/83 (22%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSL-RALNLKRN 294
+++L+ S + L+G + P ++L + + N +SG P+ L ++ + RN
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 295 KLTGSLPADLVERSNNGSLTLSV 317
+LTG +P +L L+
Sbjct: 185 RLTGKIPPTF------ANLNLAF 201
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 15/87 (17%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTA-IEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
++ + + ++G I + + + + +S N L+G P + L +L ++L RN
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
L G ++ + + + N
Sbjct: 208 MLEGDASVLF---GSDKNTQKIHLAKN 231
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ L+L ++ + G + L + L++S N+L G P+ L
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 294 NKLTGSLP 301
NK P
Sbjct: 301 NKCLCGSP 308
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 52/258 (20%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ----------VKLLMRVHHR 450
+LG GGFG VY G + DN VA+K + + V LL +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 451 --NLTALIGYCIEGNNMGLIYEYMA-SGTLDQYL--KGK-KEHMLNWVERLQIAVDSAQG 504
+ L+ + ++ LI E L ++ +G +E + Q+ +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVL----EA 161
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
+ + H ++HRD+K NIL++ + + K+ DFG + D + T GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVY 214
Query: 564 LDPEYYVLNWLNEK------SDVYSFGVVLLEIITGRRP-----VISRAEDDTTHISQWV 612
PE W+ + V+S G++L +++ G P I R + Q V
Sbjct: 215 SPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ---VFFRQRV 266
Query: 613 NSMLAEGDIRNI--VDPS 628
S + IR + PS
Sbjct: 267 -SSECQHLIRWCLALRPS 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 398 ITNNFERV--LGKGGFGEVYHG-SLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVH 448
+ +E++ +G+G +G V+ + D Q VA+K S L ++++L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGL 505
H NL L+ + L++EY T+ L + + + + Q Q +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL----QAV 115
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES---SDQIST----AVA 558
+ H K +HRDVK NIL+ + K+ DFG +R+ + S D+++T +
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS-- 170
Query: 559 GTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
PE +L + + DV++ G V E+++G
Sbjct: 171 -------PE--LL--VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 42/235 (17%)
Query: 384 APKSRQFAYSEIQKITN-NFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQV 441
P + + + KI + LG G FG+V G +VAVK+L+ ++ +
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSL 57
Query: 442 KLLMRV----------HHRNLTALIGY-CIEGNNMGLIY---EYMASGTLDQYL--KGK- 484
++ ++ H ++ L Y I + I+ EY++ G L Y+ G+
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKL--YQVISTPSD--IFMVMEYVSGGELFDYICKNGRL 113
Query: 485 KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544
E + + QI G++Y H + +VHRD+K N+LL+ + AKIADFGLS +
Sbjct: 114 DEKESRRLFQ-QIL----SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165
Query: 545 FSIESSDQISTAVAGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLLEIITGRRP 596
+ + T+ G+P Y PE V++ + + D++S GV+L ++ G P
Sbjct: 166 M--SDGEFLRTSC-GSPNYAAPE--VISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMR 446
+E++ +G+G +G V+ + + ++ VA+K + SS+ L ++ LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKE 57
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ--- 503
+ H+N+ L + L++E+ DQ LK + ++ + Q
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
GL + H ++HRD+K N+L+N + K+A+FGL+R F I + +A T Y
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWY 167
Query: 564 LDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRP 596
P+ VL K D++S G + E+ RP
Sbjct: 168 RPPD--VL--FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 63/280 (22%), Positives = 101/280 (36%), Gaps = 56/280 (20%)
Query: 384 APKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQ 440
+ + + + +LGKGGFG V+ G L D QVA+K++ +
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP 74
Query: 441 VKLLMRV--------------HHRNLTALIGYCIEGNNMGLIYEYMASGT-LDQYL--KG 483
+ + H + L+ + L+ E L Y+ KG
Sbjct: 75 LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG 134
Query: 484 K-KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGL 541
E Q+ +++ H +VHRD+K NIL++ + AK+ DFG
Sbjct: 135 PLGEGPSRCFFG-QVV----AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186
Query: 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK------SDVYSFGVVLLEIITGRR 595
+ D+ T GT Y PE W++ + V+S G++L +++ G
Sbjct: 187 GALL----HDEPYTDFDGTRVYSPPE-----WISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 596 PV-----ISRAEDDTTHISQWVNSMLAEGDIRNI--VDPS 628
P I AE H V S IR PS
Sbjct: 238 PFERDQEILEAE---LHFPAHV-SPDCCALIRRCLAPKPS 273
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 23/171 (13%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHR 450
+E + +G+G +G V + D + VA+K S + ++KLL ++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER---LQIAVDSAQGLEY 507
NL L+ C + L++E++ T+ L+ + V + QI G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII----NGIGF 139
Query: 508 LHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES---SDQIST 555
H I+HRD+K NIL+++ K+ DFG +R + D+++T
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 396 QKITNNFERV--LGKGGFGEVYHGSLDDNQQVAVKML----------SSSCCFQLLQVKL 443
Q + ++++ +G+G +G VY + VA+K + S++ + ++ L
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----IREISL 72
Query: 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
L +HH N+ +LI + L++E+M ++ LK + ++ QI + Q
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 504 ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGT 560
G+ + H I+HRD+K N+L+N K+ADFGL+R F I + T T
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVT 182
Query: 561 PGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
Y P+ VL + K D++S G + E+ITG+
Sbjct: 183 LWYRAPD--VL--MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML---------SSSCCFQLLQVKLLMRV 447
+ ++ LG+G + VY G S + VA+K + ++ + +V LL +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----IREVSLLKDL 57
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---G 504
H N+ L ++ L++EY+ D+ LK + N + + + Q G
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L Y H + ++HRD+K N+L+NE+ + K+ADFGL+R SI + + V T Y
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYR 167
Query: 565 DPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
P+ +L L D++ G + E+ TGR
Sbjct: 168 PPD--IL--LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 31/209 (14%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ------VKLLMRVHHRNLTAL 455
+ +G G FG + VAVK + + + + H N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRHPNIVRF 81
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYL--KGK-KEHMLNWVERLQIAVDSAQGLEYLHYGC 512
+ ++ +I EY + G L + + G+ E + + Q+ G+ Y H
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLL----SGVSYCH--- 133
Query: 513 KPPIVHRDVKSSNILL--NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
I HRD+K N LL + + KI DFG S+ + S Q + V GTP Y+ PE V
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPE--V 188
Query: 571 LNWLN---EKSDVYSFGVVLLEIITGRRP 596
L + +DV+S GV L ++ G P
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 38/215 (17%)
Query: 400 NNFERV--LGKGGFGEVYHGSLDDNQQVAVKML----------SSSCCFQLLQVKLLMRV 447
+ + +G+G +G VY + + A+K + S++ + ++ +L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----IREISILKEL 57
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ---G 504
H N+ L + L++E++ DQ LK + +E + Q G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL-----DQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
+ Y H ++HRD+K N+L+N + + KIADFGL+R F I + T T Y
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYR 167
Query: 565 DPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
P+ VL + K D++S G + E++ G
Sbjct: 168 APD--VL--MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 27/171 (15%)
Query: 394 EIQKITNNFERV--LGKGGFGEVYHG-SLDDNQQVAVKM--LSSSCCFQ-------LLQV 441
+++ +E++ LG+G F VY + NQ VA+K L + L ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHML-----NWVERLQ 496
KLL + H N+ L+ +N+ L++++M + L+ +K + ++ L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYM--LM 120
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547
QGLEYLH I+HRD+K +N+LL+E K+ADFGL++ F
Sbjct: 121 TL----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 29/167 (17%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMR 446
NF++V +G+G +G VY + + VA+K + S++ + ++ LL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IREISLLKE 58
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER----LQIAVDSA 502
++H N+ L+ N + L++E++ L +++ + Q+
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---- 113
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549
QGL + H ++HRD+K N+L+N + K+ADFGL+R F +
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHH 449
+ F+ + LG G FG V ++ A+K+L +L Q+ ++L V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA-VDSAQGLEYL 508
L L + +N+ ++ EY+A G + +L+ + R A + EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLT--FEYL 157
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
H +++RD+K N+L++++ ++ DFG ++ + T + GTP L PE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPEALAPEI 209
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRP 596
+ N+ D ++ GV++ E+ G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 32/170 (18%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML---------SSSCCFQLLQVKLLMRV 447
+ F+++ LG G + VY G + VA+K + S++ + ++ L+ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA----IREISLMKEL 60
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA----- 502
H N+ L N + L++E+M D LK + + ++
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFM-----DNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 503 ---QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549
QGL + H I+HRD+K N+L+N++ Q K+ DFGL+R F I
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-18
Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
N S ++SL+LS + L+G I +L+ + L L N L G P+ L + +L L L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N LTG +P+ L SN +L +S+ N
Sbjct: 476 NDLTGEIPSGL---SNCTNLNWISLSNN 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-18
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + + L L ++G TG+I P +N + + L LS N LSGT P L L LR L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 293 RNKLTGSLPADLVERSNNGSL-TLSVDGN 320
N L G +P +L +L TL +D N
Sbjct: 451 LNMLEGEIPQEL---MYVKTLETLILDFN 476
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-17
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 21/138 (15%)
Query: 192 EDDVNALRNIKSTY---GVKRNWQG--DPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSS 246
+++ L + K + +W +PC +DG+ C ++ S++LSS
Sbjct: 11 YREIHQLISFKDVLPDKNLLPDWSSNKNPC-----TFDGVTC-----RDDKVTSIDLSSK 60
Query: 247 GLT---GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303
L +S +LT +E L LSN+ ++G+ F SL +L+L RN L+G +
Sbjct: 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC-SASLTSLDLSRNSLSGPVT-T 118
Query: 304 LVERSNNGSLT-LSVDGN 320
L + L L+V N
Sbjct: 119 LTSLGSCSGLKFLNVSSN 136
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-17
Identities = 25/71 (35%), Positives = 42/71 (59%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ +L L + LTGEI +N T + ++ LSNN L+G P+++ +L +L L L
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 294 NKLTGSLPADL 304
N +G++PA+L
Sbjct: 524 NSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-16
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 7/88 (7%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ L++SS+ + I P+ + +A++ LD+S N LSG F +S L+ LN+
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+ G +P SL LS+ N
Sbjct: 257 NQFVGPIPP-----LPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-16
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ LNL + ++G I +L + LDLS+N L G P+ +S L L ++L N
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTS------TTCSSESCKKKKHK 336
L+G +P + + N C + H
Sbjct: 716 LSGPIPEMGQFETFPPA---KFLNNPGLCGYPLPRCDPSNADGYAHH 759
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNL 291
+ L+LS + G + P+F + + +E L LS+N+ SG P + L K+ L+ L+L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 292 KRNKLTGSLPADLVERSNN 310
N+ +G LP L S +
Sbjct: 351 SFNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S++ L L + L GEI + +E L L N L+G P LS +L ++L N+
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 296 LTGSLPADLVERSNNGSLT-LSVDGN 320
LTG +P + +L L + N
Sbjct: 502 LTGEIPKWI---GRLENLAILKLSNN 524
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFAN--LTAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
N + +++L+LSS+ +G I P ++ L L NN +G P LS L +L+
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 291 LKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L N L+G++P+ L + L L + N
Sbjct: 425 LSFNYLSGTIPSSL---GSLSKLRDLKLWLN 452
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-15
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 234 NPSRIISLNLSSSGLTGEISPY--FANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALN 290
+ + SL+LS + L+G ++ + + ++FL++S+N+L KL SL L+
Sbjct: 98 CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157
Query: 291 LKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L N ++G+ V G L L++ GN
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGN 188
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-15
Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ + L +S + ++G++ + +EFLD+S+N+ S P L +L+ L++
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS 231
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NKL+G + S L L++ N
Sbjct: 232 GNKLSGDFSRAI---STCTELKLLNISSN 257
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-15
Identities = 27/72 (37%), Positives = 40/72 (55%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N S N++S G SP F N ++ FLD+S N LSG P+ + +P L LNL
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 293 RNKLTGSLPADL 304
N ++GS+P ++
Sbjct: 665 HNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 2/89 (2%)
Query: 234 NPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKL-PSLRALNL 291
+ S + SL LSS+ +GE+ + ++ LDLS N SG PE L+ L SL L+L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 292 KRNKLTGSLPADLVERSNNGSLTLSVDGN 320
N +G + +L + N L + N
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNN 404
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 22/81 (27%), Positives = 42/81 (51%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
++ L++S + L+G I ++ + L+L +N +SG+ P+ + L L L+L NK
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 296 LTGSLPADLVERSNNGSLTLS 316
L G +P + + + LS
Sbjct: 692 LDGRIPQAMSALTMLTEIDLS 712
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-14
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ + ++LS++ LTGEI + L + L LSNNS SG P L SL L+L N
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTST 323
G++PA + + + N
Sbjct: 550 FNGTIPAAM------FKQSGKIAANFIA 571
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 1/69 (1%)
Query: 236 SRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ L+L+ + TGEI + + + LDLS N G P F L +L L N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 295 KLTGSLPAD 303
+G LP D
Sbjct: 329 NFSGELPMD 337
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-13
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS-KLPSLRALNLKRN 294
+ + LN+SS+ G I P L ++++L L+ N +G P+FLS +L L+L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
G++P + L L++ N
Sbjct: 305 HFYGAVPPFF---GSCSLLESLALSSN 328
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 21/70 (30%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 236 SRIISLNLSSSGLTGEIS-PYFANLTAIEFLDLSNNSLSGTFPE---FLSKLPSLRALNL 291
S + LN+SS+ L L ++E LDLS NS+SG L+ L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 292 KRNKLTGSLP 301
NK++G +
Sbjct: 186 SGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-11
Identities = 10/76 (13%), Positives = 27/76 (35%)
Query: 229 SYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRA 288
+++ + + G S L+ ++++ G S+
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 289 LNLKRNKLTGSLPADL 304
L++ N L+G +P ++
Sbjct: 637 LDMSYNMLSGYIPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 15/88 (17%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ L LS++ +G I + ++ +LDL+ N +GT P + K + N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANF 569
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTST 323
+ G + + +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 13/79 (16%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNN--SLSGTFPEFLSKLPSLRALNLKRNKLT 297
S ++++ + G+ Y N + + N G E L++L + N+
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 298 GSLPADLVERSNNGSLTLS 316
G + L +S
Sbjct: 622 GHTSPTFDNNGSMMFLDMS 640
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML----------SSSCCFQLLQVKLLMR 446
+ +E++ +G+G FGEV+ Q+VA+K + ++ L ++K+L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----LREIKILQL 72
Query: 447 VHHRNLTALIGYCIE-----GNNMGLIY---EYMASGTLDQYLKGKKEHMLNWVERLQIA 498
+ H N+ LI C G IY ++ + L G ++L +I
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVKFTLSEIK 127
Query: 499 VDSAQ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS- 554
GL Y+H + I+HRD+K++N+L+ K+ADFGL+R FS+ + Q +
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 555 -TAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGR 594
T T Y PE +L L E+ D++ G ++ E+ T
Sbjct: 185 YTNRVVTLWYRPPE--LL--LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 25/203 (12%), Positives = 56/203 (27%), Gaps = 46/203 (22%)
Query: 403 ERVLGKGGFGEVYHGSLDD--NQQVAVKMLSSSCC----FQ---LLQVKLLMRVHHRNLT 453
G + + LD ++QVA+ + L + L R+ +
Sbjct: 36 LIFHGGVPPLQFWQA-LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
++ ++ E++ G+L + + V ++ A + H +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---R 147
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
+ S + ++ G V P +
Sbjct: 148 AGVALSIDHPSRVR--------VSIDG--------------DVVLAYPATMPDA------ 179
Query: 574 LNEKSDVYSFGVVLLEIITGRRP 596
N + D+ G L ++ R P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP 201
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLMRVHH 449
+F+ R LG G FG V+ N + A+K+L +L QV +L V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIA-VDSAQGLEYL 508
+ + G + + +I +Y+ G L L+ K + N V + A V A LEYL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLA--LEYL 122
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
H I++RD+K NILL++ KI DFG ++ D T + GTP Y+ PE
Sbjct: 123 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYT-LCGTPDYIAPE- 173
Query: 569 YVLNWLNE---KS-DVYSFGVVLLEIITGRRP 596
V+ + KS D +SFG+++ E++ G P
Sbjct: 174 -VV--STKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 385 PKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLL 444
+ R+ AY+ + I G G FG V+ L ++ +VA+K + F+ +++++
Sbjct: 35 GEQREIAYTNCKVI--------GNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIM 86
Query: 445 MRVHHRNLTALIGYCIEGNNMG------LIYEYMASGTLDQYLK---GKKEHMLNWVERL 495
V H N+ L + + L+ EY+ T+ + + K+ M + +L
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKL 145
Query: 496 ---QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSD 551
Q+ + L Y+H I HRD+K N+LL+ K+ DFG ++I +
Sbjct: 146 YMYQL----LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAG 195
Query: 552 QISTAVAGTPGYLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
+ + + + Y PE + N D++S G V+ E++ G+
Sbjct: 196 EPNVSYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 379 RNDSFAPKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSC 434
++S A + ++T N FE ++LGKG FG+V + A+K+L
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV 185
Query: 435 CFQLLQV-------KLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKE 486
+V ++L H LTAL Y + + + + EY G L +L +E
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS--RE 242
Query: 487 HMLNWVERLQI-AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545
+ + +R + + L+YLH + +V+RD+K N++L++ KI DFGL +
Sbjct: 243 RVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE- 298
Query: 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
I+ + T GTP YL PE N D + GVV+ E++ GR P ++ +
Sbjct: 299 GIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 382 SFAPKSRQFAYSEIQK----ITNNFE--RVLGKGGFGEVYHGSLDD---NQQVAVKMLSS 432
S + + F EI + ++ + +G G G V + D + VA+K LS
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVC--AAYDAILERNVAIKKLSR 60
Query: 433 SCCFQLLQ--------VKLLMRVHHRNLTALIGYCIEGNNMG------LIYEYMASGTLD 478
FQ + L+ V+H+N+ L+ ++ ++ E M + L
Sbjct: 61 --PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC 117
Query: 479 QYLKGKKEHMLNWVERLQIAVDSAQ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK 535
Q ++ + +H ER+ + Q G+++LH I+HRD+K SNI++ K
Sbjct: 118 QVIQMELDH-----ERMSYLL--YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167
Query: 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-DVYSFGVVLLEIITGR 594
I DFGL+R + + T T Y PE +L +++ D++S G ++ E+I G
Sbjct: 168 ILDFGLARTA---GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 44/235 (18%)
Query: 396 QKIT-NNFE--RVLGKGGFGEVY---HGSLDDNQQV-AVKMLSSSCCFQLLQV------K 442
+K + FE +VLG+G FG+V+ S D +Q+ A+K+L + +V
Sbjct: 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 443 LLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL------ 495
+L+ V+H + L Y + + LI +++ G L L KE M E
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFT--EEDVKFYLA 133
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555
++A+ L++LH I++RD+K NILL+E+ K+ DFGLS+ SI+ + +
Sbjct: 134 ELAL----ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS 185
Query: 556 AVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
GT Y+ PE +N + D +SFGV++ E++TG P + +T
Sbjct: 186 -FCGTVEYMAPEV-----VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 385 PKSRQFAYSEIQKITNNFE--------RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCC 435
P F E+ K +E + +G G +G V +VA+K L
Sbjct: 6 PARSGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--P 61
Query: 436 FQ--------LLQVKLLMRVHHRNLTALIGYCIEGNNMG------LIYEYMASGTLDQYL 481
FQ +++LL + H N+ L+ + L+ +M + L + +
Sbjct: 62 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM 120
Query: 482 KGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538
K +K + + V Q+ +GL Y+H I+HRD+K N+ +NE + KI D
Sbjct: 121 KHEKLGEDRIQFLV--YQML----KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD 171
Query: 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL--NEKSDVYSFGVVLLEIITGR 594
FGL+R E + + T Y PE +LNW+ + D++S G ++ E+ITG+
Sbjct: 172 FGLARQADSEMTGYVVTRW-----YRAPE-VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 41/218 (18%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ---------------VKLLMRVH 448
R + G +G V G + VA+K + ++ ++LL H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 449 HRNLTAL--IGYCIEGNNMGLIY---EYMASGTLDQYLKGKK-----EHMLNWVERLQIA 498
H N+ L I E M +Y E M + L Q + ++ +H+ ++ I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM--YHIL 144
Query: 499 VDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVA 558
GL LH +VHRD+ NILL + I DF L+R ++D T
Sbjct: 145 ----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYV 194
Query: 559 GTPGYLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
Y PE V+ + + D++S G V+ E+ +
Sbjct: 195 THRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 40/190 (21%)
Query: 384 APKSRQFAYSEIQKITNNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML---------- 430
P S + + + + R+ LG+G +GEVY N+ VA+K +
Sbjct: 18 GPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP 77
Query: 431 SSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN 490
++ + +V LL + HRN+ L + + LI+EY + LK + +
Sbjct: 78 GTA----IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPD 128
Query: 491 WVERL------QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA-----KIADF 539
R+ Q+ G+ + H +HRD+K N+LL+ + KI DF
Sbjct: 129 VSMRVIKSFLYQLI----NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 540 GLSRIFSIES 549
GL+R F I
Sbjct: 182 GLARAFGIPI 191
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 55/271 (20%), Positives = 109/271 (40%), Gaps = 37/271 (13%)
Query: 340 PVVVSVAAFSTVLFALAIFCGLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKIT 399
P S A + + F ++ + G KV + ++ +Y++ + I
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKV-TTVVATPGQGPDRPQEVSYTDTKVI- 62
Query: 400 NNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGY 458
G G FG VY D + VA+K + F+ +++++ ++ H N+ L +
Sbjct: 63 -------GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 459 CIEGNNMG------LIYEYMASGTLDQYLK---GKKEHMLNWVERL---QIAVDSAQGLE 506
L+ +Y+ T+ + + K+ + +L Q+ + L
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSLA 170
Query: 507 YLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
Y+H I HRD+K N+LL+ + K+ DFG ++ + + + + Y
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRA 224
Query: 566 PEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
PE + + DV+S G VL E++ G+
Sbjct: 225 PE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 397 KIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQV-------KLLM 445
K+T N+F+ ++LGKG FG+V + A+K+L +V ++L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 446 RVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQ 503
H LTAL Y + + + + EY G L +L +E + ER + +
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS--RERVFT-EERARFYGAEIVS 116
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
LEYLH +V+RD+K N++L++ KI DFGL + I + T GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT-FCGTPEY 171
Query: 564 LDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
L PE L + D + GVV+ E++ GR P ++ +
Sbjct: 172 LAPEV-----LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 73/258 (28%), Positives = 110/258 (42%), Gaps = 36/258 (13%)
Query: 370 QKVEMEFENRNDSFAPKSRQ---FAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSLDDNQ 423
Q E E N N + P Q S ++F +V+GKG FG+V +
Sbjct: 4 QPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEE 63
Query: 424 QV-AVKMLSSSCCFQLLQVK--------LLMRVHHRNLTALIGYCIE-GNNMGLIYEYMA 473
AVK+L + + K LL V H L L + + + + + +Y+
Sbjct: 64 VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYIN 122
Query: 474 SGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL 532
G L +L+ +E R + A + A L YLH IV+RD+K NILL+ +
Sbjct: 123 GGELFYHLQ--RERCFL-EPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQG 176
Query: 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVL 587
+ DFGL + +IE + ST GTP YL PE L+++ D + G VL
Sbjct: 177 HIVLTDFGLCKE-NIEHNSTTST-FCGTPEYLAPEV-----LHKQPYDRTVDWWCLGAVL 229
Query: 588 LEIITGRRPVISRAEDDT 605
E++ G P SR +
Sbjct: 230 YEMLYGLPPFYSRNTAEM 247
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 386 KSRQFAYSEIQK----ITNNFE--RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ- 437
+ + F ++ K + + +G G +G V ++VA+K LS FQ
Sbjct: 6 RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQS 63
Query: 438 -------LLQVKLLMRVHHRNLTALI------GYCIEGNNMGLIYEYMASGTLDQYLKGK 484
++ LL + H N+ L+ + L+ +M + L + + K
Sbjct: 64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK 122
Query: 485 --KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLS 542
+E + V Q+ +GL+Y+H +VHRD+K N+ +NE + KI DFGL+
Sbjct: 123 FSEEKIQYLV--YQML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWL--NEKSDVYSFGVVLLEIITGR 594
R E + + T Y PE +L+W+ N+ D++S G ++ E++TG+
Sbjct: 174 RHADAEMTGYVVTRW-----YRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 48/257 (18%)
Query: 365 NKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--------RVLGKGGFGEVYH 416
+K+V + N + S QF E+ T F + +G G G V
Sbjct: 25 DKQVDVSYIAKHYNMSKS--KVDNQFYSVEVGDST--FTVLKRYQNLKPIGSGAQGIVC- 79
Query: 417 GSLDD---NQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTALI------GYC 459
+ D ++ VA+K LS FQ ++ L+ V+H+N+ +L+
Sbjct: 80 -AAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA-QGLEYLHYGCKPPIVH 518
E ++ L+ E M + L Q ++ + +H ER+ + G+++LH I+H
Sbjct: 137 EEFQDVYLVMELMDA-NLCQVIQMELDH-----ERMSYLLYQMLCGIKHLHSAG---IIH 187
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL-NEK 577
RD+K SNI++ KI DFGL+R + + T T Y PE +L E
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE-VILGMGYKEN 243
Query: 578 SDVYSFGVVLLEIITGR 594
D++S G ++ E++ +
Sbjct: 244 VDIWSVGCIMGEMVRHK 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 33/240 (13%)
Query: 385 PKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQ 440
P+ + S K+ +F ++LGKG FG+V+ Q A+K L
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 441 VK--------LLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNW 491
V+ L + H LT + + N+ + EY+ G L +++ H +
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFD- 116
Query: 492 VERLQI-AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ R A + GL++LH IV+RD+K NILL++ KIADFG+ + ++
Sbjct: 117 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGD 172
Query: 551 DQISTAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
+ +T GTP Y+ PE L + D +SFGV+L E++ G+ P + E++
Sbjct: 173 AKTNT-FCGTPDYIAPEI-----LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 396 QKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVK--MLSSSCCFQLLQ-VKLLMRVHH 449
+K + F+ R+ G+G FG V G VA+K + + LQ ++ L +HH
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 450 RNLTALIGYCIEGNN--------MGLIYEYMASGTLDQYLK---GKKEHMLNWVERL--- 495
N+ L + ++ EY+ TL + + ++ + ++
Sbjct: 79 PNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQIS 554
Q+ + + LH + HRD+K N+L+NE K+ DFG ++ S + +
Sbjct: 137 QLI----RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---SPSEPN 188
Query: 555 TAVAGTPGYLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
A + Y PE + + D++S G + E++ G
Sbjct: 189 VAYICSRYYRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVKLLM---RV-----HHRN 451
NF VLGKG FG+V ++ AVK+L Q V+ M RV
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 452 LTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLH 509
LT L C + + + + EY+ G L +++ + A + A GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFK-EPHAVFYAAEIAIGLFFLQ 459
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
I++RD+K N++L+ + KIADFG+ + +I T GTP Y+ PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKT-FCGTPDYIAPEI- 513
Query: 570 VLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
+ + D ++FGV+L E++ G+ P ED+
Sbjct: 514 ----IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 62/258 (24%), Positives = 106/258 (41%), Gaps = 42/258 (16%)
Query: 377 ENRNDSFAPKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVY---HGSLDDNQQV-AVKM 429
E +K+ NFE +VLG G +G+V+ S D ++ A+K+
Sbjct: 30 EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 430 LSSSCCFQLL-QVK--------LLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQ 479
L + Q + L L L Y + + LI +Y+ G L
Sbjct: 90 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFT 148
Query: 480 YLKGKKEHMLNWVERL------QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ 533
+L + E +I + LE+LH K I++RD+K NILL+
Sbjct: 149 HLS--QRERFT--EHEVQIYVGEIVL----ALEHLH---KLGIIYRDIKLENILLDSNGH 197
Query: 534 AKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNE---KS-DVYSFGVVLLE 589
+ DFGLS+ F + +++ GT Y+ P+ ++ + K+ D +S GV++ E
Sbjct: 198 VVLTDFGLSKEFVADETERAYD-FCGTIEYMAPD--IVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 590 IITGRRPVISRAEDDTTH 607
++TG P E ++
Sbjct: 255 LLTGASPFTVDGEKNSQA 272
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 48/246 (19%)
Query: 377 ENRNDSFAPKSRQFAYSEIQKITNNFE--------RVLGKGGFGEVYHGS-LDDNQQVAV 427
+ + + + F E+ K +E +G G +G V +VAV
Sbjct: 2 AHHHHHHSQERPTFYRQELNKTI--WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59
Query: 428 KMLSSSCCFQ--------LLQVKLLMRVHHRNLTALIGYCIEGNNMG------LIYEYMA 473
K LS FQ +++LL + H N+ L+ ++ L+ M
Sbjct: 60 KKLSR--PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 117
Query: 474 SGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530
+ L+ +K +K +H+ + QI +GL+Y+H I+HRD+K SN+ +NE
Sbjct: 118 A-DLNNIVKCQKLTDDHVQFLI--YQIL----RGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL--NEKSDVYSFGVVLL 588
+ KI DFGL+R ++D+++ VA T Y PE +LNW+ N+ D++S G ++
Sbjct: 168 DCELKILDFGLAR----HTADEMTGYVA-TRWYRAPE-IMLNWMHYNQTVDIWSVGCIMA 221
Query: 589 EIITGR 594
E++TGR
Sbjct: 222 ELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 40/214 (18%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNL 452
+G+G +G V S D +VA+K +S F+ L ++K+L+R H N+
Sbjct: 33 SYIGEGAYGMVC--SAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENI 87
Query: 453 TALI-----GYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQG 504
+ + ++ ++ + M + L + LK + +H+ ++ QI +G
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL--YQIL----RG 140
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE--SSDQISTAVAGTPG 562
L+Y+H ++HRD+K SN+LLN KI DFGL+R+ + + ++ VA T
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRW 196
Query: 563 YLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
Y PE +LN + D++S G +L E+++ R
Sbjct: 197 YRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK--------LLMRVHHRN 451
NF VLGKG FG+V ++ AVK+L Q V+ L +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 452 LTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLH 509
LT L C + + + + EY+ G L +++ + A + A GL +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFK-EPHAVFYAAEIAIGLFFLQ 138
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
I++RD+K N++L+ + KIADFG+ + +I T GTP Y+ PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKT-FCGTPDYIAPEI- 192
Query: 570 VLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
+ + D ++FGV+L E++ G+ P ED+
Sbjct: 193 ----IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK--------LLMRVH 448
+F+ RV+G+G + +V L ++ A+K++ + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 449 HRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLE 506
H L L C + + + + EY+ G L +++ ++ L E + + + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLP-EEHARFYSAEISLALN 124
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
YLH + I++RD+K N+LL+ + K+ D+G+ + + D ST GTP Y+ P
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTST-FCGTPNYIAP 179
Query: 567 EYYVLNWLNEKS-----DVYSFGVVLLEIITGRRP 596
E L + D ++ GV++ E++ GR P
Sbjct: 180 EI-----LRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQV-AVKMLSSSCCFQLLQVK--------LLMRVHHRN 451
F RVLGKG FG+V + + + AVK+L Q V+ L + +H
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 452 LTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLH 509
LT L C + + + + E++ G L +++ K + R + A + L +LH
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFD-EARARFYAAEIISALMFLH 141
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
I++RD+K N+LL+ + K+ADFG+ + I + +T GTP Y+ PE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG-ICNGVTTAT-FCGTPDYIAPEI- 195
Query: 570 VLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
L E D ++ GV+L E++ G P + EDD
Sbjct: 196 ----LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 49/222 (22%)
Query: 404 RVLGKGGFGEV---YHGSLDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNL 452
+LG+G +G V H + VA+K + F L ++K+L H N+
Sbjct: 17 SLLGEGAYGVVCSATH--KPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENI 71
Query: 453 TALI-----GYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQG 504
+ N + +I E M + L + + + +H+ ++ Q +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI--YQTL----RA 124
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
++ LH ++HRD+K SN+L+N K+ DFGL+R I+ S ++ G +
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGM 179
Query: 565 DPEYYVLNW-------LNEKS-----DVYSFGVVLLEIITGR 594
E+ W L DV+S G +L E+ R
Sbjct: 180 -VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 51/224 (22%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNL 452
+ LG GG G V+ S D +++VA+K + L ++K++ R+ H N+
Sbjct: 17 KPLGCGGNGLVF--SAVDNDCDKRVAIKKIV----LTDPQSVKHALREIKIIRRLDHDNI 70
Query: 453 TALI--------------GYCIEGNNMGLIYEYMASGTLDQYLKGKK---EHMLNWVERL 495
+ G E N++ ++ EYM + L L+ EH ++
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFM--Y 127
Query: 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQ-- 552
Q+ +GL+Y+H ++HRD+K +N+ +N E L KI DFGL+RI S +
Sbjct: 128 QLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 553 ISTAVAGTPGYLDPEYYVLNWLN--EKSDVYSFGVVLLEIITGR 594
+S + T Y P +L+ N + D+++ G + E++TG+
Sbjct: 181 LSEGLV-TKWYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 46/237 (19%)
Query: 396 QKIT-NNFE--RVLGKGGFGEVY---HGSLDDNQQV-AVKMLSSSCCFQ-LLQV------ 441
+KI FE RVLGKGG+G+V+ + + ++ A+K+L + +
Sbjct: 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 442 -KLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERL---- 495
+L V H + LI Y + G + LI EY++ G L L+ +E + E
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE--REGIFM--EDTACFY 126
Query: 496 --QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553
+I++ L +LH + I++RD+K NI+LN + K+ DFGL + SI
Sbjct: 127 LAEISM----ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 554 STAVAGTPGYLDPEYYVLNWLNEKS-----DVYSFGVVLLEIITGRRPVISRAEDDT 605
T GT Y+ PE L D +S G ++ +++TG P T
Sbjct: 179 HT-FCGTIEYMAPEI-----LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 55/253 (21%), Positives = 108/253 (42%), Gaps = 40/253 (15%)
Query: 363 RRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSL 419
+G +E E E N + K+ + +F+ RV+G+G + +V L
Sbjct: 21 YFQGAMGSGIEEEKEAMNTRESGKASS-------SLGLQDFDLLRVIGRGSYAKVLLVRL 73
Query: 420 DDNQQV-AVKMLSSSCCFQLLQVK--------LLMRVHHRNLTALIGYCIE-GNNMGLIY 469
++ A++++ + +H L L C + + + +
Sbjct: 74 KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVI 132
Query: 470 EYMASGTLDQYLKGKKEHMLNWVERLQI-AVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528
EY+ G L +++ ++ L E + + + + L YLH + I++RD+K N+LL
Sbjct: 133 EYVNGGDLMFHMQ--RQRKLP-EEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLL 186
Query: 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS-----DVYSF 583
+ + K+ D+G+ + + D ST GTP Y+ PE L + D ++
Sbjct: 187 DSEGHIKLTDYGMCKEG-LRPGDTTST-FCGTPNYIAPEI-----LRGEDYGFSVDWWAL 239
Query: 584 GVVLLEIITGRRP 596
GV++ E++ GR P
Sbjct: 240 GVLMFEMMAGRSP 252
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 41/184 (22%)
Query: 393 SEIQKITNNFERV---LGKGGFGEVY---HGSLDDNQQVAVK------MLSSSCCFQLLQ 440
SE +++ + FE +G+G +G VY D++ A+K + S+C +
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----E 68
Query: 441 VKLLMRVHHRNLTALIGYCIEGNNMG--LIYEYMASGTLDQYLKGK-KEHMLNWVERLQI 497
+ LL + H N+ +L + + L+++Y + L K H + + +
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPV 123
Query: 498 AVDSAQ----------GLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSR 543
+ G+ YLH ++HRD+K +NIL+ E+ + KIAD G +R
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 544 IFSI 547
+F+
Sbjct: 181 LFNS 184
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 55/241 (22%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNL 452
++G+G +G VY D + VA+K ++ F+ L ++ +L R+ +
Sbjct: 32 HLIGRGSYGYVY--LAYDKNTEKNVAIKKVNR--MFEDLIDCKRILREITILNRLKSDYI 87
Query: 453 TALIGYCIEGNNMG-----LIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQ 503
L I + + ++ E S L + K EH+ + + +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL--YNLLL---- 140
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
G ++H I+HRD+K +N LLN+ K+ DFGL+R + E I +
Sbjct: 141 GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 564 LDPEY--------YV-----------LNWLN--EKSDVYSFGVVLLEIITGRRPVISRAE 602
+V L N + D++S G + E++ + I+
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 603 D 603
+
Sbjct: 258 N 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 40/226 (17%), Positives = 89/226 (39%), Gaps = 32/226 (14%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHGS- 418
++ G + E + ++ S P + +I + +E ++G G +G V
Sbjct: 15 GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYD 74
Query: 419 LDDNQQVAVKMLSSSCCFQ--------LLQVKLLMRVHHRNLTAL--IGYCIEGNNMGLI 468
+ + VA+K + F+ L ++ +L R++H ++ + I + +
Sbjct: 75 KLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 469 Y---EYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV 521
Y E S + + + H+ + + G++Y+H I+HRD+
Sbjct: 133 YVVLEIADS-DFKKLFRTPVYLTELHIKTLL--YNLL----VGVKYVHSA---GILHRDL 182
Query: 522 KSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
K +N L+N+ K+ DFGL+R + ++ ++
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
R L ++ ++ + + ++ ++ + + L + + A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD--- 565
+HRD+ + NILL+EK KI DFGL+R I V L
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP---DYVRKGDARLPLKW 261
Query: 566 --PEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRP 596
PE +SDV+SFGV+L EI + G P
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 22/164 (13%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQV-----KLLMRV-HH 449
+ LG+G FG+V + VAVKML + K+L+ + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 450 RNLTALIGYCI-EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
N+ L+G C G + +I E+ G L YL+ K+ + + + QG +Y+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK---GARFRQGKDYV 142
Query: 509 HYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552
+ D+K + + + F + S ++
Sbjct: 143 G------AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 51/228 (22%)
Query: 404 RVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQ--------LLQVKLLMRVH-HRN 451
+ LGKG +G V+ D + VAVK + FQ ++ +L + H N
Sbjct: 15 KKLGKGAYGIVW--KSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSGHEN 70
Query: 452 LTALIGYCIEGNNMG--LIYEYMASGTLDQYLKGKK---EHMLNWVERLQIAVDSAQGLE 506
+ L+ N+ L+++YM + L ++ H V Q+ + ++
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVV--YQLI----KVIK 123
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
YLH G ++HRD+K SNILLN + K+ADFGLSR F + ++ +
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 567 EY-------YV-----------LNWLN--EKSDVYSFGVVLLEIITGR 594
+ YV L + D++S G +L EI+ G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 38/175 (21%)
Query: 400 NNFERV--LGKGGFGEVYHG--SLDDNQQVAVKML----------SSSCCFQLLQVKLLM 445
+E V +G+G +G+V+ + + VA+K + S+ + +V +L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVAVLR 66
Query: 446 RVH---HRNLTALI-----GYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLN-WVERLQ 496
+ H N+ L + L++E++ DQ L + + V
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTET 121
Query: 497 IAVDSAQ---GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548
I Q GL++LH +VHRD+K NIL+ Q K+ADFGL+RI+S +
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 40/177 (22%)
Query: 400 NNFERV--LGKGGFGEVYHG-SLDDNQQVAVKML-------------SSSCCFQLLQVKL 443
+ +E V +G G +G VY VA+K + S+ + +V L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST----VREVAL 64
Query: 444 LMRVH---HRNLTALIGYCIEGNNMG-----LIYEYMASGTLDQYLKGKKEHMLNWVER- 494
L R+ H N+ L+ C L++E++ L YL L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 495 ---LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548
Q +GL++LH C IVHRD+K NIL+ K+ADFGL+RI+S +
Sbjct: 124 DLMRQFL----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 22/90 (24%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
DN P +L+LS + L S F + ++ LDLS + L L L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 292 KRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N + S SL L
Sbjct: 84 TGNPIQSLALGAF---SGLSSLQKLVAVET 110
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 3/89 (3%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ L+LS L F +L++++ L++S+N+ L SL+ L+
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 293 RNKLTGSLPADLVERSNNGSL-TLSVDGN 320
N + S +L + SL L++ N
Sbjct: 527 LNHIMTSKKQEL--QHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 17/89 (19%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 234 NPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
++ L+ S L F +L + +LD+S+ F + L SL L +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 293 RNKLTGSLPADLVERSNNGSL-TLSVDGN 320
N + D+ + +L L +
Sbjct: 454 GNSFQENFLPDIF--TELRNLTFLDLSQC 480
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 22/89 (24%), Positives = 30/89 (33%), Gaps = 5/89 (5%)
Query: 234 NPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
S + L ++ + P F L + FLDLS L P + L SL+ LN+
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N SL L N
Sbjct: 503 HNNFFSLDTFPY---KCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S + +L L+ + + F+ L++++ L +L+ + L +L+ LN+ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 296 LTGSLPADLVERSNNGSL-TLSVDGN 320
+ + SN +L L + N
Sbjct: 136 IQSFKLPEYF--SNLTNLEHLDLSSN 159
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ L+LS + + +L+ + L L+ N + S L SL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 296 LTGSLPADLVERSNNGSLT-LSVDGN 320
L + + +L L+V N
Sbjct: 112 LASLENFPI---GHLKTLKELNVAHN 134
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLP-SLRALNL 291
N+ S + LN+S + + + L +++ LD S N + + + L P SL LNL
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 292 KRNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSS 327
+N + + L V+ C++
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVE-RMECAT 585
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 226 LNCSYEDNNPSRIISLNLSSSGLT--GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKL 283
++ + + + L+LS +GL+ G S T++++LDLS N + FL L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-L 395
Query: 284 PSLRALNLKRNKLTGSLPADL 304
L L+ + + L +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 19/71 (26%), Positives = 34/71 (47%), Gaps = 5/71 (7%)
Query: 236 SRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRA----LN 290
+ LN++ + + ++ YF+NLT +E LDLS+N + + L L + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 291 LKRNKLTGSLP 301
L N + P
Sbjct: 184 LSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 22/76 (28%), Positives = 36/76 (47%), Gaps = 3/76 (3%)
Query: 226 LNCSYEDNNPSRIISL-NLSSSGLTGEISPYFANLTAIEFLDLSNNSLS--GTFPEFLSK 282
+NC + ++ SL L+ + G + +L ++EFLDLS N LS G +
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 283 LPSLRALNLKRNKLTG 298
SL+ L+L N +
Sbjct: 372 TTSLKYLDLSFNGVIT 387
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 6/96 (6%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEF----LDLSNNSLSGTFPEFLSKLPSLRAL 289
N + + L+LSS+ + L + LDLS N ++ P ++ L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKL 205
Query: 290 NLKRNKLTGSLPADLVER-SNNGSLTLSVDGNTSTT 324
L+ N + ++ ++ + L + +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRALNL 291
P +SL+LS + + F + + L L NN S + + L L L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 292 KRNKLTGSLPADLVERSNNGSLT 314
+ + ++S L
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLC 255
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 12/68 (17%), Positives = 21/68 (30%), Gaps = 2/68 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + + S +L S + F+ + L+L N L L L + K
Sbjct: 279 NCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 293 RNKLTGSL 300
+
Sbjct: 337 GGNAFSEV 344
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 22/147 (14%), Positives = 43/147 (29%), Gaps = 20/147 (13%)
Query: 193 DDVNALRNIK------------STYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIIS 240
D AL+ I NW + + G++ N+ R+
Sbjct: 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL----NSNGRVTG 85
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRNKL 296
L+L G +G + LT +E L L ++ P+ +S S R
Sbjct: 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145
Query: 297 TGSLPADLVERSNNGSLTLSVDGNTST 323
+ + + ++ +
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQ 172
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 6/92 (6%)
Query: 231 EDNNPSRIISLNLSSSGL-TGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRAL 289
+ +I + + + L T + + + L+ N L G P F L +L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASL 358
Query: 290 NLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NL N++T +PA+ + LS N
Sbjct: 359 NLAYNQITE-IPANFC--GFTEQVENLSFAHN 387
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 14/94 (14%), Positives = 30/94 (31%), Gaps = 6/94 (6%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + N + + NL + +++ N P FL LP ++ +N+
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 293 RNKLTG-----SLPADLVERSNNGSLT-LSVDGN 320
N+ L + + + + N
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 15/86 (17%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
++ L + L G++ P F + + L+L+ N ++ F + L+ NK
Sbjct: 330 KKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 296 LTGSLPADLVERSNNGSLT-LSVDGN 320
L +P + + ++ + N
Sbjct: 389 LK-YIPNIF-DAKSVSVMSAIDFSYN 412
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 10/82 (12%), Positives = 24/82 (29%), Gaps = 3/82 (3%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
+ + E ++ L + +N + + P++ L++K N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI---TPNISVLDIKDNPNISID 603
Query: 301 PADLVERSNNGSLTLSVDGNTS 322
+ + G L D
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 10/88 (11%)
Query: 236 SRIISLNLSSSGLTG-------EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRA 288
S + +++ S + + + P + ++LSNN +S E S L +
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 289 LNLKRNKLTGSLPADLVERSNN--GSLT 314
+NL N LT +P + ++ N +
Sbjct: 462 INLMGNMLTE-IPKNSLKDENENFKNTY 488
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 19/79 (24%), Positives = 32/79 (40%), Gaps = 9/79 (11%)
Query: 234 NPSRIISLNLSSSGLTG-------EISPYFANLTAIEFLDLSNNSLSGTFPEF-LSKLPS 285
S + S+NL + LT + + F N + +DL N L+ +F + LP
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
Query: 286 LRALNLKRNKLTGSLPADL 304
L ++L N + P
Sbjct: 515 LVGIDLSYNSFSK-FPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 10/81 (12%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S +I ++S I + +N+++ + + +L LR + +
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217
Query: 296 LTGSLPADLVERSNNGSLTLS 316
+ E N+
Sbjct: 218 FVAENICEAWENENSEYAQQY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 7/81 (8%), Positives = 26/81 (32%), Gaps = 9/81 (11%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSL--------SGTFPEFLSKLP 284
+N + + + + ++ + L ++ ++++ N
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 285 SLRALNLKRNKL-TGSLPADL 304
++ + + N L T + L
Sbjct: 306 KIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 12/75 (16%), Positives = 29/75 (38%), Gaps = 8/75 (10%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSN------NSLSGTFPEFLSKLPSLRAL 289
++ ++LS + + N + ++ + N N +PE ++ PSL L
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 290 NLKRNKLTGSLPADL 304
+ N + + +
Sbjct: 572 QIGSNDIR-KVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 12/91 (13%), Positives = 22/91 (24%), Gaps = 20/91 (21%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG------------------ 274
+ + S+ +T +S LT + + N+
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238
Query: 275 -TFPEFLSKLPSLRALNLKRNKLTGSLPADL 304
T L L + + LP L
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 14/97 (14%), Positives = 39/97 (40%), Gaps = 12/97 (12%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSG-------TFPEFLSKLP 284
++ +L+ + + L + + A +++ + +D S N + K
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 285 SLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
++ ++NL N+++ S L+ +++ GN
Sbjct: 434 NVSSINLSNNQISKFPKELF---STGSPLSSINLMGN 467
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-13
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 2/89 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ + L+L S+ + + F + LDLS+N LS T +L +L+ L L
Sbjct: 94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NK+ L ++ ++ N SL L + N
Sbjct: 154 NNKIQA-LKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
+CS+ D+ P+ I LNL+ + L + F + + LD+ N++S PE
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
KLP L+ LNL+ N+L+ + +LT L + N
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTF---AFCTNLTELHLMSN 107
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
S + LNL S+G F +L ++ +DL N+L+ + SL++LNL++
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 294 NKLTGSLPADLVERSNNGSLTLSVDGN 320
N +T + + + L + N
Sbjct: 594 NLITS-VEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ L+L + + E++ + L I + LS N + +PSL+ L L+R
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
L + + +LT L + N
Sbjct: 465 ALKN-VDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 236 SRIISLNLSSSGLTGEISPYFA--NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ L LS++ + S ++++ L+LS+N + P + L L L
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
+L SL L N S+ LS+ +
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNS 232
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 23/94 (24%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ + L+LS + L + FA L +E+ L N++ F L L ++R LNLKR
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 294 NKLTGSLPADLVERSNNGSL-------TLSVDGN 320
+ S+ + + ++ S L+++ N
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 16/86 (18%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S++ SL++ + ++ L ++ L+L +N LS + + +L L+L N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 296 LTGSLPADLVERSNNGSLT-LSVDGN 320
+ +L L + N
Sbjct: 109 IQKIKNNPF---VKQKNLITLDLSHN 131
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 4/82 (4%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNL + L+ FA T + L L +NS+ K +L L+L N L+ +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+L L + N
Sbjct: 137 KLGTQ---VQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 5/91 (5%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS---KLPSLRALN 290
S + L LSS+ + F + + L L+N L + E L S+R L+
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 291 LKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L ++L+ +LT L + N
Sbjct: 229 LSNSQLST-TSNTTFLGLKWTNLTMLDLSYN 258
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 20/76 (26%), Positives = 27/76 (35%), Gaps = 3/76 (3%)
Query: 241 LNLSSSGLTG--EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L L F L + LDLSNN+++ + L L L L+L+ N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA- 517
Query: 299 SLPADLVERSNNGSLT 314
L L
Sbjct: 518 RLWKHANPGGPIYFLK 533
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 19/71 (26%), Positives = 29/71 (40%), Gaps = 8/71 (11%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS--------GTFPEFLSKLPSLR 287
+ L+LS++ + L +E LDL +N+L+ G FL L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 288 ALNLKRNKLTG 298
LNL+ N
Sbjct: 540 ILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 236 SRIISLNLSSS--GLTGEISPYFANL--TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
+ L+LS+S L + F +L + + L+L+ N +S + S L L L+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 292 KRNKLTGSLPAD 303
N++ L
Sbjct: 413 GLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS----KLPSLRA 288
+ LN+ + + G S F L +++L LSN+ S + L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 289 LNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
LNL +NK++ S G L L + N
Sbjct: 386 LNLTKNKISKIESDAF---SWLGHLEVLDLGLN 415
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 8/91 (8%)
Query: 234 NPSRIISLNLSSSGLT--------GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPS 285
++ L+L + L G + L+ + L+L +N E L
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 286 LRALNLKRNKLTGSLPADLVERSNNGSLTLS 316
L+ ++L N L + + + SL L
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-08
Identities = 16/85 (18%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 238 IISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
++S + L F L +E L++ +N + G + L +L+ L+L + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 298 -GSLPADLVERSNNGSL-TLSVDGN 320
+L + + L L++ N
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKN 391
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 47/234 (20%), Positives = 107/234 (45%), Gaps = 39/234 (16%)
Query: 375 EFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSS 433
++E+ + + Y ++K+ G+G + EV+ + +N++V VK+L
Sbjct: 24 DYESHVVEWGNQDD---YQLVRKL--------GRGKYSEVFEAINITNNEKVVVKILKPV 72
Query: 434 CCFQLL-QVKLL--MRVHHRNLTALIGYCI----EGNNMGLIYEYMASGTLDQYLKG-KK 485
++ ++K+L +R N+ L I L++E++ + Q +
Sbjct: 73 KKKKIKREIKILENLR-GGPNIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD 129
Query: 486 EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRI 544
+ ++ +I + L+Y H I+HRDVK N++++ E + ++ D+GL+
Sbjct: 130 YDIRFYM--YEIL----KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLN-EKS-DVYSFGVVLLEIITGRRP 596
+ + + VA + + PE ++++ + S D++S G +L +I + P
Sbjct: 181 YH--PGQEYNVRVA-SRYFKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 46/253 (18%), Positives = 90/253 (35%), Gaps = 70/253 (27%)
Query: 396 QKITNNFE--RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNL 452
+ + + + LG G FG V ++ ++ A+K + ++ ++ ++ + H N+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 453 TALIGYCIEGNNMG--------------------------------------LIYEYMAS 474
L+ Y + +I EY+
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 475 GTLDQYLKGKKEHMLNWVERL----------QIAVDSAQGLEYLHYGCKPPIVHRDVKSS 524
TL + LK + + Q+ + + ++H I HRD+K
Sbjct: 123 -TLHKVLK----SFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQ 170
Query: 525 NILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN--EKSDVY 581
N+L+N + K+ DFG ++ + S A + Y PE +L D++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL---IPSEPSVAYICSRFYRAPE-LMLGATEYTPSIDLW 226
Query: 582 SFGVVLLEIITGR 594
S G V E+I G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 33/150 (22%), Positives = 59/150 (39%), Gaps = 15/150 (10%)
Query: 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYC 459
+VLG G G+V ++ A+KML + +V+L R ++ ++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQCPHIVRIVDVY 80
Query: 460 ----IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY-GCKP 514
+ ++ E + G L ++ + + E +I + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 137
Query: 515 PIVHRDVKSSNILL---NEKLQAKIADFGL 541
I HRDVK N+L K+ DFG
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 17/99 (17%), Positives = 36/99 (36%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ P + L +G++ N +E L L +N +S L+ L+ +
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161
Query: 293 RNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESCK 331
N + D+ +L+L+++GN +
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD 200
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 21/102 (20%), Positives = 30/102 (29%), Gaps = 10/102 (9%)
Query: 226 LNCSYE------DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
NC P+ L S + L + F+ L + FLDL+ + +
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L L L N L L S +L L
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETAL---SGPKALKHLFFIQT 115
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 6/83 (7%)
Query: 241 LNLSS---SGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
LNL + + L +E L LS LS + L + ++L N+LT
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 298 GSLPADLVERSNNGSLTLSVDGN 320
S L S+ + L++ N
Sbjct: 514 SSSIEAL---SHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 2/83 (2%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L+L+ + L + + F NL ++ L+LS++ L + + LP+L+ LNL+ N
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
G L L +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFC 486
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 12/63 (19%), Positives = 25/63 (39%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
R+ +L L+++ L + A++ L +S L +L +L L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 296 LTG 298
++
Sbjct: 141 ISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ S + L+L+++ L+ E+ L+ ++ L LS N S PSL L++K
Sbjct: 275 HCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333
Query: 293 RNKLTGSLPAD 303
N L
Sbjct: 334 GNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 28/91 (30%), Positives = 37/91 (40%), Gaps = 5/91 (5%)
Query: 231 EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
E + S+NL S F + ++ LDL+ LS P L L +L+ L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 291 LKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L NK SN SLT LS+ GN
Sbjct: 308 LSANKFENLCQISA---SNFPSLTHLSIKGN 335
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
R+ L LS L+ F +L + +DLS+N L+ + E LS L + LNL
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLAS 532
Query: 294 NKLTGSLPADLVERSNNGSL-TLSVDGN 320
N ++ LP+ L T+++ N
Sbjct: 533 NHISIILPSLL---PILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ L+L+ + F + ++ L L+ N L LS +L+ L +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 296 LTGSLPADLVERSNNGSL-TLSVDGN 320
++ L N +L +L + N
Sbjct: 117 ISSIDFIPL---HNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 228 CSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSL 286
C+ + N S + SLNLS + + F +E LDL+ L + L L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 287 RALNLKRNKLTGSLPADLVERSNNGSL-TLSVDGN 320
+ LNL + L L +L L++ GN
Sbjct: 428 KVLNLSHSLLD-ISSEQLF--DGLPALQHLNLQGN 459
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 241 LNLSSSGLT--GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L+LS + + NL+ ++ L+LS N E + P L L+L +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
N L L++ +
Sbjct: 415 KDAQSPF--QNLHLLKVLNLSHS 435
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT-FPEFLSKLPSLRALNLKRN 294
S + L LS++ +N ++ L + N+ L L +LR L+L +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
+ + ++ N L L++ N
Sbjct: 361 DIE-TSDCCNLQLRNLSHLQSLNLSYN 386
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 14/91 (15%), Positives = 26/91 (28%), Gaps = 7/91 (7%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTA--IEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
+ + F L +E ++L + L+ L+
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 291 LKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L L+ LP+ L +L L + N
Sbjct: 285 LTATHLS-ELPSGL---VGLSTLKKLVLSAN 311
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/67 (26%), Positives = 34/67 (50%), Gaps = 1/67 (1%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ + ++LS + LT ++L I +L+L++N +S P L L R +NL+
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR 555
Query: 293 RNKLTGS 299
+N L +
Sbjct: 556 QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 3/86 (3%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS--KLPSLRALNLKRN 294
+SLNL+ + + I P + + L+ + L + SL +
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGN 320
PA ++++ +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKH 264
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 30/192 (15%), Positives = 57/192 (29%), Gaps = 24/192 (12%)
Query: 144 TTTALSSVPVSGARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTDEDDVNALRNIKS 203
+ L + V G I N + PI + D AL+ I
Sbjct: 230 KRSELETQSVRGESFTVIDNKLTKDANVPI----------QLKETAEYIKDYKALKAIWE 279
Query: 204 TYGVKRNWQGDPCVPKNY----WWDGLN--CSYED------NNPSRIISLNLSSSGLTGE 251
K NW+ N W+ + D +N R+ L+L+ G G
Sbjct: 280 ALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 252 ISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNN- 310
+ LT ++ L +S + + F + + +++++ ++
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 311 GSLTLSVDGNTS 322
L D
Sbjct: 399 NLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 24/106 (22%), Positives = 42/106 (39%), Gaps = 10/106 (9%)
Query: 223 WDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS-------GT 275
++CS +D ++ LS + + + FA + I + LSNN ++
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 276 FPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L ++L+ NKLT SL D + L+ + V N
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA-TTLPYLSNMDVSYN 763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 18/98 (18%), Positives = 31/98 (31%), Gaps = 13/98 (13%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N N + ++NL + ++L N P+FL LP L++LN+
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 293 RNKLTG---------SLPADLVERSNNGSLT-LSVDGN 320
N+ L D + + N
Sbjct: 524 CNRGISAAQLKADWTRLADDE---DTGPKIQIFYMGYN 558
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 11/81 (13%), Positives = 23/81 (28%), Gaps = 3/81 (3%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
+ + + + ++ L + +N + E L P L L++ N
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843
Query: 301 PADLVERSNNGSLTLSVDGNT 321
+ G L D
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 13/98 (13%), Positives = 30/98 (30%), Gaps = 12/98 (12%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG---------TFPEFLSKL 283
+N + + L + ++ + +L ++ L+++ N +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 284 PSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
P ++ + N L PA L L N
Sbjct: 548 PKIQIFYMGYNNLE-EFPAS-ASLQKMVKLGLLDCVHN 583
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 4/78 (5%)
Query: 234 NPSRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+I + + L S + + LD +N + F L L L
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLD 603
Query: 293 RNKLTGSLPADLVERSNN 310
N++ +P D ++
Sbjct: 604 YNQIE-EIPEDFCAFTDQ 620
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 13/92 (14%), Positives = 31/92 (33%), Gaps = 12/92 (13%)
Query: 240 SLNLSSSGLTGEISPYFA-----NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
S++ S + + E + LS N + E + + + L N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 295 KLTGSLPADLVERSNN--GSLT----LSVDGN 320
+T S+P + ++ + + + + N
Sbjct: 708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFN 738
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 12/98 (12%), Positives = 37/98 (37%), Gaps = 14/98 (14%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDL------SNNSLSGTFPEFLSKLPSL 286
+ ++++S + + N + ++ + N + +P ++ PSL
Sbjct: 750 TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 287 RALNLKRNKLTGSLPADLVER------SNNGSLTLSVD 318
L + N + + L + ++N ++++ V
Sbjct: 809 IQLQIGSNDIR-KVDEKLTPQLYILDIADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 14/90 (15%)
Query: 240 SLNLSSSGLTGEISP--YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR---- 293
+++L + LT +S L + +D+S N S +FP L+A ++
Sbjct: 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 294 --NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N++ P + + SL L + N
Sbjct: 790 EGNRILRQWPTGI---TTCPSLIQLQIGSN 816
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 16/101 (15%), Positives = 30/101 (29%), Gaps = 24/101 (23%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG-------------------TFPEFL 280
+ ++ +T IS LT ++ + +N+ +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 281 SKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
S L L + L LP L + L L++ N
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFL---YDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 12/82 (14%), Positives = 27/82 (32%), Gaps = 5/82 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L+ + + + F + L L N + +F + + L NKL
Sbjct: 577 LLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-Y 633
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+P ++ + + + N
Sbjct: 634 IP-NIFNAKSVYVMGSVDFSYN 654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 13/112 (11%), Positives = 33/112 (29%), Gaps = 10/112 (8%)
Query: 233 NNPSRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
++ L S + L ++ + +D S N + + + +N
Sbjct: 616 AFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 292 KR-----NKLTGSLPADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKKHKF 337
N++ + ++ + + N T+ S K K +
Sbjct: 676 STVTLSYNEIQKFPTELF---ATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 10/90 (11%), Positives = 27/90 (30%), Gaps = 8/90 (8%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG------TFPEFLSKLPSL 286
+ R+ +L + +P + + L + + + + +L L
Sbjct: 393 DYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 287 RALNLKRNKLTGSLPADLVERSNNGSLTLS 316
+ + + T A E +N+
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 21/98 (21%), Positives = 42/98 (42%), Gaps = 5/98 (5%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + + L+LS L F L ++ L++S+N+L ++L SL L+
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 293 RNKLTGSLPADLVERSNNGSL-TLSVDGNT-STTCSSE 328
N++ + L + SL ++ N+ + C +
Sbjct: 530 FNRIE-TSKGIL--QHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 10/102 (9%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
C D+ PS +++LS + L S F+N + +++LDLS + +
Sbjct: 16 YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L L L L N + P S SL L
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSF---SGLTSLENLVAVET 114
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 18/87 (20%), Positives = 37/87 (42%), Gaps = 1/87 (1%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNL 291
+ + + +L + L S L ++ L++++N + P + S L +L ++L
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160
Query: 292 KRNKLTGSLPADLVERSNNGSLTLSVD 318
N + DL N + LS+D
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLD 187
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 4/87 (4%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ L+ S L F +L + +LD+S + F L SL L + N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 295 KLTGSLPADLVERSNNGSL-TLSVDGN 320
+ +++ +N +L L +
Sbjct: 459 SFKDNTLSNVF--ANTTNLTFLDLSKC 483
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ + +L ++ + FAN T + FLDLS L L L+ LN+ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
L L + + SL+ L N
Sbjct: 508 NLL-FLDSSHY--NQLYSLSTLDCSFN 531
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 15/90 (16%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNL 291
+ +++ L++S + + F LT++ L ++ NS + +L L+L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 292 KRNKLTGSLPADLVERSNNGSL-TLSVDGN 320
+ +L + + L L++ N
Sbjct: 481 SKCQLE-QISWGVF--DTLHRLQLLNMSHN 507
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ +L L+ + + F+ LT++E L L+ + +L +L+ LN+ N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 296 LTG-SLPADLVERSNNGSL-TLSVDGN 320
+ LPA SN +L + + N
Sbjct: 140 IHSCKLPAYF---SNLTNLVHVDLSYN 163
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 6/96 (6%)
Query: 227 NCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPS 285
CSY D + + L+LS +G +S F L ++ LD +++L L
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 286 LRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L L++ SL L + GN
Sbjct: 426 LLYLDISYTNTKIDFDGIF---LGLTSLNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S + L+LS + + L + L L+ N + P S L SL L K
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 296 LTGSLPADLVERSNNGSL-TLSVDGN 320
L SL + + +L L+V N
Sbjct: 116 LA-SLESFPI--GQLITLKKLNVAHN 138
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ SL++ L + +L ++ L L+ N S +F LPSL L+L RN
Sbjct: 307 FKWQSLSIIRCQLK-QFP--TLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNA 361
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTSTTCSSE 328
L+ S + N L + N + S+
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSAN 394
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 18/82 (21%), Positives = 33/82 (40%), Gaps = 6/82 (7%)
Query: 240 SLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRA----LNLKRN 294
LN++ + + ++ YF+NLT + +DLS N + L L L++ N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 295 KLTGSLPADLVERSNNGSLTLS 316
+ + + LTL
Sbjct: 192 PID-FIQDQAFQGIKLHELTLR 212
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 5/86 (5%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS--KLPSLRALN 290
+ + SL L+ + + IS L ++ +LDLS N+LS + S SLR L+
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 291 LKRNKLTGSLPADLVERSNNGSLTLS 316
L N + A+ + L
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQ 407
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 2/68 (2%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
I L+ + + F L + + L+ S+ + E + K ++L++ R +L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 297 TGSLPADL 304
DL
Sbjct: 320 KQFPTLDL 327
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT-FPEFLSKLPSLRALNL 291
NP +SL++S + + F + + L L N S L L L L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 292 KRNKLTGSLPADLVERSNNGSLT 314
+ ++ E S L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLC 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 29/199 (14%), Positives = 69/199 (34%), Gaps = 49/199 (24%)
Query: 403 ERVLGKGGFGEVYHG---------SLDDNQQVAVKM--------------LSSSCCFQLL 439
+ + G +Y S Q+ ++K+ ++ Q+
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 440 QVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER----- 494
+ K L + +G+ + + Y ++ +L + L + L+ +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSL----QSALDVSPKHVLSE 158
Query: 495 ---LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI--ADFGLSRIFS--- 546
LQ+A LE+LH VH +V + NI ++ + Q+++ A +G + +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 547 --IESSDQISTAVAGTPGY 563
+ + + G +
Sbjct: 216 KHVAYVEGSRSPHEGDLEF 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 34/171 (19%)
Query: 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCF-----QLL-QVKLLMRVHHRNLTALI 456
+G+GGFG +Y ++ ++ V L ++K R
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 457 GYCIEGNNMGLIYEYMASGTLDQYLKGKK-------------EHMLNWVER-------LQ 496
+ +G + +Y SG GK + + + LQ
Sbjct: 100 IRTRKLKYLG-VPKYWGSGL--HDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156
Query: 497 IAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI--ADFGLSRIF 545
+++ LEY+H VH D+K+SN+LLN K ++ D+GL+ +
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 31/168 (18%)
Query: 403 ERVLGKGGFGEVYHG-SLDDNQQVAVKMLS--SSCCFQLLQ-VKLLMRVHHRNLTALIGY 458
+ +G GGFG +Y + ++ A ++ L +K RV ++
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKK-------------EHMLNWVER------LQIAV 499
+ + +G I + SG + KG+ + + LQ+ +
Sbjct: 102 RKQLDYLG-IPLFYGSGLTEF--KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI--ADFGLSRIF 545
LEY+H VH D+K++N+LL K ++ AD+GLS +
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 30/166 (18%)
Query: 398 ITNNF--ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHH-RN 451
+ NF + +G G FGE+ G +L N+ VA+K+ L + ++
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-------LQIAVDSAQG 504
+ + + G Y M L L E + + +R L IA+
Sbjct: 67 IPQVYYFGPCGK-----YNAMVLELLGPSL----EDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 505 LEYLHYGCKPPIVHRDVKSSNILL-----NEKLQAKIADFGLSRIF 545
+EY+H +++RDVK N L+ + I DF L++ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 28/160 (17%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHH-RNLTALIG 457
R +G+G FG ++ G +L +NQQVA+K L+ + + + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-------LQIAVDSAQGLEYLHY 510
+ EG + + L L E +L+ R A ++ +H
Sbjct: 74 FGQEGL-----HNVLVIDLLGPSL----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAK-----IADFGLSRIF 545
+V+RD+K N L+ + DFG+ + +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 404 RVLGKGGFGEVYHGSLD--DNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIG- 457
R LG G F V+ + D +N VA+K++ + ++KLL RV+ + T
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 458 ---YCI-----------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQ-IAVDSA 502
+ + G ++ +++E + L +K + + + ++ I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP-LIYVKQISKQLL 141
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNE------KLQAKIADFGLSRIFSIESSDQISTA 556
GL+Y+H C I+H D+K N+L+ +Q KIAD G + + ++ I T
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 557 VAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGR 594
Y PE V W +D++S ++ E+ITG
Sbjct: 200 E-----YRSPE--VLLGAPW-GCGADIWSTACLIFELITGD 232
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L ++ + P F L + FLDLS L P + L SL+ LN+ N+L S
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-S 508
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+P + SL + + N
Sbjct: 509 VPDGIF--DRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 21/91 (23%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSL-SGTFPEFLSKLPSLRALNL 291
+ S + L + L + +L ++ L++++N + S PE+ S L +L L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 292 KRNKLTGSLPADL--VERSNNGSLTLSVDGN 320
NK+ DL + + +L+L + N
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 236 SRIISLNLSSSGLTGEISPY--FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
++ L+ S L ++S + F +L + +LD+S+ F + L SL L +
Sbjct: 396 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 294 NKLTGSLPADL 304
N + D+
Sbjct: 455 NSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 25/101 (24%), Positives = 33/101 (32%), Gaps = 10/101 (9%)
Query: 227 NCSYE------DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFL 280
C DN P +L+LS + L S F + ++ LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 281 SKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L L L L N + SL S SL L
Sbjct: 73 QSLSHLSTLILTGNPIQ-SLALGAF--SGLSSLQKLVAVET 110
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 11/58 (18%), Positives = 27/58 (46%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
+L L+ + + F+ L++++ L +L+ + L +L+ LN+ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 4/81 (4%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L+LS + + +L+ + L L+ N + S L SL+ L L SL
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SL 115
Query: 301 PADLVERSNNGSLT-LSVDGN 320
+ + +L L+V N
Sbjct: 116 ENFPI--GHLKTLKELNVAHN 134
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 4/82 (4%)
Query: 241 LNLSSSGLT--GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L+LS +GL+ G S T++++LDLS N + T L L L+ + + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409
Query: 299 SLPADLVERSNNGSLTLSVDGN 320
+ V S + L +
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHT 431
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 19/84 (22%), Positives = 35/84 (41%), Gaps = 5/84 (5%)
Query: 228 CSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS--GTFPEFLSKLPS 285
+ + L +S+ S +L ++EFLDLS N LS G + S
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 286 LRALNLKRNKLTGSLPADLVERSN 309
L+ L+L N + ++ ++ +
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQ 397
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 18/70 (25%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
+ L+LS L ++SP F +L++++ L++++N L +L SL+ + L
Sbjct: 467 TELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525
Query: 292 KRNKLTGSLP 301
N S P
Sbjct: 526 HTNPWDCSCP 535
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 7e-10
Identities = 85/705 (12%), Positives = 181/705 (25%), Gaps = 210/705 (29%)
Query: 25 DFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSLPIDAENPNAFRPAPAVMSTAVTSE 84
DF +YKD + + + + + + + ++ E
Sbjct: 8 DF-ETGEHQYQYKDIL------SVFEDAFVD-------NFD----CKDVQDMPKSILSKE 49
Query: 85 NVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQTREFNITQNGKFYIGPIVPTYLYT 144
+ + + ++ LL+ Q + Q KF + Y +
Sbjct: 50 EIDH----IIMSKDAVSGTLRLF------WTLLSKQE---EMVQ--KFVEEVLRINYKFL 94
Query: 145 TTALSSVPV--SGARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTDEDDV------- 195
+ + + S YI +R L N +Q+ +V
Sbjct: 95 MSPIKTEQRQPSMMTRMYI---EQRDRLY------------NDNQVFAK-YNVSRLQPYL 138
Query: 196 ---NALRNIKST-----YGVK------------RNWQGDPCVPKN-YWWDGLNCSYEDNN 234
AL ++ GV +++ + +W LN ++
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW---LNLKNCNSP 195
Query: 235 PSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRAL---- 289
+ + L L +I P + + + L +S+ L P L
Sbjct: 196 ETVLEMLQK----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 290 NLKRNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFS 349
N++ K N L T S H + +++
Sbjct: 252 NVQNAKA--------WNAFNLSCKILLTTRFKQVT-DFLSAATTTHISLDHHSMTLTPDE 302
Query: 350 TV-LFALAIFC---GLRRRNKRVG-QKVEM------EFENRNDSFAPKSRQFAYSEIQKI 398
L + C L R +++ + + D++ + ++ I
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW----KHVNCDKLTTI 358
Query: 399 TNNFERVLGKGGFGEVYH----------------------GSLDDNQQVAVKMLSSSCC- 435
+ VL + +++ D V K+ S
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 436 -------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY--MASGTLDQYLKGKKE 486
+ + L ++V N AL ++ N+ ++ + LDQY
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF----- 473
Query: 487 HMLNWVERLQIAVDSAQGLEYLHYG---CKPPIVHRDVKSSNILLNEK-LQAKIADFGLS 542
Y H G R + L+ + L+ KI +
Sbjct: 474 --------------------YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA 513
Query: 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE 602
S + + ++Y + Y I P R
Sbjct: 514 WNASGSILNTL----------QQLKFY------KP---Y---------ICDNDPKYERLV 545
Query: 603 DDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS----AWKAVE 643
+ + L +++ +L ++ + A K V+
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALM--AEDEAIFEEAHKQVQ 588
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 28/165 (16%)
Query: 397 KITNNF--ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC-CFQLLQ-VKLLMRVHH-R 450
++ N + R +G G FG++Y G + ++VA+K+ QL K+ +
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 65
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-------LQIAVDSAQ 503
+ + EG+ Y M L L E + N+ R L +A
Sbjct: 66 GIPTIRWCGAEGD-----YNVMVMELLGPSL----EDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK---IADFGLSRIF 545
+EY+H +HRDVK N L+ + I DFGL++ +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 3e-09
Identities = 28/206 (13%), Positives = 56/206 (27%), Gaps = 59/206 (28%)
Query: 399 TNNFERV--LGKGGFGEVYHGSLDDNQQVAVKMLS---------------------SSCC 435
T +R +G+G FGEV+ D+ VA+K+++
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 436 FQLLQVKLLMRVHHRNLTALIGYCI------------------------------EGNNM 465
+L + + L + + +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSN 525
++ E+ G L+ + + + I L HRD+ N
Sbjct: 138 FIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 526 ILLNEKLQAKIADFGLSRIFSIESSD 551
+LL + K+ + +I S
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCG 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 28/165 (16%)
Query: 397 KITNNF--ERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVH-HR 450
++ N F R +G G FGE+Y G ++ N++VA+K+ + L K+ +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVER-------LQIAVDSAQ 503
+ + + +EG+ Y + L L E + N+ R L +A
Sbjct: 64 GIPNVRWFGVEGD-----YNVLVMDLLGPSL----EDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAK---IADFGLSRIF 545
+E++H +HRD+K N L+ +A I DFGL++ +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 41/279 (14%), Positives = 82/279 (29%), Gaps = 13/279 (4%)
Query: 19 WLLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPGWKKLSTSLPIDAENPNAFRPAPAVMS 78
WLL R + + +++ + + ++ T L + E P +V
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAP------LSVEW 287
Query: 79 TAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQTREFNITQNGKFYIGPIV 138
N + + Q + + +E + ++
Sbjct: 288 RTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGS--DSQKECVLLKDRPECWCRDS 345
Query: 139 PTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIYMVKNSSQLLTDEDDVNAL 198
T SV S + + E L+P + ++ L + L
Sbjct: 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405
Query: 199 RNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFAN 258
+ + V ++ + + + R+ L+L+ LT + +
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDLT-VL-CHLEQ 461
Query: 259 LTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L + LDLS+N L P L+ L L L N L
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 19/64 (29%), Positives = 25/64 (39%), Gaps = 5/64 (7%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF--LSKLPSLRALNLKR 293
+ L S + L + ANL ++ L L NN L L P L LNL+
Sbjct: 486 RCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQG 542
Query: 294 NKLT 297
N L
Sbjct: 543 NSLC 546
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 23/88 (26%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
P+ L+L + + ++ FA+ +E L+L+ N +S P + L +LR L L+
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+L +P + + +LT L + N
Sbjct: 90 NRLK-LIPLGVF--TGLSNLTKLDISEN 114
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
LNLS + ++ I L ++ + L L+ P L LR LN+ N+LT
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT- 309
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
+L + + G+L TL +D N
Sbjct: 310 TLEESVF--HSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L+ + ++ + P F NL + L L +N L + L +L L++ NK+
Sbjct: 60 ELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV- 117
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
L + + +L +L V N
Sbjct: 118 ILLDYMF--QDLYNLKSLEVGDN 138
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ SL + + L IS F+ L ++E L L +L+ E LS L L L L+
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 295 KLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC 330
+ ++ +R L + + +C
Sbjct: 187 NIN-AIRDYSFKRLYR-LKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 3/65 (4%)
Query: 240 SLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+L L S+ L I F L+ + LD+S N + L +L++L + N L
Sbjct: 84 TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV- 141
Query: 299 SLPAD 303
+
Sbjct: 142 YISHR 146
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
SL+++ LT + +L + FL+LS N +S L +L L+ + L +L
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA- 285
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
+ L L+V GN
Sbjct: 286 VVEPYAF--RGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 14/78 (17%), Positives = 31/78 (39%), Gaps = 2/78 (2%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L LT I ++L + L L + +++ +L L+ L +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 299 SLPADLVERSNNGSLTLS 316
++ + + N SL+++
Sbjct: 215 TMTPNCLYGLNLTSLSIT 232
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 14/82 (17%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L +S ++P + L +++ +L+ + L LR LNL N ++ +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+ ++ L + + G
Sbjct: 263 IEGSML--HELLRLQEIQLVGG 282
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 18/83 (21%), Positives = 33/83 (39%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L + I Y F L ++ L++S+ T +L +L++ LT
Sbjct: 180 VLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT- 237
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
++P V + L L++ N
Sbjct: 238 AVPYLAV--RHLVYLRFLNLSYN 258
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 15/58 (25%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
+ L L + PY F L + L++S N L+ + +L L L N L
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 15/86 (17%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L +++ T +P + L+ +E L + ++ LS L SL L++ + S
Sbjct: 70 DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 300 LPADLVERSNNGSLT-LSVDGNTSTT 324
+ + + + + + N + T
Sbjct: 128 ILTKI---NTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 15/82 (18%), Positives = 36/82 (43%), Gaps = 5/82 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L + +T + P + LT++ LD+S+++ + ++ LP + +++L N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+ L L L++ +
Sbjct: 152 IMP-L---KTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L++S S I L + +DLS N T L LP L++LN++ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI-TDIMPLKTLPELKSLNIQFDGVH-- 172
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
D + L L
Sbjct: 173 ---DYRGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 12/59 (20%), Positives = 24/59 (40%), Gaps = 3/59 (5%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
S++LS +G +I P L ++ L++ + + + P L L + G
Sbjct: 140 SIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 23/71 (32%), Positives = 33/71 (46%), Gaps = 3/71 (4%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
P L+L ++ +T EI F NL + L L NN +S P + L L L L +
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 294 NKLTGSLPADL 304
N+L LP +
Sbjct: 110 NQLK-ELPEKM 119
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 232 DNNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
P + L+L + +T ++ L + L LS NS+S L+ P LR L+
Sbjct: 188 QGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 291 LKRNKLTGSLPADLVERSNNGSL-TLSVDGN 320
L NKL +P L +++ + + + N
Sbjct: 247 LNNNKLV-KVPGGL---ADHKYIQVVYLHNN 273
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 8/77 (10%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS----GTF--PEFLSKLPSLR 287
N + L+L+++ L ++ A+ I+ + L NN++S F P + +K S
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 288 ALNLKRNKLT-GSLPAD 303
++L N + +
Sbjct: 297 GVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 6/65 (9%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L ++ ++ +ISP FA L +E L LS N L PE + +L+ L + N++T
Sbjct: 81 LILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-K 135
Query: 300 LPADL 304
+ +
Sbjct: 136 VRKSV 140
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 17/70 (24%), Positives = 37/70 (52%), Gaps = 6/70 (8%)
Query: 236 SRIISLNLSSSGLT-GEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+++I + L ++ L I F + + ++ +++ +++ T P+ L PSL L+L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 294 NKLTGSLPAD 303
NK+T + A
Sbjct: 202 NKIT-KVDAA 210
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 25/67 (37%), Positives = 32/67 (47%), Gaps = 5/67 (7%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ PS++ SLNLS +GL A L LDLS N L P +LP + L+LK
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKL---SVLDLSYNRLD-RNP-SPDELPQVGNLSLK 304
Query: 293 RNKLTGS 299
N S
Sbjct: 305 GNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 225 GLNCSYEDNNPSRIISLNLSSSGLT---GEISPYFANLTAIEFLDLSNNSLSGTFPE-FL 280
GL + + L L ++G+ G S A ++ LDLS+NSL
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 281 SKLPSLRALNLKRNKLTGSLPADL 304
L +LNL L +P L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGL 272
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 19/84 (22%), Positives = 30/84 (35%), Gaps = 7/84 (8%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS----KLPSLRALNLKRNK 295
L+++ + A+ LDLS+N G + K P+L+ L L+
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 296 LT---GSLPADLVERSNNGSLTLS 316
+ G A R L LS
Sbjct: 213 METPSGVCSALAAARVQLQGLDLS 236
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 7/70 (10%)
Query: 240 SLNLSSSGLTGEISPYFA----NLTAIEFLDLSNN---SLSGTFPEFLSKLPSLRALNLK 292
+L+LS + GE A ++ L L N + SG + L+ L+L
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236
Query: 293 RNKLTGSLPA 302
N L + A
Sbjct: 237 HNSLRDAAGA 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
++L L S L + L+ ++ + + L P+ + + L L L RN L
Sbjct: 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR- 140
Query: 299 SLPADL 304
+LPA +
Sbjct: 141 ALPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 13/90 (14%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK-RNKLTG 298
SL + +S L+ + P +L +E LDL + +P L+ L LK + L
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL- 267
Query: 299 SLPADLVERSNNGSLT----LSVDGNTSTT 324
+LP D+ LT L + G + +
Sbjct: 268 TLPLDI------HRLTQLEKLDLRGCVNLS 291
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 16/76 (21%), Positives = 29/76 (38%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L+L P F ++ L L + S T P + +L L L+L+ L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 301 PADLVERSNNGSLTLS 316
P+ + + N + +
Sbjct: 294 PSLIAQLPANCIILVP 309
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 21/93 (22%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE---------FLSKLPSLRALNL 291
L L+ + L + A+L + L + PE L +L++L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 292 KRNKLTGSLPADLVERSNNGSLT----LSVDGN 320
+ + SLPA + +L L + +
Sbjct: 191 EWTGIR-SLPASI------ANLQNLKSLKIRNS 216
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 11/73 (15%)
Query: 241 LNLSS-SGLT--------GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
L++ + LT + S L ++ L L + + P ++ L +L++L +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 292 KRNKLTGSLPADL 304
+ + L+ +L +
Sbjct: 214 RNSPLS-ALGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 9/71 (12%)
Query: 240 SLNLSS-SGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT- 297
L L S L + LT +E LDL P +++LP+ + + +
Sbjct: 257 RLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 298 ------GSLPA 302
+ PA
Sbjct: 316 LDQHRPVARPA 326
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 1/69 (1%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
N +R ++ S L ++ + ++ LDLS N LS L+ L LNL
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 294 NKLTGSLPA 302
N L
Sbjct: 68 NVLY-ETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 19/93 (20%), Positives = 39/93 (41%), Gaps = 3/93 (3%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+++ +L+LSS+ L + P F + + ++ L NN L + L +L +L+ N
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTSTTCSSE 328
D ++ T++ T +E
Sbjct: 249 FHCGTLRDFFSKNQR-VQTVAKQTVKKLTGQNE 280
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 13/66 (19%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNLKRNKLTG 298
++ L+++ +T + +++LDL N + F E + +L LNL+ N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 299 SLPADL 304
+ +
Sbjct: 183 DVKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/77 (20%), Positives = 29/77 (37%), Gaps = 4/77 (5%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNL + + ++ ++ LDLS+N L+ + ++L+ NKL
Sbjct: 173 HLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 300 LPADLVERSNNGSLTLS 316
+ L N L
Sbjct: 229 IEKALRFSQNLEHFDLR 245
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 9/52 (17%), Positives = 20/52 (38%), Gaps = 1/52 (1%)
Query: 252 ISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303
I N + ++++SL +++ L+L N L+ + A
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAA 52
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 8/65 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNLSS+ L E +L+ + LDL+NN + L PS+ L+ N ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 300 LPADL 304
+
Sbjct: 114 VSCSR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 234 NPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
I +L+ +++ ++ +S + L+NN ++ ++ L+LK
Sbjct: 97 VGPSIETLHAANNNIS-RVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N++ A+L S+ L L++ N
Sbjct: 153 LNEIDTVNFAELAASSDT--LEHLNLQYN 179
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
N +R ++ S L ++ + ++ LDLS N LS L+ L LNL
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N L + ++ + +L L ++ N
Sbjct: 68 NVLY-----ETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 13/66 (19%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNLKRNKLTG 298
++ L+++ +T + +++LDL N + F E + +L LNL+ N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 299 SLPADL 304
+ +
Sbjct: 183 DVKGQV 188
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 3/94 (3%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+++ +L+LSS+ L + P F + + ++ L NN L + L +L +L+ N
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTSTTCSSES 329
D ++ T++ T +E
Sbjct: 249 FHCGTLRDFFSKNQR-VQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 226 LNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPS 285
+N + + + LNL + + ++ ++ LDLS+N L+
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 286 LRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
+ ++L+ NKL + L + +L + GN
Sbjct: 216 VTWISLRNNKLV-LIEKAL---RFSQNLEHFDLRGN 247
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 8/65 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNLSS+ L E +L+ + LDL+NN + L PS+ L+ N ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-R 113
Query: 300 LPADL 304
+
Sbjct: 114 VSCSR 118
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 8/48 (16%), Positives = 19/48 (39%), Gaps = 1/48 (2%)
Query: 256 FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303
N + ++++SL +++ L+L N L+ + A
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAA 52
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 12/77 (15%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
I +L+ +++ ++ + L+NN ++ ++ L+LK
Sbjct: 97 VGPSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 294 NKLTGSLPADLVERSNN 310
N++ A+L S+
Sbjct: 154 NEIDTVNFAELAASSDT 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
L+L ++ ++ E+ F L + L L NN +S + S L L+ L + +
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 294 NKLTGSLPADL 304
N L +P +L
Sbjct: 112 NHLV-EIPPNL 121
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
+ P + L+L + + I + + L L +N + LS LP+LR L+
Sbjct: 189 KDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 291 LKRNKLTGSLPADLVERSNNGSLTLS 316
L NKL+ +PA L + + L
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLH 272
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 11/64 (17%), Positives = 26/64 (40%), Gaps = 7/64 (10%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS----GTFP--EFLSKLPSLRALNLKR 293
L+L ++ L+ + +L ++ + L N+++ F F K ++L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 294 NKLT 297
N +
Sbjct: 304 NPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 19/83 (22%), Positives = 38/83 (45%), Gaps = 9/83 (10%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+L L ++ ++ +I F+ L ++ L +S N L P L SL L + N++
Sbjct: 82 ALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR- 136
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
+P + S ++ + + GN
Sbjct: 137 KVPKGVF--SGLRNMNCIEMGGN 157
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 22/85 (25%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 240 SLNLSSSGLTGEISP--YFANLTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNLKRNKL 296
L L GL+ + YF NL A+ LDLS N + KL SL++++ N++
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 297 TGSLPADLVERSNNGSLTLSVDGNT 321
+L S+ N+
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANS 185
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 11/106 (10%)
Query: 233 NNPSRIISLNLSSSGLTGEISPY-----FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLR 287
+ + L L + L F L+ ++ L L++N L+ P S L +LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 288 ALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGNTSTTCSSESCKK 332
L+L N+LT L + +L L + N + +
Sbjct: 508 GLSLNSNRLT-VLSHN----DLPANLEILDISRNQLLAPNPDVFVS 548
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 16/63 (25%), Positives = 24/63 (38%), Gaps = 1/63 (1%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
++ L L S I F NL + LDL ++ + P+ L L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 295 KLT 297
L+
Sbjct: 108 GLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
S + L+LS + ++ F L ++ L+L+ N ++ E L +L+ LNL N
Sbjct: 266 SSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 295 KLT 297
L
Sbjct: 325 LLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 18/59 (30%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
LNLS + L E+ F L + ++DL N ++ + L L+ L+L+ N LT
Sbjct: 318 VLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 15/63 (23%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ LNL+ + + +I+ F L ++ L+LS N L + LP + ++L++N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 295 KLT 297
+
Sbjct: 349 HIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 240 SLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRALNLKRNKLT 297
++LS + L +I + + ++ L L+ N S + S+ PSL L L N L
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 298 GSLPADLVER--SNNGSLT-LSVDGN 320
+ +L L L ++ N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHN 490
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 3/78 (3%)
Query: 236 SRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKL--PSLRALNLK 292
+ L+LS + + + P F L +++ +D S+N + L L +L +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 293 RNKLTGSLPADLVERSNN 310
N L + D + N
Sbjct: 183 ANSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 14/76 (18%), Positives = 23/76 (30%), Gaps = 10/76 (13%)
Query: 228 CSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLR 287
CS++ LT ++ L E L LS N + L L+
Sbjct: 2 CSFDGR------IAFYRFCNLT-QV---PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQ 51
Query: 288 ALNLKRNKLTGSLPAD 303
L L ++ +
Sbjct: 52 LLELGSQYTPLTIDKE 67
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 15/67 (22%), Positives = 24/67 (35%), Gaps = 2/67 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANL--TAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
I+ + FA L +++ LDLS+ + L L+ LN
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 291 LKRNKLT 297
L NK+
Sbjct: 297 LAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 14/62 (22%), Positives = 29/62 (46%), Gaps = 5/62 (8%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
++ ++L + + F L ++ LDL +N+L+ + +PS+ + L NK
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK 392
Query: 296 LT 297
L
Sbjct: 393 LV 394
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-08
Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 8/82 (9%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LN+ S+ ++ +IS NL+ + L L+NN L E + L +L L L +N +T
Sbjct: 269 MLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-- 324
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
D+ ++ +
Sbjct: 325 ---DIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 8/82 (9%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L + ++ ++ I+ +LT ++ L++ +N +S L+ L L +L L N+L
Sbjct: 247 WLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNE 302
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+ +L TL + N
Sbjct: 303 DMEVI---GGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 9e-07
Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 3/62 (4%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L+ ++ ISP ANLT + L+L N + LS + L L + +K+
Sbjct: 114 ELYLNEDNISD-ISP-LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDV 170
Query: 300 LP 301
P
Sbjct: 171 TP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 2/65 (3%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
NN S++ SL L+++ L E LT + L LS N ++ P L+ L + + +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFA 341
Query: 293 RNKLT 297
+
Sbjct: 342 NQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ + LNL+ + +T ISP +NL + L + N ++ L L +LR L L
Sbjct: 64 YLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNE 119
Query: 294 NKLTG 298
+ ++
Sbjct: 120 DNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 15/70 (21%), Positives = 31/70 (44%), Gaps = 4/70 (5%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D + + I L + +T ++ L +I L ++ ++ + + L +L LNL
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNL 73
Query: 292 KRNKLTGSLP 301
N++T P
Sbjct: 74 NGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 17/63 (26%), Positives = 36/63 (57%), Gaps = 4/63 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+R+ SL + ++ +T +SP ANL+ + +L++ N +S + L L+ LN+ N+
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276
Query: 296 LTG 298
++
Sbjct: 277 ISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
I L ++ + I LT +E+L+L+ N ++ LS L L L +
Sbjct: 41 EELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIG 96
Query: 293 RNKLT 297
NK+T
Sbjct: 97 TNKIT 101
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 6e-06
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 4/63 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+L + ++ +T +IS NLT + L L+ +++S L+ L + +LNL N
Sbjct: 92 NLYIGTNKIT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147
Query: 300 LPA 302
L
Sbjct: 148 LSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 6e-06
Identities = 25/106 (23%), Positives = 41/106 (38%), Gaps = 22/106 (20%)
Query: 226 LNCSYEDNNPSRIIS----------LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT 275
LN N+ +S L ++ S + ++P ANLT + L L+ N +
Sbjct: 137 LNLGA--NHNLSDLSPLSNMTGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED- 191
Query: 276 FPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L+ L SL N++T D+ +N L L + N
Sbjct: 192 -ISPLASLTSLHYFTAYVNQIT-----DITPVANMTRLNSLKIGNN 231
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SL+L+ + + ISP A+LT++ + N ++ ++ + L +L + NK+T
Sbjct: 181 SLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDL 236
Query: 300 LP 301
P
Sbjct: 237 SP 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 17/81 (20%), Positives = 34/81 (41%), Gaps = 1/81 (1%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L++ L ++S ++ L ++ + + N+ + F L SL L+L N +
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 301 PADLVERSNNGSL-TLSVDGN 320
+ + SL TL + N
Sbjct: 351 LKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 21/85 (24%), Positives = 36/85 (42%), Gaps = 5/85 (5%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTF---PEFLSKLPSLRALNLKRNKL 296
+ + +S + + +L ++EFLDLS N + + PSL+ L L +N L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 297 TGSLPADLVERSNNGSLT-LSVDGN 320
S+ +LT L + N
Sbjct: 374 R-SMQKTGEILLTLKNLTSLDISRN 397
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 12/103 (11%)
Query: 226 LNCSYE------DNNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPE 278
+ + + SL+LS + +T I ++ L L ++ ++ +
Sbjct: 10 CDGRSRSFTSIPSGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGD 68
Query: 279 FLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L SL L+L N L+ SL + SL L++ GN
Sbjct: 69 AFYSLGSLEHLDLSDNHLS-SLSSSWF--GPLSSLKYLNLMGN 108
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 14/66 (21%), Positives = 24/66 (36%), Gaps = 4/66 (6%)
Query: 241 LNLSSSGLT--GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L LS + L + L + LD+S N+ P+ +R LNL +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 299 SLPADL 304
+ +
Sbjct: 424 VVKTCI 429
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ + L L SS + I F +L ++E LDLS+N LS + L SL+ LNL N
Sbjct: 50 ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 295 KLTGSLPAD 303
+L
Sbjct: 109 PYQ-TLGVT 116
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 18/114 (15%), Positives = 38/114 (33%), Gaps = 8/114 (7%)
Query: 220 NYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
Y + ++D + + N S S + E+ I L + L
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTV 305
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN--TSTTCSSESC 330
S L ++ + ++ +K+ +P + SL L + N + +C
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFS--QHLKSLEFLDLSENLMVEEYLKNSAC 356
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 20/91 (21%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 234 NPSRIISLNLSSSGLTG-EISPYFANLTAIEFLDLS-NNSLSGTFPEFLSKLPSLRALNL 291
S + LNL + ++ F NLT ++ L + + S + L SL L +
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 292 KRNKLTGSLPADLVERSNNGSLTLSVDGNTS 322
K L L + LTL + +
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 25/101 (24%), Positives = 44/101 (43%), Gaps = 14/101 (13%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
LN S + P + L++S++ L S L ++ L +S N L T P+
Sbjct: 415 LNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLK-TLPDA 469
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGN 320
S P L + + RN+L S+P + +R + + + N
Sbjct: 470 -SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQ-KIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 13/76 (17%), Positives = 24/76 (31%), Gaps = 2/76 (2%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L + + L ++ I L L + + F L S+R L L+ L
Sbjct: 153 LEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 300 LPADLVERSNNGSLTL 315
+ L + +
Sbjct: 212 QFSPLPVDEVSSPMKK 227
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 17/78 (21%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 240 SLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+L + + EI FA LT++ L++ SL + L + + L L ++
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 299 SLPADLVERSNNGSLTLS 316
L S+ L L
Sbjct: 187 LLEIFADILSSVRYLELR 204
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 20/99 (20%), Positives = 33/99 (33%), Gaps = 24/99 (24%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKL---------------- 283
SL++S + + + FL+LS+ + L
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF 449
Query: 284 -PSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
P L+ L + RNKL +LP S L + + N
Sbjct: 450 LPRLQELYISRNKLK-TLPDA----SLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 2/65 (3%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
R+ L +S + L + + + + +S N L +L SL+ + L
Sbjct: 447 SLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 292 KRNKL 296
N
Sbjct: 505 HTNPW 509
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 56/282 (19%), Positives = 96/282 (34%), Gaps = 82/282 (29%)
Query: 404 RVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALI 456
V+ K G+G L + VA+K++ S+ + L +++LL V + +
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSD-PNDP 98
Query: 457 GYC----------IEGNN---MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
I G N + +++E + L +++ L +I Q
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLN---------------------------------- 529
GL+YLH C+ I+H D+K NILL+
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 530 ---------------EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL 574
EKL+ KIAD G + ++ I T Y E + +
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT-----RQYRSLEVLIGSGY 270
Query: 575 NEKSDVYSFGVVLLEIITGRRP----VISRAEDDTTHISQWV 612
N +D++S + E+ TG D HI+ +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
LNL+ + EI Y FA I+ L + N++ P +P L L L+RN L+
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
SLP + N LT LS+ N
Sbjct: 131 SLPRGIF--HNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L +S++ L ++ Y + ++ LDLS+N L + L L L N + +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 300 LPAD 303
L
Sbjct: 333 LKLS 336
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L + LT + + N + +DLS N L K+ L L + N+L +
Sbjct: 230 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
L +L L + N
Sbjct: 287 LNLYG---QPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 15/92 (16%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 231 EDNNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRAL 289
ED + + +S + ++ + +E L+L++ + + +++ L
Sbjct: 40 EDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKL 98
Query: 290 NLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
+ N + LP + N LT L ++ N
Sbjct: 99 YMGFNAIR-YLPPHVF--QNVPLLTVLVLERN 127
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 10/82 (12%), Positives = 25/82 (30%), Gaps = 4/82 (4%)
Query: 225 GLNCSYEDNNPSRIISLNLSSSGLTGEISPYFA--NLTAIEFLDLSNNSLSGTFPEFLSK 282
C + N + ++ T ++ F L + + N+++ L
Sbjct: 9 EYKCI-DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDS 67
Query: 283 LPSLRALNLKRNKLTGSLPADL 304
+ LNL ++ +
Sbjct: 68 FRQVELLNLNDLQIE-EIDTYA 88
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L + L+ + F N + L +SNN+L + SL+ L L N+LT
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 178
Query: 299 SLPADL 304
+ L
Sbjct: 179 HVDLSL 184
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 19/63 (30%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
++ +L++S++ L I F T+++ L LS+N L+ LS +PSL N+ N
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 295 KLT 297
L+
Sbjct: 197 LLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 16/58 (27%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L+LS + L + +E L L +NS+ T LS +L+ L L N
Sbjct: 299 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L +S++ L ++ Y + ++ LDLS+N L + L L L N + +L
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339
Query: 301 PAD 303
Sbjct: 340 KLS 342
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
LNL+ + EI Y FA I+ L + N++ P +P L L L+RN L+
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
SLP + N LT LS+ N
Sbjct: 137 SLPRGIF--HNTPKLTTLSMSNN 157
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L + LT + + N + +DLS N L K+ L L + N+L +
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
L +L L + N
Sbjct: 293 LNLYG---QPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L + L+ + F N + L +SNN+L + SL+ L L N+LT
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 184
Query: 299 SLPADL 304
+ L
Sbjct: 185 HVDLSL 190
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 13/102 (12%), Positives = 32/102 (31%), Gaps = 12/102 (11%)
Query: 202 KSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTA 261
+ Y VK C+ N +C + D + +++ + + L
Sbjct: 4 QQRYNVKPRQPEYKCIDSNL---QYDCVFYDVH------IDMQTQDVYF--GFEDITLNN 52
Query: 262 IEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303
+ + N+++ L + LNL ++ +
Sbjct: 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTY 93
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 19/63 (30%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
++ +L++S++ L I F T+++ L LS+N L+ LS +PSL N+ N
Sbjct: 147 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202
Query: 295 KLT 297
L+
Sbjct: 203 LLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 16/58 (27%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L+LS + L + +E L L +NS+ T LS +L+ L L N
Sbjct: 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 3/67 (4%)
Query: 240 SLNLSSSGLTGEISPY--FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L+ S L ++S + F +L + +LD+S+ F + L SL L + N
Sbjct: 105 HLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 298 GSLPADL 304
+ D+
Sbjct: 164 ENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 18/81 (22%), Positives = 39/81 (48%), Gaps = 3/81 (3%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L+LS L ++SP F +L++++ L++S+N+ L SL+ L+ N + +
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237
Query: 300 LPADLVERSNNGSLTLSVDGN 320
++ + L++ N
Sbjct: 238 SKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 3/78 (3%)
Query: 228 CSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSL 286
CS D + + L+LS +G+ +S F L +E LD +++L L +L
Sbjct: 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128
Query: 287 RALNLKRNKLTGSLPADL 304
L++ +
Sbjct: 129 IYLDISHTHTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 19/64 (29%), Positives = 26/64 (40%), Gaps = 2/64 (3%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L ++ + P F L + FLDLS L P + L SL+ LN+ N S
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-S 213
Query: 300 LPAD 303
L
Sbjct: 214 LDTF 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 404 RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR------NLT 453
+V+GKG FG+V +Q VA+KM+ + F ++++L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
++ N++ + +E + S L + +K K + + A Q L+ LH K
Sbjct: 163 HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---K 218
Query: 514 PPIVHRDVKSSNILLNEKLQA--KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY-- 569
I+H D+K NILL ++ ++ K+ DFG S ++ T Y+ +Y
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGS----SCYEHQRVYT-------YIQSRFYRA 267
Query: 570 -----VLNWLNEKSDVYSFGVVLLEIITGR 594
+ D++S G +L E++TG
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGY 296
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 241 LNLSSSGLTGEISP--YFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRALNLKRNKLT 297
L L+ L G + +F LT++E L L +N++ P F + L+L NK+
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 298 GSLPADLVERSNNGSLT-LSVDGNTSTTCS 326
S+ + + T L + T +
Sbjct: 168 -SICEEDLLNFQGKHFTLLRLSSITLQDMN 196
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 19/79 (24%), Positives = 37/79 (46%), Gaps = 3/79 (3%)
Query: 227 NCSYEDNNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPS 285
N +++ S + + +LS S + + F++ T +E L L+ N ++ L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 286 LRALNLKRNKLTGSLPADL 304
L LNL +N L S+ + +
Sbjct: 325 LLKLNLSQNFLG-SIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 14/66 (21%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L + I F L+++ L L N + L +L L L + L G+
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 300 -LPADL 304
L +
Sbjct: 119 VLSGNF 124
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
LNLS + L I F NL +E LDLS N + + LP+L+ L L N+L
Sbjct: 327 KLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK- 384
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
S+P + SL + + N
Sbjct: 385 SVPDGIF--DRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 11/70 (15%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSL----SGTFPEFLSKLPSLRALNLKRN 294
L L+ + + +I F LT + L+LS N L S F L L L+L N
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF----ENLDKLEVLDLSYN 357
Query: 295 KLTGSLPADL 304
+ +L
Sbjct: 358 HIR-ALGDQS 366
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L +S + EI P F L++++ L + N+ +S L SL LNL N L+ S
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
LP DL + L L + N
Sbjct: 281 LPHDLF--TPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 25/88 (28%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
PS LNL + + I F +L +E L L NS+ + L SL L L
Sbjct: 74 PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N LT +P+ L L + N
Sbjct: 133 NWLT-VIPSGAF--EYLSKLRELWLRNN 157
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L + + +I F L ++ L+L +N L+ L LR L L+ N +
Sbjct: 103 VLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE- 160
Query: 299 SLPADL 304
S+P+
Sbjct: 161 SIPSYA 166
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 4/69 (5%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
++ L+L IS F L +++L+L ++ P + L L L + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGN 228
Query: 295 KLTGSLPAD 303
+
Sbjct: 229 HFP-EIRPG 236
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 6/82 (7%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNL + ++ P L +E L++S N P L SL+ L + ++++
Sbjct: 200 YLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-L 256
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+ + SL L++ N
Sbjct: 257 IERNAF--DGLASLVELNLAHN 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 9/84 (10%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLS-NNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L L ++ + I Y F + ++ LDL L L +L+ LNL +
Sbjct: 151 ELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
Query: 298 GSLPADLVERSNNGSLT-LSVDGN 320
+P + L L + GN
Sbjct: 210 -DMPNL----TPLVGLEELEMSGN 228
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 25/68 (36%), Positives = 40/68 (58%), Gaps = 6/68 (8%)
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTA-IEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
I+ LNLSS+ LTG + F L ++ LDL NN + + P+ ++ L +L+ LN+
Sbjct: 427 AESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482
Query: 294 NKLTGSLP 301
N+L S+P
Sbjct: 483 NQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 14/61 (22%), Positives = 25/61 (40%), Gaps = 1/61 (1%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
LS S + ++ FL+ + N + + + S L L+ L L+RN L +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 301 P 301
Sbjct: 393 F 393
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L LS + + I F L + L+L +N L+ L L+ L L+ N +
Sbjct: 92 ILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 299 SLPADL 304
S+P+
Sbjct: 150 SIPSYA 155
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ LNL + + I F +L +E L LS N + + L +L L L
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+LT ++P L L + N
Sbjct: 122 NRLT-TIPNGAF--VYLSKLKELWLRNN 146
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L+LS + L+ I P F L ++ L + + + L SL +NL N LT
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 299 SLPADLVERSNNGSL-TLSVDGN 320
LP DL + L + + N
Sbjct: 269 LLPHDLF--TPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 6/82 (7%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
LNL+ L EI P L ++ LDLS N LS P L L+ L + ++++
Sbjct: 189 YLNLAMCNLR-EI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-V 245
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+ + N SL +++ N
Sbjct: 246 IERNAF--DNLQSLVEINLAHN 265
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 4/70 (5%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR- 293
+ + +L L + LT I F L+ ++ L L NN + +++PSLR L+L
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170
Query: 294 NKLTGSLPAD 303
+L+ +
Sbjct: 171 KRLS-YISEG 179
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 9/84 (10%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLS-NNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
L L ++ + I Y F + ++ LDL LS L +LR LNL L
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198
Query: 298 GSLPADLVERSNNGSLT-LSVDGN 320
+P + L L + GN
Sbjct: 199 -EIPNL----TPLIKLDELDLSGN 217
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 11/74 (14%)
Query: 235 PSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRAL 289
P +L+LS + L + F + ++ LDLS + G + L L L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QSLSHLSTL 81
Query: 290 NLKRNKLTGSLPAD 303
L N + SL
Sbjct: 82 ILTGNPIQ-SLALG 94
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 17/73 (23%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 233 NNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSL-SGTFPEFLSKLPSLRALN 290
+ S + L + L + + +L ++ L++++N + S PE+ S L +L L+
Sbjct: 97 SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 291 LKRNKLTGSLPAD 303
L NK+ S+
Sbjct: 156 LSSNKIQ-SIYCT 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L+LS + I + +L+ + L L+ N + S L SL+ L L S
Sbjct: 57 LDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-S 114
Query: 300 LPAD 303
L
Sbjct: 115 LENF 118
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 233 NNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLR 287
+ + LN++ + + P YF+NLT +E LDLS+N + L ++P L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLN 179
Query: 288 A-LNLKRNKLTGSLPADLVERSNNGSLTLS 316
L+L N + + + L L
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALD 208
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 17/89 (19%)
Query: 227 NCSYED------NNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLS----GT 275
+C + N P I + L + + I P F+ + +DLSNN +S
Sbjct: 17 DCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDA 75
Query: 276 FPEFLSKLPSLRALNLKRNKLTGSLPADL 304
F L SL +L L NK+T LP L
Sbjct: 76 F----QGLRSLNSLVLYGNKIT-ELPKSL 99
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 3/64 (4%)
Query: 241 LNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
++LS++ ++ E++P F L ++ L L N ++ L SL+ L L NK+
Sbjct: 61 IDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-C 118
Query: 300 LPAD 303
L D
Sbjct: 119 LRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 10/69 (14%)
Query: 256 FANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG 311
F L +++ L L+ N ++ F L +L L+L NKL ++
Sbjct: 100 FEGLFSLQLLLLNANKINCLRVDAF----QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154
Query: 312 SLTLSVDGN 320
T+ + N
Sbjct: 155 Q-TMHLAQN 162
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 12/67 (17%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D + + L + +T +S +L + L + + + L +L +N
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 292 KRNKLTG 298
N+LT
Sbjct: 76 SNNQLTD 82
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 10/82 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SL +++ ++ I+P LT ++ L L+ N L L+ L +L L+L N+++
Sbjct: 203 SLIATNNQISD-ITP-LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS-- 256
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+L S LT L + N
Sbjct: 257 ---NLAPLSGLTKLTELKLGAN 275
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 10/103 (9%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+N + L L + ++ ISP ++LT ++ L NN +S L+ L ++ L+
Sbjct: 306 SNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAG 361
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKK 334
N+++ DL +N +T L ++ T
Sbjct: 362 HNQIS-----DLTPLANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 18/59 (30%), Positives = 32/59 (54%), Gaps = 4/59 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+N S++ LT I+P NLT + + ++NN ++ L+ L +L L L N++T
Sbjct: 72 QINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 24/82 (29%), Positives = 37/82 (45%), Gaps = 10/82 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L ++ ++ ISP A LTA+ L+L+ N L +S L +L L L N ++
Sbjct: 269 ELKLGANQISN-ISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS-- 322
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
D+ S+ L L N
Sbjct: 323 ---DISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ + + L+ + ++ P ANLT +E LD+S+N +S L+KL +L +L
Sbjct: 153 SGLTSLQQLSFGNQVT--DLKP-LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIAT 207
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+++ D+ +L LS++GN
Sbjct: 208 NNQIS-----DITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L ++ ++ ANLT I +L +N +S P L+ L + L L T +
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-N 389
Query: 300 LPADLVERSNNGSLTLSVDGNTST 323
P + + + +V G
Sbjct: 390 APVNYKANVSIPNTVKNVTGALIA 413
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 5/62 (8%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L ++ +T I P NLT + L+LS+N++S LS L SL+ L+ N++T
Sbjct: 116 GLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170
Query: 300 LP 301
P
Sbjct: 171 KP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
N + I L+ + ++ ++P ANLT I L L++ + + + + + +
Sbjct: 351 NLTNINWLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFS 349
L PA + S+ GS T + N + + S + V + FS
Sbjct: 409 GALI--APATI---SDGGSYTEPDITWNLPSYTNEVSYTFSQP---VTIGKGTTTFS 457
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 404 RVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR------NLT 453
++GKG FG+V + + VA+K++ + F ++V+LL ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L + + N++ L++E + S L L+ ++ + A L +L +
Sbjct: 120 HLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-E 177
Query: 514 PPIVHRDVKSSNILL--NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV- 570
I+H D+K NILL ++ KI DFG S S + +I Y+ +Y
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFG-S---SCQLGQRIYQ-------YIQSRFYRS 226
Query: 571 ------LNWLNEKSDVYSFGVVLLEIITGR 594
+ + + D++S G +L+E+ TG
Sbjct: 227 PEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 2/65 (3%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+L+LS + L + L A+ LD+S N L+ L L L+ L LK N+L +
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-T 138
Query: 300 LPADL 304
LP L
Sbjct: 139 LPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 24/87 (27%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
P L+LS + L T + L+L L+ LP L L+L N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHN 87
Query: 295 KLTGSLPADLVERSNNGSLT-LSVDGN 320
+L SLP +LT L V N
Sbjct: 88 QLQ-SLPLLG---QTLPALTVLDVSFN 110
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 15/65 (23%), Positives = 24/65 (36%), Gaps = 9/65 (13%)
Query: 256 FANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG 311
+E L L+NN+L+ G + L +L L L+ N L ++P
Sbjct: 144 LTPTPKLEKLSLANNNLTELPAGLL----NGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 312 SLTLS 316
L
Sbjct: 199 FAFLH 203
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 18/61 (29%), Positives = 25/61 (40%), Gaps = 1/61 (1%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
N + SG + ++ LD SNN L+ T E L L L L+ N+L L
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 301 P 301
Sbjct: 364 S 364
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 23/69 (33%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ ++SLN+SS+ LT I I+ LDL +N + + P+ + KL +L+ LN+
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452
Query: 293 RNKLTGSLP 301
N+L S+P
Sbjct: 453 SNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 14/84 (16%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 226 LNCSYE------DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
++ S + + LN+S + ++ + +L+ + L +S+N +
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 280 LSKLPSLRALNLKRNKLTGSLPAD 303
L L+L NKL +
Sbjct: 65 FKFNQELEYLDLSHNKLV-KISCH 87
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 17/73 (23%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS--GTFPEFLSKLPSLRALN 290
+ S + L+ S++ LT + +LT +E L L N L E +++ SL+ L+
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 291 LKRNKLTGSLPAD 303
+ +N ++
Sbjct: 381 ISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 3/67 (4%)
Query: 241 LNLSSSGLT--GEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLT 297
L L + L +I+ + +++ LD+S NS+S S SL +LN+ N LT
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 298 GSLPADL 304
++ L
Sbjct: 413 DTIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 32/216 (14%), Positives = 66/216 (30%), Gaps = 9/216 (4%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL 300
L +S + + F +E+LDLS+N L +L+ L+L N +L
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-AL 105
Query: 301 PADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKKHKFVVPVVVSVAAFSTVLFALAIFC 359
P E N L L + S H + V++ +
Sbjct: 106 P-ICKEFGNMSQLKFLGLSTT---HLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161
Query: 360 GLRRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL 419
+ + EF D S I+ + + + ++
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 420 DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTAL 455
N + + + ++LQ+ V + +++ +
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 24/83 (28%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+L+L GL E+ P F L A+++L L +N+L + L +L L L N+++
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS- 166
Query: 299 SLPADLVERSNNGSLT-LSVDGN 320
S+P SL L + N
Sbjct: 167 SVPERAF--RGLHSLDRLLLHQN 187
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 6/82 (7%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L + ++ + F L +++ L L N ++ P L L L L N L+ +
Sbjct: 158 LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
LP + + + +L L ++ N
Sbjct: 216 LPTEAL--APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 2/70 (2%)
Query: 235 PSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
P+ + L + ++ + F + L L +N L+ + L L L+L
Sbjct: 31 PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 294 NKLTGSLPAD 303
N S+
Sbjct: 90 NAQLRSVDPA 99
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 23/66 (34%), Positives = 28/66 (42%), Gaps = 4/66 (6%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNS-LSGTFPEFLSKLPSLRALNLKRNKLTG 298
L L S+ L I F L +E LDLS+N+ L P L L L+L R L
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ- 118
Query: 299 SLPADL 304
L L
Sbjct: 119 ELGPGL 124
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 6/82 (7%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L + L + F +L + L L N +S L SL L L +N++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+ + G L TL + N
Sbjct: 192 VHPHAF--RDLGRLMTLYLFAN 211
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 22/76 (28%), Positives = 30/76 (39%), Gaps = 6/76 (7%)
Query: 231 EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALN 290
D + L L++ GL+ + +L E L S NSL+ PE L SL N
Sbjct: 66 RDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 291 LKRNKLTGSLPADLVE 306
L+ LP L
Sbjct: 121 NNLKALS-DLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 19/69 (27%), Positives = 34/69 (49%), Gaps = 7/69 (10%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ P + L +S++ L ++ P N + ++ +D+ NNSL P+ PSL +
Sbjct: 128 DLPPLLEYLGVSNNQLE-KL-PELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAG 181
Query: 293 RNKLTGSLP 301
N+L LP
Sbjct: 182 NNQLE-ELP 189
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 23/89 (25%), Positives = 35/89 (39%), Gaps = 12/89 (13%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ P + + ++ L E+ P NL + + NNSL P+ SL ++
Sbjct: 170 DLPPSLEFIAAGNNQLE-EL-PELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAG 223
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N L LP E N LT + D N
Sbjct: 224 NNILE-ELP----ELQNLPFLTTIYADNN 247
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 23/89 (25%), Positives = 34/89 (38%), Gaps = 16/89 (17%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
P + L++S + + +S NL +L+ S+N + PSL LN+
Sbjct: 274 ELPQSLTFLDVSENIFS-GLSELPPNLY---YLNASSNEIR----SLCDLPPSLEELNVS 325
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NKL LPA L L N
Sbjct: 326 NNKLI-ELPALP------PRLERLIASFN 347
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 15/93 (16%)
Query: 235 PSRIISLNLSSSGLTGEISP--YFANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRA 288
PS L+LS + L+ + LT + L LS+N L+ F +P+LR
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF----VPVPNLRY 92
Query: 289 LNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L+L N L +L L S+ +L L + N
Sbjct: 93 LDLSSNHLH-TLDEFLF--SDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
SL LS + L IS F + + +LDLS+N L S L +L L L N +
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV- 125
Query: 299 SLPAD 303
+ +
Sbjct: 126 VVDRN 130
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 19/69 (27%), Positives = 29/69 (42%), Gaps = 5/69 (7%)
Query: 256 FANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG 311
F ++ ++ L LS N +S + +KLP L L+L NKL DL +
Sbjct: 132 FEDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 312 SLTLSVDGN 320
L + N
Sbjct: 191 KNGLYLHNN 199
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNN-SLSGTFPEFLSKLPSLRALNLKRNKLT 297
+ +S ++ + F NL+ + +++ N +L+ P+ L +LP L+ L + L
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 298 GSLPADLVERSNNGSLTLSVDGN 320
P S + L + N
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDN 140
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 236 SRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPE--FLSKLPSLRALNLK 292
S++ + + ++ I P L ++FL + N L FP+ + L +
Sbjct: 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 293 RNKLTGSLPADLVERSNNGSLTLSVDGN 320
N S+P + + N +LTL + N
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNN 166
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 14/89 (15%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D P+ I +L + + LT + L L++S N L+ + P L L +
Sbjct: 57 DCLPAHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSN 111
Query: 292 KRNKLTGSLPADLVERSNNGSLTLSVDGN 320
L +LP+ L + L + GN
Sbjct: 112 PLTHLP-ALPSGLCK--------LWIFGN 131
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
PS + L +S + LT + + L L + N L+ PE L L S +NL+
Sbjct: 238 VLPSELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 293 RNKLT 297
N L+
Sbjct: 293 GNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 30/104 (28%)
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKL----------- 283
PS + L + + LT + L L +S+N L+ + P S+L
Sbjct: 120 PSGLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLA-SLPALPSELCKLWAYNNQLT 174
Query: 284 ------PSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
L+ L++ N+L SLP L L N
Sbjct: 175 SLPMLPSGLQELSVSDNQLA-SLPTLP------SELYKLWAYNN 211
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 25/89 (28%), Positives = 36/89 (40%), Gaps = 16/89 (17%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
PS + L++S + L + + L L NN L+ + P S L+ L +
Sbjct: 178 MLPSGLQELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPS---GLKELIVS 229
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+LT SLP L L V GN
Sbjct: 230 GNRLT-SLPVLP------SELKELMVSGN 251
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 3/84 (3%)
Query: 234 NPSRIISLNLSSSGLT-GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
P+ + L L + G+I A +EFL L N L L KLP L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 293 RNKLTGSLPADLVERSNNGSLTLS 316
N++ G L + N L LS
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLS 103
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 24/82 (29%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L+L + GL +S L ++ L+LS N + G KLP+L LNL NKL
Sbjct: 53 FLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL--K 108
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
+ L L L +
Sbjct: 109 DISTLEPLKKLECLKSLDLFNC 130
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+L L+S+G+ I F++L ++E LDLS N LS + L SL LNL N
Sbjct: 80 ALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK- 137
Query: 299 SLP 301
+L
Sbjct: 138 TLG 140
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 13/77 (16%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 240 SLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
L + +S L P ++ + L L F+ S+ L L+ L
Sbjct: 178 ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
Query: 299 SLPADLVERSNNGSLTL 315
++L N +
Sbjct: 237 FHFSELSTGETNSLIKK 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 216 CVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSG 274
+ + + L ++ L + + +I FA LT +E L++ + L
Sbjct: 138 TLGETSLFSHLT---------KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 275 TFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNN 310
P+ L + ++ L L + L V+ +++
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSS 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 16/90 (17%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
+ + S+G T + +++ SL + L+++ L L
Sbjct: 230 RDTDLDTFHFSELSTGETNS----LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 292 KRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
RN+L S+P + + SL + + N
Sbjct: 285 SRNQLK-SVPDGIFD--RLTSLQKIWLHTN 311
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 15/102 (14%), Positives = 37/102 (36%), Gaps = 12/102 (11%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ +++ L+ ++G+T E+ + + +L L+N L+ +S L++L+
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 294 NKLTGSLPADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKK 334
+ D +L + T E+
Sbjct: 349 AHIQ-----DFSSVGKIPALNNNFEAEGQTITMPKETLTNNS 385
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 21/100 (21%), Positives = 33/100 (33%), Gaps = 14/100 (14%)
Query: 226 LNCSY---EDNNPSRIISL-NLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS 281
L+C + + + L + G + T + LD ++ LS
Sbjct: 259 LHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LS 315
Query: 282 KLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
+ P L L L +LT L S+N L LS
Sbjct: 316 QNPKLVYLYLNNTELT-ELDV-----SHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 12/90 (13%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D+N + ++ + L + LD N+S++ KL L L
Sbjct: 17 DDNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLIC 71
Query: 292 KRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N +T +L S N +LT L+ D N
Sbjct: 72 TSNNIT-TLDL-----SQNTNLTYLACDSN 95
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 19/102 (18%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
L+CS+ + + + LN ++ +T ++ + FLD S+N L+
Sbjct: 175 LDCSFNKITELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID-- 228
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
++ L L + N LT L S LT L
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELDV-----STLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 18/102 (17%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
LNC+ + ++ +++ L+ + ++ T + LD S N ++
Sbjct: 132 LNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD-- 186
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
+S+ L LN N +T L + N LT L N
Sbjct: 187 VSQNKLLNRLNCDTNNIT-KLDL-----NQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 25/106 (23%), Positives = 40/106 (37%), Gaps = 19/106 (17%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
LNC + N ++ L+ SS+ LT EI LT + + D S N L+
Sbjct: 196 LNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD-- 249
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGNTSTT 324
+S L L L+ + L + ++N L +G
Sbjct: 250 VSTLSKLTTLHCIQTDLL-EIDL-----THNTQLIYFQAEGCRKIK 289
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 13/97 (13%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L +S+ +T + + T + +L +N L+ ++ L L LN NKLT
Sbjct: 68 KLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-K 120
Query: 300 LPADLVERSNNGSLT-LSVDGNTSTTCSSESCKKKKH 335
L S N LT L+ NT T +
Sbjct: 121 LDV-----SQNPLLTYLNCARNTLTEIDVSHNTQLTE 152
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 19/112 (16%), Positives = 42/112 (37%), Gaps = 14/112 (12%)
Query: 226 LNCSY------EDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
L+C + + +++ L L+++ LT E+ ++ T ++ L N + F
Sbjct: 302 LDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS- 356
Query: 280 LSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT---LSVDGNTSTTCSSE 328
+ K+P+L + L S +++ L GN +
Sbjct: 357 VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 16/90 (17%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
DN P +I L ++ + L + A+L +LD +N LS T PE SL+ L++
Sbjct: 76 DNLPPQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLPE---LPASLKHLDV 127
Query: 292 KRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N+LT LP L ++ D N
Sbjct: 128 DNNQLT-MLPELP------ALLEYINADNN 150
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 23/85 (27%), Positives = 44/85 (51%), Gaps = 10/85 (11%)
Query: 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
++ SL+L +G++ +I+ +L +E L L NN ++ LS+L L L+L+ N++
Sbjct: 113 KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168
Query: 297 TGSLPADLVERSNNGSLT-LSVDGN 320
+ D+V + L L + N
Sbjct: 169 S-----DIVPLAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + I + ++S + + L + L L+ N L+ P L+ L +L L L
Sbjct: 43 NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NK+ DL + L LS++ N
Sbjct: 99 ENKVK-----DLSSLKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 20/83 (24%), Positives = 39/83 (46%), Gaps = 10/83 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SL L ++ +T +I+ + LT ++ L L +N + + L+ L L+ L L +N ++
Sbjct: 138 SLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHIS-- 191
Query: 300 LPADLVERSNNGSLT-LSVDGNT 321
DL + +L L +
Sbjct: 192 ---DLRALAGLKNLDVLELFSQE 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 4/64 (6%)
Query: 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293
+ L L+ + LT +I P ANL + +L L N + L L L++L+L+
Sbjct: 66 YLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEH 121
Query: 294 NKLT 297
N ++
Sbjct: 122 NGIS 125
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 18/82 (21%), Positives = 33/82 (40%), Gaps = 4/82 (4%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSN-NSLSGTFPEFLSKLPSLRALNLKRNKLTG 298
+ +S + + I F+NL + + + N+L PE LP+L+ L + +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117
Query: 299 SLPADLVERSNNGSLTLSVDGN 320
LP S + L + N
Sbjct: 118 HLPDVHKIHSLQ-KVLLDIQDN 138
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 17/68 (25%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 234 NPSRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N +++ LNLS + E+ F + LD+S + L L LRA +
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
Query: 293 RNKLTGSL 300
K +L
Sbjct: 235 NLKKLPTL 242
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 22/82 (26%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L+ + GLT I+ L ++ L+LS+N +SG K P+L LNL NK+
Sbjct: 46 FLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI--K 101
Query: 300 LPADLVERSNNGSL-TLSVDGN 320
+ + +L +L +
Sbjct: 102 DLSTIEPLKKLENLKSLDLFNC 123
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 10/89 (11%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
S + L L + +T ISP A LT +++L + N +S L+ L L L
Sbjct: 126 AGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD 181
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NK++ D+ ++ +L + + N
Sbjct: 182 DNKIS-----DISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
I +L+L+S+ +T +++P A L+ ++ L L N ++ L+ L +L+ L++
Sbjct: 104 AGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
+++ DL +N LT L D N
Sbjct: 160 NAQVS-----DLTPLANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 10/82 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L LS + L +S A L +I+ LDL++ ++ P L+ L +L+ L L N++T
Sbjct: 89 ELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-- 142
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
++ + +L LS+
Sbjct: 143 ---NISPLAGLTNLQYLSIGNA 161
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
I +L+ +G+T I L + L+L +N ++ L L + L L N
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNP 96
Query: 296 LT 297
L
Sbjct: 97 LK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 21/94 (22%), Positives = 42/94 (44%), Gaps = 8/94 (8%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S++ +L + ++ +ISP A+L + + L NN +S L+ +L + L
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQT 228
Query: 296 LTGSLPADLVERSNNGSLTLSVDGNTSTTCSSES 329
+T + P V +NN + V G + + +
Sbjct: 229 IT-NQP---VFYNNNLVVPNVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 16/66 (24%), Positives = 28/66 (42%), Gaps = 4/66 (6%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D + I + S +T ++ A+L I L ++ E + L +L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 292 KRNKLT 297
K N++T
Sbjct: 71 KDNQIT 76
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 2/82 (2%)
Query: 236 SRIISLNLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294
+ L + + + L + L + + L P+ P L LNL N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 295 KLTGSLPADLVERSNNGSLTLS 316
L SL V+ + L LS
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLS 111
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 23/82 (28%), Positives = 42/82 (51%), Gaps = 10/82 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SL+L +G++ +I+ +L +E L L NN ++ LS+L L L+L+ N+++
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-- 166
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
D+V + L L + N
Sbjct: 167 ---DIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N + I + ++S + + L + L L+ N L+ P L+ L +L L L
Sbjct: 40 NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95
Query: 293 RNKLTGSLPADLVERSNNGSLT-LSVDGN 320
NK+ DL + L LS++ N
Sbjct: 96 ENKIK-----DLSSLKDLKKLKSLSLEHN 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 21/83 (25%), Positives = 39/83 (46%), Gaps = 10/83 (12%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
SL L ++ +T +I+ + LT ++ L L +N +S L+ L L+ L L +N ++
Sbjct: 135 SLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-- 188
Query: 300 LPADLVERSNNGSLT-LSVDGNT 321
DL + +L L +
Sbjct: 189 ---DLRALAGLKNLDVLELFSQE 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 16/66 (24%), Positives = 31/66 (46%), Gaps = 4/66 (6%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D+ + I NL +T ++ L +I+ + +N+ + + + LP++ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 72
Query: 292 KRNKLT 297
NKLT
Sbjct: 73 NGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ L L+ + LT +I P NL + +L L N + L L L++L+L+
Sbjct: 62 QYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLE 117
Query: 293 RNKLT 297
N ++
Sbjct: 118 HNGIS 122
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 16/90 (17%), Positives = 35/90 (38%), Gaps = 18/90 (20%)
Query: 227 NCSYE------DNNPSRIISLNLSSSGLTGEISP--YFANLTAIEFLDLSNNSLS----G 274
+CS + ++ P L L+++ T + F L + ++ SNN ++ G
Sbjct: 17 DCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 275 TFPEFLSKLPSLRALNLKRNKLTGSLPADL 304
F + + L N+L ++ +
Sbjct: 76 AF----EGASGVNEILLTSNRLE-NVQHKM 100
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 16/64 (25%), Positives = 32/64 (50%), Gaps = 3/64 (4%)
Query: 241 LNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+N S++ +T +I F + + + L++N L + L SL+ L L+ N++T
Sbjct: 62 INFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-C 119
Query: 300 LPAD 303
+ D
Sbjct: 120 VGND 123
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 17/70 (24%), Positives = 33/70 (47%), Gaps = 12/70 (17%)
Query: 256 FANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG 311
F L +++ L L +N ++ +F L S+R L+L N++T ++
Sbjct: 101 FKGLESLKTLMLRSNRITCVGNDSF----IGLSSVRLLSLYDNQIT-TVAPGAF--DTLH 153
Query: 312 SLT-LSVDGN 320
SL+ L++ N
Sbjct: 154 SLSTLNLLAN 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 10/86 (11%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
L L ++ L + +L +E L + NN L L L L L+L N++T
Sbjct: 110 RLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-- 163
Query: 300 LPADLVERSNNGSLT-LSVDGNTSTT 324
+ + + + + G
Sbjct: 164 ---NTGGLTRLKKVNWIDLTGQKCVN 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
S + + N +S + ++ T ++ L LS+N +S L L L L++ RN+
Sbjct: 41 SGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNR 96
Query: 296 LT 297
L
Sbjct: 97 LK 98
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 14/77 (18%), Positives = 32/77 (41%), Gaps = 7/77 (9%)
Query: 237 RIISLNLSSSGLTGEISPYFAN---LTAIEFLDLSNNSLSGT----FPEFLSKLPSLRAL 289
+ L + + + F L +E +D+S L+ + + K+ L+ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 290 NLKRNKLTGSLPADLVE 306
N+K N L+ + +L +
Sbjct: 313 NMKYNYLSDEMKKELQK 329
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N R L+L + I A L + +D S+N + + L L+ L +
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVN 72
Query: 293 RNKLT 297
N++
Sbjct: 73 NNRIC 77
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 20/82 (24%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 240 SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299
+++ S + + ++ F L ++ L ++NN + LP L L L N L
Sbjct: 46 AIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--V 101
Query: 300 LPADLVERSNNGSLT-LSVDGN 320
DL ++ SLT L + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 10/72 (13%)
Query: 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALN 290
P + L L + T + +N + +DLSNN +S +F S + L L
Sbjct: 30 PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF----SNMTQLLTLI 84
Query: 291 LKRNKLTGSLPA 302
L N+L +P
Sbjct: 85 LSYNRLR-CIPP 95
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297
+ L+ + ++ + L A + L LS N++ LS + +LR L+L RN +
Sbjct: 28 VELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 12/84 (14%)
Query: 241 LNLSSSGLTGEISPYFANLTAIEFLDLSNN---SLSGTFPEFLSKLPSLRALNLKRNKLT 297
L+L + + +I A +E L +S N SLSG + KL +LR L + NK+T
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKIT 128
Query: 298 GSLPADLVERSNNGSL-TLSVDGN 320
++ + + L L + GN
Sbjct: 129 N--WGEIDKLAALDKLEDLLLAGN 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 11/68 (16%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSL----SGTFPEFLSKLPSLRALNLKRNK 295
L L+ + L + F L +E L +++N L G F +L +L L L RN+
Sbjct: 66 LYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVF----DQLVNLAELRLDRNQ 120
Query: 296 LTGSLPAD 303
L SLP
Sbjct: 121 LK-SLPPR 127
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 22/67 (32%), Positives = 30/67 (44%), Gaps = 11/67 (16%)
Query: 241 LNLSSSGLTGEISPY-FANLTAIEFLDLSNNSL----SGTFPEFLSKLPSLRALNLKRNK 295
L L + L + P F +LT + +L L N L G F KL SL+ L L N+
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVF----DKLTSLKELRLYNNQ 168
Query: 296 LTGSLPA 302
L +P
Sbjct: 169 LK-RVPE 174
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 24/82 (29%), Positives = 35/82 (42%), Gaps = 7/82 (8%)
Query: 227 NCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFL 280
C + P++ L+L ++ L + F LT++ L L N L
Sbjct: 13 ECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 281 SKLPSLRALNLKRNKLTGSLPA 302
+KL SL LNL N+L SLP
Sbjct: 73 NKLTSLTYLNLSTNQLQ-SLPN 93
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 13/109 (11%), Positives = 37/109 (33%), Gaps = 14/109 (12%)
Query: 233 NNPSRIISLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLSGTFPE-------FLS 281
+ P+ ++SLNL + L G + +L ++ + L + + E
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 282 KLPSLRALNLKRNKLTGS---LPADLVERSNNGSLTLSVDGNTSTTCSS 327
+ + ++ ++ S ++L+ + + S+
Sbjct: 282 NIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQK 330
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.28 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.27 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.25 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.25 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.25 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.24 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.18 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.11 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.03 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.03 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.01 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.01 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.99 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.96 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.96 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.95 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.94 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.93 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.91 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.91 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.9 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.9 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.89 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.89 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.87 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.87 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.86 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.85 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.85 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.85 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.84 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.84 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.84 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.84 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.82 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.81 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.8 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.8 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.79 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.79 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.77 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.76 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.76 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.76 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.74 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.74 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.74 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.73 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.73 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.72 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.71 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.71 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.7 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.7 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.69 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.69 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.68 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.68 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.68 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.68 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.68 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.68 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.64 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.63 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.62 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.62 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.62 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.61 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.61 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.6 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.59 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.59 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.58 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.54 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.53 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.52 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.46 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.45 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.42 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.4 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.39 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.38 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.36 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.36 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.34 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.22 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.2 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.2 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.19 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.05 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.85 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.67 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.31 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.23 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.22 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.21 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.08 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.82 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.47 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.33 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.26 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.1 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.69 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.43 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.94 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 93.66 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.44 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 89.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.84 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.71 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 87.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 85.11 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 82.6 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 80.22 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=445.30 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=214.4
Q ss_pred HHHHHHhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC
Q 037258 394 EIQKITNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG 462 (704)
Q Consensus 394 el~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 462 (704)
|+...+.+|.+.||+|+||+||+|.+. +++.||||+++... ..+.+|+.++++++|||||+++|+|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344445578899999999999999763 56789999996432 3678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 463 NNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 463 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
+..++|||||++|+|.++|.... ...++|..++.|+.|||+||+||| +++||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence 99999999999999999996532 235899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTH 607 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 607 (704)
++++.+||+|||+++.+.............||+.|||||++.++.++.++|||||||++|||+| |+.||.+.... .
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---H
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987654433344456789999999999999999999999999999999998 89999765421 2
Q ss_pred HHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.. .+..+... ..+..++..+.+|+.+||+.||++||||+||++.|+....
T Consensus 256 ~~~----~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 VVE----MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHH----HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222 22222211 1234456689999999999999999999999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=435.13 Aligned_cols=253 Identities=28% Similarity=0.471 Sum_probs=209.3
Q ss_pred hhcccccccCceEEEEEEeC------CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||+|.+. +++.||||+++.... .+.+|++++++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 45789999999999999763 478899999975432 57889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccc-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 471 YMASGTLDQYLKGKK-----------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
||++|+|.++|+... ...++|.+++.++.||++||+||| +++||||||||+|||+++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCc
Confidence 999999999997642 345999999999999999999999 899999999999999999999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+ +. .+..
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~---~~-~i~~ 245 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV---IE-CITQ 245 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH---HH-HHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HH-HHHc
Confidence 99987643333333345678999999999999999999999999999999999 89999764421 11 11 2222
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+... ..+...+.++.+|+.+||+.||++|||++||++.|+++...
T Consensus 246 ~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2211 12334556899999999999999999999999999987553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=437.23 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=202.6
Q ss_pred hhcccccccCceEEEEEEeC------CCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||+|.+. +++.||||+++.... .+.+|++++++++|||||+++|+|.+++..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999764 478899999975433 57889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 471 YMASGTLDQYLKGKK-------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
||++|+|.++++... ...++|.+++.|+.||++||+||| +++||||||||+|||+++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEc
Confidence 999999999997643 235899999999999999999999 8999999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHH
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSML 616 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 616 (704)
|||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+ +.. +
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~---~~~-i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EA---IDC-I 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HH---HHH-H
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HH---HHH-H
Confidence 9999987644433344456779999999999999999999999999999999999 89999764321 11 111 2
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+.. ...+...+.++.+|+.+||+.||++||||+||++.|+.+...
T Consensus 274 ~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22211 112334556899999999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=425.20 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=199.1
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.||+|+||+||+|.+.+ .||||+++... ..+.+|++++++++|||||+++|+|.+ +..++|||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 467899999999999998753 69999986322 256889999999999999999998865 568999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.++|+.... .+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+...........
T Consensus 116 GsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 116 SSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 999999976543 4999999999999999999999 899999999999999999999999999999876544444445
Q ss_pred ccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 555 TAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
....||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... .+...+..+.. .+.+.
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~p~~~- 260 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----SPDLS- 260 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----CCCST-
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CCCcc-
Confidence 56789999999999964 468999999999999999999999996544311 11222222211 11111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
..+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 223445678999999999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=421.24 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=207.3
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
.+.++||+|+||.||+|.. .+|+.||||+++... ...+|+.++++++|||||++++++.+++..+||||||+||+|.+
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 3467899999999999976 479999999997543 34579999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCc---ccc
Q 037258 480 YLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQ---IST 555 (704)
Q Consensus 480 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~---~~~ 555 (704)
+++.... +++..+..++.||+.||+||| +++||||||||+|||++.++ ++||+|||+|+.+....... ...
T Consensus 140 ~l~~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~ 214 (336)
T 4g3f_A 140 LIKQMGC--LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214 (336)
T ss_dssp HHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred HHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence 9987554 999999999999999999999 99999999999999999987 69999999998764332211 123
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|||||++.+..|+.++|||||||++|||++|+.||........ +. ......... ...+.
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~i~~~~~~~--------~~~~~ 280 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CL----KIASEPPPI--------REIPP 280 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HH----HHHHSCCGG--------GGSCT
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH----HHHcCCCCc--------hhcCc
Confidence 45799999999999999999999999999999999999999976554332 11 111111000 01233
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+..+.+++.+||+.||.+|||+.|+++.|...+...
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 44568899999999999999999999999998877643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=421.28 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=200.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ..+.+|++++++++|||||++++++.+++..++|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 55678999999999999965 479999999986432 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+||+|.++|...+...+++.+++.++.||+.||+||| +++||||||||+|||+++++.+||+|||+++.+.. ...
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 180 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVE 180 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--Ccc
Confidence 9999999998776666899999999999999999999 99999999999999999999999999999987531 122
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+..... +... .
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~~---------~ 244 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-GSFP---------P 244 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCCC---------C
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCCC---------C
Confidence 33456799999999999999999999999999999999999999965432 222222222 2211 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12334567899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=414.72 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=200.0
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccchh-hH--HHHHHHHHhhcccceeEEEEEEEeCC----eEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQ--LLQVKLLMRVHHRNLTALIGYCIEGN----NMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~--~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~e~~~ 473 (704)
.+.+.||+|+||+||+|.+ +|+.||||+++.... .+ ..|+..+.+++|||||+++++|.+++ .++||||||+
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 3578999999999999988 589999999976543 23 34555667889999999999998653 5899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG-----CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+|+|.++++... ++|..+.+++.|+++||+|||+. ...+||||||||+|||+++++++||+|||+++.....
T Consensus 85 ~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 85 HGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 999999998654 89999999999999999999932 1339999999999999999999999999999876433
Q ss_pred CCCc--ccccccCCCCccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc---------ccHHHH
Q 037258 549 SSDQ--ISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT---------THISQW 611 (704)
Q Consensus 549 ~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~---------~~~~~~ 611 (704)
.... ......||+.|||||++.+. .++.++|||||||++|||+||+.||........ .....
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~- 240 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE- 240 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH-
Confidence 2221 22346799999999999754 467899999999999999999887754332110 11111
Q ss_pred HHHHHhcCCcccccCCcCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 612 VNSMLAEGDIRNIVDPSLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 612 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+....... ..++.+.... ..+.+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 241 ~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 12222211 1222222111 234567889999999999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=413.75 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=206.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+|++++++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 56789999999999999965 579999999986432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
++||+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 114 ~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999999987554 999999999999999999999 999999999999999999999999999999987544444
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....... +..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~-~~~---------- 251 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIK-LEY---------- 251 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCC----------
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCC----------
Confidence 455667899999999999999999999999999999999999999965432 112222222 211
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|++.
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 122334567899999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=417.58 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=203.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|... +|+.||||++.... ..+.+|+++|++++|||||++++++.+++.++||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 445678999999999999764 79999999985332 2568899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+++.+... ....
T Consensus 156 g~L~~~l~~~~---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~ 227 (346)
T 4fih_A 156 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 227 (346)
T ss_dssp EEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCB
T ss_pred CcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCcc
Confidence 99999997643 999999999999999999999 899999999999999999999999999999876422 2334
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.... +..+. .+.+ ...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~-i~~~~-----~~~~--~~~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNL-----PPRL--KNL 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSS-----CCCC--SCG
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH-HHcCC-----CCCC--Ccc
Confidence 5678999999999999999999999999999999999999999654321 11111 11111 1111 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+.++.+|+.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 344568899999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=405.41 Aligned_cols=240 Identities=28% Similarity=0.421 Sum_probs=194.5
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 469 (704)
.|.+.||+|+||+||+|... +++.||||++.... ..+.+|++++++++|||||++++++.+ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 46678999999999999654 78999999985432 256789999999999999999999875 35689999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCC-CCcEEEEeccCccccc
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNE-KLQAKIADFGLSRIFS 546 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~ 546 (704)
|||++|+|.+++..... +++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999986544 899999999999999999999 777 999999999999984 7899999999997542
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
........||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ... ...+..+....
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~-~~~i~~~~~~~--- 249 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-YRRVTSGVKPA--- 249 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHH-HHHHTTTCCCG---
T ss_pred ----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHH-HHHHHcCCCCC---
Confidence 223445789999999998865 6999999999999999999999999654321 111 12222221111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223457889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=426.42 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=211.0
Q ss_pred HHhhhcccccccCceEEEEEEeCC------CcEEEEEecccch-----hhHHHHHHHHHhhcc-cceeEEEEEEEeC-Ce
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLDD------NQQVAVKMLSSSC-----CFQLLQVKLLMRVHH-RNLTALIGYCIEG-NN 464 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-----~~~~~E~~~l~~l~h-~nIv~l~~~~~~~-~~ 464 (704)
..+.+.+.||+|+||.||+|.+.. ++.||||+++... ..+.+|++++.+++| ||||+++|+|.+. +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 345568899999999999997532 3679999986532 256789999999965 8999999999764 56
Q ss_pred EEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 465 MGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
+++|||||++|+|.++|+... ...+++..++.++.|||+||+||| +++||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCC
Confidence 899999999999999997543 234899999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~----- 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999987754444444556789999999999999999999999999999999998 999997654321
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.+...+..+... ..+...+.++.+++.+||+.||++|||++||++.|++++..
T Consensus 296 -~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 122223332211 12333456889999999999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=396.50 Aligned_cols=240 Identities=24% Similarity=0.371 Sum_probs=189.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.|.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++||||+++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 366789999999999999975 479999999985432 246789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+ +|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 94 y~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp CC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 99 6799999976544 999999999999999999999 89999999999999999999999999999986532
Q ss_pred CcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ....... ..+..
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i-~~~~~-------- 229 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNI-SNGVY-------- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCC--------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCC--------
Confidence 223345789999999999998876 5899999999999999999999965332 1222222 22211
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122334567899999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=415.55 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=203.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|... +|+.||||++.... ..+.+|+++|++++|||||++++++.+++.++||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 445688999999999999764 79999999985332 2567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.++++... +++.++..++.||+.||+||| +++||||||||+||||+.++.+||+|||+|+.+... ....
T Consensus 233 G~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~ 304 (423)
T 4fie_A 233 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 304 (423)
T ss_dssp EEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCCB
T ss_pred CcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cccc
Confidence 99999997543 999999999999999999999 999999999999999999999999999999876422 2334
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.+.. +..+. .+.+ ...
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~-i~~~~-----~~~~--~~~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNL-----PPRL--KNL 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSC-----CCCC--SCT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH-HHcCC-----CCCC--ccc
Confidence 5678999999999999999999999999999999999999999654321 11111 11111 1111 112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 234567899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=401.98 Aligned_cols=236 Identities=25% Similarity=0.334 Sum_probs=192.2
Q ss_pred hhhcccccccCceEEEEEEe----CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
|.+.+.||+|+||+||+|+. .+++.||||+++... ..+.+|++++++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 56789999999999999965 257899999986432 25678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
|||+||+|.+++..... +++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-- 178 (304)
T ss_dssp CCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--
Confidence 99999999999987554 999999999999999999999 99999999999999999999999999999986532
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.........||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... +....... +..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~~~-------- 243 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK-AKL-------- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC--------
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc-CCC--------
Confidence 222334578999999999999999999999999999999999999999654321 12222221 111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+.++.+|+.+||+.||++|||+
T Consensus 244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1233345678999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=387.48 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=183.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCC----------
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGN---------- 463 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---------- 463 (704)
+.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 45578999999999999975 478999999985322 24678999999999999999999987544
Q ss_pred --eEEEEEeecCCCCHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 464 --NMGLIYEYMASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 464 --~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
..++|||||++|+|.+++..... ...++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999986542 23567778999999999999999 8999999999999999999999999999
Q ss_pred CccccccCCCC----------cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 037258 541 LSRIFSIESSD----------QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQ 610 (704)
Q Consensus 541 la~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 610 (704)
+|+.+...... ...+...||+.|||||++.+..|+.++|||||||++|||++ ||.... ....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 99876432221 11234579999999999999999999999999999999996 774321 1111
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+ .......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~-~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TL-TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111111110 11223346778999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=377.61 Aligned_cols=269 Identities=39% Similarity=0.682 Sum_probs=237.6
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.+.||+|+||.||+|...+++.||||++.... ..+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 468899999999999998889999999986443 2567899999999999999999999999999999999999999
Q ss_pred HHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 478 DQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 478 ~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++............
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99997654 235899999999999999999999 8999999999999999999999999999998654333333344
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+......|.......+.+...+++.+......
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH
Confidence 56689999999999999999999999999999999999999988777777777788777777777888888888777788
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 89999999999999999999999999999999987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=392.16 Aligned_cols=256 Identities=22% Similarity=0.285 Sum_probs=196.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe------CCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE------GNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 466 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ....+|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 55678999999999999965 579999999986432 245789999999999999999999764 36789
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+|||||+ |+|.+++.... .+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+++.+.
T Consensus 136 ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9999996 68999997654 4999999999999999999999 9999999999999999999999999999998764
Q ss_pred cCC--CCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 547 IES--SDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 547 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ ....+...........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCChHH
Confidence 322 22334567899999999998875 56999999999999999999999997654321 1111111111100000
Q ss_pred --------------ccCCcCCCC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 --------------IVDPSLQGN---FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 --------------~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.+..... .....+.++++|+.+||+.||.+|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00123457889999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=382.23 Aligned_cols=194 Identities=25% Similarity=0.380 Sum_probs=165.3
Q ss_pred hhhcccccccCceEEEEEEeC----CCcEEEEEecccchh--hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCC--FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||+||+|..+ .++.||||++..... ...+|+++++.+ +||||+++++++.++++.++||||+
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 556789999999999999642 468899998864432 567899999998 6999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCCC-
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESS- 550 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~~- 550 (704)
++|+|.+++.. +++.++..++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 103 ~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 103 EHESFLDILNS-----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 99999999952 899999999999999999999 9999999999999999876 7999999999976532211
Q ss_pred -------------------------CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 551 -------------------------DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 551 -------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 0112345799999999999875 58999999999999999999999996554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=375.36 Aligned_cols=285 Identities=38% Similarity=0.698 Sum_probs=244.0
Q ss_pred CCcccCHHHHHHHHhhh--cccccccCceEEEEEEeCCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEE
Q 037258 386 KSRQFAYSEIQKITNNF--ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 386 ~~~~~~~~el~~~~~~~--~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
....|++.++.....+| .+.||+|+||.||+|...+++.||||++..... .+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45678888888877776 689999999999999888899999999875432 56789999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEE
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
+.+++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999998754 334899999999999999999999333339999999999999999999999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCCcccHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA--EDDTTHISQWVNS 614 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~--~~~~~~~~~~~~~ 614 (704)
+|||++..... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........|+..
T Consensus 176 ~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCS-SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCc-ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987632 22333445669999999999999999999999999999999999999996322 2334466778777
Q ss_pred HHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 615 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
...........+..+...+....+..+.+++.+||+.||.+|||++||++.|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 777778888888888888889999999999999999999999999999999997443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=396.41 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=197.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHH---HHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLL---QVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||.||+|... +|+.||||+++.... .... ++.+++.++|||||++++++.+.+.+++|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 345789999999999999654 799999999864321 2223 35566677999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||++||+|.++|..... +++..+..++.||+.||+||| +++||||||||+||||+.+|++||+|||+|+.+...
T Consensus 271 mEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp ECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 999999999999987554 999999999999999999999 999999999999999999999999999999876422
Q ss_pred CCCcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
......||+.|||||++. +..|+.++||||+||++|||++|+.||......+.. ........ ..
T Consensus 346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~-~~------- 410 (689)
T 3v5w_A 346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT-MA------- 410 (689)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHH-CC-------
T ss_pred ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcC-CC-------
Confidence 234568999999999997 457999999999999999999999999765443321 11111111 11
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
..++...+.++.+|+.+||+.||.+|++ ++||++
T Consensus 411 ---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1123334567899999999999999998 688764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=395.93 Aligned_cols=245 Identities=21% Similarity=0.291 Sum_probs=201.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+|+++|+.++||||+++++++.+++.+++|||||+|
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 56688999999999999965 4799999999864332 457899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC--CcEEEEeccCccccccCCCCc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK--LQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfGla~~~~~~~~~~ 552 (704)
|+|.+++.... ..+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+++.+.. ..
T Consensus 239 g~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~ 311 (573)
T 3uto_A 239 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQ 311 (573)
T ss_dssp CBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TS
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---CC
Confidence 99999997543 23899999999999999999999 9999999999999999854 7999999999987642 23
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ...... .... .+...
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~-~~~~------~~~~~ 378 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVK-SCDW------NMDDS 378 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTCC------CCCSG
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-hCCC------CCCcc
Confidence 3445689999999999999999999999999999999999999996544321 111111 1111 01111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233567889999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.89 Aligned_cols=261 Identities=28% Similarity=0.372 Sum_probs=207.4
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCC----eEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGN----NMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... ++.||||++..... ....|+.++++++||||+++++++.+.. ..++||||+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 456789999999999999875 78999999975433 4456888899999999999999998743 479999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP----------PIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
++|+|.++++... +++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 105 EKGSLSDFLKANV---VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999997644 899999999999999999999 77 9999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH---------
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI--------- 608 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~--------- 608 (704)
+.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 87654333333445679999999999986 3567789999999999999999999976554322211
Q ss_pred -HHHHHHHHhcCCcccccCCcCCCC-CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 609 -SQWVNSMLAEGDIRNIVDPSLQGN-FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 609 -~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..... .... .+.+... .....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 259 ~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVV-HKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHT-TSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhh-cccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 1111 1111111 1234567799999999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=370.44 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=210.5
Q ss_pred hhhcccccccCceEEEEEEe--------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeE
Q 037258 400 NNFERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 465 (704)
+.+.+.||+|+||.||+|.. .++..||||+++... ..+.+|+++++++ +||||+++++++.+.+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 45678999999999999965 245679999997542 2567899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 466 GLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
++||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCC
Confidence 99999999999999998653 234889999999999999999999 8999999999999999999
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQ 610 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 610 (704)
+.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +..
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~ 316 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK 316 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence 9999999999987643333333344567889999999999999999999999999999999 999997644322 111
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.+..+.. ...+...+..+.+++.+||+.||.+||++.|+++.|++++....
T Consensus 317 ----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 317 ----LLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp ----HHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111111 11233445678999999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.78 Aligned_cols=278 Identities=35% Similarity=0.579 Sum_probs=226.8
Q ss_pred CCcccCHHHHHHHHhhhc--------ccccccCceEEEEEEeCCCcEEEEEecccc--------hhhHHHHHHHHHhhcc
Q 037258 386 KSRQFAYSEIQKITNNFE--------RVLGKGGFGEVYHGSLDDNQQVAVKMLSSS--------CCFQLLQVKLLMRVHH 449 (704)
Q Consensus 386 ~~~~~~~~el~~~~~~~~--------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h 449 (704)
....|++.++.+++.+|. +.||+|+||.||+|.. +++.||||++... ...+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356899999999999985 5699999999999987 6889999998542 1256789999999999
Q ss_pred cceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe
Q 037258 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL 528 (704)
Q Consensus 450 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 528 (704)
|||+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 999999999999999999999999999999997543 345899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
++++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987643333333445678999999998865 578999999999999999999999976554332 1
Q ss_pred HHHHHHHHhc-CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 609 SQWVNSMLAE-GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 609 ~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+....... ..+...+++.+. ......+..+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222222211 123334444432 3466778899999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.32 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=199.2
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.+.||+|+||.||+|.. +++.||||++.... ..+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 345678999999999999987 58899999986432 24678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 473 ASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 473 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
++|+|.+++.... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-- 191 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS-- 191 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc--
Confidence 9999999998654 223899999999999999999999 888 99999999999999999999999999975432
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..........
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~--------- 256 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCK--------- 256 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCC---------
T ss_pred cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCC---------
Confidence 2222345678999999999999999999999999999999999999996543211 1111111111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
....+...+..+.+++.+||+.||.+|||++|+++.|+.++...
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11122334567899999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.41 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=205.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 345789999999999999764 68999999875432 2567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc--
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ-- 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-- 552 (704)
|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 92 GTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999998643 23899999999999999999999 8999999999999999999999999999998763222111
Q ss_pred ----------ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc---ccHHHHHHHHHhcC
Q 037258 553 ----------ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT---THISQWVNSMLAEG 619 (704)
Q Consensus 553 ----------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~---~~~~~~~~~~~~~~ 619 (704)
......||+.|+|||++.+..++.++||||||+++|||++|..|+........ ........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~------ 241 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD------ 241 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH------
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc------
Confidence 11145799999999999999999999999999999999999999865443221 11111111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
.. .+...+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 242 -------~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 -------RY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------HT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------cc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 11122346889999999999999999999999999887543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.93 Aligned_cols=251 Identities=25% Similarity=0.467 Sum_probs=207.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|...+++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 45578999999999999998889999999987543 367889999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++..... .+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... .......
T Consensus 92 L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 166 (269)
T 4hcu_A 92 LSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 166 (269)
T ss_dssp HHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-ccccccC
Confidence 9999976443 4899999999999999999999 899999999999999999999999999999865321 1122234
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...... .+. ....+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~-~~~---------~~~~~~ 230 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIS-TGF---------RLYKPR 230 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-TTC---------CCCCCT
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh-cCc---------cCCCCC
Confidence 456778999999999999999999999999999999 99999654321 1111111 110 111122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 334578999999999999999999999999998865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.31 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=213.6
Q ss_pred HhhhcccccccCceEEEEEEe--------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCe
Q 037258 399 TNNFERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNN 464 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 464 (704)
.+.+.+.||+|+||.||+|.. ..+..||||+++... ..+.+|+++++++ +||||+++++++.+++.
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 455678999999999999965 234679999986542 2467899999999 99999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 465 MGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcC
Confidence 999999999999999998654 235899999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~------ 300 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 300 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999987643333333445567889999999999999999999999999999999 99999654321
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCC
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEK 682 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 682 (704)
+.. ..+..+.. ...+...+.++.+++.+||+.||++|||++|+++.|++++........+...
T Consensus 301 ~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 363 (382)
T 3tt0_A 301 ELF-KLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYH 363 (382)
T ss_dssp HHH-HHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-----
T ss_pred HHH-HHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 111 12222211 1112234557899999999999999999999999999999877666554443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.13 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=208.0
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|...++..||||+++... ..+.+|++++.+++||||+++++++.+++..++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 345678999999999999999888899999987543 35678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... ......
T Consensus 89 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 163 (268)
T 3sxs_A 89 CLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSV 163 (268)
T ss_dssp BHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-CEEECC
T ss_pred cHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh-hhhccc
Confidence 99999976532 3899999999999999999999 899999999999999999999999999999865322 222233
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...... .+.. . ..+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~-~~~~--~-------~~~ 227 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVS-QGHR--L-------YRP 227 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHH-TTCC--C-------CCC
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHH-cCCC--C-------CCC
Confidence 4456778999999999899999999999999999999 999996543211 111111 1110 0 111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 22345788999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=357.83 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=205.2
Q ss_pred HHhhhcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
..+.+.+.||+|+||.||+|... .+..||||+++... ..+.+|++++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34556789999999999999774 34569999987532 2567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999997553 24899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 549 SSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 549 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .... +..+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~-~~~~~------ 271 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISS-VEEGY------ 271 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH-HHTTC------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHH-HHcCC------
Confidence 221 12233456778999999999999999999999999999999 999996543221 1111 11111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.++..
T Consensus 272 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 ---RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1112234456889999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.23 Aligned_cols=265 Identities=15% Similarity=0.192 Sum_probs=212.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++.++ +|+|++++++++.++...++||||+ ++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 45678999999999999975 578999999986433 3678899999999 8999999999999999999999999 99
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc-----EEEEeccCccccccCCC
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ-----AKIADFGLSRIFSIESS 550 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DfGla~~~~~~~~ 550 (704)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.......
T Consensus 91 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 91 SLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9999998653 24899999999999999999999 999999999999999987776 99999999987643322
Q ss_pred C-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 551 D-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 551 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+............
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL- 245 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-
Confidence 1 1234567999999999999999999999999999999999999999776543332222222211111111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhccc
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNE 678 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 678 (704)
....+..+.+++.+||+.||++||++++|++.|++++........
T Consensus 246 --------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 246 --------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp --------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred --------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 112345788999999999999999999999999998875443333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.01 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=205.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +++.||||+++... ..+.+|++++++++||||+++++++.+++..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345789999999999999876 78999999987542 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 196 ~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 196 GGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 9999999986432 3899999999999999999999 89999999999999999999999999999976432111111
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ . ...+..+. ...
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~---------~~~ 335 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T----REFVEKGG---------RLP 335 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H----HHHHHTTC---------CCC
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCC---------CCC
Confidence 112335678999999999999999999999999999998 999996543211 1 11122211 111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 223345678899999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.18 Aligned_cols=243 Identities=21% Similarity=0.359 Sum_probs=201.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++..++..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 44568999999999999975 578999999985332 2567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++...... ....
T Consensus 102 ~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 173 (297)
T 3fxz_A 102 GSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173 (297)
T ss_dssp CBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCB
T ss_pred CCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--cccc
Confidence 99999997653 899999999999999999999 899999999999999999999999999999875422 2233
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.. . ...+
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~-------~~~~ 239 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-E-------LQNP 239 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-C-------CSCG
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-C-------CCCc
Confidence 45679999999999999999999999999999999999999996543211 11111111110 0 1112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 344567899999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.84 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=201.1
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 45678999999999999976 589999999986432 14568999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..... ..
T Consensus 97 ~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~ 168 (328)
T 3fe3_A 97 SGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GG 168 (328)
T ss_dssp TTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS---SC
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC---CC
Confidence 99999999976544 899999999999999999999 89999999999999999999999999999986532 22
Q ss_pred ccccccCCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||..... ........ .+..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~---------- 231 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVL-RGKY---------- 231 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC----------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC----------
Confidence 34556799999999999887765 899999999999999999999965432 12222222 1211
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122334578899999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=348.54 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=205.4
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|...++..||||+++... ..+.+|++++.+++||||+++++++.+++..++||||+++|
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 345678999999999999999888899999987543 36788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... ......
T Consensus 105 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 179 (283)
T 3gen_A 105 CLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSV 179 (283)
T ss_dssp BHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHHSTT
T ss_pred cHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc-cccccc
Confidence 99999976432 3899999999999999999999 899999999999999999999999999999865321 111223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... +..+. ....+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~-~~~~~---------~~~~~ 243 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEH-IAQGL---------RLYRP 243 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-HHTTC---------CCCCC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHH-Hhccc---------CCCCC
Confidence 3456778999999999999999999999999999998 999996544211 1111 11110 01112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+..+.+++.+||+.||.+|||++|+++.|++++..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 22345788999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=349.67 Aligned_cols=270 Identities=16% Similarity=0.199 Sum_probs=213.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ..+..|+++++++ +||||+++++++..++..++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 34578999999999999975 578999999986432 3678899999999 9999999999999999999999999 99
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc-----EEEEeccCccccccCCC
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ-----AKIADFGLSRIFSIESS 550 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DfGla~~~~~~~~ 550 (704)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.+.....
T Consensus 90 ~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 90 SLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9999998652 34999999999999999999999 899999999999999998887 99999999987643322
Q ss_pred Cc-----ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 551 DQ-----ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 551 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.......... ..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 244 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE-VL 244 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH-HH
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH-HH
Confidence 11 1245679999999999999999999999999999999999999998765433322222211111111000 00
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCCCC
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGH 684 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 684 (704)
....+ ++.+++..||+.||.+||++.+|++.|+++............++.
T Consensus 245 --------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 245 --------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp --------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred --------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 01123 789999999999999999999999999988776554444444443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=363.74 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=207.5
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCC-eE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGN-NM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~ 465 (704)
.+.+.+.||+|+||.||+|.+ .+++.||||+++.... .+.+|++++.++ +||||+++++++.+.+ ..
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 345578999999999999963 3568999999975322 467899999999 7999999999998765 48
Q ss_pred EEEEeecCCCCHHHHhhcccC-----------------------------------------------------------
Q 037258 466 GLIYEYMASGTLDQYLKGKKE----------------------------------------------------------- 486 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 486 (704)
++||||+++|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999976542
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCC
Q 037258 487 -----HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561 (704)
Q Consensus 487 -----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~ 561 (704)
..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.............||+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 12889999999999999999999 8999999999999999999999999999998764444444445667889
Q ss_pred CccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHH
Q 037258 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWK 640 (704)
Q Consensus 562 ~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 640 (704)
.|+|||++.+..++.++|||||||++|||++ |+.||........ +......+... ..+...+..
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~ 324 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDYTTPE 324 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCC---------CCCTTCCHH
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCC---------CCCCCCCHH
Confidence 9999999999999999999999999999998 9999966543221 11122222111 112233457
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 641 AVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 641 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+.+++.+||+.||.+|||+.|+++.|++++..
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 89999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=345.91 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=209.1
Q ss_pred CcccCHHHHHHHHhh------------hcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcc
Q 037258 387 SRQFAYSEIQKITNN------------FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHH 449 (704)
Q Consensus 387 ~~~~~~~el~~~~~~------------~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h 449 (704)
...++++++..++.. +.+.||+|+||.||+|... +|+.||||++.... ..+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 456888888888754 2468999999999999776 79999999986432 256789999999999
Q ss_pred cceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC
Q 037258 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529 (704)
Q Consensus 450 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 529 (704)
|||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 99999999999999999999999999999998754 3899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 037258 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS 609 (704)
Q Consensus 530 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 609 (704)
.++.+||+|||++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999999876422 22234567999999999999999999999999999999999999999654321
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
...... ..... +.+. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~-~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRL-RDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH-HHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHH-hcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 11111 1111 122335578899999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.16 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=202.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++.+++..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 445789999999999999765 78999999985432 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+........
T Consensus 89 ~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 89 GGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999976544 899999999999999999999 89999999999999999999999999999987644433334
Q ss_pred cccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+. ..... ..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~---------~~ 229 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---------LN 229 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTT---------ST
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccccc---------CC
Confidence 456789999999999987765 7899999999999999999999976544321 111111 11000 01
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112345578899999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=344.87 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=201.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHh--hcccceeEEEEEEEeC----CeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMR--VHHRNLTALIGYCIEG----NNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|.. +++.||||++..... ....|.+++.. ++||||+++++++... ...++||||+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 45578999999999999987 689999999875543 44567777766 7999999999997643 4689999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC-----KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
++|+|.++++.. .+++..++.++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 89 EMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp TTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence 999999999654 3899999999999999999999322 67999999999999999999999999999977643
Q ss_pred CCCCc--ccccccCCCCccCccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCcccHH
Q 037258 548 ESSDQ--ISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLLEIITG----------RRPVISRAEDDTTHIS 609 (704)
Q Consensus 548 ~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG----------~~Pf~~~~~~~~~~~~ 609 (704)
..... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||......... ..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~-~~ 244 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS-FE 244 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc-hh
Confidence 22211 12334799999999999876 556799999999999999999 8888665433221 11
Q ss_pred HHHHHHHhcCCcccccCCcCC-CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQ-GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.. ......... .+... ..+....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 245 ~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 245 DM-RKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hh-hHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11 111111111 11111 112345678899999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=348.97 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=203.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+|+.++++++||||+++++++.+++..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 45678999999999999975 478999999874321 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+... ..
T Consensus 93 ~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 166 (294)
T 4eqm_A 93 IEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL 166 (294)
T ss_dssp CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence 999999999986643 899999999999999999999 899999999999999999999999999999876322 22
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .... ..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~-----~~ 234 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV-----TT 234 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH-----HH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc-----ch
Confidence 2234467899999999999999999999999999999999999999654321 1111111111 1100 01
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhhhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-TMTDVLMELKECLSLEI 674 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 674 (704)
......+..+.+++.+||+.||.+|| +++++.+.|+.++....
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11223456789999999999999999 99999999998876443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=352.51 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=208.6
Q ss_pred hhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ....+|++++++++||||+++++++.+++..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 45678999999999999965 345889999986532 2457799999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCE
Q 037258 469 YEYMASGTLDQYLKGKKE----------------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 526 (704)
|||+++|+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheE
Confidence 999999999999986432 23889999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 037258 527 LLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDT 605 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~ 605 (704)
+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 260 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER- 260 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987643333233344567788999999999999999999999999999999 999997654322
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+.. .+..+.. ...+...+..+.+++.+||+.||.+||++.|+++.|++++..
T Consensus 261 --~~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 --LFN----LLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHH----HhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 1111111 112233456789999999999999999999999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=366.17 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=206.9
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEeCC-eEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEGN-NMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|... ++.||||+++... ..+.+|++++++++||||+++++++.+.+ ..++||||+++|+
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 345789999999999999885 7899999997643 36789999999999999999999987765 7999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----~~~~ 345 (450)
T 1k9a_A 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 345 (450)
T ss_dssp HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----cccC
Confidence 999998776556899999999999999999999 89999999999999999999999999999975421 1122
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .. .+..+. ....+.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~---------~~~~p~ 409 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGY---------KMDAPD 409 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTTC---------CCCCCT
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC---------CCCCCC
Confidence 357889999999999999999999999999999998 9999976544321 11 111111 112233
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+..+.+++.+||+.||.+|||+.|+++.|+++...+
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 45568999999999999999999999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=351.54 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=210.4
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.. .+++.||||+++... ..+.+|+++++++ +||||+++++++.+++..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 455688999999999999974 356899999987542 2567899999999 9999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 467 LIYEYMASGTLDQYLKGKKE----------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
+||||+++|+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcC
Confidence 99999999999999986542 24899999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~ 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFY 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHH
Confidence 99999999999987654433333445567889999999999999999999999999999999 999997654322 111
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.....+. . ...+...+..+.+++.+||+.||.+|||+.|+++.|++++..
T Consensus 259 ----~~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 259 ----KMIKEGF-R--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ----HHHHHTC-C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhccCC-C--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111 0 111223456789999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.82 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=208.8
Q ss_pred HHhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 465 (704)
..+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|+.++.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3455678999999999999975 246689999986432 2567899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcccC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 037258 466 GLIYEYMASGTLDQYLKGKKE---------------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSS 524 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 524 (704)
++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence 999999999999999986542 23789999999999999999999 899999999999
Q ss_pred CEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 037258 525 NILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAED 603 (704)
Q Consensus 525 NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~ 603 (704)
||+++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999987654443334445667889999999999999999999999999999998 99999765432
Q ss_pred CcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 604 DTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
. .. ......+. ....+...+..+.+++.+||+.||.+|||+.|+++.|+.++..
T Consensus 282 ~--~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 A--NF----YKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp H--HH----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred H--HH----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2 11 11222211 1112223456789999999999999999999999999988664
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=361.41 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=195.3
Q ss_pred HhhhcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|... ++..||||+++... ..+.+|++++++++||||+++++++.+++..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3456789999999999999764 57789999986432 25678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.++++... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 126 e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 126 EYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp ECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred eCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999997653 34899999999999999999999 8999999999999999999999999999998764322
Q ss_pred CCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 SDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .+..+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~----~i~~~-------- 266 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK----AVDEG-------- 266 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHH----HHHTT--------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC--------
Confidence 111 1222345778999999999999999999999999999998 99999654321 1111 11111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.....+...+..+.+++.+||+.||.+||++.|+++.|++++..
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01111233456789999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=374.92 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=211.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|+||.||+|.+. ++..||||+++... ..+.+|++++++++||||++++++|.+.+..++||||+++|
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 456789999999999999876 48899999997543 36788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~ 377 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 377 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECCT
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ceeecC
Confidence 9999998766566999999999999999999999 899999999999999999999999999999876322 112223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +... +..+ .....+
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~---------~~~~~~ 441 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKD---------YRMERP 441 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTT---------CCCCCC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC---------CCCCCC
Confidence 3456778999999999999999999999999999999 999997654322 2221 1111 111223
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 34456889999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.05 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=209.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCC--eEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGN--NMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 456789999999999999765 58999999986533 25578999999999999999999998765 78999999
Q ss_pred cCCCCHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccc
Q 037258 472 MASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla~~~~ 546 (704)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999987543 33899999999999999999999 8999999999999999 788889999999998764
Q ss_pred cCCCCcccccccCCCCccCccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYV--------LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
.. .......||+.|+|||++. +..++.++|||||||++|||++|+.||......... .+.+......
T Consensus 168 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~ 242 (319)
T 4euu_A 168 DD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG 242 (319)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHH
T ss_pred CC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcC
Confidence 22 2233457899999999986 578899999999999999999999999754432221 1222222221
Q ss_pred CC---ccccc-----------CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 619 GD---IRNIV-----------DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 619 ~~---~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.. +.... +..............+.+++.+||+.||++|||++|+++...+..-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11 10000 0011123456778889999999999999999999999999886543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=362.20 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=207.8
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|.+. +++.||||+++... ..+.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456789999999999999743 46789999986432 256789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEec
Q 037258 468 IYEYMASGTLDQYLKGKK-----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADF 539 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Df 539 (704)
||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999998654 234899999999999999999999 89999999999999999554 5999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~-i~~ 301 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEF-VTS 301 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHH-HHT
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHc
Confidence 99986543333333445667899999999999999999999999999999998 99999654321 11111 111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
+.. ...+...+..+.+|+.+||+.||.+||++.||++.|+.+.....
T Consensus 302 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 302 GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111 11123344578899999999999999999999999998876443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=372.81 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=207.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|.+.+++.||||+++... ..+.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 45678999999999999999889999999987532 36789999999999999999999986 567899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.++++......+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 344 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREG 344 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTTCS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceeccCC
Confidence 999998665445899999999999999999999 899999999999999999999999999999875321 1111223
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||++....++.++|||||||++|||++ |+.||...... .+ ... +..+. ....+.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~---~~~-i~~~~---------~~~~~~ 408 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EV---IRA-LERGY---------RMPRPE 408 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH---HHH-HHHTC---------CCCCCT
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HH---HHH-HHcCC---------CCCCCC
Confidence 456778999999999999999999999999999999 99999654321 11 111 11111 011123
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 4456889999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=356.55 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=206.7
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||.||+|... +++.||||+++... ..+.+|++++++++||||+++++++.+++..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 445789999999999999763 34889999987542 2567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCE
Q 037258 469 YEYMASGTLDQYLKGKK----------------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 526 (704)
|||+++|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceE
Confidence 99999999999997642 145899999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 037258 527 LLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDT 605 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~ 605 (704)
+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 283 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 283 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH--
Confidence 999999999999999987643322233345567889999999999999999999999999999999 99999654321
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.. ..+..+... ..+...+..+.+++.+||+.||.+||++.|+++.|+++..
T Consensus 284 ----~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 284 ----EVI-YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ----HHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----HHH-HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 111 122222211 1223345578999999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.27 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=199.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... +++ .||+|.+.... ..+.+|+.++++++||||++++++|.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 456789999999999999753 444 46888875322 35778999999999999999999998765 78999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 96 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 99999999999986543 4899999999999999999999 8999999999999999999999999999998775444
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .+..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~-------- 236 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE-------- 236 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTC--------
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCC--------
Confidence 4444445567889999999999999999999999999999999 999997654322 111 111111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
....+...+..+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1112233455789999999999999999999999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.17 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=202.5
Q ss_pred HhhhcccccccCceEEEEEEe-----CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeC--CeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 467 (704)
.+.+.+.||+|+||.||+|.+ .+++.||||++..... .+.+|++++++++||||+++++++... ...++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 455678999999999999974 3688999999875443 557899999999999999999998654 56899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 91 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999986543 3899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------CcccHHHHHHHHHh
Q 037258 548 ESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED---------DTTHISQWVNSMLA 617 (704)
Q Consensus 548 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~ 617 (704)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 2221 2223345677899999999999999999999999999999999998643211 00011111111111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+. ....+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 247 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 247 NNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111 112233445689999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.07 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=213.0
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 4556789999999999999765 58899999987543 3567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... .....
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~ 169 (288)
T 3kfa_A 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169 (288)
T ss_dssp EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-SSEEE
T ss_pred CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC-ccccc
Confidence 99999998766667999999999999999999999 899999999999999999999999999999876422 22333
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+ ... .....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~----~~~---------~~~~~ 233 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKD---------YRMER 233 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTT---------CCCCC
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcc---------CCCCC
Confidence 44567889999999999999999999999999999999 999996654322 11111 111 11112
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 23345678999999999999999999999999999876544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.90 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=203.6
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|.+.++..||||+++... ..+.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 45678999999999999999888899999997533 367899999999999999999999876 67899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 340 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 340 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-ceecccC
Confidence 999998655555899999999999999999999 899999999999999999999999999999876422 1122234
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... +..+. ....+.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~-i~~~~---------~~~~~~ 404 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERGY---------RMPCPP 404 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTTC---------CCCCCT
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCC---------CCCCCC
Confidence 456788999999999999999999999999999999 99999654321 11111 11111 111223
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 4456889999999999999999999999999988754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.37 Aligned_cols=241 Identities=25% Similarity=0.367 Sum_probs=200.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +|+.||+|+++... .....|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 345789999999999999765 78999999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 87 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 87 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 999999999986543 899999999999999999999 89999999999999999999999999999975321 22
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +..
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~---------- 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EEI---------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC----------
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC----------
Confidence 2334567999999999999999999999999999999999999999654321 11222221 111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+|| +++|+++
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12233456789999999999999999 8999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.91 Aligned_cols=277 Identities=18% Similarity=0.226 Sum_probs=210.8
Q ss_pred HhhhcccccccCceEEEEEEeCC------CcEEEEEecccchhhHHHHHH---------------HHHhhcccceeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD------NQQVAVKMLSSSCCFQLLQVK---------------LLMRVHHRNLTALIG 457 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~E~~---------------~l~~l~h~nIv~l~~ 457 (704)
.+.+.+.||+|+||.||+|.+.. ++.||||++.........|++ .+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45567899999999999997754 478999998765544444444 444557999999999
Q ss_pred EEEeC----CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CC
Q 037258 458 YCIEG----NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EK 531 (704)
Q Consensus 458 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~ 531 (704)
++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence 99764 4589999999 999999998643 34999999999999999999999 89999999999999998 88
Q ss_pred CcEEEEeccCccccccCCCC-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037258 532 LQAKIADFGLSRIFSIESSD-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~ 606 (704)
+.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-- 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-- 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--
Confidence 99999999999876432211 11134459999999999999999999999999999999999999997543321
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCCCCCC
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRD 686 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 686 (704)
........... ..+...+++.+. ....+.++.+++..||+.+|.+||++.++++.|++++...........++...
T Consensus 269 ~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 269 KYVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV 344 (364)
T ss_dssp HHHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred HHHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence 12222221111 122333333221 12234578899999999999999999999999999988766666666665543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.86 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=200.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcE----EEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQ----VAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... +++. ||+|.+.... ..+.+|+.++++++||||+++++++. ++..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345789999999999999754 4544 8888775332 25578999999999999999999986 46689999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp ECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999997653 23889999999999999999999 8999999999999999999999999999998875444
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +.. .+..+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~------ 236 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERL------ 236 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBC------
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCC------
Confidence 4444456678889999999999999999999999999999999 999997654322 111 11111111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+...+..+.+++.+||+.||.+||+++|+++.|+.+...
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111233567899999999999999999999999988654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=344.04 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|...+++.||||++.... ....+|++++++++||||+++++++.+++..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 44578999999999999998889999999986432 245789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 103 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~ 175 (311)
T 3niz_A 103 K-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRS 175 (311)
T ss_dssp E-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC-
T ss_pred C-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--ccc
Confidence 5 8888887644 34899999999999999999999 899999999999999999999999999999875322 222
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc---ccc----
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR---NIV---- 625 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 625 (704)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. + ..+.......... ...
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--L-PKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--H-HHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHHCCCChHHhhhhhccch
Confidence 344578999999999876 5689999999999999999999999976554332 1 1121211111100 000
Q ss_pred --CCcCC--CC-----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 --DPSLQ--GN-----FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 --d~~l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.... .. .....+.++.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00 01123457889999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.49 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=207.3
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|...+++.||||++.... ..+.+|++++++++||||+++++++. .+..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 345678999999999999998888899999986532 36678999999999999999999986 45689999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++...... ......
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 168 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTARE 168 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc-cccccc
Confidence 9999998655445999999999999999999999 899999999999999999999999999999876422 122223
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.... +..+. ....+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~~~~---------~~~~~ 232 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQN-LERGY---------RMVRP 232 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTTC---------CCCCC
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHH-Hhccc---------CCCCc
Confidence 4456789999999998899999999999999999999 99999654321 11111 11111 01112
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 23456789999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.69 Aligned_cols=239 Identities=26% Similarity=0.366 Sum_probs=199.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+++++.++||||+++++++.+++..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 45678999999999999976 578999999986432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+ +|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..... .
T Consensus 91 ~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~ 161 (336)
T 3h4j_B 91 A-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---G 161 (336)
T ss_dssp C-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---S
T ss_pred C-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---C
Confidence 9 6899999876544 899999999999999999999 89999999999999999999999999999986532 2
Q ss_pred cccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~-~ 224 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSC-V 224 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSS-C
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcC-C
Confidence 23345679999999999988776 7899999999999999999999965443221 0111110 1
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+...+..+.+++.+||+.||.+|||++|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223344567899999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=350.85 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=208.7
Q ss_pred HHhhhcccccccCceEEEEEEe--------CCCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCC
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL--------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGN 463 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 463 (704)
..+.+.+.||+|+||.||+|.. .+++.||||+++... ..+.+|+++++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 3455689999999999999976 356789999997532 2457899999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKE--------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 529 (704)
..++||||+++|+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEc
Confidence 99999999999999999986542 24899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 037258 530 EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHI 608 (704)
Q Consensus 530 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 608 (704)
.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----- 266 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 266 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-----
Confidence 999999999999987643322223334567788999999999999999999999999999999 99999654321
Q ss_pred HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 609 SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 609 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
+... .+..+... ..+...+..+.+++.+||+.||.+||++.|+++.|++++....
T Consensus 267 -~~~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 -ELFK-LLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp -HHHH-HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HHHH-HHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1111 11111111 1122344578999999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.71 Aligned_cols=244 Identities=31% Similarity=0.467 Sum_probs=190.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch--------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... ++.||||++.... ..+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 455789999999999999875 8899999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCCEEeCC--------CCcEEEEecc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP---IVHRDVKSSNILLNE--------KLQAKIADFG 540 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kL~DfG 540 (704)
+++++|.+++... .+++..++.++.|+++||+||| +.+ |+||||||+||+++. ++.+||+|||
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 88 ARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred CCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999643 3899999999999999999999 666 999999999999986 6789999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ..
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~~ 230 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAM-NK 230 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHT-SC
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhc-CC
Confidence 99765322 2224578999999999999999999999999999999999999996543211 1111111 11
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11122333456789999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.21 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=193.6
Q ss_pred HhhhcccccccCceEEEEEEeCCC----cEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeE---
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNM--- 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--- 465 (704)
.+.+.+.||+|+||.||+|..... ..||||+++... ..+.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 456688999999999999976533 279999986432 2567899999999999999999999877655
Q ss_pred ---EEEEeecCCCCHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 466 ---GLIYEYMASGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 466 ---~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
++||||+++|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999997543 224899999999999999999999 89999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ... ....
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---~~~~ 254 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN---YLIG 254 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHT
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH---HHhc
Confidence 999987643333333344567789999999999999999999999999999999 999997654322 111 1111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++++.-.
T Consensus 255 -~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 -GNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -TCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -CCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 1112334467899999999999999999999999999988743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.08 Aligned_cols=243 Identities=20% Similarity=0.344 Sum_probs=197.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||||+++.... ....|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 455789999999999999765 678999999865422 356788888887 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++... ..
T Consensus 134 ~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~~ 206 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RP 206 (396)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--CT
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc--cC
Confidence 9999999999987544 999999999999999999999 8999999999999999999999999999997532 12
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHHHhcCCcccccCCc
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT--THISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+...+.....
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------- 279 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------- 279 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-------
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-------
Confidence 2334557899999999999999999999999999999999999999965432211 1111222222222211
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+..+.+|+.+||+.||.+||++
T Consensus 280 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1223345678999999999999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.71 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=195.0
Q ss_pred HhhhcccccccCceEEEEEEeCC----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|.... +..||+|++.... ..+.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 45568899999999999997642 4579999986532 25678999999999999999999984 56788999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 169 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 169 (281)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc-
Confidence 9999999999997653 34899999999999999999999 899999999999999999999999999999876322
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .... +..+..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~------- 235 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGER------- 235 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCC-------
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCC-------
Confidence 1222234456788999999999999999999999999999997 999997654322 1111 111111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
...+...+..+.+++.+||+.||++|||+.|+++.|++++..+.
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 236 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11223345678999999999999999999999999999877543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.57 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
|.+.+.||+|+||.||+|... +|+.||+|+++... ....+|+.++++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999765 68999999986432 2467899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC----cEEEEeccCccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL----QAKIADFGLSRI 544 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla~~ 544 (704)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 94 ~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 94 LELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999997654 3899999999999999999999 89999999999999998877 799999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
+... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +...... .+...
T Consensus 169 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~-~~~~~-- 236 (361)
T 2yab_A 169 IEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT-AVSYD-- 236 (361)
T ss_dssp CCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-TTCCC--
T ss_pred cCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcCCC--
Confidence 6422 2234567999999999999999999999999999999999999999654321 1111111 11110
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+++ .+....+..+.+++.+||..||.+|||+.|+++
T Consensus 237 ~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001123457889999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=339.39 Aligned_cols=251 Identities=25% Similarity=0.456 Sum_probs=206.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|...+++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 44578999999999999998888999999987543 366789999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...... .......
T Consensus 90 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 164 (267)
T 3t9t_A 90 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 164 (267)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-ccccccc
Confidence 999997653 34899999999999999999999 899999999999999999999999999999765311 1112233
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..+.. ...+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i-~~~~~---------~~~~~ 228 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDI-STGFR---------LYKPR 228 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHH-HTTCC---------CCCCT
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHH-hcCCc---------CCCCc
Confidence 456778999999998999999999999999999999 89999654321 111111 11110 11122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234578899999999999999999999999998865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.68 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=205.0
Q ss_pred HHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhh--cccceeEEEEEEEeC----CeE
Q 037258 393 SEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRV--HHRNLTALIGYCIEG----NNM 465 (704)
Q Consensus 393 ~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~~ 465 (704)
.+.....+.+.+.||+|+||.||+|... ++.||||++..... ....|.+++..+ +||||+++++++... ...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3344456677899999999999999875 89999999865433 445566666554 899999999999887 789
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceecCCCCCCEEeCCCCcEEEE
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP--------PIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
++||||+++|+|.++++... +++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 99999999999999997653 899999999999999999999 77 99999999999999999999999
Q ss_pred eccCccccccCCCCc--ccccccCCCCccCccccccCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCC
Q 037258 538 DFGLSRIFSIESSDQ--ISTAVAGTPGYLDPEYYVLNWLNEK------SDVYSFGVVLLEIITG----------RRPVIS 599 (704)
Q Consensus 538 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwSlGvvl~elltG----------~~Pf~~ 599 (704)
|||++..+....... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997653322211 1224579999999999987766655 9999999999999999 666654
Q ss_pred CCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 600 RAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
....... ... .......... .+...... ....+.++.+++.+||+.||++|||+.|+++.|+++....
T Consensus 265 ~~~~~~~-~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPS-YED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCC-HHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCc-hhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 4332221 111 1111111111 11111111 2367788999999999999999999999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=348.10 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=180.2
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccch-hhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-CFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.+. ||||+++++++.++...++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 378999999999999764 68999999997654 36678999999997 9999999999999999999999999999999
Q ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEeccCccccccCCCCccccc
Q 037258 480 YLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 480 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 96 ~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 168 (325)
T 3kn6_A 96 RIKKKK--HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKT 168 (325)
T ss_dssp HHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC--CCCcccc
Confidence 998754 3999999999999999999999 89999999999999997665 899999999986532 2223345
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+. ...+..+... .......
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-HHHHTTTCCC------CCSHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-HHHHHcCCCC------CCccccc
Confidence 67899999999999999999999999999999999999999765432211 11222 2222222111 0000012
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+.++.+|+.+||+.||.+|||++|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 34567899999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.37 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=202.1
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... ++.||||+++... ..+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 456789999999999999885 8899999986432 2567889999999999999999999877 788999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+++|+|.+++.......+++..++.++.|++.||+||| +.+ ++||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 99999999998876656999999999999999999999 888 9999999999999999999999999875432
Q ss_pred CCcccccccCCCCccCccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNE---KSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...... .........+.
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------ 228 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGL------ 228 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCC------
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCC------
Confidence 12346789999999998765544 799999999999999999999654321 11112222111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
....+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ---RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111223345678999999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.75 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.|.+.+.||+|+||.||++... +++.||||+++........|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 4566789999999999999765 689999999987766778899999888 79999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC----CcEEEEeccCccccccCCCCc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK----LQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~~~~~~~~~ 552 (704)
|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+.++ +.+||+|||+++.+... ..
T Consensus 103 L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~--~~ 175 (342)
T 2qr7_A 103 LLDKILRQKF--FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NG 175 (342)
T ss_dssp HHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT--TC
T ss_pred HHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC--CC
Confidence 9999976543 899999999999999999999 8999999999999998543 35999999999875422 22
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +... .+..+... +...
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~-~i~~~~~~------~~~~ 245 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILA-RIGSGKFS------LSGG 245 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHH-HHHHCCCC------CCST
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHH-HHccCCcc------cCcc
Confidence 334567899999999999888999999999999999999999999764332222 2222 22222211 1111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+..+.+|+.+||+.||++||++.|+++
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22344568899999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.89 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=201.0
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc----------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS----------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..|.+.+.||+|+||.||+|... +++.||+|++... ...+.+|+.++++++||||+++++++.+++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34667899999999999999765 6899999998542 235678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC----cEEEEeccCc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL----QAKIADFGLS 542 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla 542 (704)
+||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999997644 3899999999999999999999 89999999999999999887 8999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
+.+... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ...
T Consensus 166 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~-~~~- 234 (326)
T 2y0a_A 166 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSA-VNY- 234 (326)
T ss_dssp EECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHH-TCC-
T ss_pred eECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHh-cCC-
Confidence 876322 22334679999999999999999999999999999999999999996543211 1111111 110
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000001123457889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=334.65 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=208.1
Q ss_pred HHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEe-------------
Q 037258 396 QKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIE------------- 461 (704)
Q Consensus 396 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------------- 461 (704)
....+.+.+.||+|+||.||+|... +++.||+|++........+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 3445666899999999999999775 79999999998777788999999999999999999998864
Q ss_pred ---CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 462 ---GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 462 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
....++||||+++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECc
Confidence 455899999999999999998765556999999999999999999999 89999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.... ... ..+..
T Consensus 166 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~-~~~~~ 233 (284)
T 2a19_B 166 FGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF-TDLRD 233 (284)
T ss_dssp CTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH-HHHHT
T ss_pred chhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH-HHhhc
Confidence 99998764221 2334568999999999999999999999999999999999998873211 111 11111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.+ +...+..+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 234 ~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 234 GII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111 11223468899999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.59 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=205.1
Q ss_pred HHhhhcccccccCceEEEEEEe-----CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC--CeE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNM 465 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 465 (704)
..+.+.+.||+|+||.||+|.+ .+++.||||++.... ....+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3356678999999999999983 468899999987443 3567899999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999965442 3899999999999999999999 899999999999999999999999999999876
Q ss_pred ccCCCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------CCcccHHHHHHHHH
Q 037258 546 SIESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE--------DDTTHISQWVNSML 616 (704)
Q Consensus 546 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~ 616 (704)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 433221 223345678889999999999999999999999999999999998643210 00111111111111
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
..+. ....+...+..+.+++.+||+.||.+|||+.|+++.|++++
T Consensus 257 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 11223344568999999999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.02 Aligned_cols=275 Identities=16% Similarity=0.169 Sum_probs=213.6
Q ss_pred HhhhcccccccCceEEEEEEeCC---------CcEEEEEecccchhhHHHHHHHHHhhcccceeE---------------
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD---------NQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTA--------------- 454 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~--------------- 454 (704)
.+.+.+.||+|+||.||+|.... ++.||||++... ....+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 34567899999999999997653 789999998754 46788999999999999987
Q ss_pred EEEEEEe-CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-
Q 037258 455 LIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL- 532 (704)
Q Consensus 455 l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 532 (704)
+++++.. ++..++||||+ +++|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCC
Confidence 6778776 67899999999 999999998764456999999999999999999999 89999999999999999998
Q ss_pred -cEEEEeccCccccccCCCC-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037258 533 -QAKIADFGLSRIFSIESSD-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606 (704)
Q Consensus 533 -~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~ 606 (704)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 276 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE- 276 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH-
Confidence 8999999999876432211 112345799999999999999999999999999999999999999976542221
Q ss_pred cHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCCCC
Q 037258 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGH 684 (704)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 684 (704)
.+......... ......+.... ....+..+.+++.+||+.||.+||+++|+++.|++++...........++.
T Consensus 277 ~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 277 DIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp HHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred HHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 22222211111 11112111110 112346789999999999999999999999999998876554444444443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.73 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=196.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcE----EEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQ----VAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... +++. ||+|.+... ...+.+|+.++++++||||+++++++..+. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 455789999999999999754 4544 577776432 236678999999999999999999998765 78999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+.+|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 96 ~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999999986543 3899999999999999999999 8999999999999999999999999999998765443
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.. .+..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~-------- 236 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE-------- 236 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTC--------
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCC--------
Confidence 3334445567889999999999999999999999999999999 999997654332 111 111111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
....+...+..+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11122334557899999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=349.79 Aligned_cols=245 Identities=21% Similarity=0.343 Sum_probs=192.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcc--cceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHH--RNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||++...+++.||||++.... ..+.+|++++.+++| +||+++++++.+++..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 45678999999999999988889999999985432 245789999999976 999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 90 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CCSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 567899999987543 899999999999999999999 89999999999999997 578999999999876543333
Q ss_pred cccccccCCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-----------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~----- 233 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI----- 233 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH-----
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH-----
Confidence 33445679999999999865 67889999999999999999999999653321 1111111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+++.....++...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ----~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 ----IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 12222222333334578899999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=346.18 Aligned_cols=245 Identities=18% Similarity=0.295 Sum_probs=200.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
|.+.+.||+|+||.||+|... +++.||+|++..... ...+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 456789999999999999765 688999999865432 4578999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC--CCcEEEEeccCccccccCCCCcc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE--KLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||++..+.. ...
T Consensus 87 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~---~~~ 159 (321)
T 1tki_A 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDN 159 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCE
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---CCc
Confidence 9999997643 24899999999999999999999 899999999999999987 78999999999987632 223
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ ... .+. ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~-~~~--~~~----~~ 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNA-EYT--FDE----EA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-CCC--CCH----HH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcC-CCC--CCh----hh
Confidence 34567899999999999988999999999999999999999999654321 112222211 110 000 00
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+.++.+++.+||..||.+|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0123457899999999999999999999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.81 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=208.3
Q ss_pred HhhhcccccccCceEEEEEEeCC-C-----cEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD-N-----QQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.... + ..||+|++.... ..+.+|+++++++ +||||+++++++.+++..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 34567899999999999997642 2 479999986542 2567899999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcE
Q 037258 467 LIYEYMASGTLDQYLKGKK------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQA 534 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 534 (704)
+||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeE
Confidence 9999999999999997543 234799999999999999999999 8999999999999999999999
Q ss_pred EEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 037258 535 KIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVN 613 (704)
Q Consensus 535 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 613 (704)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~---- 277 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFY---- 277 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHH----
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHH----
Confidence 9999999987644433333445567889999999999999999999999999999998 999996654322 111
Q ss_pred HHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 614 SMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 614 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
.....+.. ...+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 278 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 278 KLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 0112223457889999999999999999999999999887643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.06 Aligned_cols=245 Identities=24% Similarity=0.271 Sum_probs=192.7
Q ss_pred HHHHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhh-cccceeEEEEEEEeCCe
Q 037258 393 SEIQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRV-HHRNLTALIGYCIEGNN 464 (704)
Q Consensus 393 ~el~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 464 (704)
.++....+.+.++||+|+||+||+|... +++.||||++..... ....|+..+.++ +||||+++++++.+++.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3445556777899999999999999775 799999998754321 334455555555 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 99999999 679999887654 34999999999999999999999 88999999999999999999999999999876
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
... ........||+.|+|||++.+ .++.++|||||||++|||++|..|+..... + ..+..+....
T Consensus 207 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~--~~~~~~~~~~- 271 (311)
T 3p1a_A 207 LGT---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W--QQLRQGYLPP- 271 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H--HHHTTTCCCH-
T ss_pred ccc---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H--HHHhccCCCc-
Confidence 532 222344568999999998876 689999999999999999999777643211 1 1111111110
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+....+..+.+++.+||+.||++|||++|+++
T Consensus 272 -------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111223467899999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.86 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=195.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||||+++... .....|..++..+ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 456789999999999999765 68999999987532 2456788899888 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++... ..
T Consensus 105 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~--~~ 177 (353)
T 3txo_A 105 FVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--CN 177 (353)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC--C-
T ss_pred CCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc--cC
Confidence 9999999999987544 999999999999999999999 8999999999999999999999999999997532 12
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~--------- 241 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN-DEV--------- 241 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC---------
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CCC---------
Confidence 23344567999999999999999999999999999999999999999654321 11222222 111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTM------TDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||++ +|+++
T Consensus 242 -~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1223344578899999999999999998 77764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=334.25 Aligned_cols=265 Identities=18% Similarity=0.257 Sum_probs=208.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEE-EeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYC-IEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~e~~~~ 474 (704)
.+.+.+.||+|+||.||+|.. .+++.||||++.... .....|+++++.++|++++..+..+ ..++..++||||+ +
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 455689999999999999975 578999999865433 3678899999999988877766665 5677889999999 9
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccccCCCC
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
++|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 89 PSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999999975432 3899999999999999999999 8999999999999999 78889999999999876433221
Q ss_pred -----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 552 -----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 -----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 242 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-L- 242 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-H-
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-h-
Confidence 123356789999999999999999999999999999999999999987654433332222221111111100 0
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcc
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRN 677 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 677 (704)
....+..+.+++.+||+.||++||+++|+++.|++++.......
T Consensus 243 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 243 -------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp -------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred -------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 01123578999999999999999999999999999887554433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.46 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=207.3
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.||+|+||.||+|... +++.||||+++... ..+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999753 67889999997532 2567899999999999999999999 556789999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-ccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD-QIS 554 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~ 554 (704)
+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......... ...
T Consensus 95 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 95 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 9999997543 34899999999999999999999 899999999999999999999999999999876432221 112
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ +.. .+..+.. ...
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~i~~~~~---------~~~ 234 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGKR---------MEC 234 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----HHHTTCC---------CCC
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHhcCCc---------CCC
Confidence 23456889999999998899999999999999999998 999996644321 111 1111111 122
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCC
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 680 (704)
+...+..+.+++.+||+.||.+||++.|+++.|+++..........+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 33445689999999999999999999999999999987666555443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.30 Aligned_cols=269 Identities=18% Similarity=0.245 Sum_probs=210.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEE-EeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYC-IEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... .....|+.+++.++|++++..+.++ .+++..++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 44578999999999999975 689999999875433 3678899999999988877666655 5677889999999 89
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccccCCCC-
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~~~~~~~~- 551 (704)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||++.........
T Consensus 90 ~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 90 SLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 9999997443 34899999999999999999999 89999999999999994 7889999999999876433221
Q ss_pred ----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 552 ----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 552 ----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........... .
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 242 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-L-- 242 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-H--
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH-H--
Confidence 112456799999999999999999999999999999999999999987554333222222221111111000 0
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCCCC
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEK 682 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 682 (704)
....+..+.+++.+||+.||.+||++.|+++.|+++............+
T Consensus 243 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 3uzp_A 243 ------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp ------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCG
T ss_pred ------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 1122357889999999999999999999999999988765544444333
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.18 Aligned_cols=247 Identities=22% Similarity=0.268 Sum_probs=200.0
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3456689999999999999965 578999999986432 245789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC---CCCcEEEEeccCcccccc
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~~~~ 547 (704)
|+++|+|.+.+..... +++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||++.....
T Consensus 91 ~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 91 LVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999986544 999999999999999999999 89999999999999998 467899999999976532
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .... .+..+... ...
T Consensus 166 ~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~-~i~~~~~~-~~~- 234 (444)
T 3soa_A 166 E--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQ-QIKAGAYD-FPS- 234 (444)
T ss_dssp T--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-HHHHTCCC-CCT-
T ss_pred C--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHH-HHHhCCCC-CCc-
Confidence 2 22234567999999999999999999999999999999999999999654321 1111 12222111 111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 ----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111234567899999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.43 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=192.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------------------------------hhHHHHHHHHHhhc
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------------------------------CFQLLQVKLLMRVH 448 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------------------------------~~~~~E~~~l~~l~ 448 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 45678999999999999965 478999999985432 24678999999999
Q ss_pred ccceeEEEEEEEe--CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCE
Q 037258 449 HRNLTALIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526 (704)
Q Consensus 449 h~nIv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 526 (704)
||||+++++++.+ .+..++||||+++++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL 168 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence 9999999999987 56899999999999998876543 4899999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037258 527 LLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW---LNEKSDVYSFGVVLLEIITGRRPVISRAED 603 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~Pf~~~~~~ 603 (704)
|++.++.+||+|||+++.+... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 9999999999999999875322 22234567999999999998654 47889999999999999999999965321
Q ss_pred CcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 604 DTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...... +....... + .....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~-~~~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -----MCLHSK-IKSQALEF---P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHHHHH-HHHCCCCC---C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHHHHH-HhcccCCC---C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111 11111110 0 01223457899999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.71 Aligned_cols=247 Identities=30% Similarity=0.491 Sum_probs=199.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++||||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 345678999999999999976 478999999985322 35678999999999999999999987655 6
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCCCCc-----EEEEec
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNEKLQ-----AKIADF 539 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kL~Df 539 (704)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++. +||+||
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred EEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 9999999999999887554 34899999999999999999999 888 999999999999988776 999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYV--LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|+++... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ........
T Consensus 174 g~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIRE 244 (287)
T ss_dssp TTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHH
T ss_pred Ccccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhc
Confidence 9997532 1234467899999999984 55678999999999999999999999976543321 11111111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+ .....+...+..+.+++.+||+.||.+|||++|+++.|+++
T Consensus 245 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 11122334456899999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.78 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=199.4
Q ss_pred HHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch---------hhHHHHHHHHHhhc---ccceeEEEEEEEeC
Q 037258 396 QKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---------CFQLLQVKLLMRVH---HRNLTALIGYCIEG 462 (704)
Q Consensus 396 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 462 (704)
....|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 344566789999999999999975 578999999986322 24567777777765 99999999999875
Q ss_pred C-----eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 463 N-----NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 463 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
. ..++||||+. |+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 59999998877666999999999999999999999 8999999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG 236 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence 9999986532 222345678999999999999999999999999999999999999996644321 1111111111
Q ss_pred cCC---ccccc---CCcCCCC-------CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGD---IRNIV---DPSLQGN-------FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~---~~~~~---d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... ..... ....... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 110 00000 0000000 01233467899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=346.16 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=208.1
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCC-eE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGN-NM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~ 465 (704)
.+.+.+.||+|+||.||+|.. .+++.||||+++.... .+.+|++++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 345678999999999999963 3568999999875322 457899999999 7999999999998754 58
Q ss_pred EEEEeecCCCCHHHHhhcccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 466 GLIYEYMASGTLDQYLKGKKE--------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
++||||+++|+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCC
Confidence 999999999999999986542 22789999999999999999999 8999999999999999999
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQ 610 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 610 (704)
+.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~--- 259 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E--- 259 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--H---
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--H---
Confidence 9999999999987644333333445667889999999999999999999999999999998 999996654322 1
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
+...+..+... ..+...+..+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus 260 -~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 260 -FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp -HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11112222111 112223457899999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.15 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||+|+++... .....|..++.++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 445789999999999999765 68899999986532 1356788899887 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 91 ~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~ 163 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 163 (345)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--T
T ss_pred CCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC--C
Confidence 9999999999986543 899999999999999999999 89999999999999999999999999999975321 1
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHHHhcCCcccccCCc
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT--HISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+.....
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------- 236 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------- 236 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-------
Confidence 22344568999999999999999999999999999999999999999653321110 111112222222211
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTM 659 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 659 (704)
.++...+..+.+++.+||+.||.+||++
T Consensus 237 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1223345678999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.75 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=191.7
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.|.+.+.||+|+||.||++... +++.||||++.... ....+|+.++++++||||+++++++.+++..++||||+++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 3566889999999999999765 78999999986543 3567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc--EEEEeccCccccccCCCCc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--AKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~~~~~~~~~ 552 (704)
|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||+++... ...
T Consensus 101 ~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---~~~ 172 (361)
T 3uc3_A 101 GELYERICNAGR--FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHS 172 (361)
T ss_dssp CBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---ccC
Confidence 999999976544 899999999999999999999 899999999999999987765 9999999997432 122
Q ss_pred ccccccCCCCccCccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEK-SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... .....+....... . ..
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~-~--------~~ 241 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVK-Y--------SI 241 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTC-C--------CC
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCC-C--------CC
Confidence 2344579999999999988877655 899999999999999999997654322 2222222222111 0 00
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0111234578899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.17 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=196.9
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHH--HHhhcccceeEEEEEEEe-----CCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKL--LMRVHHRNLTALIGYCIE-----GNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~--l~~l~h~nIv~l~~~~~~-----~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. +++.||||++..... .+..|.++ +..++||||+++++.+.. ....++||||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 44578999999999999977 689999999875443 33344444 445899999999986643 2367899999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCCEEeCCCCcEEEEeccCc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP---------PIVHRDVKSSNILLNEKLQAKIADFGLS 542 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~kL~DfGla 542 (704)
+++|+|.+++.... .++..++.++.|+++||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999997654 589999999999999999999 77 9999999999999999999999999999
Q ss_pred cccccCCC------CcccccccCCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-c-
Q 037258 543 RIFSIESS------DQISTAVAGTPGYLDPEYYVL-------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-H- 607 (704)
Q Consensus 543 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~- 607 (704)
+.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87642211 122234579999999999986 46678999999999999999998887544322111 0
Q ss_pred H---------HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 608 I---------SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 608 ~---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
. ................+.... ......+..+.+++.+||+.||++|||++|+++.|++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0 001111111111111111111 1123467789999999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=345.43 Aligned_cols=249 Identities=17% Similarity=0.188 Sum_probs=204.9
Q ss_pred hhhcccccccCceEEEEE------EeCCCcEEEEEecccchh-hHHHHHHHHHhhc---ccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHG------SLDDNQQVAVKMLSSSCC-FQLLQVKLLMRVH---HRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+| ...+++.||||+++.... .+..|++++.+++ |+||+++++++..++..++||
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 455789999999999999 345789999999976543 5677888888876 999999999999999999999
Q ss_pred eecCCCCHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-----------CCcEE
Q 037258 470 EYMASGTLDQYLKGK---KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-----------KLQAK 535 (704)
Q Consensus 470 e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----------~~~~k 535 (704)
||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 999999999999753 2345999999999999999999999 899999999999999998 89999
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------- 293 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---------- 293 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----------
Confidence 9999999876544444455667899999999999999999999999999999999999999954432111
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHhhhhh
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSER-PTMTDVLMELKECLSL 672 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~ 672 (704)
.+...+.. . .....+.+++..|++.+|.+| |+++++.+.|++.+..
T Consensus 294 --------~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --------KPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------EECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------eechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111 1 124567799999999999998 6788899999888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.87 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=206.0
Q ss_pred hhcccccccCceEEEEEEeC-----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC--CeEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD-----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG--NNMGLI 468 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 468 (704)
.+.+.||+|+||.||++.+. +++.||||+++... ..+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999988653 68899999997543 2467899999999999999999999874 678999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999997654 899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--------cccHHHHHHHHHhcC
Q 037258 549 SSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD--------TTHISQWVNSMLAEG 619 (704)
Q Consensus 549 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~~~~ 619 (704)
... .......++..|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-- 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH--
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh--
Confidence 221 12334567888999999999999999999999999999999999986532110 0000001111111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.......+...+..+.+++.+||+.||.+|||+.|+++.|+++...-.
T Consensus 266 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 -------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111122234455689999999999999999999999999998876433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.36 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|...+++.||+|++.... ....+|++++++++||||+++++++.+++..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 44578999999999999988889999999985432 245789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 84 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (288)
T 1ob3_A 84 Q-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (288)
T ss_dssp E-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred C-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccc
Confidence 6 9999987643 24899999999999999999999 899999999999999999999999999999765321 122
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---ccc-----c
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRN-----I 624 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~ 624 (704)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.. +........ ... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcccc
Confidence 334578999999999976 458999999999999999999999996543211 1111 111111110 000 0
Q ss_pred cCCcCC-------CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDPSLQ-------GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++... ..+....+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111110 0111234567889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.10 Aligned_cols=261 Identities=18% Similarity=0.262 Sum_probs=200.5
Q ss_pred hhhccccccc--CceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKG--GFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
|.+.+.||+| +||.||+|... +++.||||++.... ....+|++++++++||||+++++++.+++..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 5567899999 99999999765 79999999986443 245679999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999999998775556999999999999999999999 89999999999999999999999999998865422111
Q ss_pred -----CcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc-----
Q 037258 551 -----DQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE----- 618 (704)
Q Consensus 551 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----- 618 (704)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +..........
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTS 261 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccccc
Confidence 112233478899999999987 6789999999999999999999999976543321 11100000000
Q ss_pred ----C-------------CcccccC---C------cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 619 ----G-------------DIRNIVD---P------SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 619 ----~-------------~~~~~~d---~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. ....... + .....+....+..+.+|+.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000 0 00001122345678999999999999999999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=348.14 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=199.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||++... +++.||+|++.... ....+|+++++.++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 456789999999999999764 68899999986432 2557899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.. .
T Consensus 97 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---~ 168 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---E 168 (384)
T ss_dssp CTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---T
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC---C
Confidence 999999999986543 999999999999999999999 89999999999999999999999999999987532 2
Q ss_pred cccccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+.. .... ..
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~-~~-------- 236 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFET-TV-------- 236 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHH-CC--------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhh-cc--------
Confidence 23445679999999999874 458999999999999999999999997654433222211 1111 11
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPT-MTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 664 (704)
..++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 237 --~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122334567899999999999999998 666653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.84 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=193.8
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhc--ccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVH--HRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|...+++.||||++.... ..+.+|++++++++ ||||+++++++..++..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 55678999999999999988889999999985432 25678999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 137 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 56889999998755 3899999999999999999999 99999999999999996 578999999999876433333
Q ss_pred cccccccCCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-----------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~---- 281 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII---- 281 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH----
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh----
Confidence 33445679999999999875 46889999999999999999999999653321 11111221
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
++.....++...+..+.+|+.+||+.||.+||++.|+++.
T Consensus 282 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111112222234578899999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.13 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=194.1
Q ss_pred HHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 396 QKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 396 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
....+.+.+.||+|+||.||+|... ..||||+++... ..+.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3344567899999999999999864 359999986432 2467899999999999999999965 456689999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999997544 34899999999999999999999 8999999999999999999999999999998654333
Q ss_pred CCcccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 550 SDQISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ . +......+.......
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhcccccCcchh
Confidence 333444567999999999987 6678889999999999999999999996644321 1 112222222211111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
......+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1223445689999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=337.31 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=199.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +|+.||+|+++... .....|..+++.++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 445789999999999999765 78999999986532 2456789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 88 IEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp CCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 999999999986543 899999999999999999999 99999999999999999999999999999986532
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~~---------- 220 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA-EL---------- 220 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-CC----------
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC----------
Confidence 22346799999999999999999999999999999999999999965432 1112222221 11
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+++.+||+.||++|| +++|+++
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12223345789999999999999999 8899884
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.65 Aligned_cols=249 Identities=21% Similarity=0.310 Sum_probs=200.8
Q ss_pred HHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccc---------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 397 KITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
...|.+.+.||+|+||.||+|.. .+++.||||++... ...+.+|+++++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567789999999999999965 47899999998532 235678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc---EEEEeccC
Q 037258 467 LIYEYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ---AKIADFGL 541 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGl 541 (704)
+||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886543 334899999999999999999999 899999999999999987654 99999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
+..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...... .+..
T Consensus 180 a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~---~~~~i~-~~~~ 249 (351)
T 3c0i_A 180 AIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----R---LFEGII-KGKY 249 (351)
T ss_dssp CEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----H---HHHHHH-HTCC
T ss_pred eeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----H---HHHHHH-cCCC
Confidence 987642 22223456799999999999999999999999999999999999999965321 1 111111 1111
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ..+.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0123457899999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.48 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=200.4
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..|.+.+.||+|+||.||+|... +++.||+|++.... ....+|++++++++||||+++++++.+++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667899999999999999764 68999999986432 245689999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEeccCcccccc
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGLSRIFSI 547 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~~~~ 547 (704)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||++.....
T Consensus 109 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 109 LVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999997654 3899999999999999999999 89999999999999998654 599999999987642
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..+...
T Consensus 184 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~-i~~~~~~----- 248 (362)
T 2bdw_A 184 S---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQ-IKAGAYD----- 248 (362)
T ss_dssp C---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTCCC-----
T ss_pred C---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhCCCC-----
Confidence 2 2233467999999999999999999999999999999999999999654321 11111 1122111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.........+..+.+++.+||+.||.+||++.|+++
T Consensus 249 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000111234567899999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.10 Aligned_cols=275 Identities=24% Similarity=0.360 Sum_probs=214.0
Q ss_pred ccCHHHHHHHHhhhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHh--hcccceeEEEEEEEeCC--
Q 037258 389 QFAYSEIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMR--VHHRNLTALIGYCIEGN-- 463 (704)
Q Consensus 389 ~~~~~el~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~--l~h~nIv~l~~~~~~~~-- 463 (704)
.+...+.....+.+.+.||+|+||.||+|.. +++.||||++..... ....|.+++.. ++||||+++++++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3444555566777899999999999999988 589999999975443 55778888887 79999999999998775
Q ss_pred --eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCEEeCCCCcEEE
Q 037258 464 --NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC-----KPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 464 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
..++||||+++|+|.+++.... +++..++.++.|++.||+|||... +.+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 7899999999999999997643 899999999999999999999321 478999999999999999999999
Q ss_pred EeccCccccccCCCCc--ccccccCCCCccCccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 037258 537 ADFGLSRIFSIESSDQ--ISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLLEIITG----------RRPVI 598 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG----------~~Pf~ 598 (704)
+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998764332211 23445789999999999865 344789999999999999999 77886
Q ss_pred CCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC-CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 599 SRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN-FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
....... ....+... ...... .+.+... ........+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 269 ~~~~~~~-~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDP-SVEEMRKV-VCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSC-CHHHHHHH-HTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcc-cHHHHHHH-HHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 6543221 22222222 211111 1111111 12356778999999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.22 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=196.2
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh--hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.+.+.||+|+||.||+|... ++.||||++..... .+.+|++++++++||||+++++++.+ ..++||||+++|+|
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L 86 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred eeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence 345789999999999999875 78899999975433 56789999999999999999998863 47899999999999
Q ss_pred HHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc-EEEEeccCccccccCCCCcccc
Q 037258 478 DQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ-AKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 478 ~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~DfGla~~~~~~~~~~~~~ 555 (704)
.+++..... ..+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++..... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~ 161 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMT 161 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----ccc
Confidence 999986542 24789999999999999999999322289999999999999988876 79999999976532 122
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...... ..+... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~-~~~~~~---------~~~~ 227 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAV-HNGTRP---------PLIK 227 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHH-HTTCCC---------CCBT
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHH-hcCCCC---------Cccc
Confidence 34689999999999999999999999999999999999999965433211 111111 111111 1122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 3345788999999999999999999999999988654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=348.70 Aligned_cols=266 Identities=21% Similarity=0.296 Sum_probs=211.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCC--eEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGN--NMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 456789999999999999765 58999999987533 35578999999999999999999998765 78999999
Q ss_pred cCCCCHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccc
Q 037258 472 MASGTLDQYLKGKKE-HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla~~~~ 546 (704)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999986543 33899999999999999999999 8999999999999999 778889999999998753
Q ss_pred cCCCCcccccccCCCCccCcccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL--------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+......
T Consensus 168 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~ 242 (396)
T 4eut_A 168 D---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG 242 (396)
T ss_dssp C---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHS
T ss_pred C---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcC
Confidence 2 222334679999999999875 56788999999999999999999999754432221 1222222222
Q ss_pred CC---ccccc-----------CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 619 GD---IRNIV-----------DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 619 ~~---~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
.. +.... +..............+.+++.+||+.||++||++.|+++.+++++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11 00000 001112344677888999999999999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.20 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=207.4
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|... +++.||||++..... .+.+|++++++++||||+++++++.+++..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3556899999999999999653 367899999864322 45789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 468 IYEYMASGTLDQYLKGKK--------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcC
Confidence 999999999999997643 134789999999999999999999 899999999999999999999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~~ 255 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRF-VME 255 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHH-HHT
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHHHH-HHc
Confidence 99986643322223334567889999999999999999999999999999999 89998654321 11111 112
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
+... ..+...+..+.+++.+||+.||.+|||+.|+++.|++.+..
T Consensus 256 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 256 GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2111 11223455789999999999999999999999999988664
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=372.34 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=208.0
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|.+.++..||||+++... ..+.+|++++++++|+||+++++++.+ +..++||||+++|
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 345678999999999999999888899999987533 367899999999999999999999876 6789999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......+++..++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.+... ......
T Consensus 347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~ 422 (535)
T 2h8h_A 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQ 422 (535)
T ss_dssp EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTC
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceeccc
Confidence 9999998655455899999999999999999999 899999999999999999999999999999865311 111122
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+..+. ....+
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~-~i~~~~---------~~~~~ 486 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD-QVERGY---------RMPCP 486 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHH-HHHTTC---------CCCCC
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHcCC---------CCCCC
Confidence 3456778999999999999999999999999999999 99999654321 1111 111111 11122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+..+.+|+.+||+.||++|||+++|++.|+++...
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 34456789999999999999999999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.37 Aligned_cols=240 Identities=27% Similarity=0.434 Sum_probs=198.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +|+.||||+++... .....|..++..+ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 445789999999999999765 68999999986532 2456788888877 99999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 99 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~ 171 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--G 171 (345)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred CCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--C
Confidence 9999999999986543 899999999999999999999 89999999999999999999999999999975421 1
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +. +
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~------~--- 235 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRM-DN------P--- 235 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CC------C---
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHh-CC------C---
Confidence 22344567999999999999999999999999999999999999999654321 11112211 11 1
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMT-DVL 663 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 663 (704)
.++...+..+.+++.+||+.||++||++. |++
T Consensus 236 -~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 12223456789999999999999999997 665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.16 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=197.3
Q ss_pred HhhhcccccccCceEEEEEEeC-CC-------cEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DN-------QQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|... ++ ..||+|++..... .+.+|++++++++||||+++++++.+++..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 3456789999999999999654 33 4799999865432 5678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc--------EEEEe
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--------AKIAD 538 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~D 538 (704)
+||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|
T Consensus 89 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999986543 3899999999999999999999 899999999999999998887 99999
Q ss_pred ccCccccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||++.... ......++..|+|||++.+ ..++.++||||||+++|||++|..|+....... .. ......
T Consensus 165 fg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~---~~~~~~ 233 (289)
T 4fvq_A 165 PGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RK---LQFYED 233 (289)
T ss_dssp CCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH---HHHHHT
T ss_pred Cccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HH---HHHhhc
Confidence 99986542 1223457889999999987 778999999999999999999665554332211 11 111111
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCC
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 680 (704)
..... ...+..+.+++.+||+.||.+|||+.|+++.|++++....+...++
T Consensus 234 ~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~ 284 (289)
T 4fvq_A 234 RHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284 (289)
T ss_dssp TCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----------
T ss_pred cCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcc
Confidence 11111 1112357799999999999999999999999999988665544443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.15 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=199.6
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEeC-CeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEG-NNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|... |+.||||+++... ..+.+|++++++++||||+++++++.+. +..++||||+++|+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 456789999999999999874 8899999997543 3567899999999999999999997654 57899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||++...... ...
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~ 173 (278)
T 1byg_A 102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 173 (278)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccC
Confidence 999998765444889999999999999999999 899999999999999999999999999998764321 223
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .+..+ .....+.
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~---------~~~~~~~ 237 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG---------YKMDAPD 237 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTT---------CCCCCCT
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcC---------CCCCCcc
Confidence 457889999999999999999999999999999998 999996544321 111 11111 1112223
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+..+.+++.+||+.||.+||++.|+++.|+++...+
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 44568899999999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.20 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=203.9
Q ss_pred hhhcc-cccccCceEEEEEEe---CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFER-VLGKGGFGEVYHGSL---DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.+ .||+|+||.||+|.. .+++.||||+++... ..+.+|+++++.++||||+++++++ ..+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 33445 899999999999954 246889999987542 2567899999999999999999999 567789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++++|.+++..... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp ECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 99999999999987543 899999999999999999999 8999999999999999999999999999998764322
Q ss_pred CCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 550 SDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 550 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ...+..+..
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~------ 238 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGER------ 238 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCC------
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence 211 1223446788999999998889999999999999999999 99999654321 11 111222211
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcc
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRN 677 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 677 (704)
...+...+..+.+++.+||+.||.+||++.|+++.|+++........
T Consensus 239 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 239 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 11223345679999999999999999999999999999987665433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.47 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=198.3
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||+|... +++.||+|+++... .....|+.+++.++||||+++++++.+++..++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34689999999999999765 68899999986422 24678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.++++... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+... ...
T Consensus 152 ~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~~~ 224 (410)
T 3v8s_A 152 PGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMV 224 (410)
T ss_dssp TTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SEE
T ss_pred CCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-Ccc
Confidence 9999999997643 899999999999999999999 899999999999999999999999999999876322 222
Q ss_pred ccccccCCCCccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 553 ISTAVAGTPGYLDPEYYVLNW----LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ............... +
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--p- 295 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF--P- 295 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCC--C-
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccccC--C-
Confidence 334568999999999998655 889999999999999999999999754321 111111111000000 0
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLME 665 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 665 (704)
.....+..+.+|+.+||+.+|.+ ||+++||++.
T Consensus 296 ----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 ----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 01123457889999999999988 9999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.22 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=187.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh--hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC--FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|... +++.||||+++.... .+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 455789999999999999775 678999999875432 55679999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCcc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.... ...
T Consensus 135 L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~ 206 (349)
T 2w4o_A 135 LFDRIVEKGY--YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVL 206 (349)
T ss_dssp HHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred HHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---ccc
Confidence 9999976543 899999999999999999999 899999999999999975 88999999999986532 222
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ..... . ....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~-~~~~~-~-----~~~~ 274 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRIL-NCEYY-F-----ISPW 274 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHH-TTCCC-C-----CTTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHH-hCCCc-c-----CCch
Confidence 344678999999999999999999999999999999999999996544321 1111111 11111 0 1111
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2234567899999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.05 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=196.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ....+|++++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 445789999999999999764 68999999985332 25578999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++ +|.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 84 ~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 84 DQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp SE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred CC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 86 6666655432 23999999999999999999999 89999999999999999999999999999987532 222
Q ss_pred ccccccCCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---cccc---c
Q 037258 553 ISTAVAGTPGYLDPEYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRNI---V 625 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~ 625 (704)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... .....+........ .... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccc
Confidence 334567899999999998765 7999999999999999999999875433211 11111111111110 0000 0
Q ss_pred C---------CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 D---------PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ ...........+..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00001112334567899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.74 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=193.5
Q ss_pred HhhhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||++.. .+++.||+|+++... ....+|++++++++||||+++++++.+++..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 355678999999999999976 478999999986532 14567999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999986543 889999999999999999999 8999999999999999999999999999997542
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-~~----- 238 (327)
T 3a62_A 173 H--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKC-KL----- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-CC-----
T ss_pred c--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CC-----
Confidence 2 122234567999999999999999999999999999999999999999654321 112222211 11
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 239 -----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 -----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 12223345789999999999999999 7778875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.06 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=201.0
Q ss_pred hhhcccccccCceEEEEEEeCC----CcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|.... +..||||++... ...+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 4457899999999999996532 346999998754 2256789999999999999999999865 45689999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 93 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 167 (281)
T 3cc6_A 93 LYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-D 167 (281)
T ss_dssp CCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc-c
Confidence 999999999997654 34899999999999999999999 899999999999999999999999999999875322 1
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... +..+...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~------- 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRL------- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCC-------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCC-------
Confidence 222334557889999999999999999999999999999998 999997544322 1111 1111110
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
..+...+..+.+++.+||+.||.+||++.|+++.|+++...+.
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 1122234578899999999999999999999999999877543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.95 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=188.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +|+.||||+++... ....+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 445688999999999999764 68999999986432 256789999999999999999999999999999999998
Q ss_pred CCCHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 474 SGTLDQYLKGKK----EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 474 ~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 161 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP- 161 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC-
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC-
Confidence 59999987543 234899999999999999999999 899999999999999999999999999999875322
Q ss_pred CCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---ccc--
Q 037258 550 SDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRN-- 623 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 623 (704)
........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........ ...
T Consensus 162 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 -VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp -CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGG
T ss_pred -cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhh
Confidence 122334578999999999976 468999999999999999999999997654321 1111111111100 000
Q ss_pred ---ccCCcCC------------CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 ---IVDPSLQ------------GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ---~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+... .......+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 0011123457899999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=331.06 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=201.5
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++.+++..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 3556789999999999999765 78999999986432 35678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++..... +++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..+.......
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 88 SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999976433 899999999999999999999 8999999999999999999999999999998764333333
Q ss_pred ccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+. ..... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~---~------ 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---L------ 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTT---S------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccc---c------
Confidence 3445678999999999987665 7899999999999999999999976543221 111111 11000 0
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011234557889999999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=336.09 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=200.6
Q ss_pred hcccccccCceEEEEEEeC-CC---cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeE-EEEEee
Q 037258 402 FERVLGKGGFGEVYHGSLD-DN---QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNM-GLIYEY 471 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lV~e~ 471 (704)
..+.||+|+||.||+|... ++ ..||+|++.... ..+.+|++++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 3588999999999999643 33 379999986432 2457899999999999999999999876655 999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC--
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES-- 549 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~-- 549 (704)
+.+|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 105 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999997643 34899999999999999999999 8999999999999999999999999999997653221
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.........++..|+|||.+.+..++.++||||||+++|||++|..|+....... .+...+ ..+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~----~~~~--------- 245 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFL----AQGR--------- 245 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHH----HTTC---------
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHh----hcCC---------
Confidence 1122234567889999999999999999999999999999999666654333211 222211 1111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
....+...+..+.+++.+||+.||.+|||++|+++.|++++...
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 01112233457899999999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.47 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=198.6
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.++||+|+||.||+|... +++.||||+++.... .+..|..++..++||||+++++++.+++..++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 34689999999999999776 578999999864321 3678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.. ....
T Consensus 157 ~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~-~~~~ 231 (437)
T 4aw2_A 157 VGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTV 231 (437)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-TSCE
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc-CCCc
Confidence 9999999998643 23899999999999999999999 89999999999999999999999999999976532 2223
Q ss_pred ccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 553 ISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......... ...-+
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~--~~~~p 303 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--RFQFP 303 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHH--HCCCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhhhhccc--cccCC
Confidence 334568999999999997 5678999999999999999999999997543211 1111111100 00001
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSE--RPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 664 (704)
. .....+..+.+|+.+||..+|++ ||+++|+++
T Consensus 304 ~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 304 T----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp S----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1 01123457889999999998888 999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.33 Aligned_cols=245 Identities=21% Similarity=0.286 Sum_probs=190.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHh-hcccceeEEEEEEEe----CCeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMR-VHHRNLTALIGYCIE----GNNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~lV~e~~~~gsL 477 (704)
+.||+|+||.||+|... +++.||||++... ....+|++++.+ .+||||+++++++.. .+..++||||+++|+|
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L 146 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcH
Confidence 68999999999999664 7899999999743 456778888754 589999999999875 5678999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.... ....
T Consensus 147 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~---~~~~ 220 (400)
T 1nxk_A 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSL 220 (400)
T ss_dssp HHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCC---CCcc
Confidence 99998766556999999999999999999999 899999999999999997 78999999999986532 2223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT-HISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .+..+... .....
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~------~~~~~ 290 (400)
T 1nxk_A 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE------FPNPE 290 (400)
T ss_dssp ------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCC------CCTTT
T ss_pred ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCccc------CCCcc
Confidence 4567899999999999999999999999999999999999999765433211 1111 11111111 00011
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12345678999999999999999999999973
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=337.04 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=198.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.+.||+|+||.||+|.. .+|+.||||++... ...+.+|++++++++||||+++++++.+++..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 356688999999999999975 57899999998642 1256789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 471 YMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 471 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|+++|+|.+++... ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999753 2345899999999999999999999 899999999999999999999999999999765322
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... +........
T Consensus 190 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~---- 258 (310)
T 2wqm_A 190 --TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCDYPPL---- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH-HHTTCSCCC----
T ss_pred --CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH-hhcccCCCC----
Confidence 12233456899999999999999999999999999999999999999654321 1122221 222211111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhcccCC
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 680 (704)
.....+..+.+++.+||+.||.+||++.|+++.|+++.+......+.|
T Consensus 259 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~ 306 (310)
T 2wqm_A 259 ----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306 (310)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred ----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence 112334578999999999999999999999999999988766555444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=342.86 Aligned_cols=238 Identities=22% Similarity=0.316 Sum_probs=199.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +|+.||||++.... ....+|+++++.++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 445789999999999999765 78999999986432 2457799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 999999999987543 899999999999999999999 89999999999999999999999999999987532
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+..
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~~~---------- 255 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV---------- 255 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC----------
T ss_pred -CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH-cCCC----------
Confidence 12345789999999999999999999999999999999999999965432 11122222 1211
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122234557899999999999999998 888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=339.77 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=193.4
Q ss_pred HhhhcccccccCceEEEEEEeC----CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC-----
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN----- 463 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 463 (704)
.+.+.+.||+|+||.||+|... .++.||||+++... ..+.+|+.++++++||||+++++++.+.+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3456789999999999999653 34589999986432 24678999999999999999999998754
Q ss_pred eEEEEEeecCCCCHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 464 NMGLIYEYMASGTLDQYLKGK----KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
..++||||+++|+|.+++... ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 359999999999999998532 2345999999999999999999999 999999999999999999999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
|++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .... ...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~ 264 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY----LLH 264 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHT
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH----HHc
Confidence 99987643322233344567889999999999999999999999999999999 888986544322 1111 111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.. ...+...+..+.+++.+||+.||.+||++.|+++.|++++.
T Consensus 265 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11223344578999999999999999999999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=339.42 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=192.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCC----------
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGN---------- 463 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---------- 463 (704)
+.+.+.||+|+||.||+|... +|+.||||+++.. ...+.+|++++++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 456789999999999999775 7999999998632 235678999999999999999999986543
Q ss_pred -----------------------------------------------eEEEEEeecCCCCHHHHhhcccC-CCCCHHHHH
Q 037258 464 -----------------------------------------------NMGLIYEYMASGTLDQYLKGKKE-HMLNWVERL 495 (704)
Q Consensus 464 -----------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~ 495 (704)
..++||||+++|+|.+++..... ....+..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 27999999999999999986542 335677889
Q ss_pred HHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC----------cccccccCCCCccC
Q 037258 496 QIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD----------QISTAVAGTPGYLD 565 (704)
Q Consensus 496 ~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~----------~~~~~~~gt~~y~a 565 (704)
.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999 899999999999999999999999999999876433211 12234579999999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHH
Q 037258 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELA 645 (704)
Q Consensus 566 PE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 645 (704)
||++.+..++.++|||||||++|||++|..|+... .. ........... .........+.+++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~-~~~~~~~~~~~---------~~~~~~~~~~~~li 306 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VR-IITDVRNLKFP---------LLFTQKYPQEHMMV 306 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HH-HHHHHHTTCCC---------HHHHHHCHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HH-HHHHhhccCCC---------cccccCChhHHHHH
Confidence 99999999999999999999999999987764211 11 11111111111 01123445678999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 037258 646 LACASHTSSERPTMTDVLM 664 (704)
Q Consensus 646 ~~cl~~dP~~RPs~~evl~ 664 (704)
.+||+.||.+|||++|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=336.82 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=197.8
Q ss_pred hhhcccccccCceEEEEEEeCC----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEE-eCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCI-EGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|...+ ...||+|.+.... ..+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4557899999999999997542 2368999986432 25678999999999999999999975 456789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 107 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 107 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp ECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred eCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999997643 34899999999999999999999 8999999999999999999999999999998653222
Q ss_pred C--CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 550 S--DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITG-RRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 550 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
. ........+|+.|+|||.+.+..++.++||||||+++|||++| .+||......+ .... ...+..
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~----~~~~~~----- 250 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRR----- 250 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH----HHTTCC-----
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----HhcCCC-----
Confidence 1 1223345677889999999999999999999999999999995 55554433222 1111 111110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+...+..+.+++.+||+.||.+|||++|+++.|++++..
T Consensus 251 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 251 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 011222345789999999999999999999999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=347.29 Aligned_cols=246 Identities=20% Similarity=0.302 Sum_probs=200.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+|++++++++||||+++++++.+.+..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 556789999999999999664 78999999986532 2567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC--CCcEEEEeccCccccccCCCCc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE--KLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~~~~~~~ 552 (704)
|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.+... .
T Consensus 133 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 205 (387)
T 1kob_A 133 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E 205 (387)
T ss_dssp CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC---c
Confidence 99999997643 24899999999999999999999 899999999999999974 468999999999876422 2
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .... .++ .
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~-~~~~--~~~----~ 272 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKR-CDWE--FDE----D 272 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHH-CCCC--CCS----S
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC--CCc----c
Confidence 233457999999999999999999999999999999999999999654321 11111111 1110 111 1
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 122345678999999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=347.56 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=206.1
Q ss_pred HhhhcccccccCceEEEEEEe-----CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEE--eCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCI--EGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|.+ .+++.||||++..... .+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 345678999999999999984 4688999999875433 4678999999999999999999987 4567899
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++++|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999986433 3899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--------cccHHHHHHHHHhc
Q 037258 548 ESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD--------TTHISQWVNSMLAE 618 (704)
Q Consensus 548 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~~~ 618 (704)
.... .......++..|+|||++.+..++.++||||||+++|||++|+.||....... ..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 2221 12234567888999999999999999999999999999999999986433210 00000111111111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
......+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 260 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 260 ---------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ---------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11122234455689999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=341.74 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=198.2
Q ss_pred hhcccccccCceEEEEEEeCC-----CcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLDD-----NQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.+.||+|+||.||+|.... +..||||+++... ..+.+|++++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 346899999999999996542 2469999987532 245789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 127 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 127 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999997643 34899999999999999999999 89999999999999999999999999999987643221
Q ss_pred C-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 551 D-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +... .+..+..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~-~~~~~~~------- 268 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMK-AINDGFR------- 268 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-HHHTTCC-------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHH-HHHCCCc-------
Confidence 1 11223446778999999999999999999999999999999 99999654321 1111 1111110
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
...+...+..+.+++.+||+.||.+||++.|+++.|++++....
T Consensus 269 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11122345678999999999999999999999999999876433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.05 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=199.6
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh---hHHHHHHHHHhhc-----ccceeEEEEEEEeCCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC---FQLLQVKLLMRVH-----HRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lV 468 (704)
..|.+.+.||+|+||.||+|.. .+++.||||+++.... ....|+.+++.++ ||||+++++++...+..++|
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 3455679999999999999976 5789999999875332 4567899999986 99999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC------------------
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE------------------ 530 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------------ 530 (704)
|||+ +++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 899999998776666999999999999999999999 899999999999999975
Q ss_pred -------CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037258 531 -------KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAED 603 (704)
Q Consensus 531 -------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~ 603 (704)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 78899999999986432 223457899999999999999999999999999999999999999764432
Q ss_pred CcccHHHHHHHHHhcC-----------CcccccC-Cc----CCCCCC----------------hhHHHHHHHHHHhccCC
Q 037258 604 DTTHISQWVNSMLAEG-----------DIRNIVD-PS----LQGNFD----------------NNSAWKAVELALACASH 651 (704)
Q Consensus 604 ~~~~~~~~~~~~~~~~-----------~~~~~~d-~~----l~~~~~----------------~~~~~~l~~li~~cl~~ 651 (704)
+. ...+....... .....++ .. ...... ......+.+|+.+||+.
T Consensus 266 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 266 EH---LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp HH---HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred HH---HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 11 11111111000 0000000 00 000000 01125678999999999
Q ss_pred CCCCCCCHHHHHH
Q 037258 652 TSSERPTMTDVLM 664 (704)
Q Consensus 652 dP~~RPs~~evl~ 664 (704)
||++|||++|+++
T Consensus 343 dP~~Rpta~elL~ 355 (360)
T 3llt_A 343 DPTLRPSPAELLK 355 (360)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.90 Aligned_cols=241 Identities=25% Similarity=0.386 Sum_probs=198.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||||+++... .....|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 455789999999999999775 57899999986532 2456788888887 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 102 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~ 174 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 174 (353)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred CCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--C
Confidence 9999999999986543 899999999999999999999 89999999999999999999999999999975321 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~--------- 238 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME-HNV--------- 238 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC---------
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-CCC---------
Confidence 22344567999999999999999999999999999999999999999654321 12222222 111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 239 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122334568899999999999999995 466664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.51 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.+.||+|+||.||+|.. .+|+.||+|+++... ..+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999975 478999999987532 3567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe--CCCCcEEEEeccCccccccCCCCcccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL--NEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++.+... ....
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~~~ 246 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLK 246 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CBCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cccc
Confidence 99987543 23899999999999999999999 8999999999999999 67789999999999876422 2233
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... . . .. ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~-~-~-~~----~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW-D-L-ED----EEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-C-S-CS----GGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC-C-C-Ch----hhhc
Confidence 456999999999999999999999999999999999999999654321 11222222111 0 0 00 0011
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM--ELKEC 669 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 669 (704)
..+..+.+|+.+||+.||.+|||+.|+++ .+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 23457899999999999999999999997 55544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.62 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=192.1
Q ss_pred hhhcccccccCceEEEEEEeC--CC--cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD--DN--QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~ 469 (704)
+.+.+.||+|+||.||+|... ++ ..||||.++... ..+.+|+.++++++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345689999999999999653 22 468999986432 256789999999999999999999764 46789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 171 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999997644 34889999999999999999999 8999999999999999999999999999998653222
Q ss_pred CC--cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 550 SD--QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 550 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.. .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .... +..+..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~~----- 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRR----- 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTCC-----
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCCC-----
Confidence 11 12234567788999999999999999999999999999999 677775544322 1111 111111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+...+..+.+++.+||+.||++||++.|+++.|++++..
T Consensus 315 ----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 011223445789999999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=367.37 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=199.9
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEecccc-----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 405 VLGKGGFGEVYHGSLD---DNQQVAVKMLSSS-----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.||+|+||.||+|.+. ++..||||+++.. ...+.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999653 5668999999753 2367889999999999999999999976 56899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc-ccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ-IST 555 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-~~~ 555 (704)
|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 422 L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999997543 34899999999999999999999 8999999999999999999999999999998764322111 122
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +. ..+..+.. ...+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~---------~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKR---------MECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTCC---------CCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCC---------CCCC
Confidence 3345689999999999999999999999999999998 999997654322 11 12222211 1223
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
...+..+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 3455689999999999999999999999999999876443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=337.94 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=193.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCCe----EE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGNN----MG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~ 466 (704)
.|.+.+.||+|+||.||+|.. .+++.||||+++.... .+.+|++++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 345678999999999999975 5789999999865421 45678889999999999999999876543 49
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++|+|.+++..... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+.
T Consensus 93 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999999986543 899999999999999999999 8999999999999999999999999999998764
Q ss_pred cCCCC-cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 547 IESSD-QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 547 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPS- 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCHH-
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCcc-
Confidence 32221 2233456899999999999999999999999999999999999999654321 112222222111100
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHhhhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL-MELKECLS 671 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~~ 671 (704)
......+..+.+++.+||+.||.+||++.+++ +.+.+...
T Consensus 241 ------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 241 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00112345788999999999999999766655 55555443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.25 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|+.++++++||||+++++++..++..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456789999999999999765 78899999986442 2456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++..... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 116 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~ 189 (309)
T 2h34_A 116 INGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-KL 189 (309)
T ss_dssp CCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc-cc
Confidence 999999999986543 899999999999999999999 899999999999999999999999999999765322 12
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ + .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----~---~ 255 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----P---S 255 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----G---G
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----c---c
Confidence 2233456899999999999999999999999999999999999999653321 111222111100 0 0
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhhh
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-TMTDVLMELKECLSLE 673 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 673 (704)
......+..+.+++.+||+.||++|| +++++++.|++.+...
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11222344788999999999999999 9999999999876643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.82 Aligned_cols=242 Identities=26% Similarity=0.430 Sum_probs=179.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ....+|++++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 44578999999999999976 578999999986432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 93 CHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp CTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 99999999998653 34899999999999999999999 8999999999999999999999999999998653221
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ........
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~-- 229 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY-- 229 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC--
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc--
Confidence 1223456899999999999989999999999999999999999999654432210 00000000
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122334567889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.26 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=202.8
Q ss_pred HHhhhcccccccCceEEEEEEe------CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 3456688999999999999973 357789999986432 25677999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEe
Q 037258 467 LIYEYMASGTLDQYLKGKKE-----HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIAD 538 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~D 538 (704)
+||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999986542 34899999999999999999999 899999999999999984 44699999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ... +.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~---~~~-~~ 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV---LEF-VT 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH---HHH-HH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HH---HHH-Hh
Confidence 999976543333333345567889999999999999999999999999999998 99998654321 11 111 11
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
.+.. ...+...+..+.+++.+||+.||.+||++.|+++.|+.+.....
T Consensus 260 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 260 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 1111 11122344578999999999999999999999999998876443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.27 Aligned_cols=240 Identities=28% Similarity=0.395 Sum_probs=196.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|++++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 445789999999999999654 67899999985432 2457799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.... .
T Consensus 91 ~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~----~ 161 (279)
T 3fdn_A 91 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 161 (279)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC----c
Confidence 999999999976544 899999999999999999999 9999999999999999999999999999886542 2
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... ... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~----------~ 224 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRIS-RVE----------F 224 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HTC----------C
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHH-hCC----------C
Confidence 2234457899999999999999999999999999999999999999654321 1111111 111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.++...+..+.+++.+||+.||.+||++.|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1222334578899999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.82 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=203.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +|+.||||++.... .....|++++++++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 345689999999999999765 79999999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++.......+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--- 339 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--- 339 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC---
Confidence 99999999998766556999999999999999999999 899999999999999999999999999999876322
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ..+.... .
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~-~~i~~~~----------~ 406 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVE-RLVKEVP----------E 406 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHH-HHHHHCC----------C
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHH-HHhhccc----------c
Confidence 2233457999999999999999999999999999999999999999765432211 1111 1111111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+|+.+||+.||.+|| +++|+++
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 12233456889999999999999999 7888875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.97 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=200.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+|+++++.++||||+++++++...+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 456789999999999999765 79999999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..... .
T Consensus 98 ~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~---~ 169 (476)
T 2y94_A 98 VSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---G 169 (476)
T ss_dssp CSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---T
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc---c
Confidence 999999999976543 899999999999999999999 99999999999999999999999999999987532 2
Q ss_pred cccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..... +..+..
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~-i~~~~~--------- 233 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKK-ICDGIF--------- 233 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHH-HHTTCC---------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHH-HhcCCc---------
Confidence 22345679999999999988765 68999999999999999999999654321 11111 111111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+..+.+++.+||+.||.+|||++|+++
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112223457889999999999999999999997
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=338.95 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=203.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcE--EEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQ--VAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... ++.. ||||.++... ..+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 456789999999999999654 5654 4999886422 2567899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEE
Q 037258 471 YMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 536 (704)
|+++|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence 999999999997643 235899999999999999999999 899999999999999999999999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .... .
T Consensus 184 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~-~ 253 (327)
T 1fvr_A 184 ADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE-K 253 (327)
T ss_dssp CCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-H
T ss_pred cccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHH-H
Confidence 99999874321 112233456889999999999899999999999999999998 99999654321 1111 1
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
+..+. ....+...+..+.+++.+||+.||.+|||+.|+++.|++++....
T Consensus 254 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 254 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred hhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 111223345678999999999999999999999999999877543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=336.87 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=193.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+|++++++++||||+++++++.+++..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 445789999999999999765 58999999885432 24567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 85 ~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 157 (311)
T 4agu_A 85 DHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SD 157 (311)
T ss_dssp SEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--cc
Confidence 99999998876543 899999999999999999999 899999999999999999999999999999875322 22
Q ss_pred ccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH-----------hcCC
Q 037258 553 ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML-----------AEGD 620 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------~~~~ 620 (704)
......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+.... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHTCG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhccccccccccccccc
Confidence 2344578999999999976 67899999999999999999999999765432211 1111111 0000
Q ss_pred cc---cccCCcCCCC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IR---NIVDPSLQGN---FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~---~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. ...++..... .....+..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0001000000 00234457889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.06 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=196.4
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.||+|+||.||++... +|+.||||+++... .....|..++..++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34689999999999999774 78999999986432 24578999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++.+... ...
T Consensus 144 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~-~~~ 218 (412)
T 2vd5_A 144 VGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTV 218 (412)
T ss_dssp CSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SCE
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCC-Ccc
Confidence 9999999998643 24899999999999999999999 899999999999999999999999999999876322 222
Q ss_pred ccccccCCCCccCccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 553 ISTAVAGTPGYLDPEYYV-------LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......... ...
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~--~~~ 290 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYGKIVHYKE--HLS 290 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHH--HCC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhccc--CcC
Confidence 233467999999999997 3578999999999999999999999996643211 1111111000 000
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSER---PTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 664 (704)
-+. .....+.++.+++.+||. +|.+| |+++|+++
T Consensus 291 ~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 291 LPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 011 112334578999999999 99998 58999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.44 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=197.8
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 465 (704)
.|.+.+.||+|+||.||+|.. .+++.||||++.... ..+..|++++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 455678999999999999965 578999999986532 1456799999999999999999999999999
Q ss_pred EEEEeecCCC-CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 466 GLIYEYMASG-TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 466 ~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
++||||+.+| +|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999999777 99999986544 899999999999999999999 89999999999999999999999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 180 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------- 236 (335)
T 3dls_A 180 LERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------- 236 (335)
T ss_dssp CCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred CCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence 6422 22334678999999999988776 88999999999999999999999643211
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 -~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1112234578999999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.45 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=200.9
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc----------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS----------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..|.+.+.||+|+||.||+|... +|+.||||++... ...+.+|++++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34667899999999999999765 6899999998543 224678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC----cEEEEeccCc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL----QAKIADFGLS 542 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla 542 (704)
+||||+++++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999997654 3899999999999999999999 89999999999999999888 7999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +...... ....
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~-~~~~- 235 (321)
T 2a2a_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT-SVSY- 235 (321)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-TTCC-
T ss_pred eecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hccc-
Confidence 875422 2233456899999999999999999999999999999999999999654321 1111111 1110
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..++. .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -ccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 01123457889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.74 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=193.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+|+.||||+++... .....|+.+++.++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 45578999999999999965 478999999986432 2446788899999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
+++|+|.+++.... .+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 230 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 230 ANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp CSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 99999999997654 3899999999999999999999 7 8999999999999999999999999999975321 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-~~--------- 366 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-EI--------- 366 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC---------
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhC-CC---------
Confidence 22344578999999999999999999999999999999999999999654321 111111111 11
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+..+.+|+.+||+.||.+|| +++|+++
T Consensus 367 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12223446789999999999999999 9999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.36 Aligned_cols=260 Identities=19% Similarity=0.221 Sum_probs=196.2
Q ss_pred HhhhcccccccCceEEEEEEeC----CCcEEEEEecccchh---------------hHHHHHHHHHhhcccceeEEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCC---------------FQLLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
.+.+.+.||+|+||.||+|... ++..||||++..... ....|+..++.++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 4556789999999999999775 578899999865432 234566677778999999999999
Q ss_pred Ee----CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC--c
Q 037258 460 IE----GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL--Q 533 (704)
Q Consensus 460 ~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~ 533 (704)
.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 88 77899999999 999999998765 4999999999999999999999 89999999999999998877 9
Q ss_pred EEEEeccCccccccCCC-----CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 534 AKIADFGLSRIFSIESS-----DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 534 ~kL~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~ 270 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-AV 270 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-HH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-HH
Confidence 99999999987642211 1122456799999999999999999999999999999999999999965332211 11
Q ss_pred HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 609 SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 609 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.......... +...+..... ....+..+.+++.+||+.||++||+++||++.|++..
T Consensus 271 -~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 -QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111111 1111100000 1123457899999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=327.66 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+|++++++++||||+++++++.+++..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 445789999999999999764 68999999986433 24567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc---EEEEeccCccccccCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ---AKIADFGLSRIFSIES 549 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGla~~~~~~~ 549 (704)
++++|.+.+..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 88 ~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 88 TGGELFEDIVAREF--YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp CSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 99999998876543 899999999999999999999 899999999999999986655 99999999976532
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... ...+... ...
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~-~~~~~~~-~~~--- 228 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQ-IKAGAYD-YPS--- 228 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCCC-CCT---
T ss_pred -CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHH-HHhcccc-CCc---
Confidence 222334678999999999999999999999999999999999999996543211 1111 1111111 000
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 --PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111233457889999999999999999999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.01 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=207.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhhcc-cceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRVHH-RNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ..+..|+++++.++| +++..+..++.+.+..++||||+ ++
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 45678999999999999975 578999999875433 367889999999977 55666667777888999999999 99
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccccCCCC-
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~~~~~~~- 551 (704)
+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 88 sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 88 SLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 9999997543 24999999999999999999999 8999999999999999 58889999999999876433221
Q ss_pred ----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 552 ----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 552 ----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..............+........+..+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~-- 241 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC-- 241 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH--
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh--
Confidence 12235679999999999999999999999999999999999999998765543332222222211111111111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
...+.++.+++..||+.+|++||++.+|++.|++++....
T Consensus 242 -------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 242 -------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp -------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 1223578999999999999999999999999999877554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=369.25 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEe---CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSL---DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|.+ ..++.||||+++... ..+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999954 246789999987532 256789999999999999999999964 568899999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-cc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD-QI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~ 553 (704)
|+|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 3899999999999999999999 899999999999999999999999999999876432221 22
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +...+..+.. ..
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------MG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------CC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------CC
Confidence 233456788999999999999999999999999999998 999996654321 1122222211 11
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+...+.++.+|+.+||+.||++||++++|++.|+++..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 233445689999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.92 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=193.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHH-HHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKL-LMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||||+++.... ....|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456799999999999999765 688999999865432 23444444 466799999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 120 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--~ 192 (373)
T 2r5t_A 120 YINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--H 192 (373)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--C
T ss_pred CCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc--C
Confidence 9999999999986543 889999999999999999999 89999999999999999999999999999986422 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ..
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~--------- 256 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL--------- 256 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS-CC---------
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-cc---------
Confidence 2234456799999999999999999999999999999999999999965432 1122222221 11
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 666 (704)
.++...+..+.+++.+||+.||.+||++.+.++.+
T Consensus 257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11223345788999999999999999986544443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.32 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=200.9
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc----------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS----------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 466 (704)
..+.+.+.||+|+||.||+|... +++.||+|+++.. ...+.+|++++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34667899999999999999775 6899999988543 235678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC----cEEEEeccCc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL----QAKIADFGLS 542 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla 542 (704)
+||||+++++|.+++..... +++..+..++.|++.||+||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999976543 899999999999999999999 89999999999999998877 8999999999
Q ss_pred cccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 543 RIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 543 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
...... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+ .... +......
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~ 229 (283)
T 3bhy_A 160 HKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTN-ISAVNYD 229 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTTCCC
T ss_pred eeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHH-hHhcccC
Confidence 865322 22234568999999999999999999999999999999999999996543211 1111 1111100
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhhh
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKECL 670 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 670 (704)
... ......+..+.+++.+||+.||.+||++.|+++ .++++.
T Consensus 230 --~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 230 --FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 000 001123457889999999999999999999997 455543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.38 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=199.7
Q ss_pred hhhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
+.+.+.||+|+||.||+|.. .+++.||||+++... .....|++++.++ +||||+++++++...+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 55678999999999999976 478999999986432 2456799999999 6999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 136 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999986543 899999999999999999999 8999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~----- 282 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE----- 282 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-----
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-----
Confidence 22 2222334679999999999985 3578999999999999999999999975543322 222222222111
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERP-----TMTDVLME 665 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 665 (704)
..++...+..+.+|+.+||+.||.+|| +++|+++.
T Consensus 283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 112233455788999999999999999 99999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.35 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=193.3
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
.+.+.+.||+|+||.||++.. .+++.||+|++.... ....+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 466789999999999999976 468999999986543 35678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCcccccc
Q 037258 473 ASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 473 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~~~ 547 (704)
++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++..+..
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999986542 345999999999999999999999 8999999999999999 4567899999999986532
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
........|++.|+|||.+. ..++.++||||||+++|||++|+.||......+ ............. .
T Consensus 180 ---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~-~-- 246 (285)
T 3is5_A 180 ---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYA-V-- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC-C--
T ss_pred ---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcccc-c--
Confidence 22234567899999999876 568899999999999999999999996543211 1111111110000 0
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 247 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112457889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.41 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=195.7
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch---------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
..+.+.+.||+|+||.||+|.. .+++.||+|++.... ..+..|++++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3456689999999999999966 478899999985432 256789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccc--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 037258 468 IYEYMASGTLDQYLKGKK--------------------------------------EHMLNWVERLQIAVDSAQGLEYLH 509 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH 509 (704)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999985211 112357778899999999999999
Q ss_pred cCCCCCceecCCCCCCEEeCCCC--cEEEEeccCccccccCCCC--cccccccCCCCccCcccccc--CCCCcchhHHHH
Q 037258 510 YGCKPPIVHRDVKSSNILLNEKL--QAKIADFGLSRIFSIESSD--QISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSF 583 (704)
Q Consensus 510 ~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSl 583 (704)
+.+|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||
T Consensus 186 ---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp ---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred ---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 89999999999999998776 8999999999876432221 12345679999999999975 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 037258 584 GVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663 (704)
Q Consensus 584 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 663 (704)
||++|||++|+.||......+ ........... ... ......+..+.+++.+||+.||.+||++.|++
T Consensus 263 G~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~--~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC--FEN-----PNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--TTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc--cCC-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 999999999999996544221 12222221110 000 01122356789999999999999999999998
Q ss_pred H
Q 037258 664 M 664 (704)
Q Consensus 664 ~ 664 (704)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.85 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=203.9
Q ss_pred cccCHHHHHHHHhhhc-ccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhh-cccceeEEEEE
Q 037258 388 RQFAYSEIQKITNNFE-RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRV-HHRNLTALIGY 458 (704)
Q Consensus 388 ~~~~~~el~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l-~h~nIv~l~~~ 458 (704)
..|...+.....|.+. +.||+|+||.||+|... +++.||||+++... ....+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444455555555554 89999999999999765 68999999986432 2567899999998 56999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEE
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAK 535 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k 535 (704)
+.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999999997765566999999999999999999999 899999999999999998 78999
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
|+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....
T Consensus 175 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNI 245 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHH
Confidence 9999999876322 22334679999999999999999999999999999999999999996543211 11111
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.. ... ..........+..+.+++.+||+.||.+|||++|+++.
T Consensus 246 ~~-~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQ-VNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH-TCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hh-ccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11 110 01111122345678899999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=336.57 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=191.7
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
.+.||+|+||.||+|.. .+++.||||++.... ....+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 46899999999999975 478999999986432 3567899999885 79999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc---EEEEeccCccccccCCC---
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ---AKIADFGLSRIFSIESS--- 550 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGla~~~~~~~~--- 550 (704)
|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++........
T Consensus 98 L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 98 ILSHIHKRRH--FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9999987543 899999999999999999999 899999999999999998776 99999999876532211
Q ss_pred --CcccccccCCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc--------HHHHHHHH
Q 037258 551 --DQISTAVAGTPGYLDPEYYVL-----NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH--------ISQWVNSM 615 (704)
Q Consensus 551 --~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~--------~~~~~~~~ 615 (704)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ........
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 111223568999999999875 568899999999999999999999997654322100 00111111
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..+... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 253 i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 253 IQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 2222110 000000123457899999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.21 Aligned_cols=240 Identities=27% Similarity=0.403 Sum_probs=195.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+...+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++||||+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 45578899999999999975 578999999985321 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+. |+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 136 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp CS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 97 68888886443 34899999999999999999999 89999999999999999999999999999976532
Q ss_pred cccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .......... .. .
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~~-----~ 272 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SP-----A 272 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CC-----C
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CC-----C
Confidence 22457899999999985 567899999999999999999999999654321 1112222211 11 1
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. .....+..+.+++.+||+.||++|||++|+++.
T Consensus 273 ~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 112234578899999999999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.84 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=200.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccc----hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS----CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.+.||+|+||.||+|... ++..||+|++... ...+.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 4566889999999999999765 5779999998643 2366789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccccCCC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~~~~~~ 550 (704)
+++|.+++..... +++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++..+..
T Consensus 90 ~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~--- 161 (277)
T 3f3z_A 90 GGELFERVVHKRV--FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--- 161 (277)
T ss_dssp SCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT---
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC---
Confidence 9999999876544 899999999999999999999 8999999999999999 7888999999999986542
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ .... +..+.... .
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~------~ 227 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLK-IREGTFTF------P 227 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCCCC------C
T ss_pred ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHhCCCCC------C
Confidence 2233455799999999988765 8999999999999999999999996543211 1111 11111100 0
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKEC 669 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 669 (704)
.......+..+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 0000123457899999999999999999999986 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=334.48 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=199.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||++.. .+++.||||++.... ..+.+|++++++++||||+++++++.. ....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 355678999999999999976 578999999885332 256789999999999999999999873 35789999
Q ss_pred eecCCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 470 EYMASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 470 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||+++|+|.+++... ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 999999999999763 2345899999999999999999999 88999999999999999999999999999876421
Q ss_pred CCCCc-------ccccccCCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 548 ESSDQ-------ISTAVAGTPGYLDPEYYVLNW---LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 548 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ..... ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----~~ 261 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA----VQ 261 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----HH
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----hh
Confidence 11110 112345799999999987553 68999999999999999999999954221111 11111 11
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.. .........+..+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 262 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 262 NQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 10 00011123345789999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.47 Aligned_cols=241 Identities=28% Similarity=0.422 Sum_probs=193.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV 468 (704)
+.+.+.||+|+||.||+|.. .++..||+|++.... ..+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 34567899999999999965 468899999986432 245789999999999999999999875 3568999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeC-CCCcEEEEeccCcccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLN-EKLQAKIADFGLSRIF 545 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~ 545 (704)
|||+++|+|.+++..... +++..++.++.|++.||+||| +.+ |+||||||+||+++ +++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999986543 899999999999999999999 777 99999999999998 7889999999999754
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
. ........|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ...... ...+....
T Consensus 183 ~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~~~-- 249 (290)
T 1t4h_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR-VTSGVKPA-- 249 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH-HTTTCCCG--
T ss_pred c----ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHH-HhccCCcc--
Confidence 2 222334578999999998764 5899999999999999999999999654321 111111 11111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+|||++|+++
T Consensus 250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111222357899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.07 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=183.6
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhc-ccceeEEEEEEE--------eCCe
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVH-HRNLTALIGYCI--------EGNN 464 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~~~ 464 (704)
.+.+.+.||+|+||.||+|.. .+++.||||++..... .+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 456689999999999999975 4789999998854332 5578899999996 999999999994 3345
Q ss_pred EEEEEeecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 465 MGLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
.++||||+. |+|.+++.... ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 899999996 69999887532 335999999999999999999999 888 99999999999999999999999999
Q ss_pred ccccccCCCCc----------ccccccCCCCccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 542 SRIFSIESSDQ----------ISTAVAGTPGYLDPEYY---VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 542 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 98764322111 11244689999999998 566789999999999999999999999964332110
Q ss_pred HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 609 SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 609 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
. ...............+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus 262 ---~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 262 ---V-------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---h-------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 0000001111222357899999999999999999999999998876433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.03 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=203.8
Q ss_pred hhhcccccccCceEEEEEEe-----CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCC--eEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-----DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGN--NMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV 468 (704)
+.+.+.||+|+||.||+|.+ .+++.||||++..... .+.+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45678999999999999974 3688999999865432 5678999999999999999999987654 78999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 123 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp ECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999998654 24899999999999999999999 899999999999999999999999999999876433
Q ss_pred CCCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---------CCcccHHHHHHHHHhc
Q 037258 549 SSDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAE---------DDTTHISQWVNSMLAE 618 (704)
Q Consensus 549 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~---------~~~~~~~~~~~~~~~~ 618 (704)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..||..... .........+...+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2211 12234567789999999998899999999999999999999999854310 0000111111111111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+. ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 279 ~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 279 NG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111223345689999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.08 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=190.3
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.|.+.+.||+|+||.||+|.. .+++.||||+++.... .+.+|++++++++||||+++++++.+++..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 355678999999999999965 4789999999864332 456899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe-----CCCCcEEEEeccCccccc
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL-----NEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kL~DfGla~~~~ 546 (704)
+++ +|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||++..+.
T Consensus 115 ~~~-~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 115 AEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp CSE-EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CCC-CHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 985 99999987654 899999999999999999999 8999999999999999 455569999999998753
Q ss_pred cCCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---cc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IR 622 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~ 622 (704)
.. ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..... ...... ..
T Consensus 189 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~~ 263 (329)
T 3gbz_A 189 IP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFE-VLGLPDDTTWP 263 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTTTST
T ss_pred Cc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHH-HhCCCchhhhh
Confidence 22 2223445689999999999874 58999999999999999999999996543221 1111111 111000 00
Q ss_pred ccc-CCcCCCCC------------ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIV-DPSLQGNF------------DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~-d~~l~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .+.....+ ....+..+.+|+.+||+.||.+|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00000000 1113467889999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=325.60 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=199.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|++++++++||||+++++++.+++..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 456789999999999999765 67899999985432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---- 166 (284)
T 2vgo_A 96 APRGELYKELQKHGR--FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---- 166 (284)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS----
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc----
Confidence 999999999986543 899999999999999999999 99999999999999999999999999999875432
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ... .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~------~---- 229 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIV-NVD------L---- 229 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-TTC------C----
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHh-ccc------c----
Confidence 1223457899999999999999999999999999999999999999654321 1111111 111 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||++.|+++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122334457889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=339.96 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=192.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||.||+|... +++.||||++..... ...+|++++++++||||+++++++.+++..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 445789999999999999765 789999999864432 33468999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... ...
T Consensus 84 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~ 156 (324)
T 3mtl_A 84 -KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKT 156 (324)
T ss_dssp -EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred -cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccc
Confidence 59999987654 34899999999999999999999 899999999999999999999999999999764321 222
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---cccccC---
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRNIVD--- 626 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 626 (704)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........ ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchh
Confidence 334578999999999876 568999999999999999999999997654322 1222222221110 110000
Q ss_pred ------CcCCCC----CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 ------PSLQGN----FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ------~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..... .....+..+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 01123457889999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.64 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=186.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccc------hhhHHHHHHHHHhhc-ccceeEEEEEEEeCC--eEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS------CCFQLLQVKLLMRVH-HRNLTALIGYCIEGN--NMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lV 468 (704)
.|.+.+.||+|+||.||+|.. .+|+.||||++... .....+|+.++.++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 345678999999999999965 47899999988532 124568999999997 999999999998544 78999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99998 5999999764 3899999999999999999999 899999999999999999999999999999865321
Q ss_pred C-------------------CCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 549 S-------------------SDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 549 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~ 240 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN--QL 240 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence 1 1122344679999999999986 678999999999999999999999997654221 11
Q ss_pred HHHHHHHHhcCCcccc---------------------cCCcCCCCC------------ChhHHHHHHHHHHhccCCCCCC
Q 037258 609 SQWVNSMLAEGDIRNI---------------------VDPSLQGNF------------DNNSAWKAVELALACASHTSSE 655 (704)
Q Consensus 609 ~~~~~~~~~~~~~~~~---------------------~d~~l~~~~------------~~~~~~~l~~li~~cl~~dP~~ 655 (704)
.. +...+.......+ ........+ ....+..+.+|+.+||+.||++
T Consensus 241 ~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 11 1111110000000 000000000 0123457899999999999999
Q ss_pred CCCHHHHHHH
Q 037258 656 RPTMTDVLME 665 (704)
Q Consensus 656 RPs~~evl~~ 665 (704)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.22 Aligned_cols=256 Identities=19% Similarity=0.286 Sum_probs=196.7
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeC---------------
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEG--------------- 462 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------------- 462 (704)
.|.+.+.||+|+||.||+|.. .+|+.||||++........+|+++++.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 355678999999999999965 5799999999987766677899999999999999999998543
Q ss_pred -----------------------CeEEEEEeecCCCCHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 037258 463 -----------------------NNMGLIYEYMASGTLDQYLKG--KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517 (704)
Q Consensus 463 -----------------------~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 517 (704)
...++||||++ |+|.+.+.. .....+++..+..++.|+++||+||| +.+|+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~ 163 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGIC 163 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCc
Confidence 34889999998 488887764 22345999999999999999999999 99999
Q ss_pred ecCCCCCCEEeC-CCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCC
Q 037258 518 HRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRR 595 (704)
Q Consensus 518 H~Dlkp~NIll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~ 595 (704)
||||||+|||++ .++.+||+|||+++.+... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999997 6889999999999865322 223445789999999998865 58999999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHHHHhcC----------CcccccCCc-----CCCCCChhHHHHHHHHHHhccCCCCCCCCCHH
Q 037258 596 PVISRAEDDTTHISQWVNSMLAEG----------DIRNIVDPS-----LQGNFDNNSAWKAVELALACASHTSSERPTMT 660 (704)
Q Consensus 596 Pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~-----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 660 (704)
||......+ .+...+. ..... ......-+. +...++...+..+.+|+.+||+.||.+|||+.
T Consensus 241 pf~~~~~~~--~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 241 LFSGETSID--QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCChHH--HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 997644221 1111111 11000 000000011 11112333456789999999999999999999
Q ss_pred HHHH
Q 037258 661 DVLM 664 (704)
Q Consensus 661 evl~ 664 (704)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=327.16 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=200.9
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
..+.+.+.||+|+||.||++... +|+.||+|+++... ....+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 35567899999999999999765 78999999986542 24678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccccCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~~~~~ 549 (704)
++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++ ++++.+||+|||++.....
T Consensus 89 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 89 SGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred CCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999999976543 899999999999999999999 8999999999999999 7888999999999875421
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .+..+... .
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~-~i~~~~~~------~ 226 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFE-KIKEGYYE------F 226 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHCCCC------C
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHcCCCC------C
Confidence 2233456899999999999999999999999999999999999999654321 1111 12222111 1
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
........+..+.+++.+||+.||.+||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122334567899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=336.27 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=196.1
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe--------CC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE--------GN 463 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~ 463 (704)
.|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 355678999999999999976 578999999885432 245789999999999999999999987 45
Q ss_pred eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..++||||+++ +|.+.+..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 68999999985 88877765433 3899999999999999999999 8999999999999999999999999999998
Q ss_pred ccccCCC--CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-
Q 037258 544 IFSIESS--DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG- 619 (704)
Q Consensus 544 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 619 (704)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 7642221 222345678999999999876 458999999999999999999999997654322 111111111110
Q ss_pred --CcccccCCc----C---CC-CCC-hh------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 620 --DIRNIVDPS----L---QG-NFD-NN------SAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 620 --~~~~~~d~~----l---~~-~~~-~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.....-... + .. ... .. ....+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 0 00 000 00 13458899999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.06 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=195.1
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeCCe------EEEEEeec
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEGNN------MGLIYEYM 472 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lV~e~~ 472 (704)
.|.+.+.||+|+||.||+|....+..||+|++........+|+++++.++||||+++++++...+. .++||||+
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 356678999999999999998777779999887666666789999999999999999999965433 78999999
Q ss_pred CCCCHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccccCCC
Q 037258 473 ASGTLDQYLKG-KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 473 ~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~~~~~~ 550 (704)
+++.+...... .....+++..+..++.|+++||+||| +.+|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 121 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~-- 195 (394)
T 4e7w_A 121 PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-- 195 (394)
T ss_dssp SEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--
T ss_pred CccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC--
Confidence 87544333321 12345999999999999999999999 89999999999999998 7899999999999875322
Q ss_pred CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc-----------
Q 037258 551 DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE----------- 618 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------- 618 (704)
.......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+. .+..
T Consensus 196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 196 -EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPSREQIKTMNP 271 (394)
T ss_dssp -CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCG
T ss_pred -CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHHHhhCh
Confidence 223346789999999998765 58999999999999999999999997654221 1111111 1000
Q ss_pred ----CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 ----GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 ----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+.......+...+....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000000112234568999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.82 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=202.2
Q ss_pred HHHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh---hHHHHHHHHHhhc--------ccceeEEEEEEE-
Q 037258 394 EIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC---FQLLQVKLLMRVH--------HRNLTALIGYCI- 460 (704)
Q Consensus 394 el~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~E~~~l~~l~--------h~nIv~l~~~~~- 460 (704)
++....|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+|++++++++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 33344566789999999999999965 5788999999976432 5678999999986 888999999988
Q ss_pred ---eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCC----
Q 037258 461 ---EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKL---- 532 (704)
Q Consensus 461 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~---- 532 (704)
.+...++||||+ +++|.+.+.......+++..++.++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 456899999999 667777776655456999999999999999999999 77 999999999999999775
Q ss_pred ---------------------------------------------cEEEEeccCccccccCCCCcccccccCCCCccCcc
Q 037258 533 ---------------------------------------------QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567 (704)
Q Consensus 533 ---------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 567 (704)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999865321 23457899999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH---HHHHHhc--------CCc-ccccCCc-----C-
Q 037258 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW---VNSMLAE--------GDI-RNIVDPS-----L- 629 (704)
Q Consensus 568 ~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~---~~~~~~~--------~~~-~~~~d~~-----l- 629 (704)
++.+..++.++|||||||++|||++|+.||.............. +...... +.. ...+... +
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999976554332211111 1111100 000 0000000 0
Q ss_pred -------------CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 -------------QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234567788999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=326.24 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=193.3
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
..+.+.+.||+|+||.||+|... +++.||||++... .....+|+..+.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 34556789999999999999765 7999999998643 22557788888888 9999999999999999999999
Q ss_pred eecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC----------------
Q 037258 470 EYMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---------------- 531 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---------------- 531 (704)
||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999998653 245899999999999999999999 8999999999999999844
Q ss_pred ---CcEEEEeccCccccccCCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 037258 532 ---LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH 607 (704)
Q Consensus 532 ---~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~ 607 (704)
..+||+|||.+...... ....||+.|+|||.+.+. .++.++|||||||++|||++|..|+.... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----Q 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----H
T ss_pred CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----H
Confidence 47999999999875322 223589999999999866 66789999999999999999998763321 1
Q ss_pred HHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. ..+..+... ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~-----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 W-----HEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-----HHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----HHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 111122111 112233457899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.61 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=200.8
Q ss_pred hcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 402 FERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.||+|+||.||+|... +|+.||+|++.... .....|++++++++||||+++++++.+.+..++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 4578999999999999775 69999999986432 245779999999999999999999999999999999999
Q ss_pred CCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~--~ 343 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--Q 343 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC--C
Confidence 999999997654 345999999999999999999999 899999999999999999999999999999875322 1
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ ..
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~-~~---------- 410 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQ-AV---------- 410 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHC-CC----------
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhc-cc----------
Confidence 22334589999999999999999999999999999999999999997654322 112222222211 11
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTM-----TDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 664 (704)
.++...+..+.+++.+||+.||.+||++ +|+++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1223345678999999999999999975 66653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.96 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=194.5
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||+|... +++.||||++..... ...+|++++++++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 445789999999999999765 589999998754322 3467999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+... ..
T Consensus 107 ~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 179 (331)
T 4aaa_A 107 DHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GE 179 (331)
T ss_dssp SEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--cc
Confidence 99999988765443 899999999999999999999 899999999999999999999999999999765322 22
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH----------HHHhcC-C
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN----------SMLAEG-D 620 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~----------~~~~~~-~ 620 (704)
......|+..|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..... ...... .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhccc
Confidence 23445789999999999875 78999999999999999999999996654321 1111110 000000 0
Q ss_pred cccccCCcCCCCC-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRNIVDPSLQGNF-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+...... ....+..+.+|+.+||+.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111 1133567999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.16 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=197.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 445789999999999999765 78999999986432 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+|+|.+++..... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 115 ~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 115 GGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp TCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 9999999987544 899999999999999999999 64 8999999999999999999999999999765321
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH---------HHHh------
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN---------SMLA------ 617 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~~------ 617 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......... ....
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 2234578999999999999999999999999999999999999997543221100000000 0000
Q ss_pred --------cCCccc----ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 --------EGDIRN----IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 --------~~~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+ +.............+..+.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 00000000111223557899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.34 Aligned_cols=253 Identities=18% Similarity=0.288 Sum_probs=197.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-hhHHHHHHHHHhhc-ccceeEEEEEEEe--CCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-CFQLLQVKLLMRVH-HRNLTALIGYCIE--GNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|.. .+++.||||+++... ....+|++++++++ ||||+++++++.+ ....++||||+++
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 45678999999999999965 578999999997543 36788999999997 9999999999987 6678999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCcc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~~ 553 (704)
++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 118 ~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~ 186 (330)
T 3nsz_A 118 TDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QE 186 (330)
T ss_dssp CCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT---CC
T ss_pred hhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC---Cc
Confidence 999999854 889999999999999999999 89999999999999999776 8999999999865322 22
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHHhcCC----
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN--------SMLAEGD---- 620 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~---- 620 (704)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+..... ..+....
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHhccccc
Confidence 344578999999999987 6789999999999999999999999965433211 1111110 0000000
Q ss_pred ----------cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 ----------IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.................+..+.+|+.+||+.||.+|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000111111122234678999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.55 Aligned_cols=242 Identities=23% Similarity=0.371 Sum_probs=199.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||+|... +++.||+|++.... ..+..|+.+++.++||||+++++++.+++..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 445789999999999999765 68899999985432 2456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++..... +++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 97 CRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp CTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 999999999876543 899999999999999999999 899999999999999999999999999999875322 2
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +...... ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~---------- 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIK-KNEY---------- 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-TTCC----------
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-hccC----------
Confidence 2234467899999999999989999999999999999999999999654321 1111111 1110
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122334578899999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.48 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=193.6
Q ss_pred HhhhcccccccCceEEEEEEeC--CCc--EEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD--DNQ--QVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.+.+.+.||+|+||.||+|.+. +++ .||||+++... ..+.+|++++++++||||+++++++.++. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3456789999999999999753 333 68999986431 25578999999999999999999998765 889
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|+||+++|+|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999998653 23899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 548 ESSDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 548 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER---- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC----
Confidence 22211 2234567788999999999889999999999999999999 99999654321 122222221111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
...+...+..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111233456799999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.82 Aligned_cols=242 Identities=25% Similarity=0.413 Sum_probs=199.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+...+.||+|+||.||+|.. .+++.||||++.... ..+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 44578999999999999965 478999999985432 356789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+... ...
T Consensus 104 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 175 (303)
T 3a7i_A 104 GGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIK 175 (303)
T ss_dssp TEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCC
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccc
Confidence 99999999753 3899999999999999999999 899999999999999999999999999999775322 122
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ....+.. +. .
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~-----~~----~ 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLF-LIPKNNP-----PT----L 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCC-----CC----C
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHH-HhhcCCC-----CC----C
Confidence 34457899999999999999999999999999999999999999654321 1111 1111111 11 1
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22334578899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.76 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=195.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeC------CeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~e~~ 472 (704)
|.+.+.||+|+||.||+|... +|+.||||++........+|++++++++||||+++++++... ...++||||+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 455789999999999999775 689999999977666667899999999999999999998642 2367999999
Q ss_pred CCCCHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccccCC
Q 037258 473 ASGTLDQYLKG--KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIES 549 (704)
Q Consensus 473 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~~~ 549 (704)
++ +|.+.+.. .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 136 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~- 210 (420)
T 1j1b_A 136 PE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG- 210 (420)
T ss_dssp CE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred cc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC-
Confidence 86 67666653 22345999999999999999999999 9999999999999999965 57899999999875322
Q ss_pred CCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-------Hh--cC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM-------LA--EG 619 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~--~~ 619 (704)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+...+... +. ..
T Consensus 211 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 211 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp --CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCS
T ss_pred --CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhCh
Confidence 223346789999999999765 78999999999999999999999997644211 222222110 00 00
Q ss_pred CcccccCCcCCC-----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIRNIVDPSLQG-----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+...+.+.. .+....+.++.+|+.+||+.||.+||++.|+++
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111111111110 012234568999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=342.52 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=189.1
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCe
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNN 464 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 464 (704)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 3456689999999999999965 468999999986432 13578999999999999999999975 456
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEEeccC
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIADFGL 541 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGl 541 (704)
.++||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred eEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 8999999999999999876543 899999999999999999999 89999999999999997544 599999999
Q ss_pred ccccccCCCCcccccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.. .+..
T Consensus 289 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~----~i~~ 359 (419)
T 3i6u_A 289 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD----QITS 359 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----HHHT
T ss_pred ceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----HHhc
Confidence 987532 223345679999999999863 577889999999999999999999997644322 1111 1111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+..... + ......+..+.+++.+||+.||.+||+++|+++
T Consensus 360 ~~~~~~--~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNFI--P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCCC--H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCC--c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111100 0 001123457899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.40 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=199.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||++... +++.||+|++.... ..+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 445789999999999999765 67899999986432 2557799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++..... +++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 123 ~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 123 CRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp CTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred CCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 999999999876543 899999999999999999999 899999999999999999999999999999875322 2
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||...... +...... ....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~~---------- 258 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIK-KNEY---------- 258 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HTCC----------
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHh-cCCC----------
Confidence 2234567899999999999999999999999999999999999999654321 1111111 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+......+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223457889999999999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.15 Aligned_cols=247 Identities=29% Similarity=0.372 Sum_probs=199.4
Q ss_pred HHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
...|.+.+.||+|+||.||+|... +++.||||++... .....+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 345777899999999999999765 7899999998532 235678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccc
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFS 546 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~~~ 546 (704)
||+++|+|.+.+..... +++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 101 e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999876543 899999999999999999999 89999999999999995 45679999999998653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
. ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... +.... +..+....
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~~--- 241 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKR-VETGKYAF--- 241 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTCCCS---
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCCC---
Confidence 2 222345679999999999876 5899999999999999999999999654321 11111 11221110
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000112345678999999999999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.18 Aligned_cols=247 Identities=10% Similarity=-0.032 Sum_probs=177.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHHHHHHHHhh--cccceeEEE-------EEEEeC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLLQVKLLMRV--HHRNLTALI-------GYCIEG 462 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~E~~~l~~l--~h~nIv~l~-------~~~~~~ 462 (704)
+.+.+.||+|+||.||+|... +++.||||++..... ....|++++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 445789999999999999764 789999999876331 335565444444 699988865 444433
Q ss_pred -----------------CeEEEEEeecCCCCHHHHhhcccCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCceec
Q 037258 463 -----------------NNMGLIYEYMASGTLDQYLKGKKEHMLNWVER------LQIAVDSAQGLEYLHYGCKPPIVHR 519 (704)
Q Consensus 463 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ivH~ 519 (704)
...++||||++ |+|.+++...... +.+..+ ..++.|++.||+||| +++|+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHr 218 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccC
Confidence 34899999999 8999999865322 455556 788899999999999 8999999
Q ss_pred CCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 037258 520 DVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPV 597 (704)
Q Consensus 520 Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf 597 (704)
||||+|||++.++.+||+|||+++... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998653 11224556799999999987 68999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 598 ISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.......... ......................+..+.+|+.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7664322110 0000000011111111112244668999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.64 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCHH
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLD 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 478 (704)
..||+|+||.||+|.. .+++.||||++.... ..+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4899999999999975 578899999986432 25678999999999999999999999999999999999999999
Q ss_pred HHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccccCCCCccccc
Q 037258 479 QYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 479 ~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++...... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCcccc
Confidence 9998653 334678999999999999999999 899999999999999987 889999999999865321 122334
Q ss_pred ccCCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 557 VAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
..|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ ........ . ..+ ..+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~-~-----~~~----~~~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMF-K-----VHP----EIP 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHHH-C-----CCC----CCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhccc-c-----ccc----ccc
Confidence 57899999999997653 78999999999999999999999965432111 11111010 0 011 122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 334567889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.57 Aligned_cols=241 Identities=24% Similarity=0.372 Sum_probs=190.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|+++++.++||||+++++++.+++..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 456789999999999999775 78999999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++++|.+++..... +++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--- 164 (276)
T 2h6d_A 93 VSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--- 164 (276)
T ss_dssp CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC---
Confidence 999999999976543 899999999999999999999 899999999999999999999999999999765321
Q ss_pred cccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..... .+..+..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~--------- 228 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFK-KIRGGVF--------- 228 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCCC---------
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHH-HhhcCcc---------
Confidence 22334568999999999987765 6899999999999999999999965322 11111 1111111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 229 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122234578899999999999999999999973
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.59 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=191.0
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhc--ccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVH--HRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||.||++...+++.||||++.... ..+.+|++++.+++ |+||+++++++.+++..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 45678999999999999988889999999985322 25578999999997 4999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+++|.+++.... .+++..++.++.|+++||+||| +.+|+||||||+||++++ +.+||+|||++..+......
T Consensus 109 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 56889999998654 3899999999999999999999 899999999999999965 79999999999876433333
Q ss_pred cccccccCCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 552 QISTAVAGTPGYLDPEYYVL-----------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~---- 253 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII---- 253 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH----
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHH----
Confidence 33345678999999999875 46888999999999999999999999654321 11111111
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
++.....++...+..+.+++.+||+.||.+||++.|+++.
T Consensus 254 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111112222334578899999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.81 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=198.2
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+..|++++++++||||+++++++.+ +...++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 445789999999999999765 78999999986432 246789999999999999999998864 568999999
Q ss_pred ecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 471 YMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGCKPP-----IVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
|+++|+|.+++.... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999997643 344899999999999999999999 667 9999999999999999999999999997
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .+ ...+..+...
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~- 234 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFR- 234 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCC-
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH----HHHHhhcccc-
Confidence 65321 22233457899999999999989999999999999999999999999654321 11 1122222221
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELK 667 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 667 (704)
..+...+..+.+++.+||+.||.+||++.|+++.+.
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 112234557899999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.41 Aligned_cols=251 Identities=24% Similarity=0.268 Sum_probs=188.6
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+++++.++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 45578999999999999965 478999999986432 2557899999999999999999999654 4679
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 144 lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 99999976 57666643 2889999999999999999999 8999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc--------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE-------- 618 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 618 (704)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+...+ ..+..
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~-~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVI-EQLGTPCPEFMKK 289 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCSCCHHHHTT
T ss_pred C---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HhcCCCCHHHHHH
Confidence 2 223445689999999999999999999999999999999999999997644211 111111 11000
Q ss_pred -----------CC------cccccCCcCCCC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 -----------GD------IRNIVDPSLQGN---FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 -----------~~------~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. +...+...+... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000000000 01122567899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=333.69 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=196.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch---------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+|++++++++||||+++++++.+.+..++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4556789999999999999765 68999999986422 2456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++ +|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 91 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999986 8998887654 34888999999999999999999 899999999999999999999999999999875322
Q ss_pred CCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---Ccccc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DIRNI 624 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 624 (704)
........+|+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+..... ..... .....
T Consensus 166 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~-~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 166 --NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE-TLGTPTEEQWPDM 240 (346)
T ss_dssp --CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTTTSSST
T ss_pred --cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HcCCCChhhhhhh
Confidence 2233456789999999999754 58899999999999999999999986543211 1111111 11110 00000
Q ss_pred ---cCCcCCC---CCC-----hhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 625 ---VDPSLQG---NFD-----NNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 625 ---~d~~l~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.+..... ..+ ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 001 2334679999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.37 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=183.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 45678999999999999965 478999999986432 245678899999999999999999999999999999999
Q ss_pred CCCHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 474 SGTLDQYLKGK------KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 474 ~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
+++|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 99999998742 2334899999999999999999999 89999999999999999999999999999876532
Q ss_pred CCC---CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 548 ESS---DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 548 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ . ...... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~-~~~~ 246 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQN-DPPS 246 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHTS-SCCC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhcc-CCCc
Confidence 211 112234578999999999875 5689999999999999999999999976543221 1 111111 1111
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..............+..+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 10000001112233457889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.16 Aligned_cols=254 Identities=17% Similarity=0.253 Sum_probs=200.8
Q ss_pred HhhhcccccccCceEEEEEEe--CCCcEEEEEecccchh---hHHHHHHHHHhhcccc------eeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRN------LTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l 467 (704)
.|.+.+.||+|+||.||+|.. .+++.||||+++.... ....|+++++.++|++ ++++++++...+..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 456688999999999999975 3688999999975432 5678899999998775 9999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-----------------
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE----------------- 530 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------------- 530 (704)
||||+ +++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 889999998776556899999999999999999999 899999999999999987
Q ss_pred --CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 531 --KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 531 --~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--- 242 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH--- 242 (339)
T ss_dssp ESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH---
T ss_pred ccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---
Confidence 66899999999976432 12345789999999999999999999999999999999999999976443221
Q ss_pred HHHHHHHHhc--------CCccccc---------------------CCc-CCCCCChhHHHHHHHHHHhccCCCCCCCCC
Q 037258 609 SQWVNSMLAE--------GDIRNIV---------------------DPS-LQGNFDNNSAWKAVELALACASHTSSERPT 658 (704)
Q Consensus 609 ~~~~~~~~~~--------~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 658 (704)
...+...... ....... .+. .........+..+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1111111100 0000000 000 000123456778999999999999999999
Q ss_pred HHHHHH
Q 037258 659 MTDVLM 664 (704)
Q Consensus 659 ~~evl~ 664 (704)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.14 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=197.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|... +|+.||||++.... ..+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 4556789999999999999765 68999999986543 36788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...... .....
T Consensus 110 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~ 183 (314)
T 3com_A 110 SVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRN 183 (314)
T ss_dssp EHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCBC
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--ccccC
Confidence 9999997432 34899999999999999999999 899999999999999999999999999999765322 12233
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .... ......... ..+.
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~-------~~~~ 249 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFM-IPTNPPPTF-------RKPE 249 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSCCCCC-------SSGG
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHH-HhcCCCccc-------CCcc
Confidence 4578999999999999999999999999999999999999996543211 1111 111111000 1122
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+..+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 33567899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.16 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=191.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccc---hhhHHHHHHHHHhh-cccceeEEEEEEEe------CCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS---CCFQLLQVKLLMRV-HHRNLTALIGYCIE------GNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~lV 468 (704)
+.+.+.||+|+||.||+|.. .+++.||||++... .....+|+.+++++ +||||+++++++.. .+..++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 34578999999999999976 47899999998543 23667899999999 89999999999987 4678999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999999998765556999999999999999999999 899999999999999999999999999999765321
Q ss_pred CCCcccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 549 SSDQISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
........|++.|+|||++. +..++.++|||||||++|||++|+.||....... ...... ......
T Consensus 183 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~ 253 (326)
T 2x7f_A 183 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP-RNPAPR 253 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCC
T ss_pred --ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhh-cCcccc
Confidence 11233457899999999987 5678899999999999999999999996543211 111111 111111
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. ....+..+.+++.+||..||.+||++.|+++
T Consensus 254 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 254 LK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1223457889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.61 Aligned_cols=244 Identities=26% Similarity=0.389 Sum_probs=196.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNM 465 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 465 (704)
+.+.+.||+|+||.||+|... +|+.||||++.... ..+..|+.+++++ +||||+++++++...+..
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 445689999999999999875 79999999985432 2456789999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 037258 466 GLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~ 545 (704)
++||||+++++|.+++..... +++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++..+
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999986543 899999999999999999999 899999999999999999999999999999876
Q ss_pred ccCCCCcccccccCCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVL------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .... .+..+
T Consensus 251 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~-~i~~~ 320 (365)
T 2y7j_A 251 EPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLR-MIMEG 320 (365)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHT
T ss_pred CCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHhC
Confidence 422 22345679999999999864 35889999999999999999999999653321 1111 11111
Q ss_pred CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... ..+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 321 ~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 0000 0122356889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.45 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=175.3
Q ss_pred cccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEEEeecCCCCH
Q 037258 403 ERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLIYEYMASGTL 477 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~e~~~~gsL 477 (704)
.+.||+|+||.||+|... +++.||||++.............++.++||||+++++++.. +...++||||+++|+|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L 113 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEH
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCH
Confidence 457999999999999765 78999999997655444444455677899999999999976 4558999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++..... ...
T Consensus 114 ~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~----~~~ 186 (336)
T 3fhr_A 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NAL 186 (336)
T ss_dssp HHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc----ccc
Confidence 99998776666999999999999999999999 899999999999999976 45599999999976532 223
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ........+. ........
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~ 257 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ------YGFPNPEW 257 (336)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCTTTS
T ss_pred ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc------cccCchhh
Confidence 34568999999999998899999999999999999999999996654322100 0000000000 00111111
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM--ELKE 668 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 668 (704)
...+..+.+++.+||+.||.+|||++|+++ .+++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 234567899999999999999999999997 4444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.14 Aligned_cols=194 Identities=25% Similarity=0.308 Sum_probs=169.9
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhh------cccceeEEEEEEEeCCeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRV------HHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~lV 468 (704)
.|.+.+.||+|+||.||+|... +++.||||++..... ....|+++++.+ +|+||+++++++...+..++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 3566799999999999999654 689999999976543 456788888887 467999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc--EEEEeccCccccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ--AKIADFGLSRIFS 546 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~~~ 546 (704)
|||+. ++|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++....
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 69999998876666999999999999999999999 889999999999999999887 9999999997542
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 254 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 254 Q-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp C-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 2234578999999999999999999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.03 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=196.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch--------hhHHHHHHHHHhhcccceeEEEEEEE--eCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNLTALIGYCI--EGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lV 468 (704)
|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++. +.+..++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 456789999999999999764 78899999986432 25678999999999999999999984 45678999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||++++ |.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999876 888887665566999999999999999999999 899999999999999999999999999999876433
Q ss_pred CCCcccccccCCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
..........|+..|+|||++.+.. ++.++||||||+++|||++|+.||..... ...... +..+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-i~~~~~----- 230 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFEN-IGKGSY----- 230 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHCCC-----
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHH-HhcCCC-----
Confidence 3333444567899999999987643 47899999999999999999999965331 111111 112111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122334578899999999999999999999963
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.30 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=198.2
Q ss_pred hhhcccccccCceEEEEEEe--CCCcEEEEEecccch------hhHHHHHHHHHhh---cccceeEEEEEEE-----eCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL--DDNQQVAVKMLSSSC------CFQLLQVKLLMRV---HHRNLTALIGYCI-----EGN 463 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~~ 463 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 45678999999999999987 468899999985322 2456788777776 8999999999987 456
Q ss_pred eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..++||||++ |+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 69999998766556999999999999999999999 8999999999999999999999999999997
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---C
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---D 620 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~ 620 (704)
.... ........|+..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+....... .
T Consensus 169 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGG
T ss_pred cccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCccc
Confidence 6532 223345678999999999999999999999999999999999999997644221 111111111100 0
Q ss_pred ccc-------ccCC---cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IRN-------IVDP---SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~~-------~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .+.. .....+....+..+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 0001112334567889999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.20 Aligned_cols=194 Identities=24% Similarity=0.370 Sum_probs=161.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 466 (704)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|++++++++||||+++++++... +..+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 3556789999999999999654 68899999986432 2567899999999999999999999866 5799
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||++ |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9999987 59999997654 3899999999999999999999 8999999999999999999999999999998764
Q ss_pred cCCCC--------------------cccccccCCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 037258 547 IESSD--------------------QISTAVAGTPGYLDPEYY-VLNWLNEKSDVYSFGVVLLEIITGRRPVI 598 (704)
Q Consensus 547 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG~~Pf~ 598 (704)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32211 123567899999999986 56679999999999999999998655553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.59 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=195.5
Q ss_pred HHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCC
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGN 463 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 463 (704)
...|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345677899999999999999764 68899999986432 14578999999999999999999987655
Q ss_pred eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc---EEEEecc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ---AKIADFG 540 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfG 540 (704)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999997654 3899999999999999999999 899999999999999987654 9999999
Q ss_pred CccccccCCCCcccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 541 LSRIFSIESSDQISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 541 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
++..... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+... +.
T Consensus 163 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~----~~ 233 (322)
T 2ycf_A 163 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----IT 233 (322)
T ss_dssp TCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----HH
T ss_pred cceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----HH
Confidence 9986531 22234457899999999974 4678899999999999999999999997654322 11111 11
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.... .+. .....+..+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111110 000 01123457889999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=349.51 Aligned_cols=246 Identities=29% Similarity=0.369 Sum_probs=201.0
Q ss_pred HHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccc-------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
...|.+.+.||+|+||.||+|... +++.||||++... .....+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345677899999999999999765 7899999998432 23567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe---CCCCcEEEEeccCcccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL---NEKLQAKIADFGLSRIF 545 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~ 545 (704)
|||+.+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 105 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999976544 899999999999999999999 8999999999999999 56789999999999865
Q ss_pred ccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... +.... +..+....
T Consensus 180 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~~-- 246 (484)
T 3nyv_A 180 EAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKK-VEKGKYTF-- 246 (484)
T ss_dssp CCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCCC--
T ss_pred ccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHcCCCCC--
Confidence 322 22345679999999999876 6899999999999999999999999654321 11111 22221110
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 247 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00011234567899999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=347.31 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=197.5
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
..|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35667899999999999999765 78899999986432 256789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCcccccc
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSI 547 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~~~ 547 (704)
|+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.. +.+||+|||++..+..
T Consensus 117 ~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999998876544 899999999999999999999 8999999999999999764 4599999999987642
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
........||+.|+|||++. ..++.++||||+||++|+|++|+.||...... +.... +..+... ...+
T Consensus 192 ---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~-~~~~ 259 (494)
T 3lij_A 192 ---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRK-VEKGKYT-FDSP 259 (494)
T ss_dssp ---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTCCC-CCSG
T ss_pred ---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC-CCch
Confidence 22234567999999999886 46899999999999999999999999654421 11111 1112111 0001
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKEC 669 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 669 (704)
. ....+..+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 260 ~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 260 E-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp G-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred h-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1 1223457889999999999999999999986 34443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.38 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=201.3
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---------------------hhHHHHHHHHHhhcccceeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---------------------CFQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
+.+.+.||+|+||.||+|.. +++.||||++.... ..+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999999988 89999999986432 466889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHH------hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCC
Q 037258 459 CIEGNNMGLIYEYMASGTLDQY------LKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~ 531 (704)
+.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+||| + .+|+||||||+||+++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999 66544556999999999999999999999 7 999999999999999999
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-WLNE-KSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS 609 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 609 (704)
+.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||....... ..
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~- 261 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL- 261 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH-
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH-
Confidence 99999999999875322 33456789999999999877 6666 9999999999999999999997654321 11
Q ss_pred HHHHHHHhcCCcccccC------CcCC---CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 610 QWVNSMLAEGDIRNIVD------PSLQ---GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. .+..+......+ +... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 262 --~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 --FN-NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HH-HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HH-HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 122221110000 0000 0011334568899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.60 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=181.6
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-----h-HHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-----F-QLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~-~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|.. .+++.||||++..... . ...+...++.++||||+++++++.+++..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 45678999999999999976 5789999999865422 1 223344577789999999999999999999999999
Q ss_pred CCCCHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 473 ASGTLDQYLKGK--KEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 473 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
++ +|.+++... ....+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 163 (290)
T 3fme_A 89 DT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD- 163 (290)
T ss_dssp SE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred cc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc-
Confidence 75 888887642 2345999999999999999999999 77 9999999999999999999999999999765322
Q ss_pred CCcccccccCCCCccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 550 SDQISTAVAGTPGYLDPEYY----VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ............. .
T Consensus 164 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~-- 233 (290)
T 3fme_A 164 --VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP-Q-- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC-C--
T ss_pred --ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC-C--
Confidence 222344789999999996 5667899999999999999999999999653321 1111122221111 0
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111233457899999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.84 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=189.1
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|++++++++||||+++++++... ...+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 45678999999999999976 579999999985421 2457899999999999999999999865 3469
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999999 78999999763 3899999999999999999999 8999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-----
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD----- 620 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 620 (704)
. ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+.. +........
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~-i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKE-IMKVTGTPPAEFVQ 251 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCHHHHH
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHhcCCCCHHHHH
Confidence 2 1334578999999999887 689999999999999999999999997644211 1111 111000000
Q ss_pred -------------cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 -------------IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 -------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+.......+. ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000010 111233567899999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.46 Aligned_cols=189 Identities=22% Similarity=0.386 Sum_probs=148.5
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 466 (704)
.|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3556889999999999999654 78999999986421 2567899999999999999999999543 5789
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+. |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 134 lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999985 69999997654 3999999999999999999999 8999999999999999999999999999998764
Q ss_pred cCCCC-------------------------cccccccCCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 037258 547 IESSD-------------------------QISTAVAGTPGYLDPEYY-VLNWLNEKSDVYSFGVVLLEIITG 593 (704)
Q Consensus 547 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG 593 (704)
..... .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 22111 123456789999999986 466799999999999999999993
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=358.44 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=199.7
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
+.+.+.||+|+||.||+|... +++.||||+++... .....|..++..+ +||+|+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445789999999999999764 68899999986432 2456788888877 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 423 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred CcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 9999999999987654 999999999999999999999 89999999999999999999999999999986422 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.. ..
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~---------- 558 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME-HN---------- 558 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHS-SC----------
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-CC----------
Confidence 22345578999999999999999999999999999999999999999764321 12222221 11
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTM-----TDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 664 (704)
..++...+.++.+|+.+||+.||++||++ +||++
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12233455689999999999999999998 66654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.99 Aligned_cols=238 Identities=16% Similarity=0.132 Sum_probs=185.0
Q ss_pred hhcccccccCceEEEEEEe-CCCcEEEEEecccc-------hhhHHHHH---HHHHhhcccceeEEE-------EEEEeC
Q 037258 401 NFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS-------CCFQLLQV---KLLMRVHHRNLTALI-------GYCIEG 462 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-------~~~~~~E~---~~l~~l~h~nIv~l~-------~~~~~~ 462 (704)
.+.+.||+|+||.||+|.. .+|+.||||++... ...+.+|+ +++++++||||++++ +++.+.
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 4468999999999999975 57999999998532 12556788 455566899999998 676655
Q ss_pred C-----------------eEEEEEeecCCCCHHHHhhcccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 037258 463 N-----------------NMGLIYEYMASGTLDQYLKGKKE-----HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRD 520 (704)
Q Consensus 463 ~-----------------~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 520 (704)
+ ..++||||+ +|+|.+++..... ..+++..++.++.|++.||+||| +.+|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 3 278999999 6799999986532 11335888899999999999999 89999999
Q ss_pred CCCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccC-----------CCCcchhHHHHHHHHHH
Q 037258 521 VKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN-----------WLNEKSDVYSFGVVLLE 589 (704)
Q Consensus 521 lkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwSlGvvl~e 589 (704)
|||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999998532 12344567 999999999987 89999999999999999
Q ss_pred HHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHH
Q 037258 590 IITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELK 667 (704)
Q Consensus 590 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 667 (704)
|++|+.||........ ...+.. . ....+..+.+++.+||+.||++||++.|+++ .++
T Consensus 306 lltg~~Pf~~~~~~~~---------------~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 306 IWCADLPITKDAALGG---------------SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHSSCCC------CC---------------SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHHCCCCCcccccccc---------------hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 9999999965443221 111111 0 0123457889999999999999999999986 444
Q ss_pred hh
Q 037258 668 EC 669 (704)
Q Consensus 668 ~~ 669 (704)
++
T Consensus 365 ~~ 366 (377)
T 3byv_A 365 QL 366 (377)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=348.30 Aligned_cols=244 Identities=28% Similarity=0.367 Sum_probs=195.4
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----------------hhHHHHHHHHHhhcccceeEEEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----------------CFQLLQVKLLMRVHHRNLTALIGYCI 460 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~~~~~ 460 (704)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3556789999999999999765 68899999986432 24578999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC---cEEEE
Q 037258 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL---QAKIA 537 (704)
Q Consensus 461 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~ 537 (704)
+++..++||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999976543 999999999999999999999 89999999999999998776 69999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|||++..+... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... +.... +.
T Consensus 192 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~ 260 (504)
T 3q5i_A 192 DFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIKK-VE 260 (504)
T ss_dssp CCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HH
T ss_pred ECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HH
Confidence 99999876422 2334567999999999987 46899999999999999999999999654321 11111 11
Q ss_pred cCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+...... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 KGKYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HCCCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22111000 000123457899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=329.61 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=194.4
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||.||+|.... .||+|+++... ..+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4457899999999999998753 59999986432 245678999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC---C
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES---S 550 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~---~ 550 (704)
+++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||++....... .
T Consensus 113 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 113 GRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp SEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999997654 34899999999999999999999 89999999999999998 6799999999987643211 1
Q ss_pred CcccccccCCCCccCcccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 037258 551 DQISTAVAGTPGYLDPEYYVL---------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 621 (704)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..... ...+..
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~ 260 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQ-MGTGMK 260 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHH-HHTTCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-hccCCC
Confidence 122234568899999999874 45788999999999999999999999654321 11111 112211
Q ss_pred ccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 037258 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIV 675 (704)
Q Consensus 622 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 675 (704)
..... ...+..+.+++.+||+.||.+|||+.|+++.|+++......
T Consensus 261 ~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 261 PNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111 11233688999999999999999999999999998765443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.93 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=197.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------------hhHHHHHHHHHhhc-ccceeEEEEEEEeCCe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------------CFQLLQVKLLMRVH-HRNLTALIGYCIEGNN 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 464 (704)
+.+.+.||+|+||.||+|... +++.||||++.... ....+|+++++++. ||||+++++++..++.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 445789999999999999765 68999999985431 24567899999995 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+++++|.+++..... +++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999986543 899999999999999999999 89999999999999999999999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYV------LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
+... .......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..... +..
T Consensus 174 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~ 243 (298)
T 1phk_A 174 LDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRM-IMS 243 (298)
T ss_dssp CCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHH
T ss_pred cCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHH-Hhc
Confidence 5322 2233457899999999985 456789999999999999999999999654321 11111 111
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 000111234567899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.95 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=180.6
Q ss_pred cccccccCceEEEEEEeC---CCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEeecCCC
Q 037258 403 ERVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYEYMASG 475 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~~~g 475 (704)
.++||+|+||.||+|... +++.||||++.... ....+|++++++++||||+++++++.. +...++||||+.+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~- 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-
Confidence 468999999999999865 57899999997543 367789999999999999999999964 6789999999975
Q ss_pred CHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe----CCCCcEEEEeccCccc
Q 037258 476 TLDQYLKGKK-------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL----NEKLQAKIADFGLSRI 544 (704)
Q Consensus 476 sL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla~~ 544 (704)
+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 8888876332 224899999999999999999999 8999999999999999 6778999999999987
Q ss_pred cccCCC-CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc------ccHHHHHHHHH
Q 037258 545 FSIESS-DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT------THISQWVNSML 616 (704)
Q Consensus 545 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~------~~~~~~~~~~~ 616 (704)
+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......+...+
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~ 261 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence 642211 122345678999999999987 4589999999999999999999999976543210 01111111111
Q ss_pred hcCC---cccccC-------------CcCCC--------CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 617 AEGD---IRNIVD-------------PSLQG--------NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 617 ~~~~---~~~~~d-------------~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.... +..+.. ..... ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1000 000000 00000 000011346889999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=329.35 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=200.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch---hhHHHHHHHHHhhc-----------ccceeEEEEEEEeCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---CFQLLQVKLLMRVH-----------HRNLTALIGYCIEGN 463 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~ 463 (704)
.|.+.+.||+|+||.||+|.. .+++.||||++.... .....|++++++++ |+||+++++++...+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 456789999999999999975 578999999997543 25577888888876 899999999998654
Q ss_pred ----eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeC------CCC
Q 037258 464 ----NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLN------EKL 532 (704)
Q Consensus 464 ----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~------~~~ 532 (704)
..++||||+ +++|.+++.......+++..+..++.|++.||+||| ++ +|+||||||+|||++ ..+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcc
Confidence 789999999 889999998766566999999999999999999999 77 999999999999994 445
Q ss_pred cEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 037258 533 QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV 612 (704)
Q Consensus 533 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~ 612 (704)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............+
T Consensus 176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 8999999999865321 23457899999999999999999999999999999999999999765432211111111
Q ss_pred HHHHh-cCCc---------------------ccccCCc---------CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHH
Q 037258 613 NSMLA-EGDI---------------------RNIVDPS---------LQGNFDNNSAWKAVELALACASHTSSERPTMTD 661 (704)
Q Consensus 613 ~~~~~-~~~~---------------------~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 661 (704)
..... .+.. ..+.... ....++...+..+.+|+.+||+.||.+|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 11110 0000 0000000 011245677889999999999999999999999
Q ss_pred HHH--HHHhhhh
Q 037258 662 VLM--ELKECLS 671 (704)
Q Consensus 662 vl~--~L~~~~~ 671 (704)
+++ .+++...
T Consensus 331 ll~hp~f~~~~~ 342 (373)
T 1q8y_A 331 LVNHPWLKDTLG 342 (373)
T ss_dssp HHTCGGGTTCTT
T ss_pred HhhChhhhcccC
Confidence 987 4444433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=358.36 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=201.5
Q ss_pred HHhhhcccccccCceEEEEEEeC----CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
..+.+.+.||+|+||.||+|... .+..||||+++... ..+.+|+.++++++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 34556789999999999999764 24679999986532 25678999999999999999999985 4568999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 469 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999998653 24899999999999999999999 899999999999999999999999999999876322
Q ss_pred CCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||...... .. .... ..+...
T Consensus 545 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~---~~~i-~~~~~~----- 611 (656)
T 2j0j_A 545 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV---IGRI-ENGERL----- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHH-HHTCCC-----
T ss_pred -cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHH-HcCCCC-----
Confidence 2222334556789999999999999999999999999999997 99999654321 11 1111 111111
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
..+...+..+.+++.+||+.||.+||++.|+++.|++++..+
T Consensus 612 ----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 122334568899999999999999999999999999987644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.09 Aligned_cols=196 Identities=23% Similarity=0.316 Sum_probs=167.3
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhhc-cc-----ceeEEEEEEEeCCeEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRVH-HR-----NLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~lV 468 (704)
.+.+.+.||+|+||.||+|... +++.||||+++.... ....|+.++..++ |+ +|+++++++...+..++|
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 3556789999999999999654 688999999975532 4566888888875 44 499999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccc
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EKLQAKIADFGLSRIFS 546 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfGla~~~~ 546 (704)
|||++ |+|.+++.......+++..+..++.|++.||.|||.. +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 135 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 99996 5999999877655699999999999999999999931 46899999999999994 57789999999998753
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRA 601 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~ 601 (704)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 213 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 213 Q-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp C-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 1234678999999999999999999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.29 Aligned_cols=245 Identities=20% Similarity=0.308 Sum_probs=193.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.+.+.||+|+||.||+|... +++.||+|++.... ..+..|++++++++||||+++++++..++..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 456789999999999999775 68999999986443 3567899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...... ....
T Consensus 101 ~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 174 (302)
T 2j7t_A 101 GAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKR 174 (302)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-
T ss_pred CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cccc
Confidence 99999987643 23899999999999999999999 899999999999999999999999999987543111 1112
Q ss_pred ccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 555 TAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
....|+..|+|||++. +..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~----- 242 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSD-PPTL----- 242 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCC-----
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccC-Cccc-----
Confidence 3356899999999984 667889999999999999999999999654321 1111111111 1111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112233557899999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=330.57 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=187.9
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC------eEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN------NMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 466 (704)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 45578999999999999965 478999999986421 24578999999999999999999998654 789
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 99999975 78888853 2889999999999999999999 8999999999999999999999999999998653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWV-------------- 612 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~-------------- 612 (704)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +...+
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTTS
T ss_pred c---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHh
Confidence 2 2223446789999999999999999999999999999999999999976442110 00000
Q ss_pred ----HHHHhcC-Cc-----ccccCCcCCCC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhh
Q 037258 613 ----NSMLAEG-DI-----RNIVDPSLQGN---FDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKEC 669 (704)
Q Consensus 613 ----~~~~~~~-~~-----~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 669 (704)
....... .. ...+....... .....+..+.+|+.+||+.||.+|||++|+++ .++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0000000 00 00000000000 01223678999999999999999999999997 44443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.71 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=189.4
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEe-------------
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIE------------- 461 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~------------- 461 (704)
.+.+.+.||+|+||.||+|.. .+++.||||++..... ...+|++++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 345678999999999999976 4789999999865432 56789999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 462 GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 462 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
.+..++||||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 456899999999999999998643 23788999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCC------------CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 542 SRIFSIESS------------DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 542 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
+........ ........|++.|+|||++.+. .++.++|||||||++|||++ ||.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hH
Confidence 986532110 1122345689999999999864 78999999999999999998 553211 11
Q ss_pred HHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 609 SQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 609 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...... +... .......+....+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKK-LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHH-HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHh-cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 1111 111222334455567899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.68 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=190.7
Q ss_pred HHHHHHHhh--hcccccccCceEEEEEEeCCCcEEEEEecccch---------------hhHHHHHHHHHhhcccceeEE
Q 037258 393 SEIQKITNN--FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---------------CFQLLQVKLLMRVHHRNLTAL 455 (704)
Q Consensus 393 ~el~~~~~~--~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~nIv~l 455 (704)
.++.....+ +.+.||+|+||.||+|...+|+.||||++.... ..+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 344443333 478999999999999988889999999885321 356789999999999999999
Q ss_pred EEEEEeC-----CeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 456 IGYCIEG-----NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 456 ~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
++++... ...++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 9998542 36899999998 58888887543 34899999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||++..... ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ..
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~ 243 (362)
T 3pg1_A 170 NNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---QL 243 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred CCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 99999999999975432 222344678999999999886 678999999999999999999999997644211 11
Q ss_pred HHHHHHHhcCCc-----------ccccCCcCCC-------CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 610 QWVNSMLAEGDI-----------RNIVDPSLQG-------NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 610 ~~~~~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..+......... ...+...... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111100000 0000000000 011223457899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=330.01 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV 468 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 556789999999999999654 78899999986432 2557899999999999999999999765 368999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+.+ +|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 109 ~e~~~~-~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCSE-EHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccCc-CHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 999974 9999997643 899999999999999999999 899999999999999999999999999999876422
Q ss_pred CC-CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc----
Q 037258 549 SS-DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR---- 622 (704)
Q Consensus 549 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 622 (704)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+..........
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHH
Confidence 21 112345679999999998764 4589999999999999999999999976543321 11111111110000
Q ss_pred -----------cccCCcCC--CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 -----------NIVDPSLQ--GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 -----------~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+... .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0001123457899999999999999999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.19 Aligned_cols=254 Identities=19% Similarity=0.261 Sum_probs=197.9
Q ss_pred HhhhcccccccCceEEEEEEeC-CC-cEEEEEecccchh---hHHHHHHHHHhhcccc------eeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DN-QQVAVKMLSSSCC---FQLLQVKLLMRVHHRN------LTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~---~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l 467 (704)
.|.+.+.||+|+||.||+|... ++ +.||||+++.... ....|++++++++|++ ++.+++++...+..++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 4566889999999999999764 44 7899999975432 5567899999998877 9999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEe-------------------
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILL------------------- 528 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll------------------- 528 (704)
||||+ +++|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 668888887665556999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 037258 529 NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI 608 (704)
Q Consensus 529 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~ 608 (704)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--- 247 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH--- 247 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred cCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 5678999999999976432 22345789999999999999999999999999999999999999976443211
Q ss_pred HHHHHHHHhc--------CCcccc-cCCc---------------------CCCCCChhHHHHHHHHHHhccCCCCCCCCC
Q 037258 609 SQWVNSMLAE--------GDIRNI-VDPS---------------------LQGNFDNNSAWKAVELALACASHTSSERPT 658 (704)
Q Consensus 609 ~~~~~~~~~~--------~~~~~~-~d~~---------------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 658 (704)
...+...... ...... .... ............+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 1111111100 000000 0000 000112345668999999999999999999
Q ss_pred HHHHHH
Q 037258 659 MTDVLM 664 (704)
Q Consensus 659 ~~evl~ 664 (704)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.11 Aligned_cols=248 Identities=29% Similarity=0.389 Sum_probs=198.7
Q ss_pred HHHHHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 395 IQKITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 395 l~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.....+.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34456677899999999999999765 78999999985432 256789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC---CcEEEEeccCccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRI 544 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~ 544 (704)
|+||+++++|.+++..... +++..++.++.|++.||+||| +.+++||||||+||+++.+ +.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999876543 899999999999999999999 8999999999999999764 4699999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
..... ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .... .+..+.....
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~ 242 (287)
T 2wei_A 174 FQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILK-RVETGKYAFD 242 (287)
T ss_dssp BCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHCCCCCC
T ss_pred ecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHcCCCCCC
Confidence 53221 22334578899999988764 899999999999999999999999654321 1111 1222211100
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. +. ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~-~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00 1123457889999999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.06 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=177.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeC------CeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 466 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 45578999999999999964 578999999986432 2556899999999999999999999754 5689
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+|+|++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 999999 67999998763 3899999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---cc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IR 622 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~ 622 (704)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ....+........ +.
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHT
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 2 2334678999999999887 678999999999999999999999996644211 1111111111000 00
Q ss_pred c--------ccC--CcCC-CCC---ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 623 N--------IVD--PSLQ-GNF---DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 623 ~--------~~d--~~l~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. .+. +... ..+ ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0000 000 01224578899999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.96 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=185.9
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCCHHHH
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQY 480 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 480 (704)
.+.||+|+||+||.+...+|+.||||++..... ....|++++.++ +||||+++++++.+++..++||||+. |+|.++
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~ 98 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDL 98 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence 578999999999877777899999999865433 557899999887 89999999999999999999999996 699999
Q ss_pred hhcccCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC-------------CcEEEEeccCc
Q 037258 481 LKGKKEHM-----LNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK-------------LQAKIADFGLS 542 (704)
Q Consensus 481 l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kL~DfGla 542 (704)
+....... ..+..++.++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 98654211 123345789999999999999 8999999999999999654 48999999999
Q ss_pred cccccCCCCc--ccccccCCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 037258 543 RIFSIESSDQ--ISTAVAGTPGYLDPEYYVL-------NWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWV 612 (704)
Q Consensus 543 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 612 (704)
+.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i~ 251 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SNII 251 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHHH
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HHHh
Confidence 8764322111 1234579999999999975 678999999999999999999 999996543211 1111
Q ss_pred HHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 613 NSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 613 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. +... .+..........+.++.+++.+||+.||.+|||+.|+++
T Consensus 252 ----~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 252 ----R-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----H-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----c-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1110 011111224566788999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.91 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=173.2
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----hHHHHHH-HHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----FQLLQVK-LLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+.+.||+|+||.||+|... +|+.||||++..... ....|+. +++.++||||+++++++.+++..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 44688999999999999764 789999999865321 3344544 6677899999999999999999999999998
Q ss_pred CCCHHHHhhc---ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 474 SGTLDQYLKG---KKEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 474 ~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+ +|.+++.. .....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 179 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS- 179 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc-
Confidence 5 88887763 22345899999999999999999999 77 9999999999999999999999999999865322
Q ss_pred CCcccccccCCCCccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 550 SDQISTAVAGTPGYLDPEYY----VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .. .......
T Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~------~~~~~~~ 246 (327)
T 3aln_A 180 --IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL------TQVVKGD 246 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSC
T ss_pred --cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH------HHHhcCC
Confidence 122334689999999998 466789999999999999999999999965432110 00 0011111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.+........+..+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111122234568999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.93 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=193.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV 468 (704)
+.+.+.||+|+||.||+|... +|+.||||++.... ....+|++++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 445789999999999999765 68999999986432 2456899999999999999999998764 678999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+. |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+...
T Consensus 93 ~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp ECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99997 5999998764 3899999999999999999999 899999999999999999999999999999876422
Q ss_pred CCCc--------ccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 037258 549 SSDQ--------ISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619 (704)
Q Consensus 549 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 619 (704)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 242 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGTP 242 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCC
Confidence 1111 1223568999999998764 678999999999999999999999997654211 111111111110
Q ss_pred CcccccC--------------CcCCC----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 DIRNIVD--------------PSLQG----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ~~~~~~d--------------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....... +.... ......+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00000 001133467889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.91 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=182.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCe-------EEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNN-------MGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------~~lV 468 (704)
+.+.+.||+|+||.||+|... +++.||||++..... ....+++.+..++||||+++++++...+. .++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 445789999999999999764 789999998855433 45667788888999999999999976433 7899
Q ss_pred EeecCCCCHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCcccc
Q 037258 469 YEYMASGTLDQYLKG--KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRIF 545 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~ 545 (704)
|||+++ +|.+.+.. .....+++..+..++.|++.||.|||. ++.+|+||||||+|||++. ++.+||+|||+++.+
T Consensus 105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred eecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 999986 55554432 223458899999999999999999993 3689999999999999996 899999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH---------
Q 037258 546 SIESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM--------- 615 (704)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~--------- 615 (704)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 183 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 183 SPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp CTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred CCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCCCCHHHHH
Confidence 422 223345689999999998765 48999999999999999999999997644321 111111100
Q ss_pred -Hhc-CCcccccCCc------CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 616 -LAE-GDIRNIVDPS------LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 616 -~~~-~~~~~~~d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... .......+.. .........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0000000000 001122235678999999999999999999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.63 Aligned_cols=234 Identities=24% Similarity=0.405 Sum_probs=194.0
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----------hhHHHHHHHHHhhc--ccceeEEEEEEEeCCeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----------CFQLLQVKLLMRVH--HRNLTALIGYCIEGNNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~ 465 (704)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ..+..|+.++++++ |+||+++++++..++..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 355678999999999999965 578999999986442 24567999999996 59999999999999999
Q ss_pred EEEEeecCC-CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC-CCCcEEEEeccCcc
Q 037258 466 GLIYEYMAS-GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSR 543 (704)
Q Consensus 466 ~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~ 543 (704)
++|+|++.+ ++|.+++..... +++..++.++.|+++||+||| +.+|+||||||+|||++ +++.+||+|||++.
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 999999986 899999986543 899999999999999999999 89999999999999998 78899999999998
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (704)
.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ... +..
T Consensus 199 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~-~~~- 260 (320)
T 3a99_A 199 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQV- 260 (320)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CCC-
T ss_pred cccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc-ccc-
Confidence 7642 22334568999999999987665 6889999999999999999999954211 011 110
Q ss_pred cccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 623 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+....+..+.+++.+||+.||++|||++|+++
T Consensus 261 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223457889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.10 Aligned_cols=246 Identities=28% Similarity=0.383 Sum_probs=186.6
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch-hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+...+.||+|+||+||.....+++.||||++.... ....+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 34468999999999776666689999999986543 3567899999999 79999999999999999999999996 599
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-----CCcEEEEeccCccccccCCC-C
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-----KLQAKIADFGLSRIFSIESS-D 551 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DfGla~~~~~~~~-~ 551 (704)
.+++...... ..+..++.++.|++.||+||| +.+|+||||||+|||++. ...+||+|||+++.+..... .
T Consensus 105 ~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 105 QEYVEQKDFA-HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHHHhcCCC-ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 9999865532 444566789999999999999 899999999999999953 33688999999987643221 1
Q ss_pred cccccccCCCCccCccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 552 QISTAVAGTPGYLDPEYYV---LNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||....... .......... ..
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~-~~--- 249 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSL-DC--- 249 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCCC-TT---
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCCc-cc---
Confidence 2234567999999999997 4567889999999999999999 999985433211 1111111110 00
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
. .........+.+|+.+||+.||.+|||+.|+++
T Consensus 250 -~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 -L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 112345667889999999999999999999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.62 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=189.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeE------E
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNM------G 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~------~ 466 (704)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+|+.+++.++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445789999999999999654 78999999986532 2557899999999999999999999877654 9
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+. ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 124 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 9999997 588888743 2899999999999999999999 8999999999999999999999999999997653
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-----
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD----- 620 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 620 (704)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.... .......
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~-~~~~~~~~~~~~ 267 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL-KVTGVPGTEFVQ 267 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCHHHHT
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCcHHHHH
Confidence 2 2334578999999999987 788999999999999999999999996543211 111111 1000000
Q ss_pred -cc--------cccCCcCCCC---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 621 -IR--------NIVDPSLQGN---FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 621 -~~--------~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
+. ..+....... .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0000000000 011235678999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.25 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=186.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEE--------------
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCI-------------- 460 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~-------------- 460 (704)
|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 445789999999999999765 58999999886433 25678999999999999999999874
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC-CCCcEEEEec
Q 037258 461 EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADF 539 (704)
Q Consensus 461 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Df 539 (704)
+....++||||++ |+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+||+++ +++.+||+||
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999998 5999999753 3899999999999999999999 89999999999999997 5679999999
Q ss_pred cCccccccCCC-CcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 037258 540 GLSRIFSIESS-DQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617 (704)
Q Consensus 540 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 617 (704)
|+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------~~~~~~ 239 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ------MQLILE 239 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHH
Confidence 99987632211 112234567899999998875 6789999999999999999999999976542111 111111
Q ss_pred cCC-------------cccccCCcCC-C-----CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 618 EGD-------------IRNIVDPSLQ-G-----NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 618 ~~~-------------~~~~~d~~l~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
... +...+..... . ......+..+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 0000000000 0 001123567899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.12 Aligned_cols=240 Identities=27% Similarity=0.432 Sum_probs=190.4
Q ss_pred HHHHHHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch----------hhHHHHHHHHHhh----cccceeEEEEE
Q 037258 394 EIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----------CFQLLQVKLLMRV----HHRNLTALIGY 458 (704)
Q Consensus 394 el~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~E~~~l~~l----~h~nIv~l~~~ 458 (704)
+.....|.+.+.||+|+||.||+|.. .+++.||||++.... .....|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34445567789999999999999965 478899999986432 1345689999998 89999999999
Q ss_pred EEeCCeEEEEEee-cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC-CCCcEEE
Q 037258 459 CIEGNNMGLIYEY-MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKI 536 (704)
Q Consensus 459 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 536 (704)
+...+..++|+|+ +.+++|.+++..... +++..++.++.|+++||+||| +.+|+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 789999999987543 899999999999999999999 89999999999999998 8899999
Q ss_pred EeccCccccccCCCCcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 037258 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615 (704)
Q Consensus 537 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 615 (704)
+|||++...... ......|+..|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~ 245 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------I 245 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------H
Confidence 999999876422 2334568999999999987666 4589999999999999999999954210 0
Q ss_pred HhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 616 LAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 616 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.. ... .++...+..+.+++.+||+.||++||++.|+++.
T Consensus 246 ~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 LE-AEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH-TCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hh-hcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 000 1222344578899999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.77 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=190.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCe------EE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNN------MG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~ 466 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+|+.++++++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 44578999999999999976 478999999986432 245789999999999999999999987653 59
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+. |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 106 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 9999997 588888753 3899999999999999999999 8999999999999999999999999999997643
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------ 619 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 619 (704)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.. +.......
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQ-ILKVTGVPGTEFVQ 249 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHH-HHHHHCBCCHHHHT
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHHH
Confidence 2 1234578999999999886 678999999999999999999999997644211 1111 11100000
Q ss_pred ------------CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 ------------DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 ------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.....+.+. ......+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000001111 112344668999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.60 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=174.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----h-HHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----F-QLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~-~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
+.+.+.||+|+||.||+|... +|+.||||++..... . ...+..+++.++||||+++++++.+++..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 345689999999999999775 789999999864322 1 223344677789999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP-PIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
++.+..+... ....+++..+..++.|+++||+||| +. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 107 -~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (318)
T 2dyl_A 107 -GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--- 178 (318)
T ss_dssp -SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred -CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC---
Confidence 4455555443 2344899999999999999999999 74 9999999999999999999999999999765322
Q ss_pred cccccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 552 QISTAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ............ .
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-~---- 248 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP-P---- 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-C----
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-C----
Confidence 2233456899999999984 557889999999999999999999999653321 111222222211 1
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+. .....+..+.+++.+||+.||.+||++.|+++
T Consensus 249 -~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 -LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 010 01123457889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.31 Aligned_cols=266 Identities=26% Similarity=0.328 Sum_probs=203.1
Q ss_pred HHhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe------CCeE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE------GNNM 465 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~ 465 (704)
..+.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3466789999999999999965 468999999986532 246779999999999999999999765 6778
Q ss_pred EEEEeecCCCCHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCc---EEEEeccC
Q 037258 466 GLIYEYMASGTLDQYLKGKK-EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQ---AKIADFGL 541 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGl 541 (704)
++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998654 234889999999999999999999 899999999999999987664 99999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD- 620 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 620 (704)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.........
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 9875322 223456789999999999999999999999999999999999999965321 1111100000000
Q ss_pred ---cccc------cCC--cCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHhhhhhhh
Q 037258 621 ---IRNI------VDP--SLQGNFDNNSAWKAVELALACASHTSSERPTMTD-----VLMELKECLSLEI 674 (704)
Q Consensus 621 ---~~~~------~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~~ 674 (704)
.... ... ..........+..+.+++.+||..||++|||+.| ..+.++.++....
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 0000 000 1112234567889999999999999999999988 5577777776554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.76 Aligned_cols=227 Identities=11% Similarity=0.097 Sum_probs=181.1
Q ss_pred HHhhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 398 ITNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 398 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
..|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|+.++.+++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34667899999999999999765 58999999996542 35678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++++|.+++... ....++.+++.|++.||+||| +.+|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999643 355678899999999999999 8999999999999999999999998543
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
|++| ++.++|||||||++|||++|+.||.......... ..........
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQP 222 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSCB
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccCC
Confidence 3332 5889999999999999999999997655422100 0000000000
Q ss_pred C--CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 630 Q--GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 630 ~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
. .......+..+.+++.+||+.||.+| |+.|+++.|+++....
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 01112345678999999999999999 9999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.65 Aligned_cols=221 Identities=21% Similarity=0.290 Sum_probs=177.1
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHH-HhhcccceeEEEEEEEe----CCeEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLL-MRVHHRNLTALIGYCIE----GNNMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~lV~e~~~~gs 476 (704)
.+.||+|+||.||+|.. .+++.||||+++.. ....+|+.++ +..+||||+++++++.. ....++||||+++|+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 101 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 101 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCB
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCc
Confidence 37899999999999966 57899999999753 4567788887 55699999999999987 677899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCcc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++....
T Consensus 102 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------- 171 (299)
T 3m2w_A 102 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------- 171 (299)
T ss_dssp HHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------
Confidence 999998876566999999999999999999999 899999999999999998 7889999999986532
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
+..++.++|||||||++|||++|+.||........ ............. ..
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~--~~ 221 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQY--EF 221 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC--SS
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccc--cC
Confidence 23467899999999999999999999965432210 0000001100000 11
Q ss_pred C----hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 D----NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 234568999999999999999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=339.98 Aligned_cols=235 Identities=20% Similarity=0.270 Sum_probs=189.3
Q ss_pred HhhhcccccccCceEEEEEEeC--CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCe-----EE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD--DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNN-----MG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~ 466 (704)
.|.+.+.||+|+||.||+|... +++.||||++.... ..+..|++++.+++||||+++++++...+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 4567889999999999999765 68999999986432 245789999999999999999999987655 79
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+++++|.+++.. .+++..++.++.||+.||+||| +++|+||||||+|||++.+ .+||+|||+++...
T Consensus 161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999999988765 3899999999999999999999 8999999999999999986 89999999998753
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.. ....||+.|+|||++.+.. +.++|||||||++|||++|..||........ .
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~---- 285 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P---- 285 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C----
T ss_pred cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c----
Confidence 21 3457999999999987664 8999999999999999999988754221100 0
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERP-TMTDVLMELKECLS 671 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 671 (704)
...........+.+++.+||+.||.+|| +++++.+.|..++.
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0001112345788999999999999999 56667777776653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=318.03 Aligned_cols=232 Identities=16% Similarity=0.124 Sum_probs=172.8
Q ss_pred hcccccccCceEEEEEE-eCCCcEEEEEecccch-------hhHHHHHHHHHhhcc-cc---------------------
Q 037258 402 FERVLGKGGFGEVYHGS-LDDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHH-RN--------------------- 451 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h-~n--------------------- 451 (704)
..+.||+|+||.||+|. ..+|+.||||++.... ..+.+|+.+++.++| +|
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 36789999999999997 4579999999987322 245688888888876 21
Q ss_pred eeEEEEEEEe-----CCeEEEEEeecCCCCHHHHhhc-----ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 037258 452 LTALIGYCIE-----GNNMGLIYEYMASGTLDQYLKG-----KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDV 521 (704)
Q Consensus 452 Iv~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 521 (704)
...+..++.. ....+++|+++ +++|.+++.. .....+++..++.++.|+++||+||| +++|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCc
Confidence 1111111221 12456777765 6799999852 22334778899999999999999999 899999999
Q ss_pred CCCCEEeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCcccc----------ccCCCCcchhHHHHHHHHHHHH
Q 037258 522 KSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY----------VLNWLNEKSDVYSFGVVLLEII 591 (704)
Q Consensus 522 kp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVwSlGvvl~ell 591 (704)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999998765321 344567 999999999 5556889999999999999999
Q ss_pred hCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 592 TGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 592 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+|+.||........ ....+... ...+..+.+|+.+||+.||++||++.|+++
T Consensus 312 tg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 312 CADLPNTDDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HSSCCCCTTGGGSC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchhhh---------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999965443221 11111110 122357899999999999999999888864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.02 Aligned_cols=239 Identities=17% Similarity=0.169 Sum_probs=182.9
Q ss_pred HHHhhhcccccccCceEEEEEEeCCCcEEEEEecccch------------hhHHHHHHHHHhhc---------ccceeEE
Q 037258 397 KITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------------CFQLLQVKLLMRVH---------HRNLTAL 455 (704)
Q Consensus 397 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---------h~nIv~l 455 (704)
...+.+.+.||+|+||.||+|.. +|+.||||++.... ....+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34567789999999999999987 68999999986542 45688999999886 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Q 037258 456 IGYCI------------------------------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505 (704)
Q Consensus 456 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L 505 (704)
.+.+. +.+..++||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87653 26789999999999987776644 3389999999999999999
Q ss_pred HHHhcCCCCCceecCCCCCCEEeCCCC--------------------cEEEEeccCccccccCCCCcccccccCCCCccC
Q 037258 506 EYLHYGCKPPIVHRDVKSSNILLNEKL--------------------QAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565 (704)
Q Consensus 506 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~a 565 (704)
+|||+ +.+|+||||||+|||++.++ .+||+|||+++.... ....||+.|+|
T Consensus 175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence 99993 47899999999999999887 899999999987642 23479999999
Q ss_pred ccccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHH
Q 037258 566 PEYYVLNWLNEKSDVYSFGVV-LLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVEL 644 (704)
Q Consensus 566 PE~~~~~~~~~~sDVwSlGvv-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 644 (704)
||++.+.. +.++||||+|++ .+++++|..||.... ................ ...........+.++.+|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHH
Confidence 99998776 899999998777 778889999983210 0000111111111111 111111234577889999
Q ss_pred HHhccCCCCCCCCCHHHHH
Q 037258 645 ALACASHTSSERPTMTDVL 663 (704)
Q Consensus 645 i~~cl~~dP~~RPs~~evl 663 (704)
+.+||+.| |++|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=275.81 Aligned_cols=182 Identities=15% Similarity=0.066 Sum_probs=129.0
Q ss_pred ccccccCceEEEEE-EeCCCcEEEEEecccch--------------hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEE
Q 037258 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC--------------CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 467 (704)
...+.|+.|.+..+ +.-.|+.+++|++.... ..+.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34667777776665 34468899999985431 1567899999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||++|++|.++|..... ++.. +|+.||+.||+|+| ++|||||||||+|||+++++.+||+|||+++....
T Consensus 320 VMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999987653 5553 58899999999999 99999999999999999999999999999987632
Q ss_pred CCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 596 (704)
. ........||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 2234456799999999998764 57789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=250.45 Aligned_cols=179 Identities=20% Similarity=0.267 Sum_probs=143.9
Q ss_pred cccccccCceEEEEEEeCCCcEEEEEecccch------------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 403 ERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.||+|+||.||+|.. .++.+++|+..... ..+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 57899999999999954 57889998753221 135789999999999999966666667788899999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999975 4689999999999999 899999999999999999 999999999987642211
Q ss_pred Cc-----ccccccCCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 037258 551 DQ-----ISTAVAGTPGYLDPEYYVL--NWLNEKSDVYSFGVVLLEIITGRRPV 597 (704)
Q Consensus 551 ~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~Pf 597 (704)
.. ......||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1235679999999999986 66888899999999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.2e-22 Score=204.55 Aligned_cols=137 Identities=15% Similarity=0.096 Sum_probs=112.4
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEecccch----------------------hhHHHHHHHHHhhcccceeEEEEEE
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC----------------------CFQLLQVKLLMRVHHRNLTALIGYC 459 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~~~~ 459 (704)
+.+.||+|+||.||+|...+|+.||||+++... ..+.+|++++++++| +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 358999999999999988889999999986322 246789999999984 5555544
Q ss_pred EeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEec
Q 037258 460 IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADF 539 (704)
Q Consensus 460 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 539 (704)
.. +..++||||+++|+|.+ +.. .....++.|++.||+||| +.+|+||||||+|||++ ++.+||+||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred ec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 33 55699999999999998 532 124479999999999999 99999999999999999 999999999
Q ss_pred cCccccccCCCCcccccccCCCCccCccccc
Q 037258 540 GLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570 (704)
Q Consensus 540 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 570 (704)
|++... ..+.|||++.
T Consensus 237 G~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp TTCEET---------------TSTTHHHHHH
T ss_pred CCCeEC---------------CCCCHHHHHH
Confidence 998643 3578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=170.40 Aligned_cols=131 Identities=19% Similarity=0.247 Sum_probs=103.3
Q ss_pred hcccccccCceEEEEEEe-CCCcE--EEEEecccch----------------------------hhHHHHHHHHHhhccc
Q 037258 402 FERVLGKGGFGEVYHGSL-DDNQQ--VAVKMLSSSC----------------------------CFQLLQVKLLMRVHHR 450 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~----------------------------~~~~~E~~~l~~l~h~ 450 (704)
+.+.||+|+||.||+|.. .+|+. ||||+++... .....|+..+.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999999977 68888 9999864321 1357799999999988
Q ss_pred ce--eEEEEEEEeCCeEEEEEeecCC-C----CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 037258 451 NL--TALIGYCIEGNNMGLIYEYMAS-G----TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKS 523 (704)
Q Consensus 451 nI--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 523 (704)
++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.|||. +.+|+||||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCST
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCH
Confidence 64 344432 356899999942 4 67766543 2244667899999999999994 57999999999
Q ss_pred CCEEeCCCCcEEEEeccCcccc
Q 037258 524 SNILLNEKLQAKIADFGLSRIF 545 (704)
Q Consensus 524 ~NIll~~~~~~kL~DfGla~~~ 545 (704)
+|||+++ .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.61 E-value=5.8e-16 Score=162.42 Aligned_cols=129 Identities=28% Similarity=0.469 Sum_probs=111.8
Q ss_pred cCChhhHHHHHHhhhhcC---CCCCCCC-CCCCCCCCceeeeecCCCCCCCCceEEEEcCCCCCcc--cCchhhcccccc
Q 037258 189 LTDEDDVNALRNIKSTYG---VKRNWQG-DPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTG--EISPYFANLTAI 262 (704)
Q Consensus 189 ~~~~~~~~al~~~~~~~~---~~~~w~~-~~c~~~~~~w~gv~c~~~~~~~~~l~~l~L~~n~l~g--~~p~~~~~l~~L 262 (704)
.|.++|..||++||..++ .+.+|.. .+||. +.|.||.|+... ...+|+.|+|++|+|+| .+|+.|++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~--~~w~gv~C~~~~-~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc--CCCcceEeCCCC-CCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 478999999999999885 3568963 34431 249999997432 23689999999999999 999999999999
Q ss_pred ceEeccC-CcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCCC
Q 037258 263 EFLDLSN-NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 263 ~~L~l~~-N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n 320 (704)
++|+|++ |+++|.+|..|+++++|++|+|++|+++|.+|..+.++++|+.|+|+.|.-
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 137 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCcc
Confidence 9999995 999999999999999999999999999999999999999999999987743
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.4e-16 Score=163.06 Aligned_cols=132 Identities=12% Similarity=0.101 Sum_probs=97.3
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccchh--------------------------hHHHHHHHHHhhccccee
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC--------------------------FQLLQVKLLMRVHHRNLT 453 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv 453 (704)
|.+.+.||+|++|.||+|...+|+.||||+++.... ....|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 446789999999999999988999999998753211 113456666666555442
Q ss_pred EEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-
Q 037258 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL- 532 (704)
Q Consensus 454 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 532 (704)
-..-+.. ...+|||||++|++|.++... .....++.|++.+|.+|| +.|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence 2111111 223799999999888765431 234568899999999999 88999999999999998776
Q ss_pred ---------cEEEEeccCccc
Q 037258 533 ---------QAKIADFGLSRI 544 (704)
Q Consensus 533 ---------~~kL~DfGla~~ 544 (704)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.3e-15 Score=173.16 Aligned_cols=128 Identities=18% Similarity=0.264 Sum_probs=109.5
Q ss_pred cCChhhHHHHHHhhhhcCCCCCCCCCC----CCCCCCce------------eeeecCCCCCCCCceEEEEcCCCCCcccC
Q 037258 189 LTDEDDVNALRNIKSTYGVKRNWQGDP----CVPKNYWW------------DGLNCSYEDNNPSRIISLNLSSSGLTGEI 252 (704)
Q Consensus 189 ~~~~~~~~al~~~~~~~~~~~~w~~~~----c~~~~~~w------------~gv~c~~~~~~~~~l~~l~L~~n~l~g~~ 252 (704)
.+..+|..||++||+.++.. +|+.+. +.|..|.| .||.|+. -.+|+.|+|++|+|+|.+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecC----CCCEEEEECccCCCCCcC
Confidence 35578999999999998655 896332 22223479 9999974 369999999999999999
Q ss_pred chhhccccccceEec-cCCcccCC--------------------------------------------------------
Q 037258 253 SPYFANLTAIEFLDL-SNNSLSGT-------------------------------------------------------- 275 (704)
Q Consensus 253 p~~~~~l~~L~~L~l-~~N~l~g~-------------------------------------------------------- 275 (704)
|++|++|++|++|+| ++|.|+|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877666
Q ss_pred --------------------CCcccCCCCCCCeEeccCCCCCC-----------------Ccccccc--cccCCCccccc
Q 037258 276 --------------------FPEFLSKLPSLRALNLKRNKLTG-----------------SLPADLV--ERSNNGSLTLS 316 (704)
Q Consensus 276 --------------------iP~~~~~l~~L~~l~l~~N~l~g-----------------~~p~~~~--~~~~l~~l~l~ 316 (704)
||.+|++|++|+.|+|++|+|+| .+|..++ ++++|+.|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 89999999999999999999999 4999988 99999999999
Q ss_pred cCCCC
Q 037258 317 VDGNT 321 (704)
Q Consensus 317 ~~~n~ 321 (704)
.|...
T Consensus 500 ~N~l~ 504 (876)
T 4ecn_A 500 NCPNM 504 (876)
T ss_dssp SCTTC
T ss_pred CCCCC
Confidence 87644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.2e-14 Score=162.90 Aligned_cols=123 Identities=20% Similarity=0.291 Sum_probs=105.4
Q ss_pred CChhhHHHHHHhhhhcCC------------CCCCCC-CCCCCCCCce---eeeecCCCCCCCCceEEEEcCCCCCcccCc
Q 037258 190 TDEDDVNALRNIKSTYGV------------KRNWQG-DPCVPKNYWW---DGLNCSYEDNNPSRIISLNLSSSGLTGEIS 253 (704)
Q Consensus 190 ~~~~~~~al~~~~~~~~~------------~~~w~~-~~c~~~~~~w---~gv~c~~~~~~~~~l~~l~L~~n~l~g~~p 253 (704)
....|..||.+|+...+. ..+|+. .+|| .| .||+|+.. .+|+.|+|++|+|+|.+|
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c----~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~lp 98 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD----MWGAQPGVSLNSN----GRVTGLSLEGFGASGRVP 98 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG----GTTCCTTEEECTT----CCEEEEECTTSCCEEEEC
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc----cccCCCCeEEcCC----CCEEEEEecCcccCCcCC
Confidence 446799999999987632 236853 2333 69 99999743 699999999999999999
Q ss_pred hhhccccccceEeccCC---------------------------------------------------------------
Q 037258 254 PYFANLTAIEFLDLSNN--------------------------------------------------------------- 270 (704)
Q Consensus 254 ~~~~~l~~L~~L~l~~N--------------------------------------------------------------- 270 (704)
++|++|++|++|+|++|
T Consensus 99 ~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~ 178 (636)
T 4eco_A 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178 (636)
T ss_dssp GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC
T ss_pred hHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccc
Confidence 99999999999999998
Q ss_pred ---------------cccCCCCcccCCCCCCCeEeccCCCCCCC-----------------cccccc--cccCCCccccc
Q 037258 271 ---------------SLSGTFPEFLSKLPSLRALNLKRNKLTGS-----------------LPADLV--ERSNNGSLTLS 316 (704)
Q Consensus 271 ---------------~l~g~iP~~~~~l~~L~~l~l~~N~l~g~-----------------~p~~~~--~~~~l~~l~l~ 316 (704)
+|+| ||.+++++++|++|+|++|+|+|. +|..++ ++++|+.|+|+
T Consensus 179 ~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~ 257 (636)
T 4eco_A 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257 (636)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEec
Confidence 4556 999999999999999999999996 999999 99999999999
Q ss_pred cCCCC
Q 037258 317 VDGNT 321 (704)
Q Consensus 317 ~~~n~ 321 (704)
.|...
T Consensus 258 ~n~l~ 262 (636)
T 4eco_A 258 NCPNL 262 (636)
T ss_dssp CCTTC
T ss_pred CCcCC
Confidence 87644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-13 Score=160.84 Aligned_cols=121 Identities=26% Similarity=0.342 Sum_probs=83.7
Q ss_pred CChhhHHHHHHhhhhcC---CCCCCC-CCCCCCCCCceeeeecCCCCCCCCceEEEEcCCCCCccc---Cch--------
Q 037258 190 TDEDDVNALRNIKSTYG---VKRNWQ-GDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGE---ISP-------- 254 (704)
Q Consensus 190 ~~~~~~~al~~~~~~~~---~~~~w~-~~~c~~~~~~w~gv~c~~~~~~~~~l~~l~L~~n~l~g~---~p~-------- 254 (704)
..++|..||++||+.+. .+.+|. +++|| .|.||+|+ ..+|+.|+|+++++.|. +|+
T Consensus 9 ~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C----~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKNLLPDWSSNKNPC----TFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG----GSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred CCHHHHHHHHHHHhhCCCcccccCCCCCCCCc----CCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 45789999999999773 478995 45565 79999996 25788888888888876 554
Q ss_pred ---------------hhccccccceEeccCCcccCCCCc--ccCCCCCCCeEeccCCCCCCCccccc-ccccCCCccccc
Q 037258 255 ---------------YFANLTAIEFLDLSNNSLSGTFPE--FLSKLPSLRALNLKRNKLTGSLPADL-VERSNNGSLTLS 316 (704)
Q Consensus 255 ---------------~~~~l~~L~~L~l~~N~l~g~iP~--~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~l~~l~l~ 316 (704)
.|++|++|++|||++|.++|.+|. .+++|++|++|+|++|+++|.+|..+ .++++|+.|+|+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 455556666666666666666666 66666666666666666666666554 555566666555
Q ss_pred cCC
Q 037258 317 VDG 319 (704)
Q Consensus 317 ~~~ 319 (704)
.|.
T Consensus 160 ~n~ 162 (768)
T 3rgz_A 160 ANS 162 (768)
T ss_dssp SSC
T ss_pred CCc
Confidence 443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=122.66 Aligned_cols=99 Identities=23% Similarity=0.216 Sum_probs=86.6
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|+|+.|.|+... +.+.+|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 468899998543 24578999999999999998999999999999999999999766667899999999999999
Q ss_pred CCCCCcccccccccCCCccccccCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
+|++..|..|..+++|+.|+|+.|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~ 113 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNP 113 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCC
Confidence 9997777779999999998887664
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-12 Score=149.75 Aligned_cols=87 Identities=26% Similarity=0.445 Sum_probs=83.1
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
+.++.|+.|||++|+|+|.||.+|++|++|+.|+|++|+|+|.||..|++|++|+.|||++|+|+|.+|..+..++.|+.
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC
Q 037258 313 LTLSVDG 319 (704)
Q Consensus 313 l~l~~~~ 319 (704)
|++++|.
T Consensus 709 L~ls~N~ 715 (768)
T 3rgz_A 709 IDLSNNN 715 (768)
T ss_dssp EECCSSE
T ss_pred EECcCCc
Confidence 9998774
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=117.86 Aligned_cols=98 Identities=19% Similarity=0.182 Sum_probs=82.9
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~ 295 (704)
...-+.|+... +.+.+|+.|+|++|+|++..|..|++|++|++|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 13 ~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 13 DQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp CSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 34567887542 245789999999999999999999999999999999999996555567999999999999999
Q ss_pred CCCCcccccccccCCCccccccCC
Q 037258 296 LTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 296 l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
|++..|..|..+++|+.|+|+.|.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~ 116 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNP 116 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSC
T ss_pred cceeCHHHhccccCCCEEEeCCCC
Confidence 997666669999999998887664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.26 E-value=8.5e-12 Score=124.30 Aligned_cols=100 Identities=21% Similarity=0.178 Sum_probs=86.1
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~ 295 (704)
+|.+|.|+... +.+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 79999998543 345789999999999999889999999999999999999985545667999999999999999
Q ss_pred CCCCcccccccccCCCccccccCCCC
Q 037258 296 LTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 296 l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|++..|..|..+++|+.|+|+.|...
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCccChhHhCcchhhCeEeccCCccc
Confidence 99777777889999999999887654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.7e-13 Score=139.49 Aligned_cols=129 Identities=18% Similarity=0.280 Sum_probs=105.5
Q ss_pred CChhhHHHHHHhhhhcC-C----CCCCC-CCCCCCCCCceeeeecCCC-----CCCCCceEEEEcCCCCCcccCchhhcc
Q 037258 190 TDEDDVNALRNIKSTYG-V----KRNWQ-GDPCVPKNYWWDGLNCSYE-----DNNPSRIISLNLSSSGLTGEISPYFAN 258 (704)
Q Consensus 190 ~~~~~~~al~~~~~~~~-~----~~~w~-~~~c~~~~~~w~gv~c~~~-----~~~~~~l~~l~L~~n~l~g~~p~~~~~ 258 (704)
...+|..||.+||..+. . ..+|. ...|.+..|.|.|+.|... .....+|+.|+|++|+|+ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 44788999999998762 2 34562 1122233347999999521 123578999999999999 99999999
Q ss_pred ccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 259 LTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 259 l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|++|++|+|++|.|+ .+|..++.+++|++|+|++|+|+ .+|..+..+++|+.|+|+.|...
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~ 163 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence 999999999999999 99999999999999999999999 89999999999999999886543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=120.06 Aligned_cols=100 Identities=22% Similarity=0.254 Sum_probs=86.7
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|..|.|+... +.+..|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..|++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 467889997543 24568999999999998 88899999999999999999999877788999999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..|..|..+++|+.|+|+.|.-.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~ 115 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS 115 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCC
Confidence 999888888999999999999887654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=120.00 Aligned_cols=101 Identities=20% Similarity=0.222 Sum_probs=77.0
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCch-hhccccccceEeccCCcccCCCCcccCCCCCCCeEeccC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~ 293 (704)
|.|..+.|+... ..+.+|+.|+|++|+|++..+. .|++|++|++|+|++|+|++.+|..|..+++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 468888887543 1234788888888888865554 478888888888888888877788888888888888888
Q ss_pred CCCCCCcccccccccCCCccccccCCCC
Q 037258 294 NKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 294 N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|+|++..|..|..+++|+.|+|+.|...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 115 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 8888777777888888888888776543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=116.73 Aligned_cols=101 Identities=24% Similarity=0.241 Sum_probs=86.9
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|.+|.|+... +.+++|+.|+|++|+|++..+..|+++++|++|+|++|+|++..|..+..+++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 479999997543 24568999999999999777778899999999999999999666667899999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..|..+..+++|+.|+|+.|.-.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 113 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLK 113 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CccccCHHHhhCCcccCEEECcCCcce
Confidence 999877777889999999999887544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=1.6e-11 Score=118.83 Aligned_cols=86 Identities=23% Similarity=0.335 Sum_probs=81.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++.+|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 57899999999999999999999999999999999999998888889999999999999999999999999999999998
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 132 ~L~~N~ 137 (192)
T 1w8a_A 132 NLASNP 137 (192)
T ss_dssp ECTTCC
T ss_pred EeCCCC
Confidence 887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.8e-11 Score=116.82 Aligned_cols=101 Identities=23% Similarity=0.244 Sum_probs=85.5
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|.+|.|+..+ +.+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|++|
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 479999997543 34568999999999999777777899999999999999999666666889999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..+..+..+++|+.|+|+.|.-.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 113 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQ 113 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCc
Confidence 999766677889999999999877544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.2e-11 Score=118.46 Aligned_cols=100 Identities=16% Similarity=0.179 Sum_probs=58.3
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCch-hhccccccceEeccCCcccCCCCcccCCCCCCCeEeccC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKR 293 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~ 293 (704)
|.|..+.|+... ..+..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 357777776432 1223455666666666655442 356666666666666666655555566666666666666
Q ss_pred CCCCCCcccccccccCCCccccccCCC
Q 037258 294 NKLTGSLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 294 N~l~g~~p~~~~~~~~l~~l~l~~~~n 320 (704)
|+|++..|..|..+++|+.|+|+.|..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l 117 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRI 117 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcC
Confidence 666655555566666666666655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=4e-11 Score=127.19 Aligned_cols=99 Identities=20% Similarity=0.146 Sum_probs=83.5
Q ss_pred CceeeeecCCC--------CCCCCceEEEEcCC-CCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEec
Q 037258 221 YWWDGLNCSYE--------DNNPSRIISLNLSS-SGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291 (704)
Q Consensus 221 ~~w~gv~c~~~--------~~~~~~l~~l~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l 291 (704)
|.|.+|.|+.. -..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 36889999865 23456799999996 9999888899999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccCCCccccccCCC
Q 037258 292 KRNKLTGSLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 292 ~~N~l~g~~p~~~~~~~~l~~l~l~~~~n 320 (704)
++|+|++..|..+..+. |+.|+|..|.-
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~ 115 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPL 115 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCc
Confidence 99999965555555444 88888876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=7.4e-11 Score=119.88 Aligned_cols=135 Identities=13% Similarity=0.070 Sum_probs=106.8
Q ss_pred hcccccccCceEEEEEEeCCCcEEEEEeccc----chhhHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSS----SCCFQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 402 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+...++.|+.+.||++... ++.+++|+... ......+|+++++.+. +..+.++++++.+.+..++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 4667888888999999754 68899999864 2236788999999884 6778899999998899999999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG--------------------------------------------- 511 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------------- 511 (704)
|.+.+.. ......++.+++++|..||..
T Consensus 97 l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 97 CSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 9876421 122347788999999999951
Q ss_pred -----------CCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 512 -----------CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 512 -----------~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
....++|+|+++.||+++++..+.|+||+.+..
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998765567999997743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.15 E-value=6.6e-11 Score=117.07 Aligned_cols=101 Identities=23% Similarity=0.212 Sum_probs=81.0
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|..|.|+... ..+.+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 468899997543 23457889999999998777778888999999999999998877888889999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..+..|..+++|+.|+|+.|...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~ 117 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKIN 117 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCC
Confidence 998544455778888888888877544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=115.42 Aligned_cols=86 Identities=22% Similarity=0.252 Sum_probs=79.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 79 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 158 (220)
T 2v70_A 79 GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158 (220)
T ss_dssp TCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence 57899999999999998888889999999999999999998889999999999999999999999889999999999988
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 159 ~L~~N~ 164 (220)
T 2v70_A 159 NLLANP 164 (220)
T ss_dssp ECCSCC
T ss_pred EecCcC
Confidence 877553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.08 E-value=4.1e-11 Score=125.29 Aligned_cols=111 Identities=28% Similarity=0.488 Sum_probs=93.7
Q ss_pred CCCCCCCCCC--CceeeeecCC-----------CCCCCCceEEEEcCC-CCCcccCchhhccccccceEeccCCcccCCC
Q 037258 211 WQGDPCVPKN--YWWDGLNCSY-----------EDNNPSRIISLNLSS-SGLTGEISPYFANLTAIEFLDLSNNSLSGTF 276 (704)
Q Consensus 211 w~~~~c~~~~--~~w~gv~c~~-----------~~~~~~~l~~l~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~i 276 (704)
|.|-.|.... ..-..+..+. .-..+++|+.|+|++ |+++|.+|..|++|++|++|+|++|+++|.+
T Consensus 38 w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 117 (313)
T 1ogq_A 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117 (313)
T ss_dssp STTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC
T ss_pred CcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcC
Confidence 9999897532 2233333221 113567999999995 9999999999999999999999999999999
Q ss_pred CcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 277 PEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 277 P~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|..++++++|++|+|++|+++|.+|..+..+++|+.|+|+.|...
T Consensus 118 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 162 (313)
T 1ogq_A 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred CHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCccc
Confidence 999999999999999999999999999999999999999877543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=4.7e-10 Score=113.42 Aligned_cols=130 Identities=15% Similarity=0.031 Sum_probs=98.0
Q ss_pred ccc-ccCceEEEEEEeCCCcEEEEEecccch-hhHHHHHHHHHhhcccc--eeEEEEEEEeCCeEEEEEeecCCCCHHHH
Q 037258 405 VLG-KGGFGEVYHGSLDDNQQVAVKMLSSSC-CFQLLQVKLLMRVHHRN--LTALIGYCIEGNNMGLIYEYMASGTLDQY 480 (704)
Q Consensus 405 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 480 (704)
.++ .|..+.||++...+|+.+++|+..... .....|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 344 555699999988778889999976542 35678999999986555 456888888888899999999998884
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 037258 481 LKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC------------------------------------------------ 512 (704)
Q Consensus 481 l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------------ 512 (704)
... .+ ...++.++++.|..||...
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 221 11 2356778888888888421
Q ss_pred -------CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 513 -------KPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 513 -------~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999998753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=2e-10 Score=111.01 Aligned_cols=90 Identities=24% Similarity=0.300 Sum_probs=79.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (193)
T 2wfh_A 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHL 131 (193)
T ss_dssp GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred cccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEE
Confidence 46799999999999998888899999999999999999998888889999999999999999996555678899999988
Q ss_pred ccccCCCCccccC
Q 037258 314 TLSVDGNTSTTCS 326 (704)
Q Consensus 314 ~l~~~~n~s~~c~ 326 (704)
+|+.| + +.|.
T Consensus 132 ~L~~N--~-~~C~ 141 (193)
T 2wfh_A 132 AIGAN--P-LYCD 141 (193)
T ss_dssp ECCSS--C-EECS
T ss_pred EeCCC--C-eecC
Confidence 77654 4 4553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.1e-10 Score=112.18 Aligned_cols=83 Identities=20% Similarity=0.205 Sum_probs=44.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 78 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 157 (220)
T 2v9t_B 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157 (220)
T ss_dssp TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE
Confidence 34555555555555553333334555555555555555555555555555555555555555555444455555555554
Q ss_pred ccc
Q 037258 314 TLS 316 (704)
Q Consensus 314 ~l~ 316 (704)
+|+
T Consensus 158 ~L~ 160 (220)
T 2v9t_B 158 HLA 160 (220)
T ss_dssp ECC
T ss_pred EeC
Confidence 443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.3e-10 Score=125.99 Aligned_cols=107 Identities=20% Similarity=0.208 Sum_probs=88.7
Q ss_pred CCCCCCCCceee--eecCCCC-----CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCC
Q 037258 214 DPCVPKNYWWDG--LNCSYED-----NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPS 285 (704)
Q Consensus 214 ~~c~~~~~~w~g--v~c~~~~-----~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~ 285 (704)
||| +..|.|.+ |.|+..+ ..+++|+.|+|++|++++..|..|++|++|++|+|++|.+.+.+| ..|..+++
T Consensus 2 ~p~-~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~ 80 (455)
T 3v47_A 2 DPG-TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred CCc-cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence 566 34567777 8897543 234689999999999999889999999999999999999988774 57999999
Q ss_pred CCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 286 LRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 286 L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|++|+|++|++++..|..+..+++|+.|+|+.|...
T Consensus 81 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 116 (455)
T 3v47_A 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116 (455)
T ss_dssp CCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCB
T ss_pred CCEEeCCCCccCccChhhccCcccCCEEeCCCCCCC
Confidence 999999999999888999999999999999887653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.3e-10 Score=129.85 Aligned_cols=96 Identities=21% Similarity=0.139 Sum_probs=78.8
Q ss_pred eeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC
Q 037258 225 GLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298 (704)
Q Consensus 225 gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g 298 (704)
.+.|+..+ +.++.++.|||++|+|++..|.+|.+|++|++|||++|+|++..|..|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 47887433 344578999999999997777789999999999999999997667788999999999999999986
Q ss_pred CcccccccccCCCccccccCCC
Q 037258 299 SLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 299 ~~p~~~~~~~~l~~l~l~~~~n 320 (704)
..|..|.++++|+.|+|+.|.-
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l 136 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNL 136 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCC
T ss_pred CCHHHhcCCCCCCEEECCCCcC
Confidence 6666788888888888887754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.3e-10 Score=114.32 Aligned_cols=99 Identities=22% Similarity=0.273 Sum_probs=83.8
Q ss_pred eeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCC
Q 037258 223 WDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296 (704)
Q Consensus 223 w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l 296 (704)
|..|.|+... +.++.|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus 16 ~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 95 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95 (251)
T ss_dssp GTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcc
Confidence 4556665332 2446799999999999988888999999999999999999988888899999999999999999
Q ss_pred CCCcccccccccCCCccccccCCCC
Q 037258 297 TGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 297 ~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
++..|..+..+++|+.|+|+.|.-.
T Consensus 96 ~~~~~~~~~~l~~L~~L~L~~N~l~ 120 (251)
T 3m19_A 96 ASLPLGVFDHLTQLDKLYLGGNQLK 120 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cccChhHhcccCCCCEEEcCCCcCC
Confidence 9877788899999999999887544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.99 E-value=7e-10 Score=105.49 Aligned_cols=86 Identities=21% Similarity=0.243 Sum_probs=75.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 129 (177)
T 2o6r_A 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129 (177)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE
Confidence 56899999999999997777778999999999999999997777778999999999999999996666567889999998
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 130 ~l~~N~ 135 (177)
T 2o6r_A 130 WLHTNP 135 (177)
T ss_dssp ECCSSC
T ss_pred EecCCC
Confidence 887653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.96 E-value=8.1e-10 Score=112.76 Aligned_cols=113 Identities=24% Similarity=0.257 Sum_probs=90.7
Q ss_pred CCCCCCCCCCCCCCceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccC
Q 037258 208 KRNWQGDPCVPKNYWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS 281 (704)
Q Consensus 208 ~~~w~~~~c~~~~~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~ 281 (704)
.+.|.|..|.+. ..|..|.|+... ..+..|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+.
T Consensus 4 ~C~~~~~~C~c~-~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~ 82 (270)
T 2o6q_A 4 LCKKDGGVCSCN-NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK 82 (270)
T ss_dssp CBGGGTCSBEEE-TTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTS
T ss_pred cCCCCCCCCEeC-CCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhc
Confidence 456888887432 246778887433 2345799999999999977777999999999999999999954445568
Q ss_pred CCCCCCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 282 KLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 282 ~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
.+++|++|+|++|++++..+..+..+++|+.|+|+.|...
T Consensus 83 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 122 (270)
T 2o6q_A 83 ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK 122 (270)
T ss_dssp SCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC
Confidence 8999999999999999777777889999999999877543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=4.5e-10 Score=103.52 Aligned_cols=81 Identities=28% Similarity=0.355 Sum_probs=39.6
Q ss_pred CceEEEEcCCCCCc-ccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 236 SRIISLNLSSSGLT-GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 236 ~~l~~l~L~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..++.+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34445555555554 44554445555555555555555433 3344455555555555555544444444445555444
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
++.|
T Consensus 95 ls~N 98 (149)
T 2je0_A 95 LSGN 98 (149)
T ss_dssp CTTS
T ss_pred CCCC
Confidence 4443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=108.83 Aligned_cols=84 Identities=23% Similarity=0.237 Sum_probs=56.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|..|++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 4566777777777777555555677777777777777777 667767777777777777777775555556666777766
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+|+.|
T Consensus 165 ~l~~N 169 (229)
T 3e6j_A 165 YLFGN 169 (229)
T ss_dssp ECTTS
T ss_pred EeeCC
Confidence 55543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.4e-09 Score=109.78 Aligned_cols=87 Identities=23% Similarity=0.228 Sum_probs=74.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 105 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 56789999999999997766778999999999999999996666678999999999999999998777788888999988
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+|+.|.-
T Consensus 185 ~l~~N~~ 191 (251)
T 3m19_A 185 TLFGNQF 191 (251)
T ss_dssp ECCSCCB
T ss_pred EeeCCce
Confidence 8776543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4e-10 Score=103.88 Aligned_cols=84 Identities=29% Similarity=0.291 Sum_probs=72.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCC-cccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS-LPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+|++. ..|+++++|++|+|++|.+++.+|..+..+++|+.|+|++|++++. .|..+..+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 568899999999999866 7889999999999999999988888888899999999999999873 4588889999998
Q ss_pred cccccCC
Q 037258 313 LTLSVDG 319 (704)
Q Consensus 313 l~l~~~~ 319 (704)
|+++.|.
T Consensus 118 L~l~~N~ 124 (149)
T 2je0_A 118 LDLFNCE 124 (149)
T ss_dssp EECTTCG
T ss_pred EeCcCCc
Confidence 8887663
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.94 E-value=7e-10 Score=116.73 Aligned_cols=87 Identities=25% Similarity=0.293 Sum_probs=68.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++ +|+.|++|++|++|+|++|++.|.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|
T Consensus 204 ~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 282 (328)
T 4fcg_A 204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282 (328)
T ss_dssp GCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE
T ss_pred CCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE
Confidence 45678888888888884 66678888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+|+.|...
T Consensus 283 ~L~~n~~~ 290 (328)
T 4fcg_A 283 DLRGCVNL 290 (328)
T ss_dssp ECTTCTTC
T ss_pred eCCCCCch
Confidence 77766543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.3e-09 Score=114.26 Aligned_cols=136 Identities=14% Similarity=0.145 Sum_probs=105.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecc--cc-----hhhHHHHHHHHHhhc--ccceeEEEEEEEeC---CeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLS--SS-----CCFQLLQVKLLMRVH--HRNLTALIGYCIEG---NNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~-----~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lV~e~ 471 (704)
+.|+.|.++.||+....+ ..+++|+.. .. .....+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568999999999998754 678899876 32 236678999999987 45578899988776 458899999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC--------------------------------------- 512 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 512 (704)
++|..+.+... ..++...+..++.++++.|..||...
T Consensus 123 v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99987754211 12678888899999999999999520
Q ss_pred ----------------CCCceecCCCCCCEEeCCCCc--EEEEeccCccc
Q 037258 513 ----------------KPPIVHRDVKSSNILLNEKLQ--AKIADFGLSRI 544 (704)
Q Consensus 513 ----------------~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~ 544 (704)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.93 E-value=7.6e-10 Score=104.22 Aligned_cols=85 Identities=31% Similarity=0.386 Sum_probs=64.1
Q ss_pred CCCceEEEEcCCCCCc-ccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLT-GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+++ |.+|..|..+++|+.|+|++|.|++. ..++.+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4567777888888877 77777777788888888888887754 56777788888888888887777777777777877
Q ss_pred cccccCCC
Q 037258 313 LTLSVDGN 320 (704)
Q Consensus 313 l~l~~~~n 320 (704)
|+|+.|.-
T Consensus 100 L~Ls~N~l 107 (168)
T 2ell_A 100 LNLSGNKL 107 (168)
T ss_dssp EECBSSSC
T ss_pred EeccCCcc
Confidence 77776644
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=9.2e-10 Score=124.36 Aligned_cols=85 Identities=28% Similarity=0.320 Sum_probs=76.8
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCc-ccccccccCCC
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL-PADLVERSNNG 311 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~~~~l~ 311 (704)
+.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.|++|+.|+|++|+|++.+ |..+..+++|+
T Consensus 460 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~ 536 (567)
T 1dce_A 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536 (567)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred cccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence 35678999999999999 899999999999999999999996 88 7999999999999999999887 99999999999
Q ss_pred ccccccCCC
Q 037258 312 SLTLSVDGN 320 (704)
Q Consensus 312 ~l~l~~~~n 320 (704)
.|+|+.|.-
T Consensus 537 ~L~L~~N~l 545 (567)
T 1dce_A 537 LLNLQGNSL 545 (567)
T ss_dssp EEECTTSGG
T ss_pred EEEecCCcC
Confidence 998887643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.5e-09 Score=119.38 Aligned_cols=100 Identities=24% Similarity=0.192 Sum_probs=88.2
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~ 295 (704)
.|..|.|+... +.+++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 46789997543 345689999999999999999999999999999999999998888999999999999999999
Q ss_pred CCCCcccccccccCCCccccccCCCC
Q 037258 296 LTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 296 l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|++..+..+..+++|+.|+|+.|.-.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~ 160 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIE 160 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcc
Confidence 99766777999999999999887643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.91 E-value=7.1e-10 Score=127.55 Aligned_cols=72 Identities=17% Similarity=0.153 Sum_probs=67.1
Q ss_pred CCcccCchhhccccccceEeccCCcccCC-----------------CCcccC--CCCCCCeEeccCCCCCCCcccccccc
Q 037258 247 GLTGEISPYFANLTAIEFLDLSNNSLSGT-----------------FPEFLS--KLPSLRALNLKRNKLTGSLPADLVER 307 (704)
Q Consensus 247 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------iP~~~~--~l~~L~~l~l~~N~l~g~~p~~~~~~ 307 (704)
+|+| ||++|++|++|++|+|++|+|+|. +|.+++ +|++|++|+|++|++.|.+|..++++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4556 899999999999999999999986 999999 99999999999999999999999999
Q ss_pred cCCCccccccCC
Q 037258 308 SNNGSLTLSVDG 319 (704)
Q Consensus 308 ~~l~~l~l~~~~ 319 (704)
++|+.|+|+.|.
T Consensus 273 ~~L~~L~Ls~n~ 284 (636)
T 4eco_A 273 PEMQLINVACNR 284 (636)
T ss_dssp SSCCEEECTTCT
T ss_pred CCCCEEECcCCC
Confidence 999999998775
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.8e-09 Score=105.42 Aligned_cols=85 Identities=24% Similarity=0.243 Sum_probs=57.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 74 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 153 (208)
T 2o6s_A 74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 153 (208)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEE
Confidence 45677777777777775555556777777777777777775555556777777777777777775555556667777766
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+++.|
T Consensus 154 ~l~~N 158 (208)
T 2o6s_A 154 WLHDN 158 (208)
T ss_dssp ECCSC
T ss_pred EecCC
Confidence 66554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=116.32 Aligned_cols=100 Identities=26% Similarity=0.210 Sum_probs=76.0
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhc-cccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
.+..|.|+... ..+..++.|+|++|+|++..+..|. +|++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 19 ~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 19 ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 56778887532 2344577888888888877777776 8888888888888888666677888888888888888
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..|..|..+++|+.|+|+.|...
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~ 125 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIV 125 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCccc
Confidence 888666667788888888888776543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.4e-09 Score=124.58 Aligned_cols=92 Identities=23% Similarity=0.256 Sum_probs=79.1
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccc-cCCC
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVER-SNNG 311 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~-~~l~ 311 (704)
..+++|+.|+|++|+|++.+|..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|++|+|++..|..+..+ ++|+
T Consensus 491 ~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~ 570 (635)
T 4g8a_A 491 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 570 (635)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCC
T ss_pred hhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCC
Confidence 356789999999999999889999999999999999999998888889999999999999999999999988887 5788
Q ss_pred ccccccCCCCccccCC
Q 037258 312 SLTLSVDGNTSTTCSS 327 (704)
Q Consensus 312 ~l~l~~~~n~s~~c~~ 327 (704)
.|+|+. || +.|.+
T Consensus 571 ~L~L~~--Np-~~C~C 583 (635)
T 4g8a_A 571 FLNLTQ--ND-FACTC 583 (635)
T ss_dssp EEECTT--CC-BCCSG
T ss_pred EEEeeC--CC-CcccC
Confidence 776654 55 66753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.2e-10 Score=125.13 Aligned_cols=85 Identities=19% Similarity=0.192 Sum_probs=64.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhc-cccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+|+|.+|..|. +|++|+.|+|++|.|++. |. +..+++|+.|+|++|+|++ +|..+..+++|+.
T Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~ 218 (487)
T 3oja_A 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218 (487)
T ss_dssp GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred CCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccE
Confidence 356788888888888887887776 788888888888888854 33 3458888888888888885 5555888888888
Q ss_pred cccccCCCC
Q 037258 313 LTLSVDGNT 321 (704)
Q Consensus 313 l~l~~~~n~ 321 (704)
|+|+.|...
T Consensus 219 L~Ls~N~l~ 227 (487)
T 3oja_A 219 ISLRNNKLV 227 (487)
T ss_dssp EECTTSCCC
T ss_pred EEecCCcCc
Confidence 888877544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=8.1e-10 Score=124.64 Aligned_cols=86 Identities=20% Similarity=0.104 Sum_probs=69.5
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 45788888888888877788888888888888888888877777888888888888888888877777788888888888
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
++.|.-
T Consensus 105 Ls~n~l 110 (549)
T 2z81_A 105 LMGNPY 110 (549)
T ss_dssp CTTCCC
T ss_pred CCCCcc
Confidence 877643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.3e-09 Score=118.79 Aligned_cols=100 Identities=23% Similarity=0.234 Sum_probs=84.0
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~ 295 (704)
.|..|.|+... +.+.+|+.|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.+|++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 46789997543 345688999999999998888899999999999999999998889999999999999999999
Q ss_pred CCCCcccccccccCCCccccccCCCC
Q 037258 296 LTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 296 l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+++..+..|.++++|+.|+|+.|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~ 117 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIV 117 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCC
T ss_pred CCccCcccccCCCCCCEEECCCCccc
Confidence 99655566888999999988877543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.7e-09 Score=109.65 Aligned_cols=98 Identities=19% Similarity=0.189 Sum_probs=81.2
Q ss_pred eeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC-C
Q 037258 224 DGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK-L 296 (704)
Q Consensus 224 ~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~-l 296 (704)
..|.|+... +.+++|+.|+|++|++++..+..|.++++|++|+|++|.+++..|..+..+++|++|+|++|+ +
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l 93 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (285)
T ss_dssp CEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred eEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCc
Confidence 447776432 345689999999999998777889999999999999999998778889999999999999997 7
Q ss_pred CCCcccccccccCCCccccccCCCC
Q 037258 297 TGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 297 ~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
++..|..+..+++|+.|+++.|...
T Consensus 94 ~~~~~~~~~~l~~L~~L~l~~n~l~ 118 (285)
T 1ozn_A 94 RSVDPATFHGLGRLHTLHLDRCGLQ 118 (285)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred cccCHHHhcCCcCCCEEECCCCcCC
Confidence 7666888999999999988877543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.3e-09 Score=128.58 Aligned_cols=68 Identities=24% Similarity=0.239 Sum_probs=64.9
Q ss_pred CchhhccccccceEeccCCcccC-----------------CCCcccC--CCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 252 ISPYFANLTAIEFLDLSNNSLSG-----------------TFPEFLS--KLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 252 ~p~~~~~l~~L~~L~l~~N~l~g-----------------~iP~~~~--~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
||+.|++|++|+.|+|++|+|+| .||.+++ +|++|+.|+|++|++.|.+|..+.++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 89999999999999999999998 4999988 9999999999999999999999999999999
Q ss_pred cccccCC
Q 037258 313 LTLSVDG 319 (704)
Q Consensus 313 l~l~~~~ 319 (704)
|+|+.|.
T Consensus 520 L~Ls~N~ 526 (876)
T 4ecn_A 520 LNIACNR 526 (876)
T ss_dssp EECTTCT
T ss_pred EECcCCC
Confidence 9998875
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-09 Score=101.51 Aligned_cols=88 Identities=22% Similarity=0.192 Sum_probs=72.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCC-CCcccCCCCCCCeEeccCCCCCCCcc---cccccccC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT-FPEFLSKLPSLRALNLKRNKLTGSLP---ADLVERSN 309 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-iP~~~~~l~~L~~l~l~~N~l~g~~p---~~~~~~~~ 309 (704)
.+++|+.|+|++|++++.+|..+.++++|++|+|++|+|++. .+..+..+++|+.|+|++|.+++..+ ..+..+++
T Consensus 69 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~ 148 (168)
T 2ell_A 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQ 148 (168)
T ss_dssp CCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSS
T ss_pred cCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCcc
Confidence 567899999999999988888888899999999999999853 22678899999999999999996544 47888899
Q ss_pred CCccccccCCCC
Q 037258 310 NGSLTLSVDGNT 321 (704)
Q Consensus 310 l~~l~l~~~~n~ 321 (704)
|+.|+++.+...
T Consensus 149 L~~L~l~~n~~~ 160 (168)
T 2ell_A 149 LTYLDGYDREDQ 160 (168)
T ss_dssp CCEETTEETTSC
T ss_pred CcEecCCCCChh
Confidence 998888776543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.7e-09 Score=108.16 Aligned_cols=96 Identities=21% Similarity=0.180 Sum_probs=80.4
Q ss_pred eecCCCCC---CCCceEEEEcCCCCCcccCchhhccccccceEeccCCc-ccCCCCcccCCCCCCCeEeccC-CCCCCCc
Q 037258 226 LNCSYEDN---NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNS-LSGTFPEFLSKLPSLRALNLKR-NKLTGSL 300 (704)
Q Consensus 226 v~c~~~~~---~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~iP~~~~~l~~L~~l~l~~-N~l~g~~ 300 (704)
|.|..... .+..|+.|+|++|+|++..+..|.++++|++|+|++|+ +++..|..|..+++|+.|+|++ |++++..
T Consensus 18 v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp EEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred eEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 55964221 34589999999999997777799999999999999997 8855556899999999999999 9999766
Q ss_pred ccccccccCCCccccccCCCC
Q 037258 301 PADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 301 p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|..|..+++|+.|+++.|.-.
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~ 118 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLK 118 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCC
T ss_pred HHHhCCCCCCCEEeCCCCCCc
Confidence 678999999999999887544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.85 E-value=4.1e-09 Score=107.60 Aligned_cols=86 Identities=24% Similarity=0.234 Sum_probs=72.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..++.+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 131 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (272)
T 3rfs_A 131 KLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 210 (272)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEE
Confidence 56788999999999997777778889999999999999997777778889999999999999998777778888889888
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+++.|.
T Consensus 211 ~l~~N~ 216 (272)
T 3rfs_A 211 WLHDNP 216 (272)
T ss_dssp ECCSSC
T ss_pred EccCCC
Confidence 876653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.8e-09 Score=107.91 Aligned_cols=88 Identities=22% Similarity=0.244 Sum_probs=77.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..|..|+++++|++|+|++|+|++..|..++.+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 57889999999999998777889999999999999999997777778999999999999999998777778899999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 187 ~L~~N~l~ 194 (272)
T 3rfs_A 187 RLYQNQLK 194 (272)
T ss_dssp ECCSSCCS
T ss_pred ECCCCcCC
Confidence 99877544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=2e-09 Score=110.14 Aligned_cols=97 Identities=21% Similarity=0.139 Sum_probs=83.4
Q ss_pred eeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC
Q 037258 225 GLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298 (704)
Q Consensus 225 gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g 298 (704)
.+.|.... +.+..|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 47786432 234579999999999998777799999999999999999997777789999999999999999998
Q ss_pred CcccccccccCCCccccccCCCC
Q 037258 299 SLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 299 ~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
..|..+..+++|+.|+++.|...
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~ 113 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLA 113 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCC
T ss_pred cChhhhcCCccccEEECCCCCcc
Confidence 88889999999999998877543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=3.8e-09 Score=120.72 Aligned_cols=96 Identities=21% Similarity=0.212 Sum_probs=70.2
Q ss_pred eeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC
Q 037258 225 GLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG 298 (704)
Q Consensus 225 gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g 298 (704)
.|.|+... +.+++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++
T Consensus 15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 47776432 234577778888888877777777777888888888777776667777777777777777777777
Q ss_pred CcccccccccCCCccccccCCC
Q 037258 299 SLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 299 ~~p~~~~~~~~l~~l~l~~~~n 320 (704)
..|..|.++++|+.|+|+.|..
T Consensus 95 ~~p~~~~~l~~L~~L~L~~n~l 116 (606)
T 3vq2_A 95 FSPGSFSGLTSLENLVAVETKL 116 (606)
T ss_dssp CCTTSSTTCTTCCEEECTTSCC
T ss_pred cChhhcCCcccCCEEEccCCcc
Confidence 7777777777777777766643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.84 E-value=2.1e-09 Score=104.16 Aligned_cols=84 Identities=21% Similarity=0.353 Sum_probs=49.6
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..++.+++|+.|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 4556666666666665556666666666666666666665555556666666666666665333444 455566666665
Q ss_pred cccCC
Q 037258 315 LSVDG 319 (704)
Q Consensus 315 l~~~~ 319 (704)
++.|.
T Consensus 166 l~~n~ 170 (197)
T 4ezg_A 166 IQFDG 170 (197)
T ss_dssp CTTBC
T ss_pred CCCCC
Confidence 55543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=1.9e-09 Score=123.21 Aligned_cols=110 Identities=20% Similarity=0.198 Sum_probs=81.7
Q ss_pred CCCCCCCCCCCceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCC
Q 037258 211 WQGDPCVPKNYWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLP 284 (704)
Q Consensus 211 w~~~~c~~~~~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~ 284 (704)
|.+.+|.... .+.-+.|+..+ +.+..++.|+|++|+|++..|..|++|++|++|+|++|++++..|..|++++
T Consensus 3 ~~~~~C~~~~-~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 3 SSDQKCIEKE-VNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ---CCCEEEE-TTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred cccCceeccc-CCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 4445564211 23357786432 2345788888888888887788888888888888888888887788888888
Q ss_pred CCCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 285 SLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 285 ~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++|+|++|++++..|..+..+++|+.|+++.|...
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 118 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCcc
Confidence 8888888888888878888888888888888776543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.84 E-value=3e-09 Score=121.40 Aligned_cols=86 Identities=21% Similarity=0.194 Sum_probs=63.3
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++..|..|++|++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|..+++|+.|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 45677777777777777777777788888888888887776667777777888888888877754444467777777777
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
|+.|..
T Consensus 154 Ls~N~l 159 (597)
T 3oja_B 154 MSNNNL 159 (597)
T ss_dssp CCSSCC
T ss_pred eeCCcC
Confidence 776654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.7e-09 Score=115.11 Aligned_cols=100 Identities=22% Similarity=0.188 Sum_probs=85.9
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~ 295 (704)
.|..|.|+... +.+..++.|+|++|+|++..+..|.+|++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 46789997532 345678999999999998888999999999999999999997777889999999999999999
Q ss_pred CCCCcccccccccCCCccccccCCCC
Q 037258 296 LTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 296 l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
|++..+..|..+++|+.|+|+.|.-.
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~ 149 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIE 149 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCC
T ss_pred CCeeCHhHhhccccCceeeCCCCccc
Confidence 99666668999999999999877543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.82 E-value=2.8e-09 Score=113.64 Aligned_cols=85 Identities=26% Similarity=0.217 Sum_probs=48.4
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 45555566666666555555555566666666666665544444555556666666666665555555555555555555
Q ss_pred cccCC
Q 037258 315 LSVDG 319 (704)
Q Consensus 315 l~~~~ 319 (704)
|+.|.
T Consensus 143 L~~N~ 147 (361)
T 2xot_A 143 LSQNQ 147 (361)
T ss_dssp CCSSC
T ss_pred CCCCc
Confidence 55543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.9e-09 Score=125.58 Aligned_cols=84 Identities=26% Similarity=0.311 Sum_probs=67.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|+ .||..|++|++|++|+|++|+|+ .||..|+.|++|++|+|++|.|+ .||..|..+++|+.|
T Consensus 245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L 321 (727)
T 4b8c_D 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL 321 (727)
T ss_dssp GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence 4567888888888888 78888888888888888888888 77888888888888888888886 778888888888888
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+|+.|..
T Consensus 322 ~L~~N~l 328 (727)
T 4b8c_D 322 GVEGNPL 328 (727)
T ss_dssp ECTTSCC
T ss_pred eCCCCcc
Confidence 7776643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.81 E-value=5.1e-09 Score=99.28 Aligned_cols=80 Identities=21% Similarity=0.190 Sum_probs=71.9
Q ss_pred EEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccC
Q 037258 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVD 318 (704)
Q Consensus 239 ~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~ 318 (704)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+.|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67999999996 8898775 89999999999999888999999999999999999999765566789999999999887
Q ss_pred CCC
Q 037258 319 GNT 321 (704)
Q Consensus 319 ~n~ 321 (704)
.-.
T Consensus 92 ~l~ 94 (174)
T 2r9u_A 92 HLK 94 (174)
T ss_dssp CCC
T ss_pred ccc
Confidence 654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.80 E-value=5.3e-09 Score=98.75 Aligned_cols=81 Identities=20% Similarity=0.225 Sum_probs=72.8
Q ss_pred eEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccccc
Q 037258 238 IISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSV 317 (704)
Q Consensus 238 l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~ 317 (704)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|+.
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999999 6888774 8999999999999988899999999999999999999977777789999999999998
Q ss_pred CCCC
Q 037258 318 DGNT 321 (704)
Q Consensus 318 ~~n~ 321 (704)
|.-.
T Consensus 88 N~l~ 91 (170)
T 3g39_A 88 NQLK 91 (170)
T ss_dssp SCCC
T ss_pred CccC
Confidence 8654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=2.8e-09 Score=113.25 Aligned_cols=88 Identities=22% Similarity=0.142 Sum_probs=77.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
..++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|+.|
T Consensus 50 ~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 129 (353)
T 2z80_A 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFL 129 (353)
T ss_dssp CCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEE
T ss_pred ccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEE
Confidence 34589999999999997766799999999999999999998888889999999999999999996555558999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 130 ~L~~n~l~ 137 (353)
T 2z80_A 130 NLLGNPYK 137 (353)
T ss_dssp ECTTCCCS
T ss_pred ECCCCCCc
Confidence 99877544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7.4e-09 Score=106.84 Aligned_cols=82 Identities=22% Similarity=0.221 Sum_probs=44.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+..+.+|+.|
T Consensus 122 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l 200 (290)
T 1p9a_G 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200 (290)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred CCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeE
Confidence 3455555666666665444445555566666666666665333333455556666666666655 555555555555544
Q ss_pred ccc
Q 037258 314 TLS 316 (704)
Q Consensus 314 ~l~ 316 (704)
+|+
T Consensus 201 ~L~ 203 (290)
T 1p9a_G 201 FLH 203 (290)
T ss_dssp ECC
T ss_pred EeC
Confidence 443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7.2e-09 Score=106.93 Aligned_cols=87 Identities=25% Similarity=0.219 Sum_probs=52.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 98 ~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 45566666666666665555566666666666666666664444455666666666666666664333344556666666
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+|+.|.-
T Consensus 178 ~L~~N~l 184 (290)
T 1p9a_G 178 LLQENSL 184 (290)
T ss_dssp ECCSSCC
T ss_pred ECCCCcC
Confidence 6655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.2e-09 Score=112.02 Aligned_cols=83 Identities=20% Similarity=0.255 Sum_probs=42.0
Q ss_pred CCceEEEEcCCCCCcccCchhhccc-----cccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCC--ccccc--c
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANL-----TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS--LPADL--V 305 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~--~p~~~--~ 305 (704)
+++|+.|+|++|+|++. |..|+++ ++|++|+|++|++++..|..++.+++|+.|+|++|++.|. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 44555555555555544 4555554 5555555555555544445555555555555555555443 22232 4
Q ss_pred cccCCCccccccC
Q 037258 306 ERSNNGSLTLSVD 318 (704)
Q Consensus 306 ~~~~l~~l~l~~~ 318 (704)
.+++|+.|+|+.|
T Consensus 199 ~l~~L~~L~L~~N 211 (312)
T 1wwl_A 199 KFPTLQVLALRNA 211 (312)
T ss_dssp SCTTCCEEECTTS
T ss_pred cCCCCCEEECCCC
Confidence 4555555555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=104.46 Aligned_cols=88 Identities=20% Similarity=0.232 Sum_probs=70.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC-CcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG-SLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+..++.+++|+.|+|++|++++ .+|..+..+++|+.
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~ 153 (276)
T 2z62_A 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153 (276)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred CCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCE
Confidence 46788888888888887777788888888888888888886666678888888888888888876 46888888888888
Q ss_pred cccccCCCC
Q 037258 313 LTLSVDGNT 321 (704)
Q Consensus 313 l~l~~~~n~ 321 (704)
|+|+.|...
T Consensus 154 L~Ls~N~l~ 162 (276)
T 2z62_A 154 LDLSSNKIQ 162 (276)
T ss_dssp EECCSSCCC
T ss_pred EECCCCCCC
Confidence 888766543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.76 E-value=9.7e-09 Score=106.62 Aligned_cols=85 Identities=21% Similarity=0.216 Sum_probs=66.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCccccccccc-CCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERS-NNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~-~l~~ 312 (704)
.+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..+..++ +|+.
T Consensus 173 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 252 (306)
T 2z66_A 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252 (306)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCE
T ss_pred hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCE
Confidence 567788888888888877778888888888888888888866666778888888888888888888888877774 7777
Q ss_pred cccccC
Q 037258 313 LTLSVD 318 (704)
Q Consensus 313 l~l~~~ 318 (704)
|+|+.|
T Consensus 253 L~L~~N 258 (306)
T 2z66_A 253 LNLTQN 258 (306)
T ss_dssp EECTTC
T ss_pred EEccCC
Confidence 776554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.76 E-value=1e-08 Score=107.77 Aligned_cols=98 Identities=21% Similarity=0.245 Sum_probs=84.3
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|..+.|+... ...++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..++.+++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 468999997543 23468999999999999888889999999999999999999888999999999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+++ .+|..+. ++|+.|+++.|.-.
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~ 136 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIR 136 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccC
Confidence 999 7887766 78888888776543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.1e-08 Score=112.55 Aligned_cols=87 Identities=21% Similarity=0.204 Sum_probs=60.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..|..|+++++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 297 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 376 (455)
T 3v47_A 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376 (455)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence 45667777777777776666677777777777777777766666667777777777777777776666677777777777
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+|+.|.-
T Consensus 377 ~L~~N~l 383 (455)
T 3v47_A 377 ALDTNQL 383 (455)
T ss_dssp ECCSSCC
T ss_pred ECCCCcc
Confidence 7666543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.7e-08 Score=106.10 Aligned_cols=97 Identities=25% Similarity=0.295 Sum_probs=83.7
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|+.+.|+... ..++.|+.|+|++|+|++..+..|+++++|++|+|++|++++..|..++.+++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 478899997432 23468999999999999887789999999999999999999888999999999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n 320 (704)
+++ .+|..+. ++|+.|+++.|..
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l 133 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEI 133 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCC
T ss_pred cCC-ccChhhc--ccccEEECCCCcc
Confidence 999 7887765 6888888876643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.5e-08 Score=103.32 Aligned_cols=85 Identities=24% Similarity=0.254 Sum_probs=61.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 131 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (270)
T 2o6q_A 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210 (270)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE
Confidence 56777888888888776555567778888888888888876555567777888888888888876555567777777766
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+|+.|
T Consensus 211 ~l~~N 215 (270)
T 2o6q_A 211 QLQEN 215 (270)
T ss_dssp ECCSS
T ss_pred EecCC
Confidence 66544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=7.8e-09 Score=116.77 Aligned_cols=80 Identities=25% Similarity=0.325 Sum_probs=74.5
Q ss_pred ceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccc
Q 037258 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~ 316 (704)
.|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|+.|++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999996 776 999999999999999999 999999999999999999999997 78 89999999999999
Q ss_pred cCCCC
Q 037258 317 VDGNT 321 (704)
Q Consensus 317 ~~~n~ 321 (704)
.|...
T Consensus 517 ~N~l~ 521 (567)
T 1dce_A 517 NNRLQ 521 (567)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 88654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-08 Score=104.32 Aligned_cols=84 Identities=27% Similarity=0.231 Sum_probs=39.8
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCc-ccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNS-LSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
+++|+.|+|++|++++..|..|+++++|++|+|++|. +++..|..+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3444445555555444444444445555555555444 333334444444455555555555444444444444444444
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+++.|
T Consensus 135 ~l~~n 139 (285)
T 1ozn_A 135 YLQDN 139 (285)
T ss_dssp ECCSS
T ss_pred ECCCC
Confidence 44443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.73 E-value=7.8e-09 Score=120.40 Aligned_cols=85 Identities=29% Similarity=0.316 Sum_probs=80.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+..|+.|+|++|+|. .||..+.+|++|++|+|++|.|+ .||..|++|++|+.|+|++|+|+ .+|..|+.+++|+.|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 5788999999999999 89999999999999999999999 99999999999999999999999 899999999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+|+.|...
T Consensus 299 ~L~~N~l~ 306 (727)
T 4b8c_D 299 YFFDNMVT 306 (727)
T ss_dssp ECCSSCCC
T ss_pred ECCCCCCC
Confidence 99988543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.73 E-value=5.1e-09 Score=99.41 Aligned_cols=79 Identities=20% Similarity=0.205 Sum_probs=52.1
Q ss_pred ceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCccc--ccccccCCCccc
Q 037258 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA--DLVERSNNGSLT 314 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~~~l~~l~ 314 (704)
+|+.|+|++|+|++. +.|++|++|++|+|++|+|++..|..++.+++|+.|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 677777777777754 56777777777777777777433333466777777777777774 5665 666667777666
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
++.|
T Consensus 120 l~~N 123 (176)
T 1a9n_A 120 ILRN 123 (176)
T ss_dssp CCSS
T ss_pred ecCC
Confidence 6544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=1.1e-08 Score=106.13 Aligned_cols=180 Identities=19% Similarity=0.168 Sum_probs=119.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccc--hhhHHHHHHHHHhhc-ccc--eeEEEEEEEeCC---eEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSS--CCFQLLQVKLLMRVH-HRN--LTALIGYCIEGN---NMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lV~e~~~~g 475 (704)
+.++.|....||+.. ..+++|+.... ......|.++++.+. +.. +.+++......+ ..++||++++|.
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 458999999999863 56899987654 235678999998883 332 345555443333 347899999998
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG-------------------------------------------- 511 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 511 (704)
+|.+.... .++..++..++.++++.|..||..
T Consensus 102 ~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 102 PLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp ECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred ECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 88754321 267777888888888888888841
Q ss_pred -----------CCCCceecCCCCCCEEeCC--CCcEEEEeccCccccccCCCCcccccccCCCCc---cCcccccc----
Q 037258 512 -----------CKPPIVHRDVKSSNILLNE--KLQAKIADFGLSRIFSIESSDQISTAVAGTPGY---LDPEYYVL---- 571 (704)
Q Consensus 512 -----------~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~---- 571 (704)
....++|+|+++.||++++ ...+.|+||+.+..-.. .... .....+ ..|+....
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~--~~Dl----~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP--DNDF----ISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT--THHH----HTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh--HHHH----HHHHhhccccCHHHHHHHHHH
Confidence 0135799999999999988 45678999998865311 0000 000011 22222110
Q ss_pred -C---------CCCcchhHHHHHHHHHHHHhCCCCC
Q 037258 572 -N---------WLNEKSDVYSFGVVLLEIITGRRPV 597 (704)
Q Consensus 572 -~---------~~~~~sDVwSlGvvl~elltG~~Pf 597 (704)
+ ......+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0112368999999999999998876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.72 E-value=8.6e-09 Score=109.10 Aligned_cols=80 Identities=19% Similarity=0.169 Sum_probs=73.8
Q ss_pred EEEcCCC-CCcccCchhhccccccceEeccC-CcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccccc
Q 037258 240 SLNLSSS-GLTGEISPYFANLTAIEFLDLSN-NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSV 317 (704)
Q Consensus 240 ~l~L~~n-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~ 317 (704)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++..|..|+.|++|+.|+|++|+|+|..|..|.++++|+.|+|+.
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4699998 899 5888 99999999999996 999988888999999999999999999999999999999999999998
Q ss_pred CCCC
Q 037258 318 DGNT 321 (704)
Q Consensus 318 ~~n~ 321 (704)
|...
T Consensus 90 N~l~ 93 (347)
T 2ifg_A 90 NALE 93 (347)
T ss_dssp SCCS
T ss_pred Cccc
Confidence 8654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.71 E-value=9e-09 Score=106.84 Aligned_cols=87 Identities=22% Similarity=0.258 Sum_probs=61.7
Q ss_pred CCCceEEEEcCCCCCcc-cCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTG-EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|.+++ .+|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 45677777777777776 56667777777777777777777666777777777777777777777655556677777777
Q ss_pred cccccCCC
Q 037258 313 LTLSVDGN 320 (704)
Q Consensus 313 l~l~~~~n 320 (704)
|+|+.|..
T Consensus 228 L~L~~N~l 235 (306)
T 2z66_A 228 LDYSLNHI 235 (306)
T ss_dssp EECTTSCC
T ss_pred eECCCCCC
Confidence 77766644
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.6e-08 Score=114.49 Aligned_cols=95 Identities=20% Similarity=0.236 Sum_probs=78.6
Q ss_pred eeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCC
Q 037258 224 DGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297 (704)
Q Consensus 224 ~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~ 297 (704)
.-+.|+... +.+++|+.|+|++|+|++..|..|++|++|++|+|++|+|++..|..|+.+++|++|+|++|+|+
T Consensus 34 ~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp CEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 456676432 23468999999999999888889999999999999999999888888999999999999999998
Q ss_pred CCcccccccccCCCccccccCCCC
Q 037258 298 GSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 298 g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
.+|.. .+++|+.|+|+.|...
T Consensus 114 -~lp~~--~l~~L~~L~Ls~N~l~ 134 (562)
T 3a79_B 114 -NISCC--PMASLRHLDLSFNDFD 134 (562)
T ss_dssp -EECSC--CCTTCSEEECCSSCCS
T ss_pred -ccCcc--ccccCCEEECCCCCcc
Confidence 78877 7888888888877644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.70 E-value=8.2e-09 Score=97.97 Aligned_cols=84 Identities=21% Similarity=0.139 Sum_probs=73.8
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCc--ccCCCCCCCeEeccCCCCCCCcccc----ccc
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE--FLSKLPSLRALNLKRNKLTGSLPAD----LVE 306 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~--~~~~l~~L~~l~l~~N~l~g~~p~~----~~~ 306 (704)
..+++|+.|+|++|+|++..|..|+++++|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..
T Consensus 61 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~ 138 (176)
T 1a9n_A 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYK 138 (176)
T ss_dssp CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHH
T ss_pred ccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHH
Confidence 35789999999999999655555699999999999999996 7887 8999999999999999998 67875 889
Q ss_pred ccCCCccccccC
Q 037258 307 RSNNGSLTLSVD 318 (704)
Q Consensus 307 ~~~l~~l~l~~~ 318 (704)
+++|+.|+++.+
T Consensus 139 l~~L~~Ld~~~n 150 (176)
T 1a9n_A 139 VPQVRVLDFQKV 150 (176)
T ss_dssp CTTCSEETTEEC
T ss_pred CCccceeCCCcC
Confidence 999999988755
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.70 E-value=8.3e-09 Score=99.87 Aligned_cols=84 Identities=20% Similarity=0.218 Sum_probs=76.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|.++ .++.|.++++|++|+|++|++++..|..++.|++|+.|+|++|++++..|..+..+++|+.|
T Consensus 64 ~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L 141 (197)
T 4ezg_A 64 YAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141 (197)
T ss_dssp GCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEE
T ss_pred cCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEE
Confidence 4678999999999765 44589999999999999999998889999999999999999999999899999999999999
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+++.|.
T Consensus 142 ~L~~n~ 147 (197)
T 4ezg_A 142 DLSYNG 147 (197)
T ss_dssp ECCSCT
T ss_pred EccCCC
Confidence 998775
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.6e-08 Score=111.18 Aligned_cols=91 Identities=20% Similarity=0.150 Sum_probs=79.5
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 294 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCE
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCE
Confidence 35788999999999999999999999999999999999999888999999999999999999999777777888999998
Q ss_pred cccccCCCCccccC
Q 037258 313 LTLSVDGNTSTTCS 326 (704)
Q Consensus 313 l~l~~~~n~s~~c~ 326 (704)
|+|+.| + ..|.
T Consensus 295 L~L~~N--p-~~Cd 305 (452)
T 3zyi_A 295 LHLHHN--P-WNCD 305 (452)
T ss_dssp EECCSS--C-EECS
T ss_pred EEccCC--C-cCCC
Confidence 877654 4 5564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.8e-08 Score=115.14 Aligned_cols=89 Identities=21% Similarity=0.206 Sum_probs=78.4
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC-CcccccccccCCC
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG-SLPADLVERSNNG 311 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~l~ 311 (704)
..+++|+.|+|++|++++..|..|++|++|++|+|++|.+++..|..++++++|++|+|++|++++ .+|..+.++++|+
T Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~ 156 (606)
T 3vq2_A 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156 (606)
T ss_dssp TTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCC
T ss_pred hchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCC
Confidence 367899999999999998889999999999999999999997777889999999999999999986 6899999999999
Q ss_pred ccccccCCCC
Q 037258 312 SLTLSVDGNT 321 (704)
Q Consensus 312 ~l~l~~~~n~ 321 (704)
.|+++.|...
T Consensus 157 ~L~Ls~n~l~ 166 (606)
T 3vq2_A 157 HVDLSYNYIQ 166 (606)
T ss_dssp EEECCSSCCC
T ss_pred EEEccCCcce
Confidence 9998887644
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.69 E-value=1.4e-08 Score=109.23 Aligned_cols=82 Identities=26% Similarity=0.316 Sum_probs=38.6
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccc-cccccCCCccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD-LVERSNNGSLT 314 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~l~~l~ 314 (704)
++|+.|+|++|++++..+..|+++++|++|+|++|.+++..|..++.+++|++|+|++|+++ .+|.. +..+++|+.|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 34444455555554444444555555555555555555444444445555555555555554 22322 34444555444
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
++.|
T Consensus 148 L~~n 151 (390)
T 3o6n_A 148 MSNN 151 (390)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 4443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.69 E-value=1.6e-08 Score=110.82 Aligned_cols=92 Identities=20% Similarity=0.169 Sum_probs=79.5
Q ss_pred CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 233 ~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 283 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCE
Confidence 35778999999999999988999999999999999999999888889999999999999999999777777888999998
Q ss_pred cccccCCCCccccCC
Q 037258 313 LTLSVDGNTSTTCSS 327 (704)
Q Consensus 313 l~l~~~~n~s~~c~~ 327 (704)
|+|+. |+ +.|.+
T Consensus 284 L~L~~--Np-~~CdC 295 (440)
T 3zyj_A 284 IHLHH--NP-WNCNC 295 (440)
T ss_dssp EECCS--SC-EECSS
T ss_pred EEcCC--CC-ccCCC
Confidence 77764 44 55643
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2e-08 Score=94.92 Aligned_cols=146 Identities=15% Similarity=0.157 Sum_probs=86.6
Q ss_pred eeeeeccCCCCCCceecCCCCCCceeecCCCCC-ceeccc-cccccCCCCCCCCChHHHHhhcccccCCCcceEEEeeCC
Q 037258 20 LLRRYDFGSITNKSVRYKDDIYDRLWMPKNYPG-WKKLST-SLPIDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEP 97 (704)
Q Consensus 20 l~~R~~~g~~~~~~~ryp~D~~dR~W~~~~~~~-~~~~~t-~~~~~~~~~~~~~~p~~v~~ta~~~~~~~~~~~~~~~~~ 97 (704)
.+-|.|.|+. ... |..+|.|.++.... ....+. ...+.. .....+|..|.|||=.... .+... -+
T Consensus 6 ~~~~INcGg~--~~~----d~~gr~w~~D~~~~~~g~~~~~~~~~~~--~~~~~~~~~lY~TaR~~~~---~~tY~--f~ 72 (174)
T 2jwp_A 6 VIWAVNAGGE--SHV----DVHGIHYRKDPLEGRVGRASDYGMKLPI--LRSNPEDQVLYQTERYNED---SFGYD--IP 72 (174)
T ss_dssp EEEEEEETSS--SEE----ETTTEEECSSCSSTTCCCCCCCCTTSCC--SSSCHHHHHTTTCCCCCCS---CEEEE--EE
T ss_pred EEEEEECCCC--Ccc----CCCCCEEcCCcCcccCCcccccccceEe--cccCCCCchhhhhhccCCC---CeEEE--EE
Confidence 3568999953 222 67899999864311 011110 111111 1123478889999987542 23322 23
Q ss_pred CCCCCceEEEEEeeeeeccCCCceeEEEEEEcCeeeccCcccc-------cceeeeEEe----------eeecCCceEEE
Q 037258 98 TDPASQYYVYMHFCEVEVLLANQTREFNITQNGKFYIGPIVPT-------YLYTTTALS----------SVPVSGARIEY 160 (704)
Q Consensus 98 ~~~~~~~~v~l~Fae~~~~~~~~~R~F~i~lng~~~~~~~~p~-------~~~~~~~~~----------~~~~~~~~~~~ 160 (704)
.+++..|.|-|||+|+... +.+.|.|||++||+.....+.+. .......+. .+...++.+++
T Consensus 73 v~~~G~Y~VrLhF~ei~~~-~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I 151 (174)
T 2jwp_A 73 IKEEGEYVLVLKFAEVYFA-QSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSV 151 (174)
T ss_dssp CCSCEEEEEEEEEECCSCC-CSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEE
T ss_pred eCCCeEEEEEEEEeccccC-CCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEE
Confidence 5667799999999999743 56889999999998664333221 111111111 01124567899
Q ss_pred EEeccCCCchhhHHHHHHHhh
Q 037258 161 IINATERSTLQPILNAMEIYM 181 (704)
Q Consensus 161 ~l~~t~~S~lpPllna~e~~~ 181 (704)
++.+.. .-.|+|||+||+.
T Consensus 152 ~f~p~~--~~~a~inaIEI~~ 170 (174)
T 2jwp_A 152 EFVKGY--YDNPKVCALFIMK 170 (174)
T ss_dssp EEECSS--SCSSSEEEEEEES
T ss_pred EEeccC--CCCcEEEEEEEEe
Confidence 998653 3359999999874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=7.1e-09 Score=108.11 Aligned_cols=84 Identities=23% Similarity=0.271 Sum_probs=69.2
Q ss_pred CCceEEEEcCCCCCcccCchhh--ccccccceEeccCCcccCCCCcccCCC-----CCCCeEeccCCCCCCCcccccccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYF--ANLTAIEFLDLSNNSLSGTFPEFLSKL-----PSLRALNLKRNKLTGSLPADLVER 307 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~--~~l~~L~~L~l~~N~l~g~iP~~~~~l-----~~L~~l~l~~N~l~g~~p~~~~~~ 307 (704)
+++|+.|+|++|+++|.+|..+ +++++|++|+|++|+|++. |..++.+ ++|++|+|++|++++..|..+..+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 5678888888888888888876 8888888888888888866 7777766 888888888888887777888888
Q ss_pred cCCCccccccCC
Q 037258 308 SNNGSLTLSVDG 319 (704)
Q Consensus 308 ~~l~~l~l~~~~ 319 (704)
++|+.|+|+.|.
T Consensus 173 ~~L~~L~Ls~N~ 184 (312)
T 1wwl_A 173 PALSTLDLSDNP 184 (312)
T ss_dssp SSCCEEECCSCT
T ss_pred CCCCEEECCCCC
Confidence 888888887775
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.68 E-value=1.4e-08 Score=113.66 Aligned_cols=84 Identities=23% Similarity=0.193 Sum_probs=68.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC-CcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG-SLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+|++..|..|++|++|++|+|++|+|+ .||.. .+++|++|+|++|++++ .+|..++.+++|+.
T Consensus 43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 119 (520)
T 2z7x_B 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119 (520)
T ss_dssp TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCE
T ss_pred ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceE
Confidence 4677888888888888777888888888888888888888 67776 78888888888888887 57888888888888
Q ss_pred cccccCCC
Q 037258 313 LTLSVDGN 320 (704)
Q Consensus 313 l~l~~~~n 320 (704)
|+++.|.-
T Consensus 120 L~L~~n~l 127 (520)
T 2z7x_B 120 LGLSTTHL 127 (520)
T ss_dssp EEEEESSC
T ss_pred EEecCccc
Confidence 88877643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.1e-08 Score=114.40 Aligned_cols=88 Identities=20% Similarity=0.207 Sum_probs=70.6
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|.|++..|..|++|++|++|+|++|.|++..|..|+++++|++|+|++|.|++..|..+..+++|+.|
T Consensus 97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 176 (597)
T 3oja_B 97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176 (597)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence 56788888888888888777788888888888888888884444456888888888888888888778888888888888
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+|+.|...
T Consensus 177 ~L~~N~l~ 184 (597)
T 3oja_B 177 QLSSNRLT 184 (597)
T ss_dssp ECTTSCCS
T ss_pred ECcCCCCC
Confidence 88776543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2e-08 Score=116.46 Aligned_cols=83 Identities=29% Similarity=0.365 Sum_probs=40.5
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
++|+.|+|++|+|++..+..|+++++|++|+|++|.+++..|..+++|++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 35555555555555444444555555555555555555444444444444555555444444322223444444444444
Q ss_pred ccC
Q 037258 316 SVD 318 (704)
Q Consensus 316 ~~~ 318 (704)
+.|
T Consensus 105 ~~n 107 (680)
T 1ziw_A 105 MSN 107 (680)
T ss_dssp CSS
T ss_pred CCC
Confidence 433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.5e-08 Score=114.30 Aligned_cols=84 Identities=27% Similarity=0.287 Sum_probs=45.6
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC-CcccccccccCCCcc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG-SLPADLVERSNNGSL 313 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~l 313 (704)
+++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..|+.+++|++|+|++|++++ .+|..+.++++|+.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4455555555555555555555555555555555555554444445555555555555555554 344455555555555
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+++.|
T Consensus 129 ~L~~n 133 (549)
T 2z81_A 129 RIGNV 133 (549)
T ss_dssp EEEES
T ss_pred ECCCC
Confidence 55544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.65 E-value=2.2e-08 Score=110.77 Aligned_cols=86 Identities=21% Similarity=0.183 Sum_probs=49.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..|..|++|++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 34556666666666665555566666666666666666663333345556666666666666665555556666666655
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 134 ~l~~n~ 139 (477)
T 2id5_A 134 EVGDND 139 (477)
T ss_dssp EECCTT
T ss_pred ECCCCc
Confidence 555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.3e-08 Score=121.13 Aligned_cols=87 Identities=23% Similarity=0.184 Sum_probs=62.4
Q ss_pred CCCceEEEEcCCCCCcccC-chhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccc--cccccCC
Q 037258 234 NPSRIISLNLSSSGLTGEI-SPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD--LVERSNN 310 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~~~l 310 (704)
.+++|+.|+|++|++.+.| |..|++|++|++|+|++|+|++..|..|++|++|++|+|++|.+++.+|.. +.++++|
T Consensus 46 ~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L 125 (844)
T 3j0a_A 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125 (844)
T ss_dssp SCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSC
T ss_pred ccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCC
Confidence 5566777777777666666 556777777777777777777777777777777777777777777766655 7777777
Q ss_pred CccccccCCC
Q 037258 311 GSLTLSVDGN 320 (704)
Q Consensus 311 ~~l~l~~~~n 320 (704)
+.|+|+.|..
T Consensus 126 ~~L~Ls~N~l 135 (844)
T 3j0a_A 126 TRLDLSKNQI 135 (844)
T ss_dssp CEEEEESCCC
T ss_pred CEEECCCCcc
Confidence 7777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.2e-08 Score=108.34 Aligned_cols=101 Identities=21% Similarity=0.199 Sum_probs=84.1
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCc-ccCCCCCCCe-Eecc
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRA-LNLK 292 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~-~~~~l~~L~~-l~l~ 292 (704)
|+|..|.|+... +.+.+++.|+|++|+|+...+..|.+|++|++|+|++|++.+.||. .|.+|++|.. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 578889997532 2346899999999999954445799999999999999999888875 5789999875 6778
Q ss_pred CCCCCCCcccccccccCCCccccccCCCC
Q 037258 293 RNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 293 ~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|+|++..|..|..+++|+.|+++.|+..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred CCcccccCchhhhhccccccccccccccc
Confidence 89999777888999999999999887654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.6e-08 Score=104.61 Aligned_cols=86 Identities=27% Similarity=0.349 Sum_probs=77.4
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
.++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 191 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 368999999999999888999999999999999999999877878999999999999999999 8999999999999999
Q ss_pred cccCCCC
Q 037258 315 LSVDGNT 321 (704)
Q Consensus 315 l~~~~n~ 321 (704)
++.|.-.
T Consensus 270 l~~N~i~ 276 (330)
T 1xku_A 270 LHNNNIS 276 (330)
T ss_dssp CCSSCCC
T ss_pred CCCCcCC
Confidence 8877544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=113.57 Aligned_cols=84 Identities=18% Similarity=0.088 Sum_probs=39.5
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..+.++++|+.|+
T Consensus 56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~ 135 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135 (606)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence 34444444444444444444444444444444444444444444444444444444444444443344444444444444
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
++.|
T Consensus 136 L~~n 139 (606)
T 3t6q_A 136 LGSN 139 (606)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 4443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=112.50 Aligned_cols=85 Identities=21% Similarity=0.362 Sum_probs=49.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCccc-CCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS-GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|.+++.+|..|.++++|+.|+|++|.++ |.+|..+..+++|+.|+|++|++++..|..+..+++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 3455566666666665555555555556666666665555 455555555555555555555555555555555555555
Q ss_pred cccccC
Q 037258 313 LTLSVD 318 (704)
Q Consensus 313 l~l~~~ 318 (704)
|+++.|
T Consensus 499 L~l~~n 504 (570)
T 2z63_A 499 LNMASN 504 (570)
T ss_dssp EECCSS
T ss_pred EeCCCC
Confidence 555544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.62 E-value=4.5e-08 Score=105.35 Aligned_cols=87 Identities=22% Similarity=0.254 Sum_probs=73.6
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcc-cCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF-LSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~-~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. +..+++|++|+|++|++++..|..+..+++|+.
T Consensus 91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 169 (390)
T 3o6n_A 91 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 169 (390)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCE
T ss_pred CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCE
Confidence 5678999999999999887888899999999999999998 56654 688999999999999999877888888899998
Q ss_pred cccccCCCC
Q 037258 313 LTLSVDGNT 321 (704)
Q Consensus 313 l~l~~~~n~ 321 (704)
|+++.|...
T Consensus 170 L~l~~n~l~ 178 (390)
T 3o6n_A 170 LQLSSNRLT 178 (390)
T ss_dssp EECCSSCCS
T ss_pred EECCCCcCC
Confidence 888876543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.61 E-value=3e-08 Score=112.24 Aligned_cols=84 Identities=24% Similarity=0.202 Sum_probs=72.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC-CcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG-SLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~ 312 (704)
.+++|+.|+|++|+|++..|..|++|++|++|+|++|+|+ .+|.. .+++|++|+|++|++++ ++|..+.++++|+.
T Consensus 74 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~ 150 (562)
T 3a79_B 74 FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF 150 (562)
T ss_dssp TCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCE
T ss_pred cCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccE
Confidence 5678999999999999888888999999999999999998 78876 78999999999999986 56788999999998
Q ss_pred cccccCCC
Q 037258 313 LTLSVDGN 320 (704)
Q Consensus 313 l~l~~~~n 320 (704)
|+++.|.-
T Consensus 151 L~L~~n~l 158 (562)
T 3a79_B 151 LGLSAAKF 158 (562)
T ss_dssp EEEECSBC
T ss_pred EecCCCcc
Confidence 88887643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.61 E-value=2.5e-08 Score=110.69 Aligned_cols=93 Identities=19% Similarity=0.145 Sum_probs=80.8
Q ss_pred eeeeecCCCCCCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccC-CCCCCCeEeccCCCCCCCcc
Q 037258 223 WDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLS-KLPSLRALNLKRNKLTGSLP 301 (704)
Q Consensus 223 w~gv~c~~~~~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~-~l~~L~~l~l~~N~l~g~~p 301 (704)
+.++.|. .+++|+.|+|++|+|++..|..|+++++|+.|+|++|.|+|.+|..+. .+++|+.|+|++|.|++. |
T Consensus 111 l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~ 185 (487)
T 3oja_A 111 ISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (487)
T ss_dssp CCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred CCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c
Confidence 4556664 367899999999999999999999999999999999999998998886 799999999999999976 3
Q ss_pred cccccccCCCccccccCCCC
Q 037258 302 ADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~~n~ 321 (704)
. +..+++|..|+|+.|...
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 186 G-QVVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp C-CCCCTTCCEEECCSSCCC
T ss_pred c-cccCCCCCEEECCCCCCC
Confidence 3 345899999999988654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=2.4e-08 Score=103.90 Aligned_cols=85 Identities=19% Similarity=0.097 Sum_probs=46.7
Q ss_pred CCCceEEEEcCCCCCcccCc----hhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCC--ccc--ccc
Q 037258 234 NPSRIISLNLSSSGLTGEIS----PYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS--LPA--DLV 305 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~--~p~--~~~ 305 (704)
.+++|+.|+|++|++++.+| ..+..+++|++|+|++|++++..|..++.+++|++|+|++|++.|. +|. .+.
T Consensus 115 ~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 194 (310)
T 4glp_A 115 TGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPH 194 (310)
T ss_dssp CCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTT
T ss_pred cCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhh
Confidence 34556666666666665444 3344566666666666666655555566666666666666665542 221 224
Q ss_pred cccCCCccccccC
Q 037258 306 ERSNNGSLTLSVD 318 (704)
Q Consensus 306 ~~~~l~~l~l~~~ 318 (704)
.+++|+.|+|+.|
T Consensus 195 ~l~~L~~L~Ls~N 207 (310)
T 4glp_A 195 KFPAIQNLALRNT 207 (310)
T ss_dssp SSCCCCSCBCCSS
T ss_pred cCCCCCEEECCCC
Confidence 5555665555544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=4e-08 Score=111.19 Aligned_cols=83 Identities=20% Similarity=0.111 Sum_probs=46.9
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
.+|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|+.|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 34555666666655555555555566666666655555444455555555555555555555544455555555555555
Q ss_pred ccC
Q 037258 316 SVD 318 (704)
Q Consensus 316 ~~~ 318 (704)
+.|
T Consensus 108 ~~n 110 (570)
T 2z63_A 108 VET 110 (570)
T ss_dssp TTS
T ss_pred ccc
Confidence 544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=3.9e-08 Score=116.85 Aligned_cols=85 Identities=24% Similarity=0.323 Sum_probs=48.1
Q ss_pred CCCceEEEEcCCCCCcccCchh--hccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcccccccc--c
Q 037258 234 NPSRIISLNLSSSGLTGEISPY--FANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLPADLVER--S 308 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~--~ 308 (704)
.+++|+.|+|++|+|++.+|.. |++|++|++|+|++|.+++..| ..|++|++|++|+|++|++++..|..+..+ +
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~ 174 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence 4455556666666665555544 5556666666666666655433 345556666666666666665555555555 5
Q ss_pred CCCccccccC
Q 037258 309 NNGSLTLSVD 318 (704)
Q Consensus 309 ~l~~l~l~~~ 318 (704)
+|+.|+++.|
T Consensus 175 ~L~~L~L~~n 184 (844)
T 3j0a_A 175 TLSFFSLAAN 184 (844)
T ss_dssp SSCCCEECCS
T ss_pred ccceEECCCC
Confidence 5555555544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=3.9e-08 Score=104.31 Aligned_cols=85 Identities=27% Similarity=0.274 Sum_probs=70.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCccc--ccccccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA--DLVERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~~~l~ 311 (704)
.+++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..++.+++|++|+|++|+++ .+|. .+..+++|+
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 5678999999999999887888999999999999999998544445888999999999999998 4555 788889999
Q ss_pred ccccccCC
Q 037258 312 SLTLSVDG 319 (704)
Q Consensus 312 ~l~l~~~~ 319 (704)
.|+++.|.
T Consensus 153 ~L~l~~n~ 160 (353)
T 2z80_A 153 ILRVGNMD 160 (353)
T ss_dssp EEEEEESS
T ss_pred EEECCCCc
Confidence 88888764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.9e-08 Score=111.06 Aligned_cols=87 Identities=23% Similarity=0.222 Sum_probs=77.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccC--CCCcccCCCCCCCeEeccCCCCCCCcccc-cccccCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG--TFPEFLSKLPSLRALNLKRNKLTGSLPAD-LVERSNN 310 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~iP~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~l 310 (704)
.+++|+.|+|++|++++.+|..|+++++|+.|+|++|++++ .+|..++.+++|+.|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 57889999999999999999999999999999999999997 67788999999999999999999878875 7788899
Q ss_pred CccccccCCC
Q 037258 311 GSLTLSVDGN 320 (704)
Q Consensus 311 ~~l~l~~~~n 320 (704)
+.|+++.|.-
T Consensus 402 ~~L~Ls~N~l 411 (520)
T 2z7x_B 402 LSLNMSSNIL 411 (520)
T ss_dssp CEEECCSSCC
T ss_pred CEEECcCCCC
Confidence 9998887754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.2e-08 Score=112.78 Aligned_cols=90 Identities=23% Similarity=0.325 Sum_probs=43.8
Q ss_pred CCCCCCCCCceeee-ecCCCCCCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEec
Q 037258 213 GDPCVPKNYWWDGL-NCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291 (704)
Q Consensus 213 ~~~c~~~~~~w~gv-~c~~~~~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l 291 (704)
++||......|.|+ .|. ..+|+.|+|++|+|++ ||..+. ++|++|+|++|+|+ .|| ..+++|+.|+|
T Consensus 40 ~~~~~~~~~~~~~l~~C~-----~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~L 107 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECL-----INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDA 107 (571)
T ss_dssp CCTTCCHHHHHHHHHHHH-----HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEEC
T ss_pred CCccccccchhhhccccc-----cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEc
Confidence 45664222247777 563 1245555555555554 444442 45555555555555 444 23445555555
Q ss_pred cCCCCCCCcccccccccCCCccccccC
Q 037258 292 KRNKLTGSLPADLVERSNNGSLTLSVD 318 (704)
Q Consensus 292 ~~N~l~g~~p~~~~~~~~l~~l~l~~~ 318 (704)
++|+|++ +|. +.. +|+.|+|+.|
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls~N 130 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVDNN 130 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECCSS
T ss_pred cCCCCCC-cch-hhc--CCCEEECCCC
Confidence 5555554 444 332 4444444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.54 E-value=1e-07 Score=100.18 Aligned_cols=84 Identities=18% Similarity=0.207 Sum_probs=74.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..|..|++|++|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|
T Consensus 76 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 152 (332)
T 2ft3_A 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152 (332)
T ss_dssp TCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEE
T ss_pred CCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEE
Confidence 5789999999999999888999999999999999999999 8888766 899999999999997666678999999999
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|..
T Consensus 153 ~l~~n~l 159 (332)
T 2ft3_A 153 EMGGNPL 159 (332)
T ss_dssp ECCSCCC
T ss_pred ECCCCcc
Confidence 9887654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.53 E-value=3.6e-08 Score=98.39 Aligned_cols=82 Identities=23% Similarity=0.299 Sum_probs=41.7
Q ss_pred CCceEEEEcCCCC-CcccCchhhccccccceEeccC-CcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCC-
Q 037258 235 PSRIISLNLSSSG-LTGEISPYFANLTAIEFLDLSN-NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG- 311 (704)
Q Consensus 235 ~~~l~~l~L~~n~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~- 311 (704)
+++|+.|+|++|+ +++..+..|.++++|++|+|++ |+|++..|..|..+++|+.|+|++|++++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4455555555554 4433333555555555555555 55553333445555555555555555553 444 44444444
Q ss_pred --ccccccC
Q 037258 312 --SLTLSVD 318 (704)
Q Consensus 312 --~l~l~~~ 318 (704)
.|+++.|
T Consensus 132 L~~L~l~~N 140 (239)
T 2xwt_C 132 FFILEITDN 140 (239)
T ss_dssp EEEEEEESC
T ss_pred ccEEECCCC
Confidence 4444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-07 Score=110.13 Aligned_cols=87 Identities=26% Similarity=0.229 Sum_probs=65.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccc--cccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLV--ERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~~~~l~ 311 (704)
.+++|+.|+|++|++++..|..|++|++|++|+|++|.+++..|..++++++|+.|+|++|++++..|..+. .+++|+
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 174 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEES
T ss_pred cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhcccccccc
Confidence 567788888888888766667788888888888888888877777777888888888888888876666543 346777
Q ss_pred ccccccCCC
Q 037258 312 SLTLSVDGN 320 (704)
Q Consensus 312 ~l~l~~~~n 320 (704)
.|+++.|..
T Consensus 175 ~L~L~~n~l 183 (680)
T 1ziw_A 175 KLELSSNQI 183 (680)
T ss_dssp EEECTTCCC
T ss_pred EEECCCCcc
Confidence 777776643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=7.3e-08 Score=100.26 Aligned_cols=81 Identities=28% Similarity=0.280 Sum_probs=43.1
Q ss_pred CCceEEEEcCCCCCcccCch----hhccccccceEeccCCcccCCCCcccCCC---CCCCeEeccCCCCCCCcccccccc
Q 037258 235 PSRIISLNLSSSGLTGEISP----YFANLTAIEFLDLSNNSLSGTFPEFLSKL---PSLRALNLKRNKLTGSLPADLVER 307 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~iP~~~~~l---~~L~~l~l~~N~l~g~~p~~~~~~ 307 (704)
+++|+.|+|++|+|+ .+|. .++++++|++|||++|+|++.+|..+..+ ++|+.|+|++|+|+ .+|..+.
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-- 271 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-- 271 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--
Confidence 445555555555554 2222 23455555555555555555555555544 35555555555555 4555543
Q ss_pred cCCCccccccCC
Q 037258 308 SNNGSLTLSVDG 319 (704)
Q Consensus 308 ~~l~~l~l~~~~ 319 (704)
++|+.|+|+.|.
T Consensus 272 ~~L~~L~Ls~N~ 283 (310)
T 4glp_A 272 AKLRVLDLSSNR 283 (310)
T ss_dssp SCCSCEECCSCC
T ss_pred CCCCEEECCCCc
Confidence 455555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=6e-08 Score=97.84 Aligned_cols=79 Identities=27% Similarity=0.296 Sum_probs=66.1
Q ss_pred CCCceEEEEcCCCCCcc--cCchhhccccccceEeccCCcccCCCCcccCCCC--CCCeEeccCCCCCCCccc-------
Q 037258 234 NPSRIISLNLSSSGLTG--EISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLP--SLRALNLKRNKLTGSLPA------- 302 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~--~L~~l~l~~N~l~g~~p~------- 302 (704)
.+++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..+. +|++|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 46799999999999998 6778899999999999999999965 3344444 999999999999998874
Q ss_pred ccccccCCCccc
Q 037258 303 DLVERSNNGSLT 314 (704)
Q Consensus 303 ~~~~~~~l~~l~ 314 (704)
.+..+++|..|+
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 356778887664
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.46 E-value=4.8e-09 Score=101.63 Aligned_cols=82 Identities=18% Similarity=0.228 Sum_probs=69.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++ +| .|.++++|+.|+|++|.|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|
T Consensus 46 ~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L 120 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence 46789999999999986 77 8999999999999999998 788888888899999999999986 66 68888899988
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|.-
T Consensus 121 ~l~~N~i 127 (198)
T 1ds9_A 121 YMSNNKI 127 (198)
T ss_dssp EESEEEC
T ss_pred ECCCCcC
Confidence 8877643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2.3e-07 Score=95.59 Aligned_cols=79 Identities=29% Similarity=0.405 Sum_probs=46.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++. +.++++++|+.|+|++|++++..| +..+++|+.|+|++|++++ +|. +..+++|+.|
T Consensus 132 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L 205 (291)
T 1h6t_A 132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVL 205 (291)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEE
T ss_pred CCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEE
Confidence 345666666666666643 456666666666666666664333 6666666666666666663 332 5566666666
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+++.|
T Consensus 206 ~l~~n 210 (291)
T 1h6t_A 206 ELFSQ 210 (291)
T ss_dssp EEEEE
T ss_pred ECcCC
Confidence 65544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.42 E-value=1.6e-07 Score=99.03 Aligned_cols=83 Identities=23% Similarity=0.285 Sum_probs=55.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred cCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 456677777777777643 456677777777777777774 33 36667777777777777776666667777777777
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|.-
T Consensus 317 ~L~~n~l 323 (347)
T 4fmz_A 317 FLSQNHI 323 (347)
T ss_dssp ECCSSSC
T ss_pred EccCCcc
Confidence 6666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.40 E-value=2.7e-07 Score=95.12 Aligned_cols=82 Identities=27% Similarity=0.398 Sum_probs=72.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++. +.+.+|++|+.|+|++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|
T Consensus 110 ~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L 183 (291)
T 1h6t_A 110 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183 (291)
T ss_dssp TCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred cCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEE
Confidence 578999999999999964 5799999999999999999964 568999999999999999997655 8999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 184 ~L~~N~i~ 191 (291)
T 1h6t_A 184 YLSKNHIS 191 (291)
T ss_dssp ECCSSCCC
T ss_pred ECCCCcCC
Confidence 99888654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.39 E-value=4e-07 Score=94.55 Aligned_cols=81 Identities=25% Similarity=0.327 Sum_probs=51.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..+ ++++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..| +..+++|+.|
T Consensus 127 ~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 200 (308)
T 1h6u_A 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEV 200 (308)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred CCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEE
Confidence 45667777777777764333 6667777777777777763 443 6667777777777777764333 6666666666
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+|+.|.-
T Consensus 201 ~L~~N~l 207 (308)
T 1h6u_A 201 HLKNNQI 207 (308)
T ss_dssp ECTTSCC
T ss_pred EccCCcc
Confidence 6665543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.39 E-value=1.2e-08 Score=98.92 Aligned_cols=83 Identities=24% Similarity=0.299 Sum_probs=73.2
Q ss_pred CceEEEEcCCCCCcccCch------hhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccC
Q 037258 236 SRIISLNLSSSGLTGEISP------YFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSN 309 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~------~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~ 309 (704)
.+++.++|+.+.|+|.+|. .|+++++|++|+|++|+|++ +| .+..+++|+.|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4566777888888888777 99999999999999999996 88 8999999999999999999 79998888899
Q ss_pred CCccccccCCCC
Q 037258 310 NGSLTLSVDGNT 321 (704)
Q Consensus 310 l~~l~l~~~~n~ 321 (704)
|+.|+|+.|...
T Consensus 95 L~~L~L~~N~l~ 106 (198)
T 1ds9_A 95 LEELWISYNQIA 106 (198)
T ss_dssp CSEEEEEEEECC
T ss_pred CCEEECcCCcCC
Confidence 999999877543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.38 E-value=1.7e-07 Score=97.77 Aligned_cols=82 Identities=20% Similarity=0.218 Sum_probs=44.8
Q ss_pred CCceEEEEcCCCCCcccCchhhc-cccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
+++|+.|+|++|++++..|..+. .+++|++|+|++|+|++ +|. ...+++|+.|+|++|++++ +|..+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCc-chhhhcccCcccEE
Confidence 45566666666666655555543 55666666666666653 232 2235566666666666653 44445555556655
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 220 ~L~~N~ 225 (317)
T 3o53_A 220 SLRNNK 225 (317)
T ss_dssp ECTTSC
T ss_pred ECcCCc
Confidence 555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.38 E-value=3e-07 Score=95.90 Aligned_cols=82 Identities=21% Similarity=0.206 Sum_probs=68.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++. | ....+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 167 ~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L 242 (317)
T 3o53_A 167 SSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242 (317)
T ss_dssp GTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEE
T ss_pred ccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEE
Confidence 467899999999999865 3 3445899999999999999 46666889999999999999999 688888889999988
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+++.|.
T Consensus 243 ~l~~N~ 248 (317)
T 3o53_A 243 DLRGNG 248 (317)
T ss_dssp ECTTCC
T ss_pred EccCCC
Confidence 877654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.38 E-value=3.9e-07 Score=103.55 Aligned_cols=78 Identities=28% Similarity=0.393 Sum_probs=43.3
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++. +.|+.|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++ +| .+..+++|+.|+
T Consensus 130 l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~ 203 (605)
T 1m9s_A 130 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLE 203 (605)
T ss_dssp CTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEE
T ss_pred CCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEE
Confidence 45555566666665543 455556666666666666654444 5555666666666666554 22 355555555555
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
|+.|
T Consensus 204 L~~N 207 (605)
T 1m9s_A 204 LFSQ 207 (605)
T ss_dssp CCSE
T ss_pred ccCC
Confidence 5443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.36 E-value=3e-07 Score=93.18 Aligned_cols=78 Identities=23% Similarity=0.331 Sum_probs=66.4
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
.+|+.|+|++|+|++ +| .++++++|+.|+|++|+|++ +| .++.+++|+.|+|++|++++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 688999999999996 43 69999999999999999995 55 588999999999999999976 67888889998888
Q ss_pred ccCC
Q 037258 316 SVDG 319 (704)
Q Consensus 316 ~~~~ 319 (704)
+.|.
T Consensus 180 ~~N~ 183 (263)
T 1xeu_A 180 TGQK 183 (263)
T ss_dssp EEEE
T ss_pred CCCc
Confidence 7653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=5.9e-07 Score=93.28 Aligned_cols=18 Identities=28% Similarity=0.475 Sum_probs=7.1
Q ss_pred hccccccceEeccCCccc
Q 037258 256 FANLTAIEFLDLSNNSLS 273 (704)
Q Consensus 256 ~~~l~~L~~L~l~~N~l~ 273 (704)
+.+|++|+.|+|++|+++
T Consensus 125 l~~l~~L~~L~l~~n~l~ 142 (308)
T 1h6u_A 125 LAGLSNLQVLYLDLNQIT 142 (308)
T ss_dssp GTTCTTCCEEECCSSCCC
T ss_pred hcCCCCCCEEECCCCccC
Confidence 333333444444443333
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.34 E-value=5.5e-07 Score=91.26 Aligned_cols=77 Identities=23% Similarity=0.295 Sum_probs=40.1
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++..| |++|++|+.|+|++|+|++ +|.... ++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 4566666666666664333 6666666666666666663 443221 445555555555543 22 344444444444
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
|+.|
T Consensus 135 Ls~N 138 (263)
T 1xeu_A 135 IRNN 138 (263)
T ss_dssp CTTS
T ss_pred CCCC
Confidence 4444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.33 E-value=4.1e-07 Score=103.38 Aligned_cols=82 Identities=28% Similarity=0.425 Sum_probs=72.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++ + +.|.+|++|+.|+|++|+|++. ..++.|++|+.|+|++|+|++..| +..+++|+.|
T Consensus 107 ~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 180 (605)
T 1m9s_A 107 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 180 (605)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred cCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEE
Confidence 57899999999999996 3 5699999999999999999964 568999999999999999998777 8999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+|+.|...
T Consensus 181 ~Ls~N~i~ 188 (605)
T 1m9s_A 181 YLSKNHIS 188 (605)
T ss_dssp ECCSSCCC
T ss_pred ECcCCCCC
Confidence 99887544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.4e-06 Score=86.69 Aligned_cols=134 Identities=17% Similarity=0.068 Sum_probs=97.7
Q ss_pred cccccCce-EEEEEEeC-CCcEEEEEecccchh-hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCCCHHHH
Q 037258 405 VLGKGGFG-EVYHGSLD-DNQQVAVKMLSSSCC-FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASGTLDQY 480 (704)
Q Consensus 405 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~-~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 480 (704)
.+..|..| .||+.... ++..+++|+-..... ....|...|+.+. +-.+.++++++.+++..++|||+++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 45556655 68988654 567899998765433 5677888888874 33467889999999999999999999888776
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------
Q 037258 481 LKGKKEHMLNWVERLQIAVDSAQGLEYLHYG------------------------------------------------- 511 (704)
Q Consensus 481 l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------------- 511 (704)
..... .....+..+++..|..||..
T Consensus 111 ~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 111 LEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 54321 22345666777777777731
Q ss_pred ------CCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 512 ------CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 512 ------~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877777999998753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.31 E-value=8.1e-08 Score=100.86 Aligned_cols=82 Identities=24% Similarity=0.221 Sum_probs=38.4
Q ss_pred CceEEEEcCCCCCccc-CchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC-CCCCC-cccccccccCCCc
Q 037258 236 SRIISLNLSSSGLTGE-ISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN-KLTGS-LPADLVERSNNGS 312 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N-~l~g~-~p~~~~~~~~l~~ 312 (704)
++|+.|+|++|.+++. +|..+.++++|++|+|++|.+++.+|..++.+++|+.|+|++| .+++. +|..+..+++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4444444444444443 4444444444455555444444444444444444555555444 34431 3444444444444
Q ss_pred ccccc
Q 037258 313 LTLSV 317 (704)
Q Consensus 313 l~l~~ 317 (704)
|+++.
T Consensus 173 L~l~~ 177 (336)
T 2ast_B 173 LNLSW 177 (336)
T ss_dssp EECCC
T ss_pred EcCCC
Confidence 44443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.3e-07 Score=100.80 Aligned_cols=78 Identities=19% Similarity=0.334 Sum_probs=59.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCC-------CeEeccCCCCCCCccccccc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSL-------RALNLKRNKLTGSLPADLVE 306 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L-------~~l~l~~N~l~g~~p~~~~~ 306 (704)
.+++|+.|+|++|+|++ +|. |+ ++|+.|+|++|+|+ .||. +.. +| +.|+|++|+|+ .||..+..
T Consensus 158 ~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~ 228 (571)
T 3cvr_A 158 LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS 228 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG
T ss_pred cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc
Confidence 35678888888888886 777 65 88888888888888 7777 554 66 88888888888 68888888
Q ss_pred ccCCCccccccCCC
Q 037258 307 RSNNGSLTLSVDGN 320 (704)
Q Consensus 307 ~~~l~~l~l~~~~n 320 (704)
+++|+.|+|+.|..
T Consensus 229 l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 229 LDPTCTIILEDNPL 242 (571)
T ss_dssp SCTTEEEECCSSSC
T ss_pred CCCCCEEEeeCCcC
Confidence 88888887776643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.24 E-value=9.9e-07 Score=96.95 Aligned_cols=79 Identities=23% Similarity=0.259 Sum_probs=63.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++. | ++++++|++|+|++|+|++ +| ++++++|++|+|++|++++ +| +..+++|+.|
T Consensus 62 ~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L 132 (457)
T 3bz5_A 62 KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYL 132 (457)
T ss_dssp GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEE
T ss_pred ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEE
Confidence 567888888888888863 4 8888888888888888886 44 7888888888888888886 55 7888888888
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 133 ~l~~N~l~ 140 (457)
T 3bz5_A 133 NCARNTLT 140 (457)
T ss_dssp ECTTSCCS
T ss_pred ECCCCccc
Confidence 88776543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.5e-07 Score=101.01 Aligned_cols=86 Identities=16% Similarity=0.154 Sum_probs=68.5
Q ss_pred CCCceEEEEcCCCCCc----ccCchhhccccccceEeccCCcccCC----CCccc--CCCCCCCeEeccCCCCCC----C
Q 037258 234 NPSRIISLNLSSSGLT----GEISPYFANLTAIEFLDLSNNSLSGT----FPEFL--SKLPSLRALNLKRNKLTG----S 299 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~--~~l~~L~~l~l~~N~l~g----~ 299 (704)
.+++|+.|+|++|+|+ +.+|..+.++++|+.|+|++|.|++. +|..+ +.+++|+.|+|++|.+++ .
T Consensus 214 ~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~ 293 (386)
T 2ca6_A 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293 (386)
T ss_dssp GCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred cCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHH
Confidence 4578888888888886 67888888888888888888888865 66766 448888888888888887 4
Q ss_pred ccccc-ccccCCCccccccCC
Q 037258 300 LPADL-VERSNNGSLTLSVDG 319 (704)
Q Consensus 300 ~p~~~-~~~~~l~~l~l~~~~ 319 (704)
+|..+ .++++|+.|+|+.|.
T Consensus 294 l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 294 LKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHHHHHHCTTCCEEECTTSB
T ss_pred HHHHHHhcCCCceEEEccCCc
Confidence 88877 557888888877654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.22 E-value=9.4e-07 Score=97.39 Aligned_cols=81 Identities=23% Similarity=0.311 Sum_probs=54.6
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..| ++++++|+.|+|++|++++..| +..+++|+.|+|++|++++. ..+..+++|+.|
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 45677777777777775443 6777777777777777776554 56677777777777777754 356666677766
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|..
T Consensus 359 ~l~~n~l 365 (466)
T 1o6v_A 359 SAGHNQI 365 (466)
T ss_dssp ECCSSCC
T ss_pred eCCCCcc
Confidence 6665543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.22 E-value=8.9e-07 Score=93.33 Aligned_cols=81 Identities=26% Similarity=0.370 Sum_probs=55.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..+ +..+++|+.|+|++|.+++ ++ .+..+++|+.|+|++|++++. +.+..+++|+.|
T Consensus 219 ~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L 292 (347)
T 4fmz_A 219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292 (347)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-Ch-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEE
Confidence 45677777777777774333 7777777777777777774 43 467777777777777777753 346677777777
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|..
T Consensus 293 ~L~~n~l 299 (347)
T 4fmz_A 293 FLNNNQL 299 (347)
T ss_dssp ECCSSCC
T ss_pred ECcCCcC
Confidence 7766643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-06 Score=96.06 Aligned_cols=78 Identities=23% Similarity=0.341 Sum_probs=60.0
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTL 315 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l 315 (704)
++|+.|+|++|++++ +| +|+++++|++|+|++|++++ +|..+ .+|++|+|++|++++ +| .+..+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 578888888888886 77 58888888888888888884 77643 478888888888886 66 5788888888877
Q ss_pred ccCCCC
Q 037258 316 SVDGNT 321 (704)
Q Consensus 316 ~~~~n~ 321 (704)
+.|.-.
T Consensus 203 ~~N~l~ 208 (454)
T 1jl5_A 203 DNNSLK 208 (454)
T ss_dssp CSSCCS
T ss_pred CCCcCC
Confidence 766543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=7.5e-06 Score=84.80 Aligned_cols=133 Identities=19% Similarity=0.127 Sum_probs=92.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccc--hhhHHHHHHHHHhhccc---ceeEEEEEEE-eCCeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSS--CCFQLLQVKLLMRVHHR---NLTALIGYCI-EGNNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lV~e~~~~gsL 477 (704)
+.++.|....||+. +..+++|+-... ......|.++|+.+.+. .+.+.+.++. ..+..++|||+++|.++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 45788888999987 567889986533 23567899999999753 3566777764 34567899999999888
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG---------------------------------------------- 511 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 511 (704)
.+..-. .++..+...++.++++.|..||..
T Consensus 101 ~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 101 GEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp HHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred chhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 763211 134445555555555555555521
Q ss_pred -----------CCCCceecCCCCCCEEeCC---CCc-EEEEeccCccc
Q 037258 512 -----------CKPPIVHRDVKSSNILLNE---KLQ-AKIADFGLSRI 544 (704)
Q Consensus 512 -----------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DfGla~~ 544 (704)
....++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 455 48999998754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.6e-06 Score=98.63 Aligned_cols=77 Identities=29% Similarity=0.383 Sum_probs=64.2
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 4678888999998885 66 56688899999999998 6777 6788999999999999 8898999999999888
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
|+.|.-
T Consensus 291 L~~N~l 296 (622)
T 3g06_A 291 LEGNPL 296 (622)
T ss_dssp CCSCCC
T ss_pred ecCCCC
Confidence 877643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.20 E-value=3.7e-07 Score=98.01 Aligned_cols=85 Identities=22% Similarity=0.286 Sum_probs=63.9
Q ss_pred CCceEEEEcCCCCCcccCc----hhhccccccceEeccCC---cccCCCCccc-------CCCCCCCeEeccCCCCCC--
Q 037258 235 PSRIISLNLSSSGLTGEIS----PYFANLTAIEFLDLSNN---SLSGTFPEFL-------SKLPSLRALNLKRNKLTG-- 298 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p----~~~~~l~~L~~L~l~~N---~l~g~iP~~~-------~~l~~L~~l~l~~N~l~g-- 298 (704)
+++|+.|+|++|+|++..+ ..|.++++|++|+|++| +++|.+|..+ ..+++|++|+|++|+|++
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 4568888888888887644 34667888888888874 5666777655 678888888888888887
Q ss_pred --CcccccccccCCCccccccCC
Q 037258 299 --SLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 299 --~~p~~~~~~~~l~~l~l~~~~ 319 (704)
.+|..+..+++|+.|+|+.|+
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~ 133 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNG 133 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSC
T ss_pred HHHHHHHHHhCCCCCEEECcCCC
Confidence 577778888888888777654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.19 E-value=1.3e-06 Score=96.17 Aligned_cols=80 Identities=28% Similarity=0.356 Sum_probs=62.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++++..| |++|++|++|+|++|++++..| ++++++|++|+|++|++++. |. +..+++|+.|
T Consensus 66 ~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L 139 (466)
T 1o6v_A 66 YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRL 139 (466)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEE
T ss_pred hhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEE
Confidence 46788888888888885543 8888888888888888885444 88888888888888888854 33 7788888888
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+++.|.
T Consensus 140 ~l~~n~ 145 (466)
T 1o6v_A 140 ELSSNT 145 (466)
T ss_dssp EEEEEE
T ss_pred ECCCCc
Confidence 887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.17 E-value=3e-07 Score=96.49 Aligned_cols=82 Identities=22% Similarity=0.264 Sum_probs=74.0
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCC-CCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT-FPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
.+++.|+|++|.+++.++. +.++++|++|+|++|.+++. +|..+..+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 6899999999999977665 66899999999999999876 898899999999999999999999999999999999999
Q ss_pred cccC
Q 037258 315 LSVD 318 (704)
Q Consensus 315 l~~~ 318 (704)
++.+
T Consensus 149 L~~~ 152 (336)
T 2ast_B 149 LSGC 152 (336)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 8766
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.6e-06 Score=95.23 Aligned_cols=68 Identities=22% Similarity=0.231 Sum_probs=49.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVER 307 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 307 (704)
.+++|+.|+|++|+|++. .++++++|+.|+|++|+|+| +| ++.+++|+.|+|++|+|+|..+..+.++
T Consensus 189 ~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L 256 (457)
T 3bz5_A 189 QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKL 256 (457)
T ss_dssp TCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred cCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence 456777888888888764 37777888888888888875 66 7777888888888888877554444433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.15 E-value=5e-07 Score=96.13 Aligned_cols=82 Identities=29% Similarity=0.302 Sum_probs=40.7
Q ss_pred ceEEEEcCCCCCcccCc----hhhcccc-ccceEeccCCcccCCCCcccCCC-----CCCCeEeccCCCCCCCccccccc
Q 037258 237 RIISLNLSSSGLTGEIS----PYFANLT-AIEFLDLSNNSLSGTFPEFLSKL-----PSLRALNLKRNKLTGSLPADLVE 306 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~iP~~~~~l-----~~L~~l~l~~N~l~g~~p~~~~~ 306 (704)
+|+.|+|++|+|++..+ ..|.+++ +|++|+|++|.|++..+..++.+ ++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 35555555555554444 4444554 55555555555554444444443 55555555555555444443333
Q ss_pred c-----cCCCccccccC
Q 037258 307 R-----SNNGSLTLSVD 318 (704)
Q Consensus 307 ~-----~~l~~l~l~~~ 318 (704)
. ++|+.|+|+.|
T Consensus 103 ~l~~~~~~L~~L~Ls~N 119 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWN 119 (362)
T ss_dssp HHHTSCTTCCEEECCSS
T ss_pred HHHhCCCCccEEECcCC
Confidence 2 45555555444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=5.6e-06 Score=87.69 Aligned_cols=76 Identities=9% Similarity=-0.004 Sum_probs=56.2
Q ss_pred ccc-cccCceEEEEEEeC-------CCcEEEEEecccch-------hhHHHHHHHHHhhcc---cceeEEEEEEEeC---
Q 037258 404 RVL-GKGGFGEVYHGSLD-------DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHH---RNLTALIGYCIEG--- 462 (704)
Q Consensus 404 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h---~nIv~l~~~~~~~--- 462 (704)
+.| +.|....+|+.... +++.+++|+..... .....|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998664 26789999876533 356789999988853 3567788887665
Q ss_pred CeEEEEEeecCCCCHHH
Q 037258 463 NNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 463 ~~~~lV~e~~~~gsL~~ 479 (704)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2.4e-06 Score=93.81 Aligned_cols=76 Identities=24% Similarity=0.313 Sum_probs=46.1
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCC--Ccccccccc------
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTG--SLPADLVER------ 307 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g--~~p~~~~~~------ 307 (704)
++|+.|+|++|+|++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|+|++|+++| .+|.++..+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~ 388 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHL 388 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC--
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccc
Confidence 467777777777775 5554 467777777777777 5666 46777888888888877 677777766
Q ss_pred -------cCCCccccccCC
Q 037258 308 -------SNNGSLTLSVDG 319 (704)
Q Consensus 308 -------~~l~~l~l~~~~ 319 (704)
++|+.|+++.|.
T Consensus 389 ~~i~~~~~~L~~L~ls~N~ 407 (454)
T 1jl5_A 389 AEVPELPQNLKQLHVETNP 407 (454)
T ss_dssp -------------------
T ss_pred cccccccCcCCEEECCCCc
Confidence 567777666554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.05 E-value=9e-07 Score=94.11 Aligned_cols=82 Identities=26% Similarity=0.285 Sum_probs=47.5
Q ss_pred ceEEEEcCCCCCcccCchhhccc-----cccceEeccCCcccCCCCcccCC----C-CCCCeEeccCCCCCCCccccccc
Q 037258 237 RIISLNLSSSGLTGEISPYFANL-----TAIEFLDLSNNSLSGTFPEFLSK----L-PSLRALNLKRNKLTGSLPADLVE 306 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~iP~~~~~----l-~~L~~l~l~~N~l~g~~p~~~~~ 306 (704)
+|+.|+|++|+|++..+..|+.+ ++|++|+|++|.|++..+..++. + ++|+.|+|++|+|++..+..+..
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 56666666666666666666554 66666666666666555543332 2 56666666666666554444332
Q ss_pred -----ccCCCccccccC
Q 037258 307 -----RSNNGSLTLSVD 318 (704)
Q Consensus 307 -----~~~l~~l~l~~~ 318 (704)
..+|+.|+|+.|
T Consensus 132 ~l~~~~~~L~~L~Ls~N 148 (362)
T 3goz_A 132 AFSNLPASITSLNLRGN 148 (362)
T ss_dssp HHTTSCTTCCEEECTTS
T ss_pred HHHhCCCceeEEEccCC
Confidence 135666665554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.94 E-value=1.6e-06 Score=87.32 Aligned_cols=76 Identities=24% Similarity=0.322 Sum_probs=57.7
Q ss_pred EEcCCCC---CcccCchhhccccccceEeccCCcccC--CCCcccCCCCCCCeEeccCCCCCCCccccccccc--CCCcc
Q 037258 241 LNLSSSG---LTGEISPYFANLTAIEFLDLSNNSLSG--TFPEFLSKLPSLRALNLKRNKLTGSLPADLVERS--NNGSL 313 (704)
Q Consensus 241 l~L~~n~---l~g~~p~~~~~l~~L~~L~l~~N~l~g--~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~--~l~~l 313 (704)
++++.|. +.+.++....+|++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 5566664 333344444678999999999999998 6778888999999999999999975 4455555 77777
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+|+.|
T Consensus 226 ~L~~N 230 (267)
T 3rw6_A 226 WLDGN 230 (267)
T ss_dssp ECTTS
T ss_pred EccCC
Confidence 66544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.5e-05 Score=80.67 Aligned_cols=139 Identities=16% Similarity=0.237 Sum_probs=82.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchhhHHHHHHHHHhhccc--ceeEEEE------EEEeCCeEEEEEeecCCC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHR--NLTALIG------YCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~------~~~~~~~~~lV~e~~~~g 475 (704)
+.|+.|..+.||+....+| .+++|+..........|..++..+... .+.+++. +....+..++||+|++|.
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~ 116 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGR 116 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCB
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCc
Confidence 3466677899999987655 489999876544445566666666422 2333332 123466789999999986
Q ss_pred CHH--------------HHhhcccC------------CCCCHHHH-------------------------------HHHH
Q 037258 476 TLD--------------QYLKGKKE------------HMLNWVER-------------------------------LQIA 498 (704)
Q Consensus 476 sL~--------------~~l~~~~~------------~~l~~~~~-------------------------------~~i~ 498 (704)
++. ..++.... ....|... ..+.
T Consensus 117 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (346)
T 2q83_A 117 PFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFI 196 (346)
T ss_dssp CCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHH
Confidence 542 11121110 01123211 0111
Q ss_pred HHHHHHHHHHhc----------CCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 499 VDSAQGLEYLHY----------GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 499 ~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..+..++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 123345666652 125789999999999999888889999999774
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.9e-06 Score=95.52 Aligned_cols=72 Identities=28% Similarity=0.306 Sum_probs=65.6
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNN 310 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l 310 (704)
.+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .||..+.++++|+.|+|++|.|+|.+|..+..+...
T Consensus 239 ~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~ 310 (622)
T 3g06_A 239 LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310 (622)
T ss_dssp CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHS
T ss_pred CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcccc
Confidence 5688999999999999 6777 6789999999999999 899999999999999999999999999988877643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.88 E-value=7.3e-06 Score=86.60 Aligned_cols=84 Identities=17% Similarity=0.162 Sum_probs=69.8
Q ss_pred CCCceEEEEcCCCCCcccCch-hhccccccce-EeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISP-YFANLTAIEF-LDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~-~~~~l~~L~~-L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~ 311 (704)
.+++|+.|+|++|++.+.+|+ .|.+|++|.. +++++|+|++..|..|..+++|+.|++++|++++..+..+....++.
T Consensus 52 ~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~ 131 (350)
T 4ay9_X 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131 (350)
T ss_dssp TCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCE
T ss_pred CCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhh
Confidence 578999999999999888876 6889998875 67788999977788899999999999999999976666666666666
Q ss_pred cccccc
Q 037258 312 SLTLSV 317 (704)
Q Consensus 312 ~l~l~~ 317 (704)
.|++..
T Consensus 132 ~l~l~~ 137 (350)
T 4ay9_X 132 LLDIQD 137 (350)
T ss_dssp EEEEES
T ss_pred hhhhcc
Confidence 666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.85 E-value=2e-06 Score=94.42 Aligned_cols=83 Identities=28% Similarity=0.247 Sum_probs=51.6
Q ss_pred CceEEEEcCCCCCccc----CchhhccccccceEeccCCcccCCCCcccCC-----CCCCCeEeccCCCCCC----Cccc
Q 037258 236 SRIISLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLSGTFPEFLSK-----LPSLRALNLKRNKLTG----SLPA 302 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~-----l~~L~~l~l~~N~l~g----~~p~ 302 (704)
++|+.|+|++|.+++. ++..+.++++|+.|+|++|.+++..+..+.. +++|+.|+|++|++++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 4666666666666654 4555666667777777777666544433332 5567777777777665 5666
Q ss_pred ccccccCCCccccccC
Q 037258 303 DLVERSNNGSLTLSVD 318 (704)
Q Consensus 303 ~~~~~~~l~~l~l~~~ 318 (704)
.+..+++|+.|+++.|
T Consensus 393 ~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 393 TLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHCCCCCEEECCSS
T ss_pred HHHhCCCccEEECCCC
Confidence 6666667776666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.67 E-value=5.9e-06 Score=88.08 Aligned_cols=85 Identities=24% Similarity=0.242 Sum_probs=61.6
Q ss_pred CceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccC----CCCcccCCCCCCCeEeccCCCCCCC----cccc
Q 037258 236 SRIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRNKLTGS----LPAD 303 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~iP~~~~~l~~L~~l~l~~N~l~g~----~p~~ 303 (704)
+.|+.|+|++|+|+. .++..+..+++|++|+|++|.|+. .++..+..+++|+.|+|++|.|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 468888888888865 355566778888888888888874 2455667778888888888888742 3444
Q ss_pred cccccCCCccccccCCC
Q 037258 304 LVERSNNGSLTLSVDGN 320 (704)
Q Consensus 304 ~~~~~~l~~l~l~~~~n 320 (704)
+...++|+.|+|+.|.-
T Consensus 235 L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 235 AREHPSLELLHLYFNEL 251 (372)
T ss_dssp HHHCSSCCEEECTTSSC
T ss_pred HHhCCCCCEEeccCCCC
Confidence 55567888888877643
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.65 E-value=4.8e-06 Score=91.25 Aligned_cols=84 Identities=20% Similarity=0.233 Sum_probs=42.6
Q ss_pred CCceEEEEcCCCCCccc----CchhhccccccceEeccCCcccCCCCcccCC-----CCCCCeEeccCCCCCCC----cc
Q 037258 235 PSRIISLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLSGTFPEFLSK-----LPSLRALNLKRNKLTGS----LP 301 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~-----l~~L~~l~l~~N~l~g~----~p 301 (704)
+++|+.|+|++|++++. ++..+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 34555555555555543 4555555555555555555554332222221 24555555555555543 34
Q ss_pred cccccccCCCccccccC
Q 037258 302 ADLVERSNNGSLTLSVD 318 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~ 318 (704)
..+..+++|+.|+++.|
T Consensus 335 ~~l~~~~~L~~L~Ls~n 351 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNN 351 (461)
T ss_dssp HHHHHCSSCCEEECCSS
T ss_pred HHHhhCCCccEEEccCC
Confidence 44445555555555544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0002 Score=76.84 Aligned_cols=70 Identities=11% Similarity=0.103 Sum_probs=47.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccc-----------hhhHHHHHHHHHhhcc--c-ceeEEEEEEEeCCeEEEE
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-----------CCFQLLQVKLLMRVHH--R-NLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~lV 468 (704)
+.||.|.++.||++... +++.++||..... ......|.++++.+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999654 4688999975321 1134678888887742 3 34456544 34556899
Q ss_pred EeecCCC
Q 037258 469 YEYMASG 475 (704)
Q Consensus 469 ~e~~~~g 475 (704)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00039 Score=71.79 Aligned_cols=135 Identities=17% Similarity=0.144 Sum_probs=90.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch-hhHHHHHHHHHhhc---ccceeEEEEEEEeCCeEEEEEeecCCCCHH-
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC-CFQLLQVKLLMRVH---HRNLTALIGYCIEGNNMGLIYEYMASGTLD- 478 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~- 478 (704)
+.|+.|....+|+... ++..+++|+..... ..+..|...|+.+. ...+.++++++...+..++||||+++..+.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~ 120 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ 120 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc
Confidence 4688999999999976 46788899876443 35678888888884 356788999888888899999999987642
Q ss_pred -------H---HhhcccC-C-------------------CCCHHHHH---HHH----------------HHHHHH-HHHH
Q 037258 479 -------Q---YLKGKKE-H-------------------MLNWVERL---QIA----------------VDSAQG-LEYL 508 (704)
Q Consensus 479 -------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~~-L~~L 508 (704)
. .|+.... . .-+|.... ++. ..++.. ...|
T Consensus 121 ~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L 200 (312)
T 3jr1_A 121 SSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTL 200 (312)
T ss_dssp THHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHh
Confidence 1 1222111 0 12454321 111 111111 2234
Q ss_pred h-cCCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 037258 509 H-YGCKPPIVHRDVKSSNILLNEKLQAKIADFG 540 (704)
Q Consensus 509 H-~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 540 (704)
. ......++|+|+.+.|++++.++ +.|.|+.
T Consensus 201 ~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 201 SKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp TTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 12256799999999999999887 8899974
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.42 E-value=2.4e-05 Score=83.28 Aligned_cols=83 Identities=23% Similarity=0.145 Sum_probs=35.9
Q ss_pred CceEEEEcCCCCCcccCchhh-ccccccceEeccCCcccCCCCccc-----CCCCCCCeEeccCCCCCC----Ccccccc
Q 037258 236 SRIISLNLSSSGLTGEISPYF-ANLTAIEFLDLSNNSLSGTFPEFL-----SKLPSLRALNLKRNKLTG----SLPADLV 305 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~iP~~~-----~~l~~L~~l~l~~N~l~g----~~p~~~~ 305 (704)
.+|+.|+|++|+|+..-...+ ..|++|+.|+|++|+|+..-...+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555555543322222 234455555555555542211211 223445555555555442 1223333
Q ss_pred cccCCCccccccC
Q 037258 306 ERSNNGSLTLSVD 318 (704)
Q Consensus 306 ~~~~l~~l~l~~~ 318 (704)
.+++|+.|+|+.|
T Consensus 181 ~~~~L~~L~Ls~N 193 (372)
T 3un9_A 181 GNTSVTHLSLLHT 193 (372)
T ss_dssp TCSSCCEEECTTS
T ss_pred cCCCcCEEeCCCC
Confidence 4444555554444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00058 Score=71.25 Aligned_cols=139 Identities=11% Similarity=0.031 Sum_probs=76.4
Q ss_pred ccccccCceE-EEEEEeCCCcEEEEEecccch-hhHHHHHHHHHhhcccc--eeEEEEEEEeCCeEEEEEeecCCCCHHH
Q 037258 404 RVLGKGGFGE-VYHGSLDDNQQVAVKMLSSSC-CFQLLQVKLLMRVHHRN--LTALIGYCIEGNNMGLIYEYMASGTLDQ 479 (704)
Q Consensus 404 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~ 479 (704)
+.|+.|+... +|+....+++.+++|...... .....|+.++..+.... +.+++.+..+.+ ++|||++.+..+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE 101 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence 3455555554 667765446778888765543 45567888888775333 456676643333 68999998766654
Q ss_pred Hhhccc---------------------C---CCCCHHHHH-------H-------------HHHHHHHHHHHHh---cCC
Q 037258 480 YLKGKK---------------------E---HMLNWVERL-------Q-------------IAVDSAQGLEYLH---YGC 512 (704)
Q Consensus 480 ~l~~~~---------------------~---~~l~~~~~~-------~-------------i~~~ia~~L~~LH---~~~ 512 (704)
.+.... . ..++..... . ....+...++.+. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 443210 0 001111100 0 0001111222221 112
Q ss_pred CCCceecCCCCCCEEeCCC----CcEEEEeccCccc
Q 037258 513 KPPIVHRDVKSSNILLNEK----LQAKIADFGLSRI 544 (704)
Q Consensus 513 ~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~ 544 (704)
...++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5679999999999999874 6799999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.32 E-value=4e-05 Score=72.95 Aligned_cols=83 Identities=13% Similarity=0.196 Sum_probs=46.1
Q ss_pred CceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEec--cCCCCCCC----cc
Q 037258 236 SRIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNL--KRNKLTGS----LP 301 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l--~~N~l~g~----~p 301 (704)
+.|+.|+|++|+|.. .+...+...++|++|+|++|.|+.. +...+...++|+.|+| ++|.+... +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 456666666666653 2334444556666666666666532 4445555666666666 56666533 22
Q ss_pred cccccccCCCccccccC
Q 037258 302 ADLVERSNNGSLTLSVD 318 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~ 318 (704)
..+...+.|+.|+|+.|
T Consensus 145 ~~L~~n~~L~~L~L~~n 161 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFT 161 (185)
T ss_dssp HHHHHCSSCCEEECCCS
T ss_pred HHHHhCCCcCEEeccCC
Confidence 23333455666655443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.31 E-value=4.6e-05 Score=72.51 Aligned_cols=86 Identities=16% Similarity=0.226 Sum_probs=68.0
Q ss_pred CCceEEEEcCCC-CCcc----cCchhhccccccceEeccCCcccC----CCCcccCCCCCCCeEeccCCCCCCC----cc
Q 037258 235 PSRIISLNLSSS-GLTG----EISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRNKLTGS----LP 301 (704)
Q Consensus 235 ~~~l~~l~L~~n-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~iP~~~~~l~~L~~l~l~~N~l~g~----~p 301 (704)
.+.|+.|+|++| +|.. .+...+...++|++|+|++|.|.. .+...+...++|++|+|++|+|... +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 468999999999 8875 355667778999999999999974 2455566778999999999999854 55
Q ss_pred cccccccCCCccccccCCC
Q 037258 302 ADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~~n 320 (704)
..+.....|+.|+|+.++|
T Consensus 115 ~~L~~n~~L~~L~L~~~~N 133 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQ 133 (185)
T ss_dssp HGGGGCSSCCEEECCCCSS
T ss_pred HHHHhCCCceEEEecCCCC
Confidence 6677778899999944333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.23 E-value=3.9e-05 Score=86.86 Aligned_cols=84 Identities=15% Similarity=0.172 Sum_probs=47.2
Q ss_pred CceEEEEcCCC--CCcccCchhhcc-ccccceEeccCCcccC-CCCcccCCCCCCCeEeccCCCCCCC-cccccccccCC
Q 037258 236 SRIISLNLSSS--GLTGEISPYFAN-LTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNLKRNKLTGS-LPADLVERSNN 310 (704)
Q Consensus 236 ~~l~~l~L~~n--~l~g~~p~~~~~-l~~L~~L~l~~N~l~g-~iP~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~~~~l 310 (704)
++|+.|+|+.+ .+++..+..++. +++|+.|+|++|++++ .+|..+..+++|+.|+|++|.|++. ++..+..+++|
T Consensus 436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L 515 (592)
T 3ogk_B 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515 (592)
T ss_dssp TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence 44555555422 244444444433 5666666666666665 3455556667777777777776544 33334456667
Q ss_pred CccccccCC
Q 037258 311 GSLTLSVDG 319 (704)
Q Consensus 311 ~~l~l~~~~ 319 (704)
+.|+|+.|.
T Consensus 516 ~~L~ls~n~ 524 (592)
T 3ogk_B 516 RYLWVQGYR 524 (592)
T ss_dssp CEEEEESCB
T ss_pred CeeECcCCc
Confidence 766666554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0015 Score=70.63 Aligned_cols=78 Identities=8% Similarity=0.065 Sum_probs=46.9
Q ss_pred CCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc-cCCCCccCccccccC---CCCcchhHHHHHHHHH
Q 037258 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV-AGTPGYLDPEYYVLN---WLNEKSDVYSFGVVLL 588 (704)
Q Consensus 513 ~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~ 588 (704)
...++|||+++.|||++.++ ++|+||+.+..-... ....... .-...|.+|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 77899999999999999876 999999988642100 0000000 001235555544311 1122355667777888
Q ss_pred HHHhC
Q 037258 589 EIITG 593 (704)
Q Consensus 589 elltG 593 (704)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.21 E-value=3.9e-05 Score=86.85 Aligned_cols=81 Identities=12% Similarity=0.131 Sum_probs=52.2
Q ss_pred CCceEEEEcCCCCCccc----CchhhccccccceEeccCCccc----CCCCcccCCCCCCCeEeccCCCCCCCccccccc
Q 037258 235 PSRIISLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLS----GTFPEFLSKLPSLRALNLKRNKLTGSLPADLVE 306 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~----g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 306 (704)
+++|+.|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+..
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 35667777777766655 4555566677777777777766 2344445566777777777777664 6666666
Q ss_pred ccCCCccccc
Q 037258 307 RSNNGSLTLS 316 (704)
Q Consensus 307 ~~~l~~l~l~ 316 (704)
+++|+.|+++
T Consensus 242 ~~~L~~L~l~ 251 (592)
T 3ogk_B 242 AANLEEFCGG 251 (592)
T ss_dssp CTTCCEEEEC
T ss_pred hhHHHhhccc
Confidence 6666666665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00035 Score=72.85 Aligned_cols=82 Identities=21% Similarity=0.170 Sum_probs=65.0
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCC-eEeccCCCCCCCcccccccccCCCc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLR-ALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~-~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
+++|+.|+|++|+++..-+..|.+|++|+.|+|.+| ++ .|+ ..|.+|++|+ .|+|++ +++..-+..|.++.+|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 468899999999998544557999999999999988 77 454 5688999999 999988 777444567888999998
Q ss_pred cccccCC
Q 037258 313 LTLSVDG 319 (704)
Q Consensus 313 l~l~~~~ 319 (704)
|++..|.
T Consensus 302 l~l~~n~ 308 (329)
T 3sb4_A 302 VLATGDK 308 (329)
T ss_dssp EEECSSC
T ss_pred EEeCCCc
Confidence 8876554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0013 Score=67.45 Aligned_cols=67 Identities=6% Similarity=0.048 Sum_probs=44.8
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccchh---hHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEeec-CCCCH
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEYM-ASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~-~~gsL 477 (704)
+.|+.|....+|+. +.+++|+...... ....|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 5688998765322 34678888887754333 355544 343457899999 65444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00067 Score=73.50 Aligned_cols=70 Identities=17% Similarity=0.268 Sum_probs=49.8
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEeccc-ch-hhHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEeec
Q 037258 404 RVLGKGGFGEVYHGSLDD--------NQQVAVKMLSS-SC-CFQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~-~~-~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~ 472 (704)
+.|+.|....+|+....+ ++.+++|+... .. .....|..+++.+...++ .++++.+.+ .+|+||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 567888889999998753 57899999854 23 455678888888864444 466665532 3899999
Q ss_pred CCCCH
Q 037258 473 ASGTL 477 (704)
Q Consensus 473 ~~gsL 477 (704)
+|.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 86443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0016 Score=66.43 Aligned_cols=70 Identities=16% Similarity=0.140 Sum_probs=51.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEecccch----hhHHHHHHHHHhhcc---cceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC----CFQLLQVKLLMRVHH---RNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+|.|..+.||+.+..+|+.|++|+..... ..+..|...|+.+.. -.+.+++++. .-++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 5689999999999999999999999865432 246789999888842 1244555442 2378999998765
Q ss_pred H
Q 037258 477 L 477 (704)
Q Consensus 477 L 477 (704)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.94 E-value=9.8e-05 Score=83.54 Aligned_cols=84 Identities=12% Similarity=0.059 Sum_probs=45.5
Q ss_pred CCceEEEEcC--C----CCCcc-----cCchhhccccccceEeccCCcccCCCCcccCC-CCCCCeEeccCCCCCCCccc
Q 037258 235 PSRIISLNLS--S----SGLTG-----EISPYFANLTAIEFLDLSNNSLSGTFPEFLSK-LPSLRALNLKRNKLTGSLPA 302 (704)
Q Consensus 235 ~~~l~~l~L~--~----n~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~-l~~L~~l~l~~N~l~g~~p~ 302 (704)
+++|+.|+|+ + |++++ .++..+.++++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+.
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 5667777776 3 45542 2223355566666666655 454444444443 56666666666666544444
Q ss_pred cc-ccccCCCccccccCC
Q 037258 303 DL-VERSNNGSLTLSVDG 319 (704)
Q Consensus 303 ~~-~~~~~l~~l~l~~~~ 319 (704)
.+ ..+++|+.|+|+.+.
T Consensus 475 ~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp HHHHHCTTCCEEEEESCS
T ss_pred HHHhcCCCcCEEECcCCC
Confidence 33 445566666665543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.005 Score=59.03 Aligned_cols=103 Identities=14% Similarity=0.106 Sum_probs=66.8
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
-+|.+.|.... .+++++++|.++.|.+.+|.-+-. +..-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 37999998655 459999999999999999887721 11111333456899999999888764 1110
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 596 (704)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123567888763 3456888999999999998874443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0029 Score=65.37 Aligned_cols=139 Identities=9% Similarity=0.123 Sum_probs=79.7
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEeccc--chhhHHHHHHHHHhhcccce--eEEEEE------EEeCCeEEEEEeecC
Q 037258 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSS--SCCFQLLQVKLLMRVHHRNL--TALIGY------CIEGNNMGLIYEYMA 473 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~nI--v~l~~~------~~~~~~~~lV~e~~~ 473 (704)
+.|+.|....+|+....+| .+++|+... .......|+.++..+....+ .+++.. ....+..++|++|++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 3466788899999987666 688998876 23355678888877753332 333321 123456789999999
Q ss_pred CCCHHH--------------Hhhccc----CC---CC---CHHHHHH------------HHHHHHHHHHHHhc----CCC
Q 037258 474 SGTLDQ--------------YLKGKK----EH---ML---NWVERLQ------------IAVDSAQGLEYLHY----GCK 513 (704)
Q Consensus 474 ~gsL~~--------------~l~~~~----~~---~l---~~~~~~~------------i~~~ia~~L~~LH~----~~~ 513 (704)
|..+.. .++... .. .. .|..... +...+.+.++.++. ...
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 865321 112110 00 01 1222110 00113344555542 124
Q ss_pred CCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 514 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..++|+|+++.||+++++..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 579999999999999887656899999774
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0002 Score=81.04 Aligned_cols=64 Identities=16% Similarity=0.253 Sum_probs=29.9
Q ss_pred CceEEEEcCCCCCcccCchhhc-cccccceEeccCC-cccCC-CCcccCCCCCCCeEeccCCCCCCC
Q 037258 236 SRIISLNLSSSGLTGEISPYFA-NLTAIEFLDLSNN-SLSGT-FPEFLSKLPSLRALNLKRNKLTGS 299 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N-~l~g~-iP~~~~~l~~L~~l~l~~N~l~g~ 299 (704)
++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++.
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~ 171 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDV 171 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCc
Confidence 3455555555555544444443 4455555555554 33321 333333455555555555554443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0015 Score=58.03 Aligned_cols=56 Identities=29% Similarity=0.417 Sum_probs=37.1
Q ss_pred EEEcCCCCCc-ccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCC
Q 037258 240 SLNLSSSGLT-GEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLT 297 (704)
Q Consensus 240 ~l~L~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~ 297 (704)
.++.++++|+ ..+|..|. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777776 45664432 35778888888888333345677777777777777654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0077 Score=62.35 Aligned_cols=137 Identities=14% Similarity=0.156 Sum_probs=80.0
Q ss_pred cccccCceEEEEEEeCCCcEEEEEecccc---hhhHHHHHHHHHhhcccc--eeEEEEE-----EEeCCeEEEEEeecCC
Q 037258 405 VLGKGGFGEVYHGSLDDNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRN--LTALIGY-----CIEGNNMGLIYEYMAS 474 (704)
Q Consensus 405 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~n--Iv~l~~~-----~~~~~~~~lV~e~~~~ 474 (704)
.++ |....||+....+|+.+++|+.... ......|..++..+.... +.+++.. ...++..++||++++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 456 7788999987777878999998632 335566888887775322 3344432 2234566889999987
Q ss_pred CCHH-----H------H---hhccc-------CCCCCHHHH----------------------HHHHHHHHHHHHHHhc-
Q 037258 475 GTLD-----Q------Y---LKGKK-------EHMLNWVER----------------------LQIAVDSAQGLEYLHY- 510 (704)
Q Consensus 475 gsL~-----~------~---l~~~~-------~~~l~~~~~----------------------~~i~~~ia~~L~~LH~- 510 (704)
..+. . . ++... ....++... ...+..++..++.+..
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 1 1 11110 011222211 0111122222222211
Q ss_pred CCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 511 ~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.....++|||+++.||+++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999999 4 899999987753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0012 Score=68.59 Aligned_cols=79 Identities=14% Similarity=0.072 Sum_probs=66.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccc-eEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIE-FLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+.+|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+..|.+|++|+.|+|++|+++..-+..|.++++|+.
T Consensus 248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL 325 (329)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence 5679999999998 7755556899999999 999999 787344578999999999999999999555558888999887
Q ss_pred cc
Q 037258 313 LT 314 (704)
Q Consensus 313 l~ 314 (704)
+.
T Consensus 326 ly 327 (329)
T 3sb4_A 326 IY 327 (329)
T ss_dssp EE
T ss_pred hc
Confidence 64
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0039 Score=66.14 Aligned_cols=137 Identities=18% Similarity=0.236 Sum_probs=80.9
Q ss_pred ccccccCceEEEEEEeC--------CCcEEEEEecccc---hhhHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~ 471 (704)
+.|..|-...+|+.... +++.+++|+.... .....+|.++++.+...++ .++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45777888899998764 3478999997442 2345678888888853333 456666543 399999
Q ss_pred cCCCCHHHH-----------------hhccc---CCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 037258 472 MASGTLDQY-----------------LKGKK---EHMLN--WVERLQIAVDSAQ-------------------GLEYLH- 509 (704)
Q Consensus 472 ~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-------------------~L~~LH- 509 (704)
++|.+|..- |+... .+... +.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655310 11111 11122 3444444433321 122322
Q ss_pred ---c-CCCCCceecCCCCCCEEeCCC----CcEEEEeccCccc
Q 037258 510 ---Y-GCKPPIVHRDVKSSNILLNEK----LQAKIADFGLSRI 544 (704)
Q Consensus 510 ---~-~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~ 544 (704)
. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 124568999999999999876 6899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0042 Score=65.72 Aligned_cols=70 Identities=11% Similarity=0.213 Sum_probs=45.0
Q ss_pred ccccccCceEEEEEEeCC---------CcEEEEEecccchh---hHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEe
Q 037258 404 RVLGKGGFGEVYHGSLDD---------NQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e 470 (704)
+.|+.|....+|+....+ ++.+++|+...... ....|.++++.+...++ .++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457788889999997754 26899999765332 23678888888864443 4566543 2 268999
Q ss_pred ecCCCCH
Q 037258 471 YMASGTL 477 (704)
Q Consensus 471 ~~~~gsL 477 (704)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0051 Score=66.98 Aligned_cols=70 Identities=13% Similarity=0.151 Sum_probs=48.2
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEecccchh---hHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 404 RVLGKGGFGEVYHGSLDD-NQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
+.|+.|-...+|+....+ +..+++|+...... ....|..++..+...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568888889999998765 57899998754322 33689999998865555 46776662 2 359999987544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0046 Score=54.82 Aligned_cols=49 Identities=20% Similarity=0.253 Sum_probs=39.6
Q ss_pred eeecCCCC--------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCccc
Q 037258 225 GLNCSYED--------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLS 273 (704)
Q Consensus 225 gv~c~~~~--------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 273 (704)
-|.|+..+ +.+.+|+.|+|++|+|+..-+..|..|++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 37887543 23448999999999999655667899999999999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.00071 Score=71.47 Aligned_cols=86 Identities=14% Similarity=0.241 Sum_probs=58.4
Q ss_pred CCCceEEEEcCC--CCCccc-----Cchhh--ccccccceEeccCCcccCCCCccc---CCCCCCCeEeccCCCCCCC--
Q 037258 234 NPSRIISLNLSS--SGLTGE-----ISPYF--ANLTAIEFLDLSNNSLSGTFPEFL---SKLPSLRALNLKRNKLTGS-- 299 (704)
Q Consensus 234 ~~~~l~~l~L~~--n~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~iP~~~---~~l~~L~~l~l~~N~l~g~-- 299 (704)
.+++|+.|+|+. |...|. +.+.+ ..+++|++|+|++|.+++..+..+ ..+++|+.|+|+.|.|++.
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 567888888853 222221 12223 357899999999998875444333 3578899999999998863
Q ss_pred --cccccccccCCCccccccCC
Q 037258 300 --LPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 300 --~p~~~~~~~~l~~l~l~~~~ 319 (704)
++..+..+++|+.|+|+.|.
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBB
T ss_pred HHHHhhcccCCcceEEECCCCc
Confidence 55555677888888887653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.26 E-value=0.00075 Score=63.04 Aligned_cols=82 Identities=20% Similarity=0.104 Sum_probs=61.1
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCc-ccCCCCcccCCC----CCCCeEeccCCC-CCCCcccccccccC
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNS-LSGTFPEFLSKL----PSLRALNLKRNK-LTGSLPADLVERSN 309 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~iP~~~~~l----~~L~~l~l~~N~-l~g~~p~~~~~~~~ 309 (704)
.+|+.|||+++.++..-=..+.+|++|+.|+|+++. ++..==..++.+ ++|+.|+|+++. +|-.-=..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999886555667899999999999985 653211224443 479999999985 76433345678889
Q ss_pred CCcccccc
Q 037258 310 NGSLTLSV 317 (704)
Q Consensus 310 l~~l~l~~ 317 (704)
|+.|+++.
T Consensus 141 L~~L~L~~ 148 (176)
T 3e4g_A 141 LKYLFLSD 148 (176)
T ss_dssp CCEEEEES
T ss_pred CCEEECCC
Confidence 99888863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.016 Score=60.50 Aligned_cols=68 Identities=9% Similarity=0.088 Sum_probs=45.2
Q ss_pred cccCceEEEEEEeCCCcEEEEEecccchhhHHHHHHHHHhhcccc---eeEEEEE------EEeCCeEEEEEeecCCCCH
Q 037258 407 GKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRN---LTALIGY------CIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 407 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~n---Iv~l~~~------~~~~~~~~lV~e~~~~gsL 477 (704)
|.|....||+....+| .+++|+..... ...|+.++..+.... +.+.+.. ....+..++||+|++|..+
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred cCccccceEEEEeCCC-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 3344689999987777 89999876543 246777777664322 3444432 2335678999999998765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.0016 Score=68.79 Aligned_cols=86 Identities=16% Similarity=0.207 Sum_probs=61.7
Q ss_pred CCceEEEEcCCCCCcccCchhhc--cccccceEeccC--CcccCC-----CCccc--CCCCCCCeEeccCCCCCCCcccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFA--NLTAIEFLDLSN--NSLSGT-----FPEFL--SKLPSLRALNLKRNKLTGSLPAD 303 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----iP~~~--~~l~~L~~l~l~~N~l~g~~p~~ 303 (704)
.++|+.|+|..++++...-..++ +|++|+.|+|+. |...|. +-..+ ..+++|+.|+|++|.+....+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 57899999999988765555565 789999999863 332222 11122 35799999999999988655554
Q ss_pred cc---cccCCCccccccCCC
Q 037258 304 LV---ERSNNGSLTLSVDGN 320 (704)
Q Consensus 304 ~~---~~~~l~~l~l~~~~n 320 (704)
+. .+++|+.|+|+.|..
T Consensus 272 la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVL 291 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCC
T ss_pred HHhCccCCCCCEEECCCCCC
Confidence 44 478899999987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.43 E-value=0.0084 Score=57.00 Aligned_cols=83 Identities=22% Similarity=0.271 Sum_probs=41.7
Q ss_pred CceEEEEcCCC-CCcc----cCchhhccccccceEeccCCcccC----CCCcccCCCCCCCeEeccCCCCCCCc----cc
Q 037258 236 SRIISLNLSSS-GLTG----EISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRNKLTGSL----PA 302 (704)
Q Consensus 236 ~~l~~l~L~~n-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~iP~~~~~l~~L~~l~l~~N~l~g~~----p~ 302 (704)
+.|+.|+|++| +|.. .|-..+..-+.|+.|+|++|+|.. .|-..|..-+.|+.|+|++|+|...- -+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 34566666664 5432 233445555666666666666652 12233334456666666666665221 11
Q ss_pred ccccccCCCccccccC
Q 037258 303 DLVERSNNGSLTLSVD 318 (704)
Q Consensus 303 ~~~~~~~l~~l~l~~~ 318 (704)
.+..-..|+.|+|+.+
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 2223344555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.05 Score=58.12 Aligned_cols=82 Identities=7% Similarity=0.034 Sum_probs=42.8
Q ss_pred CCCceEEEEcCCCCCc-----ccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcccccccc
Q 037258 234 NPSRIISLNLSSSGLT-----GEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLPADLVER 307 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~ 307 (704)
.+.+|+.|+|.+|.+. -.-+..|.+|++|+.|+|. |+++ .|+ ..|.+|++|+.|+|.+| ++..-+..|.++
T Consensus 269 ~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 269 YCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp TCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred CCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence 3455666666555543 2223456666666666666 3354 333 34556666666666444 442223345555
Q ss_pred cCCCccccccCC
Q 037258 308 SNNGSLTLSVDG 319 (704)
Q Consensus 308 ~~l~~l~l~~~~ 319 (704)
+|+.|.+..|.
T Consensus 346 -~L~~l~l~~n~ 356 (401)
T 4fdw_A 346 -GIKEVKVEGTT 356 (401)
T ss_dssp -CCCEEEECCSS
T ss_pred -CCCEEEEcCCC
Confidence 66666655543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.22 Score=53.41 Aligned_cols=70 Identities=11% Similarity=0.215 Sum_probs=48.3
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEecccchh---hHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEee
Q 037258 404 RVLGKGGFGEVYHGSLDD--------NQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~ 471 (704)
+.+..|-...+|+....+ ++.+++|+...... ...+|..+++.+...++ .++++.+ .+ ++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEE
Confidence 457778889999997753 57899999765332 44688888888854333 4555433 22 689999
Q ss_pred cCCCCH
Q 037258 472 MASGTL 477 (704)
Q Consensus 472 ~~~gsL 477 (704)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=93.66 E-value=0.066 Score=57.15 Aligned_cols=78 Identities=13% Similarity=0.129 Sum_probs=53.1
Q ss_pred ceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccc
Q 037258 237 RIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316 (704)
Q Consensus 237 ~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~ 316 (704)
+|+.|+|.+ +++..-+..|.+|++|+.++|++|+++ .||...-.+.+|+.+.|.+| ++..-...|.++.+|+.+.+.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 477777775 666444567888888888888888887 66654444678888888744 553333467777777777765
Q ss_pred c
Q 037258 317 V 317 (704)
Q Consensus 317 ~ 317 (704)
.
T Consensus 235 ~ 235 (401)
T 4fdw_A 235 E 235 (401)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.42 E-value=0.021 Score=54.29 Aligned_cols=83 Identities=10% Similarity=0.146 Sum_probs=58.5
Q ss_pred CceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEeccCCCC---CC----Cc
Q 037258 236 SRIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNLKRNKL---TG----SL 300 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l~~N~l---~g----~~ 300 (704)
+.|+.|+|++|+|.. .|...+..-+.|+.|+|++|+|+.. |-..+..-+.|+.|+|++|.. .. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 579999999999984 3455566779999999999999842 344566667899999997633 31 13
Q ss_pred ccccccccCCCccccccC
Q 037258 301 PADLVERSNNGSLTLSVD 318 (704)
Q Consensus 301 p~~~~~~~~l~~l~l~~~ 318 (704)
-..+..-+.|..|+++++
T Consensus 150 a~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCcCeEeccCC
Confidence 334444566666666543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.44 E-value=0.65 Score=49.32 Aligned_cols=30 Identities=37% Similarity=0.526 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEe------CCCCcEEEEeccCccc
Q 037258 515 PIVHRDVKSSNILL------NEKLQAKIADFGLSRI 544 (704)
Q Consensus 515 ~ivH~Dlkp~NIll------~~~~~~kL~DfGla~~ 544 (704)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4566799999998854
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=89.50 E-value=0.077 Score=49.33 Aligned_cols=64 Identities=9% Similarity=0.080 Sum_probs=47.6
Q ss_pred CCCceEEEEcCCCC-CcccCchhhccc----cccceEeccCCc-ccCCCCcccCCCCCCCeEeccCCC-CC
Q 037258 234 NPSRIISLNLSSSG-LTGEISPYFANL----TAIEFLDLSNNS-LSGTFPEFLSKLPSLRALNLKRNK-LT 297 (704)
Q Consensus 234 ~~~~l~~l~L~~n~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~iP~~~~~l~~L~~l~l~~N~-l~ 297 (704)
.+++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. +|..==..+..+++|+.|+|+++. ++
T Consensus 83 ~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 83 GLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp TCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred CCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 57899999999985 775444456664 479999999974 663211246789999999999885 44
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.84 E-value=0.39 Score=50.78 Aligned_cols=78 Identities=17% Similarity=0.123 Sum_probs=48.4
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcc-cccccccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLP-ADLVERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~ 311 (704)
.+.+|+.+.+.++ ++-.-...|.++++|+.++|.++ ++ .|+ ..|.+|.+|+.++|..| ++ .|+ .+|.++.+|+
T Consensus 295 ~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 295 GCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLK 369 (394)
T ss_dssp TCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCC
T ss_pred ccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCC
Confidence 3456666676544 55233446777777777777643 55 443 45777777777777666 55 343 3566777777
Q ss_pred ccccc
Q 037258 312 SLTLS 316 (704)
Q Consensus 312 ~l~l~ 316 (704)
.+.+.
T Consensus 370 ~i~lp 374 (394)
T 4fs7_A 370 KVELP 374 (394)
T ss_dssp EEEEE
T ss_pred EEEEC
Confidence 66653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.71 E-value=0.66 Score=48.60 Aligned_cols=77 Identities=9% Similarity=0.141 Sum_probs=42.3
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcc-cccccccCCCc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLP-ADLVERSNNGS 312 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~~ 312 (704)
+..|+.+.+..+ ++-.-...|.++++|+.+.|.+|.++ .|+ ..|.+|.+|+.++|..| ++ .|+ .+|.++.+|+.
T Consensus 262 ~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~ 337 (379)
T 4h09_A 262 CTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALST 337 (379)
T ss_dssp CTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCC
T ss_pred eehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCE
Confidence 344555555432 33222345666666666666666666 343 45666666776666544 44 333 34566666665
Q ss_pred ccc
Q 037258 313 LTL 315 (704)
Q Consensus 313 l~l 315 (704)
+.+
T Consensus 338 i~i 340 (379)
T 4h09_A 338 ISY 340 (379)
T ss_dssp CCC
T ss_pred EEE
Confidence 554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=87.21 E-value=0.78 Score=48.41 Aligned_cols=75 Identities=12% Similarity=0.274 Sum_probs=33.4
Q ss_pred CceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcc-cccccccCCCcc
Q 037258 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLP-ADLVERSNNGSL 313 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~~~~l~~l 313 (704)
..|+.+.+. ++++..-...|.++++|+.++|.+| ++ .|. ..|.+|.+|+.+.|..+ ++ .|. .+|.++.+|+.+
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNI 362 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEE
Confidence 344444443 2333222234555555555555433 33 232 34555555555555433 33 232 245555555544
Q ss_pred cc
Q 037258 314 TL 315 (704)
Q Consensus 314 ~l 315 (704)
.+
T Consensus 363 ~~ 364 (394)
T 4gt6_A 363 EY 364 (394)
T ss_dssp EE
T ss_pred EE
Confidence 44
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=85.11 E-value=0.48 Score=50.10 Aligned_cols=74 Identities=12% Similarity=0.164 Sum_probs=55.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+.+|+.++|.++ ++-.-...|.++++|+.++|..| ++ .|+ ..|.+|++|+.++|..| ++ .+...|.++++|+.
T Consensus 318 ~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 318 SCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 5678999999754 76334568999999999999877 77 554 57999999999999765 33 34455666666553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=82.60 E-value=0.89 Score=47.95 Aligned_cols=77 Identities=13% Similarity=0.235 Sum_probs=55.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+.+|+.++|..+ ++-.-...|.++++|+.+.|.++ ++ .|+ ..|.+|++|+.+++.+|.... ..+..+.+|+.
T Consensus 309 ~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~ 382 (394)
T 4gt6_A 309 GCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQN 382 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--
T ss_pred CCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCE
Confidence 4678999999864 66344568999999999999755 77 665 579999999999999886431 45666677776
Q ss_pred cccc
Q 037258 313 LTLS 316 (704)
Q Consensus 313 l~l~ 316 (704)
+.+.
T Consensus 383 i~i~ 386 (394)
T 4gt6_A 383 LPVA 386 (394)
T ss_dssp ----
T ss_pred EEeC
Confidence 6553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.10 E-value=3.4 Score=39.34 Aligned_cols=116 Identities=10% Similarity=0.083 Sum_probs=79.0
Q ss_pred cccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEE
Q 037258 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNIL 527 (704)
Q Consensus 448 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 527 (704)
.||+.++. .+-.+.+.+.+.++.-+.+-=...++. .+...+++++.+|+....+++ .=+|--++|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 68888876 566666766666665432211222332 778999999999998886666 2478889999999
Q ss_pred eCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 037258 528 LNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVI 598 (704)
Q Consensus 528 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~ 598 (704)
++.++.+++.=.|+...+ +|. ..+...=.-.+=+++..+++++..|.
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999877754332 221 01122223357788999999998873
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=80.22 E-value=2 Score=44.87 Aligned_cols=80 Identities=18% Similarity=0.201 Sum_probs=59.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCC-cccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFP-EFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
.+..|+.+.|..+ ++..-...|.++.+|+.+.+..+ ++ .|+ ..|..|++|+.++|.+|.++-.-...|.++.+|+.
T Consensus 238 ~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~ 314 (379)
T 4h09_A 238 GMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSS 314 (379)
T ss_dssp TCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCE
T ss_pred CCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCE
Confidence 3567788888765 55344567888899999988654 55 444 46888999999999998888333457888899988
Q ss_pred cccc
Q 037258 313 LTLS 316 (704)
Q Consensus 313 l~l~ 316 (704)
+.|.
T Consensus 315 i~lp 318 (379)
T 4h09_A 315 VTLP 318 (379)
T ss_dssp EECC
T ss_pred EEcC
Confidence 8774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 704 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 5e-67
Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 27/276 (9%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTAL 455
+ +G G FG VY G VAVKML+ + +V +L + H N+
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
+GY + ++ ++ +L +L + ++ + IA +AQG++YLH
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL---N 572
I+HRD+KS+NI L+E L KI DFGL+ + S S ++G+ ++ PE + N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
+ +SDVY+FG+VL E++TG+ P ++ I V R + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIFMVG--------RGYLSPDLS-K 233
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668
+N L C ERP +L ++
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-63
Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 29/300 (9%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRNLTALIGY 458
+ +GKG FGEV+ G ++VAVK+ SS F+ ++ + + H N+ I
Sbjct: 7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 459 CIEGNN----MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH----- 509
+ N + L+ +Y G+L YL + +++A+ +A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF--SIESSDQISTAVAGTPGYLDPE 567
KP I HRD+KS NIL+ + IAD GL+ + ++ D GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 568 YYVLN------WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHI----SQWVNSMLA 617
+ +++D+Y+ G+V EI + + S +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 618 EGDIRNIVDPSLQGNFDNNSAWKAV-ELALACASHTSSERPTMTDVLMELKECLSLEIVR 676
+ + P++ + + A + + ++ C + R T + L + E ++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 67/273 (24%), Positives = 119/273 (43%), Gaps = 23/273 (8%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIGY 458
LG G FGEV+ G + + +VAVK L L + L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+ +I EYM +G+L +LK L + L +A A+G+ ++ + +H
Sbjct: 77 VTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD++++NIL+++ L KIADFGL+R+ ++ + PE KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 579 DVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638
DV+SFG++L EI+T R + ++ ++ + +N
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNP---------------EVIQNLERGYRMVRPDNCP 236
Query: 639 WKAVELALACASHTSSERPTMTDVLMELKECLS 671
+ +L C +RPT + L++ +
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-59
Identities = 58/273 (21%), Positives = 119/273 (43%), Gaps = 23/273 (8%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIG 457
F + +G G FG V+ G + +VA+K + + + + +++M++ H L L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
C+E + L++E+M G L YL+ + + L + +D +G+ Y + ++
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM---AYLEEACVI 123
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRD+ + N L+ E K++DFG++R + ST + PE + + + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 578 SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637
SDV+SFGV++ E+ + + + ++ + + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS---------------EVVEDISTGFRLYKPRLA 227
Query: 638 AWKAVELALACASHTSSERPTMTDVLMELKECL 670
+ ++ C +RP + +L +L E
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-59
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIG 457
F + LG G FG V +G VA+KM+ + + + K++M + H L L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
C + + +I EYMA+G L YL+ + H + L++ D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 518 HRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEK 577
HRD+ + N L+N++ K++DFGLSR + S + PE + + + K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 578 SDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637
SD+++FGV++ EI + + R + + + L+ + +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNS---------------ETAEHIAQGLRLYRPHLA 226
Query: 638 AWKAVELALACASHTSSERPTMTDVLMELKE 668
+ K + +C + ERPT +L + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-58
Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 23/294 (7%)
Query: 382 SFAPKSRQFAYSEIQKITNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQ--- 437
+ P S + E+++ + LG G +GEVY G + VAVK L
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 438 LLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQI 497
L + ++ + H NL L+G C +I E+M G L YL+ ++ V L +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
A + +EYL K +HRD+ + N L+ E K+ADFGLSR+ + +
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617
+ PE N + KSDV++FGV+L EI T +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------- 223
Query: 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671
+ +++ + K EL AC S+RP+ ++ +
Sbjct: 224 --QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 27/276 (9%)
Query: 402 FERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHHRNLTALIGYC 459
+ +GKG FG+V G +VAVK + + Q ++ ++ H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 460 IEGNN-MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+E + ++ EYMA G+L YL+ + +L L+ ++D + +EYL VH
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+ + N+L++E AK++DFGL++ S + PE + KS
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 579 DVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638
DV+SFG++L EI + R R D+ V+ + + +
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLK---------------DVVPRVEKGYKMDAPDGCP 226
Query: 639 WKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674
E+ C ++ RP+ + +L+ + E+
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 1e-57
Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 42/304 (13%)
Query: 390 FAYSEIQKITNNF-----------ERVLGKGGFGEVYHGSLDDNQQ----VAVKMLSSSC 434
F + + + F E+V+G G FGEV G L + VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 435 CFQLLQ-----VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHML 489
+ + ++ + H N+ L G + + +I E+M +G+LD +L+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 490 NWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549
++ + + A G++YL VHRD+ + NIL+N L K++DFGLSR ++
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 550 SDQISTAVAG---TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTT 606
SD T+ G + PE SDV+S+G+V+ E+++ +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240
Query: 607 HISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL 666
D+ N ++ + + +L L C + RP ++ L
Sbjct: 241 -------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 667 KECL 670
+ +
Sbjct: 288 DKMI 291
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 23/281 (8%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHR 450
EI + + E LG+G FGEV+ G+ + +VA+K L L + +++ ++ H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 72
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + ++ EYM+ G+L +LKG+ L + + +A A G+ Y+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
VHRD++++NIL+ E L K+ADFGL+R+ ++ + PE +
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630
KSDV+SFG++L E+ T R + ++ + V+ +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYR 232
Query: 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671
+L C ERPT + L++ +
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 75/334 (22%), Positives = 135/334 (40%), Gaps = 53/334 (15%)
Query: 370 QKVEMEFENRNDSFAPKSRQFAYSEIQKIT-NNFE--RVLGKGGFGEVYHGSL------D 420
Q V++ + N+ F R++ Y + N E +VLG G FG+V + +
Sbjct: 6 QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 65
Query: 421 DNQQVAVKMLSSSCCFQLLQ-----VKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMAS 474
+ QVAVKML + +K++ ++ H N+ L+G C + LI+EY
Sbjct: 66 VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125
Query: 475 GTLDQYLKGKKEHM---------------------LNWVERLQIAVDSAQGLEYLHYGCK 513
G L YL+ K+E L + + L A A+G+E+L
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---F 182
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
VHRD+ + N+L+ KI DFGL+R +S+ + ++ PE
Sbjct: 183 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633
KSDV+S+G++L EI + + + + ++ + +
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVN--------------PYPGIPVDANFYKLIQNGFKMDQ 288
Query: 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELK 667
+ + + +C + S +RP+ ++ L
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 1e-56
Identities = 80/314 (25%), Positives = 123/314 (39%), Gaps = 53/314 (16%)
Query: 392 YSEIQKITNNFE--RVLGKGGFGEVYHG------SLDDNQQVAVKMLSSSCCFQLLQ--- 440
++ NN E R +G+G FG V+ + VAVKML +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 441 --VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM---------- 488
L+ + N+ L+G C G M L++EYMA G L+++L+ H
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 489 ------------LNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKI 536
L+ E+L IA A G+ YL + VHRD+ + N L+ E + KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 537 ADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
ADFGLSR + A ++ PE N +SDV+++GVVL EI +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 597 VISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSER 656
M E I + D ++ +N + L C S ++R
Sbjct: 242 --------------PYYGMAHEEVIYYVRDGNILACPENCPL-ELYNLMRLCWSKLPADR 286
Query: 657 PTMTDVLMELKECL 670
P+ + L+
Sbjct: 287 PSFCSIHRILQRMC 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 43/304 (14%)
Query: 395 IQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMR 446
++ ++FE LG G G V+ +A K++ + +++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
+ + G + + E+M G+LDQ LK K + ++++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
YL K I+HRDVK SNIL+N + + K+ DFG+S D ++ + GT Y+ P
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSP 172
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIITGRRP---------------------------VIS 599
E + +SD++S G+ L+E+ GR P +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 600 RAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTM 659
+++ M + IV+ + + + C +ER +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 660 TDVL 663
++
Sbjct: 293 KQLM 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 45/306 (14%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VK 442
E + +F + LG G FG+V + D VAVKML S + +K
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 443 LLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM------------- 488
+L + +H N+ L+G C G +I EY G L +L+ K++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 489 ---LNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF 545
L+ + L + A+G+ +L +HRD+ + NILL KI DFGL+R
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 546 SIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
+S+ + ++ PE +SDV+S+G+ L E+ +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------- 246
Query: 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME 665
M + ++ + ++ + ++ C +RPT ++
Sbjct: 247 -----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 666 LKECLS 671
+++ +S
Sbjct: 302 IEKQIS 307
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-56
Identities = 70/274 (25%), Positives = 109/274 (39%), Gaps = 34/274 (12%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRNLTA 454
F+ +G+G F VY G + +VA L + + ++L + H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 455 LIGYCIE----GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
+ L+ E M SGTL YLK K + +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT 130
Query: 511 GCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
PPI+HRD+K NI + KI D GL+ + + AV GTP ++ PE Y
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMY 185
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629
+E DVY+FG+ +LE+ T P + A R +
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVK 230
Query: 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+FD + + E+ C ER ++ D+L
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 31/290 (10%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSCCFQLLQ-----VKLL 444
+ +F V+G+G FG VYHG+L DN AVK L+ + ++
Sbjct: 23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 445 MRVHHRNLTALIGYCIEG-NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
H N+ +L+G C+ + ++ YM G L +++ + H + + + A+
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAK 141
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI--STAVAGTP 561
G+ + VHRD+ + N +L+EK K+ADFGL+R + D + T
Sbjct: 142 GM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621
++ E KSDV+SFGV+L E++T P + +L
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQG--- 250
Query: 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671
R ++ P E+ L C + RP+ ++++ + S
Sbjct: 251 RRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 30/289 (10%)
Query: 393 SEIQKITNNFERVLGKGGFGEVYHGSLDDNQQ-----VAVKMLSSSCCFQLLQ-----VK 442
+EI ++V+G G FGEVY G L + VA+K L + +
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
++ + H N+ L G + M +I EYM +G LD++L+ +K+ + ++ + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGML---R 117
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF-SIESSDQISTAVAGTP 561
+ Y VHRD+ + NIL+N L K++DFGLSR+ + ++
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621
+ PE SDV+SFG+V+ E++T L+ ++
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
++ + + +L + C + RP D++ L + +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 29/291 (9%)
Query: 403 ERVLGKGGFGEVYHG---SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRNLTA 454
+ LG G FG V G VA+K+L + +++ ++ + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 455 LIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKP 514
LIG C + + L+ E G L ++L GK+E + ++ + G++YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEE---K 128
Query: 515 PIVHRDVKSSNILLNEKLQAKIADFGLSRIF-SIESSDQISTAVAGTPGYLDPEYYVLNW 573
VHRD+ + N+LL + AKI+DFGLS+ + +S +A + PE
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633
+ +SDV+S+GV + E ++ + + + ++ ++ +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------EVMAFIEQGKRMEC 233
Query: 634 DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGH 684
+ L C + +RP V ++ C + EGH H
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 33/278 (11%)
Query: 401 NFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRN 451
++E +G G +G D + + K L + + +V LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 452 LTALIGYCIEGNN--MGLIYEYMASGTLDQYLK--GKKEHMLNWVERLQIAVDSAQGLEY 507
+ I+ N + ++ EY G L + K+ L+ L++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 508 LHY--GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
H ++HRD+K +N+ L+ K K+ DFGL+RI + + A GTP Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625
PE NEKSD++S G +L E+ P + ++ + IR
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGK 230
Query: 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ + + + E+ + RP++ ++L
Sbjct: 231 FRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 35/287 (12%)
Query: 392 YSEIQKITN-----NFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----V 441
Y + + N LG G FG+VY + + + A K++ + +L +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDS 501
+L H N+ L+ NN+ ++ E+ A G +D + + E L + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQT 119
Query: 502 AQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561
L YLH I+HRD+K+ NIL K+ADFG+S + + Q + GTP
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTP 174
Query: 562 GYLDPEYYVLNWL-----NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSML 616
++ PE + + K+DV+S G+ L+E+ P + + + S
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEP 232
Query: 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ + + + C R T + +L
Sbjct: 233 PTLAQPSRWSSNFK------------DFLKKCLEKNVDARWTTSQLL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 33/288 (11%)
Query: 403 ERVLGKGGFGEVYHGSLDD---NQQVAVKMLSSSCCFQLLQ------VKLLMRVHHRNLT 453
++ LG G FG V G + VAVK+L + L+ ++ ++ + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
+IG C + M L+ E G L++YL+ + + +++ + G++YL
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIF-SIESSDQISTAVAGTPGYLDPEYYVLN 572
VHRD+ + N+LL + AKI+DFGLS+ + E+ + T + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
+ KSDV+SFGV++ E + + + ++ +++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------------EVTAMLEKGERMG 230
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGH 680
+ +L C ++ RP V + L+ ++V NEGH
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN-YYYDVV-NEGH 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 63/273 (23%), Positives = 111/273 (40%), Gaps = 28/273 (10%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHRN 451
+++ + LG+G +GEV + + VAVK++ + + + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ G+ EGN L EY + G L ++ + + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
I HRD+K N+LL+E+ KI+DFGL+ +F + +++ + GT Y+ PE
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 572 NWLN-EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630
+ E DV+S G+VL ++ G + D S W + I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA--- 235
Query: 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ L S R T+ D+
Sbjct: 236 ----------PLALLHKILVENPSARITIPDIK 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 70/270 (25%), Positives = 109/270 (40%), Gaps = 34/270 (12%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-------LLQVKLLMRVHHRNLT 453
R LGKG FG VY +A+K+L + + +V++ + H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L GY + + LI EY GT+ + L+ K + + A L Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH---S 124
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
++HRD+K N+LL + KIADFG S + T + GT YL PE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633
+EK D++S GV+ E + G+ P + T+ + E + V +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTEGAR--- 232
Query: 634 DNNSAWKAVELALACASHTSSERPTMTDVL 663
+L H S+RP + +VL
Sbjct: 233 ---------DLISRLLKHNPSQRPMLREVL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-52
Identities = 63/313 (20%), Positives = 120/313 (38%), Gaps = 44/313 (14%)
Query: 401 NFERVLGKGGFGEVYHGSLDDNQQ-----VAVKMLSSSCCFQLLQ-----VKLLMRVHHR 450
+VLG G FG VY G + VA+K L + + + ++ V +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
++ L+G C+ LI + M G L Y++ K+++ L V A+G+ YL
Sbjct: 72 HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLED 129
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
+VHRD+ + N+L+ KI DFGL+++ E + + ++ E +
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630
+SDV+S+GV + E++T +I +I++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EISSILEKGER 231
Query: 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVRNEGHEKGHRDPRRM 690
+ + C + RP ++++E + RDP+R
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA--------------RDPQRY 277
Query: 691 VTLNLDTESSPSA 703
+ + D +
Sbjct: 278 LVIQGDERMHLPS 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 1e-51
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 37/271 (13%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-------LLQVKLLMRVHHRNLTAL 455
R +G G FG VY + +++ VA+K +S S + +V+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 456 IGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP 515
G + + L+ EY D KK L VE + + QGL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 516 IVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW-- 573
++HRDVK+ NILL+E K+ DFG + I + + GTP ++ PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEG 189
Query: 574 -LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
+ K DV+S G+ +E+ + P+ + + +I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNESPAL 234
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ + +C +RPT +L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 401 NFERVLGKGGFGEVYHGSLDDN---QQVAVKMLSSSCCFQLLQ-----VKLLMRV-HHRN 451
F+ V+G+G FG+V + + A+K + + +++L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM--------------LNWVERLQI 497
+ L+G C + L EY G L +L+ + L+ + L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
A D A+G++YL + +HRD+ + NIL+ E AKIADFGLSR + T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMG 186
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLA 617
++ E + SDV+S+GV+L EI++ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---------------MT 231
Query: 618 EGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
++ + + N + +L C ERP+ +L+ L L
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 8e-49
Identities = 56/270 (20%), Positives = 105/270 (38%), Gaps = 30/270 (11%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSS-------CCFQLLQVKLLMRVHHRNLT 453
F ++LG+G F V L +++ A+K+L + + ++ R+ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L + + Y +G L +Y++ K + A+ + L Y
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYT---AEIVSALEYLHG 126
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
I+HRD+K NILLNE + +I DFG +++ S ES + + GT Y+ PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 574 LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633
+ SD+++ G ++ +++ G P + + E D P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP------ 235
Query: 634 DNNSAWKAVELALACASHTSSERPTMTDVL 663
KA +L +++R ++
Sbjct: 236 ------KARDLVEKLLVLDATKRLGCEEME 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 9e-49
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 37/288 (12%)
Query: 402 FERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHHR 450
R LG+G FG VY G + +VA+K ++ + + ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHM--------LNWVERLQIAVDSA 502
++ L+G +G +I E M G L YL+ + M + + +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
G+ YL VHRD+ + N ++ E KI DFG++R +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622
++ PE SDV+SFGVVL EI T ++ +R
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--------------LR 246
Query: 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
+++ L DN EL C + RP+ +++ +KE +
Sbjct: 247 FVMEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-48
Identities = 54/265 (20%), Positives = 110/265 (41%), Gaps = 27/265 (10%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ----LLQVKLLMRVHHRNLTALIGY 458
+G+G G VY + Q+VA++ ++ + + ++ ++ + N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVH 518
+ G+ + ++ EY+A G+L + E ++ + + + Q LE+LH ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 519 RDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKS 578
RD+KS NILL K+ DFG + E S + + GTP ++ PE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 579 DVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNSA 638
D++S G++ +E+I G P E+ + + E + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFR-------- 247
Query: 639 WKAVELALACASHTSSERPTMTDVL 663
+ C +R + ++L
Sbjct: 248 ----DFLNRCLDMDVEKRGSAKELL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 67/281 (23%), Positives = 100/281 (35%), Gaps = 33/281 (11%)
Query: 402 FERVLGKGGFGEVYHGSLD----DNQQVAVKMLSSSCCFQ-------LLQVKLLMRVHHR 450
LG G FG V G D VAVK L Q + +V + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
NL L G + M ++ E G+L L+ + H + AV A+G+ YL
Sbjct: 72 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE- 128
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF-SIESSDQISTAVAGTPGYLDPEYY 569
+HRD+ + N+LL + KI DFGL R + + + PE
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 570 VLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628
+ SD + FGV L E+ T G+ P I + I
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------LHKIDKEG 231
Query: 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669
+ + + + C +H +RPT + L E
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 6e-48
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 30/292 (10%)
Query: 394 EIQKITNNFERVLGKGGFGEVYHGSLDDNQQ----VAVKMLSSSCCFQLLQ-----VKLL 444
EIQ+ R +G+G FG+V+ G + VA+K + + + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 445 MRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQG 504
+ H ++ LIG E N + +I E G L + +++ L+ + A +
Sbjct: 63 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTA 120
Query: 505 LEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYL 564
L YL VHRD+ + N+L++ K+ DFGLSR +S+ ++ ++
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 176
Query: 565 DPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624
PE SDV+ FGV + EI+ Q V + G I N
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----------QGVKNNDVIGRIENG 225
Query: 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVR 676
+ N L C ++ S RP T++ +L L E +
Sbjct: 226 ERLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-48
Identities = 73/296 (24%), Positives = 112/296 (37%), Gaps = 44/296 (14%)
Query: 402 FERVLGKGGFGEVYHG------SLDDNQQVAVKMLSSSCC------FQLLQVKLLMRVHH 449
+ LG+G FG+V + VAVKML L+ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 450 RNLTALIGYCIE-GNNMGLIYEYMASGTLDQYLKGKKEHM--------------LNWVER 494
N+ L+G C + G + +I E+ G L YL+ K+ L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 495 LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
+ + A+G+E+L +HRD+ + NILL+EK KI DFGL+R +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS 614
++ PE +SDV+SFGV+L EI + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCR 248
Query: 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
L EG D + + + L C S+RPT ++++ L L
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 402 FERVLGKGGFGEVYHG--------SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRV- 447
+ LG+G FG+V + +VAVKML S + L ++++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 448 HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKK--------------EHMLNWVE 493
H+N+ L+G C + + +I EY + G L +YL+ ++ E L+ +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 494 RLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553
+ A A+G+EYL +HRD+ + N+L+ E KIADFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN 613
+T ++ PE +SDV+SFGV+L EI T +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--------- 244
Query: 614 SMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672
++ ++ + + +N + + C S+RPT ++ +L ++L
Sbjct: 245 ------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 2e-44
Identities = 53/278 (19%), Positives = 112/278 (40%), Gaps = 33/278 (11%)
Query: 397 KITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----VKLLMRVHH 449
+ + ++ LG G FG V+ + K +++ + ++ ++HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
L L + M LI E+++ G L + +++ ++ E + + +GL+++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 510 YGCKPPIVHRDVKSSNILL--NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
+ IVH D+K NI+ + KI DFGL+ + D+I T + PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE 198
Query: 568 YYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627
+ +D+++ GV+ +++G P + +T ++N+
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---------------LQNVKRC 243
Query: 628 SLQGNFDNNSAW--KAVELALACASHTSSERPTMTDVL 663
+ + D S+ +A + +R T+ D L
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 56/312 (17%), Positives = 116/312 (37%), Gaps = 34/312 (10%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLL---QVKLLMRVHHRNLTALIG 457
LG+G FG V+ + K + Q+L ++ +L HRN+ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 458 YCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIV 517
+ +I+E+++ + + + LN E + + L++LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 518 HRDVKSSNILLNEK--LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLN 575
H D++ NI+ + KI +FG +R + P Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 576 EKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635
+D++S G ++ +++G P ++ +I N + F
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------NIMNAEYTFDEEAFKE 229
Query: 636 NSAWKAVELALACASHTSSERPTMTDVLM-----ELKECLSLEIVRNEGHEKGHRDPRRM 690
S +A++ R T ++ L + E +S +++R K R +
Sbjct: 230 ISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT---LKHRRYYHTL 285
Query: 691 VTLNLDTESSPS 702
+ +L+ S +
Sbjct: 286 IKKDLNMVVSAA 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (404), Expect = 4e-44
Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 29/275 (10%)
Query: 398 ITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----VKLLMRVHHR 450
+ ++++ LG G FG V+ A K + + ++ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
L L + N M +IYE+M+ G L + + + + ++ E ++ +GL ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 511 GCKPPIVHRDVKSSNILLNEKL--QAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEY 568
VH D+K NI+ K + K+ DFGL+ Q GT + PE
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEV 196
Query: 569 YVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628
+ +D++S GV+ +++G P +D+T ++++
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------------NVKSCDWNM 244
Query: 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
F S + + R T+ L
Sbjct: 245 DDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-43
Identities = 54/280 (19%), Positives = 105/280 (37%), Gaps = 26/280 (9%)
Query: 392 YSEIQKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKL 443
+ + + I + ++ VLG G F EV + VA+K ++ + +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 444 LMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQ 503
L ++ H N+ AL G ++ LI + ++ G L + K + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 504 GLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGY 563
++YLH + L+E + I+DFGLS++ E + + GTPGY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 175
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
+ PE ++ D +S GV+ ++ G P E+D Q + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKA--------- 224
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ + ++ + A + +R T L
Sbjct: 225 --EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 5e-43
Identities = 63/286 (22%), Positives = 119/286 (41%), Gaps = 34/286 (11%)
Query: 397 KITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-------LLQVKLLMR 446
+++ +E +LG GG EV+ L ++ VAVK+L + + +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 447 VHHRNLTALIGYCIEGNNMG----LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
++H + A+ G ++ EY+ TL + + + +++ A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI---A 118
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST-AVAGTP 561
+ L++ + I+HRDVK +NI+++ K+ DFG++R + + T AV GT
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDI 621
YL PE + ++ +SDVYS G VL E++TG P + +S + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQHVREDPIP 233
Query: 622 RNIVDPSLQGNFDNNSAWKAVELALACASHTSSERP-TMTDVLMEL 666
+ L + D + L + R T ++ +L
Sbjct: 234 PSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (388), Expect = 1e-42
Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 46/285 (16%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-------------VKLLMRV 447
+ +LG+G V ++ AVK++ + V +L +V
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 448 H-HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
H N+ L L+++ M G L YL K L+ E +I + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 124
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
LH K IVHRD+K NILL++ + K+ DFG S + V GTP YL P
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 178
Query: 567 EYYVLNWL------NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD 620
E + ++ D++S GV++ ++ G P R +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--------------- 223
Query: 621 IRNIVDPSLQGNFDNNSAW--KAVELALACASHTSSERPTMTDVL 663
+R I+ + Q + +L +R T + L
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 61/273 (22%), Positives = 106/273 (38%), Gaps = 33/273 (12%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSC--------CFQLLQVKLLMRVHHRNL 452
++LGKG FG+V+ NQ A+K L C + + L + H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
T + N+ + EY+ G L +++ H + A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFL---H 120
Query: 513 KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLN 572
IV+RD+K NILL++ KIADFG+ + D + GTP Y+ PE +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--MLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 573 WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632
N D +SFGV+L E++ G+ P + + + ++ +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMDNPFYPRWLEKEAK-- 231
Query: 633 FDNNSAWKAVELALACASHTSSERPTMTDVLME 665
+L + +R + + +
Sbjct: 232 ----------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 31/283 (10%)
Query: 404 RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ---------VKLLMRVHHRNLT 453
LG+G F VY + NQ VA+K + + +KLL + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 454 ALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK 513
L+ +N+ L++++M + + ++ + L+ L Y +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML-----MTLQGLEYLHQ 118
Query: 514 PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNW 573
I+HRD+K +N+LL+E K+ADFGL++ F S ++ T T Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 574 L-NEKSDVYSFGVVLLEIITGRRPVISRAEDD----------TTHISQW--VNSMLAEGD 620
+ D+++ G +L E++ + ++ D T QW + S+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
++ L F ++L R T T L
Sbjct: 237 FKSFPGIPLHHIFSAAGD-DLLDLIQGLFLFNPCARITATQAL 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 57/296 (19%), Positives = 104/296 (35%), Gaps = 33/296 (11%)
Query: 395 IQKITNNFE--RVLGKGGFGEVYHG--SLDDNQQVAVKMLSSSCCFQLLQV--------- 441
+ + +E +G+G +G+V+ + + VA+K + + + +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 442 KLLMRVHHRNLTALIGYCIEGNNMGLIYEYM----ASGTLDQYLKGKKEHMLNWVERLQI 497
+ L H N+ L C + L YL E + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 498 AVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557
+GL++LH +VHRD+K NIL+ Q K+ADFGL+RI+S T+V
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSV 175
Query: 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD----------TTH 607
T Y PE + + D++S G + E+ + ++ D
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 608 ISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
W + + F + +L L C + ++R + L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 3e-41
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVK-------LLMRVHH 449
+F+ R LG G FG V+ S + + A+K+L +L QV+ +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
+ + G + + +I +Y+ G L L+ + + +A+ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALE 118
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
Y I++RD+K NILL++ KI DFG ++ ++ + GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVV 173
Query: 570 VLNWLNEKSDVYSFGVVLLEIITGRRP 596
N+ D +SFG+++ E++ G P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (380), Expect = 1e-40
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 23/230 (10%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ----------LLQVKLLMR 446
N+F R++G+GGFGEVY D + A+K L + + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 447 VHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLE 506
+ + + + I + M G L +L + A + GLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121
Query: 507 YLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
++H +V+RD+K +NILL+E +I+D GL+ F S + A GT GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAP 174
Query: 567 EYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSM 615
E + +D +S G +L +++ G P D I + +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 53/289 (18%), Positives = 103/289 (35%), Gaps = 26/289 (8%)
Query: 396 QKITNNFERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTA 454
Q+++ +V+G G FG VY D + VA+K + F+ +++++ ++ H N+
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 455 LIGYCIEGNN------MGLIYEYMASGTLDQYLK-GKKEHMLNWVERLQIAVDSAQGLEY 507
L + + L+ +Y+ + + L + + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 508 LHYGCKPPIVHRDVKSSNILLNEK-LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDP 566
+H I HRD+K N+LL+ K+ DFG ++ + + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPE 192
Query: 567 EYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDD------------TTHISQWVNS 614
+ DV+S G VL E++ G+ + D T + +N
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 615 MLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
E I F + +A+ L +T + R T +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 6e-40
Identities = 57/284 (20%), Positives = 113/284 (39%), Gaps = 30/284 (10%)
Query: 394 EIQK--ITNNFE---RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQVKLLMRV 447
+I+K I ++++ +VLG G G+V + ++ A+KML + +V+L R
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRA 61
Query: 448 -HHRNLTALIGYC----IEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
++ ++ + ++ E + G L ++ + + E +I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+ ++YLH I HRDVK N+L K+ DFG ++ +S T
Sbjct: 122 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCY 175
Query: 560 TPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619
TP Y+ PE ++ D++S GV++ ++ G P + H M
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF------YSNHGLAISPGMKTRI 229
Query: 620 DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ P+ + + S + L ++R T+T+ +
Sbjct: 230 RMGQYEFPNPE--WSEVSE-EVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 9e-40
Identities = 40/288 (13%), Positives = 95/288 (32%), Gaps = 28/288 (9%)
Query: 398 ITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHHRNL 452
+ +++ R +G+G FG ++ G +L +NQQVA+K L+ + +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 453 TALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
+ Y + ++ + +L+ L + A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-LCGRKFSVKTVAMAAKQMLARVQSIH--- 118
Query: 513 KPPIVHRDVKSSNILLNEKLQ-----AKIADFGLSRIFSIESSDQI-----STAVAGTPG 562
+ +V+RD+K N L+ + DFG+ + + + Q ++GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIR 622
Y+ ++ + + D+ + G V + + G P + + +R
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 623 NIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
+ + + + P + + L
Sbjct: 239 ELCA---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 56/294 (19%), Positives = 109/294 (37%), Gaps = 34/294 (11%)
Query: 398 ITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-----VKLLMRVHH 449
+ + +G+G +G V + +VA+K +S Q +K+L+R H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 450 RNLTALIGYCIEGN----NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
N+ + + ++ L + LK + L+ +GL
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIF-SIESSDQISTAVAGTPGYL 564
+Y+H ++HRD+K SN+LLN KI DFGL+R+ T T Y
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 565 DPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
PE + + + D++S G +L E+++ R + D + + ++ D+
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 624 IVDPSLQGNFDNNSAWK--------------AVELALACASHTSSERPTMTDVL 663
I++ + + A++L + +R + L
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 59/299 (19%), Positives = 113/299 (37%), Gaps = 40/299 (13%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ------VKLLMRVHHR 450
+ +E +G+G FGEV+ Q+VA+K + + +K+L + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 451 NLTALIGYCIEG--------NNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
N+ LI C ++ L++++ + L+ ++R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQ 124
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS--TAVAGT 560
L L+Y + I+HRD+K++N+L+ K+ADFGL+R FS+ + Q + T T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 561 PGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG 619
Y PE + D++ G ++ E+ T + E + + +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 620 DIRNIVDPSLQGNFDNNSAWK---------------AVELALACASHTSSERPTMTDVL 663
N+ + L + K A++L ++R D L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 4e-39
Identities = 49/284 (17%), Positives = 97/284 (34%), Gaps = 26/284 (9%)
Query: 400 NNFE--RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRN 451
+ +G+G +G VY + + A+K + + + ++ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L + L++E++ E L V Q L + Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFL---LQLLNGIAYC 116
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
++HRD+K N+L+N + + KIADFGL+R F + + +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 572 NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD----- 626
+ D++S G + E++ G +E D + + N+ +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 627 -------PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
P +F ++L ++R T L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 1e-38
Identities = 48/287 (16%), Positives = 97/287 (33%), Gaps = 26/287 (9%)
Query: 397 KITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ--VKLLMRVHHRN 451
++ N + R +G G FG++Y G + ++VA+K+ L K+ +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
I +C + ++ + +L+ + L +A +EY+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 512 CKPPIVHRDVKSSNILLNEK---LQAKIADFGLSRIFSIESSDQI-----STAVAGTPGY 563
+HRDVK N L+ I DFGL++ + + Q + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 564 LDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623
++ + + D+ S G VL+ G P ++ +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAATKRQKYERISEKKMS 234
Query: 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670
L + + + C S ++P + + +
Sbjct: 235 TPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 4e-38
Identities = 60/277 (21%), Positives = 100/277 (36%), Gaps = 46/277 (16%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ----------LLQVKLLMRVH-- 448
+LG GGFG VY G + DN VA+K + ++V LL +V
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 449 HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYL 508
+ L+ + ++ LI E + L Q LE +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFF---WQVLEAV 123
Query: 509 HYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPE 567
+ ++HRD+K NIL++ + + K+ DFG + D + T GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 568 YYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626
+ + + + V+S G++L +++ G P E + R V
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-----------FFRQRVS 228
Query: 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
Q L C + S+RPT ++
Sbjct: 229 SECQ------------HLIRWCLALRPSDRPTFEEIQ 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 53/287 (18%), Positives = 110/287 (38%), Gaps = 32/287 (11%)
Query: 401 NFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVHHRN 451
NF+ +G+G +G VY + + VA+K + + + ++ LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 452 LTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG 511
+ L+ N + L++E++ L +++ + QGL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 512 CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
++HRD+K N+L+N + K+ADFGL+R F + T T Y PE +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLG 176
Query: 572 N-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630
+ + D++S G + E++T R + + + + ++ ++ S+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 631 GNFDNNSAWK--------------AVELALACASHTSSERPTMTDVL 663
+ W L + ++R + L
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 397 KIT-NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ-------LLQVKLLM 445
K+T N+F+ ++LGKG FG+V + A+K+L + + ++L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 446 RVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGL 505
H LTAL + + + EY G L +L +E + A+ +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYG---AEIV 115
Query: 506 EYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLD 565
L Y +V+RD+K N++L++ KI DFGL + S GTP YL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 566 PEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
PE N D + GVV+ E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 42/287 (14%)
Query: 396 QKITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ----------VK 442
+ + + ++ LG G F V Q A K + + V
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 443 LLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
+L + H N+ L ++ LI E +A G L +L K+ +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--- 122
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNE----KLQAKIADFGLSRIFSIESSDQISTAVA 558
L ++Y I H D+K NI+L + K + KI DFGL+ +
Sbjct: 123 --LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIF 177
Query: 559 GTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618
GTP ++ PE L ++D++S GV+ +++G P + + +T
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------------- 224
Query: 619 GDIRNI--VDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVL 663
+ N+ V+ + + +N++ A + +R T+ D L
Sbjct: 225 --LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 48/286 (16%), Positives = 98/286 (34%), Gaps = 28/286 (9%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ------VKLLMRVHHR 450
+E +G+G +G V+ + + ++ VA+K + + + + LL + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 451 NLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHY 510
N+ L + L++E+ + + V+ Q L+ L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGF 116
Query: 511 GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYV 570
++HRD+K N+L+N + K+A+FGL+R F S V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFG 175
Query: 571 LNWLNEKSDVYSFGVVLLEIITGRRPV-ISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629
+ D++S G + E+ RP+ DD + E ++
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 630 QGNFDNNSAWK------------AVELALACASHTSSERPTMTDVL 663
+ A +L +R + + L
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 9e-33
Identities = 52/245 (21%), Positives = 103/245 (42%), Gaps = 29/245 (11%)
Query: 362 RRRNKRVGQKVEMEFENRNDSFAPKSRQFAYSEIQKITNNFE--RVLGKGGFGEVYHG-S 418
+ K K + +F + ++ + + Q + F+ + LG G FG V
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQL---------DQFDRIKTLGTGSFGRVMLVKH 62
Query: 419 LDDNQQVAVKMLSSSCCFQLLQ-------VKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471
+ A+K+L +L Q ++L V+ L L + +N+ ++ EY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531
+A G + +L+ + + A EYLH +++RD+K N+L++++
Sbjct: 123 VAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 177
Query: 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEII 591
++ DFG ++ + + GTP L PE + N+ D ++ GV++ E+
Sbjct: 178 GYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 592 TGRRP 596
G P
Sbjct: 233 AGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 2e-32
Identities = 49/284 (17%), Positives = 115/284 (40%), Gaps = 22/284 (7%)
Query: 400 NNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-VKLLMRV-HHRNLTA 454
++++ R LG+G + EV+ ++ +N++V VK+L ++ + +K+L + N+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 455 LIGYCIE--GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGC 512
L + L++E++ + Q + L + + + L+Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG 149
Query: 513 KPPIVHRDVKSSNILL-NEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVL 571
I+HRDVK N+++ +E + ++ D+GL+ + Q + + PE V
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVD 203
Query: 572 NWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630
+ + D++S G +L +I + P D+ + + + E I +++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEP-FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMEL-KECLSLE 673
+ N S + ++ ++ + L +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 8e-32
Identities = 61/304 (20%), Positives = 102/304 (33%), Gaps = 38/304 (12%)
Query: 390 FAYSEIQKITNNFE------RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQLLQ-- 440
F E+ K + +G G +G V +VA+K L +L
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 441 ----VKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK--KEHMLNWVER 494
++LL + H N+ L+ + ++ GK K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 495 LQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554
+ +GL Y+H I+HRD+K N+ +NE + KI DFGL+R +D
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEM 175
Query: 555 TAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN 613
T T Y PE + + D++S G ++ E+ITG+ D V
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 614 SMLAEGDIRNIVDPSLQGNFDNNSAWK--------------AVELALACASHTSSERPTM 659
++ + + + AV L + +R T
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 660 TDVL 663
+ L
Sbjct: 296 GEAL 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 396 QKIT-NNFE--RVLGKGGFGEVYHG----SLDDNQQVAVKMLSSSCCFQ--------LLQ 440
+K+ NFE +VLG G +G+V+ D + A+K+L + Q +
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 441 VKLLMRV-HHRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAV 499
++L + L L + LI +Y+ G L +L ++ + V+
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 133
Query: 500 DSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAG 559
+ + L + K I++RD+K NILL+ + DFGLS+ F + + G
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCG 192
Query: 560 TPGYLDPEYYVLNW--LNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
T Y+ P+ ++ D +S GV++ E++TG P E ++
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-29
Identities = 67/308 (21%), Positives = 113/308 (36%), Gaps = 44/308 (14%)
Query: 389 QFAYSEIQK----ITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ---- 437
F E+ K + ++ +G G +G V +VAVK LS
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 438 --LLQVKLLMRVHHRNLTALIGYCIEGN-----NMGLIYEYMASGTLDQYLKGKKEHMLN 490
+++LL + H N+ L+ N + ++ L+ +K +K L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LT 119
Query: 491 WVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550
+ +GL+Y+H I+HRD+K SN+ +NE + KI DFGL+R
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----- 171
Query: 551 DQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS 609
D T T Y PE + N+ D++S G ++ E++TGR D +
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWK--------------AVELALACASHTSSE 655
+ ++ I S + + + AV+L S +
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 656 RPTMTDVL 663
R T L
Sbjct: 292 RITAAQAL 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 9e-28
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 26/223 (11%)
Query: 398 ITNNFE--RVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ------LLQVKLLMRVH 448
+ ++ + +G G G V ++ VA+K LS Q ++ L+ V+
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 449 HRNLTALIGYCI------EGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
H+N+ +L+ E ++ L+ E M + + L+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQML 129
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPG 562
G+++LH I+HRD+K SNI++ KI DFGL+R + + T T
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRY 183
Query: 563 YLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT 605
Y PE + E D++S G ++ E++ + R D
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 3e-26
Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 23/215 (10%)
Query: 402 FERVLGKGGFGEVYHG-SLDDNQQVAVKMLSSSCCFQ---LLQVKLLMRVHHRNLTALIG 457
R LG G F V+ + +N VA+K++ + ++KLL RV+ + T
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 458 YCIE---------------GNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSA 502
G ++ +++E + L K + + + QI+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQLL 135
Query: 503 QGLEYLHYGCKPPIVHRDVKSSNILLN-EKLQAKIADFGLSRIFSIESSDQISTAVAGTP 561
GL+Y+H + I+H D+K N+L+ + ++ + + D+ T T
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 562 GYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP 596
Y PE + +D++S ++ E+ITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 7e-21
Identities = 29/205 (14%), Positives = 65/205 (31%), Gaps = 38/205 (18%)
Query: 404 RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCCF--------------QLLQVKLLMRVHH 449
+++G+G V++ + + VK + R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLH 509
R L L G + Y + + L + + K+ + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 510 YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYY 569
IVH D+ N+L++E+ I DF S E + L+ +
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE----------ILERDVR 166
Query: 570 VLN-WLNEK----SDVYSFGVVLLE 589
+ + + D+ S +L+
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.7 bits (148), Expect = 8e-11
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 3/95 (3%)
Query: 210 NWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSN 269
+ + + L+L ++ + G + L + L++S
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 270 NSLSGTFPEFLSKLPSLRALNLKRNK-LTGS-LPA 302
N+L G P+ L NK L GS LPA
Sbjct: 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 4e-10
Identities = 33/114 (28%), Positives = 45/114 (39%), Gaps = 12/114 (10%)
Query: 189 LTDEDDVNALRNIKSTYG---VKRNWQ--GDPCVPKNYWWDGLNCSYEDNNPSRIISLNL 243
L + D AL IK G +W D C N W G+ C D R+ +L+L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC---NRTWLGVLCD-TDTQTYRVNNLDL 57
Query: 244 SSSGLTG--EISPYFANLTAIEFLDLSNN-SLSGTFPEFLSKLPSLRALNLKRN 294
S L I ANL + FL + +L G P ++KL L L +
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 6e-08
Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 5/56 (8%)
Query: 266 DLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
DL NN + GT P+ L++L L +LN+ N L G +P + N + N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP----QGGNLQRFDVSAYANN 301
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 22/141 (15%), Positives = 49/141 (34%), Gaps = 8/141 (5%)
Query: 165 TERSTLQPILNAMEIYMVKNSSQLLTDEDDVNALRNIK----STYGVKRNWQGDPCVPKN 220
+ TL + N ++ + N L + L +K +
Sbjct: 232 KDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 221 YWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFL 280
+ L +N + L L + ++ ++LT ++ L +NN +S L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347
Query: 281 SKLPSLRALNLKRNKLTGSLP 301
+ L ++ L+ N+++ P
Sbjct: 348 ANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 1e-08
Identities = 24/136 (17%), Positives = 49/136 (36%), Gaps = 15/136 (11%)
Query: 168 STLQPILNAMEIYMVKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLN 227
S L P+ ++ +K + +++ + L + + + + + L
Sbjct: 254 SNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 228 CSYEDNNPSRII---------SLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE 278
+ NN S I L +++ ++ ANLT I +L +N +S P
Sbjct: 314 LYF--NNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368
Query: 279 FLSKLPSLRALNLKRN 294
L+ L + L L
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 4e-06
Identities = 13/70 (18%), Positives = 26/70 (37%), Gaps = 4/70 (5%)
Query: 232 DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
D + + L + +T +S +L + L + + + L +L +N
Sbjct: 18 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINF 73
Query: 292 KRNKLTGSLP 301
N+LT P
Sbjct: 74 SNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 9e-08
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 7/88 (7%)
Query: 223 WDGLNCSYE------DNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTF 276
+ CS + P L+L ++ +T F NL + L L NN +S
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 277 PEFLSKLPSLRALNLKRNKLTGSLPADL 304
P + L L L L +N+L LP +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLK-ELPEKM 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.9 bits (89), Expect = 0.001
Identities = 15/57 (26%), Positives = 20/57 (35%)
Query: 260 TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316
LDL NN ++ L +L L L NK++ P L LS
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (88), Expect = 0.002
Identities = 25/133 (18%), Positives = 52/133 (39%), Gaps = 3/133 (2%)
Query: 200 NIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANL 259
+K + V +N + N ++ L + +G + F +
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 260 TAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDG 319
+ ++ +++ +++ T P+ L PSL L+L NK+T A L +N L LS +
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 320 NTSTTCSSESCKK 332
++ S +
Sbjct: 207 ISAVDNGSLANTP 219
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 16/69 (23%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 230 YEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRAL 289
+ D+ + I NL +T ++ L +I+ + +N+ + + LP++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 290 NLKRNKLTG 298
L NKLT
Sbjct: 74 FLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 13/38 (34%), Positives = 18/38 (47%), Gaps = 2/38 (5%)
Query: 254 PYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNL 291
A LT ++ L LS N +S L+ L +L L L
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 15/81 (18%), Positives = 30/81 (37%), Gaps = 5/81 (6%)
Query: 240 SLNLSSSGLTGE-ISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRN 294
SL++ L+ + L + + L + L+ L P+L LNL+ N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 295 KLTGSLPADLVERSNNGSLTL 315
+L +++ S +
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 18/82 (21%), Positives = 29/82 (35%), Gaps = 7/82 (8%)
Query: 246 SGLTGEISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNLKRNKLTGSLP 301
+G+ + + L L++ +S + L SLR L+L N L +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 302 ADLVE--RSNNGSL-TLSVDGN 320
LVE R L L +
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDI 436
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 262 IEFLDLSNNSLSGT-FPEFLSKLPSLRALNLKRNKLTGSLPADLVER-SNNGSLT-LSVD 318
I+ LD+ LS + E L L + + L LT + D+ N +L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 319 GN 320
N
Sbjct: 64 SN 65
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 12/63 (19%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 240 SLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNK 295
+ L GLT IS A+ L+L +N L + + + +++
Sbjct: 31 VVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
Query: 296 LTG 298
L
Sbjct: 91 LQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 16/66 (24%), Positives = 24/66 (36%), Gaps = 10/66 (15%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFA-----NLTAIEFLDLSNNSLSGTFPEFLSKL---- 283
N S + L+LS++ L +E L L + S + L L
Sbjct: 395 ANHS-LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
Query: 284 PSLRAL 289
PSLR +
Sbjct: 454 PSLRVI 459
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 210 NWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSN 269
P + P + LN+S++ L E+ L E L S
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASF 313
Query: 270 NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLP 301
N L+ PE +L+ L+++ N L P
Sbjct: 314 NHLA-EVPELP---QNLKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 12/112 (10%)
Query: 210 NWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSN 269
N+ D + S + + + EI ++E L++SN
Sbjct: 234 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 293
Query: 270 NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT-LSVDGN 320
N L E + P L L N L +P +L L V+ N
Sbjct: 294 NKLI----ELPALPPRLERLIASFNHLA-EVPELP------QNLKQLHVEYN 334
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 1e-05
Identities = 15/92 (16%), Positives = 24/92 (26%), Gaps = 3/92 (3%)
Query: 210 NWQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSN 269
+ N + N ++ L + F + LD+S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 270 NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLP 301
+ L L LRA + K LP
Sbjct: 211 TRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 18/77 (23%), Positives = 38/77 (49%), Gaps = 2/77 (2%)
Query: 238 IISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG-TFPEFLSKLPSLRALNLKRNKL 296
+I+ S + ++ +F+ ++ +DLSN+ + T LS+ L+ L+L+ +L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 297 TGSLPADLVERSNNGSL 313
+ + L + SN L
Sbjct: 84 SDPIVNTLAKNSNLVRL 100
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 4/71 (5%)
Query: 226 LNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPS 285
+N + D + I + S +T ++ A+L I L ++ E + L +
Sbjct: 9 INVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNN 64
Query: 286 LRALNLKRNKL 296
L L LK N++
Sbjct: 65 LIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 13/81 (16%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 211 WQGDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNN 270
+ ++ N S++ +L + ++ A+L + + L NN
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN 205
Query: 271 SLSGTFPEFLSKLPSLRALNL 291
+S P L+ +L + L
Sbjct: 206 QISDVSP--LANTSNLFIVTL 224
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 37/264 (14%), Positives = 65/264 (24%), Gaps = 11/264 (4%)
Query: 62 IDAENPNAFRPAPAVMSTAVTSENVSENFLIVFWEPTDPASQYYVYMHFCEVEVLLANQT 121
+ E P A R + V + +P + E L N
Sbjct: 74 VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133
Query: 122 REFNITQNGKFYIGPIVPTYLYTTTALSSVPVSGARIEYIINATERSTLQPILNAMEIYM 181
+ + V L S+ R+E T Q + M
Sbjct: 134 GPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 193
Query: 182 VKNSSQLLTDEDDVNALRNIKSTYGVKRNWQGDPCVPKNYWWDGLNCSYEDNNPSRIISL 241
V+N + E + V + S+ + +
Sbjct: 194 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 253
Query: 242 NLSSSGLTGEISPY-FANLTAIEFLDLSNNSLSGTFPEFL-----SKLPSLRALNLKRNK 295
LS+ G + + ++ L L N + L K+P L L L N+
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313
Query: 296 LTGSLP-----ADLVERSNNGSLT 314
+ ++ G L
Sbjct: 314 FSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 6/65 (9%), Positives = 20/65 (30%), Gaps = 4/65 (6%)
Query: 236 SRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNL 291
+ + L+ ++ + +++ + LS N++ E ++ L
Sbjct: 7 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 292 KRNKL 296
Sbjct: 67 SDIFT 71
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 4e-04
Identities = 16/98 (16%), Positives = 30/98 (30%), Gaps = 3/98 (3%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
N R L+L + I A L + +D S+N + + L L+ L +
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 293 RNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCSSESC 330
N++ + L L+ +
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 109
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 4/52 (7%)
Query: 248 LTGEI---SPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKL 296
LT E+ + + N LDL + + L A++ N++
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 6e-04
Identities = 16/63 (25%), Positives = 22/63 (34%), Gaps = 3/63 (4%)
Query: 233 NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLK 292
+ + + +N LT + P T L LS N L L L LNL
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 293 RNK 295
R +
Sbjct: 64 RAE 66
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 15/74 (20%), Positives = 26/74 (35%), Gaps = 4/74 (5%)
Query: 220 NYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISP-YFANLTAIEFLDLSNNSLS---GT 275
+ L N R+ L L ++ L + + + L+L NSL G
Sbjct: 49 QASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108
Query: 276 FPEFLSKLPSLRAL 289
LPS+ ++
Sbjct: 109 QERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 13/37 (35%), Positives = 17/37 (45%), Gaps = 1/37 (2%)
Query: 263 EFLDLSNNSLSGT-FPEFLSKLPSLRALNLKRNKLTG 298
+ L L NN L + + L P L LNL+ N L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 4/72 (5%)
Query: 227 NCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSL 286
N + D + + L + +T +S +L + L + + + L +L
Sbjct: 9 NQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNL 64
Query: 287 RALNLKRNKLTG 298
+N N+LT
Sbjct: 65 TQINFSNNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 4/70 (5%)
Query: 220 NYWWDGLNCSYEDNNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEF 279
+ ++ + + + LN SS+ +T ANLT +E LD+S+N +S
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--ISV 189
Query: 280 LSKLPSLRAL 289
L+KL +L +L
Sbjct: 190 LAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGT--FPEFLSKLPSLRALNLKRNKL 296
+ LN SS + N+ + L+LSNN L + K P+L+ LNL N+L
Sbjct: 45 VVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103
Query: 297 TGSLPADLVERSNNGSLTLSVDGN 320
+L + L +DGN
Sbjct: 104 KS--ERELDKIKGLKLEELWLDGN 125
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.1 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.01 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.0 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.94 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.92 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.81 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.77 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.69 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.68 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.59 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.51 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.34 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.31 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.2 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.15 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.13 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.12 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.08 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.07 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.63 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.17 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.08 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.86 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.27 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.24 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.9 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.71 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.17 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.17 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=408.36 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=197.2
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.+.+.||+|+||.||+|.+.+++.||||+++... ..+.+|++++++++||||++++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 4578999999999999999889999999987533 3678999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.... ..+++..++.++.|+++||+||| +++|+||||||+|||+++++.+||+|||+++.+... ........
T Consensus 88 ~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-~~~~~~~~ 162 (263)
T d1sm2a_ 88 SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGT 162 (263)
T ss_dssp HHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC-Cceeecce
Confidence 99987654 34899999999999999999999 899999999999999999999999999999876422 22233446
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChhH
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNNS 637 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 637 (704)
.||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ..+.... +..+.. ...+...
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~-i~~~~~---------~~~p~~~ 227 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVED-ISTGFR---------LYKPRLA 227 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHH-HHHTCC---------CCCCTTS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHH-HHhcCC---------CCCcccc
Confidence 789999999999999999999999999999999996555433221 1111111 111111 1112334
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 638 AWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 638 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
+.++.+++.+||+.||++||||+||++.|+++++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-50 Score=414.07 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=212.1
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
.+.+.+.||+|+||+||+|.+. +++.||||+++... ..+.+|++++++++||||++++++|.+++..++||||+++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 3456789999999999999765 68899999986543 3678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.......+++..++.++.|+++||+||| +++|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~~ 173 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 173 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSSEEE
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC-CCceee
Confidence 99999998776667999999999999999999999 89999999999999999999999999999987642 223334
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+. ..+..+ .....+
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~----~~i~~~---------~~~~~~ 238 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVY----ELLEKD---------YRMERP 238 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH----HHHHTT---------CCCCCC
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHH----HHHhcC---------CCCCCC
Confidence 4556889999999999999999999999999999999988777543321 1111 122221 112233
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3455689999999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=407.87 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=207.6
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGT 476 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 476 (704)
+.+.+.||+|+||.||+|.+++++.||||+++... ..+.+|++++++++||||++++|++.+ +..++||||+++|+
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 45678999999999999999888999999986533 367899999999999999999998854 56789999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccccc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTA 556 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 556 (704)
|.+++.......+++..++.++.||++||+||| +++|+||||||+|||+++++.+||+|||+++.+.. ........
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~~~~~ 169 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREG 169 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEECCTT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC-Cccccccc
Confidence 999987766556999999999999999999999 89999999999999999999999999999987642 22233445
Q ss_pred ccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 557 VAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
..||+.|+|||++.++.++.++|||||||++|||+||..|+...... ..+ . ..+..+. ....+..
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~---~-~~i~~~~---------~~~~p~~ 234 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV---I-QNLERGY---------RMVRPDN 234 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH---H-HHHHTTC---------CCCCCTT
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHH---H-HHHHhcC---------CCCCccc
Confidence 67899999999999999999999999999999999976665433221 111 1 1122211 1112233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+.++.+|+.+||+.||++||||+||++.|++...
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 45678999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=405.18 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=202.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ..+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 45678999999999999976 478999999985432 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++.... .+++..+..++.|+++||+||| +++|+||||||+|||+++++.+||+|||+|+.+........
T Consensus 87 gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999999997654 3999999999999999999999 89999999999999999999999999999988754444444
Q ss_pred cccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ... ........ ..
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~----~~~~~~~~---------~~ 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKKTY---------LN 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHH----HHHTTCTT---------ST
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHH----HHhcCCCC---------CC
Confidence 556789999999999988776 6789999999999999999999976543221 111 11111100 01
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+.++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12234567889999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-49 Score=411.48 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=200.8
Q ss_pred cCHHHHHHHHhhh-----------cccccccCceEEEEEEeC-CC---cEEEEEecccch-----hhHHHHHHHHHhhcc
Q 037258 390 FAYSEIQKITNNF-----------ERVLGKGGFGEVYHGSLD-DN---QQVAVKMLSSSC-----CFQLLQVKLLMRVHH 449 (704)
Q Consensus 390 ~~~~el~~~~~~~-----------~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h 449 (704)
++++++.+++.+| .+.||+|+||+||+|.+. ++ ..||||++.... ..+.+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4455555655554 468999999999999764 23 368999875432 256889999999999
Q ss_pred cceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC
Q 037258 450 RNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN 529 (704)
Q Consensus 450 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 529 (704)
||||+++|+|.+++..++||||+++|+|.+++..... .+++.+++.++.||++||+||| +++|+||||||+|||++
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEEC
Confidence 9999999999999999999999999999998876543 4899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeccCccccccCCCCcc---cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 037258 530 EKLQAKIADFGLSRIFSIESSDQI---STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDT 605 (704)
Q Consensus 530 ~~~~~kL~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~ 605 (704)
.++.+||+|||+++.+........ .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-- 240 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999987643322211 223457899999999999999999999999999999998 89999654321
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+. .. +..+. ....+...+..+.+|+.+||+.||++||||.||++.|++++.
T Consensus 241 -~~~---~~-i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 -DVI---NA-IEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -HHH---HH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHH---HH-HHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111 11 11111 112233456689999999999999999999999999998765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=406.05 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=198.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
+.+.+.||+|+||+||+|+++ ..||||+++... ..+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 345789999999999999874 369999985332 256789999999999999999998754 56899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|+|.+++..... .+++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+++..........
T Consensus 87 ~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 87 GSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9999999976543 4899999999999999999999 89999999999999999999999999999987654444444
Q ss_pred cccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 554 STAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... . +......+... +.+
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~~----p~~- 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYLS----PDL- 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSCC----CCG-
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCCC----Ccc-
Confidence 556789999999999874 358899999999999999999999997644321 1 11222222111 111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
...+...+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223345689999999999999999999999999987653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=398.24 Aligned_cols=239 Identities=28% Similarity=0.408 Sum_probs=202.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||+||+|... +++.||+|++.... ..+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 556789999999999999764 78999999985332 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 88 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred cCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence 999999999986554 999999999999999999999 89999999999999999999999999999976532
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +.....
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~-i~~~~~---------- 221 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKR-ISRVEF---------- 221 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTCC----------
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCCC----------
Confidence 2234567999999999999999999999999999999999999999654321 11111 111111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122334567899999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=397.13 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=208.5
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccc---hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCCCH
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASGTL 477 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 477 (704)
.|.+.||+|+||+||+|.+++++.||||+++.. ...+.+|++++++++||||++++|+|.+++..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 367899999999999999988999999998653 34778999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++..... .+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.+... ........
T Consensus 87 ~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 161 (258)
T d1k2pa_ 87 LNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGS 161 (258)
T ss_dssp HHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCCS
T ss_pred HHhhhcccc-CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC-Cceeeccc
Confidence 999776543 3889999999999999999999 899999999999999999999999999999876432 23334456
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
.||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ + . ..+..+.. ...+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~---~-~~i~~~~~---------~~~p~~ 225 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T---A-EHIAQGLR---------LYRPHL 225 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H---H-HHHHTTCC---------CCCCTT
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H---H-HHHHhCCC---------CCCccc
Confidence 78999999999999999999999999999999998 899996654321 1 1 12222211 112233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
.+.++.+|+.+||+.||++|||++|+++.|.++
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 456889999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=393.87 Aligned_cols=243 Identities=21% Similarity=0.359 Sum_probs=203.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 45678899999999999975 579999999986432 2568899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++.+.. .....
T Consensus 102 g~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred CcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 9999988754 3899999999999999999999 89999999999999999999999999999987642 22334
Q ss_pred ccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCC
Q 037258 555 TAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFD 634 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 634 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+... ...+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~--------~~~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE--------LQNP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC--------CSSG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC--------CCCc
Confidence 5567999999999999999999999999999999999999999654321 1122222222110 1122
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 635 NNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 635 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+..+.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 344568899999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=406.95 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=205.9
Q ss_pred hhhcccccccCceEEEEEEeCC-C-----cEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCCeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLDD-N-----QQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 467 (704)
+.+.+.||+|+||+||+|.... + ..||||++..... .+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 4567999999999999997532 2 3699998854322 567899999998 89999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCE
Q 037258 468 IYEYMASGTLDQYLKGKKE---------------------HMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 526 (704)
||||+++|+|.++++.... ..+++..++.++.||++||+||| +++||||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhcc
Confidence 9999999999999976532 34899999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 037258 527 LLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDT 605 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~ 605 (704)
|++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.....
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~- 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987755444444556678999999999999999999999999999999998 899997654322
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKE 668 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 668 (704)
.+. ..+..+. ....+...+.++.+|+.+||+.||++|||++||++.|..
T Consensus 275 -~~~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 -NFY----KLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -HHH----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHH----HHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 111 2222211 112233445689999999999999999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=396.66 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=204.6
Q ss_pred cc-cccccCceEEEEEEeC---CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 403 ER-VLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 403 ~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.+ .||+|+||.||+|.+. ++..||||+++... ..+.+|++++++++||||++++|+|.+ +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 44 4999999999999653 45579999986432 256789999999999999999999865 56899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC-c
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD-Q 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-~ 552 (704)
+|+|.+++.... ..+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 ~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 92 GGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999999986543 24899999999999999999999 899999999999999999999999999999876433221 2
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+. ..+..+.. .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~---------~ 231 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKR---------M 231 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCC---------C
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC---------C
Confidence 2334568899999999999999999999999999999998 99999765432 111 12222221 1
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhc
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEIVR 676 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 676 (704)
..+...+.++.+|+.+||+.||++|||+.+|++.|+.+......+
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 223345568899999999999999999999999999876543333
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=396.74 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 404 RVLGKGGFGEVYHGSLD---DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
+.||+|+||.||+|.+. .++.||||+++... ..+.+|++++++++||||++++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999754 34689999986432 256789999999999999999999865 467899999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc-c
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ-I 553 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-~ 553 (704)
|+|.+++..... +++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999986544 999999999999999999999 8999999999999999999999999999998764332222 2
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+ ...+..+.. ..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~---------~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGER---------MG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCC---------CC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcCCC---------CC
Confidence 334678999999999999999999999999999999998 89999754321 11 122222211 12
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
.+...+.++.+|+.+||+.||++|||++||++.|+...
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 23344568899999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=396.05 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=198.2
Q ss_pred hhcccccccCceEEEEEEeCCC-----cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLDDN-----QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
.+.++||+|+||.||+|.+... ..||||+++... ..+.+|++++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 4578999999999999976532 479999985432 256789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+.+|++.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 ~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 90 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999887554 34999999999999999999999 89999999999999999999999999999987643222
Q ss_pred -CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 551 -DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 551 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
........||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+. ..+..+ .
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~---------~ 230 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDG---------F 230 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTT---------C
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhcc---------C
Confidence 22233456899999999999999999999999999999999977766443221 1111 112221 1
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
....+...+..+.+|+.+||+.||++||||.||++.|++++..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1223334556899999999999999999999999999987754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=396.95 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=203.5
Q ss_pred HhhhcccccccCceEEEEEEeCCCcEEEEEecccch---hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC---CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
.+.+.+.||+|+||.||+|.+.+++.||||+++... ..+.+|+.++++++||||++++++|.+ +..++||||+++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 356789999999999999999888899999986543 367899999999999999999999854 5678999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIST 555 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 555 (704)
+|.+++.......++|.+++.++.||+.||+||| +.+|+||||||+|||+++++++||+|||+++.+.. .......
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~~~~ 172 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 172 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccC-CCceeec
Confidence 9999998766556999999999999999999999 89999999999999999999999999999987632 2223344
Q ss_pred cccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCCh
Q 037258 556 AVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDN 635 (704)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 635 (704)
...||+.|+|||++..+.++.++|||||||++|||++|..|+...... .+...... .+. ....+.
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~-~~~---------~~~~~~ 237 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVE-RGY---------RMPCPP 237 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH-TTC---------CCCCCT
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHH-hcC---------CCCCCc
Confidence 567899999999999999999999999999999999977776543321 11111111 111 112233
Q ss_pred hHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 636 NSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 636 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+.++.+++.+||+.||++|||+++|+++|++...
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 445689999999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=390.65 Aligned_cols=240 Identities=28% Similarity=0.428 Sum_probs=193.8
Q ss_pred hhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe----CCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE----GNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 469 (704)
.|.+.||+|+||+||+|... +++.||+|++.... ..+.+|++++++++||||+++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999764 68899999985432 245789999999999999999999875 35689999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCEEeC-CCCcEEEEeccCccccc
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPP--IVHRDVKSSNILLN-EKLQAKIADFGLSRIFS 546 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~~ 546 (704)
||+++|+|.+++..... +++..+..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999986544 899999999999999999999 777 99999999999996 57899999999997642
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
........||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .. +...+..+....
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~-~~~~i~~~~~~~--- 232 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPA--- 232 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCG---
T ss_pred ----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HH-HHHHHHcCCCCc---
Confidence 223345689999999998865 5999999999999999999999999654321 11 111222221111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112223456889999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=397.76 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=201.1
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ..+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 56789999999999999976 478999999986432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 90 ~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999887654 999999999999999999999 999999999999999999999999999999887544444
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~-~~~~---------- 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKII-KLEY---------- 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-TTCC----------
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHH-cCCC----------
Confidence 4455678999999999999999999999999999999999999999654321 1111221 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
.++...+.++.+|+.+||+.||.+|||++|+++.
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1223345678999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=395.45 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=188.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEe--CCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIE--GNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e 470 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++..... .+.+|++++++++||||+++++++.+ ++..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 45678999999999999965 5789999999864321 45789999999999999999999865 456899999
Q ss_pred ecCCCCHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 471 YMASGTLDQYLKGKK--EHMLNWVERLQIAVDSAQGLEYLHYGC--KPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999987532 445999999999999999999999321 2359999999999999999999999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. ..+..+....
T Consensus 166 ~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~-~~i~~~~~~~--- 233 (269)
T d2java1 166 H--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELA-GKIREGKFRR--- 233 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHHTCCCC---
T ss_pred c--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHH-HHHHcCCCCC---
Confidence 2 222344578999999999999999999999999999999999999999654321 111 2222222221
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+...+.++.+|+.+||+.||.+|||++|+++
T Consensus 234 ------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12234557899999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=391.39 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=200.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|.. .+++.||||+++... ..+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 45578899999999999976 478999999985432 3668899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCccc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQIS 554 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~ 554 (704)
|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 94 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~ 167 (288)
T d2jfla1 94 GAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR 167 (288)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHHH
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccccc
Confidence 99999987543 34999999999999999999999 89999999999999999999999999999976532 11223
Q ss_pred ccccCCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcC
Q 037258 555 TAVAGTPGYLDPEYYV-----LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSL 629 (704)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 629 (704)
....||+.|+|||++. +..++.++|||||||++|||++|+.||......+. +...... ....
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~-~~~~------ 234 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKS-EPPT------ 234 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHS-CCCC------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcC-CCCC------
Confidence 4567999999999984 45688999999999999999999999976543221 1111111 1111
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 630 QGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122344568899999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=388.90 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=199.5
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEEeecCCCCH
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIYEYMASGTL 477 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~~~~gsL 477 (704)
.+.+.||+|+||.||+|.++ |+.||||+++... ..+.+|++++++++||||++++|+|.+ .+.+++||||+++|+|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 46788999999999999984 7899999997654 367899999999999999999999965 4668999999999999
Q ss_pred HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcccccc
Q 037258 478 DQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQISTAV 557 (704)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 557 (704)
.+++.......+++..+++++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~ 160 (262)
T d1byga_ 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTG 160 (262)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC-----CCccc
Confidence 99998765455899999999999999999999 89999999999999999999999999999986532 22344
Q ss_pred cCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCCChh
Q 037258 558 AGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNFDNN 636 (704)
Q Consensus 558 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 636 (704)
.++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+..++ ..+ ....++..
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~---------~~~~~~~~ 224 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKG---------YKMDAPDG 224 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTT---------CCCCCCTT
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcC---------CCCCCCcc
Confidence 67889999999999999999999999999999998 67777554322 222222 111 11223334
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 637 SAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 637 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
.+.++.+|+.+||+.||.+|||+.|++++|+++..-
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 456889999999999999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=405.16 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=200.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||+||+|.. .+|+.||+|+++... ..+.+|++++++++||||++++++|.++++.++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 44568999999999999975 478999999985332 256789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCK-PPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
+|+|.+++..... +++..+..++.|++.||+||| + ++|+||||||+|||+++++.+||+|||+|+.+.. .
T Consensus 88 gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~ 158 (322)
T d1s9ja_ 88 GGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158 (322)
T ss_dssp TEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----H
T ss_pred CCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----C
Confidence 9999999986554 999999999999999999999 6 4899999999999999999999999999987642 2
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH-HHHHHhc--------C----
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQW-VNSMLAE--------G---- 619 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~--------~---- 619 (704)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.............. ....... .
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 23456899999999999999999999999999999999999999976543221000000 0000000 0
Q ss_pred ----------Cccc----ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHh
Q 037258 620 ----------DIRN----IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKE 668 (704)
Q Consensus 620 ----------~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 668 (704)
...+ ..............+.++.+|+.+||+.||.+|||++|+++ .+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000 00000000001123457899999999999999999999997 4554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-47 Score=394.31 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=188.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|.+.+.||+|+||+||+|... +|+.||||++..... .+.+|++++++++||||+++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 567899999999999999764 789999999864322 44679999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccccCCC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN---EKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~~~~~~~ 550 (704)
+|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+. +++.+||+|||+++....
T Consensus 91 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 91 GGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp SCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 999999997654 3999999999999999999999 89999999999999994 578999999999986532
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +.. ...
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~-~~~------~~~ 229 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILK-AEY------EFD 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHT-TCC------CCC
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhc-cCC------CCC
Confidence 22334567999999999999999999999999999999999999999654321 11111111 111 111
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.......+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1122344567899999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-47 Score=393.53 Aligned_cols=239 Identities=27% Similarity=0.391 Sum_probs=196.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+...+.||+|+||.||+|.. .+|+.||||+++... ..+.+|++++++++||||+++++++.+++..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 55578899999999999965 578999999985432 1467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
|++|+|..++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 97 CLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999987765543 3999999999999999999999 89999999999999999999999999999986532
Q ss_pred cccccccCCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 552 QISTAVAGTPGYLDPEYYVL---NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... +........ .....
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~~~---- 234 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPAL---- 234 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCC----
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CCCCC----
Confidence 234579999999999864 46899999999999999999999999654321 112222221 11111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 235 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223457899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=388.08 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=196.2
Q ss_pred HhhhcccccccCceEEEEEEeCC----CcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLDD----NQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.+.||+|+||.||+|.+.. +..||||+++.... .+.+|++++++++||||+++++++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 35567899999999999997642 35689998864322 5678999999999999999999986 46789999
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+||++++++.+||+|||+++.+...
T Consensus 87 E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 9999999999876544 34899999999999999999999 999999999999999999999999999999876422
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||......+ +... +..+...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~~~------ 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERL------ 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCC------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCCCC------
Confidence 2233445678999999999999999999999999999999998 899986654322 2211 1222111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
..+...+..+.+|+.+||+.||++|||++||++.|+.++..+.
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1233445689999999999999999999999999999876554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=385.92 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=201.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccc----------hhhHHHHHHHHHhhcccceeEEEEEEEeCCeEEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSS----------CCFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGL 467 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 467 (704)
.|.+.+.||+|+||+||+|.. .+|+.||||+++.. ...+.+|++++++++||||+++++++.+++..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356678999999999999976 57999999998532 1246789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC----cEEEEeccCcc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL----QAKIADFGLSR 543 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla~ 543 (704)
|||||++|+|.+++..... +++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 91 v~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999987654 999999999999999999999 99999999999999998776 59999999998
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
.+.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ...... ....
T Consensus 166 ~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~-~~~~-- 233 (293)
T d1jksa_ 166 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVS-AVNY-- 233 (293)
T ss_dssp ECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-TTCC--
T ss_pred hcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC--
Confidence 7632 223345678999999999999999999999999999999999999997543211 111111 1111
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..........+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011223457889999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.3e-46 Score=393.26 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=202.7
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
.|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+|++++++++||||+++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 356789999999999999976 4799999999865433 45789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccccCCCC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+|+|.+++..... .+++..+..++.||+.||+||| +++||||||||+|||++ .++.+||+|||+++.+.. .
T Consensus 107 gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~ 179 (350)
T d1koaa2 107 GGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K 179 (350)
T ss_dssp SCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---T
T ss_pred CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc---c
Confidence 9999999965432 3999999999999999999999 99999999999999996 457899999999987642 2
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ .. ....
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~-~~------~~~~ 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSC-DW------NMDD 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CC------CSCC
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CC------CCCc
Confidence 3344578999999999999999999999999999999999999999654321 122222211 11 0111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
......+..+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345678999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=389.92 Aligned_cols=252 Identities=30% Similarity=0.474 Sum_probs=205.7
Q ss_pred hhhcccccccCceEEEEEEeC------CCcEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||+||+|+.. +++.||||+++... ..+.+|++++++++||||++++++|.+.+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 345789999999999999753 45789999986432 2578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCE
Q 037258 469 YEYMASGTLDQYLKGKK----------------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNI 526 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 526 (704)
|||+++|+|.+++.... ...+++..++.++.|++.||+||| +++||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccce
Confidence 99999999999996432 234889999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCc
Q 037258 527 LLNEKLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR-RPVISRAEDDT 605 (704)
Q Consensus 527 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~-~Pf~~~~~~~~ 605 (704)
|++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|. .||......
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence 99999999999999998764444444445667889999999999999999999999999999999996 566543321
Q ss_pred ccHHHHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 037258 606 THISQWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECL 670 (704)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 670 (704)
+.. ..+..+... ..+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 250 ----e~~-~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 ----EVI-YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----HHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHH-HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111 122333221 123334567899999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=387.94 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=205.7
Q ss_pred HhhhcccccccCceEEEEEEeC--------CCcEEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCe
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD--------DNQQVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNN 464 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 464 (704)
.+.+.+.||+|+||.||+|+.. ++..||||+++... .++..|+..+.++ +||||++++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 3456789999999999999642 23479999986533 2556788888888 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 465 MGLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecC
Confidence 999999999999999997553 245899999999999999999999 999999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 609 (704)
++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~-- 245 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E-- 245 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H--
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H--
Confidence 99999999999998765555455566788999999999999999999999999999999998 68887543321 1
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
+...+..+.. ...+...+..+.+|+.+||+.||++|||+.||++.|+++++++
T Consensus 246 --~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 246 --LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp --HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 1122222211 1222334567999999999999999999999999999997753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=389.87 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=199.4
Q ss_pred hhhcccccccCceEEEEEEeC-CCc----EEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQ----QVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
+.+.++||+|+||+||+|.+. +|+ +||||+++... ..+.+|++++++++||||++++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 455789999999999999764 444 68999875432 2578899999999999999999999875 567888
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
||+.+|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999999887654 34899999999999999999999 8999999999999999999999999999998875444
Q ss_pred CCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
.........||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +.. .+..+.
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~-------- 230 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE-------- 230 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTC--------
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCC--------
Confidence 4444455678999999999999999999999999999999998 788886554322 222 122221
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
....+...+..+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus 231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111233445678999999999999999999999999988654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-46 Score=392.35 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=202.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMAS 474 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 474 (704)
|.+.+.||+|+||.||+|.. .+|+.||||+++.... .+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 56789999999999999975 5799999999865432 456799999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccccCCCCc
Q 037258 475 GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLN--EKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++.+.. ..
T Consensus 111 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~~ 183 (352)
T d1koba_ 111 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 183 (352)
T ss_dssp CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TS
T ss_pred ChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC---CC
Confidence 99999886543 23899999999999999999999 89999999999999998 678999999999987642 23
Q ss_pred ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCC
Q 037258 553 ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGN 632 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 632 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +....... +.. .....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~~------~~~~~ 250 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKR-CDW------EFDED 250 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHH-CCC------CCCSS
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC------CCCcc
Confidence 344567999999999999999999999999999999999999999654321 11122211 111 11111
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 633 FDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.....+.++.+|+.+||+.||.+|||++|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22334567899999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=385.62 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=202.2
Q ss_pred hhcccccccCceEEEEEEeCCC----cEEEEEecccch-----hhHHHHHHHHHhhcccceeEEEEEEEe-CCeEEEEEe
Q 037258 401 NFERVLGKGGFGEVYHGSLDDN----QQVAVKMLSSSC-----CFQLLQVKLLMRVHHRNLTALIGYCIE-GNNMGLIYE 470 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e 470 (704)
+|.++||+|+||+||+|.+.++ ..||||+++... ..+.+|++++++++||||++++|++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4577899999999999976432 368999986321 257899999999999999999999876 468999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... .+++..+++++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 110 ~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999886543 3788899999999999999999 89999999999999999999999999999987643322
Q ss_pred C--cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCc
Q 037258 551 D--QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPS 628 (704)
Q Consensus 551 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 628 (704)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ++..+ +..+...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~~~------ 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGRRL------ 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCC------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCC------
Confidence 1 22334678999999999999999999999999999999999888875433211 11111 1122111
Q ss_pred CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 629 LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 629 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+...+.++.+|+.+||+.||++||+|.||++.|++++.
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122345678999999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=388.12 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=196.7
Q ss_pred HhhhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeC-CeE
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEG-NNM 465 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~ 465 (704)
.+.+.+.||+|+||.||+|... +++.||||+++.... .+..|+.++.++ +|+||+.+++++.+. ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3556789999999999999653 346899999864322 456677777776 689999999998765 568
Q ss_pred EEEEeecCCCCHHHHhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC
Q 037258 466 GLIYEYMASGTLDQYLKGKK--------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK 531 (704)
Q Consensus 466 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 531 (704)
++||||+++|+|.++++... ...+++..++.++.||++||+||| +++|+||||||+|||++++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCC
Confidence 99999999999999997543 234889999999999999999999 8999999999999999999
Q ss_pred CcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCcccHHH
Q 037258 532 LQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR-RPVISRAEDDTTHISQ 610 (704)
Q Consensus 532 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~ 610 (704)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. .||......+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------ 244 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------ 244 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999998765444444455678999999999999999999999999999999999975 5665433221
Q ss_pred HHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 611 WVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 611 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.+...+..+... ..+...+.++.+++.+||+.||++|||++|+++.|++++.
T Consensus 245 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122222222211 1223345578999999999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=381.98 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=201.1
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccchh-hHHH--HHHHHHhhcccceeEEEEEEEeCC----eEEEEEeecC
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC-FQLL--QVKLLMRVHHRNLTALIGYCIEGN----NMGLIYEYMA 473 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~--E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~e~~~ 473 (704)
-+.+.||+|+||.||+|++ +|+.||||+++.... .+.. |+..+.+++||||++++++|.+.+ .+++||||++
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 4578899999999999987 588999999975544 3334 444556789999999999998653 6899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYG-----CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
+|+|.++++... ++|..++.++.|++.||+|||+. .+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 85 HGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 999999998653 89999999999999999999942 1369999999999999999999999999999877433
Q ss_pred CCC--cccccccCCCCccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc--------ccHHHHH
Q 037258 549 SSD--QISTAVAGTPGYLDPEYYVLN------WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDT--------THISQWV 612 (704)
Q Consensus 549 ~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~--------~~~~~~~ 612 (704)
... .......||+.|+|||++.+. .++.++|||||||++|||+||..||........ .......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 222 123456899999999998754 367899999999999999999988754332211 0111112
Q ss_pred HHHHhcCCcccccCCcCCCCC-ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 037258 613 NSMLAEGDIRNIVDPSLQGNF-DNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLE 673 (704)
Q Consensus 613 ~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 673 (704)
......+. .++.+.... ..+....+.+|+.+||+.||++|||+.||++.|+++...+
T Consensus 242 ~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 242 RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 22222211 122221111 2345667999999999999999999999999999887544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=385.34 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=203.0
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+|+.||||+++... ....+|+.+|++++||||+++++++.+++.+++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 45678999999999999975 579999999986432 2467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|.+++..... +++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.... ..
T Consensus 87 ~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 999999999987654 899999999999999999999 99999999999999999999999999999986532 22
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.... ...+.+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~-i~~~~~---------- 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFEL-ILMEEI---------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC----------
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHH-HhcCCC----------
Confidence 3345578999999999999999999999999999999999999999765421 11111 112211
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
.++...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 123344567899999999999999995 788876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=386.80 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=209.1
Q ss_pred HhhhcccccccCceEEEEEEe------CCCcEEEEEecccchh-----hHHHHHHHHHhh-cccceeEEEEEEEeCCeEE
Q 037258 399 TNNFERVLGKGGFGEVYHGSL------DDNQQVAVKMLSSSCC-----FQLLQVKLLMRV-HHRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 466 (704)
.+.+.+.||+|+||.||+|.+ .+++.||||+++.... .+.+|+.+++++ +||||++++++|.+++..+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 455688999999999999975 3567899999864322 567899999999 6999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccc----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC
Q 037258 467 LIYEYMASGTLDQYLKGKK----------------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE 530 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 530 (704)
+||||+++|+|.++++... ...+++..+..++.||++||+||| +++++||||||+||+++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccc
Confidence 9999999999999997543 225889999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCCcccHH
Q 037258 531 KLQAKIADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRP-VISRAEDDTTHIS 609 (704)
Q Consensus 531 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P-f~~~~~~~~~~~~ 609 (704)
++.+|++|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+..| |......+ .+.
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~~~ 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFY 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 999999999999887544444455567899999999999999999999999999999999995555 43333211 111
Q ss_pred HHHHHHHhcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 037258 610 QWVNSMLAEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSL 672 (704)
Q Consensus 610 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 672 (704)
..+..+. ....+...+..+.+|+.+||+.||.+||||+||+++|++++..
T Consensus 259 ----~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 ----KMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----HHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222221 1122233456799999999999999999999999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=380.55 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=193.4
Q ss_pred hhhcccccccCceEEEEEEeC--CC--cEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD--DN--QQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
+.+.+.||+|+||.||+|.+. ++ ..||||+++... ..+.+|++++++++||||++++|+|.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 345788999999999999653 22 378999986421 256889999999999999999999976 467899
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|++.+++..... .+++..++.++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.+...
T Consensus 89 ~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999999998876543 3999999999999999999999 899999999999999999999999999999887433
Q ss_pred CCCc-ccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 549 SSDQ-ISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIIT-GRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 549 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
.... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +........+..
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~----- 233 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER----- 233 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC-----
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCC-----
Confidence 3222 2334567889999999999999999999999999999998 89999654322 122222222211
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKEC 669 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 669 (704)
...+...+..+.+|+.+||+.||++|||++||++.|+++
T Consensus 234 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112233456789999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=377.43 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=200.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 45678999999999999976 579999999986432 2567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+++|+|..++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 86 IEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp CCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred cCCcccccccccccc--ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 999999999987654 888999999999999999999 99999999999999999999999999999987632
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +..
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~-~~~---------- 218 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN-AEL---------- 218 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-CCC----------
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHc-CCC----------
Confidence 233568999999999999999999999999999999999999999654321 12222222 111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+.++.+++.+||+.||.+|| |++|+++
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12223345788999999999999996 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.2e-45 Score=374.02 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-------hHHHHHHHHHhhcccceeEEEEEEEeCC----eEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-------FQLLQVKLLMRVHHRNLTALIGYCIEGN----NMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 467 (704)
|.+.+.||+|+||.||+|.. .+|+.||||+++.... .+.+|++++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 55678999999999999965 5799999999864321 4678999999999999999999998653 4789
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
||||+++|+|.+++..... +++.+++.++.||+.||+||| +.+|+||||||+|||++.++..+|+|||.+.....
T Consensus 89 vmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999999999876654 899999999999999999999 89999999999999999999999999999876532
Q ss_pred CCC-CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC
Q 037258 548 ESS-DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 548 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 626 (704)
... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.....+.......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~--- 234 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP--- 234 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCG---
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCC---
Confidence 222 2234456799999999999999999999999999999999999999965432 122233333322111
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERP-TMTDVLMELKECL 670 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 670 (704)
.......+.++.+++.+||+.||.+|| |++|+++.|.++.
T Consensus 235 ----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011223446789999999999999999 8999999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=382.10 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=200.9
Q ss_pred hhcccccccCceEEEEEEeC-CCc--EEEEEecccch-----hhHHHHHHHHHhh-cccceeEEEEEEEeCCeEEEEEee
Q 037258 401 NFERVLGKGGFGEVYHGSLD-DNQ--QVAVKMLSSSC-----CFQLLQVKLLMRV-HHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
.+.+.||+|+||.||+|.+. +|. .||||+++... ..+.+|+++++++ +||||++++++|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 45789999999999999764 444 57888875322 2578999999998 799999999999999999999999
Q ss_pred cCCCCHHHHhhcc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEE
Q 037258 472 MASGTLDQYLKGK--------------KEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIA 537 (704)
Q Consensus 472 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 537 (704)
+++|+|.++++.. ....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence 9999999999754 2345999999999999999999999 8999999999999999999999999
Q ss_pred eccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCcccHHHHHHHHH
Q 037258 538 DFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRR-PVISRAEDDTTHISQWVNSML 616 (704)
Q Consensus 538 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~-Pf~~~~~~~~~~~~~~~~~~~ 616 (704)
|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. ||..... .+... .+
T Consensus 170 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~-~i 239 (309)
T d1fvra_ 170 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE-KL 239 (309)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-HG
T ss_pred ccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHH-HH
Confidence 99999765321 22234568999999999999999999999999999999999765 5643321 11111 12
Q ss_pred hcCCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 617 AEGDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 617 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
..+. ....+...+.++.+|+.+||+.||++||||+||++.|++++.
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221 112233455689999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=382.18 Aligned_cols=246 Identities=21% Similarity=0.279 Sum_probs=196.6
Q ss_pred cccccccCceEEEEEEe-CCCcEEEEEecccchhhHHHHHHHHHhh-cccceeEEEEEEEe----CCeEEEEEeecCCCC
Q 037258 403 ERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCCFQLLQVKLLMRV-HHRNLTALIGYCIE----GNNMGLIYEYMASGT 476 (704)
Q Consensus 403 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lV~e~~~~gs 476 (704)
.+.||+|+||+||+|.. .+++.||||+++.. ....+|++++.++ +||||+++++++.+ +..+++|||||+||+
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~ 95 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 95 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEE
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCc
Confidence 35799999999999965 57899999999753 4567899887655 89999999999875 467899999999999
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCCcc
Q 037258 477 LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
|.+++.......+++.++..++.||+.||+||| +.+|+||||||+|||+++ .+.+||+|||+++..... ..
T Consensus 96 L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~---~~ 169 (335)
T d2ozaa1 96 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NS 169 (335)
T ss_dssp HHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC---CC
T ss_pred HHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCC---Cc
Confidence 999998766566999999999999999999999 999999999999999985 457999999999876422 23
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.+........ .+......+ ...+....
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~------~~~~~~~~ 240 (335)
T d2ozaa1 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMG------QYEFPNPE 240 (335)
T ss_dssp CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC------SSSCCTTH
T ss_pred cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcC------CCCCCCcc
Confidence 345679999999999999999999999999999999999999996654322110 000000000 00111111
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1234568999999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-44 Score=385.09 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=196.0
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh-------hHHH---HHHHHHhhcccceeEEEEEEEeCCeEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC-------FQLL---QVKLLMRVHHRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 468 (704)
|.+.+.||+|+||.||+|... +|+.||||++..... .... ++++++.++||||+++++++.+++..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999764 799999999854321 2233 35666777899999999999999999999
Q ss_pred EeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccC
Q 037258 469 YEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIE 548 (704)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~ 548 (704)
|||+++|+|.+++..... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+++.+...
T Consensus 86 mE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp ECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999999987654 889999999999999999999 999999999999999999999999999999876422
Q ss_pred CCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCC
Q 037258 549 SSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDP 627 (704)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 627 (704)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+... ... .....
T Consensus 161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~-~~~~~-------- 224 (364)
T d1omwa3 161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDR-MTLTM-------- 224 (364)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHH-HSSSC--------
T ss_pred ----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-hcccC--------
Confidence 2345679999999999974 568999999999999999999999997655433211 111 11000
Q ss_pred cCCCCCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 628 SLQGNFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 628 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
...++...+.++.+|+.+||+.||.+||| ++|+++
T Consensus 225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11122334567899999999999999999 688875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-44 Score=369.33 Aligned_cols=244 Identities=26% Similarity=0.339 Sum_probs=200.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------------hhHHHHHHHHHhhc-ccceeEEEEEEEeCCe
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------------CFQLLQVKLLMRVH-HRNLTALIGYCIEGNN 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 464 (704)
|.+.+.||+|+||+||+|+. .+|+.||||+++... ..+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 45678999999999999976 578999999985421 14578999999997 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+++|+|.++++.... +++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999986554 999999999999999999999 89999999999999999999999999999987
Q ss_pred cccCCCCcccccccCCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVL------NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE 618 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 618 (704)
+.. ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ....+..
T Consensus 160 ~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~ 229 (277)
T d1phka_ 160 LDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMS 229 (277)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred ccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHh
Confidence 642 223345679999999999863 356889999999999999999999997543211 1111222
Q ss_pred CCcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 619 GDIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 619 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+... .........+.++.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2211 111122345568999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=380.25 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=207.0
Q ss_pred hhcccccccCceEEEEEEeC------CCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLD------DNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIY 469 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 469 (704)
.+.+.||+|+||.||+|.+. +++.||||+++.... .+.+|++++++++||||++++++|..++..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 46789999999999999653 357899999964322 4578999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 037258 470 EYMASGTLDQYLKGKK--------EHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGL 541 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl 541 (704)
||+++|+|.+++.... ...+++..+.+++.|+++||.||| +++|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999987542 234789999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHHhcCC
Q 037258 542 SRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGR-RPVISRAEDDTTHISQWVNSMLAEGD 620 (704)
Q Consensus 542 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 620 (704)
++.+.............+|+.|+|||.+.+..++.++|||||||++|||+||. .||..... .+...... .+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i~-~~~ 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM-EGG 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHH-TTC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-hCC
Confidence 98775444444445567899999999999999999999999999999999985 66644322 22222222 222
Q ss_pred cccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 037258 621 IRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLS 671 (704)
Q Consensus 621 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 671 (704)
.. ..+...+..+.+++.+||+.+|.+||||+||++.|++.+.
T Consensus 253 ~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 1122344679999999999999999999999999988765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=375.07 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEecccch---------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 404 RVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC---------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
++||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6899999999999976 478999999985432 146789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++++..+..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 84 ~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp EEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred chHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 987777765443 3888999999999999999999 999999999999999999999999999999875422 222
Q ss_pred cccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccC------
Q 037258 554 STAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVD------ 626 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------ 626 (704)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+.............+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccch
Confidence 344679999999999875 467999999999999999999999996544321 1111111111110000000
Q ss_pred Cc-CC--CCC-----ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 627 PS-LQ--GNF-----DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 627 ~~-l~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. .. ... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00 000 1123467899999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=377.96 Aligned_cols=241 Identities=27% Similarity=0.425 Sum_probs=198.8
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch-------hhHHHHHHHHH-hhcccceeEEEEEEEeCCeEEEEEe
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC-------CFQLLQVKLLM-RVHHRNLTALIGYCIEGNNMGLIYE 470 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lV~e 470 (704)
|.+.+.||+|+||+||+|... +|+.||||+++... .....|+.++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456789999999999999664 79999999986432 13456666665 6899999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCC
Q 037258 471 YMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~ 550 (704)
|+++|+|.+++..... +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.... .
T Consensus 84 y~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--G 156 (320)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred ecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc--c
Confidence 9999999999987654 899999999999999999999 89999999999999999999999999999986532 2
Q ss_pred CcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCC
Q 037258 551 DQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQ 630 (704)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 630 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .. ..+..+. +
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~-~~i~~~~------~--- 220 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LF-HSIRMDN------P--- 220 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC------C---
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HH-HHHHcCC------C---
Confidence 233445689999999999999999999999999999999999999997543211 11 1122221 1
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 037258 631 GNFDNNSAWKAVELALACASHTSSERPTMT-DVLM 664 (704)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 664 (704)
.++...+.++.+|+.+||+.||.+||++. |+++
T Consensus 221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12233456789999999999999999996 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=374.26 Aligned_cols=245 Identities=18% Similarity=0.300 Sum_probs=200.9
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccchh---hHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCC---FQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
|.+.+.||+|+||+||+|... +++.||||+++.... ...+|+++|++++||||+++++++.+++.+++|||||++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 456789999999999999764 789999999975543 4568999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCC--CcEEEEeccCccccccCCCCcc
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEK--LQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfGla~~~~~~~~~~~ 553 (704)
+|.+++.... ..+++.++..++.||++||+||| +.+|+||||||+|||++.+ ..+||+|||+++... ....
T Consensus 87 ~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---~~~~ 159 (321)
T d1tkia_ 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDN 159 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---TTCE
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc---cCCc
Confidence 9999997654 23899999999999999999999 8999999999999999854 489999999998653 2233
Q ss_pred cccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCCCC
Q 037258 554 STAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQGNF 633 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 633 (704)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... +........ ... +....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~-~~~------~~~~~ 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNA-EYT------FDEEA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-CCC------CCHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CCC------CChhh
Confidence 44567899999999999999999999999999999999999999654421 112222211 110 00000
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 634 DNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 634 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
....+.++.+|+.+||..||.+|||++|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0123457899999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-44 Score=376.72 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=200.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch-------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEee
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEY 471 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 471 (704)
+.+.+.||+|+||.||+|.. .+|+.||||+++... ....+|+++++.++||||+++++++.+.+..++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 45578999999999999976 479999999986432 2457899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCC
Q 037258 472 MASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSD 551 (704)
Q Consensus 472 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~ 551 (704)
+.+|+|.+++..... +++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+++.+..
T Consensus 123 ~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred ccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 999999999977654 999999999999999999999 99999999999999999999999999999987632
Q ss_pred cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccCCcCCC
Q 037258 552 QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIVDPSLQG 631 (704)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 631 (704)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........ .+..
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~-~~~~---------- 255 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV---------- 255 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC----------
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHh-cCCC----------
Confidence 22346799999999999999999999999999999999999999965432 11122222 1111
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 037258 632 NFDNNSAWKAVELALACASHTSSERP-----TMTDVLM 664 (704)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 664 (704)
.++...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223455789999999999999994 8999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=366.61 Aligned_cols=233 Identities=24% Similarity=0.402 Sum_probs=193.1
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch----------hhHHHHHHHHHhhc--ccceeEEEEEEEeCCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC----------CFQLLQVKLLMRVH--HRNLTALIGYCIEGNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 466 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|+.++++++ ||||+++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 56678999999999999975 578999999986432 13568999999997 899999999999999999
Q ss_pred EEEeecCC-CCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-CCcEEEEeccCccc
Q 037258 467 LIYEYMAS-GTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-KLQAKIADFGLSRI 544 (704)
Q Consensus 467 lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~ 544 (704)
+||||+.+ +++.+++..... +++..+..++.|+++||+||| +++|+||||||+|||++. ++.+||+|||+++.
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 99999976 678888876543 999999999999999999999 999999999999999985 47999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 037258 545 FSIESSDQISTAVAGTPGYLDPEYYVLNWL-NEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN 623 (704)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (704)
... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .. .+..
T Consensus 161 ~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~-~~~~-- 221 (273)
T d1xwsa_ 161 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------II-RGQV-- 221 (273)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HH-HCCC--
T ss_pred ccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hh-hccc--
Confidence 532 23345679999999999987765 6779999999999999999999954210 11 1111
Q ss_pred ccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 624 IVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 624 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 222 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 --------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112233457899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=363.86 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=196.5
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++||||+++++++.++++.++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 34468999999999999975 579999999985432 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
.+ ++.+++.......+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||+++.... ...
T Consensus 84 ~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 84 HQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp SE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred CC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 75 5555555544556999999999999999999999 89999999999999999999999999999987532 233
Q ss_pred ccccccCCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC--Cccccc-CCc
Q 037258 553 ISTAVAGTPGYLDPEYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG--DIRNIV-DPS 628 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-d~~ 628 (704)
......||+.|+|||.+.... ++.++||||+||++|+|++|+.||......+ .+........... ...... .+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccccc
Confidence 344568999999999877654 5789999999999999999999996543211 1111111100000 000000 000
Q ss_pred CCCCC-----------ChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 629 LQGNF-----------DNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 629 l~~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
....+ ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 11234678999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-43 Score=362.50 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=195.5
Q ss_pred hhhcccccccCceEEEEEEeCCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeecC
Q 037258 400 NNFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYMA 473 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 473 (704)
|...+.||+|+||+||+|...+|+.||||+++... ..+.+|+.++++++||||+++++++.+++..++++||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 34568899999999999998999999999985432 256789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCcc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQI 553 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 553 (704)
++.+..+..... .+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||.+...... ...
T Consensus 84 ~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 84 QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 877777765443 4999999999999999999999 899999999999999999999999999999875322 223
Q ss_pred cccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---cccc-----
Q 037258 554 STAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD---IRNI----- 624 (704)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 624 (704)
.....+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+.... ....... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~-~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHH-HhhCCCChhhccchhhhhh
Confidence 3445689999999998754 56899999999999999999999997544221 111111 1111100 0000
Q ss_pred cCCcCC-------CCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 625 VDPSLQ-------GNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 625 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+.... .......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0112233567899999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=362.15 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=192.9
Q ss_pred hhhcccccccCceEEEEEEe-CC-CcEEEEEecccch------hhHHHHHHHHHhh---cccceeEEEEEEEe-----CC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DD-NQQVAVKMLSSSC------CFQLLQVKLLMRV---HHRNLTALIGYCIE-----GN 463 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 463 (704)
|.+.+.||+|+||+||+|.. .+ ++.||||+++... ....+|+.+++.+ +||||++++++|.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 45578999999999999976 34 6779999985322 2456788877766 79999999999863 34
Q ss_pred eEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 464 NMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 464 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
..+++|||+.++++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++
T Consensus 89 ~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 6889999998876654443 33345899999999999999999999 8999999999999999999999999999987
Q ss_pred ccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC---
Q 037258 544 IFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGD--- 620 (704)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 620 (704)
... .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.. +........
T Consensus 165 ~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~ 238 (305)
T d1blxa_ 165 IYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGK-ILDVIGLPGEED 238 (305)
T ss_dssp CCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCGGG
T ss_pred hhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCchhc
Confidence 643 2334456789999999999999999999999999999999999999997554321 1111 111111000
Q ss_pred cc------cc-cC---CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 621 IR------NI-VD---PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 621 ~~------~~-~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.. .. .. ......+....+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 00 00001122334567889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=366.63 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=197.9
Q ss_pred HhhhcccccccCceEEEEEEeC-CCcEEEEEecccchhhHHHHHHHHHhhcccceeEEEEEEEeC------CeEEEEEee
Q 037258 399 TNNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSCCFQLLQVKLLMRVHHRNLTALIGYCIEG------NNMGLIYEY 471 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~e~ 471 (704)
+|+..++||+|+||+||+|... +|+.||||++........+|++++++++||||+++++++... ...++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 3455688999999999999764 799999999987766677899999999999999999998643 347899999
Q ss_pred cCCCCHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCC
Q 037258 472 MASGTLDQYLKG-KKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIES 549 (704)
Q Consensus 472 ~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~ 549 (704)
++++.+..+... .....+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++.+..
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~-- 175 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-- 175 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT--
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccC--
Confidence 987644444332 22345999999999999999999999 99999999999999999775 899999999987632
Q ss_pred CCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH----------HHhc
Q 037258 550 SDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS----------MLAE 618 (704)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~----------~~~~ 618 (704)
........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...... ....
T Consensus 176 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 176 -GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp -TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCC
T ss_pred -CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhhcc
Confidence 223345679999999998875 578999999999999999999999996554321 11111110 0000
Q ss_pred C----CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhhh
Q 037258 619 G----DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKECL 670 (704)
Q Consensus 619 ~----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 670 (704)
. ..................+.++.+|+.+||+.||++|||++|+++ .++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 001000000011112234567899999999999999999999996 355543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-41 Score=348.97 Aligned_cols=261 Identities=15% Similarity=0.191 Sum_probs=208.1
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch--hhHHHHHHHHHhhcc-cceeEEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC--CFQLLQVKLLMRVHH-RNLTALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e~~~~g 475 (704)
|.+.+.||+|+||.||+|... +|+.||||+++... .....|++.++.++| +|++.+++++.++...++||||+ ++
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 556889999999999999754 78999999985433 356789999999965 89999999999999999999999 68
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC-----CCcEEEEeccCccccccCCC
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE-----KLQAKIADFGLSRIFSIESS 550 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DfGla~~~~~~~~ 550 (704)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 86 ~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 86 SLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9999987544 34899999999999999999999 999999999999999974 56899999999987643322
Q ss_pred C-----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 037258 551 D-----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNIV 625 (704)
Q Consensus 551 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (704)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........++
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l- 240 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL- 240 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh-
Confidence 2 1233567999999999999999999999999999999999999999765544332222222211111111111
Q ss_pred CCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 626 DPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 626 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
. ...+.++.+++..|+..+|++||+++.+.+.|++++....
T Consensus 241 ----~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 241 ----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp ----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----c----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1 1223578899999999999999999999999998876443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-41 Score=350.52 Aligned_cols=260 Identities=18% Similarity=0.233 Sum_probs=198.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch--hhHHHHHHHHHhhccccee-EEEEEEEeCCeEEEEEeecCCC
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLT-ALIGYCIEGNNMGLIYEYMASG 475 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~~~g 475 (704)
|.+.+.||+|+||.||+|.. .+|+.||||++.... .....|+++++.++|+|++ .+.++..+++..++||||+ ++
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 56788999999999999965 578999999876433 3678899999999877655 5555667788899999999 45
Q ss_pred CHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccccCCCC-
Q 037258 476 TLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNE---KLQAKIADFGLSRIFSIESSD- 551 (704)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~~~~~~~- 551 (704)
+|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++. +..+||+|||+++.+......
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 88 SLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred chhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 7776665433 34999999999999999999999 899999999999999864 457999999999887433221
Q ss_pred ----cccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHH-HHHHHHHhcCCcccccC
Q 037258 552 ----QISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHIS-QWVNSMLAEGDIRNIVD 626 (704)
Q Consensus 552 ----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d 626 (704)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+...... ......
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 240 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEVL-- 240 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHHHH--
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChhHh--
Confidence 1234567999999999999999999999999999999999999999765543322211 11111111 111100
Q ss_pred CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 037258 627 PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLMELKECLSLEI 674 (704)
Q Consensus 627 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 674 (704)
....+.++.+++..||+.+|++||+++++.+.|+.+.....
T Consensus 241 -------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 241 -------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 11234578899999999999999999999999998765433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=356.20 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=190.4
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe--------CCe
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE--------GNN 464 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~ 464 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+|+++|++++||||+++++++.. .+.
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 45678999999999999976 589999999975332 246789999999999999999999865 346
Q ss_pred EEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 465 MGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 465 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
.++||||+.++.+........ .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 899999998877665554433 3889999999999999999999 99999999999999999999999999999987
Q ss_pred cccCCC--CcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC--
Q 037258 545 FSIESS--DQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG-- 619 (704)
Q Consensus 545 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 619 (704)
+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ...+.......
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCCCCh
Confidence 643222 1223345799999999998765 689999999999999999999999965432211 11111111110
Q ss_pred -CcccccCCcC--------CCCCCh-------hHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 620 -DIRNIVDPSL--------QGNFDN-------NSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 620 -~~~~~~d~~l--------~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.......... ...... .....+++|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000000 000000 11345779999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=349.99 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=199.5
Q ss_pred hhhcccccccCceEEEEEEe----CCCcEEEEEecccch--------hhHHHHHHHHHhhcc-cceeEEEEEEEeCCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL----DDNQQVAVKMLSSSC--------CFQLLQVKLLMRVHH-RNLTALIGYCIEGNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 466 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ..+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 66789999999999999964 257899999985422 246789999999977 89999999999999999
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+.+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999987654 788999999999999999999 8999999999999999999999999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLN--WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRNI 624 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (704)
.. .........|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.. .......... .
T Consensus 181 ~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~-~---- 252 (322)
T d1vzoa_ 181 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-E---- 252 (322)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-C----
T ss_pred cc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC-C----
Confidence 22 22334456799999999999754 4688999999999999999999999766543321 1111211111 1
Q ss_pred cCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 037258 625 VDPSLQGNFDNNSAWKAVELALACASHTSSERPT-----MTDVLM 664 (704)
Q Consensus 625 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 664 (704)
..++...+.++.+++.+||+.||++||| ++|+++
T Consensus 253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1123345668999999999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=349.65 Aligned_cols=255 Identities=19% Similarity=0.294 Sum_probs=195.2
Q ss_pred HhhhcccccccCceEEEEEEe-CCCcEEEEEecccch-hhHHHHHHHHHhhc-ccceeEEEEEEEeC--CeEEEEEeecC
Q 037258 399 TNNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC-CFQLLQVKLLMRVH-HRNLTALIGYCIEG--NNMGLIYEYMA 473 (704)
Q Consensus 399 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~e~~~ 473 (704)
.|.+.+.||+|+||+||+|.. .+|+.||||+++... ....+|+++|++++ ||||+++++++... ...++||||+.
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 355678999999999999976 578999999987654 36678999999995 99999999999854 56899999999
Q ss_pred CCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccccCCCCc
Q 037258 474 SGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL-QAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 474 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~ 552 (704)
+++|.++.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++..... .
T Consensus 116 ~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~---~ 184 (328)
T d3bqca1 116 NTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---Q 184 (328)
T ss_dssp SCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---C
T ss_pred CCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC---C
Confidence 999987643 3899999999999999999999 99999999999999998655 6999999999875422 2
Q ss_pred ccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc--HHHH-----HHHHHhcCCc---
Q 037258 553 ISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTH--ISQW-----VNSMLAEGDI--- 621 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~--~~~~-----~~~~~~~~~~--- 621 (704)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... +... ..........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 33456789999999998865 57999999999999999999999997654322110 0000 0000000000
Q ss_pred ---ccccC--------CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 622 ---RNIVD--------PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 622 ---~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
..... ...........+.++.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00111112334567899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=344.48 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=198.7
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCCeEEEEEeec
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 472 (704)
|++.+.||+|+||+||+|.. .+++.||||+++... ..+.+|+.+++.++||||+++++++.+.+..++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 44568999999999999975 578999999985332 25678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCCCCc
Q 037258 473 ASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIESSDQ 552 (704)
Q Consensus 473 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 552 (704)
.+++|..++..... +++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||.++..... ..
T Consensus 84 ~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~ 156 (292)
T d1unla_ 84 DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VR 156 (292)
T ss_dssp SEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CS
T ss_pred cccccccccccccc--cchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC--Cc
Confidence 99999888876543 889999999999999999999 899999999999999999999999999999876422 22
Q ss_pred ccccccCCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC---Ccc---ccc
Q 037258 553 ISTAVAGTPGYLDPEYYVLNW-LNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG---DIR---NIV 625 (704)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~ 625 (704)
......++..|+|||.+.+.. ++.++||||+||++|||++|+.||....... .....+....... ... ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcc
Confidence 333456788999999987664 6899999999999999999999985433211 1111111111110 000 000
Q ss_pred C---------CcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 626 D---------PSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 626 d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
+ ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001112334567889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=357.26 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=190.3
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEeCC------eEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIEGN------NMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 466 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ....+|+++|++++||||++++++|...+ +++
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 45578999999999999975 579999999986432 14578999999999999999999998654 579
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+ +++|..+++... +++..++.++.|++.||+||| +++|+||||||+|||++.++.+|++|||+++...
T Consensus 100 lv~e~~-~~~l~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEEECC-SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecc-cccHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccC
Confidence 999999 567888776543 999999999999999999999 9999999999999999999999999999998753
Q ss_pred cCCCCcccccccCCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc-------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVL-NWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAE------- 618 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------- 618 (704)
. ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +..... ....
T Consensus 173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~ 244 (346)
T d1cm8a_ 173 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMK-VTGTPPAEFVQ 244 (346)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHH
T ss_pred C-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHh-ccCCCcHHHHh
Confidence 2 2345679999999999876 4578999999999999999999999966542211 111110 0000
Q ss_pred -C----------CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHhhh
Q 037258 619 -G----------DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLME--LKECL 670 (704)
Q Consensus 619 -~----------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 670 (704)
. .........+. ......+..+++|+.+||+.||.+|||++|+++. ++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 00000000000 1112334578899999999999999999999974 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=352.04 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=190.8
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh-----hHHHHHHHHHhhcccceeEEEEEEEeCC----eEEEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC-----FQLLQVKLLMRVHHRNLTALIGYCIEGN----NMGLIY 469 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~ 469 (704)
|.+.+.||+|+||+||+|.. .+|+.||||++..... .+.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 44568999999999999965 5899999999864321 5578999999999999999999997653 335556
Q ss_pred eecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccccCC
Q 037258 470 EYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSIES 549 (704)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~ 549 (704)
+|+.+|+|.+++.... +++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 THLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EECCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EeecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 6777999999997543 999999999999999999999 8999999999999999999999999999998754322
Q ss_pred C-CcccccccCCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc----
Q 037258 550 S-DQISTAVAGTPGYLDPEYYV-LNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEGDIRN---- 623 (704)
Q Consensus 550 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 623 (704)
. ........||+.|+|||++. +..++.++||||+||++|||++|+.||......+.. ..............
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNCI 240 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHTC
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhhhh
Confidence 2 22234567999999999985 456789999999999999999999999665432111 11111110000000
Q ss_pred --------c-cCCcCCC-C---CChhHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 037258 624 --------I-VDPSLQG-N---FDNNSAWKAVELALACASHTSSERPTMTDVLME 665 (704)
Q Consensus 624 --------~-~d~~l~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 665 (704)
. ..+.... . .....+.++++|+.+||+.||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 0 001223478899999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=342.57 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=183.3
Q ss_pred hhhcccccccCceEEEEEEeC-CCcEEEEEecccch------hhHHHHHHHHHhhcccceeEEEEEEEe------CCeEE
Q 037258 400 NNFERVLGKGGFGEVYHGSLD-DNQQVAVKMLSSSC------CFQLLQVKLLMRVHHRNLTALIGYCIE------GNNMG 466 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 466 (704)
|.+.+.||+|+||+||+|... +|+.||||++.... ....+|+.++++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 445689999999999999764 79999999986432 246789999999999999999999964 36889
Q ss_pred EEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCccccc
Q 037258 467 LIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFS 546 (704)
Q Consensus 467 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~ 546 (704)
+||||+.++.+ +.+.. .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+|++|||+++...
T Consensus 99 iv~Ey~~~~l~-~~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSEEHH-HHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeccchHHH-Hhhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccc
Confidence 99999976544 44432 3899999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-------------
Q 037258 547 IESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVN------------- 613 (704)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~------------- 613 (704)
.........+|+.|+|||++.+..+++++||||+||++|||++|+.||....... .......
T Consensus 171 ---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 ---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHTTS
T ss_pred ---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCCCHHHHHHh
Confidence 2233455678999999999999999999999999999999999999996543211 1111000
Q ss_pred -----HHHhcC-Cc-----ccccCCcCCC---CCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 614 -----SMLAEG-DI-----RNIVDPSLQG---NFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 614 -----~~~~~~-~~-----~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
...... .. .......... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00 0000000100 012345678899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=349.58 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=191.2
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh------hHHHHHHHHHhhcccceeEEEEEEEeC-----CeEEE
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC------FQLLQVKLLMRVHHRNLTALIGYCIEG-----NNMGL 467 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 467 (704)
|...+.||+|+||+||+|.. .+|+.||||+++.... ...+|+++|++++||||+++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 45578999999999999965 5799999999864322 457899999999999999999998643 34567
Q ss_pred EEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEeccCcccccc
Q 037258 468 IYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSRIFSI 547 (704)
Q Consensus 468 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~ 547 (704)
|++|+.+|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp EEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred EEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC-
Confidence 77888899999999654 3999999999999999999999 8999999999999999999999999999987542
Q ss_pred CCCCcccccccCCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC-------
Q 037258 548 ESSDQISTAVAGTPGYLDPEYYVLN-WLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNSMLAEG------- 619 (704)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 619 (704)
.......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+...... ...+.......
T Consensus 173 ----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 ----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKK 245 (348)
T ss_dssp ----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTT
T ss_pred ----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhh
Confidence 233456788999999987765 568999999999999999999999965442211 11111110000
Q ss_pred -----------CcccccCCcCCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHhh
Q 037258 620 -----------DIRNIVDPSLQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM--ELKEC 669 (704)
Q Consensus 620 -----------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 669 (704)
.........+. ......+..+++|+.+||+.||.+|||++|+++ .+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000000 000123457889999999999999999999997 45544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-35 Score=313.07 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=190.6
Q ss_pred hhhcccccccCceEEEEEEe-CCCcEEEEEecccchh---hHHHHHHHHHhhc-----------ccceeEEEEEEEe--C
Q 037258 400 NNFERVLGKGGFGEVYHGSL-DDNQQVAVKMLSSSCC---FQLLQVKLLMRVH-----------HRNLTALIGYCIE--G 462 (704)
Q Consensus 400 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~E~~~l~~l~-----------h~nIv~l~~~~~~--~ 462 (704)
|.+.+.||+|+||+||+|.. .+|+.||||+++.... ...+|++++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 67789999999999999976 5799999999976532 4567888888775 5789999988864 3
Q ss_pred CeEEEEEeecCCCC-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCC------cEE
Q 037258 463 NNMGLIYEYMASGT-LDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKL------QAK 535 (704)
Q Consensus 463 ~~~~lV~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------~~k 535 (704)
...+++++++..+. ............+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++ .++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceee
Confidence 55667777665544 3344444445568999999999999999999993 38999999999999998654 399
Q ss_pred EEeccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-
Q 037258 536 IADFGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVLLEIITGRRPVISRAEDDTTHISQWVNS- 614 (704)
Q Consensus 536 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~- 614 (704)
++|||.+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||.................
T Consensus 173 l~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 173 IADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp ECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred Eeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999976532 22346799999999999999999999999999999999999999976543221111111110
Q ss_pred --HHh--------cC----------CcccccCCc----------CCCCCChhHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 037258 615 --MLA--------EG----------DIRNIVDPS----------LQGNFDNNSAWKAVELALACASHTSSERPTMTDVLM 664 (704)
Q Consensus 615 --~~~--------~~----------~~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 664 (704)
.+. .. .....+... ....+....+.++.+|+.+||+.||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00 000000000 011234567788999999999999999999999987
Q ss_pred H--HHhhh
Q 037258 665 E--LKECL 670 (704)
Q Consensus 665 ~--L~~~~ 670 (704)
. +++..
T Consensus 328 Hp~f~~~~ 335 (362)
T d1q8ya_ 328 HPWLKDTL 335 (362)
T ss_dssp CGGGTTCT
T ss_pred CcccCCCC
Confidence 3 55443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.6e-22 Score=191.03 Aligned_cols=165 Identities=15% Similarity=0.127 Sum_probs=117.8
Q ss_pred hhcccccccCceEEEEEEeCCCcEEEEEecccchh----------------------hHHHHHHHHHhhcccceeEEEEE
Q 037258 401 NFERVLGKGGFGEVYHGSLDDNQQVAVKMLSSSCC----------------------FQLLQVKLLMRVHHRNLTALIGY 458 (704)
Q Consensus 401 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~~~ 458 (704)
.+.+.||+|+||.||+|...+|+.||||+++.... ....|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999888999999998643211 22457788889999999988765
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCEEeCCCCcEEEEe
Q 037258 459 CIEGNNMGLIYEYMASGTLDQYLKGKKEHMLNWVERLQIAVDSAQGLEYLHYGCKPPIVHRDVKSSNILLNEKLQAKIAD 538 (704)
Q Consensus 459 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 538 (704)
. ..+++|||++++.+.+ ++......++.|++++|+||| +.+|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999998865433 334455689999999999999 8999999999999999976 589999
Q ss_pred ccCccccccCCCCcccccccCCCCccCccccccCCCCcchhHHHHHHHH
Q 037258 539 FGLSRIFSIESSDQISTAVAGTPGYLDPEYYVLNWLNEKSDVYSFGVVL 587 (704)
Q Consensus 539 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 587 (704)
||++.............. .... -.| +..+.|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~r---d~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILER---DVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHH---HHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHH---HHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999976532111100000 0000 001 1245678899999976443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.71 E-value=3e-18 Score=177.30 Aligned_cols=127 Identities=29% Similarity=0.489 Sum_probs=111.7
Q ss_pred cCChhhHHHHHHhhhhcC---CCCCCC--CCCCCCCCCceeeeecCCCCCCCCceEEEEcCCCCCcc--cCchhhccccc
Q 037258 189 LTDEDDVNALRNIKSTYG---VKRNWQ--GDPCVPKNYWWDGLNCSYEDNNPSRIISLNLSSSGLTG--EISPYFANLTA 261 (704)
Q Consensus 189 ~~~~~~~~al~~~~~~~~---~~~~w~--~~~c~~~~~~w~gv~c~~~~~~~~~l~~l~L~~n~l~g--~~p~~~~~l~~ 261 (704)
.|.++|.+||++||+.+. .+.+|. +|+|. +.|.||+|+.. +...+|+.|+|++|+++| .||++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~-~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeCC-CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 488999999999999873 467895 35552 36999999854 345699999999999999 58999999999
Q ss_pred cceEeccC-CcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCC
Q 037258 262 IEFLDLSN-NSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 262 L~~L~l~~-N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
|++|+|++ |+|+|.||.+|++|++|++|+|++|+|+|..|..+..+..|+.++++.|.
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~ 136 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence 99999997 89999999999999999999999999999999999999999998887664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.24 E-value=6.3e-12 Score=119.29 Aligned_cols=100 Identities=19% Similarity=0.217 Sum_probs=87.0
Q ss_pred ceeeeecCCCC------CCCCceEEEEcCCCCCcccC-chhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 222 WWDGLNCSYED------NNPSRIISLNLSSSGLTGEI-SPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 222 ~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
.|..|.|+... +.++.++.|+|++|+|++.+ +..|.+|++|+.|+|++|++++..+..+..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 58889998543 34568999999999998766 457899999999999999999888999999999999999999
Q ss_pred CCCCCcccccccccCCCccccccCCCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|++..|..|.++++|+.|+|+.|.-.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~ 115 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred cccccCHHHHhCCCcccccccCCcccc
Confidence 999777778999999999999988654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=7e-11 Score=107.80 Aligned_cols=107 Identities=26% Similarity=0.335 Sum_probs=84.2
Q ss_pred CCCCCCCCceeeeecCCCC--------CCCCceEEEEcCCC-CCcccCchhhccccccceEeccCCcccCCCCcccCCCC
Q 037258 214 DPCVPKNYWWDGLNCSYED--------NNPSRIISLNLSSS-GLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLP 284 (704)
Q Consensus 214 ~~c~~~~~~w~gv~c~~~~--------~~~~~l~~l~L~~n-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~ 284 (704)
+.|++. .+.+|+|+..+ ..+++|+.|+|++| .|+..-+..|.+|++|+.|+|++|+|++.-|..|..++
T Consensus 3 ~~C~c~--~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 3 DACCPH--GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp SSSCCS--SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCCcC--CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccc
Confidence 456553 47789997543 24578999999876 48866667899999999999999999966678899999
Q ss_pred CCCeEeccCCCCCCCcccccccccCCCccccccCCCCccccC
Q 037258 285 SLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNTSTTCS 326 (704)
Q Consensus 285 ~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~s~~c~ 326 (704)
+|++|+|++|+|+ .+|.......++..|+|+. |+ ..|.
T Consensus 81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~--Np-~~C~ 118 (156)
T d2ifga3 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSG--NP-LHCS 118 (156)
T ss_dssp CCCEEECCSSCCS-CCCSTTTCSCCCCEEECCS--SC-CCCC
T ss_pred cccceeccCCCCc-ccChhhhccccccccccCC--Cc-ccCC
Confidence 9999999999999 7777766666788776654 55 4554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.01 E-value=1.2e-10 Score=110.33 Aligned_cols=85 Identities=24% Similarity=0.345 Sum_probs=78.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 57899999999999999999999999999999999999997777889999999999999999998778889999999988
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+|+.|
T Consensus 132 ~L~~N 136 (192)
T d1w8aa_ 132 NLASN 136 (192)
T ss_dssp ECTTC
T ss_pred ccccc
Confidence 87655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.00 E-value=2.3e-10 Score=99.89 Aligned_cols=82 Identities=29% Similarity=0.357 Sum_probs=70.9
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCc-ccccccccCCCc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSL-PADLVERSNNGS 312 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~~~~l~~ 312 (704)
.+.+|+.|+|++|+|+ .+|+.|+.+++|+.|+|++|.|+ .+|+ ++.+++|+.|++++|+++... +..+..+++|+.
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCCCCCchhhcCCCCCCE
Confidence 5678999999999998 78889999999999999999999 5775 899999999999999998432 256888899998
Q ss_pred cccccC
Q 037258 313 LTLSVD 318 (704)
Q Consensus 313 l~l~~~ 318 (704)
|+++.|
T Consensus 95 L~l~~N 100 (124)
T d1dcea3 95 LNLQGN 100 (124)
T ss_dssp EECTTS
T ss_pred EECCCC
Confidence 888765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.94 E-value=4.5e-10 Score=98.00 Aligned_cols=78 Identities=26% Similarity=0.324 Sum_probs=69.6
Q ss_pred EEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccC
Q 037258 239 ISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVD 318 (704)
Q Consensus 239 ~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~ 318 (704)
+.|+|++|+|+ .+| .+.+|++|++|+|++|+|+ .+|+.++.+++|+.|+|++|+|+ .+| .+..+++|+.|+++.|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 36999999999 666 4999999999999999999 78989999999999999999999 466 5899999999999887
Q ss_pred CCC
Q 037258 319 GNT 321 (704)
Q Consensus 319 ~n~ 321 (704)
.-.
T Consensus 76 ~i~ 78 (124)
T d1dcea3 76 RLQ 78 (124)
T ss_dssp CCC
T ss_pred ccC
Confidence 654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.92 E-value=1.9e-10 Score=117.53 Aligned_cols=112 Identities=26% Similarity=0.458 Sum_probs=94.1
Q ss_pred CCCCCCCCCCCC--ceeeeec-----------CCCCCCCCceEEEEcCC-CCCcccCchhhccccccceEeccCCcccCC
Q 037258 210 NWQGDPCVPKNY--WWDGLNC-----------SYEDNNPSRIISLNLSS-SGLTGEISPYFANLTAIEFLDLSNNSLSGT 275 (704)
Q Consensus 210 ~w~~~~c~~~~~--~w~gv~c-----------~~~~~~~~~l~~l~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 275 (704)
.|.|--|..... .-..+.- ...-+.+++|+.|+|++ |+|+|.||++|++|++|++|+|++|+|+|.
T Consensus 37 ~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~ 116 (313)
T d1ogqa_ 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred cCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccc
Confidence 699988875432 1222211 11224688999999997 899999999999999999999999999999
Q ss_pred CCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccccCCCC
Q 037258 276 FPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 276 iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
.|..+..+.+|+.+++++|++.+.+|..+.+++.++.++++.|...
T Consensus 117 ~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred ccccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence 9999999999999999999999999999999999999998877543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=1.9e-09 Score=98.75 Aligned_cols=85 Identities=19% Similarity=0.185 Sum_probs=68.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
++.+++.|+|++|+|+ .||..+..+++|+.|||++|+|+ .++. +..+++|++|+|++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCccccccccccccc
Confidence 3467899999999998 66777788999999999999998 6654 8889999999999999984333445678899988
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 93 ~L~~N~i~ 100 (162)
T d1a9na_ 93 ILTNNSLV 100 (162)
T ss_dssp ECCSCCCC
T ss_pred eecccccc
Confidence 88877543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=4.1e-09 Score=104.84 Aligned_cols=93 Identities=26% Similarity=0.272 Sum_probs=79.5
Q ss_pred eecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCC
Q 037258 226 LNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGS 299 (704)
Q Consensus 226 v~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~ 299 (704)
|.|+..+ +.++.|+.|+|++|+|++..+..|.+|++|++|+|++|+|+ .+|. ++.+++|+.|+|++|+|+ .
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~ 91 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-S 91 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-S
T ss_pred EEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-c
Confidence 7786432 23468999999999999776788999999999999999999 6775 588999999999999999 5
Q ss_pred cccccccccCCCccccccCCCC
Q 037258 300 LPADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 300 ~p~~~~~~~~l~~l~l~~~~n~ 321 (704)
+|..+..+++|+.|+++.+...
T Consensus 92 ~~~~~~~l~~L~~L~l~~~~~~ 113 (266)
T d1p9ag_ 92 LPLLGQTLPALTVLDVSFNRLT 113 (266)
T ss_dssp CCCCTTTCTTCCEEECCSSCCC
T ss_pred cccccccccccccccccccccc
Confidence 6888999999999999877654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=1.4e-08 Score=100.85 Aligned_cols=90 Identities=23% Similarity=0.269 Sum_probs=80.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+.++..|++++|.+++..+..+..+++|+.|++++|+|++..|..|..+++|++|+|++|+|+ .||+++..+.+|+.|
T Consensus 122 ~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L 200 (266)
T d1p9ag_ 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200 (266)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred cccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE
Confidence 5678999999999999777788899999999999999999877888999999999999999999 899999999999977
Q ss_pred ccccCCCCccccCC
Q 037258 314 TLSVDGNTSTTCSS 327 (704)
Q Consensus 314 ~l~~~~n~s~~c~~ 327 (704)
+|+ ||| +.|.+
T Consensus 201 ~L~--~Np-~~CdC 211 (266)
T d1p9ag_ 201 FLH--GNP-WLCNC 211 (266)
T ss_dssp ECC--SCC-BCCSG
T ss_pred Eec--CCC-CCCCc
Confidence 765 566 77753
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=6.8e-09 Score=104.20 Aligned_cols=90 Identities=21% Similarity=0.247 Sum_probs=77.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
..++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|++|++++|++++..|..|..+.+|+.|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 45688999999999998888899999999999999999998889999999999999999999998888889999999987
Q ss_pred ccccCCCCccccC
Q 037258 314 TLSVDGNTSTTCS 326 (704)
Q Consensus 314 ~l~~~~n~s~~c~ 326 (704)
+|+ +|+ ..|.
T Consensus 231 ~l~--~N~-l~C~ 240 (284)
T d1ozna_ 231 RLN--DNP-WVCD 240 (284)
T ss_dssp ECC--SSC-EECS
T ss_pred Eec--CCC-CCCC
Confidence 765 445 5564
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.63 E-value=3.4e-08 Score=99.95 Aligned_cols=96 Identities=25% Similarity=0.307 Sum_probs=78.2
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN 294 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N 294 (704)
|.|++|.|+..+ +.++.|+.|+|++|+|+...+..|.+|++|++|++++|.++...|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 478999998532 23578999999999999555568999999999999999999777889999999999999999
Q ss_pred CCCCCcccccccccCCCccccccCC
Q 037258 295 KLTGSLPADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 295 ~l~g~~p~~~~~~~~l~~l~l~~~~ 319 (704)
+++ .+|..+. ..+..|.+..|.
T Consensus 90 ~l~-~l~~~~~--~~l~~L~~~~n~ 111 (305)
T d1xkua_ 90 QLK-ELPEKMP--KTLQELRVHENE 111 (305)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSC
T ss_pred ccC-cCccchh--hhhhhhhccccc
Confidence 999 6776543 456666655543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=1.1e-08 Score=93.50 Aligned_cols=82 Identities=20% Similarity=0.229 Sum_probs=68.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCccc--ccccccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPA--DLVERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~~~l~ 311 (704)
.+++|+.|||++|+|+ .++ .|..|++|++|+|++|+++...|..+..+++|+.|+|++|+++ .+++ .+..+++|+
T Consensus 39 ~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~ 115 (162)
T d1a9na_ 39 TLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT 115 (162)
T ss_dssp GTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC
T ss_pred ccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccc
Confidence 4678999999999999 564 5899999999999999999544445678999999999999998 4553 678889999
Q ss_pred ccccccC
Q 037258 312 SLTLSVD 318 (704)
Q Consensus 312 ~l~l~~~ 318 (704)
.|+++.|
T Consensus 116 ~L~l~~N 122 (162)
T d1a9na_ 116 YLCILRN 122 (162)
T ss_dssp EEECCSS
T ss_pred hhhcCCC
Confidence 8887755
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=3.9e-08 Score=98.48 Aligned_cols=88 Identities=20% Similarity=0.197 Sum_probs=80.8
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+..|+.|++++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++++.|
T Consensus 127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 56789999999999997777889999999999999999998778889999999999999999999999999999999999
Q ss_pred ccccCCCC
Q 037258 314 TLSVDGNT 321 (704)
Q Consensus 314 ~l~~~~n~ 321 (704)
+++.|.-.
T Consensus 207 ~l~~N~i~ 214 (284)
T d1ozna_ 207 YLFANNLS 214 (284)
T ss_dssp ECCSSCCS
T ss_pred cccccccc
Confidence 99887654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.51 E-value=4.7e-08 Score=98.90 Aligned_cols=85 Identities=27% Similarity=0.346 Sum_probs=62.2
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|.+++.++..|.+++.++.|++++|.+++..|..+..+++|++|+|++|+|+ .+|.++..+++|+.|
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence 3566777777777777777777777777777777777777666667777777777777777777 567777777777777
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+|+.|.
T Consensus 248 ~Ls~N~ 253 (305)
T d1xkua_ 248 YLHNNN 253 (305)
T ss_dssp ECCSSC
T ss_pred ECCCCc
Confidence 776654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.47 E-value=5.2e-08 Score=101.51 Aligned_cols=79 Identities=22% Similarity=0.254 Sum_probs=67.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.++.++.|+|++|+|++.. .+..|++|+.|+|++|+|+ .+| .+++|++|++|+|++|+|++.+| +.++++|+.|
T Consensus 305 ~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L 378 (384)
T d2omza2 305 NLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378 (384)
T ss_dssp GCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE
T ss_pred hhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEe
Confidence 4578899999999999753 3889999999999999998 466 58999999999999999997655 8889999999
Q ss_pred ccccC
Q 037258 314 TLSVD 318 (704)
Q Consensus 314 ~l~~~ 318 (704)
+|+.|
T Consensus 379 ~L~~N 383 (384)
T d2omza2 379 GLNDQ 383 (384)
T ss_dssp ECCCE
T ss_pred eCCCC
Confidence 88765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=2e-07 Score=84.23 Aligned_cols=83 Identities=18% Similarity=0.123 Sum_probs=72.0
Q ss_pred eEEEEcCCCCCcccCchhhccccccceEeccCC-cccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccccc
Q 037258 238 IISLNLSSSGLTGEISPYFANLTAIEFLDLSNN-SLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLTLS 316 (704)
Q Consensus 238 l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~ 316 (704)
...++.+++++. .+|..+..+++|+.|+|++| .|+..-+..|..+++|+.|+|++|+|+...|..|..+++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 345899999998 78889999999999999866 5884445679999999999999999997667889999999999999
Q ss_pred cCCCC
Q 037258 317 VDGNT 321 (704)
Q Consensus 317 ~~~n~ 321 (704)
.|.-.
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 88765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.31 E-value=2.4e-07 Score=89.31 Aligned_cols=77 Identities=25% Similarity=0.379 Sum_probs=65.3
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
..++|+.|++++|.+++.. .|++|++|+.|+|++|++++ +|. ++++++|++|+|++|++++ +|. +.++++|+.|
T Consensus 149 ~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L 222 (227)
T d1h6ua2 149 GLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSP-LANTSNLFIV 222 (227)
T ss_dssp GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEE
T ss_pred cccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEE
Confidence 4578999999999998543 38999999999999999994 665 8899999999999999994 553 8888999988
Q ss_pred ccc
Q 037258 314 TLS 316 (704)
Q Consensus 314 ~l~ 316 (704)
+++
T Consensus 223 ~ls 225 (227)
T d1h6ua2 223 TLT 225 (227)
T ss_dssp EEE
T ss_pred Eee
Confidence 875
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=2.4e-07 Score=90.00 Aligned_cols=100 Identities=20% Similarity=0.240 Sum_probs=81.4
Q ss_pred CceeeeecCCCC------CCCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCc-ccCCCCCCCeEecc-
Q 037258 221 YWWDGLNCSYED------NNPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRALNLK- 292 (704)
Q Consensus 221 ~~w~gv~c~~~~------~~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~-~~~~l~~L~~l~l~- 292 (704)
|....|.|+..+ +.+.+++.|+|++|+|+...+..|.+|++|++|+|++|.+...+|. .|..+++++.|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 356778897432 2345899999999999955555799999999999999999876654 68889999999986
Q ss_pred CCCCCCCcccccccccCCCccccccCCC
Q 037258 293 RNKLTGSLPADLVERSNNGSLTLSVDGN 320 (704)
Q Consensus 293 ~N~l~g~~p~~~~~~~~l~~l~l~~~~n 320 (704)
.|++....|..|..+++|+.|++..++-
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred cccccccccccccccccccccccchhhh
Confidence 5788877788899999999999987654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.20 E-value=2.8e-08 Score=93.86 Aligned_cols=82 Identities=18% Similarity=0.238 Sum_probs=64.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|+ .++ .|.+|++|+.|+|++|+|+ .+|.....+++|+.|+|++|+++. ++ .+..+++|+.|
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEE
T ss_pred cccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccccccc
Confidence 4678888899988888 565 5888888999999988888 777766666788888888888884 43 47778888888
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.|.-
T Consensus 121 ~L~~N~i 127 (198)
T d1m9la_ 121 YMSNNKI 127 (198)
T ss_dssp EESEEEC
T ss_pred ccccchh
Confidence 8876643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=6.4e-06 Score=80.58 Aligned_cols=127 Identities=14% Similarity=0.104 Sum_probs=89.1
Q ss_pred CceEEEEEEeCCCcEEEEEecccchh----hHHHHHHHHHhhc-ccceeEEEEEEEeCCeEEEEEeecCCCCHHHHhhcc
Q 037258 410 GFGEVYHGSLDDNQQVAVKMLSSSCC----FQLLQVKLLMRVH-HRNLTALIGYCIEGNNMGLIYEYMASGTLDQYLKGK 484 (704)
Q Consensus 410 ~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~ 484 (704)
+.+.||+... +++.++||+...... ...+|...+..+. +--+.+++.+..+++..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468999865 556678888764432 4577888888774 333567888888889999999999998886654321
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 037258 485 KEHMLNWVERLQIAVDSAQGLEYLHYG----------------------------------------------------- 511 (704)
Q Consensus 485 ~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------------------- 511 (704)
.....++.++++.+..||+.
T Consensus 105 -------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 -------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp -------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred -------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11233455566666666631
Q ss_pred ---CCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 512 ---CKPPIVHRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 512 ---~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012379999999999999876667999997753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.15 E-value=1.1e-06 Score=82.54 Aligned_cols=80 Identities=28% Similarity=0.374 Sum_probs=54.1
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|++. ++ |++|++|++|++++|.+. .+|. +..+++|+.|++++|.+... ..+..+++|+.|
T Consensus 60 ~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L 133 (199)
T d2omxa2 60 YLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRL 133 (199)
T ss_dssp GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEE
T ss_pred cCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cccccccccccccccccccc--cccchhhhhHHh
Confidence 356777777777777753 32 777777777777777776 4553 67777777777777777643 235666777777
Q ss_pred ccccCC
Q 037258 314 TLSVDG 319 (704)
Q Consensus 314 ~l~~~~ 319 (704)
+++.|.
T Consensus 134 ~l~~n~ 139 (199)
T d2omxa2 134 ELSSNT 139 (199)
T ss_dssp ECCSSC
T ss_pred hhhhhh
Confidence 766554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.13 E-value=1.5e-06 Score=82.42 Aligned_cols=77 Identities=27% Similarity=0.373 Sum_probs=64.7
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.++.++.+++++|.+++ +..+.+|++|+.|++++|++++ +++ ++++++|+.|+|++|+++ .+| .+..+++|+.|
T Consensus 132 ~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L 205 (210)
T d1h6ta2 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVL 205 (210)
T ss_dssp GCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEE
T ss_pred ccccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEE
Confidence 45788999999999885 3467889999999999999984 554 889999999999999998 566 58889999988
Q ss_pred ccc
Q 037258 314 TLS 316 (704)
Q Consensus 314 ~l~ 316 (704)
+|+
T Consensus 206 ~Ls 208 (210)
T d1h6ta2 206 ELF 208 (210)
T ss_dssp EEE
T ss_pred Ecc
Confidence 875
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.12 E-value=1.8e-06 Score=81.07 Aligned_cols=80 Identities=21% Similarity=0.318 Sum_probs=57.5
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+.+|+.|+|++|+++ .++ .+..|++|++|+|++|+|++ ++. ++++++|+.|++++|.+. .+| .+..+..|+.|+
T Consensus 39 l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 457778888888877 443 47778888888888888874 443 778888888888888777 444 367777777777
Q ss_pred cccCCC
Q 037258 315 LSVDGN 320 (704)
Q Consensus 315 l~~~~n 320 (704)
++.+..
T Consensus 113 l~~~~~ 118 (199)
T d2omxa2 113 LFNNQI 118 (199)
T ss_dssp CCSSCC
T ss_pred cccccc
Confidence 765543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.08 E-value=2.2e-06 Score=81.22 Aligned_cols=79 Identities=28% Similarity=0.380 Sum_probs=49.3
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+++|+.|+|++|+|++ ++ .+++|++|++|+|++|+|+ .+| .+..+++|+.|++++|.+. .+ ..+..+++++.+.
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccc
Confidence 5667777777777764 33 2566777777777777776 355 3666777777777777665 23 2455666666665
Q ss_pred cccCC
Q 037258 315 LSVDG 319 (704)
Q Consensus 315 l~~~~ 319 (704)
++.+.
T Consensus 141 ~~~n~ 145 (210)
T d1h6ta2 141 LGNNK 145 (210)
T ss_dssp CCSSC
T ss_pred ccccc
Confidence 55543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.07 E-value=5.5e-08 Score=91.84 Aligned_cols=81 Identities=23% Similarity=0.260 Sum_probs=69.0
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcc--cccccccCCC
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLP--ADLVERSNNG 311 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p--~~~~~~~~l~ 311 (704)
.+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|+++ .++. +..+++|+.|+|++|+++ .++ ..+..+++|+
T Consensus 68 ~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~ 143 (198)
T d1m9la_ 68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLE 143 (198)
T ss_dssp HHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHH-HHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCS
T ss_pred CCccccChhhcccccc-ccccccccccccccccccccccc-cccc-ccccccccccccccchhc-cccccccccCCCccc
Confidence 4678999999999998 78887888889999999999999 5554 788999999999999998 444 4688899999
Q ss_pred ccccccC
Q 037258 312 SLTLSVD 318 (704)
Q Consensus 312 ~l~l~~~ 318 (704)
.|+|+.|
T Consensus 144 ~L~L~~N 150 (198)
T d1m9la_ 144 DLLLAGN 150 (198)
T ss_dssp EEEECSS
T ss_pred eeecCCC
Confidence 8887655
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.07 E-value=1.8e-06 Score=89.43 Aligned_cols=79 Identities=22% Similarity=0.307 Sum_probs=63.0
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+.+|+.|+|++++++ .+ +.|..|++|++|+|++|+|+ .+|. +++|++|++|+|++|++++. + .+..+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccc-c-cccccccccccc
Confidence 567889999999888 44 46888999999999999998 4554 88899999999999999854 3 277888888887
Q ss_pred cccCC
Q 037258 315 LSVDG 319 (704)
Q Consensus 315 l~~~~ 319 (704)
+..+.
T Consensus 117 ~~~~~ 121 (384)
T d2omza2 117 LFNNQ 121 (384)
T ss_dssp CCSSC
T ss_pred ccccc
Confidence 76554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=8.8e-06 Score=79.15 Aligned_cols=129 Identities=17% Similarity=0.056 Sum_probs=86.9
Q ss_pred cccccCc-eEEEEEEeCCCcEEEEEecccchh-hHHHHHHHHHhhccc--ceeEEEEEEEeCCeEEEEEeecCCCCHHHH
Q 037258 405 VLGKGGF-GEVYHGSLDDNQQVAVKMLSSSCC-FQLLQVKLLMRVHHR--NLTALIGYCIEGNNMGLIYEYMASGTLDQY 480 (704)
Q Consensus 405 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 480 (704)
.+..|.. +.||+...+++..+++|....... ....|...++.+... .+.+++++..+++..++||++++|.++.+.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 3445554 689999888888899998765544 456788888877533 356778888888889999999988665331
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHhc--------------------------------------------------
Q 037258 481 LKGKKEHMLNWVERLQIAVDSAQGLEYLHY-------------------------------------------------- 510 (704)
Q Consensus 481 l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------------------------------------------------- 510 (704)
. ... ...+.++++.|.-||.
T Consensus 97 ~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 97 H-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp C-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred c-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 1 110 1112233333333331
Q ss_pred -----CCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 511 -----GCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 511 -----~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
.....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012347999999999999987667899999774
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=1.4e-06 Score=79.07 Aligned_cols=78 Identities=26% Similarity=0.211 Sum_probs=45.7
Q ss_pred CCceEEEEcCCCCCccc--CchhhccccccceEeccCCcccCCCCc-ccCCCCCCCeEeccCCCCCCCcccc-------c
Q 037258 235 PSRIISLNLSSSGLTGE--ISPYFANLTAIEFLDLSNNSLSGTFPE-FLSKLPSLRALNLKRNKLTGSLPAD-------L 304 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~iP~-~~~~l~~L~~l~l~~N~l~g~~p~~-------~ 304 (704)
++.|+.|+|++|+|+.. ++..+..|++|+.|+|++|.++ .+++ ......+|+.|+|++|.+++..... +
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 45677777777777642 2345666777777777777777 4443 2223345677777777776544422 3
Q ss_pred ccccCCCcc
Q 037258 305 VERSNNGSL 313 (704)
Q Consensus 305 ~~~~~l~~l 313 (704)
..+++|+.|
T Consensus 143 ~~~P~L~~L 151 (162)
T d1koha1 143 ERFPKLLRL 151 (162)
T ss_dssp TTSTTCCEE
T ss_pred HHCCCCCEE
Confidence 345555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.76 E-value=1.4e-05 Score=81.19 Aligned_cols=77 Identities=26% Similarity=0.338 Sum_probs=56.5
Q ss_pred CCCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCcc
Q 037258 234 NPSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSL 313 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l 313 (704)
.+++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++ .|+.. .++|++|+|++|+++ .+|. ++.+++|+.|
T Consensus 56 ~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L 125 (353)
T d1jl5a_ 56 LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKII 125 (353)
T ss_dssp CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceee
Confidence 3567888888888888 777654 46778888888887 55531 146888999999888 6774 5778888888
Q ss_pred ccccCCC
Q 037258 314 TLSVDGN 320 (704)
Q Consensus 314 ~l~~~~n 320 (704)
+++.+..
T Consensus 126 ~l~~~~~ 132 (353)
T d1jl5a_ 126 DVDNNSL 132 (353)
T ss_dssp ECCSSCC
T ss_pred ccccccc
Confidence 8766544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.70 E-value=1.7e-05 Score=75.77 Aligned_cols=79 Identities=23% Similarity=0.317 Sum_probs=60.6
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccccccccCCCccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPADLVERSNNGSLT 314 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~ 314 (704)
+.+|+.|+|++|+|+ .++ .|.+|++|++|+|++|++++..| +..+++|+.|++++|.++ .++ .+..+++|+.+.
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEE
T ss_pred cCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccc
Confidence 567888888888888 454 58888888888888888885433 788888888888888887 454 467777888777
Q ss_pred cccCC
Q 037258 315 LSVDG 319 (704)
Q Consensus 315 l~~~~ 319 (704)
++.+.
T Consensus 114 l~~~~ 118 (227)
T d1h6ua2 114 LTSTQ 118 (227)
T ss_dssp CTTSC
T ss_pred ccccc
Confidence 76544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.63 E-value=2.2e-05 Score=79.61 Aligned_cols=60 Identities=30% Similarity=0.421 Sum_probs=41.0
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCCCCCCCcccc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRNKLTGSLPAD 303 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N~l~g~~p~~ 303 (704)
+++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .+|..
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence 456777777777777 56643 456777777777777 67653 456777777777777 56653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.40 E-value=9.9e-05 Score=70.74 Aligned_cols=80 Identities=19% Similarity=0.183 Sum_probs=61.6
Q ss_pred CCceEEEEcCCCCCcccCchhhccccccceE-eccCCcccCCCCc-ccCCCCCCCeEeccCCCCCCCcccccccccCCCc
Q 037258 235 PSRIISLNLSSSGLTGEISPYFANLTAIEFL-DLSNNSLSGTFPE-FLSKLPSLRALNLKRNKLTGSLPADLVERSNNGS 312 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~~p~~~~~l~~L~~L-~l~~N~l~g~iP~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~l~~ 312 (704)
...++.|++++|+++ .++..+.+..+++.+ ++++|+|+ .||. .|..+++|+.|+|++|+|+...+..|.++.+|+.
T Consensus 152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 229 (242)
T ss_dssp BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred cccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccccc
Confidence 357899999999999 555555556665555 67888999 6765 5889999999999999999443446888888877
Q ss_pred cccc
Q 037258 313 LTLS 316 (704)
Q Consensus 313 l~l~ 316 (704)
|++.
T Consensus 230 l~~~ 233 (242)
T d1xwdc1 230 RSTY 233 (242)
T ss_dssp SSEE
T ss_pred CcCC
Confidence 7653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.00064 Score=70.17 Aligned_cols=71 Identities=11% Similarity=0.102 Sum_probs=46.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEecccc-----------hhhHHHHHHHHHhhc---ccceeEEEEEEEeCCeEEEE
Q 037258 404 RVLGKGGFGEVYHGSLD-DNQQVAVKMLSSS-----------CCFQLLQVKLLMRVH---HRNLTALIGYCIEGNNMGLI 468 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV 468 (704)
+.||.|....||+.... +++.|+||.-... ......|.+.|+.+. ...+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 56899999999999765 4678999964221 113356888877663 2345566654 45566899
Q ss_pred EeecCCCC
Q 037258 469 YEYMASGT 476 (704)
Q Consensus 469 ~e~~~~gs 476 (704)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=3.1e-05 Score=76.69 Aligned_cols=84 Identities=25% Similarity=0.250 Sum_probs=68.6
Q ss_pred CCCceEEEEcCCCCCccc-CchhhccccccceEeccCCcccCCCCcccCCCCCCCeEeccCC-CCCCC-cccccccccCC
Q 037258 234 NPSRIISLNLSSSGLTGE-ISPYFANLTAIEFLDLSNNSLSGTFPEFLSKLPSLRALNLKRN-KLTGS-LPADLVERSNN 310 (704)
Q Consensus 234 ~~~~l~~l~L~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~iP~~~~~l~~L~~l~l~~N-~l~g~-~p~~~~~~~~l 310 (704)
...+|+.|||+++.+++. ++..+.++++|++|+|+++.+++..+..++.+++|+.|+|+++ .++.. +..-+..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 356899999999998865 4566889999999999999999888899999999999999995 56521 23334567899
Q ss_pred Ccccccc
Q 037258 311 GSLTLSV 317 (704)
Q Consensus 311 ~~l~l~~ 317 (704)
+.|++++
T Consensus 124 ~~L~ls~ 130 (284)
T d2astb2 124 DELNLSW 130 (284)
T ss_dssp CEEECCC
T ss_pred ccccccc
Confidence 9998865
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=2.9e-05 Score=69.95 Aligned_cols=69 Identities=28% Similarity=0.315 Sum_probs=50.9
Q ss_pred cccCchhhccccccceEeccCCcccCC--CCcccCCCCCCCeEeccCCCCCCCccc-ccccccCCCccccccC
Q 037258 249 TGEISPYFANLTAIEFLDLSNNSLSGT--FPEFLSKLPSLRALNLKRNKLTGSLPA-DLVERSNNGSLTLSVD 318 (704)
Q Consensus 249 ~g~~p~~~~~l~~L~~L~l~~N~l~g~--iP~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~~~l~~l~l~~~ 318 (704)
...++..+.++++|++|+|++|+|+.. ++..+..|++|+.|+|++|+++ .+++ ......+|+.|+++.|
T Consensus 54 ~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~N 125 (162)
T d1koha1 54 AATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGN 125 (162)
T ss_dssp HHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTS
T ss_pred hhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCC
Confidence 335666667899999999999999942 3455678999999999999999 4554 3333456676666544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.86 E-value=9.3e-05 Score=77.59 Aligned_cols=81 Identities=27% Similarity=0.277 Sum_probs=38.2
Q ss_pred ceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccC----CCCcccC-CCCCCCeEeccCCCCCCC----cccc
Q 037258 237 RIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSG----TFPEFLS-KLPSLRALNLKRNKLTGS----LPAD 303 (704)
Q Consensus 237 ~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~iP~~~~-~l~~L~~l~l~~N~l~g~----~p~~ 303 (704)
+++.|+|++|+|+- .|+..+..+++|+.|||++|.|+. .+...+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 44455555555541 333444555555555665555531 1112221 123455556655555432 3344
Q ss_pred cccccCCCcccccc
Q 037258 304 LVERSNNGSLTLSV 317 (704)
Q Consensus 304 ~~~~~~l~~l~l~~ 317 (704)
+..+++|+.|+++.
T Consensus 108 l~~~~~L~~L~L~~ 121 (460)
T d1z7xw1 108 LRTLPTLQELHLSD 121 (460)
T ss_dssp TTSCTTCCEEECCS
T ss_pred hhcccccccccccc
Confidence 44455555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.63 E-value=0.00012 Score=76.71 Aligned_cols=83 Identities=27% Similarity=0.239 Sum_probs=42.7
Q ss_pred CceEEEEcCCCCCcccCchh----hccccccceEeccCCcccC----CCCcccC-CCCCCCeEeccCCCCCC----Cccc
Q 037258 236 SRIISLNLSSSGLTGEISPY----FANLTAIEFLDLSNNSLSG----TFPEFLS-KLPSLRALNLKRNKLTG----SLPA 302 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~~p~~----~~~l~~L~~L~l~~N~l~g----~iP~~~~-~l~~L~~l~l~~N~l~g----~~p~ 302 (704)
..|+.+++++|.++..-... +....+|++|+|++|+|+. .++..+. ..+.|+.|+|++|+|+. .+++
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 35566666666665432222 2333456666666666543 1333332 24456666666666652 2334
Q ss_pred ccccccCCCccccccC
Q 037258 303 DLVERSNNGSLTLSVD 318 (704)
Q Consensus 303 ~~~~~~~l~~l~l~~~ 318 (704)
.+..+++|++|+|+.|
T Consensus 392 ~l~~~~~L~~L~Ls~N 407 (460)
T d1z7xw1 392 TLLANHSLRELDLSNN 407 (460)
T ss_dssp HHHHCCCCCEEECCSS
T ss_pred HHhcCCCCCEEECCCC
Confidence 4445556666665544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.61 E-value=0.00059 Score=67.08 Aligned_cols=81 Identities=25% Similarity=0.245 Sum_probs=45.9
Q ss_pred CceEEEEcCCC--CCccc-CchhhccccccceEeccCC-cccCCCCcccCCCCCCCeEeccC-CCCCCCcccccccccCC
Q 037258 236 SRIISLNLSSS--GLTGE-ISPYFANLTAIEFLDLSNN-SLSGTFPEFLSKLPSLRALNLKR-NKLTGSLPADLVERSNN 310 (704)
Q Consensus 236 ~~l~~l~L~~n--~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~iP~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~~~~l 310 (704)
+.|+.|+|++. .++.. +..-+.++++|++|+|++| .+++..+..++++++|++|+|++ +.++......+.++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 45666666653 23321 3333345666666666653 45555555666666666666666 35555555556666666
Q ss_pred Cccccc
Q 037258 311 GSLTLS 316 (704)
Q Consensus 311 ~~l~l~ 316 (704)
+.|++.
T Consensus 228 ~~L~l~ 233 (284)
T d2astb2 228 KTLQVF 233 (284)
T ss_dssp CEEECT
T ss_pred CEEeee
Confidence 666554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0031 Score=62.96 Aligned_cols=131 Identities=12% Similarity=0.128 Sum_probs=75.9
Q ss_pred eEEEEEEeCCCcEEEEEecccc---hhhHHHHHHHHHhhccccee--EEE-----EEEEeCCeEEEEEeecCCCCHH---
Q 037258 412 GEVYHGSLDDNQQVAVKMLSSS---CCFQLLQVKLLMRVHHRNLT--ALI-----GYCIEGNNMGLIYEYMASGTLD--- 478 (704)
Q Consensus 412 g~Vy~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~nIv--~l~-----~~~~~~~~~~lV~e~~~~gsL~--- 478 (704)
-.||++..++|+.+++|+.... ......|...+..+....+. ..+ ..+..++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 5899999999999999998654 23556788888877533321 111 1223456678899998764321
Q ss_pred --HH---------hhc----cc---CCCCCHH----------------------HHHHHHHHHHHHHHHHh-cCCCCCce
Q 037258 479 --QY---------LKG----KK---EHMLNWV----------------------ERLQIAVDSAQGLEYLH-YGCKPPIV 517 (704)
Q Consensus 479 --~~---------l~~----~~---~~~l~~~----------------------~~~~i~~~ia~~L~~LH-~~~~~~iv 517 (704)
.+ ++. .. +...++. .....+.++...+.-.- .....++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11 110 00 1111211 11222233333332221 22346789
Q ss_pred ecCCCCCCEEeCCCCcEEEEeccCccc
Q 037258 518 HRDVKSSNILLNEKLQAKIADFGLSRI 544 (704)
Q Consensus 518 H~Dlkp~NIll~~~~~~kL~DfGla~~ 544 (704)
|+|+.+.|||++++ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.27 E-value=0.0038 Score=64.15 Aligned_cols=70 Identities=17% Similarity=0.251 Sum_probs=48.7
Q ss_pred ccccccCceEEEEEEeCCC--------cEEEEEecccch--hhHHHHHHHHHhhcccce-eEEEEEEEeCCeEEEEEeec
Q 037258 404 RVLGKGGFGEVYHGSLDDN--------QQVAVKMLSSSC--CFQLLQVKLLMRVHHRNL-TALIGYCIEGNNMGLIYEYM 472 (704)
Q Consensus 404 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~--~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~ 472 (704)
+.|+.|-.-.+|+....++ +.|.+++..... ....+|..+++.+.-.++ .++++++.+ .+|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 5688888899999977543 567788765322 245678888888854444 477777643 6899999
Q ss_pred CCCCH
Q 037258 473 ASGTL 477 (704)
Q Consensus 473 ~~gsL 477 (704)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.24 E-value=0.00044 Score=69.99 Aligned_cols=83 Identities=22% Similarity=0.315 Sum_probs=49.6
Q ss_pred CceEEEEcCCCCCccc-----CchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEeccCCCCCCCcccccc-
Q 037258 236 SRIISLNLSSSGLTGE-----ISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNLKRNKLTGSLPADLV- 305 (704)
Q Consensus 236 ~~l~~l~L~~n~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l~~N~l~g~~p~~~~- 305 (704)
..|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-...++
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4577777777776531 334566677777777777776532 444566677777777777777643222221
Q ss_pred ---c--ccCCCccccccC
Q 037258 306 ---E--RSNNGSLTLSVD 318 (704)
Q Consensus 306 ---~--~~~l~~l~l~~~ 318 (704)
. ...|..|++++|
T Consensus 266 ~l~~~~~~~L~~L~ls~N 283 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYN 283 (344)
T ss_dssp HHHTCSSCCCCEEECCSS
T ss_pred HhhhccCCCCCEEECCCC
Confidence 1 234566666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.90 E-value=0.0014 Score=58.66 Aligned_cols=42 Identities=38% Similarity=0.498 Sum_probs=18.4
Q ss_pred hccccccceEeccCCcccC----CCCcccCCCCCCCeEeccCCCCC
Q 037258 256 FANLTAIEFLDLSNNSLSG----TFPEFLSKLPSLRALNLKRNKLT 297 (704)
Q Consensus 256 ~~~l~~L~~L~l~~N~l~g----~iP~~~~~l~~L~~l~l~~N~l~ 297 (704)
+...+.|+.|+|++|.+.. .+-..+...+.|+.|+|++|.++
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3444445555555554431 11122333444555555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.90 E-value=0.0011 Score=59.49 Aligned_cols=83 Identities=10% Similarity=0.134 Sum_probs=59.6
Q ss_pred CCceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEeccCCCCCCC-------
Q 037258 235 PSRIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNLKRNKLTGS------- 299 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l~~N~l~g~------- 299 (704)
.+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.++.. +=..+...++|+.|+|++|.+...
T Consensus 43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~ 122 (167)
T d1pgva_ 43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 122 (167)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHH
Confidence 4679999999999974 3344566779999999999999842 233577789999999999977631
Q ss_pred cccccccccCCCcccccc
Q 037258 300 LPADLVERSNNGSLTLSV 317 (704)
Q Consensus 300 ~p~~~~~~~~l~~l~l~~ 317 (704)
+...+...+.|..|++++
T Consensus 123 l~~~L~~n~sL~~l~l~~ 140 (167)
T d1pgva_ 123 MMMAIEENESLLRVGISF 140 (167)
T ss_dssp HHHHHHHCSSCCEEECCC
T ss_pred HHHHHHhCCCccEeeCcC
Confidence 223344455666665544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.76 E-value=0.00098 Score=67.25 Aligned_cols=85 Identities=20% Similarity=0.180 Sum_probs=66.0
Q ss_pred CCceEEEEcCCCCCcc----cCchhhccccccceEeccCCcccCC-----CCcccCCCCCCCeEeccCCCCCCC----cc
Q 037258 235 PSRIISLNLSSSGLTG----EISPYFANLTAIEFLDLSNNSLSGT-----FPEFLSKLPSLRALNLKRNKLTGS----LP 301 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~-----iP~~~~~l~~L~~l~l~~N~l~g~----~p 301 (704)
...|+.|++++|+++. .+...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|.|+.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 4578899999998863 3555677889999999999998732 344577889999999999998633 44
Q ss_pred cccccccCCCccccccCC
Q 037258 302 ADLVERSNNGSLTLSVDG 319 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~~ 319 (704)
..+..+++|+.|+|+.|.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~ 254 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCL 254 (344)
T ss_dssp HHGGGCTTCCEEECTTCC
T ss_pred ccccccccchhhhhhcCc
Confidence 567778889988887654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.71 E-value=0.0061 Score=60.30 Aligned_cols=153 Identities=8% Similarity=0.065 Sum_probs=80.9
Q ss_pred cCHHHHHHHHhhh--c-----ccccccCceEEEEEEeCCCcEEEEEecccch--hhHHHHHHHHHhhccccee--EEEE-
Q 037258 390 FAYSEIQKITNNF--E-----RVLGKGGFGEVYHGSLDDNQQVAVKMLSSSC--CFQLLQVKLLMRVHHRNLT--ALIG- 457 (704)
Q Consensus 390 ~~~~el~~~~~~~--~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~nIv--~l~~- 457 (704)
++.+|+......+ . +.|..|---+.|+...++|+ +++|++.... .+...|++++..+.+.++. ..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence 4455666655443 2 23456666888999887665 8999986532 2445677777777543321 1110
Q ss_pred -----EEEeCCeEEEEEeecCCCCHHH--------------Hhhcc----c---CCCCC------------------HHH
Q 037258 458 -----YCIEGNNMGLIYEYMASGTLDQ--------------YLKGK----K---EHMLN------------------WVE 493 (704)
Q Consensus 458 -----~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~----~---~~~l~------------------~~~ 493 (704)
+.........++.+..+..... .++.. . ..... ...
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1122345566677666533211 00000 0 00000 001
Q ss_pred HHHHHHHHHHHHHHHh-cCCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 037258 494 RLQIAVDSAQGLEYLH-YGCKPPIVHRDVKSSNILLNEKLQAKIADFGLSR 543 (704)
Q Consensus 494 ~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~ 543 (704)
....+..+...+...+ .....++||+|+.++||+++++...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1122222333333333 1336789999999999999988777899999775
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.17 E-value=0.0057 Score=54.39 Aligned_cols=87 Identities=16% Similarity=0.222 Sum_probs=56.1
Q ss_pred CCceEEEEcCC-CCCccc----CchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEeccCCCCCCC----cc
Q 037258 235 PSRIISLNLSS-SGLTGE----ISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNLKRNKLTGS----LP 301 (704)
Q Consensus 235 ~~~l~~l~L~~-n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l~~N~l~g~----~p 301 (704)
.+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35788888887 456432 334456778888888888887642 223355678888888888887633 22
Q ss_pred cccccccCCCccccccCCCC
Q 037258 302 ADLVERSNNGSLTLSVDGNT 321 (704)
Q Consensus 302 ~~~~~~~~l~~l~l~~~~n~ 321 (704)
..+...++++.++|+.++|.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~ 115 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQP 115 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSC
T ss_pred HHHHhCccccEEeeccCCCc
Confidence 34555666776666655544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.17 E-value=0.013 Score=51.79 Aligned_cols=84 Identities=13% Similarity=0.185 Sum_probs=61.8
Q ss_pred CCceEEEEcCCCCCccc----CchhhccccccceEeccCCcccCC----CCcccCCCCCCCeEec--cCCCCCC----Cc
Q 037258 235 PSRIISLNLSSSGLTGE----ISPYFANLTAIEFLDLSNNSLSGT----FPEFLSKLPSLRALNL--KRNKLTG----SL 300 (704)
Q Consensus 235 ~~~l~~l~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----iP~~~~~l~~L~~l~l--~~N~l~g----~~ 300 (704)
.++|+.|+|++|+++.. +-..+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+.. .+
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 46899999999998764 344567789999999999998643 3355778899997555 5677752 24
Q ss_pred ccccccccCCCccccccC
Q 037258 301 PADLVERSNNGSLTLSVD 318 (704)
Q Consensus 301 p~~~~~~~~l~~l~l~~~ 318 (704)
...+...++|..|++.++
T Consensus 125 a~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHCSSCCEEECCCS
T ss_pred HHHHHhCCCcCEEeCcCC
Confidence 445667788888887654
|